<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <script src="https://code.jquery.com/jquery-3.5.1.min.js"></script>
    <!-- <link rel="stylesheet" type="text/css" href="https://cdn.datatables.net/1.10.23/css/jquery.dataTables.min.css"> -->
    <!-- <script src="https://cdn.datatables.net/1.10.23/js/jquery.dataTables.min.js"></script> -->
    <script src="./myscript.js"></script>
    <link rel="stylesheet" type="text/css" href="./style.css">
    <title>b1</title>
</head>

<body>
    <input type="text" id="search-block" placeholder="搜索模块" onkeyup="mysearch()"/>
    <input type="text" id="search-week" placeholder="搜索周" onkeyup="mysearch()"/>
    <input type="text" id="search-grade" placeholder="搜索年级" onkeyup="mysearch()"/>
    <input type="text" id="search-question" placeholder="搜索题干" onkeyup="mysearch()"/>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>模块</th>
      <th>周</th>
      <th>年级</th>
      <th>问题</th>
      <th>答案</th>
      <th>正确答案</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>1. 下列哪种物质不属于第二信使(2.0分)</td>
      <td>A.ACh<br>B.IP3<br>C.Ca2+<br>D.cAMP<br>E.DG</td>
      <td>A.ACh</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>2. 完全由膜固有电学性质而非离子通道激活所引起的电活动是(2.0分)</td>
      <td>A.动作电位<br>B.局部反应<br>C.电紧张电位<br>D.终板电位<br>E.突触后电位</td>
      <td>C.电紧张电位</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>3. 氧和二氧化碳的跨膜转运方式(2.0分)</td>
      <td>A.主动转运<br>B.易化扩散<br>C.单纯扩散<br>D.继发性主动转运<br>E.入胞和出胞作用</td>
      <td>C.单纯扩散</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>4. 如果某细胞兴奋期周期的绝对不应期为2ms，理论上每秒内所能产生和传导的动作电位数最多不超过(2.0分)</td>
      <td>A.B．50次<br>B.A．5次<br>C.C．100次<br>D.D．400次<br>E.E．500次</td>
      <td>E.E．500次</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>5. 允许水溶性小分子和离子等物质在细胞间通讯的结构是(2.0分)</td>
      <td>A.紧密连接<br>B.缝隙连接<br>C.桥粒<br>D.化学性突触<br>E.曲张体</td>
      <td>B.缝隙连接</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>6. 在跨膜物质转运中，转运体和载体转运的主要区别是(2.0分)</td>
      <td>A.转运体转运没有饱和现象<br>B.被转运物完全不同<br>C.转运体可同时转运多种物质<br>D.转运速率有明显差异<br>E.转运体转运需直接耗能</td>
      <td>C.转运体可同时转运多种物质</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>7. 神经细胞动作电位和局部兴奋的共同点是(2.0分)</td>
      <td>A.都有不应期<br>B.反应幅度都随传播距离增大而减小<br>C.都可以叠加或总和<br>D.反应幅度都随刺激强度增大而增大<br>E.都有Na+ 通道的激活</td>
      <td>E.都有Na+ 通道的激活</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>8. 运动神经纤维末梢释放ACh属于(2.0分)</td>
      <td>A.单纯扩散<br>B.主动转运<br>C.易化扩散<br>D.出胞<br>E.入胞</td>
      <td>D.出胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>9. G蛋白是下列何物的简称(2.0分)</td>
      <td>A.鸟苷酸结合蛋白<br>B.腺苷酸结合蛋白<br>C.三磷酸肌醇<br>D.cAMP<br>E.转录调节因子</td>
      <td>A.鸟苷酸结合蛋白</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>10. 神经细胞兴奋性的周期性变化(2.0分)</td>
      <td>A.有效不应期-相对不应期-超常期<br>B.绝对不应期-局部反应期-超常期<br>C.有效不应期-相对不应期-低常期<br>D.绝对不应期-相对不应期-低常期-超常期<br>E.绝对不应期-相对不应期-超常期-低常期</td>
      <td>E.绝对不应期-相对不应期-超常期-低常期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>11. 用来衡量组织兴奋性高低的指标通常是(2.0分)</td>
      <td>A.组织反应强度<br>B.阈刺激<br>C.动作电位频率<br>D.动作电位幅度<br>E.刺激持续时间</td>
      <td>B.阈刺激</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>12. 骨骼肌终板膜上ACh受体阳离子通道与ACh结合而使Na+ 内流远大于K+ 外流，是因为(2.0分)</td>
      <td>A.ACh受体阳离子通道对Na+ 通透性远大于K+<br>B.细胞膜两侧Na+ 浓度差远大于K+ 浓度差<br>C.Na+ 平衡电位距离静息电位较近<br>D.Na+ 的电化学驱动力远大于K+ 的电化学驱动力<br>E.K+ 平衡电位距离静息电位较远</td>
      <td>D.Na+ 的电化学驱动力远大于K+ 的电化学驱动力</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>13. 神经静息电位数值与膜两侧(2.0分)</td>
      <td>A.K+ 浓度差呈反变关系<br>B.Na+ 浓度差呈正变关系<br>C.Na+ 浓度差呈反变关系<br>D.K+ 浓度差呈正变关系<br>E.Ca2+ 浓度差呈反变关系</td>
      <td>D.K+ 浓度差呈正变关系</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>14. 下列哪种物质是鸟苷酸环化酶受体的配体？(2.0分)</td>
      <td>A.ANP<br>B.DA<br>C.ACh<br>D.NA<br>E.IGF</td>
      <td>A.ANP</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>15. 以神经和肌细胞为例，正常时膜内K+ 浓度约为膜外浓度的(2.0分)</td>
      <td>A.B．30倍<br>B.A．12倍<br>C.C．50倍<br>D.D．70倍<br>E.E．90倍</td>
      <td>A.B．30倍</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>16. 以神经和肌细胞为例，正常时膜外的Na+ 浓度约为膜内浓度的(2.0分)</td>
      <td>A.A．2倍<br>B.D．24倍<br>C.C．12倍<br>D.B．6倍<br>E.E．30倍</td>
      <td>C.C．12倍</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>17. 局部反应的空间总和是指(2.0分)</td>
      <td>A.同一部位连续的阈上刺激引起的去极化反应的叠加<br>B.同一时间不同部位的阈下刺激引起的去极化反应的叠加<br>C.同一时间不同部位的阈上刺激引起的去极化反应的叠加<br>D.同一部位连续的阈下刺激引起的去极化反应的叠加<br>E.同一部位一个足够大的刺激引起的去极化反应</td>
      <td>B.同一时间不同部位的阈下刺激引起的去极化反应的叠加</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>18. 神经细胞在静息条件下，电化学驱动力较小的离子是(2.0分)</td>
      <td>A.Na+ 和Cl-<br>B.K+ 和Cl-<br>C.K+ 和Na+<br>D.Na+ 和Ca2+<br>E.K+ 和Ca2+</td>
      <td>B.K+ 和Cl-</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>19. 可兴奋细胞的正后电位是指(2.0分)</td>
      <td>A.锋电位之后的缓慢超极化电位<br>B.静息电位基础上发生的缓慢超极化电位<br>C.锋电位之后的缓慢去极化电位<br>D.静息电位基础上发生的缓慢去极化电位<br>E.锋电位之后的缓慢去极化过程和超极化电位</td>
      <td>A.锋电位之后的缓慢超极化电位</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>20. 神经细胞静息电位的错误论述(2.0分)</td>
      <td>A.数值接近K+ 平衡电位<br>B.膜外正电，膜内负电<br>C.属于细胞内电位<br>D.数值接近Na+ 平衡电位<br>E.不同种类细胞数值不同</td>
      <td>D.数值接近Na+ 平衡电位</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>21. 阈下刺激时膜电位可出现(2.0分)</td>
      <td>A.去极化<br>B.极化<br>C.复极<br>D.超极化<br>E.超射</td>
      <td>A.去极化</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>22. 一般情况下，神经细胞的阈电位值较其静息电位值(2.0分)</td>
      <td>A.大10～20mv<br>B.小，但很接近<br>C.小40～50mv<br>D.小10～20mv<br>E.大40～50mv</td>
      <td>D.小10～20mv</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>23. 关于局部兴奋的错误叙述(2.0分)</td>
      <td>A.无不应期<br>B.属于低幅去极化<br>C.衰减性扩布<br>D.由阈下刺激引起<br>E.开放的Na+ 通道性质不同</td>
      <td>E.开放的Na+ 通道性质不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>24. 在神经轴突膜内外两侧实际测得的静息电位(2.0分)</td>
      <td>A.等于Na+ 的平衡电位<br>B.等于K+ 的平衡电位<br>C.略小于K+ 的平衡电位<br>D.略大于K+ 的平衡电位<br>E.接近于Na+ 的平衡电位</td>
      <td>C.略小于K+ 的平衡电位</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>25. 下列关于神经纤维膜上电压门控Na+ 通道与K+ 通道共同点的描述，错误的是(2.0分)</td>
      <td>A.都有失活状态<br>B.都有关闭状态<br>C.都有激活状态<br>D.都有开放状态<br>E.都有静息状态</td>
      <td>A.都有失活状态</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>26. 当达到K+ 平衡电位时(2.0分)</td>
      <td>A.K+ 的净外电流为零<br>B.膜内电位为正<br>C.膜两侧电位梯度为零<br>D.膜外K+ 浓度高于膜内<br>E.膜两侧K+ 浓度梯度为零</td>
      <td>A.K+ 的净外电流为零</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>27. 神经干动作电位幅度在一定范围内与刺激强度成正变的原因(2.0分)</td>
      <td>A.局部电流不同<br>B.离子通道不同<br>C.全或无定律<br>D.局部电位不同<br>E.各条纤维兴奋性不同</td>
      <td>E.各条纤维兴奋性不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>28. 下列哪项不属于由载体介导的易化扩散的特点(2.0分)</td>
      <td>A.结构特异性<br>B.有竞争性抑制<br>C.有饱和性<br>D.具有电压依赖性<br>E.与膜通道蛋白无关</td>
      <td>D.具有电压依赖性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>29. 神经纤维动作电位去极相中，膜内外两侧电位发生倒转，称为(2.0分)</td>
      <td>A.反极化<br>B.复极化<br>C.超极化<br>D.去极化<br>E.极化</td>
      <td>A.反极化</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>30. 神经细胞在产生动作电位时，去极相的变化方向是朝向下列哪种电位的变化方向(2.0分)</td>
      <td>A.K+ 的平衡电位<br>B.Cl- 的平衡电位<br>C.Ca2+ 的平衡电位<br>D.Na+ 的平衡电位<br>E.有机负离子的平衡电位</td>
      <td>D.Na+ 的平衡电位</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>31. 下列关于神经细胞动作电位复极相形成机制的描述，正确的是(2.0分)</td>
      <td>A.仅因Na+ 通道失活所致<br>B.仅因Cl- 通道激活所致<br>C.由Na+ 通道失活和K+ 通道激活共同所致<br>D.仅因K+ 通道激活所致<br>E.由K+ 通道和Cl- 通道一同激活所致</td>
      <td>C.由Na+ 通道失活和K+ 通道激活共同所致</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>32. 用相同数目的葡萄糖分子替代浸浴液中的Na+ 后，神经纤维动作电位的幅度将(2.0分)</td>
      <td>A.逐渐增大<br>B.基本不变<br>C.逐渐减小<br>D.先增大后减小<br>E.先减小后增大</td>
      <td>C.逐渐减小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>33. 增加离体神经纤维浸浴液中的Na+ 浓度，则单根神经纤维动作电位的超射值将(2.0分)</td>
      <td>A.减小<br>B.增大<br>C.不变<br>D.先增大后减小<br>E.先减小后增大</td>
      <td>B.增大</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>34. 神经轴突经河豚毒素处理后，其生物电的改变为(2.0分)</td>
      <td>A.静息电位值不变，动作电位幅度减小<br>B.静息电位值减小，动作电位幅度减小<br>C.静息电位值加大，动作电位幅度加大<br>D.静息电位值减小，动作电位幅度加大<br>E.静息电位值加大，动作电位幅度减小</td>
      <td>A.静息电位值不变，动作电位幅度减小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>35. 神经细胞膜对Na+ 通透性增加时，静息电位将(2.0分)</td>
      <td>A.减小<br>B.不变<br>C.先增大后减小<br>D.增大<br>E.先减小后增大</td>
      <td>A.减小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>36. 低温、缺氧或代谢抑制剂影响细胞的Na+-K+ 泵活动时，生物电的改变为(2.0分)</td>
      <td>A.静息电位值减小，动作电位幅度减小<br>B.静息电位值减小，动作电位幅度增大<br>C.静息电位值增大，动作电位幅度增大<br>D.静息电位值增大，动作电位幅度减小<br>E.静息电位值和动作电位幅度均不改变</td>
      <td>A.静息电位值减小，动作电位幅度减小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>37. 神经纤维上前后两个紧接的锋电位，其中后一锋电位最早见于前一锋电位兴奋性周期的(2.0分)</td>
      <td>A.超常期<br>B.相对不应期<br>C.绝对不应期<br>D.低常期<br>E.低常期之后</td>
      <td>B.相对不应期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>38. 生理学所说的可兴奋组织(2.0分)</td>
      <td>A.仅指肌肉<br>B.仅指腺体<br>C.包括神经和腺体<br>D.仅指神经<br>E.包括神经、肌肉和腺体</td>
      <td>E.包括神经、肌肉和腺体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>39. 某肌细胞静息电位为－7OmV，当变为＋20mV时称为(2.0分)</td>
      <td>A.反极化<br>B.去极化<br>C.超极化<br>D.极化<br>E.复极化</td>
      <td>A.反极化</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>40. 刺激是(2.0分)</td>
      <td>A.外环境的变化<br>B.生物体感受的环境变化<br>C.内环境的变化<br>D.引起机体抑制的环境变化<br>E.引起机体兴奋的环境变化</td>
      <td>B.生物体感受的环境变化</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>41. 安静时细胞膜内K+ 向膜外移动是通过(2.0分)</td>
      <td>A.易化扩散<br>B.出胞<br>C.单纯扩散<br>D.主动转运<br>E.入胞</td>
      <td>A.易化扩散</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>42. 葡萄糖进入红细胞属于(2.0分)</td>
      <td>A.单纯扩散<br>B.出胞<br>C.主动转运<br>D.易化扩散<br>E.入胞</td>
      <td>D.易化扩散</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>43. 神经细胞在一次兴奋后，阈值最低的时期是(2.0分)</td>
      <td>A.绝对不应期<br>B.相对不应期<br>C.低常期<br>D.超常期<br>E.兴奋性恢复正常后</td>
      <td>D.超常期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>44. 在可兴奋细胞，能以不衰减的形式在细胞膜上传导的电活动是(2.0分)</td>
      <td>A.静息电位<br>B.动作电位<br>C.终板电位<br>D.感受器电位<br>E.突触后电位</td>
      <td>B.动作电位</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>45. 在心肌、平滑肌的同步性收缩中起重要作用的结构是(2.0分)</td>
      <td>A.桥粒<br>B.紧密连接<br>C.缝隙连接<br>D.化学性突触<br>E.曲张体</td>
      <td>C.缝隙连接</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>46. ACh在骨骼肌终板膜上实现跨膜信号转导的结构属于(2.0分)</td>
      <td>A.酶耦联受体<br>B.电压门控通道<br>C.机械门控通道<br>D.化学门控通道<br>E.G蛋白耦联受体</td>
      <td>D.化学门控通道</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>47. 在膜蛋白的帮助下，某些蛋白质分子选择性地进入细胞的物质跨膜转运方式是(2.0分)</td>
      <td>A.继发性主动转运<br>B.原发性主动转运<br>C.经载体易化扩散<br>D.受体介导入胞<br>E.液相入胞</td>
      <td>D.受体介导入胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>48. 神经细胞动作电位的主要组成(2.0分)</td>
      <td>A.阈电位<br>B.锋电位<br>C.负后电位<br>D.局部电位<br>E.正后电位</td>
      <td>B.锋电位</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>49. 通道扩散的特点(2.0分)</td>
      <td>A.消耗化学能<br>B.逆浓度梯度<br>C.转运小分子物质<br>D.转运脂溶性物质<br>E.无选择性</td>
      <td>C.转运小分子物质</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2007</td>
      <td>50. 有髓神经纤维的传导特点(2.0分)</td>
      <td>A.传导速度慢<br>B.跳跃式传导<br>C.单向传导<br>D.衰减性传导<br>E.电缆式传导</td>
      <td>B.跳跃式传导</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>1. 下述中，关于像素和体素的不准确的概念是哪项(2.0分)</td>
      <td>A.CT图像的基本组成单元称为体素<br>B.像素大小与图像的分辨率高低成反比<br>C.体素是一个三维概念<br>D.体素是被矩阵排列分隔的基本成像单元<br>E.像素实际上是体素在成像时的表现</td>
      <td>A.CT图像的基本组成单元称为体素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>2. CT探测器的作用是(2.0分)</td>
      <td>A.探测中心线是否准直<br>B.探测病人位置是否准确<br>C.探测扫描时散射线是多少<br>D.探测透过射线以获得正确曝光量<br>E.探测透过射线以获得测量数据</td>
      <td>E.探测透过射线以获得测量数据</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>3. 某县历年流脑发病率均在12/10万~20/10万之间,去年该县流脑发病率为16/10万,试判断其流行强度： (2.0分)</td>
      <td>A.散发<br>B.暴发<br>C.流行<br>D.大流行<br>E.以上均不对</td>
      <td>A.散发</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>4. 下列哪一种传染病一般呈严格的季节性： (2.0分)</td>
      <td>A.虫媒传染病<br>B.寄生虫病<br>C.呼吸道传染病<br>D.肠道传染病<br>E.血液传染病</td>
      <td>A.虫媒传染病</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>5. 某地共有居民200000人，2003年罹患SARS 20人,其中死亡1人，该地2003年SARS的（）为5%。(2.0分)</td>
      <td>A.发病率<br>B.病死率<br>C.患病率<br>D.罹患率<br>E.以上都不对</td>
      <td>B.病死率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>6. 某社区共有居民500人，2009年4月新发甲型H1N1流感病例10人，截至2009年6月底，共有甲型H1N1流感病例50人，则该社区2009年4月甲型H1N1流感发病率为2%，2009年上半年（）为10%。(2.0分)</td>
      <td>A.发病率<br>B.病死率<br>C.患病率<br>D.罹患率<br>E.死亡率</td>
      <td>C.患病率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>7. 下列那条染色体是中着丝粒染色体： (2.0分)</td>
      <td>A.1号染色体<br>B. 4号染色体<br>C. X染色体<br>D.21号粒染色体</td>
      <td>A.1号染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>8. 通过人类染色体制备及核型分析可用来检测那种遗传突变？ (2.0分)</td>
      <td>A.. 点突变<br>B. 移码突变<br>C. 21三体<br>D.线粒体突变</td>
      <td>C. 21三体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>9. SSCP不适合检测的突变类型是： (2.0分)</td>
      <td>A.已知单碱基突变<br>B.碱基置换<br>C.未知单碱基突变<br>D.外显子缺失突变</td>
      <td>D.外显子缺失突变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>10. 若发现视野没有分裂相，二个主要原因有： (2.0分)</td>
      <td>A.秋水仙素浓度或处理时间不合适<br>B.胰酶消化时间过长<br>C.Giemsa染色时间不够<br>D.低渗时间太短</td>
      <td>A.秋水仙素浓度或处理时间不合适</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>11. PCR产物大小由下列哪种因素决定： (2.0分)</td>
      <td>A.模板量<br>B.退火温度<br>C.引物序列<br>D.变性温度</td>
      <td>C.引物序列</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>12. PCR产物特异性不高时，需要： (2.0分)</td>
      <td>A.降低退火温度<br>B.增加引物和Taq DNA聚合酶的浓度<br>C.改变Mg++浓度<br>D.增加退火时间及延伸时间</td>
      <td>C.改变Mg++浓度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>13. The TATA box is located in the (2.0分)</td>
      <td>A.Splice enhancer.<br>B.Intron-exon border.<br>C.Promoter<br>D.Poly-A addition site.<br>E.Cap site.</td>
      <td>C.Promoter</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>14. The splice donor is located (2.0分)</td>
      <td>A.At the promoter.<br>B.At the 5' end of the intron.<br>C.At the branch point of the intron.<br>D.At the 3' end of the intron.<br>E.At the enhancer.</td>
      <td>B.At the 5' end of the intron.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>15. A nonsense mutation involves (2.0分)</td>
      <td>A.a regulatory sequence.<br>B.an AG splice acceptor site.<br>C.the creation of a different amino acid.<br>D.the creation of a stop codon.<br>E.the creation of the same amino acid.</td>
      <td>D.the creation of a stop codon.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>16. An example of genomic imprinting is (2.0分)</td>
      <td>A.Covalent modification of histones<br>B.Differentiation of cells to form a specific tissue<br>C.Mosaicism<br>D.Paternal X inactivation</td>
      <td>D.Paternal X inactivation</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>17. The carrier frequency for the autosomal recessive disorder Tay-Sachs disease in the Ashkenazi Jewish population is approximately 1 in 30. Which of the following population genetic forces could explain the high carrier frequency in this population, relative to other US populations? (2.0分)</td>
      <td>A.heterozygote advantage<br>B.genetic drift<br>C.high mutation rate<br>D.A and B<br>E.B and C</td>
      <td>D.A and B</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>18. In a Robertsonian translocation fusion occurs at the: (2.0分)</td>
      <td>A.telomeres.<br>B.centromeres.<br>C.histones.<br>D.ends of the long arms.<br>E.Middle of the long arms.</td>
      <td>B.centromeres.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>19. The cause of Down syndrome is known to be(2.0分)</td>
      <td>A.a pituitary（垂体）deficiency<br>B.the presence of one extra sex chromosome<br>C.the presence of one extra autosome<br>D.the absence of one autosome<br>E.a pair of recessive genes</td>
      <td>C.the presence of one extra autosome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>20. The presence of two or more cell lines from different zygotes in a single individual is known as: (2.0分)</td>
      <td>A.mosaicism.<br>B.diploidy. （二倍体）<br>C.aneuploidy.（非整倍体）<br>D.euploidy. （整倍体）<br>E.chimaerism.</td>
      <td>E.chimaerism.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>21. Which of the following is an example of monosomy? (2.0分)</td>
      <td>A.46,XX<br>B.47,XXX<br>C.69,XYY<br>D.45,X<br>E.46,XX,5p-</td>
      <td>D.45,X</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>22. Which of the following statements is true of X inactivation? (2.0分)</td>
      <td>A.The paternal X is always inactive in female somatic cells<br>B.Because of X inactivation, males with an XXY genotype have no apparent phenotype<br>C.The entire inactivated X chromosome is transcriptionally silent<br>D.There will be two Barr bodies in each somatic cell of an XXX female<br>E.X inactivation hypothesis was first proposed by Francis Collins</td>
      <td>D.There will be two Barr bodies in each somatic cell of an XXX female</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>23. In a condition such as hypertension the recurrence risk will be greatest for which of the following relatives of an affected individual? (2.0分)</td>
      <td>A.Brother<br>B.Nephew<br>C.Grandchild<br>D.Aunt<br>E.Grandchild's child</td>
      <td>A.Brother</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>24. The proportion of genes shared by first cousins is on average ___. (2.0分)</td>
      <td>A.1/2<br>B.1/4<br>C.1/8<br>D.1/16<br>E.1/32</td>
      <td>C.1/8</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>25. A study of a disorder reveals that monozygotic twins are concordant 40% of the time, whereas full siblings are concordant 10% of the time. Which of the following is the best interpretation of this finding? (2.0分)</td>
      <td>A.The trait has no genetic component.<br>B.The trait is completely determined by genetics.<br>C.The trait is completely determined by environmental factors..<br>D.Genes contribute to the trait, but are not deterministic.<br>E.The trait must be due to the biology of twinning.</td>
      <td>D.Genes contribute to the trait, but are not deterministic.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>26. A case-control association study indicates a 1.6 fold relative risk of diabetes in individuals who carry a specific allele. What is the most reasonable interpretation of this result? (2.0分)</td>
      <td>A.The allele causes the trait in the study population.<br>B.The allele may not cause the trait, but the gene does cause the trait in the study population.<br>C.The allele is closely linked to another allele that causes the trait in the study population.<br>D.There is an association between the allele and expressing the trait in the population that was studied.<br>E.No association exists between the allele and diabetes in the study population.</td>
      <td>D.There is an association between the allele and expressing the trait in the population that was studied.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>27. Both of Mary's sons have the X-linked disorder Duchenne muscular dystrophy. A deletion in the DMD gene is found in each of the boys, but no mutation in DMD is found when a blood sample from Mary is analyzed. What is the most likely explanation? (2.0分)</td>
      <td>A.The boys were affected by separate mutation events in DMD<br>B.The mutation was inherited from the boys' father<br>C.Mary is germline mosaic for a DMD deletion<br>D. The phenotype is not penetrant in Mary<br>E.The phenotype is X-linked recessive</td>
      <td>C.Mary is germline mosaic for a DMD deletion</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>28. Which inheritance pattern best describes the pedigree shown here? (2.0分)</td>
      <td>A.AD<br>B.AR<br>C.XD<br>D.XR<br>E.Mitochodrial</td>
      <td>D.XR</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>29. Male to male transmission is a key feature of which pattern of inheritance? (2.0分)</td>
      <td>A.AD<br>B.AR<br>C.XD<br>D.XR<br>E.Mitochodrial</td>
      <td>A.AD</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>30. Which of the following disorders does NOT show X-linked inheritance? (2.0分)</td>
      <td>A.Duchenne muscular dystrophy<br>B.Tay-Sachs disease<br>C.Hemophilia A<br>D.Hemophilia B<br>E.Red-green blindness</td>
      <td>B.Tay-Sachs disease</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>31. Leber hereditary optic atrophy (LHON) is caused by a mutation in: (2.0分)</td>
      <td>A.chromosome 13.<br>B.chromosome 18.<br>C.chromosome 21.<br>D.chromosome 5.<br>E.mitochondrial DNA.</td>
      <td>E.mitochondrial DNA.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>32. A dominantly inherited trait affects a child and his grandmother, but neither parent. This best illustrates which of the following principles? (2.0分)</td>
      <td>A.Variable expressivity.<br>B.New mutation.<br>C.Somatic mosaicism.<br>D.Non-penetrance<br>E.Genomic imprinting</td>
      <td>D.Non-penetrance</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>33. Two parents with autosomal recessive albinism have a child who does not have albinism. This is best explained by: (2.0分)</td>
      <td>A.An incorrect diagnosis in one parent.<br>B.Misattributed paternity.（亲子关系出错）<br>C.Genetic heterogeneity.<br>D.Reversion of one of the mutant alleles to wild type.<br>E.Pleiotropy.</td>
      <td>C.Genetic heterogeneity.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>34. A thalassemia is a hemoglobin disorder in which (2.0分)</td>
      <td>A.The beta-globin chain is present at normal levels but is misfolded<br>B.Any globin chain is present at normal levels but is misfolded<br>C.The beta-globin chain is absent or is present at reduced levels<br>D.Any globin chain is absent or is present at reduced levels<br>E.Either B or D is true, depending upon the type of thalassemia</td>
      <td>D.Any globin chain is absent or is present at reduced levels</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>35. The presence of genes in the same chromosome is an example of (2.0分)</td>
      <td>A.Linkage<br>B.Coordination<br>C.Free assortment<br>D.Segregations<br>E.Fusion</td>
      <td>A.Linkage</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>36. Why might a woman opt for chrionic villus sampling (CVS) over amniocentesis for prenatal diagnosis？ (2.0分)</td>
      <td>A.It is more accurate than amniocentesis.<br>B.There are much lower complication rates for CVS.<br>C.It can be performed earlier in gestation.<br>D.More doctors are trained to perform CVS than amniocentesis.<br>E.More genetic disorders can be found by CVS than by amniocentesis.</td>
      <td>C.It can be performed earlier in gestation.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>37. The risk for miscarriage associated with amniocentesis is approximately ____. (2.0分)</td>
      <td>A.1/10<br>B.1/50<br>C.1/100 - 1/200<br>D.1/1000<br>E.1/3000</td>
      <td>C.1/100 - 1/200</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>38. Availability of DNA testing for many single disease traits has allowed routine prenatal screening of couples for disorders prevalent in their ethnic group. Which of the following genetic disorders has a similar incidence in different ethnic groups and would not be subject to different criteria for screening? (2.0分)</td>
      <td>A.Cystic fibrosis<br>B.Thalassemias<br>C.Tay-Sachs disease<br>D.Down syndrome<br>E.Huntington disease</td>
      <td>D.Down syndrome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>39. Which of the following techniques was NOT used to detect an unknown mutation? (2.0分)</td>
      <td>A.SSCP<br>B.ASO<br>C.DHPLC<br>D.DGGE<br>E.DNA sequencing</td>
      <td>B.ASO</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>40. Which of the following prenatal diagnostic techniques routinely allows fetal chromosomes to be analyzed during first trimester of pregnancy? (2.0分)</td>
      <td>A. Cordocentesis<br>B.Amniocentesis<br>C.Chorionic villus sampling<br>D.Radiography<br>E.Maternal triple testing</td>
      <td>C.Chorionic villus sampling</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>41. In the gene chip illustrated above, a cDNA library made from a control, unaffected individual has been labelled with a green probe and a cDNA library made from a patient has been labelled with a red probe. Based upon the color of the spots labelled A, B, and C, we can conclude which of the following relationships? (2.0分)</td>
      <td>A.Gene B is expressed at a higher level and gene A at a lower level in the patient than in the control, and gene C is expressed at the same level in both people.<br>B.The mRNA from gene A is degraded more rapidly and that from gene B less rapidly in the patient than the control, but the mRNA from gene C is equally stable for both individuals.<br>C.Gene B is expressed at a higher level and gene A at a lower level in the patient than the control, and gene C is not present at all in the patient.<br>D.The mRNA from gene A is degraded more rapidly and that from gene B less rapidly in the patient than the control, and the mRNA from gene C is not present at all in the patient.<br>E.Either A or B</td>
      <td>E.Either A or B</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>42. In the beta-thalassemia case presented in the first week, one might imagine that an embryonic stem cell transplant might cure 何尼科. Where would one obtain such cells? (2.0分)</td>
      <td>A.From the umbilicord cord blood（脐带血）<br>B.From the chorion（绒毛膜）<br>C.From the inner cell mass of the blastocyst（胚泡的内细胞团）<br>D.From the syncytiotrophoblast（合体滋养层）<br>E.From the white blood cells</td>
      <td>C.From the inner cell mass of the blastocyst（胚泡的内细胞团）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>43. Why might a woman opt for chrionic villus sampling (CVS) over amniocentesis for prenatal diagnosis？ (2.0分)</td>
      <td>A.It is more accurate than amniocentesis.<br>B.There are much lower complication rates for CVS.<br>C.It can be performed earlier in gestation.<br>D.More doctors are trained to perform CVS than amniocentesis.<br>E.More genetic disorders can be found by CVS than by amniocentesis.</td>
      <td>C.It can be performed earlier in gestation.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>44. Why might a woman opt for chrionic villus sampling (CVS) over amniocentesis for prenatal diagnosis？ (2.0分)</td>
      <td>A.It is more accurate than amniocentesis.<br>B.There are much lower complication rates for CVS.<br>C.It can be performed earlier in gestation.<br>D.More doctors are trained to perform CVS than amniocentesis.<br>E.More genetic disorders can be found by CVS than by amniocentesis.</td>
      <td>C.It can be performed earlier in gestation.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>45. Which of the following properties would a single nucleotide polymorphism (SNP) have to be detected by Southern blot? (2.0分)</td>
      <td>A.It must alter the encoded amino acid sequence<br>B.It must alter a splice site<br>C.It must alter a restriction site<br>D.It must be a nonsense mutation<br>E.It must alter the stability of the encoded mRNA</td>
      <td>C.It must alter a restriction site</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>46. Becky is a 7-day-old infant who has phenylketonuria. Her parents have come to you for advice on managing her condition. Which of the following statements most accurately describes the best management for this disorder? (2.0分)</td>
      <td>A.All protein must be eliminated from the diet.<br>B.A protein-restricted diet must be followed.<br>C.A high-protein diet in a pregnant mother causes phenylketonuria.<br>D.A high-protein diet must be followed<br>E.A high-protein diet must be followed.</td>
      <td>B.A protein-restricted diet must be followed.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>47. Advantages of using adenoviruses for gene therapy include: (2.0分)</td>
      <td>A.long term expression.<br>B.short term expression.<br>C.low risk of insertional mutagenesis.<br>D.low immunogenecity.<br>E.easy assembly.</td>
      <td>C.low risk of insertional mutagenesis.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>48. Which of the following is the usual treatment of hemophilia A? (2.0分)</td>
      <td>A.Blood transfusion<br>B.Liver transplant<br>C.Bone marrow transplant<br>D.Infusion of factor VIII as needed<br>E.Spleen transplant</td>
      <td>D.Infusion of factor VIII as needed</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>49. Which of the following gene-therapy vectors preferentially infects nerve cells? (2.0分)</td>
      <td>A.Adeno-associated virus<br>B.Retrovirus<br>C.Herpes virus<br>D.Adenovirus<br>E.Liposome</td>
      <td>C.Herpes virus</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2010</td>
      <td>50. Which of the following vectors targets both dividing and non-dividing cells? (2.0分)</td>
      <td>A.Retrovirus<br>B.Adenovirus<br>C.Adeno-associated virus<br>D.Herpes virus<br>E.Liposome</td>
      <td>B.Adenovirus</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>1. 下述中，关于像素和体素的不准确的概念是哪项(2.0分)</td>
      <td>A.CT图像的基本组成单元称为体素<br>B.像素大小与图像的分辨率高低成反比<br>C.体素是一个三维概念<br>D.体素是被矩阵排列分隔的基本成像单元<br>E.像素实际上是体素在成像时的表现</td>
      <td>A.CT图像的基本组成单元称为体素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>2. CT探测器的作用是(2.0分)</td>
      <td>A.探测中心线是否准直<br>B.探测病人位置是否准确<br>C.探测扫描时散射线是多少<br>D.探测透过射线以获得正确曝光量<br>E.探测透过射线以获得测量数据</td>
      <td>E.探测透过射线以获得测量数据</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>3. 某县历年流脑发病率均在12/10万~20/10万之间,去年该县流脑发病率为16/10万,试判断其流行强度： (2.0分)</td>
      <td>A.散发<br>B.暴发<br>C.流行<br>D.大流行<br>E.以上均不对</td>
      <td>A.散发</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>4. 下列哪一种传染病一般呈严格的季节性： (2.0分)</td>
      <td>A.虫媒传染病<br>B.寄生虫病<br>C.呼吸道传染病<br>D.肠道传染病<br>E.血液传染病</td>
      <td>A.虫媒传染病</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>5. 某地共有居民200000人，2003年罹患SARS 20人,其中死亡1人，该地2003年SARS的（）为5%。(2.0分)</td>
      <td>A.发病率<br>B.病死率<br>C.患病率<br>D.罹患率<br>E.以上都不对</td>
      <td>B.病死率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>6. 某社区共有居民500人，2009年4月新发甲型H1N1流感病例10人，截至2009年6月底，共有甲型H1N1流感病例50人，则该社区2009年4月甲型H1N1流感发病率为2%，2009年上半年（）为10%。(2.0分)</td>
      <td>A.发病率<br>B.病死率<br>C.患病率<br>D.罹患率<br>E.死亡率</td>
      <td>C.患病率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>7. 下列那条染色体是中着丝粒染色体： (2.0分)</td>
      <td>A.1号染色体<br>B. 4号染色体<br>C. X染色体<br>D.21号粒染色体</td>
      <td>A.1号染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>8. 通过人类染色体制备及核型分析可用来检测那种遗传突变？ (2.0分)</td>
      <td>A.. 点突变<br>B. 移码突变<br>C. 21三体<br>D.线粒体突变</td>
      <td>C. 21三体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>9. SSCP不适合检测的突变类型是： (2.0分)</td>
      <td>A.已知单碱基突变<br>B.碱基置换<br>C.未知单碱基突变<br>D.外显子缺失突变</td>
      <td>D.外显子缺失突变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>10. 若发现视野没有分裂相，二个主要原因有： (2.0分)</td>
      <td>A.秋水仙素浓度或处理时间不合适<br>B.胰酶消化时间过长<br>C.Giemsa染色时间不够<br>D.低渗时间太短</td>
      <td>A.秋水仙素浓度或处理时间不合适</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>11. PCR产物大小由下列哪种因素决定： (2.0分)</td>
      <td>A.模板量<br>B.退火温度<br>C.引物序列<br>D.变性温度</td>
      <td>C.引物序列</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>12. PCR产物特异性不高时，需要： (2.0分)</td>
      <td>A.降低退火温度<br>B.增加引物和Taq DNA聚合酶的浓度<br>C.改变Mg++浓度<br>D.增加退火时间及延伸时间</td>
      <td>C.改变Mg++浓度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>13. The TATA box is located in the (2.0分)</td>
      <td>A.Splice enhancer.<br>B.Intron-exon border.<br>C.Promoter<br>D.Poly-A addition site.<br>E.Cap site.</td>
      <td>C.Promoter</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>14. The splice donor is located (2.0分)</td>
      <td>A.At the promoter.<br>B.At the 5' end of the intron.<br>C.At the branch point of the intron.<br>D.At the 3' end of the intron.<br>E.At the enhancer.</td>
      <td>B.At the 5' end of the intron.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>15. A nonsense mutation involves (2.0分)</td>
      <td>A.a regulatory sequence.<br>B.an AG splice acceptor site.<br>C.the creation of a different amino acid.<br>D.the creation of a stop codon.<br>E.the creation of the same amino acid.</td>
      <td>D.the creation of a stop codon.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>16. An example of genomic imprinting is (2.0分)</td>
      <td>A.Covalent modification of histones<br>B.Differentiation of cells to form a specific tissue<br>C.Mosaicism<br>D.Paternal X inactivation</td>
      <td>D.Paternal X inactivation</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>17. The carrier frequency for the autosomal recessive disorder Tay-Sachs disease in the Ashkenazi Jewish population is approximately 1 in 30. Which of the following population genetic forces could explain the high carrier frequency in this population, relative to other US populations? (2.0分)</td>
      <td>A.heterozygote advantage<br>B.genetic drift<br>C.high mutation rate<br>D.A and B<br>E.B and C</td>
      <td>D.A and B</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>18. In a Robertsonian translocation fusion occurs at the: (2.0分)</td>
      <td>A.telomeres.<br>B.centromeres.<br>C.histones.<br>D.ends of the long arms.<br>E.Middle of the long arms.</td>
      <td>B.centromeres.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>19. The cause of Down syndrome is known to be(2.0分)</td>
      <td>A.a pituitary（垂体）deficiency<br>B.the presence of one extra sex chromosome<br>C.the presence of one extra autosome<br>D.the absence of one autosome<br>E.a pair of recessive genes</td>
      <td>C.the presence of one extra autosome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>20. The presence of two or more cell lines from different zygotes in a single individual is known as: (2.0分)</td>
      <td>A.mosaicism.<br>B.diploidy. （二倍体）<br>C.aneuploidy.（非整倍体）<br>D.euploidy. （整倍体）<br>E.chimaerism.</td>
      <td>E.chimaerism.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>21. Which of the following is an example of monosomy? (2.0分)</td>
      <td>A.46,XX<br>B.47,XXX<br>C.69,XYY<br>D.45,X<br>E.46,XX,5p-</td>
      <td>D.45,X</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>22. Which of the following statements is true of X inactivation? (2.0分)</td>
      <td>A.The paternal X is always inactive in female somatic cells<br>B.Because of X inactivation, males with an XXY genotype have no apparent phenotype<br>C.The entire inactivated X chromosome is transcriptionally silent<br>D.There will be two Barr bodies in each somatic cell of an XXX female<br>E.X inactivation hypothesis was first proposed by Francis Collins</td>
      <td>D.There will be two Barr bodies in each somatic cell of an XXX female</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>23. In a condition such as hypertension the recurrence risk will be greatest for which of the following relatives of an affected individual? (2.0分)</td>
      <td>A.Brother<br>B.Nephew<br>C.Grandchild<br>D.Aunt<br>E.Grandchild's child</td>
      <td>A.Brother</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>24. The proportion of genes shared by first cousins is on average ___. (2.0分)</td>
      <td>A.1/2<br>B.1/4<br>C.1/8<br>D.1/16<br>E.1/32</td>
      <td>C.1/8</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>25. A study of a disorder reveals that monozygotic twins are concordant 40% of the time, whereas full siblings are concordant 10% of the time. Which of the following is the best interpretation of this finding? (2.0分)</td>
      <td>A.The trait has no genetic component.<br>B.The trait is completely determined by genetics.<br>C.The trait is completely determined by environmental factors..<br>D.Genes contribute to the trait, but are not deterministic.<br>E.The trait must be due to the biology of twinning.</td>
      <td>D.Genes contribute to the trait, but are not deterministic.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>26. A case-control association study indicates a 1.6 fold relative risk of diabetes in individuals who carry a specific allele. What is the most reasonable interpretation of this result? (2.0分)</td>
      <td>A.The allele causes the trait in the study population.<br>B.The allele may not cause the trait, but the gene does cause the trait in the study population.<br>C.The allele is closely linked to another allele that causes the trait in the study population.<br>D.There is an association between the allele and expressing the trait in the population that was studied.<br>E.No association exists between the allele and diabetes in the study population.</td>
      <td>D.There is an association between the allele and expressing the trait in the population that was studied.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>27. Both of Mary's sons have the X-linked disorder Duchenne muscular dystrophy. A deletion in the DMD gene is found in each of the boys, but no mutation in DMD is found when a blood sample from Mary is analyzed. What is the most likely explanation? (2.0分)</td>
      <td>A.The boys were affected by separate mutation events in DMD<br>B.The mutation was inherited from the boys' father<br>C.Mary is germline mosaic for a DMD deletion<br>D. The phenotype is not penetrant in Mary<br>E.The phenotype is X-linked recessive</td>
      <td>C.Mary is germline mosaic for a DMD deletion</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>28. Which inheritance pattern best describes the pedigree shown here? (2.0分)</td>
      <td>A.AD<br>B.AR<br>C.XD<br>D.XR<br>E.Mitochodrial</td>
      <td>D.XR</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>29. Male to male transmission is a key feature of which pattern of inheritance? (2.0分)</td>
      <td>A.AD<br>B.AR<br>C.XD<br>D.XR<br>E.Mitochodrial</td>
      <td>A.AD</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>30. Which of the following disorders does NOT show X-linked inheritance? (2.0分)</td>
      <td>A.Duchenne muscular dystrophy<br>B.Tay-Sachs disease<br>C.Hemophilia A<br>D.Hemophilia B<br>E.Red-green blindness</td>
      <td>B.Tay-Sachs disease</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>31. Leber hereditary optic atrophy (LHON) is caused by a mutation in: (2.0分)</td>
      <td>A.chromosome 13.<br>B.chromosome 18.<br>C.chromosome 21.<br>D.chromosome 5.<br>E.mitochondrial DNA.</td>
      <td>E.mitochondrial DNA.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>32. A dominantly inherited trait affects a child and his grandmother, but neither parent. This best illustrates which of the following principles? (2.0分)</td>
      <td>A.Variable expressivity.<br>B.New mutation.<br>C.Somatic mosaicism.<br>D.Non-penetrance<br>E.Genomic imprinting</td>
      <td>D.Non-penetrance</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>33. Two parents with autosomal recessive albinism have a child who does not have albinism. This is best explained by: (2.0分)</td>
      <td>A.An incorrect diagnosis in one parent.<br>B.Misattributed paternity.（亲子关系出错）<br>C.Genetic heterogeneity.<br>D.Reversion of one of the mutant alleles to wild type.<br>E.Pleiotropy.</td>
      <td>C.Genetic heterogeneity.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>34. A thalassemia is a hemoglobin disorder in which (2.0分)</td>
      <td>A.The beta-globin chain is present at normal levels but is misfolded<br>B.Any globin chain is present at normal levels but is misfolded<br>C.The beta-globin chain is absent or is present at reduced levels<br>D.Any globin chain is absent or is present at reduced levels<br>E.Either B or D is true, depending upon the type of thalassemia</td>
      <td>D.Any globin chain is absent or is present at reduced levels</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>35. The presence of genes in the same chromosome is an example of (2.0分)</td>
      <td>A.Linkage<br>B.Coordination<br>C.Free assortment<br>D.Segregations<br>E.Fusion</td>
      <td>A.Linkage</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>36. Why might a woman opt for chrionic villus sampling (CVS) over amniocentesis for prenatal diagnosis？ (2.0分)</td>
      <td>A.It is more accurate than amniocentesis.<br>B.There are much lower complication rates for CVS.<br>C.It can be performed earlier in gestation.<br>D.More doctors are trained to perform CVS than amniocentesis.<br>E.More genetic disorders can be found by CVS than by amniocentesis.</td>
      <td>C.It can be performed earlier in gestation.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>37. The risk for miscarriage associated with amniocentesis is approximately ____. (2.0分)</td>
      <td>A.1/10<br>B.1/50<br>C.1/100 - 1/200<br>D.1/1000<br>E.1/3000</td>
      <td>C.1/100 - 1/200</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>38. Availability of DNA testing for many single disease traits has allowed routine prenatal screening of couples for disorders prevalent in their ethnic group. Which of the following genetic disorders has a similar incidence in different ethnic groups and would not be subject to different criteria for screening? (2.0分)</td>
      <td>A.Cystic fibrosis<br>B.Thalassemias<br>C.Tay-Sachs disease<br>D.Down syndrome<br>E.Huntington disease</td>
      <td>D.Down syndrome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>39. Which of the following techniques was NOT used to detect an unknown mutation? (2.0分)</td>
      <td>A.SSCP<br>B.ASO<br>C.DHPLC<br>D.DGGE<br>E.DNA sequencing</td>
      <td>B.ASO</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>40. Which of the following prenatal diagnostic techniques routinely allows fetal chromosomes to be analyzed during first trimester of pregnancy? (2.0分)</td>
      <td>A. Cordocentesis<br>B.Amniocentesis<br>C.Chorionic villus sampling<br>D.Radiography<br>E.Maternal triple testing</td>
      <td>C.Chorionic villus sampling</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>41. In the gene chip illustrated above, a cDNA library made from a control, unaffected individual has been labelled with a green probe and a cDNA library made from a patient has been labelled with a red probe. Based upon the color of the spots labelled A, B, and C, we can conclude which of the following relationships? (2.0分)</td>
      <td>A.Gene B is expressed at a higher level and gene A at a lower level in the patient than in the control, and gene C is expressed at the same level in both people.<br>B.The mRNA from gene A is degraded more rapidly and that from gene B less rapidly in the patient than the control, but the mRNA from gene C is equally stable for both individuals.<br>C.Gene B is expressed at a higher level and gene A at a lower level in the patient than the control, and gene C is not present at all in the patient.<br>D.The mRNA from gene A is degraded more rapidly and that from gene B less rapidly in the patient than the control, and the mRNA from gene C is not present at all in the patient.<br>E.Either A or B</td>
      <td>E.Either A or B</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>42. In the beta-thalassemia case presented in the first week, one might imagine that an embryonic stem cell transplant might cure 何尼科. Where would one obtain such cells? (2.0分)</td>
      <td>A.From the umbilicord cord blood（脐带血）<br>B.From the chorion（绒毛膜）<br>C.From the inner cell mass of the blastocyst（胚泡的内细胞团）<br>D.From the syncytiotrophoblast（合体滋养层）<br>E.From the white blood cells</td>
      <td>C.From the inner cell mass of the blastocyst（胚泡的内细胞团）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>43. Why might a woman opt for chrionic villus sampling (CVS) over amniocentesis for prenatal diagnosis？ (2.0分)</td>
      <td>A.It is more accurate than amniocentesis.<br>B.There are much lower complication rates for CVS.<br>C.It can be performed earlier in gestation.<br>D.More doctors are trained to perform CVS than amniocentesis.<br>E.More genetic disorders can be found by CVS than by amniocentesis.</td>
      <td>C.It can be performed earlier in gestation.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>44. Why might a woman opt for chrionic villus sampling (CVS) over amniocentesis for prenatal diagnosis？ (2.0分)</td>
      <td>A.It is more accurate than amniocentesis.<br>B.There are much lower complication rates for CVS.<br>C.It can be performed earlier in gestation.<br>D.More doctors are trained to perform CVS than amniocentesis.<br>E.More genetic disorders can be found by CVS than by amniocentesis.</td>
      <td>C.It can be performed earlier in gestation.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>45. Which of the following properties would a single nucleotide polymorphism (SNP) have to be detected by Southern blot? (2.0分)</td>
      <td>A.It must alter the encoded amino acid sequence<br>B.It must alter a splice site<br>C.It must alter a restriction site<br>D.It must be a nonsense mutation<br>E.It must alter the stability of the encoded mRNA</td>
      <td>C.It must alter a restriction site</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>46. Becky is a 7-day-old infant who has phenylketonuria. Her parents have come to you for advice on managing her condition. Which of the following statements most accurately describes the best management for this disorder? (2.0分)</td>
      <td>A.All protein must be eliminated from the diet.<br>B.A protein-restricted diet must be followed.<br>C.A high-protein diet in a pregnant mother causes phenylketonuria.<br>D.A high-protein diet must be followed<br>E.A high-protein diet must be followed.</td>
      <td>B.A protein-restricted diet must be followed.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>47. Advantages of using adenoviruses for gene therapy include: (2.0分)</td>
      <td>A.long term expression.<br>B.short term expression.<br>C.low risk of insertional mutagenesis.<br>D.low immunogenecity.<br>E.easy assembly.</td>
      <td>C.low risk of insertional mutagenesis.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>48. Which of the following is the usual treatment of hemophilia A? (2.0分)</td>
      <td>A.Blood transfusion<br>B.Liver transplant<br>C.Bone marrow transplant<br>D.Infusion of factor VIII as needed<br>E.Spleen transplant</td>
      <td>D.Infusion of factor VIII as needed</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>49. Which of the following gene-therapy vectors preferentially infects nerve cells? (2.0分)</td>
      <td>A.Adeno-associated virus<br>B.Retrovirus<br>C.Herpes virus<br>D.Adenovirus<br>E.Liposome</td>
      <td>C.Herpes virus</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2011</td>
      <td>50. Which of the following vectors targets both dividing and non-dividing cells? (2.0分)</td>
      <td>A.Retrovirus<br>B.Adenovirus<br>C.Adeno-associated virus<br>D.Herpes virus<br>E.Liposome</td>
      <td>B.Adenovirus</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>1. 儿童和少年期抽动症(2.0分)</td>
      <td>A.抽动往往是唯一的症状<br>B.抽动的发作常常有诱因<br>C.抽动片刻也不能控制<br>D.抽动是固定的<br>E.患儿自己不能察觉</td>
      <td>B.抽动的发作常常有诱因</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>2. 加剧抽动症各种抽动症状的因素可以有(2.0分)</td>
      <td>A.疲劳<br>B.上呼吸道感染<br>C.紧张<br>D.进食兴奋性药物、食物<br>E.以上都是</td>
      <td>E.以上都是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>3. 抽动症的治疗(2.0分)</td>
      <td>A.药物治疗能治愈<br>B.症状消失即可停药<br>C.缓解焦虑有利症状控制<br>D.儿童抽动症一般不考虑用药<br>E.儿童抽动症应该首先考虑用药</td>
      <td>C.缓解焦虑有利症状控制</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>4. 关于儿童抽动，错误的观点是(2.0分)</td>
      <td>A.抽动的表现是快速、反复、有目的的<br>B.抽动的轻重变化可以很大<br>C.可以有缓解期<br>D.可以伴有强迫症状<br>E.可以伴有发声</td>
      <td>A.抽动的表现是快速、反复、有目的的</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>5. 已被当地诊所诊断过敏性鼻炎、过敏性结膜炎的13岁男孩，对治疗无反应请求会诊排除抽动症，你可能还想了解的是(2.0分)</td>
      <td>A.症状的具体描述、症状持续时间、间隙期、家族史<br>B.症状是否可变、可控或不自主<br>C.是否伴有注意力不集中、学习困难、强迫性动作、社交退缩<br>D.耳鼻喉科的检查、治疗经过<br>E.过敏原化验结果</td>
      <td>A.症状的具体描述、症状持续时间、间隙期、家族史</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>6. 家长对眨眼、耸鼻为主要临床表现的短暂性抽动障碍患儿应该(2.0分)</td>
      <td>A.一概不予提醒<br>B.一发作即提醒<br>C.有机会就提醒<br>D.个别悄悄提醒<br>E.大庭广众提醒</td>
      <td>A.一概不予提醒</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>7. 关于儿童学习困难，正确的描述是(2.0分)</td>
      <td>A.儿童学习困难与智力发育落后有关<br>B.纠正儿童学习困难需要反复刻苦地学习<br>C.纠正儿童学习困难需要积极控制多动<br>D.纠正儿童学习困难需要加强脑营养<br>E.纠正儿童学习困难需要专项训练</td>
      <td>E.纠正儿童学习困难需要专项训练</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>8. 儿童学习困难的特征是(2.0分)</td>
      <td>A.有教育机会被剥夺的病史<br>B.学科成绩中等偏下<br>C.技能障碍在入学时已存在<br>D.智力低于正常1SD以上<br>E.智力低于正常2SD以上</td>
      <td>C.技能障碍在入学时已存在</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>9. 2年级学生，因多动、学习成绩差来诊。家长表述孩子自幼顽皮，但看电视认真，入学后成绩进行性下降，用中枢兴奋剂无效。检查结果患儿用手点读认真，但合上书后不能回答所读，IQ108。你的临床印象是(2.0分)</td>
      <td>A.注意缺陷伴多动障碍<br>B.紧张焦虑状态<br>C.学习习惯差<br>D.学习困难<br>E.顽皮</td>
      <td>D.学习困难</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>10. 孤独症谱系障碍的主要核心表现是(2.0分)</td>
      <td>A.多重复语言、无视觉交流、好非生命物质<br>B.动作简单重复、刻板保持统一、缺乏对眼交流<br>C.语言单一、人称指代你我不分、30个月内出现症状<br>D.交往上喜好自己玩、生活中行为多刻板、强烈要求环境统一<br>E.社会交往上的严重障碍、语言沟通出现质的损害、行为兴趣狭窄刻板</td>
      <td>E.社会交往上的严重障碍、语言沟通出现质的损害、行为兴趣狭窄刻板</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>11. 5岁男孩，从2岁开始一直只会叫"mama……",对家长的简单指令也不理解，不会叫大小便，好一个人玩，体检发现患儿口水多，尤在逗他玩时口水更多，且手舞足蹈，最可能的诊断是(2.0分)</td>
      <td>A.表达性语言发育障碍<br>B.21--三体综合症<br>C.精神发育迟滞<br>D.孤独症谱系障碍<br>E.耳聋</td>
      <td>C.精神发育迟滞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>12. 胎儿的中枢神经系统和周围神经系统的发育来源： (2.0分)</td>
      <td>A.神经管， 神经嵴<br>B.神经嵴， 神经管<br>C.神经元， 神经胶质<br>D.神经元， 神经胶质</td>
      <td>A.神经管， 神经嵴</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>13. 脊神经完成髓鞘化的时间(2.0分)</td>
      <td>A.4个月<br>B.1岁<br>C.2岁<br>D.3岁</td>
      <td>D.3岁</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>14. 热性惊厥首次发作年龄(2.0分)</td>
      <td>A.6个月-3岁<br>B.6个月-6岁<br>C.3个月-3岁<br>D.3个月-6岁</td>
      <td>A.6个月-3岁</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>15. 单纯性热性惊厥发作特点: (2.0分)</td>
      <td>A.多见，全身性发作，持续时间短，发作次数少，复发次数少<br>B.多见，部分性发作，持续时间长，发作次数多，复发次数多<br>C.少见，全身性发作，持续时间短，发作次数少，复发次数少<br>D.少见，部分性发作，持续时间长，发作次数多，复发次数多</td>
      <td>A.多见，全身性发作，持续时间短，发作次数少，复发次数少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>16. 患儿，男，1岁，因发热1天伴抽搐1次就诊，诊断急性上呼吸道感染，热性惊厥。既往已类似发作2次，试问需如何防治？ (2.0分)</td>
      <td>A.安定1mg/kg.d，连续3天，或直至体温恢复正常<br>B.安定2mg/kg.d，直至体温恢复正常<br>C.安定2mg/kg.d，连续3天，或直至体温恢复正常<br>D.丙戊酸20 mg/kg.d，连续应用3年</td>
      <td>A.安定1mg/kg.d，连续3天，或直至体温恢复正常</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>17. 热性惊厥发展成癫痫的危险因素(2.0分)</td>
      <td>A.CFS，直系亲属中有癫痫病史，神经系统发育异常<br>B.FS，直系亲属中有热性惊厥病史，神经系统发育异常<br>C.CFS，直系亲属中有癫痫病史，神经系统发育正常<br>D.FS，直系亲属中有热性惊厥史，神经系统发育异常</td>
      <td>A.CFS，直系亲属中有癫痫病史，神经系统发育异常</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>18. 一健康小儿，头围40cm, 两手已张开，非对称性颈紧张性反射偶能引出，马上消失；俯卧位时肘支撑抬胸，竖头较稳，但还不能两手支撑独坐片刻。该小儿最可能的年龄是(2.0分)</td>
      <td>A.1-2 月龄<br>B.3-4月龄<br>C.5-6月龄<br>D.7-8月龄<br>E.9-10月龄</td>
      <td>B.3-4月龄</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>19. 下列小儿运动发育的规律中哪一点是错误的？ (2.0分)</td>
      <td>A.具有头尾规律，即由头向尾发育<br>B.从中心向周围发育<br>C.先有反面的动作发育，再有正面的动作发育<br>D.由泛化到集中<br>E.由简单到复杂</td>
      <td>C.先有反面的动作发育，再有正面的动作发育</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>20. 小儿粗大运动发育里程碑，下列哪一项是错误的？ (2.0分)</td>
      <td>A.6-7月龄能自己拉物体站立<br>B.10-12月龄能手膝交叉爬行<br>C.18月龄能跑，并后退走<br>D.24月龄能并足跳跃<br>E.3周岁能双足交替上下楼梯</td>
      <td>A.6-7月龄能自己拉物体站立</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>21. 一健康男孩，体重9.9kg, 乳牙6颗，脊柱出现第三个弯曲，会用手指认图片, 手膝爬行快, 独走几步，不稳。其年龄最可能是(2.0分)</td>
      <td>A.7个月<br>B.9个月<br>C.10个月<br>D.12个月<br>E.18个月</td>
      <td>D.12个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>22. 一男孩，8月龄，因出生时曾有窒息，随访就诊，出生体重3.75KG。体检：体重8.6 kg, 身长71cm, 头围44cm, 前囟1.0×1.0cm, 平软, 乳牙未萌。两手均能抓取方木，并能传递物体，扶婴儿腋下能支撑自己体重站立；拉坐时头屈曲、臂屈曲主动用力，俯卧位时能用上肢撑起身体，向前匍匐爬行，独坐稳并双手玩玩具，非对称性颈紧张反射未引出，降落伞反射存在。患儿最可能的诊断是： (2.0分)</td>
      <td>A.体重低下<br>B.运动发育迟缓<br>C.生长迟缓<br>D.脑性瘫痪<br>E.生长发育正常范围</td>
      <td>E.生长发育正常范围</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>23. 下列有关气质的描述，正确的是(2.0分)</td>
      <td>A.气质是个性心理特征之一，相对稳定，不受环境因素和种族的影响。<br>B.与遗传有关,具有稳定性和不可变性<br>C.主要表现在心理活动的强度、速度、稳定性、灵活性和指向性方面<br>D.每种气质类型都有各自的优缺点，气质有好坏之分<br>E.儿童气质对儿童良好个性的形成以及身心健康发展有着重要的作用，易养型的孩子不会出现行为问题</td>
      <td>C.主要表现在心理活动的强度、速度、稳定性、灵活性和指向性方面</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>24. 下列哪一项属于难养型的气质特点(2.0分)</td>
      <td>A.反应强度低<br>B.生物功能的规律性较强<br>C.情绪多为积极<br>D.高的反应强度，适应性较慢<br>E.容易接受新事物或陌生人</td>
      <td>D.高的反应强度，适应性较慢</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>25. 对活动度高、注意容易分散的孩子，下列哪项处理是错的？(2.0分)</td>
      <td>A.增加一些丰富的体育活动<br>B.尽可能限制孩子的活动，以减少孩子的活动度<br>C.必要时安排一些与年龄匹配的需要安静的活动<br>D.引导、鼓励孩子集中注意力于需要完成的任务<br>E.当孩子完成任务时适当表扬</td>
      <td>B.尽可能限制孩子的活动，以减少孩子的活动度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>26. 下列哪一项提示养育环境与气质调适不良或拟合不良（Poorer of fit）(2.0分)</td>
      <td>A.父母对孩子的退缩和反应性强的行为非常焦虑、急躁，且教育指导意见不一致<br>B.养育者虽不喜欢孩子的气质特点，仍有能力去忍耐并引导孩子的行为<br>C.养育者能根据孩子的气质特点作出反应<br>D.家庭气氛和谐、轻松，对孩子的过激反应能冷静处理<br>E.养育者理解孩子的行为发育受什么因素影响（并不是完全由后天习得，也不是故意的）</td>
      <td>A.父母对孩子的退缩和反应性强的行为非常焦虑、急躁，且教育指导意见不一致</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>27. 下列哪一项提示可能有言语或语言发育障碍？(2.0分)</td>
      <td>A.3个月时不会对妈妈的声音和逗笑出现有意义的社会性微笑<br>B.4个月时不会和大人玩"躲猫猫"<br>C.5个月时不会对自己的名字有反应<br>D.6个月时不会用姿势性语言，如招手表示再见<br>E.7个月时还不会指认图片</td>
      <td>A.3个月时不会对妈妈的声音和逗笑出现有意义的社会性微笑</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>28. 7月小儿语言发育应为(2.0分)</td>
      <td>A.能哭叫<br>B.笑出声音<br>C.喃喃地发出单音节<br>D.能发出"爸爸、妈妈"等复音，但无意识<br>E.能叫出物体的名字</td>
      <td>D.能发出"爸爸、妈妈"等复音，但无意识</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>29. 与发育性语言发育障碍比较，儿童孤独症最关键的核心症状是：(2.0分)</td>
      <td>A.语言理解障碍或落后，不能理解词义<br>B.缺乏社会交流的技能, 不懂交流法则, 不能理解隐晦、幽默等语言含义<br>C.交互性的社交障碍，缺乏眼神交流、手势交流和情感共享, 并伴刻板性行为<br>D.语言表达障碍或缺乏, 无语言结构<br>E.智力发育落后</td>
      <td>C.交互性的社交障碍，缺乏眼神交流、手势交流和情感共享, 并伴刻板性行为</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>30. 一女孩， 36月龄，因口齿不清就诊。说话口齿不清，词汇量少，如ping guo 发音为Ping dou, 约2/3的话不能被外人理解。不能完成有先后顺序的指令。G2P2,出生时足月，无窒息抢救史。18月龄时会独走，24月龄时会叫"爸爸、妈妈"。体检见特殊面容，检查脑干听觉诱发电位提示双耳未见异常。儿童发育量表评估发育商（DQ）为46分，其中粗大运动DQ 56分,精细动作DQ53分,语言能DQ36分，应人能DQ 48分，应物能DQ46分。适应性社会能力缺陷。该患儿最可能的诊断是(2.0分)</td>
      <td>A.听力障碍<br>B.全面发育迟缓<br>C.语言障碍<br>D.社会交流(语用)障碍<br>E.言语发音障碍</td>
      <td>B.全面发育迟缓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>31. 神经系统发育过程中，以下结构最后出现的结构是(2.0分)</td>
      <td>A.神经板<br>B.神经管<br>C.神经沟<br>D.神经褶</td>
      <td>B.神经管</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>32. 外周神经系统来源于(2.0分)</td>
      <td>A.神经管<br>B.神经脊细胞<br>C.前脑泡<br>D.后脑泡</td>
      <td>B.神经脊细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>33. 下列有关神经细胞发育过程的说法，错误的是(2.0分)</td>
      <td>A.放射状胶质细胞形成发育过程中细胞迁移的脚手架<br>B.较早分化的较大神经元先迁移并形成最内层，依次顺序向外；而较晚分化的较小神经元则通过已形成的层次迁移并形成其外侧新的层次<br>C.神经元的轴突和树突的结构是预先被"决定"的。<br>D.在决定神经细胞命运的过程中，细胞之间的相互作用起重要作用。</td>
      <td>C.神经元的轴突和树突的结构是预先被"决定"的。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>34. 关于神经诱导因子，错误的说法是(2.0分)</td>
      <td>A.神经诱导因子拮抗表皮诱导因子的作用<br>B.神经诱导因子直接作用于外胚层细胞，使其转化为神经组织<br>C.在没有表皮诱导因子存在的条件下，神经诱导因子的存在与否和神经诱导无关<br>D.神经诱导因子不是唯一的</td>
      <td>B.神经诱导因子直接作用于外胚层细胞，使其转化为神经组织</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>35. 下面关于关键期正确的一项是(2.0分)</td>
      <td>A.关键期结束后树突棘不再具有运动性。<br>B.关键期的结束通常伴随着抑制性突触传递的增强。<br>C.关键期结束后无法诱导突触可塑性。<br>D.在关键期之前短期单眼剥夺会造成眼优势柱的变化。</td>
      <td>B.关键期的结束通常伴随着抑制性突触传递的增强。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>36. 初级视皮层存在眼优势柱的位于皮层第几层？ (2.0分)</td>
      <td>A.第I层<br>B.第II/III层<br>C.第IV层<br>D.第V层</td>
      <td>C.第IV层</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>37. 以下哪一项不属于活动依赖性的突触重排(2.0分)</td>
      <td>A.突触分离。<br>B.突触会聚。<br>C.突触竞争。<br>D.轴突生长。</td>
      <td>D.轴突生长。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>38. 穿过三边孔者为 (2.0分)</td>
      <td>A.旋肩胛动脉<br>B.肩胛上动脉<br>C.肩胛背动脉<br>D.肩胛下动脉<br>E.旋肱前动脉</td>
      <td>A.旋肩胛动脉</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>39. 关于腋动脉，何者是错误的？ (2.0分)</td>
      <td>A.胸小肌是其分段标志<br>B.其中第三段最表浅，也是最细的一段<br>C.较恒定的分支数目有6条<br>D.最大的分支是胸上动脉<br>E.臂丛的三束在腋动脉的第二段分别居其内、外和后方</td>
      <td>D.最大的分支是胸上动脉</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>40. 支配前锯肌的神经是(2.0分)</td>
      <td>A.胸内侧神经<br>B.胸外侧神经<br>C.胸背神经<br>D.肩胛下神经<br>E.胸长神经</td>
      <td>E.胸长神经</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>41. 关于腋淋巴结，何者是错误的？ (2.0分)</td>
      <td>A.前群沿胸外侧血管周围排列<br>B.后群沿肩胛下血管周围排列<br>C.外侧群沿腋血管的远侧端排列<br>D.中央群位于腋窝底中<br>E.尖群沿胸最上血管周围排列</td>
      <td>E.尖群沿胸最上血管周围排列</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>42. 与闭孔神经位置关系最密切的肌是(2.0分)</td>
      <td>A.耻骨肌<br>B.长收肌<br>C.短收肌<br>D.大收肌<br>E.股薄肌</td>
      <td>C.短收肌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>43. 关于腹股沟浅淋巴结的叙述，下列哪项是错误的？ (2.0分)</td>
      <td>A.分上、下两群<br>B.上群沿腹股沟韧带下方斜行排列<br>C.下群沿大隐静脉末段纵行排列<br>D.只收纳下肢的浅淋巴管<br>E.输出管注入腹股沟深淋巴结或髂外淋巴结</td>
      <td>D.只收纳下肢的浅淋巴管</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>44. 支配内收肌群的主要神经是(2.0分)</td>
      <td>A.闭孔神经<br>B.阴部神经<br>C.股神经<br>D.生殖股神经<br>E.胫神经</td>
      <td>A.闭孔神经</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>45. 关于股鞘，何者是错误的？ (2.0分)</td>
      <td>A.中间是股静脉<br>B.外侧是股动脉<br>C.内侧形成股管<br>D.股管的开口为股环<br>E.是腹股沟直疝发生的部位</td>
      <td>E.是腹股沟直疝发生的部位</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>46. 耻骨肌(2.0分)</td>
      <td>A.由闭孔神经支配<br>B.由股神经支配<br>C.由生殖股神经支配<br>D.由闭孔神经和股神经支配<br>E.由闭孔神经、股神经和生殖股神经支配</td>
      <td>D.由闭孔神经和股神经支配</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>47. 关于股动脉，何者是错误的？ (2.0分)</td>
      <td>A.是髂外动脉的直接延续<br>B.是股三角内的中心结构<br>C.向下穿收肌腱裂孔后移行为腘动脉<br>D.有四条分支<br>E.最大的分支是旋股外侧动脉</td>
      <td>E.最大的分支是旋股外侧动脉</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>48. 股三角内的结构由外向内依次为(2.0分)</td>
      <td>A.股管、股动脉、股静脉、股神经<br>B.股动脉、股神经、股静脉、股管<br>C.股神经、股管、股动脉、股静脉<br>D.股神经、股动脉、股静脉、股管<br>E.股神经、股静脉、股动脉、股管</td>
      <td>D.股神经、股动脉、股静脉、股管</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>49. 关于腋腔的叙述，下列哪一项是错误的？ (2.0分)</td>
      <td>A.为一锥形管道<br>B.顶为骨性，底为膜性<br>C.对腔内的血管神经最有威胁的是锁骨<br>D.前后壁均有血管神经通道<br>E.臂丛不是腋腔的内容</td>
      <td>E.臂丛不是腋腔的内容</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2013</td>
      <td>50. 腋鞘及其内容在腋腔内的定位（由顶至底）(2.0分)</td>
      <td>A.在顶部靠近内壁和后壁，在底部靠近外壁和前壁<br>B.在顶部靠近外壁和后壁，在底部靠近外壁和前壁<br>C.在顶部靠近内壁和前壁，在底部靠近外壁和后壁<br>D.在顶部靠近内壁和前壁，在底部靠近外壁和前壁<br>E.在顶部靠近外壁和前壁，在底部靠近外壁和后壁</td>
      <td>C.在顶部靠近内壁和前壁，在底部靠近外壁和后壁</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>1. 神经系统发育过程中，以下结构最后出现的结构是：(2.5分)</td>
      <td>A.神经板<br>B.神经管<br>C.神经沟<br>D.神经褶<br>E.神经嵴</td>
      <td>B.神经管</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>2. 外周神经系统来源于：(2.5分)</td>
      <td>A.神经管<br>B.神经脊细胞<br>C.前脑泡<br>D.后脑泡<br>E.中脑泡</td>
      <td>B.神经脊细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>3. 下列有关神经细胞发育过程的说法，错误的是：(2.5分)</td>
      <td>A.放射状胶质细胞形成发育过程中细胞迁移的脚手架<br>B.较早分化的较大神经元先迁移并形成最内层，依次顺序向外；<br>C.较晚分化的较小神经元则通过已形成的层次迁移并形成其外侧新的层次<br>D.神经元的轴突和树突的结构是预先被"决定"的。<br>E.在决定神经细胞命运的过程中，细胞之间的相互作用起重要作用。</td>
      <td>D.神经元的轴突和树突的结构是预先被"决定"的。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>4. 关于神经诱导因子，错误的说法是：(2.5分)</td>
      <td>A.神经诱导因子拮抗表皮诱导因子的作用<br>B.神经诱导因子直接作用于外胚层细胞，使其转化为神经组织<br>C.在没有表皮诱导因子存在的条件下，神经诱导因子的存在与否和神经诱导无关<br>D.神经神经诱导因子诱导因子不是唯一的<br>E.神经诱导因子能直接结合BMP</td>
      <td>B.神经诱导因子直接作用于外胚层细胞，使其转化为神经组织</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>5. 关于神经发育过程中的程序性细胞死亡（programmed cell death, PCD)，错误的说法是：(2.5分)</td>
      <td>A.约20%~50%产生于胚胎时期的神经元在成体发育过程中通过PCD死亡<br>B.神经系统发育过程中，凡不能与靶区正确匹配和参与正常神经网络形成的神经元均通过PCD加以清除<br>C.PCD使神经系统的发育达到了结构的高度精细和功能的尽善尽美<br>D.PCD是由细胞内特定基因程序性表达介导的细胞死亡<br>E.PCD是发育中的一种正常现象</td>
      <td>A.约20%~50%产生于胚胎时期的神经元在成体发育过程中通过PCD死亡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>6. 运动发育需经过以下阶段，其正确顺序为：①反射运动；②胚胎自发运动；③复杂运动。(2.5分)</td>
      <td>A.①③②<br>B.①②③<br>C.③②①<br>D.②③①<br>E.②①③</td>
      <td>E.②①③</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>7. 初级视皮层存在眼优势柱的位于皮层第几层？(2.5分)</td>
      <td>A.第I层<br>B.第II/III层<br>C.第IV层<br>D.第V层<br>E.第VI层</td>
      <td>C.第IV层</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>8. 以下哪些受体对LTP的形成和调节起到重要作用：(2.5分)</td>
      <td>A.GlyR<br>B.AMPAR<br>C.ASICs<br>D.AMPAR和NMDAR<br>E.NMDAR</td>
      <td>D.AMPAR和NMDAR</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>9. 下列哪一个不属于易养型特点？(2.5分)</td>
      <td>A.生物功能的规律性强<br>B.容易接受新的事物和陌生人<br>C.情绪多为积极<br>D.情绪反应的强度适中<br>E.高的反应强度</td>
      <td>E.高的反应强度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>10. 一健康小儿，头围40cm, 两手已张开，非对称性颈紧张性反射偶能引出，马上消失；俯卧位时肘支撑抬胸，竖头较稳，但还不能两手支撑独坐片刻。该小儿最可能的年龄是：(2.5分)</td>
      <td>A.1-2 月龄<br>B.3-4月龄<br>C.5-6月龄<br>D.7-8月龄<br>E.9-10月龄</td>
      <td>B.3-4月龄</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>11. 下列小儿运动发育的规律中哪一点是错误的？(2.5分)</td>
      <td>A.具有头尾规律，即由头向尾发育<br>B.从中心向周围发育<br>C.先有反面的动作发育，再有正面的动作发育<br>D.由泛化到集中<br>E.由简单到复杂</td>
      <td>C.先有反面的动作发育，再有正面的动作发育</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>12. 小儿精细运动发育里程碑，下列哪项是错误的？(2.5分)</td>
      <td>A.3月龄时握持反射消失, 可以有意识的够取物体<br>B.抓物先用手掌的桡侧，然后用尺侧<br>C.6-7月龄能玩弄小物体，将物体从一只手转移到另一只手；<br>D.9-10月龄开始用拇指食指捏取小物体<br>E.15月龄能几页几页翻书</td>
      <td>B.抓物先用手掌的桡侧，然后用尺侧</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>13. 一健康女婴前来体检。测量头围42cm，前囟1.5cm×1.2cm，身长65cm，双手支撑三脚架样独坐一会，出牙1颗，最可能的年龄是：(2.5分)</td>
      <td>A.3~4个月<br>B.5~6个月<br>C.7~8个月<br>D.8~9个月<br>E.10~12个月</td>
      <td>B.5~6个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>14. 下列有关气质的描述，正确的是：(2.5分)</td>
      <td>A.气质是个性心理特征之一，相对稳定，不受环境因素和种族的影响。<br>B.与遗传有关,具有稳定性和不可变性<br>C.主要表现在心理活动的强度、速度、稳定性、灵活性和指向性方面<br>D.每种气质类型都有各自的优缺点，气质有好坏之分<br>E.儿童气质对儿童良好个性的形成以及身心健康发展有着重要的作用，易养型的孩子不会出现行为问题</td>
      <td>C.主要表现在心理活动的强度、速度、稳定性、灵活性和指向性方面</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>15. 下列哪一项不属于缓慢发动型的气质特点？(2.5分)</td>
      <td>A.对新事物和陌生人的最初反应退缩<br>B.对新事物适应慢<br>C.对周围事物的反应强度较高，易出现激烈反应<br>D.消极情绪较多<br>E.一旦适应新环境和周围人后，能很好的与同伴相处</td>
      <td>C.对周围事物的反应强度较高，易出现激烈反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>16. 对活动度高、注意容易分散的孩子，下列哪项处理是错的？(2.5分)</td>
      <td>A.增加一些丰富的体育活动<br>B.尽可能限制孩子的活动，以减少孩子的活动度<br>C.必要时安排一些与年龄匹配的需要安静的活动<br>D.引导、鼓励孩子集中注意力于需要完成的任务<br>E.当孩子完成任务时适当表扬</td>
      <td>B.尽可能限制孩子的活动，以减少孩子的活动度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>17. 下列哪一项提示养育环境与气质调适不良或拟合不良（Poorer of fit）?(2.5分)</td>
      <td>A.父母对孩子的退缩和反应性强的行为非常焦虑、急躁，且教育指导意见不一致<br>B.养育者虽不喜欢孩子的气质特点，仍有能力去忍耐并引导孩子的行为<br>C.养育者能根据孩子的气质特点作出反应<br>D.家庭气氛和谐、轻松，对孩子的过激反应能冷静处理<br>E.养育者理解孩子的行为发育受什么因素影响（并不是完全由后天习得，也不是故意的）</td>
      <td>A.父母对孩子的退缩和反应性强的行为非常焦虑、急躁，且教育指导意见不一致</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>18. 根据大人讲的词汇，指认相应的图片、能以拍手表示"欢迎"，并能有意识的叫"妈妈"，还不会说其他的单词和两个字的词，最可能的发育年龄是：(2.5分)</td>
      <td>A.5-6个月<br>B.7-8个月<br>C.10-12个月<br>D.18-24个月<br>E.12-18个月</td>
      <td>C.10-12个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>19. 下列哪一项提示可能有言语或语言发育障碍？(2.5分)</td>
      <td>A.3个月时不会对妈妈的声音和逗笑出现有意义的社会性微笑<br>B.4个月时不会和大人玩"躲猫猫"<br>C.5个月时不会对自己的名字有反应<br>D.6个月时不会用姿势性语言，如招手表示再见<br>E.7个月时还不会指认图片</td>
      <td>A.3个月时不会对妈妈的声音和逗笑出现有意义的社会性微笑</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>20. 7月小儿语言发育应为：(2.5分)</td>
      <td>A.能哭叫<br>B.笑出声音<br>C.喃喃地发出单音节<br>D.能发出"爸爸、妈妈"等复音，但无意识<br>E.能叫出物体的名字</td>
      <td>D.能发出"爸爸、妈妈"等复音，但无意识</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>21. 与发育性语言发育障碍比较，儿童孤独症最关键的核心症状是：(2.5分)</td>
      <td>A.语言理解障碍或落后，不能理解词义<br>B.缺乏社会交流的技能, 不懂交流法则, 不能理解隐晦、幽默等语言含义<br>C.交互性的社交障碍，缺乏眼神交流、手势交流和情感共享, 并伴刻板性行为<br>D.语言表达障碍或缺乏, 无语言结构<br>E.智力发育落后</td>
      <td>C.交互性的社交障碍，缺乏眼神交流、手势交流和情感共享, 并伴刻板性行为</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>22. 关于儿童和少年期抽动症：(2.5分)</td>
      <td>A.抽动往往是单一的症状<br>B.抽动的发作常常有诱因<br>C.抽动片刻也不能控制<br>D.抽动一定是固定的<br>E.患儿自己不能察觉</td>
      <td>B.抽动的发作常常有诱因</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>23. 加剧抽动症各种抽动症状的因素可以有：(2.5分)</td>
      <td>A.疲劳<br>B.上呼吸道感染<br>C.紧张<br>D.玩电子游戏<br>E.以上都是</td>
      <td>E.以上都是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>24. 慢性抽动的特点是：(2.5分)</td>
      <td>A.进行性、不自主的舞蹈样运动<br>B.肌张力低下<br>C.能受意志控制一段时间<br>D.病史达2个月以上<br>E.可见角膜K-F色素环</td>
      <td>C.能受意志控制一段时间</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>25. 抽动症的治疗：(2.5分)</td>
      <td>A.药物治疗能治愈<br>B.症状消失即可停药<br>C.缓解焦虑有利症状控制<br>D.儿童抽动症一般不考虑用药<br>E.儿童抽动症应该首先考虑用药</td>
      <td>C.缓解焦虑有利症状控制</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>26. 纠正儿童学习困难，正确的描述是：(2.5分)</td>
      <td>A.需要家教帮助作业<br>B.需要专项训练<br>C.需要积极控制多动<br>D.需要加强脑营养<br>E.需要反复刻苦地学习</td>
      <td>B.需要专项训练</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>27. 对于有阅读障碍的患儿：(2.5分)</td>
      <td>A.用以写代读来以长补短，提高自尊<br>B.建议药物治疗<br>C.与遗传无关，由后天环境造成<br>D.困难要达到影响学习和生活的程度才诊断<br>E.反复诵读，强化训练</td>
      <td>D.困难要达到影响学习和生活的程度才诊断</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>28. 儿童学习困难的特征是：(2.5分)</td>
      <td>A.有教育机会被剥夺的病史<br>B.学科成绩中等偏下<br>C.技能障碍在入学时已存在<br>D.智力低于正常1SD以上<br>E.智力低于正常2SD以上</td>
      <td>C.技能障碍在入学时已存在</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>29. 目前对学习困难的认识：(2.5分)</td>
      <td>A.学习困难往往与多动症相随<br>B.学习困难加剧了多动症的症状<br>C.学习困难与教育失败有一定关系<br>D.学习困难的学科成绩与其智力相比存在明显差异<br>E.以上都是</td>
      <td>E.以上都是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>30. 下列哪一点不是小儿单纯型高热惊厥的临床特点：(2.5分)</td>
      <td>A.惊厥多见于6个月至3岁的小儿<br>B.发作前均有发热，多在发病初期体温骤升时发生<br>C.惊厥呈全身性，持续时间不超过10分钟<br>D.多伴有呼吸道、消化道感染，而无中枢神经系统感染<br>E.发作1周后脑电图异常</td>
      <td>E.发作1周后脑电图异常</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>31. 以下哪项不符合复杂性热性惊厥的特点：(2.5分)</td>
      <td>A.一次惊厥发作持续15分钟以上<br>B.24小时内反复发作2次或2次以上<br>C.首次发病年龄小于6个月<br>D.局灶性发作<br>E.反复频繁的发作，累计发作总数5次以上</td>
      <td>C.首次发病年龄小于6个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>32. 男孩，1岁半，夏季，头天流清涕，今晨低热，上午体温升高达39.7℃，突发全身强直－阵挛性惊厥，惊厥中面色青紫，意识丧失，持续数分钟自停。再数分钟后患儿完全清醒，下午体温38.5℃，患儿精神良好。病后不吐无泻。体检无病理征。血常规白细胞及分叶球增高，最可能的诊断应是：(2.5分)</td>
      <td>A.化脓性脑膜炎<br>B.单纯性热性惊厥<br>C.复杂性热性惊厥<br>D.癫痫<br>E.病毒性脑炎</td>
      <td>B.单纯性热性惊厥</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>33. 男孩，2岁半，自1岁后每遇发热38℃余即出现全身性强直－阵挛样痫性发作，先后已有类似发作3次，每次持续20～30分钟。发作后嗜睡半小时余，清醒后恢复正常活动。体格检查无异常，患儿最可能的诊断应是：(2.5分)</td>
      <td>A.复杂性热性惊厥<br>B.单纯性热性惊厥<br>C.原发性癫痫<br>D.低钙惊厥<br>E.继发性癫痫</td>
      <td>A.复杂性热性惊厥</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>34. 关于神经元的产生，下列错误的说法是：(2.5分)</td>
      <td>A.神经干细胞的水平分裂（分裂板为水平方向）产生两个相同子代细胞<br>B.Notch-1和Numb的分布方式对神经干细胞的子代细胞的命运有重要的决定作用<br>C.不对称细胞分裂可以造成细胞的多样性<br>D.转录因子的按顺序表达使神经母细胞每次分裂后产生不同的神经元<br>E.神经元由细胞体和突起组成，其轴突或长的树突组成神经纤维</td>
      <td>A.神经干细胞的水平分裂（分裂板为水平方向）产生两个相同子代细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>35. 下面关于关键期正确的一项是：(2.5分)</td>
      <td>A.关键期结束后树突棘不再具有运动性。<br>B.关键期的结束通常伴随着抑制性突触传递的增强。<br>C.关键期结束后无法诱导突触可塑性。<br>D.在关键期之前短期单眼剥夺会造成眼优势柱的变化。<br>E.关键期对于人的行为发育具有的临床意义不是很明显</td>
      <td>B.关键期的结束通常伴随着抑制性突触传递的增强。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>36. 穿过三边孔者为：(2.5分)</td>
      <td>A.旋肩胛动脉<br>B.肩胛上动脉<br>C.肩胛背动脉<br>D.肩胛下动脉<br>E.旋肱前动脉</td>
      <td>A.旋肩胛动脉</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>37. 下列哪群腋淋巴结肿大，可出现锁骨下丰满现象？(2.5分)</td>
      <td>A.中央淋巴结<br>B.外侧淋巴结<br>C.肩胛下淋巴结<br>D.尖淋巴结<br>E.胸肌淋巴结</td>
      <td>D.尖淋巴结</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>38. 关于腋动脉，何者是错误的？(2.5分)</td>
      <td>A.胸小肌是其分段标志<br>B.其中第三段最表浅，也是最细的一段<br>C.较恒定的分支数目有6条<br>D.最大的分支是胸上动脉<br>E.臂丛的三束在腋动脉的第二段分别居其内、外和后方</td>
      <td>D.最大的分支是胸上动脉</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>39. 尺神经由臂丛(2.5分)</td>
      <td>A.外束发出<br>B.内束发出<br>C.后束发出<br>D.内、外束分支合成<br>E.以上均不对</td>
      <td>B.内束发出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>0</td>
      <td>2014</td>
      <td>40. 支配前锯肌的神经是(2.5分)</td>
      <td>A.胸内侧神经<br>B.胸外侧神经<br>C.胸背神经<br>D.肩胛下神经<br>E.胸长神经</td>
      <td>E.胸长神经</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>1. 关于"流行病学"，下列说法哪项是错误的： (2.0分)</td>
      <td>A.流行病学从疾病分布入手探讨疾病的流行因素<br>B.流行病学是从群体角度研究疾病与健康<br>C.流行病学属于预防医学的范畴<br>D.流行病学中的研究群体是指所有人群<br>E.流行病学已深入临床医学的研究中</td>
      <td>D.流行病学中的研究群体是指所有人群</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>2. 下列哪一种指标常用来说明疾病对人的生命危险程度： (2.0分)</td>
      <td>A.死亡率<br>B.罹患率<br>C.发病率<br>D.患病率<br>E.病死率</td>
      <td>E.病死率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>3. 表示传染病的流行强度宜用下列哪种指标： (2.0分)</td>
      <td>A.死亡率<br>B.患病率<br>C.罹患率<br>D.发病率<br>E.病死率</td>
      <td>D.发病率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>4. 某县历年流脑发病率均在12/10万~20/10万之间,去年该县流脑发病率为16/10万,试判断其流行强度： (2.0分)</td>
      <td>A.暴发<br>B.散发<br>C.流行<br>D.大流行<br>E.以上均不对</td>
      <td>B.散发</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>5. 下列哪一种传染病一般呈严格的季节性： (2.0分)</td>
      <td>A.虫媒传染病<br>B.肠道传染病<br>C.呼吸道传染病<br>D.寄生虫病<br>E.血液传染病</td>
      <td>A.虫媒传染病</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>6. 某地共有居民200000人，2003年罹患SARS 20人,其中死亡1人，该地2003年SARS的（ ）为5%。(2.0分)</td>
      <td>A.发病率<br>B.病死率<br>C.罹患率<br>D.患病率<br>E.以上都不对</td>
      <td>B.病死率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>7. 人类染色体核型分析中不包括哪些特征： (2.0分)</td>
      <td>A.染色体形态特征<br>B.染色体大小<br>C.染色体数目<br>D.染色体复制</td>
      <td>D.染色体复制</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>8. 下列哪条染色体是亚中着丝粒染色体： (2.0分)</td>
      <td>A.3号染色体<br>B.2号染色体<br>C.22染色体<br>D.13号染色体</td>
      <td>B.2号染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>9. 单链DNA迁移率与下列哪种因素无关： (2.0分)</td>
      <td>A.DNA的碱基序列<br>B.DNA长度<br>C.凝胶浓度<br>D.电泳时间</td>
      <td>D.电泳时间</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>10. 下哪项不能作为判断G带制备好坏的标准：(2.0分)</td>
      <td>A.染色体形态和分散良好，最好无重叠现象，即使染色体个别重叠，也要能明显辨别<br>B.细胞完整，轮廓清晰，染色体在同一平面上均匀分布<br>C.所观察的染色体长短大致一样，处于同一有丝分裂时期<br>D.在所观察的染色体周围有多个散在的染色体</td>
      <td>D.在所观察的染色体周围有多个散在的染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>11. If the normal sequence of genes on a chromosome is ABCDEFG, then a change in the sequence to AEDCBFG would be an example of a(2.0分)</td>
      <td>A.Missense mutation<br>B.Frame shift mutation<br>C.Inversion<br>D.Translocation<br>E.Duplication</td>
      <td>C.Inversion</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>12. Polymorphisms(2.0分)</td>
      <td>A.Refers to allelic variations that are common ( in >1% of population)<br>B.Refer to multiple conformations observed for the same sequence of DNA<br>C.Refer to the mutant sequence of DNA from patients<br>D.Are produced by insertions or deletions<br>E.Are produced by inversion</td>
      <td>A.Refers to allelic variations that are common ( in >1% of population)</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>13. The best estimate for the number of human genes is:(2.0分)</td>
      <td>A.100,000<br>B.1,000,000<br>C.50,000<br>D.25,000<br>E.15,000</td>
      <td>D.25,000</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>14. Which of the following cell types would not be a possible source of DNA?(2.0分)</td>
      <td>A.Liver cells.<br>B.Brain cells.<br>C.Red blood cells.<br>D.Skin cells.<br>E.Heart cells.</td>
      <td>C.Red blood cells.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>15. A mechanism of epigenetic inheritance is(2.0分)</td>
      <td>A.non-coding RNAs<br>B.genomic imprinting<br>C.histone modification<br>D.DNA methylation<br>E.All of the above</td>
      <td>E.All of the above</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>16. A male is found to have a 46 CAG repeats. Which of the following disorders is the most likely diagnosis?(2.0分)</td>
      <td>A.Fragile X syndrome<br>B.Huntington disease<br>C.Fragile-X-associated Tremor Ataxia Syndrome<br>D.Friedreich ataxia<br>E.Myotonic dystrophy</td>
      <td>B.Huntington disease</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>17. The process that allows humans to be more complex than common weeds such as Arabadopsis (拟南芥。一种十字花科植物。模式生物), despite an equivalent number of genes, is(2.0分)</td>
      <td>A.nucleotide expansion<br>B.alternative splicing<br>C.nucleotide polymorphisms<br>D.transcription<br>E.translation</td>
      <td>B.alternative splicing</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>18. Robertsonian translocations(2.0分)</td>
      <td>A.Occur with roughly equal frequency for all autosomal chromosomes.<br>B.Are the most common chromosome rearrangements in human.<br>C.Are unbalanced translocations.<br>D.Account for Down syndrome in about 95% of the cases.<br>E.Involve the deleterious loss of sole copies of genes for ribosomal RNA.</td>
      <td>B.Are the most common chromosome rearrangements in human.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>19. Which of the following karyotypes is not compatible with survival to birth?(2.0分)</td>
      <td>A.47,XY,+13<br>B.47,XY,+ 21<br>C.47,XY,+18<br>D.45,X<br>E.45,Y</td>
      <td>E.45,Y</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>20. In a Robertsonian translocation fusion occurs at the:(2.0分)</td>
      <td>A.telomeres.<br>B.ends of the long arms.<br>C.histones.<br>D.centromeres.<br>E.Middle of the long arms.</td>
      <td>D.centromeres.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>21. The cause of Down's syndrome is known to be(2.0分)</td>
      <td>A.a pituitary（垂体）deficiency<br>B.the absence of one autosome<br>C.the presence of one extra autosome<br>D.the presence of one extra sex chromosome<br>E.a pair of recessive genes</td>
      <td>C.the presence of one extra autosome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>22. The presence of two or more cell lines from different zygotes in a single individual is known as:(2.0分)</td>
      <td>A.diploidy. （二倍体）<br>B.mosaicism.<br>C.aneuploidy.（非整倍体）<br>D.euploidy. （整倍体）<br>E.chimaerism.</td>
      <td>E.chimaerism.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>23. Which of the following is an example of monosomy?(2.0分)</td>
      <td>A.46,XX<br>B.47,XXX<br>C.45,X<br>D.69,XYY<br>E.46,XX,5p-</td>
      <td>C.45,X</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>24. Disorders with this mode of inheritance are sometimes found more commonly in societies that practice consanguinity: (2.0分)</td>
      <td>A.autosomal recessive<br>B.multifactorial<br>C.X-linked<br>D.autosomal dominant<br>E.cancer</td>
      <td>A.autosomal recessive</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>25. Both of Mary's sons have the X-linked disorder Duchenne muscular dystrophy. A deletion in the DMD gene is found in each of the boys, but no mutation in DMD is found when a blood sample from Mary is analyzed. What is the most likely explanation? (2.0分)</td>
      <td>A.The boys were affected by separate mutation events in DMD<br>B.Mary is germline mosaic for a DMD deletion<br>C.The mutation was inherited from the boys' father<br>D.The phenotype is not penetrant in Mary<br>E.The phenotype is X-linked recessive</td>
      <td>B.Mary is germline mosaic for a DMD deletion</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>26. Which inheritance pattern best describes the pedigree shown here?(2.0分)</td>
      <td>A.AD<br>B.XD<br>C.AR<br>D.XR<br>E.Mitochodrial</td>
      <td>D.XR</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>27. Male to male transmission is a key feature of which pattern of inheritance?(2.0分)</td>
      <td>A.AR<br>B.AD<br>C.XD<br>D.XR<br>E.Mitochodrial</td>
      <td>B.AD</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>28. Which of the following disorders does NOT show X-linked inheritance?(2.0分)</td>
      <td>A.Hemophilia A<br>B.Hemophilia B<br>C.Tay-Sachs disease<br>D.Duchenne muscular dystrophy<br>E.Red-green blindness</td>
      <td>C.Tay-Sachs disease</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>29. Leber hereditary optic atrophy (LHON) is caused by a mutation in:(2.0分)</td>
      <td>A.chromosome 18.<br>B.chromosome 21.<br>C.chromosome 5.<br>D.chromosome 13.<br>E.mitochondrial DNA.</td>
      <td>E.mitochondrial DNA.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>30. A dominantly inherited trait affects a child and his grandmother, but neither parent. This best illustrates which of the following principles?(2.0分)</td>
      <td>A.Variable expressivity.<br>B.Non-penetrance<br>C.Somatic mosaicism.<br>D.New mutation.<br>E.Genomic imprinting</td>
      <td>B.Non-penetrance</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>31. Which of the following genes conveys susceptibility for polygenic Alzheimer disease? (2.0分)</td>
      <td>A.APP<br>B.APOE<br>C.PS2<br>D.PS1<br>E.DMD</td>
      <td>B.APOE</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>32. Which of the following conditions does NOT show multifactorial inheritance? (2.0分)</td>
      <td>A.Hirschsprung disease（先天性巨结肠症）<br>B.Spina bifida (neural tube defects)（脊柱裂。神经管缺陷）<br>C.Pyloric stenosis（幽门狭窄）<br>D.Schizophrenia<br>E.Marfan syndrome</td>
      <td>E.Marfan syndrome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>33. In a condition such as hypertension the recurrence risk will be greatest for which of the following relatives of an affected individual?(2.0分)</td>
      <td>A.Nephew<br>B.Aunt<br>C.Brother<br>D.Grandchild<br>E.Grandchild's child</td>
      <td>C.Brother</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>34. The proportion of genes shared by first cousins is on average ___.(2.0分)</td>
      <td>A.1/16<br>B.1/8<br>C.1/2<br>D.1/4<br>E.1/32</td>
      <td>B.1/8</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>35. A study of a disorder reveals that monozygotic twins are concordant 40% of the time, whereas full siblings are concordant 10% of the time. Which of the following is the best interpretation of this finding?(2.0分)</td>
      <td>A.Genes contribute to the trait, but are not deterministic.<br>B.The trait is completely determined by genetics.<br>C.The trait is completely determined by environmental factors..<br>D.The trait has no genetic component.<br>E.The trait must be due to the biology of twinning.</td>
      <td>A.Genes contribute to the trait, but are not deterministic.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>36. A case-control association study indicates a 1.6 fold relative risk of diabetes in individuals who carry a specific allele. What is the most reasonable interpretation of this result?(2.0分)</td>
      <td>A.There is an association between the allele and expressing the trait in the population that was studied.<br>B.The allele is closely linked to another allele that causes the trait in the study population.<br>C.The allele causes the trait in the study population.<br>D.The allele may not cause the trait, but the gene does cause the trait in the study population.<br>E.No association exists between the allele and diabetes in the study population.</td>
      <td>A.There is an association between the allele and expressing the trait in the population that was studied.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>37. To say that two alleles are in linkage disequilibrium implies that:(2.0分)</td>
      <td>A.One allele arose from the other by mutation.<br>B.The alleles function together in the same pathway.<br>C.The two alleles are together in the same haplotype more often that predicted by chance.<br>D.The alleles are so close that recombination never occurs between them.<br>E.The alleles have relationship.</td>
      <td>C.The two alleles are together in the same haplotype more often that predicted by chance.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>38. Why might a woman opt for chrionic villus sampling (CVS) over amniocentesis for prenatal diagnosis？ (2.0分)</td>
      <td>A.It is more accurate than amniocentesis.<br>B.There are much lower complication rates for CVS.<br>C.More doctors are trained to perform CVS than amniocentesis.<br>D.It can be performed earlier in gestation.<br>E.More genetic disorders can be found by CVS than by amniocentesis.</td>
      <td>D.It can be performed earlier in gestation.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>39. The risk for miscarriage associated with amniocentesis is approximately ____.(2.0分)</td>
      <td>A.1/1000<br>B.1/50<br>C.1/100 - 1/200<br>D.1/10<br>E.1/3000</td>
      <td>C.1/100 - 1/200</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>40. Availability of DNA testing for many single disease traits has allowed routine prenatal screening of couples for disorders prevalent in their ethnic group. Which of the following genetic disorders has a similar incidence in different ethnic groups and wou(2.0分)</td>
      <td>A.Cystic fibrosis<br>B.Tay-Sachs disease<br>C.Thalassemias<br>D.Down syndrome<br>E.Huntington disease</td>
      <td>D.Down syndrome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>41. Which of the following techniques was NOT used to detect an unknown mutation?(2.0分)</td>
      <td>A.DHPLC<br>B.ASO<br>C.SSCP<br>D.DGGE<br>E.DNA sequencing</td>
      <td>B.ASO</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>42. Which of the following prenatal diagnostic techniques routinely allows fetal chromosomes to be analyzed during first trimester of pregnancy?(2.0分)</td>
      <td>A.Amniocentesis<br>B.Cordocentesis<br>C.Chorionic villus sampling<br>D.Radiography<br>E.Maternal triple testing</td>
      <td>C.Chorionic villus sampling</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>43. Who won the Nobel Prize for His (their) contributions to PCR technique?(2.0分)</td>
      <td>A.Southern E<br>B.Watson J and Crick F<br>C.Mullis K<br>D.Sanger F<br>E.Yuet Wai Kan</td>
      <td>C.Mullis K</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>44. For what purpose are prenatal screening tests best used?(2.0分)</td>
      <td>A.To diagnose a suspected disease in a parent<br>B.To diagnose a suspected disease in a fetus<br>C.To obtain fetal cells for chromosome karyotyping<br>D.To identify individuals who should undergo diagnostic testing<br>E.To examine the DNA of a fetus for suspected mutations in a specific gene</td>
      <td>D.To identify individuals who should undergo diagnostic testing</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>45. The majority of vectors used for gene transfer in the clinical setting are derived from: (2.0分)</td>
      <td>A.insects<br>B.bacteria<br>C.automated DNA synthesis<br>D.viruses<br>E.yeast</td>
      <td>D.viruses</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>46. Gene therapy is an established, broadly available procedure for the treatment of: (2.0分)</td>
      <td>A.hemophilia<br>B.deafness<br>C.cystic fibrosis<br>D.melanoma<br>E.no disease as yet</td>
      <td>E.no disease as yet</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>47. Becky is a 7-day-old infant who has phenylketonuria. Her parents have come to you for advice on managing her condition. Which of the following statements most accurately describes the best management for this disorder? (2.0分)</td>
      <td>A.A protein-restricted diet must be followed.<br>B.A high-protein diet in a pregnant mother causes phenylketonuria.<br>C.A high-protein diet must be followed<br>D.All protein must be eliminated from the diet.<br>E.A high-protein diet must be followed.</td>
      <td>A.A protein-restricted diet must be followed.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>48. Advantages of using adenoviruses for gene therapy include:(2.0分)</td>
      <td>A.short term expression.<br>B.low immunogenecity.<br>C.long term expression.<br>D.low risk of insertional mutagenesis.<br>E.easy assembly.</td>
      <td>D.low risk of insertional mutagenesis.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>49. Which of the following is the usual treatment of hemophilia A?(2.0分)</td>
      <td>A.Liver transplant<br>B.Blood transfusion<br>C.Bone marrow transplant<br>D.Infusion of factor VIII as needed<br>E.Spleen transplant</td>
      <td>D.Infusion of factor VIII as needed</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2007</td>
      <td>50. Which of the following gene-therapy vectors preferentially infects nerve cells?(2.0分)</td>
      <td>A.Herpes virus<br>B.Retrovirus<br>C.Adeno-associated virus<br>D.Adenovirus<br>E.Liposome</td>
      <td>A.Herpes virus</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>1. 下列那条染色体是中着丝粒染色体： (2.0分)</td>
      <td>A. X染色体<br>B. 4号染色体<br>C.1号染色体<br>D.21号粒染色体</td>
      <td>C.1号染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>2. 若单个样本的SSCP结果为阳性，这说明： (2.0分)</td>
      <td>A.样本检测区域有突变<br>B.样本一定为致病突变<br>C.样本检测区域无突变<br>D.无法分析</td>
      <td>A.样本检测区域有突变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>3. SSCP的电泳结果应分析哪种形态的DNA： (2.0分)</td>
      <td>A.单链<br>B.三链<br>C.双链<br>D.单链和双链</td>
      <td>A.单链</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>4. 某社区共有居民500人，2009年4月新发甲型H1N1流感病例10人，截至2009年6月底，共有甲型H1N1流感病例50人，则该社区2009年4月甲型H1N1流感（ ）为2%。(2.0分)</td>
      <td>A.患病率<br>B.发病率<br>C.罹患率<br>D.病死率<br>E.死亡率</td>
      <td>B.发病率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>5. 疾病的时间分布中，周期性是指： (2.0分)</td>
      <td>A.疾病发生频率经过一个相当规律的时间间隔，呈现规律性变动的状况<br>B.以日、周、月计数的短期观察数据<br>C.对疾病动态的连续数年乃至数十年的观察，在这个长时间内观察探讨疾病的病原体、临床表现、发病率、死亡率等的变化或它们同时发生的变化情况<br>D.疾病每年在一定的季节内呈现发病率升高的现象<br>E.以上都不对</td>
      <td>A.疾病发生频率经过一个相当规律的时间间隔，呈现规律性变动的状况</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>6. A nonsense mutation involves (2.0分)</td>
      <td>A.a regulatory sequence.<br>B.the creation of a different amino acid.<br>C.an AG splice acceptor site.<br>D.the creation of a stop codon.<br>E.the creation of the same amino acid.</td>
      <td>D.the creation of a stop codon.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>7. A study of a disorder reveals that monozygotic twins are concordant 40% of the time, whereas full siblings are concordant 10% of the time. Which of the following is the best interpretation of this finding? (2.0分)</td>
      <td>A.Genes contribute to the trait, but are not deterministic.<br>B.The trait is completely determined by genetics.<br>C.The trait is completely determined by environmental factors..<br>D.The trait has no genetic component.<br>E.The trait must be due to the biology of twinning.</td>
      <td>A.Genes contribute to the trait, but are not deterministic.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>8. 0.075M的 KCl在人类染色体制备过程的作用不包括： (2.0分)</td>
      <td>A.红细胞解体<br>B.染色体分散<br>C.白细胞膨胀<br>D.淋巴细胞解体</td>
      <td>D.淋巴细胞解体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>9. Which of the following gene-therapy vectors preferentially infects nerve cells? (2.0分)</td>
      <td>A.Adeno-associated virus<br>B.Retrovirus<br>C.Adenovirus<br>D.Herpes virus<br>E.Liposome</td>
      <td>D.Herpes virus</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>10. The splice donor is located(2.0分)</td>
      <td>A.At the 3' end of the intron.<br>B.At the branch point of the intron.<br>C.At the promoter.<br>D.At the 5' end of the intron.<br>E.At the enhancer.</td>
      <td>D.At the 5' end of the intron.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>11. SSCP分析的检测灵敏度主要与哪个因素有关： (2.0分)</td>
      <td>A.核酸片段大小<br>B.引物序列<br>C.碱基突变类型<br>D.DNA的碱基序列</td>
      <td>A.核酸片段大小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>12. CT值的定义是以（C）的衰减系数为标准来计算各种组织的CT值(2.0分)</td>
      <td>A.水<br>B.骨<br>C.空气<br>D.脑组织<br>E.以上都不是</td>
      <td>A.水</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>13. 植物血凝素在人类染色体制备过程的作用机理： (2.0分)</td>
      <td>A.促进红细胞解体<br>B.细胞周期阻滞在有丝分裂中期<br>C.促进染色体凝集<br>D.刺激淋巴细胞增殖。</td>
      <td>D.刺激淋巴细胞增殖。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>14. Becky is a 7-day-old infant who has phenylketonuria. Her parents have come to you for advice on managing her condition. Which of the following statements most accurately describes the best management for this disorder? (2.0分)</td>
      <td>A.A protein-restricted diet must be followed.<br>B.All protein must be eliminated from the diet.<br>C.A high-protein diet in a pregnant mother causes phenylketonuria.<br>D.A high-protein diet must be followed<br>E.A high-protein diet must be followed.</td>
      <td>A.A protein-restricted diet must be followed.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>15. 下哪项不能作为判断G带制备好坏的标准： (2.0分)</td>
      <td>A.染色体形态和分散良好，无重叠现象，即使染色体个别重叠，也要能明显辨别<br>B.细胞完整，轮廓清晰，染色体在同一平面上均匀分布<br>C.所观察的染色体长短大致一样，处于同一有丝分裂时期<br>D.在所观察的染色体周围有多个散在的染色体</td>
      <td>D.在所观察的染色体周围有多个散在的染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>16. 下述中，关于像素和体素的不准确的概念是哪项(2.0分)</td>
      <td>A.体素是一个三维概念<br>B.像素大小与图像的分辨率高低成反比<br>C.CT图像的基本组成单元称为体素<br>D.体素是被矩阵排列分隔的基本成像单元<br>E.像素实际上是体素在成像时的表现</td>
      <td>C.CT图像的基本组成单元称为体素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>17. CT探测器的作用是(2.0分)</td>
      <td>A.探测扫描时散射线是多少<br>B.探测病人位置是否准确<br>C.探测中心线是否准直<br>D.探测透过射线以获得正确曝光量<br>E.探测透过射线以获得测量数据</td>
      <td>E.探测透过射线以获得测量数据</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>18. 某县历年流脑发病率均在12/10万~20/10万之间,去年该县流脑发病率为16/10万,试判断其流行强度： (2.0分)</td>
      <td>A.大流行<br>B.暴发<br>C.流行<br>D.散发<br>E.以上均不对</td>
      <td>D.散发</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>19. 有关窗技术的，下列关于窗位的概念，正确的是(2.0分)</td>
      <td>A.床位相当于显示灰阶的中心<br>B.窗位与所显示的组织CT直无关<br>C.不同机器的窗位值不同<br>D.窗位规定所显示CT直的范围<br>E.通常窗位选择以水的CT直为标准</td>
      <td>A.床位相当于显示灰阶的中心</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>20. 下列关于CT值得概念，那一项是正确的(2.0分)</td>
      <td>A.反映了物质内水的成分<br>B.是物质密度的绝对值<br>C.不同的机器产生的CT值不同<br>D.CT值反映了物质的密度<br>E.根据CT值可以对病变做出定性诊断</td>
      <td>D.CT值反映了物质的密度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>21. G带制备中染色体带型不好的原因不包括： (2.0分)</td>
      <td>A.染色体标本不好<br>B.胰酶消化时间不合适<br>C.Giemsa染色时间不够<br>D.显微镜分辨率不够</td>
      <td>D.显微镜分辨率不够</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>22. n a condition such as hypertension the recurrence risk will be greatest for which of the following relatives of an affected individual? (2.0分)</td>
      <td>A.Brother<br>B.Aunt<br>C.Grandchild<br>D.Nephew<br>E.Grandchild's child</td>
      <td>A.Brother</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>23. 秋水仙素在人类染色体制备过程的作用机理： (2.0分)</td>
      <td>A.促进染色体合成<br>B.促进淋巴细胞解体<br>C.细胞周期阻滞在有丝分裂中期<br>D.刺激淋巴细胞增殖。</td>
      <td>C.细胞周期阻滞在有丝分裂中期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>24. Which of the following statements is true of X inactivation? (2.0分)</td>
      <td>A.Because of X inactivation, males with an XXY genotype have no apparent phenotype<br>B.The paternal X is always inactive in female somatic cells<br>C.the entire inactivated X chromosome is transcriptionally silent<br>D.There will be two Barr bodies in each somatic cell of an XXX female</td>
      <td>D.There will be two Barr bodies in each somatic cell of an XXX female</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>25. In cancer cells, one observes _____ (increased/decreased) methylation of __________(CpG islands/repeat sequences). (2.0分)</td>
      <td>A.Increased; CpG islands<br>B.Decreased; repeat sequences<br>C.Decreased; CpG islands<br>D.Increased; repeat sequences</td>
      <td>A.Increased; CpG islands</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>26. Which of the following statements is true of X inactivation? (2.0分)</td>
      <td>A.There will be two Barr bodies in each somatic cell of an XXX female<br>B.Because of X inactivation, males with an XXY genotype have no apparent phenotype<br>C.The entire inactivated X chromosome is transcriptionally silent<br>D.The paternal X is always inactive in female somatic cells<br>E.X inactivation hypothesis was first proposed by Francis Collins</td>
      <td>A.There will be two Barr bodies in each somatic cell of an XXX female</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>27. The TATA box is located in the(2.0分)</td>
      <td>A.Poly-A addition site.<br>B.Promoter<br>C.Splice enhancer.<br>D.Intron-exon border.<br>E.Cap site.</td>
      <td>B.Promoter</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>28. The presence of two or more cell lines from different zygotes in a single individual is known as: (2.0分)</td>
      <td>A.mosaicism.<br>B.euploidy. （整倍体）<br>C.aneuploidy.（非整倍体）<br>D.diploidy. （二倍体）<br>E.chimaerism.</td>
      <td>E.chimaerism.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>29. Which of the following is the usual treatment of hemophilia A? (2.0分)</td>
      <td>A.Bone marrow transplant<br>B.Liver transplant<br>C.Blood transfusion<br>D.Infusion of factor VIII as needed<br>E.Spleen transplant</td>
      <td>D.Infusion of factor VIII as needed</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>30. The presence of genes in the same chromosome is an example of (2.0分)</td>
      <td>A.Free assortment<br>B.Linkage<br>C.Segregations<br>D.Coordination<br>E.Fusion</td>
      <td>B.Linkage</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>31. Which of the following conditions does NOT show multifactorial inheritance? (2.0分)</td>
      <td>A.Pyloric stenosis（幽门狭窄）<br>B.Hirschsprung disease（先天性巨结肠症）<br>C.Spina bifida (neural tube defects)（脊柱裂。神经管缺陷）<br>D.Schizophrenia<br>E.Marfan syndrome</td>
      <td>E.Marfan syndrome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>32. Which of the following is an example of monosomy?(2.0分)</td>
      <td>A.47,XXX<br>B.69,XYY<br>C.45,X<br>D.46,XX<br>E.46,XX,5p-</td>
      <td>C.45,X</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>33. The proportion of genes shared by first cousins is on average ___. (2.0分)</td>
      <td>A.1/4<br>B.1/2<br>C.1/8<br>D.1/16<br>E.1/32</td>
      <td>C.1/8</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>34. A thalassemia is a hemoglobin disorder in which(2.0分)</td>
      <td>A.The beta-globin chain is present at normal levels but is misfolded<br>B.Any globin chain is present at normal levels but is misfolded<br>C.Any globin chain is absent or is present at reduced levels<br>D.The beta-globin chain is absent or is present at reduced levels<br>E.Either B or D is true, depending upon the type of thalassemia</td>
      <td>C.Any globin chain is absent or is present at reduced levels</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>35. A case-control association study indicates a 1.6 fold relative risk of diabetes in individuals who carry a specific allele. What is the most reasonable interpretation of this result? (2.0分)</td>
      <td>A.There is an association between the allele and expressing the trait in the population that was studied.<br>B.The allele may not cause the trait, but the gene does cause the trait in the study population.<br>C.The allele is closely linked to another allele that causes the trait in the study population.<br>D.The allele causes the trait in the study population.<br>E.No association exists between the allele and diabetes in the study population.</td>
      <td>A.There is an association between the allele and expressing the trait in the population that was studied.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>36. An example of genomic imprinting is (2.0分)</td>
      <td>A.Differentiation of cells to form a specific tissue<br>B.Covalent modification of histones<br>C.Mosaicism<br>D.Paternal X inactivation</td>
      <td>D.Paternal X inactivation</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>37. Two parents with autosomal recessive albinism have a child who does not have albinism. This is best explained by:(2.0分)</td>
      <td>A.Misattributed paternity.（亲子关系出错）<br>B.An incorrect diagnosis in one parent.<br>C.Genetic heterogeneity.<br>D.Reversion of one of the mutant alleles to wild type.<br>E.Pleiotropy.</td>
      <td>C.Genetic heterogeneity.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>38. 细胞周期中哪个时期可制备良好的染色体标本： (2.0分)</td>
      <td>A. S 期<br>B. G2期<br>C.G1期<br>D. M 期</td>
      <td>D. M 期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>39. Why might a woman opt for chrionic villus sampling (CVS) over amniocentesis for prenatal diagnosis？(2.0分)</td>
      <td>A.There are much lower complication rates for CVS.<br>B.It is more accurate than amniocentesis.<br>C.It can be performed earlier in gestation.<br>D.More doctors are trained to perform CVS than amniocentesis.<br>E.More genetic disorders can be found by CVS than by amniocentesis.</td>
      <td>C.It can be performed earlier in gestation.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>40. 下列哪一种传染病一般呈严格的季节性： (2.0分)</td>
      <td>A.呼吸道传染病<br>B.虫媒传染病<br>C.肠道传染病<br>D.寄生虫病<br>E.血液传染病</td>
      <td>B.虫媒传染病</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>41. The cause of Down syndrome is known to be (2.0分)</td>
      <td>A.the presence of one extra sex chromosome<br>B.a pituitary（垂体）deficiency<br>C.the presence of one extra autosome<br>D.the absence of one autosome<br>E.a pair of recessive genes</td>
      <td>C.the presence of one extra autosome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>42. A couple decide to have prenatal diagnosis because their previous child has Tay-Sachs disease. Which of the following prenatal diagnostic techniques is optimal for fetal diagnosis? (2.0分)</td>
      <td>A.Maternal serum α-fetoprotein (MSAFP)<br>B.Percutaneous umbilical blood sampling<br>C.Amniotic fluid α-fetoprotein levels<br>D.Chorionic villus sampling (CVS)<br>E.Fetal X-rays</td>
      <td>D.Chorionic villus sampling (CVS)</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>43. Which of the following techniques was mostly used to detect a trisomy? (2.0分)</td>
      <td>A.PCR-SSCP<br>B.Southern blot<br>C.FISH<br>D.RFLP<br>E.DNA sequencing</td>
      <td>C.FISH</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>44. Why might a woman opt for chrionic villus sampling (CVS) over amniocentesis for prenatal diagnosis？(2.0分)</td>
      <td>A.It is more accurate than amniocentesis.<br>B.There are much lower complication rates for CVS.<br>C.More doctors are trained to perform CVS than amniocentesis.<br>D.It can be performed earlier in gestation.<br>E.More genetic disorders can be found by CVS than by amniocentesis.</td>
      <td>D.It can be performed earlier in gestation.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>45. Advantages of using adenoviruses for gene therapy include: (2.0分)</td>
      <td>A.low risk of insertional mutagenesis.<br>B.short term expression.<br>C.long term expression.<br>D.low immunogenecity.<br>E.easy assembly.</td>
      <td>A.low risk of insertional mutagenesis.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>46. Types of nucleic acid hybridisation include the below EXCEPT(2.0分)</td>
      <td>A.Western blotting<br>B.Microarray<br>C.Southern blotting<br>D.Northern blotting<br>E.DNA fingerprinting</td>
      <td>A.Western blotting</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>47. 某地共有居民200000人，2003年罹患SARS 20人,其中死亡1人，该地2003年SARS的（ ）为5%。(2.0分)</td>
      <td>A.发病率<br>B.患病率<br>C.病死率<br>D.罹患率<br>E.以上都不对</td>
      <td>C.病死率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>48. A dominantly inherited trait affects a child and his grandmother, but neither parent. This best illustrates which of the following principles? (2.0分)</td>
      <td>A.Variable expressivity.<br>B.Somatic mosaicism.<br>C.New mutation.<br>D.Non-penetrance<br>E.Genomic imprinting</td>
      <td>D.Non-penetrance</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>49. In a Robertsonian translocation fusion occurs at the:(2.0分)</td>
      <td>A.histones.<br>B.centromeres.<br>C.telomeres.<br>D.ends of the long arms.<br>E.Middle of the long arms.</td>
      <td>B.centromeres.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2008</td>
      <td>50. Which of the following vectors targets both dividing and non-dividing cells? (2.0分)</td>
      <td>A.Adeno-associated virus<br>B.Retrovirus<br>C.Herpes virus<br>D.Adenovirus<br>E.Liposome</td>
      <td>D.Adenovirus</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>1. 下述中，关于像素和体素的不准确的概念是哪项(2.0分)</td>
      <td>A.CT图像的基本组成单元称为体素<br>B.像素大小与图像的分辨率高低成反比<br>C.体素是一个三维概念<br>D.体素是被矩阵排列分隔的基本成像单元<br>E.像素实际上是体素在成像时的表现</td>
      <td>A.CT图像的基本组成单元称为体素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>2. CT探测器的作用是(2.0分)</td>
      <td>A.探测中心线是否准直<br>B.探测病人位置是否准确<br>C.探测扫描时散射线是多少<br>D.探测透过射线以获得正确曝光量<br>E.探测透过射线以获得测量数据</td>
      <td>E.探测透过射线以获得测量数据</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>3. 某县历年流脑发病率均在12/10万~20/10万之间,去年该县流脑发病率为16/10万,试判断其流行强度： (2.0分)</td>
      <td>A.散发<br>B.暴发<br>C.流行<br>D.大流行<br>E.以上均不对</td>
      <td>A.散发</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>4. 下列哪一种传染病一般呈严格的季节性： (2.0分)</td>
      <td>A.虫媒传染病<br>B.寄生虫病<br>C.呼吸道传染病<br>D.肠道传染病<br>E.血液传染病</td>
      <td>A.虫媒传染病</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>5. 某地共有居民200000人，2003年罹患SARS 20人,其中死亡1人，该地2003年SARS的（）为5%。(2.0分)</td>
      <td>A.发病率<br>B.病死率<br>C.患病率<br>D.罹患率<br>E.以上都不对</td>
      <td>B.病死率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>6. 某社区共有居民500人，2009年4月新发甲型H1N1流感病例10人，截至2009年6月底，共有甲型H1N1流感病例50人，则该社区2009年4月甲型H1N1流感发病率为2%，2009年上半年（）为10%。(2.0分)</td>
      <td>A.发病率<br>B.病死率<br>C.患病率<br>D.罹患率<br>E.死亡率</td>
      <td>C.患病率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>7. 下列那条染色体是中着丝粒染色体： (2.0分)</td>
      <td>A.1号染色体<br>B. 4号染色体<br>C. X染色体<br>D.21号粒染色体</td>
      <td>A.1号染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>8. 通过人类染色体制备及核型分析可用来检测那种遗传突变？ (2.0分)</td>
      <td>A.. 点突变<br>B. 移码突变<br>C. 21三体<br>D.线粒体突变</td>
      <td>C. 21三体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>9. SSCP不适合检测的突变类型是： (2.0分)</td>
      <td>A.已知单碱基突变<br>B.碱基置换<br>C.未知单碱基突变<br>D.外显子缺失突变</td>
      <td>D.外显子缺失突变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>10. 若发现视野没有分裂相，二个主要原因有： (2.0分)</td>
      <td>A.秋水仙素浓度或处理时间不合适<br>B.胰酶消化时间过长<br>C.Giemsa染色时间不够<br>D.低渗时间太短</td>
      <td>A.秋水仙素浓度或处理时间不合适</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>11. PCR产物大小由下列哪种因素决定： (2.0分)</td>
      <td>A.模板量<br>B.退火温度<br>C.引物序列<br>D.变性温度</td>
      <td>C.引物序列</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>12. PCR产物特异性不高时，需要： (2.0分)</td>
      <td>A.降低退火温度<br>B.增加引物和Taq DNA聚合酶的浓度<br>C.改变Mg++浓度<br>D.增加退火时间及延伸时间</td>
      <td>C.改变Mg++浓度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>13. The TATA box is located in the (2.0分)</td>
      <td>A.Splice enhancer.<br>B.Intron-exon border.<br>C.Promoter<br>D.Poly-A addition site.<br>E.Cap site.</td>
      <td>C.Promoter</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>14. The splice donor is located (2.0分)</td>
      <td>A.At the promoter.<br>B.At the 5' end of the intron.<br>C.At the branch point of the intron.<br>D.At the 3' end of the intron.<br>E.At the enhancer.</td>
      <td>B.At the 5' end of the intron.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>15. A nonsense mutation involves (2.0分)</td>
      <td>A.a regulatory sequence.<br>B.an AG splice acceptor site.<br>C.the creation of a different amino acid.<br>D.the creation of a stop codon.<br>E.the creation of the same amino acid.</td>
      <td>D.the creation of a stop codon.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>16. An example of genomic imprinting is (2.0分)</td>
      <td>A.Covalent modification of histones<br>B.Differentiation of cells to form a specific tissue<br>C.Mosaicism<br>D.Paternal X inactivation</td>
      <td>D.Paternal X inactivation</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>17. The carrier frequency for the autosomal recessive disorder Tay-Sachs disease in the Ashkenazi Jewish population is approximately 1 in 30. Which of the following population genetic forces could explain the high carrier frequency in this population, relative to other US populations? (2.0分)</td>
      <td>A.heterozygote advantage<br>B.genetic drift<br>C.high mutation rate<br>D.A and B<br>E.B and C</td>
      <td>D.A and B</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>18. In a Robertsonian translocation fusion occurs at the: (2.0分)</td>
      <td>A.telomeres.<br>B.centromeres.<br>C.histones.<br>D.ends of the long arms.<br>E.Middle of the long arms.</td>
      <td>B.centromeres.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>19. The cause of Down syndrome is known to be(2.0分)</td>
      <td>A.a pituitary（垂体）deficiency<br>B.the presence of one extra sex chromosome<br>C.the presence of one extra autosome<br>D.the absence of one autosome<br>E.a pair of recessive genes</td>
      <td>C.the presence of one extra autosome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>20. The presence of two or more cell lines from different zygotes in a single individual is known as: (2.0分)</td>
      <td>A.mosaicism.<br>B.diploidy. （二倍体）<br>C.aneuploidy.（非整倍体）<br>D.euploidy. （整倍体）<br>E.chimaerism.</td>
      <td>E.chimaerism.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>21. Which of the following is an example of monosomy? (2.0分)</td>
      <td>A.46,XX<br>B.47,XXX<br>C.69,XYY<br>D.45,X<br>E.46,XX,5p-</td>
      <td>D.45,X</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>22. Which of the following statements is true of X inactivation? (2.0分)</td>
      <td>A.The paternal X is always inactive in female somatic cells<br>B.Because of X inactivation, males with an XXY genotype have no apparent phenotype<br>C.The entire inactivated X chromosome is transcriptionally silent<br>D.There will be two Barr bodies in each somatic cell of an XXX female<br>E.X inactivation hypothesis was first proposed by Francis Collins</td>
      <td>D.There will be two Barr bodies in each somatic cell of an XXX female</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>23. In a condition such as hypertension the recurrence risk will be greatest for which of the following relatives of an affected individual? (2.0分)</td>
      <td>A.Brother<br>B.Nephew<br>C.Grandchild<br>D.Aunt<br>E.Grandchild's child</td>
      <td>A.Brother</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>24. The proportion of genes shared by first cousins is on average ___. (2.0分)</td>
      <td>A.1/2<br>B.1/4<br>C.1/8<br>D.1/16<br>E.1/32</td>
      <td>C.1/8</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>25. A study of a disorder reveals that monozygotic twins are concordant 40% of the time, whereas full siblings are concordant 10% of the time. Which of the following is the best interpretation of this finding? (2.0分)</td>
      <td>A.The trait has no genetic component.<br>B.The trait is completely determined by genetics.<br>C.The trait is completely determined by environmental factors..<br>D.Genes contribute to the trait, but are not deterministic.<br>E.The trait must be due to the biology of twinning.</td>
      <td>D.Genes contribute to the trait, but are not deterministic.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>26. A case-control association study indicates a 1.6 fold relative risk of diabetes in individuals who carry a specific allele. What is the most reasonable interpretation of this result? (2.0分)</td>
      <td>A.The allele causes the trait in the study population.<br>B.The allele may not cause the trait, but the gene does cause the trait in the study population.<br>C.The allele is closely linked to another allele that causes the trait in the study population.<br>D.There is an association between the allele and expressing the trait in the population that was studied.<br>E.No association exists between the allele and diabetes in the study population.</td>
      <td>D.There is an association between the allele and expressing the trait in the population that was studied.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>27. Both of Mary's sons have the X-linked disorder Duchenne muscular dystrophy. A deletion in the DMD gene is found in each of the boys, but no mutation in DMD is found when a blood sample from Mary is analyzed. What is the most likely explanation? (2.0分)</td>
      <td>A.The boys were affected by separate mutation events in DMD<br>B.The mutation was inherited from the boys' father<br>C.Mary is germline mosaic for a DMD deletion<br>D. The phenotype is not penetrant in Mary<br>E.The phenotype is X-linked recessive</td>
      <td>C.Mary is germline mosaic for a DMD deletion</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>28. Which inheritance pattern best describes the pedigree shown here? (2.0分)</td>
      <td>A.AD<br>B.AR<br>C.XD<br>D.XR<br>E.Mitochodrial</td>
      <td>D.XR</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>29. Male to male transmission is a key feature of which pattern of inheritance? (2.0分)</td>
      <td>A.AD<br>B.AR<br>C.XD<br>D.XR<br>E.Mitochodrial</td>
      <td>A.AD</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>30. Which of the following disorders does NOT show X-linked inheritance? (2.0分)</td>
      <td>A.Duchenne muscular dystrophy<br>B.Tay-Sachs disease<br>C.Hemophilia A<br>D.Hemophilia B<br>E.Red-green blindness</td>
      <td>B.Tay-Sachs disease</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>31. Leber hereditary optic atrophy (LHON) is caused by a mutation in: (2.0分)</td>
      <td>A.chromosome 13.<br>B.chromosome 18.<br>C.chromosome 21.<br>D.chromosome 5.<br>E.mitochondrial DNA.</td>
      <td>E.mitochondrial DNA.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>32. A dominantly inherited trait affects a child and his grandmother, but neither parent. This best illustrates which of the following principles? (2.0分)</td>
      <td>A.Variable expressivity.<br>B.New mutation.<br>C.Somatic mosaicism.<br>D.Non-penetrance<br>E.Genomic imprinting</td>
      <td>D.Non-penetrance</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>33. Two parents with autosomal recessive albinism have a child who does not have albinism. This is best explained by: (2.0分)</td>
      <td>A.An incorrect diagnosis in one parent.<br>B.Misattributed paternity.（亲子关系出错）<br>C.Genetic heterogeneity.<br>D.Reversion of one of the mutant alleles to wild type.<br>E.Pleiotropy.</td>
      <td>C.Genetic heterogeneity.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>34. A thalassemia is a hemoglobin disorder in which (2.0分)</td>
      <td>A.The beta-globin chain is present at normal levels but is misfolded<br>B.Any globin chain is present at normal levels but is misfolded<br>C.The beta-globin chain is absent or is present at reduced levels<br>D.Any globin chain is absent or is present at reduced levels<br>E.Either B or D is true, depending upon the type of thalassemia</td>
      <td>D.Any globin chain is absent or is present at reduced levels</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>35. The presence of genes in the same chromosome is an example of (2.0分)</td>
      <td>A.Linkage<br>B.Coordination<br>C.Free assortment<br>D.Segregations<br>E.Fusion</td>
      <td>A.Linkage</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>36. Why might a woman opt for chrionic villus sampling (CVS) over amniocentesis for prenatal diagnosis？ (2.0分)</td>
      <td>A.It is more accurate than amniocentesis.<br>B.There are much lower complication rates for CVS.<br>C.It can be performed earlier in gestation.<br>D.More doctors are trained to perform CVS than amniocentesis.<br>E.More genetic disorders can be found by CVS than by amniocentesis.</td>
      <td>C.It can be performed earlier in gestation.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>37. The risk for miscarriage associated with amniocentesis is approximately ____. (2.0分)</td>
      <td>A.1/10<br>B.1/50<br>C.1/100 - 1/200<br>D.1/1000<br>E.1/3000</td>
      <td>C.1/100 - 1/200</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>38. Availability of DNA testing for many single disease traits has allowed routine prenatal screening of couples for disorders prevalent in their ethnic group. Which of the following genetic disorders has a similar incidence in different ethnic groups and would not be subject to different criteria for screening? (2.0分)</td>
      <td>A.Cystic fibrosis<br>B.Thalassemias<br>C.Tay-Sachs disease<br>D.Down syndrome<br>E.Huntington disease</td>
      <td>D.Down syndrome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>39. Which of the following techniques was NOT used to detect an unknown mutation? (2.0分)</td>
      <td>A.SSCP<br>B.ASO<br>C.DHPLC<br>D.DGGE<br>E.DNA sequencing</td>
      <td>B.ASO</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>40. Which of the following prenatal diagnostic techniques routinely allows fetal chromosomes to be analyzed during first trimester of pregnancy? (2.0分)</td>
      <td>A. Cordocentesis<br>B.Amniocentesis<br>C.Chorionic villus sampling<br>D.Radiography<br>E.Maternal triple testing</td>
      <td>C.Chorionic villus sampling</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>41. In the gene chip illustrated above, a cDNA library made from a control, unaffected individual has been labelled with a green probe and a cDNA library made from a patient has been labelled with a red probe. Based upon the color of the spots labelled A, B, and C, we can conclude which of the following relationships? (2.0分)</td>
      <td>A.Gene B is expressed at a higher level and gene A at a lower level in the patient than in the control, and gene C is expressed at the same level in both people.<br>B.The mRNA from gene A is degraded more rapidly and that from gene B less rapidly in the patient than the control, but the mRNA from gene C is equally stable for both individuals.<br>C.Gene B is expressed at a higher level and gene A at a lower level in the patient than the control, and gene C is not present at all in the patient.<br>D.The mRNA from gene A is degraded more rapidly and that from gene B less rapidly in the patient than the control, and the mRNA from gene C is not present at all in the patient.<br>E.Either A or B</td>
      <td>E.Either A or B</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>42. In the beta-thalassemia case presented in the first week, one might imagine that an embryonic stem cell transplant might cure 何尼科. Where would one obtain such cells? (2.0分)</td>
      <td>A.From the umbilicord cord blood（脐带血）<br>B.From the chorion（绒毛膜）<br>C.From the inner cell mass of the blastocyst（胚泡的内细胞团）<br>D.From the syncytiotrophoblast（合体滋养层）<br>E.From the white blood cells</td>
      <td>C.From the inner cell mass of the blastocyst（胚泡的内细胞团）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>43. Why might a woman opt for chrionic villus sampling (CVS) over amniocentesis for prenatal diagnosis？ (2.0分)</td>
      <td>A.It is more accurate than amniocentesis.<br>B.There are much lower complication rates for CVS.<br>C.It can be performed earlier in gestation.<br>D.More doctors are trained to perform CVS than amniocentesis.<br>E.More genetic disorders can be found by CVS than by amniocentesis.</td>
      <td>C.It can be performed earlier in gestation.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>44. Why might a woman opt for chrionic villus sampling (CVS) over amniocentesis for prenatal diagnosis？ (2.0分)</td>
      <td>A.It is more accurate than amniocentesis.<br>B.There are much lower complication rates for CVS.<br>C.It can be performed earlier in gestation.<br>D.More doctors are trained to perform CVS than amniocentesis.<br>E.More genetic disorders can be found by CVS than by amniocentesis.</td>
      <td>C.It can be performed earlier in gestation.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>45. Which of the following properties would a single nucleotide polymorphism (SNP) have to be detected by Southern blot? (2.0分)</td>
      <td>A.It must alter the encoded amino acid sequence<br>B.It must alter a splice site<br>C.It must alter a restriction site<br>D.It must be a nonsense mutation<br>E.It must alter the stability of the encoded mRNA</td>
      <td>C.It must alter a restriction site</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>46. Becky is a 7-day-old infant who has phenylketonuria. Her parents have come to you for advice on managing her condition. Which of the following statements most accurately describes the best management for this disorder? (2.0分)</td>
      <td>A.All protein must be eliminated from the diet.<br>B.A protein-restricted diet must be followed.<br>C.A high-protein diet in a pregnant mother causes phenylketonuria.<br>D.A high-protein diet must be followed<br>E.A high-protein diet must be followed.</td>
      <td>B.A protein-restricted diet must be followed.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>47. Advantages of using adenoviruses for gene therapy include: (2.0分)</td>
      <td>A.long term expression.<br>B.short term expression.<br>C.low risk of insertional mutagenesis.<br>D.low immunogenecity.<br>E.easy assembly.</td>
      <td>C.low risk of insertional mutagenesis.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>48. Which of the following is the usual treatment of hemophilia A? (2.0分)</td>
      <td>A.Blood transfusion<br>B.Liver transplant<br>C.Bone marrow transplant<br>D.Infusion of factor VIII as needed<br>E.Spleen transplant</td>
      <td>D.Infusion of factor VIII as needed</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>49. Which of the following gene-therapy vectors preferentially infects nerve cells? (2.0分)</td>
      <td>A.Adeno-associated virus<br>B.Retrovirus<br>C.Herpes virus<br>D.Adenovirus<br>E.Liposome</td>
      <td>C.Herpes virus</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2009</td>
      <td>50. Which of the following vectors targets both dividing and non-dividing cells? (2.0分)</td>
      <td>A.Retrovirus<br>B.Adenovirus<br>C.Adeno-associated virus<br>D.Herpes virus<br>E.Liposome</td>
      <td>B.Adenovirus</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>1. Gene therapy is an established, broadly available procedure for the treatment of: (3.0分)</td>
      <td>A.cystic fibrosis（囊性纤维化）<br>B.deafness（耳聋）<br>C.hemophilia（血友病）<br>D.melanoma（黑色素瘤）<br>E.no disease as yet</td>
      <td>E.no disease as yet</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>2. Which of the following vectors（载体） targets both dividing（增殖细胞） and non-dividing cells（非增殖细胞）?(3.0分)</td>
      <td>A.Retrovirus（反转录病毒）<br>B.Adenovirus（腺病毒）<br>C.Adeno-associated virus（腺病毒相关病毒）<br>D.Herpes virus（疱疹病毒）<br>E.Liposome（脂质体）</td>
      <td>B.Adenovirus（腺病毒）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>3. Which of the following must be true for gene therapy to ameliorate（改善）a genetic disease?(3.0分)</td>
      <td>A.The gene therapy vector（载体） must be able to access all cells in the body.<br>B.A wild-type（野生型） level of the encoded gene product must be achieved.<br>C.The mutated gene must be excised（切除） and replaced.<br>D.There must be a limited immune response（免疫反应） to the gene therapy vector.<br>E.The disease mutation must cause a gain of function（功能获得）.</td>
      <td>D.There must be a limited immune response（免疫反应） to the gene therapy vector.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>4. Why might a woman opt（选择） for chrionic villus sampling (CVS。绒毛膜吸取术) over amniocentesis（羊膜穿刺术） for prenatal diagnosis？ (3.0分)</td>
      <td>A.It is more accurate than amniocentesis.<br>B.There are much lower complication rates for CVS.<br>C.It can be performed earlier in gestation.<br>D.More doctors are trained to perform CVS than amniocentesis.<br>E.More genetic disorders can be found by CVS than by amniocentesis.</td>
      <td>C.It can be performed earlier in gestation.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>5. Types of nucleic acid hybridisation（核酸杂交） include the below EXCEPT(3.0分)</td>
      <td>A.Southern blotting<br>B.Microarray<br>C.Western blotting<br>D.Northern blotting<br>E.DNA fingerprinting</td>
      <td>C.Western blotting</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>6. Suppose you are attempting to find a disease-causing gene（假设你准备寻找某个新疾病基因）, and you have identified a number of families in which the disease is transmitted（假设你准备寻找某个新疾病基因，手头已有多个疾病家系）. If you have no knowledge of the gene product and no reasonable candidate locus（如果你还不知道相关的基因产物和可能的候选基因座）, which of the following would be the FIRST technique you would be most likely to use?(3.0分)</td>
      <td>A.Linkage analysis（连锁分析）<br>B.DNA sequencing（DNA测序）<br>C.Single strand conformation polymorphism (SSCP) analysis<br>D.Denaturing high-performance liquid chromatography (dHPLC)<br>E.Fluorescence in situ hybridization (FISH)</td>
      <td>A.Linkage analysis（连锁分析）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>7. In the beta-thalassemia case presented in the first week PBL, one might imagine that an embryonic stem cell transplant might cure 何尼科（即PBL案例中的那个患儿）. Where would one obtain such cells?(3.0分)</td>
      <td>A.From the umbilicord cord blood（脐带血）<br>B.From the chorion（绒毛膜）<br>C.From the inner cell mass of the blastocyst（胚泡的内细胞团）<br>D.From the syncytiotrophoblast（合体滋养层）<br>E.From the white blood cells（白细胞）</td>
      <td>C.From the inner cell mass of the blastocyst（胚泡的内细胞团）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>8. Which of the following prenatal diagnostic techniques routinely allows fetal chromosomes to be analyzed during first trimester of pregnancy?(3.0分)</td>
      <td>A.Cordocentesis<br>B.Amniocentesis<br>C.Chorionic villus sampling<br>D.Radiography<br>E.Maternal triple testing</td>
      <td>C.Chorionic villus sampling</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>9. A thalassemia（地中海贫血） is a hemoglobin disorder（血红蛋白病） in which(3.0分)</td>
      <td>A.The beta-globin chain is present at normal levels but is misfolded（错误折叠）<br>B.Any globin chain is present at normal levels but is misfolded<br>C.The beta-globin chain is absent or is present at reduced levels<br>D.Any globin chain is absent or is present at reduced levels<br>E.Either B or D is true, depending upon the type of thalassemia</td>
      <td>D.Any globin chain is absent or is present at reduced levels</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>10. Which of the following disorders does NOT show X-linked inheritance?(4.0分)</td>
      <td>A.Duchenne muscular dystrophy<br>B.Tay-Sachs disease<br>C.Hemophilia A（血友病A）<br>D.Hemophilia B<br>E.Red-green blindness（红绿色盲）</td>
      <td>B.Tay-Sachs disease</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>11. Two parents with autosomal recessive albinism（白化病） have a child who does not have albinism. This is best explained by:(3.0分)</td>
      <td>A.An incorrect diagnosis in one parent.<br>B.Misattributed paternity.（亲子关系出错）<br>C.Genetic heterogeneity.（遗传异质性）<br>D.Reversion of one of the mutant alleles to wild type.<br>E.Pleiotropy.（多效性）</td>
      <td>C.Genetic heterogeneity.（遗传异质性）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>12. Leber hereditary optic atrophy (LHON) is caused by a mutation in:(3.0分)</td>
      <td>A.chromosome 13.<br>B.chromosome 18.<br>C.chromosome 21.<br>D.chromosome 5.<br>E.mitochondrial DNA.</td>
      <td>E.mitochondrial DNA.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>13. Which of the following conditions does NOT show multifactorial inheritance（多因子遗传）? (3.0分)</td>
      <td>A.Pyloric stenosis（幽门狭窄）<br>B.Schizophrenia（精神分裂症）<br>C.Spina bifida (neural tube defects)（脊柱裂。神经管缺陷）<br>D.Hirschsprung disease（先天性巨结肠症）<br>E.Marfan syndrome</td>
      <td>E.Marfan syndrome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>14. A study of a disorder reveals that monozygotic twins are concordant（一致性） 40% of the time, whereas full siblings（同胞） are concordant 10% of the time. Which of the following is the best interpretation of this finding?(3.0分)</td>
      <td>A.The trait has no genetic component.<br>B.The trait is completely determined by genetics.<br>C.The trait is completely determined by environmental factors..<br>D.Genes contribute to the trait, but are not deterministic.<br>E.The trait must be due to the biology of twinning.</td>
      <td>D.Genes contribute to the trait, but are not deterministic.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>15. Several genetic disorders exhibit genetic association with markers in the major histocompatibility complex region（组织相容性复合体区域。即HLA）. Which of the following factors complicates the further dissection of these associations?(3.0分)</td>
      <td>A.Few markers（标志） are found in this region.<br>B.High levels of linkage disequilibrium（连锁不平衡） are found in this region.<br>C.Low levels of sequence polymorphism are found in this region.<br>D.Expression of these genes is limited.<br>E.There is hypermutability（超突变性） of the region.</td>
      <td>B.High levels of linkage disequilibrium（连锁不平衡） are found in this region.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>16. Which one of the following conditions is NOT usually regarded as multifactorial?(3.0分)</td>
      <td>A.Rheumatoid arthritis（类风关）<br>B.Insulin-dependent diabetes mellitus（胰岛素依赖型糖尿病）<br>C.McCune-Albright syndrome（McCune-Albright综合征）<br>D.Asthma（哮喘）<br>E.Parkinson disease（Parkinson病）</td>
      <td>C.McCune-Albright syndrome（McCune-Albright综合征）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>17. The presence of two or more cell lines from different zygotes in a single individual is known as:(3.0分)</td>
      <td>A.mosaicism.<br>B.diploidy. （二倍体）<br>C.aneuploidy.（非整倍体）<br>D.euploidy. （整倍体）<br>E.chimaerism.</td>
      <td>E.chimaerism.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>18. Which of the following statements is true of X inactivation（X染色体失活）?(3.0分)</td>
      <td>A.The paternal X is always inactive in female somatic cells<br>B.Because of X inactivation, males with an XXY genotype have no apparent phenotype<br>C.The entire inactivated X chromosome is transcriptionally silent<br>D.There will be two Barr bodies in each somatic cell of an XXX female<br>E.X inactivation hypothesis was first proposed by Francis Collins</td>
      <td>D.There will be two Barr bodies in each somatic cell of an XXX female</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>19. Which of the following is NOT often seen in the individual with Klinefelter syndrome?(3.0分)</td>
      <td>A.webbed neck（蹼颈）<br>B.ncreased stature（身长）<br>C.diminished IQ (on average)（轻度智力障碍）<br>D.sterility（不育）<br>E.Gynecomastia（男子乳腺发育）</td>
      <td>A.webbed neck（蹼颈）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>20. Polymorphisms（多态性）(3.0分)</td>
      <td>A.Refer to multiple conformations observed for the same sequence of DNA<br>B.Refers to allelic variations that are common ( in >1% of population)<br>C.Refer to the mutant sequence of DNA from patients<br>D.Are produced by insertions or deletions<br>E.Are produced by inversion</td>
      <td>B.Refers to allelic variations that are common ( in >1% of population)</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>21. The process that allows humans to be more complex than common weeds such as Arabadopsis (拟南芥。一种十字花科植物。模式生物), despite an equivalent number of genes, is(3.0分)</td>
      <td>A.alternative splicing（可变剪接）<br>B.nucleotide expansion（核苷酸扩增）<br>C.nucleotide polymorphisms<br>D.transcription<br>E.translation</td>
      <td>A.alternative splicing（可变剪接）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>22. The splice donor（剪接供体） is located(3.0分)</td>
      <td>A.At the promoter.<br>B.At the 5' end of the intron.<br>C.At the branch point of the intron.<br>D.At the 3' end of the intron.<br>E.At the enhancer.</td>
      <td>B.At the 5' end of the intron.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>23. SSCP不适合检测的突变类型是： (3.0分)</td>
      <td>A.已知单碱基突变<br>B.碱基置换<br>C.未知单碱基突变<br>D.外显子缺失突变</td>
      <td>D.外显子缺失突变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>24. 下哪项不能作为判断G带制备好坏的标准： (3.0分)</td>
      <td>A.细胞完整，轮廓清晰，染色体在同一平面上均匀分布<br>B.染色体形态和分散良好，无重叠现象，即使染色体个别重叠，也要能明显辨别<br>C.所观察的染色体长短大致一样，处于同一有丝分裂时期<br>D.在所观察的染色体周围有多个散在的染色</td>
      <td>D.在所观察的染色体周围有多个散在的染色</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>25. 秋水仙素在人类染色体制备过程的作用机理： (3.0分)</td>
      <td>A.促进染色体合成<br>B.细胞周期阻滞在有丝分裂中期<br>C.促进淋巴细胞解体<br>D.刺激淋巴细胞增殖</td>
      <td>B.细胞周期阻滞在有丝分裂中期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>26. 下列哪一种指标常用来说明疾病对人的生命危险程度： (3.0分)</td>
      <td>A.发病率<br>B.死亡率<br>C.患病率<br>D.罹患率<br>E.病死率</td>
      <td>E.病死率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>27. 疾病的时间分布中，周期性是指： (3.0分)</td>
      <td>A.疾病每年在一定的季节内呈现发病率升高的现象<br>B.疾病发生频率经过一个相当规律的时间间隔，呈现规律性变动的状况<br>C.以日、周、月计数的短期观察数据<br>D.对疾病动态的连续数年乃至数十年的观察，在这个长时间内观察探讨疾病的病原体、临床表现、发病率、死亡率等的变化或它们同时发生的变化情况<br>E.以上都不对</td>
      <td>B.疾病发生频率经过一个相当规律的时间间隔，呈现规律性变动的状况</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>28. 利用出生队列资料将疾病年龄分布和时间分布结合起来描述的一种方法叫做： (3.0分)</td>
      <td>A.横断面分析<br>B.生态学分析<br>C.出生队列分析<br>D.回顾性分析<br>E.以上都不对</td>
      <td>C.出生队列分析</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>29. 某地共有居民200000人，2003年罹患SARS 20人,其中死亡1人，该地2003年SARS的（ ）为5%。(3.0分)</td>
      <td>A.发病率<br>B.病死率<br>C.患病率<br>D.罹患率<br>E.以上都不对</td>
      <td>B.病死率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>30. 下述中，数字成像关于像素和体素的不准确的概念是哪项(3.0分)</td>
      <td>A.CT单一层面图像的二维基本组成单元称为像素<br>B.像素大小与图像的空间分辨率高低成正比<br>C.体素是一个三维概念，可以反应各层图像的空间分辨力大小<br>D.体素是物体体积成像是被三维矩阵分割排列的基本成像单元<br>E.像素实际上是体素在单一层面成像时的表现</td>
      <td>B.像素大小与图像的空间分辨率高低成正比</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>31. 有关窗技术的，下列关于组织显示图像灰阶密度高低的描述，正确的是(3.0分)</td>
      <td>A.窗宽显示密度范围外的组织不能显示，图像表现为黑色<br>B.与窗位CT值相同的组织显示中等亮度，适于观察<br>C.无论不同组织密度差异大小，任何图像上肉眼都能发现差别<br>D.窗宽范围以上的组织显示纯黑色<br>E.窗宽范围以下的组织显示为纯白色</td>
      <td>B.与窗位CT值相同的组织显示中等亮度，适于观察</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>32. 下列关于CT值得概念，那一项是正确的(3.0分)</td>
      <td>A.CT值反映了物质的密度相对高低<br>B.反映了物质内水的成分含量<br>C.是物质密度的绝对测量值<br>D.不同的CT机器扫描产生的CT值不同<br>E.根据CT值大小可以对病变做出定性诊断</td>
      <td>A.CT值反映了物质的密度相对高低</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2010</td>
      <td>33. 某女 has mitochondrial encephalomyopathy and stroke-like episodes (MELAS). Her genetic counselor tells her that it is very difficult to predict the severity（严重程度） of the syndrome in any affected children that she will have. What property of mitochondrial（线粒体） mutations, which is distinct from nuclear mutations（核基因组突变）, explains this variability（变异性） in the expression of mitochondrial mutations?(3.0分)</td>
      <td>A.mutation heteroplasmy（杂质性）<br>B.incomplete dominance（不完全显性）<br>C.pleiotropy（多效性）<br>D.epistasis（）上位性<br>E.the lack of DNA repair enzymes（DNA修复酶） in mitochondria</td>
      <td>A.mutation heteroplasmy（杂质性）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>1. 下述中，数字成像关于像素和体素的不准确的概念是哪项？(2.5分)</td>
      <td>A.CT单一层面图像的二维基本组成单元称为像素<br>B.像素大小与图像的空间分辨率高低成正比<br>C.体素是一个三维概念，可以反应各层图像的空间分辨力大小<br>D.体素是物体体积成像是被三维矩阵分割排列的基本成像单元<br>E.像素实际上是体素在单一层面成像时的表现</td>
      <td>B.像素大小与图像的空间分辨率高低成正比</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>2. 下列关于CT值得概念，那一项是正确的？(2.5分)</td>
      <td>A.CT值反映了物质的密度相对高低<br>B.反映了物质内水的成分含量<br>C.是物质密度的绝对测量值<br>D.不同的CT机器扫描产生的CT值不同<br>E.根据CT值大小可以对病变做出定性诊断</td>
      <td>A.CT值反映了物质的密度相对高低</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>3. 有关窗技术的，下列关于窗位的概念，正确的是(2.5分)</td>
      <td>A.窗宽相当于窗显示图像的灰阶中心CT值<br>B.窗宽规定 窗显示的组织密度范围的CT值大小<br>C.不同机器的窗位、窗宽值不同<br>D.窗位与所显示的组织CT值无关<br>E.通常窗位选择以水的CT值为标准</td>
      <td>B.窗宽规定 窗显示的组织密度范围的CT值大小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>4. 检验多能干细胞的标准是: (2.5分)</td>
      <td>A.体外向三个胚层分化的能力；<br>B.体内形成畸胎瘤的能力；<br>C.注射到囊胚后形成嵌合体的能力；<br>D.A, B 和 C</td>
      <td>D.A, B 和 C</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>5. 目前普遍认为以下哪个部位和功能性造血干细胞的发生发育及维持无关: (2.5分)</td>
      <td>A.胎肝 (fetal liver)<br>B.骨髓 (bone marrow)<br>C.血岛 (blood island)<br>D.主动脉-肾腺区(AGM)</td>
      <td>C.血岛 (blood island)</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>6. 关于"流行病学"，下列说法哪项是错误的： (2.5分)</td>
      <td>A.流行病学是从群体角度研究疾病与健康<br>B.流行病学中的研究群体是指所有人群<br>C.流行病学从疾病分布入手探讨疾病的流行因素<br>D.流行病学属于预防医学的范畴<br>E.流行病学已深入临床医学的研究中</td>
      <td>B.流行病学中的研究群体是指所有人群</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>7. 某县历年流脑发病率均在12/10万~20/10万之间,去年该县流脑发病率为16/10万,试判断其流行强度：(2.5分)</td>
      <td>A.散发<br>B.暴发<br>C.流行<br>D.大流行<br>E.以上均不对</td>
      <td>A.散发</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>8. 疾病的时间分布中，周期性是指： (2.5分)</td>
      <td>A.疾病每年在一定的季节内呈现发病率升高的现象<br>B.疾病发生频率经过一个相当规律的时间间隔，呈现规律性变动的状况<br>C.以日、周、月计数的短期观察数据<br>D.对疾病动态的连续数年乃至数十年的观察，在这个长时间内观察探讨疾病的病原体、临床表现、发病率、死亡率等的变化或它们同时发生的变化情况<br>E.以上都不对</td>
      <td>B.疾病发生频率经过一个相当规律的时间间隔，呈现规律性变动的状况</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>9. 疾病的三间分布是指时间分布、地区分布和什么分布？(2.5分)</td>
      <td>A.年龄<br>B.性别<br>C.人群<br>D.空间<br>E.季节</td>
      <td>C.人群</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>10. Polymorphisms（多态性）(2.5分)</td>
      <td>A.Refer to multiple conformations observed for the same sequence of DNA<br>B.Refers to allelic variations that are common ( in >1% of population)<br>C.Refer to the mutant sequence of DNA from patients<br>D.Are produced by insertions or deletions<br>E.Are produced by inversion</td>
      <td>B.Refers to allelic variations that are common ( in >1% of population)</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>11. The process that allows humans to be more complex than common weeds such as Arabadopsis (拟南芥。一种十字花科植物。模式生物), despite an equivalent number of genes, is(2.5分)</td>
      <td>A.alternative splicing（可变剪接）<br>B.nucleotide expansion（核苷酸扩增）<br>C.nucleotide polymorphisms<br>D.transcription<br>E.translation</td>
      <td>A.alternative splicing（可变剪接）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>12. A nonsense mutation（无义突变） involves(2.5分)</td>
      <td>A.a regulatory sequence.<br>B.an AG splice acceptor site.<br>C.the creation of a different amino acid.<br>D.the creation of a stop codon.<br>E.the creation of the same amino acid.</td>
      <td>D.the creation of a stop codon.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>13. A mechanism of epigenetic inheritance（表观遗传） is(2.5分)</td>
      <td>A.DNA methylation（甲基化）<br>B.genomic imprinting（基因组印迹）<br>C.histone modification（组蛋白修饰）<br>D.non-coding RNAs（非编码RNA）<br>E.All of the above</td>
      <td>E.All of the above</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>14. In a Robertsonian translocation fusion occurs at the:(2.5分)</td>
      <td>A.telomeres（端粒）.<br>B.centromeres（着丝粒）.<br>C.histones（组蛋白）.<br>D.ends of the long arms.<br>E.Middle of the long arms.</td>
      <td>B.centromeres（着丝粒）.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>15. Which of the following statements is true of X inactivation（X染色体失活）?(2.5分)</td>
      <td>A.The paternal X is always inactive in female somatic cells<br>B.Because of X inactivation, males with an XXY genotype have no apparent phenotype<br>C.The entire inactivated X chromosome is transcriptionally silent<br>D.There will be two Barr bodies in each somatic cell of an XXX female<br>E.X inactivation hypothesis was first proposed by Francis Collins</td>
      <td>D.There will be two Barr bodies in each somatic cell of an XXX female</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>16. Which of the following is NOT often seen in the individual with Klinefelter syndrome?(2.5分)</td>
      <td>A.webbed neck（蹼颈）<br>B.increased stature（身长）<br>C.diminished IQ (on average)（轻度智力障碍）<br>D.sterility（不育）<br>E.Gynecomastia（男子乳腺发育）</td>
      <td>A.webbed neck（蹼颈）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>17. Jim is a 5-year-old boy with moderate mental retardation（智力低下）, features of autism（自闭症）, and a long face with large ears. What inherited syndrome would be the most likely cause of these features?(2.5分)</td>
      <td>A.Down syndrome<br>B.Fragile X syndrome （脆性X综合征）<br>C.Patau syndrome （即13三体）<br>D.Edward syndrome（即18三体）<br>E.Marfan syndrome</td>
      <td>B.Fragile X syndrome （脆性X综合征）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>18. In a condition such as hypertension（高血压） the recurrence risk（再现风险） will be greatest for which of the following relatives of an affected individual?(2.5分)</td>
      <td>A.Brother<br>B.Nephew<br>C.Grandchild<br>D.Aunt<br>E.Grandchild's child</td>
      <td>A.Brother</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>19. A study of a disorder reveals that monozygotic twins are concordant（一致性） 40% of the time, whereas full siblings（同胞） are concordant 10% of the time. Which of the following is the best interpretation of this finding?(2.5分)</td>
      <td>A.The trait has no genetic component.<br>B.The trait is completely determined by genetics.<br>C.The trait is completely determined by environmental factors..<br>D.Genes contribute to the trait, but are not deterministic.<br>E.The trait must be due to the biology of twinning.</td>
      <td>D.Genes contribute to the trait, but are not deterministic.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>20. Several genetic disorders exhibit genetic association with markers in the major histocompatibility complex region（组织相容性复合体区域。即HLA）. Which of the following factors complicates the further dissection of these associations?(2.5分)</td>
      <td>A.Few markers（标志） are found in this region.<br>B.High levels of linkage disequilibrium（连锁不平衡） are found in this region.<br>C.Low levels of sequence polymorphism are found in this region.<br>D.Expression of these genes is limited.<br>E.There is hypermutability（超突变性） of the region.</td>
      <td>B.High levels of linkage disequilibrium（连锁不平衡） are found in this region.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>21. You would be likely to observe the lowest heritability（遗传率） score in (2.5分)</td>
      <td>A.Cystic fibrosis（囊性纤维化）<br>B.Spina bifida（脊柱裂）<br>C.Cleft lip/palate（唇裂/腭裂）<br>D.Mumps（腮腺炎）<br>E.Congenital heart disease（先天性心脏病）</td>
      <td>D.Mumps（腮腺炎）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>22. Both of Mary's sons have the X-linked disorder Duchenne muscular dystrophy (DMD。假性肥大性肌营养不良). A deletion（缺失） in the DMD gene is found in each of the boys, but no mutation in DMD is found when a blood sample from Mary is analyzed. What is the most likely explanation? (2.5分)</td>
      <td>A.The boys were affected by separate mutation events in DMD<br>B.The mutation was inherited from the boys' father<br>C.Mary is germline mosaic（种系嵌合体） for a DMD deletion<br>D.The phenotype is not penetrant（不外显） in Mary<br>E.The phenotype is X-linked recessive</td>
      <td>C.Mary is germline mosaic（种系嵌合体） for a DMD deletion</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>23. Two parents with autosomal recessive albinism（白化病） have a child who does not have albinism. This is best explained by:(2.5分)</td>
      <td>A.An incorrect diagnosis in one parent.<br>B.Misattributed paternity.（亲子关系出错）<br>C.Genetic heterogeneity.（遗传异质性）<br>D.Reversion of one of the mutant alleles to wild type.<br>E.Pleiotropy.（多效性）</td>
      <td>C.Genetic heterogeneity.（遗传异质性）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>24. Which of the following statements is true of X inactivation（X染色体失活）?(2.5分)</td>
      <td>A.The paternal X is always inactive in female somatic cells<br>B.Because of X inactivation, males with an XXY genotype have no apparent phenotype<br>C.the entire inactivated X chromosome is transcriptionally silent<br>D.There will be two Barr bodies in each somatic cell of an XXX female</td>
      <td>D.There will be two Barr bodies in each somatic cell of an XXX female</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>25. Which of the following disorders does NOT show X-linked inheritance?(2.5分)</td>
      <td>A.Duchenne muscular dystrophy<br>B.Tay-Sachs disease<br>C.Hemophilia A（血友病A）<br>D.Hemophilia B<br>E.Red-green blindness（红绿色盲）</td>
      <td>B.Tay-Sachs disease</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>26. Why might a woman opt（选择） for chrionic villus sampling (CVS。绒毛膜吸取术) over amniocentesis（羊膜穿刺术） for prenatal diagnosis？ (2.5分)</td>
      <td>A.It is more accurate than amniocentesis.<br>B.There are much lower complication rates for CVS.<br>C.It can be performed earlier in gestation.<br>D.More doctors are trained to perform CVS than amniocentesis.<br>E.More genetic disorders can be found by CVS than by amniocentesis.</td>
      <td>C.It can be performed earlier in gestation.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>27. Availability of DNA testing for many single disease traits has allowed routine prenatal screening of couples for disorders prevalent in their ethnic group（夫妇所在族群的高发疾病）. Which of the following genetic disorders has a similar incidence in different ethnic groups and would not be subject to different criteria for screening?(2.5分)</td>
      <td>A.Cystic fibrosis<br>B.Thalassemias<br>C.Tay-Sachs disease<br>D.Down syndrome<br>E.Huntington disease</td>
      <td>D.Down syndrome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>28. Suppose you are attempting to find a disease-causing gene（假设你准备寻找某个新疾病基因）, and you have identified a number of families in which the disease is transmitted（假设你准备寻找某个新疾病基因，手头已有多个疾病家系）. If you have no knowledge of the gene product and no reasonable candidate locus（如果你还不知道相关的基因产物和可能的候选基因座）, which of the following would be the FIRST technique you would be most likely to use?(2.5分)</td>
      <td>A.Linkage analysis（连锁分析）<br>B.DNA sequencing（DNA测序）<br>C.Single strand conformation polymorphism (SSCP) analysis<br>D.Denaturing high-performance liquid chromatography (dHPLC)<br>E.Fluorescence in situ hybridization (FISH)</td>
      <td>A.Linkage analysis（连锁分析）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>29. 某女 has mitochondrial encephalomyopathy and stroke-like episodes (MELAS). Her genetic counselor tells her that it is very difficult to predict the severity（严重程度） of the syndrome in any affected children that she will have. What property of mitochondrial（线粒体） mutations, which is distinct from nuclear mutations（核基因组突变）, explains this variability（变异性） in the expression of mitochondrial mutations?(2.5分)</td>
      <td>A.mutation heteroplasmy（杂质性）<br>B.incomplete dominance（不完全显性）<br>C.pleiotropy（多效性）<br>D.epistasis（）上位性<br>E.the lack of DNA repair enzymes（DNA修复酶） in mitochondria</td>
      <td>A.mutation heteroplasmy（杂质性）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>30. Which is false about cffDNA (cell-free fetal DNA in maternal blood)?(2.5分)</td>
      <td>A.can be used to determine fetal sex<br>B.can be used to determine fetal Rhesus group<br>C.can not be used to determine fetal karyotype<br>D.can not be used to determine fetal risk of spina bifida by now<br>E.has been used to diagnose fetal HIV infection</td>
      <td>E.has been used to diagnose fetal HIV infection</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>31. For what purpose are prenatal screening tests（产前筛查的目的） best used?(2.5分)</td>
      <td>A.To diagnose a suspected disease in a fetus<br>B.To diagnose a suspected disease in a parent<br>C.To obtain fetal cells for chromosome karyotyping<br>D.To identify individuals who should undergo diagnostic testing<br>E.To examine the DNA of a fetus for suspected mutations in a specific gene</td>
      <td>D.To identify individuals who should undergo diagnostic testing</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>32. The risk for miscarriage（流产） associated with amniocentesis（羊膜穿刺术） is approximately ____.(2.5分)</td>
      <td>A.1/10<br>B.1/50<br>C.1/100 - 1/200<br>D.1/1000<br>E.1/3000</td>
      <td>C.1/100 - 1/200</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>33. Becky is a 7-day-old infant who has phenylketonuria（苯丙酮尿症）. Her parents have come to you for advice on managing her condition. Which of the following statements most accurately describes the best management for this disorder? (2.5分)</td>
      <td>A.All protein must be eliminated（消除） from the diet.<br>B.A protein-restricted diet must be followed.<br>C.A high-protein diet in a pregnant mother causes phenylketonuria.<br>D.A high-protein diet must be followed<br>E.A high-protein diet must be followed.</td>
      <td>B.A protein-restricted diet must be followed.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>34. Which of the following gene-therapy vectors preferentially infects nerve cells?(2.5分)</td>
      <td>A.Adeno-associated virus（腺病毒相关病毒）<br>B.Retrovirus（反转录病毒）<br>C.Herpes virus（疱疹病毒）<br>D.Adenovirus（腺病毒）<br>E.Liposome（脂质体）</td>
      <td>C.Herpes virus（疱疹病毒）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>35. Which of the following is NOT currently a candidate（候选） for gene therapy?(2.5分)</td>
      <td>A.Cystic fibrosis（囊性纤维化）<br>B.Adenosine deaminase (ADA) deficiency（腺苷脱氨酶缺乏症）<br>C.Lung cancer<br>D.Bipolar affective disorder（双向情感障碍）<br>E.AIDS</td>
      <td>D.Bipolar affective disorder（双向情感障碍）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>36. Gene therapy is an established, broadly available procedure for the treatment of: (2.5分)</td>
      <td>A.cystic fibrosis（囊性纤维化）<br>B.deafness（耳聋）<br>C.hemophilia（血友病）<br>D.melanoma（黑色素瘤）<br>E.no disease as yet</td>
      <td>E.no disease as yet</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>37. Which of the following must be true for gene therapy to ameliorate（改善）a genetic disease?(2.5分)</td>
      <td>A.The gene therapy vector（载体） must be able to access all cells in the body.<br>B.A wild-type（野生型） level of the encoded gene product must be achieved.<br>C.The mutated gene must be excised（切除） and replaced.<br>D.There must be a limited immune response（免疫反应） to the gene therapy vector.<br>E.The disease mutation must cause a gain of function（功能获得）.</td>
      <td>D.There must be a limited immune response（免疫反应） to the gene therapy vector.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>38. 关于CT重建技术的临床应用，描述错误的是：(2.5分)</td>
      <td>A.反应直观，利于临床治疗计划<br>B.反应全面，不需要再费力观察大量薄层原始数据<br>C.成像角度不同，会影响病变的显示<br>D.有利于显示与周围结构关系<br>E.灌注等高级重建可提供更多血流、脏器功能等信息</td>
      <td>B.反应全面，不需要再费力观察大量薄层原始数据</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>39. 造血发育过程中功能性的造血干细胞的长期维持部位是: (2.5分)</td>
      <td>A.胎肝 (fetal liver)；<br>B.骨髓 (bone marrow);<br>C.血岛 (blood island)；<br>D.主动脉-肾腺区(AGM)</td>
      <td>B.骨髓 (bone marrow);</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2011</td>
      <td>40. 某社区共有居民500人，2009年4月新发甲型H1N1流感病例10人，截至2009年6月底，共有甲型H1N1流感病例50人，则该社区2009年4月甲型H1N1流感（A）为2%，2009年上半年（ ）为10%。(2.5分)</td>
      <td>A.发病率<br>B.病死率<br>C.患病率<br>D.罹患率<br>E.死亡率</td>
      <td>C.患病率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>1. CT的优点是： (2.5分)</td>
      <td>A.密度分辨率高<br>B.空间分辨力率高<br>C.密度分辨率低<br>D.空间分辨力低<br>E.密度分辨力低而空间分辨力高</td>
      <td>A.密度分辨率高</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>2. CT探测器对检查的作用是?(2.5分)</td>
      <td>A.探测扫描中心线是否准直<br>B.探测病人扫描位置是否准确<br>C.探测扫描时散射线的多少<br>D.探测透过射线以获得正确曝光量<br>E.探测透过射线的数量以获得测量数据</td>
      <td>E.探测透过射线的数量以获得测量数据</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>3. 下列关于CT值得概念，那一项是正确的?(2.5分)</td>
      <td>A.CT值反映了物质的密度相对高低<br>B.反映了物质内水的成分含量<br>C.是物质密度的绝对测量值<br>D.不同的CT机器扫描产生的CT值不同<br>E.根据CT值大小可以对病变做出定性诊断</td>
      <td>A.CT值反映了物质的密度相对高低</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>4. 有关窗技术的，下列关于组织显示图像灰阶密度高低的描述，正确的是： (2.5分)</td>
      <td>A.窗宽显示密度范围外的组织不能显示，图像表现为黑色<br>B.与窗位CT值相同的组织显示中等亮度，适于观察<br>C.无论不同组织密度差异大小，任何图像上肉眼都能发现差别<br>D.窗宽范围以上的组织显示纯黑色<br>E.窗宽范围以下的组织显示为纯白色</td>
      <td>B.与窗位CT值相同的组织显示中等亮度，适于观察</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>5. 以下哪种干细胞不属于成体干细胞: (2.5分)</td>
      <td>A.造血干细胞<br>B.间充质干细胞；<br>C.诱导多能干细胞<br>D.神经干细胞</td>
      <td>C.诱导多能干细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>6. 以下哪个不是成体干细胞的特点: (2.5分)</td>
      <td>A.多向分化潜能；<br>B.体外增殖能力；<br>C.移植体内后易致瘤；<br>D.A 和 C</td>
      <td>C.移植体内后易致瘤；</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>7. 下面哪个不是多能干细胞: (2.5分)</td>
      <td>A.iPSCs；<br>B.胚胎干细胞；<br>C.胚胎生殖细胞;<br>D.毛囊干细胞</td>
      <td>D.毛囊干细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>8. 下列哪一种指标常用来说明疾病对人的生命危险程度： (2.5分)</td>
      <td>A.发病率<br>B.死亡率<br>C.患病率<br>D.罹患率<br>E.病死率</td>
      <td>E.病死率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>9. 关于"流行病学"，下列说法哪项是错误的： (2.5分)</td>
      <td>A.流行病学是从群体角度研究疾病与健康<br>B.流行病学中的研究群体是指所有人群<br>C.流行病学从疾病分布入手探讨疾病的流行因素<br>D.流行病学属于预防医学的范畴<br>E.流行病学已深入临床医学的研究中</td>
      <td>B.流行病学中的研究群体是指所有人群</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>10. 下列哪一种传染病一般呈严格的季节性： (2.5分)</td>
      <td>A.虫媒传染病<br>B.寄生虫病<br>C.呼吸道传染病<br>D.肠道传染病<br>E.血液传染病</td>
      <td>A.虫媒传染病</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>11. 疾病的时间分布中，周期性是指： (2.5分)</td>
      <td>A.疾病每年在一定的季节内呈现发病率升高的现象<br>B.疾病发生频率经过一个相当规律的时间间隔，呈现规律性变动的状况<br>C.以日、周、月计数的短期观察数据<br>D.对疾病动态的连续数年乃至数十年的观察，在这个长时间内观察探讨疾病的病原体、临床表现、发病率、死亡率等的变化或它们同时发生的变化情况<br>E.以上都不对</td>
      <td>B.疾病发生频率经过一个相当规律的时间间隔，呈现规律性变动的状况</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>12. 利用出生队列资料将疾病年龄分布和时间分布结合起来描述的一种方法叫做： (2.5分)</td>
      <td>A.横断面分析<br>B.生态学分析<br>C.出生队列分析<br>D.回顾性分析<br>E.以上都不对</td>
      <td>C.出生队列分析</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>13. The human genome is estimated to consist of approximately how many genes?(2.5分)</td>
      <td>A.15 000-30 000<br>B.30 000-45 000<br>C.45 000-60 000<br>D.60 000-75 000<br>E.75 000-90 000</td>
      <td>A.15 000-30 000</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>14. Which of the following cell types would NOT be a possible source of DNA?(2.5分)</td>
      <td>A.Red blood cells<br>B.Brain cells<br>C.Liver cells<br>D.Skin cells<br>E.Heart cells</td>
      <td>A.Red blood cells</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>15. What percent of the human genome codes for polypeptide（多肽）?(2.5分)</td>
      <td>A.0.01<br>B.0.1<br>C.0.25<br>D.0.4<br>E.0.5</td>
      <td>A.0.01</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>16. Which of the following best describes a microsatellite（微卫星）?(2.5分)</td>
      <td>A.A region of repetitive DNA sequences at the end of a chromosome<br>B.A nucleotide sequence within a gene<br>C.Nucleic acid that determines the amino acid sequence in proteins<br>D.A type of DNA polymorphism<br>E.The region of DNA where two identical sister chromatids come closest in contact</td>
      <td>D.A type of DNA polymorphism</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>17. Which of the following karyotypes（核型） is NOT compatible with survival to birth?(2.5分)</td>
      <td>A.47,XY,+13<br>B.47,XY,+18<br>C.47,XY,+21<br>D.45,X<br>E. 45,Y</td>
      <td>E. 45,Y</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>18. The cause of Down syndrome is known to be?(2.5分)</td>
      <td>A.a pituitary（垂体）deficiency（缺陷）<br>B.the presence of one extra sex chromosome<br>C.the presence of one extra autosome<br>D.the absence of one autosome<br>E.a pair of recessive genes</td>
      <td>C.the presence of one extra autosome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>19. The presence of two or more cell lines from different zygotes in a single individual is known as:(2.5分)</td>
      <td>A.mosaicism.（【同源】嵌合体）<br>B.diploidy.（二倍体）<br>C.aneuploidy.（非整倍体）<br>D.euploidy.（整倍体）<br>E.chimaerism.（【异源】嵌合体）</td>
      <td>E.chimaerism.（【异源】嵌合体）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>20. Karin is a 3-year girl with developmental delay who was noted to have a heart defect as a newborn. Her pediatrician suspects she has a chromosome disorder and collects a blood sample. In what stage of mitosis will the white blood cells be tested to diagnose a chromosome disorder?(2.5分)</td>
      <td>A.interphase<br>B.prophase<br>C.metaphase<br>D.anaphase<br>E.telophase</td>
      <td>C.metaphase</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>21. Which of the following genes conveys susceptibility for polygenic Alzheimer disease? (2.5分)</td>
      <td>A.APP<br>B.PS1<br>C.PS2<br>D.APOE<br>E.DMD</td>
      <td>D.APOE</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>22. A case-control association study（病例-对照关联研究） indicates a 1.6 fold relative risk of diabetes（糖尿病） in individuals who carry a specific allele. What is the most reasonable interpretation of this result?(2.5分)</td>
      <td>A.The allele causes the trait in the study population.<br>B.The allele may not cause the trait, but the gene does cause the trait in the study population.<br>C.The allele is closely linked to another allele that causes the trait in the study population.<br>D.There is an association between the allele and expressing the trait in the population that was studied.<br>E.No association exists between the allele and diabetes in the study population.</td>
      <td>D.There is an association between the allele and expressing the trait in the population that was studied.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>23. A person is found to be homozygous（纯合子） for the ε4 allele at ApoE. Which of the following statements regarding his risk of Alzheimer disease is true?(2.5分)</td>
      <td>A.He will almost certainly develop Alzheimer disease.<br>B.He is protected from Alzheimer disease.<br>C.He is at increased risk of Alzheimer disease.<br>D.This result has no bearing on his risk of Alzheimer disease.<br>E.This result is a positive false.</td>
      <td>C.He is at increased risk of Alzheimer disease.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>24. Which one of the following conditions is NOT usually regarded as multifactorial?(2.5分)</td>
      <td>A.Rheumatoid arthritis（类风关）<br>B.Insulin-dependent diabetes mellitus（胰岛素依赖型糖尿病）<br>C.McCune-Albright syndrome（McCune-Albright综合征）<br>D.Asthma（哮喘）<br>E.Parkinson disease（Parkinson病）</td>
      <td>C.McCune-Albright syndrome（McCune-Albright综合征）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>25. Who won the Nobel Prize for His (their) contributions to PCR technique?(2.5分)</td>
      <td>A.Southern E<br>B.Sanger F<br>C.Mullis K<br>D.Watson J and Crick F<br>E.Yuet Wai Kan</td>
      <td>C.Mullis K</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>26. Which of the following techniques was NOT used to detect an unknown mutation（未知突变）?(2.5分)</td>
      <td>A.SSCP<br>B.ASO<br>C.dHPLC<br>D.DGGE<br>E.DNA sequencing</td>
      <td>B.ASO</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>27. Types of nucleic acid hybridisation（核酸杂交） include the below EXCEPT(2.5分)</td>
      <td>A.Southern blotting<br>B.Microarray<br>C.Western blotting<br>D.Northern blotting<br>E.DNA fingerprinting</td>
      <td>C.Western blotting</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>28. Which of the following techniques was mostly used to detect a trisomy（三体）?(2.5分)</td>
      <td>A.RFLP<br>B.Southern blot<br>C.FISH<br>D.PCR-HRM<br>E.DNA sequencing</td>
      <td>C.FISH</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>29. In the beta-thalassemia（beta-地中海贫血） case presented in the first week PBL, one might imagine that an embryonic stem cell transplant （胚胎干细胞移植）might cure 何尼科（即PBL案例中的那个患儿）. Where would one obtain such cells?(2.5分)</td>
      <td>A.From the umbilicord cord blood（脐带血）<br>B.From the chorion（绒毛膜）<br>C.From the inner cell mass of the blastocyst（胚泡的内细胞团）<br>D.From the syncytiotrophoblast（合体滋养层）<br>E.From the white blood cells（白细胞）</td>
      <td>C.From the inner cell mass of the blastocyst（胚泡的内细胞团）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>30. Which of the following properties would a single nucleotide polymorphism (SNP) have to be detected by Southern blot? (2.5分)</td>
      <td>A.It must alter the encoded amino acid sequence<br>B.It must alter a splice site（剪接位点）<br>C.It must alter a restriction site（限制酶酶切位点）<br>D.It must be a nonsense mutation（无义突变）<br>E.It must alter the stability（稳定性） of the encoded mRNA</td>
      <td>C.It must alter a restriction site（限制酶酶切位点）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>31. 下列哪种遗传病可通过染色体分析而确诊?(2.5分)</td>
      <td>A.精神分裂症<br>B.血友病B<br>C.Klinefelter综合征<br>D.alpha-地中海贫血<br>E.白化症</td>
      <td>C.Klinefelter综合征</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>32. Disorders with this mode of inheritance（遗传方式） are sometimes found more commonly in societies that practice consanguinity（近亲婚配）(2.5分)</td>
      <td>A.autosomal recessive<br>B.autosomal dominant<br>C.X-linked<br>D.multifactorial<br>E.cancer</td>
      <td>A.autosomal recessive</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>33. Male to male transmission（传递） is a key feature of which pattern of inheritance?(2.5分)</td>
      <td>A.D<br>B.AR<br>C.XD<br>D.XR<br>E.Mitochodrial</td>
      <td>A.D</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>34. Leber hereditary optic atrophy (LHON) is caused by a mutation in:(2.5分)</td>
      <td>A.chromosome 13.<br>B.chromosome 18.<br>C.chromosome 21.<br>D.chromosome 5.<br>E.mitochondrial DNA.</td>
      <td>E.mitochondrial DNA.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>35. The presence of genes in the same chromosome is an example of(2.5分)</td>
      <td>A.Linkage （连锁）<br>B.Coordination（协同）<br>C.Free assortment（自由组合）<br>D.Segregations（分离）<br>E.Fusion（融合）</td>
      <td>A.Linkage （连锁）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>36. The majority of vectors（载体） used for gene transfer（基因转移） in the clinical setting are derived from: (2.5分)</td>
      <td>A.automated DNA synthesis（自主DNA合成）<br>B.bacteria<br>C.insects<br>D.viruses<br>E.yeast</td>
      <td>D.viruses</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>37. Advantages of using adenoviruses（腺病毒） for gene therapy include:(2.5分)</td>
      <td>A.long term expression（表达时间长）.<br>B.short term expression（表达时间短）.<br>C.low risk of insertional mutagenesis（插入诱变的风险低）.<br>D.low immunogenecity（免疫排斥性低）.<br>E.easy assembly（易于组装）.</td>
      <td>C.low risk of insertional mutagenesis（插入诱变的风险低）.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>38. Which, if any, of the following statements is false?(2.5分)</td>
      <td>A.RNA interference (RNAi) is a cellular defense mechanism that is triggered by the presence in cells of unnatural double-stranded RNA, as can occur after viral infections.<br>B.RNAi therapy is a type of RNA-targeted therapy in which specific double-stranded RNA constructs are engineered to appear in diseased cells in order to incite the cells to destroy any RNA that contains the same sequence.<br>C.By destroying RNAs that are related to a specifically introduced genetic construct, artificial RNAi is effectively a type of gene-specific silencing.<br>D.RNAi therapy is best suited to silencing genes so as to replicate a phenotype caused by loss-of-function mutations.<br>E.Drs. Fire and Mello discovered RNAi phenomenon in 1998 and got a Nobel Prize in 2006.</td>
      <td>D.RNAi therapy is best suited to silencing genes so as to replicate a phenotype caused by loss-of-function mutations.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>39. Which of the following can be used as vectors（载体） in somatic cell gene therapy（体细胞基因治疗）?(2.5分)</td>
      <td>A.Retrovirus（反转录病毒）<br>B.Liposome（脂质体）<br>C.Adenovirus（腺病毒）<br>D.Adeno-associated virus（腺病毒相关病毒）<br>E.All of the above</td>
      <td>E.All of the above</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2012</td>
      <td>40. Which of the following is the usual treatment of hemophilia A（血友病A）?(2.5分)</td>
      <td>A.Blood transfusion<br>B.Liver transplant<br>C.Bone marrow transplant<br>D.Infusion of factor VIII as needed<br>E.Spleen transplant</td>
      <td>D.Infusion of factor VIII as needed</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>1. 以下哪种干细胞不属于成体干细胞: (2.5分)</td>
      <td>A.造血干细胞<br>B.间充质干细胞<br>C.诱导多能干细胞<br>D.神经干细胞</td>
      <td>C.诱导多能干细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>2. 以下哪个不是成体干细胞的特点: (2.5分)</td>
      <td>A.多向分化潜能<br>B.体外增殖能力；<br>C.移植体内后易致瘤<br>D.A 和 C</td>
      <td>C.移植体内后易致瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>3. 下面哪个不是多能干细胞: (2.5分)</td>
      <td>A.iPSCs<br>B.胚胎干细胞；<br>C.胚胎生殖细胞<br>D.毛囊干细胞</td>
      <td>D.毛囊干细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>4. 下列哪一种指标常用来说明疾病对人的生命危险程度： (2.5分)</td>
      <td>A.发病率<br>B.死亡率<br>C.患病率<br>D.罹患率<br>E.病死率</td>
      <td>E.病死率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>5. CT的优点是： (2.5分)</td>
      <td>A.密度分辨率高<br>B.空间分辨力率高<br>C.密度分辨率低<br>D.空间分辨力低<br>E.密度分辨力低而空间分辨力高</td>
      <td>A.密度分辨率高</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>6. CT探测器对检查的作用是?(2.5分)</td>
      <td>A.探测扫描中心线是否准直<br>B.探测病人扫描位置是否准确<br>C.探测扫描时散射线的多少<br>D.探测透过射线以获得正确曝光量<br>E.探测透过射线的数量以获得测量数据</td>
      <td>E.探测透过射线的数量以获得测量数据</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>7. 下列关于CT值得概念，那一项是正确的?(2.5分)</td>
      <td>A.CT值反映了物质的密度相对高低<br>B.反映了物质内水的成分含量<br>C.是物质密度的绝对测量值<br>D.不同的CT机器扫描产生的CT值不同<br>E.根据CT值大小可以对病变做出定性诊断</td>
      <td>A.CT值反映了物质的密度相对高低</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>8. 有关窗技术的，下列关于组织显示图像灰阶密度高低的描述，正确的是： (2.5分)</td>
      <td>A.窗宽显示密度范围外的组织不能显示，图像表现为黑色<br>B.与窗位CT值相同的组织显示中等亮度，适于观察<br>C.无论不同组织密度差异大小，任何图像上肉眼都能发现差别<br>D.窗宽范围以上的组织显示纯黑色<br>E.窗宽范围以下的组织显示为纯白色</td>
      <td>B.与窗位CT值相同的组织显示中等亮度，适于观察</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>9. 关于"流行病学"，下列说法哪项是错误的： (2.5分)</td>
      <td>A.流行病学是从群体角度研究疾病与健康<br>B.流行病学中的研究群体是指所有人群<br>C.流行病学从疾病分布入手探讨疾病的流行因素<br>D.流行病学属于预防医学的范畴<br>E.流行病学已深入临床医学的研究中</td>
      <td>B.流行病学中的研究群体是指所有人群</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>10. 下列哪一种传染病一般呈严格的季节性： (2.5分)</td>
      <td>A.虫媒传染病<br>B.寄生虫病<br>C.呼吸道传染病<br>D.肠道传染病<br>E.血液传染病</td>
      <td>A.虫媒传染病</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>11. 疾病的时间分布中，周期性是指： (2.5分)</td>
      <td>A.疾病每年在一定的季节内呈现发病率升高的现象<br>B.疾病发生频率经过一个相当规律的时间间隔，呈现规律性变动的状况<br>C.以日、周、月计数的短期观察数据<br>D.对疾病动态的连续数年乃至数十年的观察，在这个长时间内观察探讨疾病的病原体、临床表现、发病率、死亡率等的变化或它们同时发生的变化情况<br>E.以上都不对</td>
      <td>B.疾病发生频率经过一个相当规律的时间间隔，呈现规律性变动的状况</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>12. 利用出生队列资料将疾病年龄分布和时间分布结合起来描述的一种方法叫做： (2.5分)</td>
      <td>A.横断面分析<br>B.生态学分析<br>C.出生队列分析<br>D.回顾性分析<br>E.以上都不对</td>
      <td>C.出生队列分析</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>13. The human genome is estimated to consist of approximately how many genes?(2.5分)</td>
      <td>A.15 000-30 000<br>B.30 000-45 000<br>C.45 000-60 000<br>D.60 000-75 000<br>E.75 000-90 000</td>
      <td>A.15 000-30 000</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>14. Which of the following cell types would NOT be a possible source of DNA?(2.5分)</td>
      <td>A.Red blood cells<br>B.Brain cells<br>C.Liver cells<br>D.Skin cells<br>E.Heart cells</td>
      <td>A.Red blood cells</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>15. What percent of the human genome codes for polypeptide（多肽）?(2.5分)</td>
      <td>A.0.01<br>B.0.1<br>C.0.25<br>D.0.4<br>E.0.5</td>
      <td>A.0.01</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>16. Which of the following best describes a microsatellite（微卫星）?(2.5分)</td>
      <td>A.A region of repetitive DNA sequences at the end of a chromosome<br>B.A nucleotide sequence within a gene<br>C.Nucleic acid that determines the amino acid sequence in proteins<br>D.A type of DNA polymorphism<br>E.The region of DNA where two identical sister chromatids come closest in contact</td>
      <td>D.A type of DNA polymorphism</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>17. Which of the following karyotypes（核型） is NOT compatible with survival to birth?(2.5分)</td>
      <td>A.47,XY,+13<br>B.47,XY,+18<br>C.47,XY,+21<br>D. 45,X<br>E.45,Y</td>
      <td>E.45,Y</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>18. The cause of Down syndrome is known to be?(2.5分)</td>
      <td>A.a pituitary（垂体）deficiency（缺陷）<br>B.the presence of one extra sex chromosome<br>C.the presence of one extra autosome<br>D.the absence of one autosome<br>E.a pair of recessive genes</td>
      <td>C.the presence of one extra autosome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>19. The presence of two or more cell lines from different zygotes in a single individual is known as:(2.5分)</td>
      <td>A.mosaicism.（【同源】嵌合体）<br>B.diploidy.（二倍体）<br>C.aneuploidy.（非整倍体）<br>D.euploidy.（整倍体）<br>E.chimaerism.（【异源】嵌合体）</td>
      <td>E.chimaerism.（【异源】嵌合体）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>20. Karin is a 3-year girl with developmental delay who was noted to have a heart defect as a newborn. Her pediatrician suspects she has a chromosome disorder and collects a blood sample. In what stage of mitosis will the white blood cells be tested to diagnose a chromosome disorder?(2.5分)</td>
      <td>A.interphase<br>B.prophase<br>C.metaphase<br>D.anaphase<br>E.telophase</td>
      <td>C.metaphase</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>21. Which of the following genes conveys susceptibility for polygenic Alzheimer disease? (2.5分)</td>
      <td>A.APP<br>B.PS1<br>C.PS2<br>D.APOE<br>E.DMD</td>
      <td>D.APOE</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>22. A case-control association study（病例-对照关联研究） indicates a 1.6 fold relative risk of diabetes（糖尿病） in individuals who carry a specific allele. What is the most reasonable interpretation of this result?(2.5分)</td>
      <td>A.The allele causes the trait in the study population.<br>B.The allele may not cause the trait, but the gene does cause the trait in the study population.<br>C.The allele is closely linked to another allele that causes the trait in the study population.<br>D.There is an association between the allele and expressing the trait in the population that was studied.<br>E.No association exists between the allele and diabetes in the study population.</td>
      <td>D.There is an association between the allele and expressing the trait in the population that was studied.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>23. A person is found to be homozygous（纯合子） for the ε4 allele at ApoE. Which of the following statements regarding his risk of Alzheimer disease is true?(2.5分)</td>
      <td>A.He will almost certainly develop Alzheimer disease.<br>B.He is protected from Alzheimer disease.<br>C.He is at increased risk of Alzheimer disease.<br>D.This result has no bearing on his risk of Alzheimer disease.<br>E.This result is a positive false.</td>
      <td>C.He is at increased risk of Alzheimer disease.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>24. Which one of the following conditions is NOT usually regarded as multifactorial?(2.5分)</td>
      <td>A.Rheumatoid arthritis（类风关）<br>B.Insulin-dependent diabetes mellitus（胰岛素依赖型糖尿病）<br>C.McCune-Albright syndrome（McCune-Albright综合征）<br>D.Asthma（哮喘）<br>E.Parkinson disease（Parkinson病）</td>
      <td>C.McCune-Albright syndrome（McCune-Albright综合征）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>25. Who won the Nobel Prize for His (their) contributions to PCR technique?(2.5分)</td>
      <td>A.Southern E<br>B.Sanger F<br>C.Mullis K<br>D.Watson J and Crick F<br>E.Yuet Wai Kan</td>
      <td>C.Mullis K</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>26. Which of the following techniques was NOT used to detect an unknown mutation（未知突变）?(2.5分)</td>
      <td>A.SSCP<br>B.ASO<br>C.dHPLC<br>D.DGGE<br>E.DNA sequencing</td>
      <td>B.ASO</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>27. Types of nucleic acid hybridisation（核酸杂交） include the below EXCEPT(2.5分)</td>
      <td>A.Southern blotting<br>B.Microarray<br>C.Western blotting<br>D.Northern blotting<br>E.DNA fingerprinting</td>
      <td>C.Western blotting</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>28. Which of the following techniques was mostly used to detect a trisomy（三体）?(2.5分)</td>
      <td>A.RFLP<br>B.Southern blot<br>C.FISH<br>D.PCR-HRM<br>E.DNA sequencing</td>
      <td>C.FISH</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>29. In the beta-thalassemia（beta-地中海贫血） case presented in the first week PBL, one might imagine that an embryonic stem cell transplant （胚胎干细胞移植）might cure 何尼科（即PBL案例中的那个患儿）. Where would one obtain such cells?(2.5分)</td>
      <td>A.From the umbilicord cord blood（脐带血）<br>B.From the chorion（绒毛膜）<br>C.From the inner cell mass of the blastocyst（胚泡的内细胞团）<br>D.From the syncytiotrophoblast（合体滋养层）<br>E.From the white blood cells（白细胞）</td>
      <td>C.From the inner cell mass of the blastocyst（胚泡的内细胞团）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>30. Which of the following properties would a single nucleotide polymorphism (SNP) have to be detected by Southern blot? (2.5分)</td>
      <td>A.It must alter the encoded amino acid sequence<br>B.It must alter a splice site（剪接位点）<br>C.It must alter a restriction site（限制酶酶切位点）<br>D.It must be a nonsense mutation（无义突变）<br>E.It must alter the stability（稳定性） of the encoded mRNA</td>
      <td>C.It must alter a restriction site（限制酶酶切位点）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>31. 下列哪种遗传病可通过染色体分析而确诊?(2.5分)</td>
      <td>A.精神分裂症<br>B.血友病B<br>C.Klinefelter综合征<br>D.alpha-地中海贫血<br>E.白化症</td>
      <td>C.Klinefelter综合征</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>32. Disorders with this mode of inheritance（遗传方式） are sometimes found more commonly in societies that practice consanguinity（近亲婚配）(2.5分)</td>
      <td>A.autosomal recessive<br>B.autosomal dominant<br>C.X-linked<br>D.multifactorial<br>E.cancer</td>
      <td>A.autosomal recessive</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>33. Male to male transmission（传递） is a key feature of which pattern of inheritance?(2.5分)</td>
      <td>A.D<br>B.AR<br>C.XD<br>D.XR<br>E.Mitochodrial</td>
      <td>A.D</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>34. Leber hereditary optic atrophy (LHON) is caused by a mutation in:(2.5分)</td>
      <td>A.chromosome 13.<br>B.chromosome 18.<br>C.chromosome 21.<br>D.chromosome 5.<br>E.mitochondrial DNA.</td>
      <td>E.mitochondrial DNA.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>35. The presence of genes in the same chromosome is an example of(2.5分)</td>
      <td>A.Linkage （连锁）<br>B.Coordination（协同）<br>C.Free assortment（自由组合）<br>D.Segregations（分离）<br>E.Fusion（融合）</td>
      <td>A.Linkage （连锁）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>36. The majority of vectors（载体） used for gene transfer（基因转移） in the clinical setting are derived from: (2.5分)</td>
      <td>A.automated DNA synthesis（自主DNA合成）<br>B.bacteria<br>C.insects<br>D.viruses<br>E.yeast</td>
      <td>D.viruses</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>37. Advantages of using adenoviruses（腺病毒） for gene therapy include:(2.5分)</td>
      <td>A.long term expression（表达时间长）.<br>B.short term expression（表达时间短）.<br>C.low risk of insertional mutagenesis（插入诱变的风险低）.<br>D.low immunogenecity（免疫排斥性低）.<br>E.easy assembly（易于组装）.</td>
      <td>C.low risk of insertional mutagenesis（插入诱变的风险低）.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>38. Which, if any, of the following statements is false?(2.5分)</td>
      <td>A.RNA interference (RNAi) is a cellular defense mechanism that is triggered by the presence in cells of unnatural double-stranded RNA, as can occur after viral infections.<br>B.RNAi therapy is a type of RNA-targeted therapy in which specific double-stranded RNA constructs are engineered to appear in diseased cells in order to incite the cells to destroy any RNA that contains the same sequence.<br>C.By destroying RNAs that are related to a specifically introduced genetic construct, artificial RNAi is effectively a type of gene-specific silencing.<br>D.RNAi therapy is best suited to silencing genes so as to replicate a phenotype caused by loss-of-function mutations.<br>E.Drs. Fire and Mello discovered RNAi phenomenon in 1998 and got a Nobel Prize in 2006.</td>
      <td>D.RNAi therapy is best suited to silencing genes so as to replicate a phenotype caused by loss-of-function mutations.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>39. Which of the following can be used as vectors（载体） in somatic cell gene therapy（体细胞基因治疗）?(2.5分)</td>
      <td>A.Retrovirus（反转录病毒）<br>B.Liposome（脂质体）<br>C.Adenovirus（腺病毒）<br>D.Adeno-associated virus（腺病毒相关病毒）<br>E.All of the above</td>
      <td>E.All of the above</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2013</td>
      <td>40. Which of the following is the usual treatment of hemophilia A（血友病A）?(2.5分)</td>
      <td>A.Blood transfusion<br>B.Liver transplant<br>C.Bone marrow transplant<br>D.Infusion of factor VIII as needed<br>E.Spleen transplant</td>
      <td>D.Infusion of factor VIII as needed</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>1. CT的优点是： (2.5分)</td>
      <td>A.密度分辨率高<br>B.密度分辨率低<br>C.空间分辨力率高<br>D.空间分辨力低<br>E.密度分辨力低而空间分辨力高</td>
      <td>A.密度分辨率高</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>2. 以下哪个不是成体干细胞的特点: (2.5分)</td>
      <td>A.多向分化潜能<br>B.体外增殖能力；<br>C.移植体内后易致瘤<br>D.A 和 C</td>
      <td>C.移植体内后易致瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>3. 下面哪个不是多能干细胞: (2.5分)</td>
      <td>A.iPSCs<br>B.胚胎干细胞；<br>C.胚胎生殖细胞<br>D.毛囊干细胞</td>
      <td>D.毛囊干细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>4. 下列哪一种指标常用来说明疾病对人的生命危险程度： (2.5分)</td>
      <td>A.发病率<br>B.死亡率<br>C.患病率<br>D.罹患率<br>E.病死率</td>
      <td>E.病死率</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>5. 以下哪种干细胞不属于成体干细胞: (2.5分)</td>
      <td>A.造血干细胞<br>B.间充质干细胞；<br>C.诱导多能干细胞<br>D.神经干细胞</td>
      <td>C.诱导多能干细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>6. CT探测器对检查的作用是?(2.5分)</td>
      <td>A.探测扫描中心线是否准直<br>B.探测病人扫描位置是否准确<br>C.探测扫描时散射线的多少<br>D.探测透过射线以获得正确曝光量<br>E.探测透过射线的数量以获得测量数据</td>
      <td>E.探测透过射线的数量以获得测量数据</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>7. 下列关于CT值得概念，那一项是正确的?(2.5分)</td>
      <td>A.CT值反映了物质的密度相对高低<br>B.反映了物质内水的成分含量<br>C.是物质密度的绝对测量值<br>D.不同的CT机器扫描产生的CT值不同<br>E.根据CT值大小可以对病变做出定性诊断</td>
      <td>A.CT值反映了物质的密度相对高低</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>8. 有关窗技术的，下列关于组织显示图像灰阶密度高低的描述，正确的是： (2.5分)</td>
      <td>A.窗宽显示密度范围外的组织不能显示，图像表现为黑色<br>B.与窗位CT值相同的组织显示中等亮度，适于观察<br>C.无论不同组织密度差异大小，任何图像上肉眼都能发现差别<br>D.窗宽范围以上的组织显示纯黑色<br>E.窗宽范围以下的组织显示为纯白色</td>
      <td>B.与窗位CT值相同的组织显示中等亮度，适于观察</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>9. 关于"流行病学"，下列说法哪项是错误的： (2.5分)</td>
      <td>A.流行病学是从群体角度研究疾病与健康<br>B.流行病学中的研究群体是指所有人群<br>C.流行病学从疾病分布入手探讨疾病的流行因素<br>D.流行病学属于预防医学的范畴<br>E.流行病学已深入临床医学的研究中</td>
      <td>B.流行病学中的研究群体是指所有人群</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>10. 下列哪一种传染病一般呈严格的季节性： (2.5分)</td>
      <td>A.虫媒传染病<br>B.寄生虫病<br>C.呼吸道传染病<br>D.肠道传染病<br>E.血液传染病</td>
      <td>A.虫媒传染病</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>11. 疾病的时间分布中，周期性是指： (2.5分)</td>
      <td>A.疾病每年在一定的季节内呈现发病率升高的现象<br>B.疾病发生频率经过一个相当规律的时间间隔，呈现规律性变动的状况<br>C.以日、周、月计数的短期观察数据<br>D.对疾病动态的连续数年乃至数十年的观察，在这个长时间内观察探讨疾病的病原体、临床表现、发病率、死亡率等的变化或它们同时发生的变化情况<br>E.以上都不对</td>
      <td>B.疾病发生频率经过一个相当规律的时间间隔，呈现规律性变动的状况</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>12. 利用出生队列资料将疾病年龄分布和时间分布结合起来描述的一种方法叫做： (2.5分)</td>
      <td>A.横断面分析<br>B.生态学分析<br>C.出生队列分析<br>D.回顾性分析<br>E.以上都不对</td>
      <td>C.出生队列分析</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>13. 在一个家庭中，罹患某种复杂疾病的人数多，提示在此家庭中本病的(2.5分)</td>
      <td>A.遗传率较低。<br>B.阈值较高。<br>C.易患性较高。<br>D.易患性较低。<br>E.遗传率较高。</td>
      <td>C.易患性较高。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>14. 多基因病的特点是(2.5分)</td>
      <td>A.发病率大多低于0.1％<br>B.无明显家族倾向<br>C.患者同胞中发病率远低于单基因病<br>D.有多个基因参与疾病的发生<br>E.通常遗传因素发挥的作用微小</td>
      <td>D.有多个基因参与疾病的发生</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>15. 当一种多基因病的群体发病率具有性别差异时，群体发病率高的性别一方的易患性阈值(2.5分)</td>
      <td>A.极高<br>B.低<br>C.高<br>D.极低<br>E.不变</td>
      <td>B.低</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>16. 精神分裂症的再现风险与下列哪一项因素无关？(2.5分)</td>
      <td>A.本病一般人群的发病率大小<br>B.病情严重程度<br>C.家庭成员数<br>D.近亲结婚<br>E.家庭中的患者人数</td>
      <td>C.家庭成员数</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>17. HGP是(2.5分)</td>
      <td>A.在线人类孟德尔遗传数据<br>B.人类基因组计划<br>C.国家核酸数据库<br>D.水稻基因组计划<br>E.癌症基因组解剖计划</td>
      <td>B.人类基因组计划</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>18. 遗传多态性变异体在群体中的出现频率通常(2.5分)</td>
      <td>A.大于1%<br>B.等于1%<br>C.小于1%<br>D.大于或等于1%<br>E.小于或等于1%</td>
      <td>A.大于1%</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>19. 下列哪一项属于表观遗传?(2.5分)</td>
      <td>A.X染色体-常染色体易位<br>B.基因组印记<br>C.微卫星DNA<br>D.自发突变<br>E.三核苷酸重复扩增</td>
      <td>B.基因组印记</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>20. 在鉴定疾病基因时，要确定可能的疾病候选基因及其所在的染色体区域。关于疾病候选基因的选取，下列哪一项描述不对？(2.5分)</td>
      <td>A.候选基因发生功能失去突变，可导致相关疾病的表型<br>B.构建了相关的种间同源基因（orthologous gene）动物模型之后，发现动物具有相似的疾病表型<br>C.候选基因的不同突变均可导致相关疾病的表型<br>D.候选基因的基因表达谱与相关疾病的表型吻合<br>E.候选基因可以为假基因</td>
      <td>E.候选基因可以为假基因</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>21. 衡量2个基因座之间是否连锁，用哪一项统计数据？Which the following is the statistical measurement we use to assess linkage between two loci?(2.5分)</td>
      <td>A.LODs值<br>B.关联系数值<br>C.TDT（传递不平衡检验）值<br>D.标记（marker）分析值<br>E.连锁不平衡值</td>
      <td>A.LODs值</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>22. 下列哪一项亲属不属于某个个体的二级亲属？(2.5分)</td>
      <td>A.父、母<br>B.祖父、祖母<br>C.外祖父、外祖母<br>D.叔、伯、姑<br>E.舅、姨</td>
      <td>A.父、母</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>23. 在X连锁显性遗传病（XD）中，女性患者的病情通常较轻。这是因为(2.5分)</td>
      <td>A.从性遗传<br>B.遗传异质性<br>C.不规则显性遗传<br>D.假常染色体遗传<br>E.X染色体随机失活</td>
      <td>E.X染色体随机失活</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>24. 在单基因病中，男-男传递可视为是区分哪一种遗传方式的关键？(2.5分)</td>
      <td>A.XD<br>B.XR<br>C.AD<br>D.AR<br>E.线粒体遗传方式</td>
      <td>C.AD</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>25. 一位女性的哥哥和舅父患红绿色盲，该致病基因来源于(2.5分)</td>
      <td>A.该女性的父亲<br>B.该女性的外祖父<br>C.该女性的外祖母<br>D.该女性的祖母<br>E.该女性的祖父</td>
      <td>C.该女性的外祖母</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>26. 一对表现型正常的夫妇，连生了3个苯丙酮尿症患儿。他们生育表型正常孩子的概率？(2.5分)</td>
      <td>A.25%<br>B.50%<br>C.75%<br>D.100%<br>E.0</td>
      <td>C.75%</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>27. 人类染色体的类型划分主要根据(2.5分)</td>
      <td>A.端粒的位置<br>B.染色体的长短<br>C.次缢痕的位置<br>D.着丝粒的位置<br>E.随体的有无</td>
      <td>D.着丝粒的位置</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>28. 如果在某一体细胞中染色体的数目在二倍体的基础上增加一条可形成(2.5分)</td>
      <td>A.单倍体<br>B.三倍体<br>C.单体<br>D.三体<br>E.部分三体</td>
      <td>D.三体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>29. 46, XY, t(4; 6)(q35; q21)表示(2.5分)</td>
      <td>A.某一女性体内发生了染色体的插入<br>B.某一男性体内发生了染色体的易位<br>C.某一男性带有等臂染色体<br>D.某一女性个体带有易位型的畸变染色体<br>E.某一男性个体含有缺失型的畸变染色体</td>
      <td>B.某一男性体内发生了染色体的易位</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>30. 最常见的染色体畸变综合征是(2.5分)</td>
      <td>A.Klinefelter综合征<br>B.Down综合征<br>C.Turner综合征<br>D.猫叫综合征<br>E.Edwards综合征</td>
      <td>B.Down综合征</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>31. 在临床上，遗传病的生化检查主要是指针对下列哪一项的检查？(2.5分)</td>
      <td>A.病原体<br>B.DNA<br>C.RNA<br>D.微量元素<br>E.蛋白质和酶</td>
      <td>E.蛋白质和酶</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>32. 下列哪一项描述aCGH检测优于FISH的说法是正确的?(2.5分)</td>
      <td>A.aCGH可分辨出平衡性重排（如易位、倒位等）。<br>B.aCGH分析无须进行细胞培养，因而出具检测报告的时间更快。<br>C.aCGH 进行检测的重复性高，可精确确定畸变发生的位置。<br>D.B和C都对<br>E.以上说法都对</td>
      <td>C.aCGH 进行检测的重复性高，可精确确定畸变发生的位置。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>33. 关于孕妇血浆中的胎儿游离DNA（cell-free fetal DNA，cfDNA）的检测技术，哪一项叙述是错误的？(2.5分)</td>
      <td>A.可用于确定胎儿的性别<br>B.可用于确定胎儿的Rh血型<br>C.不能确定胎儿的染色体核型<br>D.目前尚不能确定胎儿罹患脊柱裂（spina bifida）的风险<br>E.已经用于诊断胎儿是否感染了HIV感染</td>
      <td>E.已经用于诊断胎儿是否感染了HIV感染</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>34. 不能用于染色体核型分析的材料是(2.5分)</td>
      <td>A.外周血<br>B.绒毛膜<br>C.排泄物<br>D.肿瘤<br>E.皮肤</td>
      <td>B.绒毛膜</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>35. 基因诊断与其他诊断方法比较，最主要的特点在于(2.5分)</td>
      <td>A.费用低<br>B.检测周期时间短<br>C.取材方便<br>D.针对基因结构<br>E.针对病变细胞</td>
      <td>D.针对基因结构</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>36. 对孕妇和胎儿损伤最小的产前诊断方法为(2.5分)</td>
      <td>A.羊膜穿刺术<br>B.胎儿镜检查<br>C.B超检查<br>D.绒毛取样术（CVS）<br>E.X-射线检查</td>
      <td>C.B超检查</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>37. 肝豆状核变性（Wilson病）是神经内科最常见的一种常染色体隐性遗传病，属于铜代谢障碍性疾病。应用某些药物与铜离子形成螯合物的原理，可给予患者服用(2.5分)</td>
      <td>A.青霉素<br>B.青霉胺<br>C.维生素B12<br>D.硫酸镁<br>E.去铁胺B</td>
      <td>B.青霉胺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>38. 给苯丙酮尿症患儿喂哺低苯丙氨酸奶粉，属于(2.5分)</td>
      <td>A.补其所缺<br>B.去其所余<br>C.酶疗法<br>D.维生素疗法<br>E.禁其所忌</td>
      <td>E.禁其所忌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>39. 关于遗传病的基因治疗，下列哪一项叙述是正确的？(2.5分)</td>
      <td>A.用于基因治疗的载体应该能够进入身体的所有细胞中<br>B.被转入的基因的表达产物应该达到野生型基因表达的那种水平<br>C.突变基因应该被切除和替代掉<br>D.用于基因治疗的载体引起的机体免疫反应应该很小<br>E.用于基因治疗的遗传病的突变类型必须是功能获得突变</td>
      <td>D.用于基因治疗的载体引起的机体免疫反应应该很小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>1</td>
      <td>2014</td>
      <td>40. 在基因治疗时去除整个变异基因，用有功能的正常基因取代，从而使致病基因得到永久的更正。这种治疗策略称为(2.5分)</td>
      <td>A.基因失活<br>B.基因添加<br>C.基因修复<br>D.基因复制<br>E.基因突变</td>
      <td>C.基因修复</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>1. 对环境雌激素的评价，以下错误的一项是：(2.0分)</td>
      <td>A.环境雌激素对儿童神经系统无损害<br>B.环境雌激素有抗天然雄激素效应<br>C.儿童对环境雌激素更具易感性<br>D.有些植物雌激素对健康有益</td>
      <td>A.环境雌激素对儿童神经系统无损害</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>2. 在家庭教育氛围中，父母受教育程度与儿童的心理发展一般来说：(2.0分)</td>
      <td>A.正、负向相关相等<br>B.是呈负相关<br>C.是呈正相关<br>D.不一定有相关性</td>
      <td>C.是呈正相关</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>3. 黑种人跑步快的遗传特点是：(2.0分)</td>
      <td>A.驱干和四肢的比例特殊<br>B.骨骼肌特别发达<br>C.体成份中脂肪含量少<br>D.日照使骨骼发育佳</td>
      <td>A.驱干和四肢的比例特殊</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>4. 氟对于人体来说:(2.0分)</td>
      <td>A.体内不需要氟的存在<br>B.体内积存越多对机体越有益<br>C.氟仅仅对保护牙齿有益<br>D.体内微量存在对机体有益</td>
      <td>D.体内微量存在对机体有益</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>5. 遗传因素对生长发育的影响来源于：(2.0分)</td>
      <td>A.家族性与血缘性<br>B.家族性与种族性<br>C.家族性与地域性<br>D.种族性与迁徙性</td>
      <td>B.家族性与种族性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>6. 环境因素决定了生长发育的：(2.0分)</td>
      <td>A.潜力性<br>B.现实性<br>C.可能性<br>D.程度性</td>
      <td>B.现实性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>7. 环境因素对个体生长发育的影响起始于：(2.0分)</td>
      <td>A.父母生殖细胞形成时<br>B.胎儿期<br>C.出生后<br>D.受精卵形成时</td>
      <td>A.父母生殖细胞形成时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>8. 生长长期变化的趋势：(2.0分)</td>
      <td>A.可以是正、负向的<br>B.一定是正向的<br>C.不会停滞的<br>D.达到一定程度会停滞的</td>
      <td>D.达到一定程度会停滞的</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>9. 双生子是研究儿童生长发育影响因素的天然素材是基于：(2.0分)</td>
      <td>A.同卵双生子的基因相同而环境不同<br>B.同卵双生子的基因相同<br>C.同卵双生子的基因相同且环境相同<br>D.同卵双生子与异卵双生子的基因不同</td>
      <td>B.同卵双生子的基因相同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>10. 平衡膳食是指：(2.0分)</td>
      <td>A.一日三餐的平衡<br>B.各种营养素间的平衡<br>C.营养素摄入与人体需求的平衡<br>D.主副食及荤素的平衡</td>
      <td>C.营养素摄入与人体需求的平衡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>11. 有关超声波的特性下列正确的是：(2.0分)</td>
      <td>A.大于16Hz的机械纵波<br>B.大于20M Hz的机械横波<br>C.大于20M Hz的机械纵波<br>D.16--20MHz的机械纵波<br>E.小于16Hz的机械横波</td>
      <td>C.大于20M Hz的机械纵波</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>12. 有关超声多普勒以下哪项错误：(2.0分)</td>
      <td>A.脉冲多普勒有距离选通功能<br>B.脉冲多普勒能测高速血流<br>C.有彩色多普勒、脉冲多普勒和连续多普勒等<br>D.连续多普勒无距离选通功能<br>E.彩色多普勒是半定量显示</td>
      <td>B.脉冲多普勒能测高速血流</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>13. 在扫描中，清楚地分辨物体，能够测定其结构间最小距离，决定于声束的 (2.0分)</td>
      <td>A.强度<br>B.衰减<br>C.波长<br>D.速度<br>E.波幅</td>
      <td>C.波长</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>14. 波的峰压或高度称 (2.0分)</td>
      <td>A.周期<br>B.波幅<br>C.频率<br>D.波长<br>E.速度</td>
      <td>B.波幅</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>15. 频率增大，穿透将 (2.0分)</td>
      <td>A.增大十倍<br>B.减小<br>C.不变<br>D.增大<br>E.减小十倍</td>
      <td>B.减小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>16. 连续多普勒的特点为：(2.0分)</td>
      <td>A.速度分辨力佳, 距离分辨力差<br>B.速度分辨力差，距离分辨力佳<br>C.速度分辨力差，距离分辨力亦差<br>D.速度分辨力佳, 距离分辨力亦佳<br>E.以上都错误</td>
      <td>A.速度分辨力佳, 距离分辨力差</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>17. 液体属于声学类型中的 (2.0分)</td>
      <td>A.全反射型<br>B.无反射型<br>C.多反射型<br>D.少反射型<br>E.混合反射型</td>
      <td>B.无反射型</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>18. 彩色血流显像中对向探头的湍流血流颜色应为 (2.0分)</td>
      <td>A.兰色血流<br>B.红色血流<br>C.混色血流<br>D.以红色为主的五彩镶嵌血流<br>E.以兰色为主五彩镶嵌血流</td>
      <td>D.以红色为主的五彩镶嵌血流</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>19. 对湍流状态的血流作出定量诊断，需依靠：(2.0分)</td>
      <td>A.ＰＷＤ<br>B.ＣＷＤ<br>C.ＣＤＦＩ<br>D.２－ＤＥ<br>E.Ｍ－ＭＯＤＥ</td>
      <td>B.ＣＷＤ</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>20. 关于压电效应那种说法正确? (2.0分)</td>
      <td>A.在交变电场的作用导致压电晶体厚度的交替改变从而产生声振动，即由电能转变为声能。<br>B.逆压电效应(接收)<br>C.正压电效应(产生)<br>D.由压电晶体自主产生超声波</td>
      <td>A.在交变电场的作用导致压电晶体厚度的交替改变从而产生声振动，即由电能转变为声能。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>21. 梯度磁场的目的是(2.0分)</td>
      <td>A.帮助空间定位<br>B.减少磁场强度<br>C.增加磁场的均匀性<br>D.增加磁场强度<br>E.减小伪影</td>
      <td>A.帮助空间定位</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>22. 相位编码将导致Y轴上的像素：(2.0分)</td>
      <td>A.相位相同 频率不同<br>B.相位不同 频率相同<br>C.相位不同 频率不同<br>D.相位相同 频率相同<br>E.与频率无关</td>
      <td>B.相位不同 频率相同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>23. 梯度回波序列的主要优点是(2.0分)</td>
      <td>A.提高图像信噪比<br>B.提高对比分辨率<br>C.减低噪声<br>D.提高空间分辨率<br>E.缩短扫描时间</td>
      <td>E.缩短扫描时间</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>24. 自旋回波（SE）序列中去相位是指(2.0分)</td>
      <td>A.180°脉冲激励后<br>B.90°脉冲激励后<br>C.180°脉冲激励时<br>D.磁场不均匀所致的相位差别<br>E.以上都不对</td>
      <td>C.180°脉冲激励时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>25. 影响图像对比度的主要成像参数是(2.0分)</td>
      <td>A.磁场系统<br>B.脉冲序列<br>C.纵向磁化矢量<br>D.横向磁化矢量<br>E.以上都不对</td>
      <td>D.横向磁化矢量</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>26. 对CT而言，MRI的优点包括以下几方面，错误的是 (2.0分)</td>
      <td>A.密度分辨率高<br>B.空间分辨率高<br>C.多参数成像，信息量大<br>D.直接的多平面成像<br>E.无碘过敏危险</td>
      <td>B.空间分辨率高</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>27. 小儿体格发育的两个高峰期是 (2.0分)</td>
      <td>A.青春期、婴儿期<br>B.学龄期、学龄前期<br>C.青春期、幼儿期<br>D.青春期、学龄期<br>E.学龄期、新生儿期</td>
      <td>A.青春期、婴儿期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>28. 一男婴，体重7.5kg，身长66cm，头围44cm，左腕骨骨化中心2个。此婴儿最可能的月龄是 (2.0分)</td>
      <td>A.4个月<br>B.10个月<br>C.2个月<br>D.6个月<br>E.12个月</td>
      <td>D.6个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>29. 正常小儿头围48cm时几个月？ (2.0分)</td>
      <td>A.24个月<br>B.6个月<br>C.10个月<br>D.12个月<br>E.60个月</td>
      <td>A.24个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>30. 正常10个月婴儿的标准体重为：(2.0分)</td>
      <td>A.7.5Kg<br>B.8.5Kg<br>C.6Kg<br>D.9Kg<br>E.以上均不是</td>
      <td>B.8.5Kg</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>31. 一健康女婴，能独坐一会儿，能用手摇玩具，能认识熟人及生人，脊柱出现了第二个生理性弯曲，其年龄大约为(2.0分)</td>
      <td>A.4个月<br>B.9个月<br>C.8个月<br>D.6个月<br>E.以上均不是</td>
      <td>D.6个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>32. 在人一生中，生理、心理发生巨大变化的时期是(2.0分)</td>
      <td>A.学龄期<br>B.幼儿期<br>C.学龄前期<br>D.青春期</td>
      <td>D.青春期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>33. 小儿年龄阶段中哪一期体格发育最快 (2.0分)</td>
      <td>A.婴儿期<br>B.幼儿期<br>C.学龄期<br>D.学龄前期<br>E.以上都不是</td>
      <td>A.婴儿期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>34. 关于生长发育的规律，下列哪项是错误的 (2.0分)</td>
      <td>A.由简单到复杂<br>B.由粗到细<br>C.由低级到高级<br>D.由上到下<br>E.由远到近</td>
      <td>E.由远到近</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>35. 3岁小儿身长95cm，体重15kg，牙齿20个，属于(2.0分)</td>
      <td>A.身材异常高大<br>B.体重身长超过正常范围<br>C.肥胖症<br>D.正常范围<br>E.营养不良</td>
      <td>D.正常范围</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>36. 青春期增长最快的是(2.0分)</td>
      <td>A.颈部<br>B.头部<br>C.脊柱<br>D.上肢<br>E.下肢</td>
      <td>E.下肢</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>37. DMD的遗传方式：(2.0分)</td>
      <td>A.AD<br>B.XD<br>C.XR<br>D.AR</td>
      <td>C.XR</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>38. DMD的最常见突变形式：(2.0分)</td>
      <td>A.点突变<br>B.缺失突变<br>C.重复突变<br>D.无义突变</td>
      <td>B.缺失突变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>39. 以下不是多重PCR特点的是：(2.0分)</td>
      <td>A.灵敏性<br>B.高效性<br>C.经济简便性<br>D.高保真性</td>
      <td>D.高保真性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>40. 以下不是琼脂糖凝胶电泳优点的是：(2.0分)</td>
      <td>A.琼脂糖透明无紫外吸收，电泳过程和结果可直接用紫外光灯检测及定量测定。<br>B.操作简单，电泳速度快，样品不需事先处理就可以进行电泳。<br>C.电泳后区带不易染色，样品不易洗脱，不便于样品定量测定及回收。<br>D.电泳图谱清晰，分辨率高，重复性好</td>
      <td>C.电泳后区带不易染色，样品不易洗脱，不便于样品定量测定及回收。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>41. 溴化乙锭的性能不包括：(2.0分)</td>
      <td>A.与DNA结合后促进DNA的复制和转录<br>B.250～310 nm波长的紫外光激发其发出橙红色光，常用于检测核酸分子。<br>C.能嵌入到双链核酸碱基对平面之间<br>D.是一种强诱变剂，有致癌作用。</td>
      <td>A.与DNA结合后促进DNA的复制和转录</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>42. DMD基因定位于：(2.0分)</td>
      <td>A.1q22.2-22.3<br>B.Xq21.2-21.3<br>C.3p21.2-21.3<br>D.Xq22.2-22.3</td>
      <td>B.Xq21.2-21.3</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>43. Which of the following is, in most cases, inherited as a complex genetic trait? (2.0分)</td>
      <td>A.Down syndrome<br>B.Neurofibromatosis神经纤维瘤病<br>C.Neural tube defects<br>D.Cystic fibrosis<br>E.Duchenne muscular dystrophy</td>
      <td>C.Neural tube defects</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>44. A 21-year-old man requests genetic testing for Huntington's disease. Family history includes a grandmother who had been affected. Which of the following describes the most direct diagnostic procedure for this patient? (2.0分)</td>
      <td>A.Polyglutamine（多谷氨酰胺）analysis<br>B.Gene deletion analysis<br>C.Missense mutation analysis<br>D.CAG repeat analysis<br>E.Protein concentration analysis</td>
      <td>D.CAG repeat analysis</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>45. The pedigree shows your patient, Marsha, who is affected with a single gene, autosomal dominant disorder that shows 80% penetrance, and her two children, Michael and Marcus. Michael is also clinically affected with the disorder. The probability that Marcus will have the clinical signs with the disorder is closet to which of the following choices? (2.0分)</td>
      <td>A.40%<br>B.20%<br>C.50%<br>D.80%<br>E.100%</td>
      <td>A.40%</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>46. Chris and his brother Todd both have Duchnne muscular dystrophy. There is a maternal history of this disorder. Jean, the boy's maternal aunt, is interested in beginning a family. What is the probability that she is a heterozygous carrier of the disease ge(2.0分)</td>
      <td>A.Virtually 0<br>B.3/8<br>C.1/4<br>D.1/8<br>E.1/2</td>
      <td>E.1/2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>47. Many disorders are not caused by single gene inheritance, but are multifactorial. In counseling situations involving these disorders, how are recurrence risks identified? (2.0分)</td>
      <td>A.Recurrence risks cannot determined for non-Mendelian disorders<br>B.Bayes theorem is applied, using modifications of "prior" risk calculation utilized among single-gene defects<br>C.The risks are determined empirically, based on previous observations of disease recurrence among actual families<br>D.Single gene inheritance risks are multiplied by a factorial fraction, chosen to represent the contribution from other genetic factors plus the environmental influence<br>E.All above is wrong</td>
      <td>C.The risks are determined empirically, based on previous observations of disease recurrence among actual families</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>48. Which of following action is acceptable in medical genetics practice? (2.0分)</td>
      <td>A.Discuss the cases with your friend because she is very interested in anything funny<br>B.Discuss the cases with your colleagues in the hallway<br>C.Put all the patient genetic testing reports at the front desk and let the patients search for their own ones because it is easy<br>D.Put all the information on the internet and call for people to support the known name patients<br>E.None of the above</td>
      <td>E.None of the above</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>49. About genetic counselling (2.0分)</td>
      <td>A.The individual who seeks genetic counselling is the proband<br>B.Genetic disorders are accidents of nature, so guilt feelings are rare<br>C.Genetic counselling is all about recurrence risk<br>D.Patient support groups have little value given that modern medical genetics is so technically complex<br>E.Good counselling should not be measured by the patient's/client's ability to remember genetic risks</td>
      <td>E.Good counselling should not be measured by the patient's/client's ability to remember genetic risks</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2007</td>
      <td>50. Bob has hypophosphatemic rickets（抗维生素D佝偻病）. He and his wife Jill come to the genetics for counseling because they would like to have children. What can you tell them about the likelihood that any daughters will be affected? Any sons? (2.0分)</td>
      <td>A.0% daughters, 100% sons<br>B.100% daughters, 50% sons<br>C.100% daughters, 50% sons<br>D.100% daughters, 0% sons<br>E.50% daughters, 100% sons</td>
      <td>D.100% daughters, 0% sons</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>1. 在扫描中，清楚地分辨物体，能够测定其结构间最小距离，决定于声束的(2.0分)</td>
      <td>A.速度<br>B.波长<br>C.衰减<br>D.强度<br>E.波幅</td>
      <td>B.波长</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>2. 下列关于青春期发育的知识正确的是：(2.0分)</td>
      <td>A.男孩进入青春期发育的标志为喉结突出<br>B.男孩生长发育第二高峰比女孩晚1岁<br>C.女孩进入青春发育的标志为初潮<br>D.青春期发育时一般先有骨龄的加速，然后再有线性生长的加速<br>E.神经内分泌调节趋于稳定</td>
      <td>D.青春期发育时一般先有骨龄的加速，然后再有线性生长的加速</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>3. 下列哪个核型式的书写正确：(2.0分)</td>
      <td>A.46, XO<br>B.46, XY<br>C.46; XY<br>D.44+XX</td>
      <td>B.46, XY</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>4. 以下有关性决定和性分化的叙述错误的是：(2.0分)</td>
      <td>A.关键的调控基因需在"正确"的关键时刻准确合适的表达才能使性分化正确进行。<br>B.胚胎的性决定和性分化具有关键的时间窗<br>C.关键时刻无AMH或睾酮作用，则内生殖管道分化为男性结构<br>D.45XO综合征是最常见的性染色体畸变综合征<br>E.性分化发育异常的诊断过程是性别鉴定和病因诊断的过程</td>
      <td>C.关键时刻无AMH或睾酮作用，则内生殖管道分化为男性结构</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>5. 以下有关性早熟的叙述错误的是：(2.0分)</td>
      <td>A.男孩真性性早熟特别要当心中枢神经系统肿瘤<br>B.男孩在9岁前出现睾丸增大<br>C.真性性早熟需要治疗，假性性早熟可以观察<br>D.女孩在8岁前出现乳房发育<br>E.女孩10岁前初潮</td>
      <td>C.真性性早熟需要治疗，假性性早熟可以观察</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>6. 有关婴儿期的描述，哪一项是正确的 （B）(2.0分)</td>
      <td>A.来自母体的免疫抗体尚未完全消失，相对此期感染性疾病较少<br>B.此期不包括新生儿期，<br>C.是小儿生长发育最迅速的时期<br>D.不易发生营养性疾病<br>E.免疫性疾病如肾炎、肾病等有增多趋势</td>
      <td>C.是小儿生长发育最迅速的时期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>7. The maternal serum level of alpha-fetoprotein (AFP) is lower than average in which situation?(2.0分)</td>
      <td>A.Neural tube defects（神经管缺陷）<br>B.Exomphalos（脐疝）<br>C.Down syndrome<br>D.Twin pregnancies</td>
      <td>C.Down syndrome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>8. 以下对核酸分子量标准描述不正确的是： (2.0分)</td>
      <td>A.是一组分子量大小已知的DNA片段混合物<br>B.可直接电泳，使用方便<br>C.用做对比来检测琼脂糖凝胶电泳的PCR产物长度<br>D.分子量精确，每个条带间隔100bp</td>
      <td>D.分子量精确，每个条带间隔100bp</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>9. 一健康女婴，营养状况好，测量头围42cm，前囟1.5cm×1.2cm，身长65cm，勉强扶坐，出牙1颗，最可能的年龄是 (2.0分)</td>
      <td>A.7~8个月<br>B.5~6个月<br>C.3~4个月<br>D.8~9个月<br>E.10~12个月</td>
      <td>B.5~6个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>10. 新生儿体温调节的特点，哪一项是正确的？ (2.0分)</td>
      <td>A.将新生儿置于预热后的辐射床，可避免蒸发散热<br>B.新生儿体温调节功能不完善，靠棕色脂肪代偿产热<br>C.早产儿日龄越小，体重越低，所需中性环境温度也越低<br>D.环境温度高时，早产儿可通过出汗而蒸发散热<br>E.将辐射床置于通风对流的过道，不会影响新生儿的体温</td>
      <td>B.新生儿体温调节功能不完善，靠棕色脂肪代偿产热</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>11. About genetic counselling(2.0分)</td>
      <td>A.The individual who seeks genetic counselling is the proband<br>B.Patient support groups have little value given that modern medical genetics is so technically complex<br>C.Genetic disorders are accidents of nature, so guilt feelings are rare<br>D.Genetic counselling is all about recurrence risk<br>E.Good counselling should not be measured by the patient's/client's ability to remember genetic risks</td>
      <td>E.Good counselling should not be measured by the patient's/client's ability to remember genetic risks</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>12. 下列哪染色体是近端着丝粒染色体： (2.0分)</td>
      <td>A.8号染色体<br>B.3号染色体<br>C.X染色体<br>D.Y染色体</td>
      <td>D.Y染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>13. 人类染色体核型分析不适合诊断下列哪些遗传病： (2.0分)</td>
      <td>A.21三体综合征<br>B.特纳氏综合征<br>C.猫叫综合征<br>D.?-地中海贫血</td>
      <td>D.?-地中海贫血</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>14. 根据着丝粒位置，人类染色体不包括： (2.0分)</td>
      <td>A.近端着丝粒染色体<br>B.亚中着丝粒染色体<br>C.中着丝粒染色体<br>D.端着丝粒染色体</td>
      <td>D.端着丝粒染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>15. 描述超声图像特征的四个参数不包括(2.0分)</td>
      <td>A.对比度<br>B.灰度<br>C.反射度<br>D.亮度<br>E.分辨率</td>
      <td>C.反射度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>16. Hox genes encode proteins with which of the following properties? (2.0分)</td>
      <td>A.Presence of DNA-binding domain<br>B.Binding of extracellular ligands in the cell membrane<br>C.Transport to lysosome<br>D.Secretion from the cell</td>
      <td>A.Presence of DNA-binding domain</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>17. 有关超声多普勒以下哪项错误：(2.0分)</td>
      <td>A.脉冲多普勒能测高速血流<br>B.有彩色多普勒、脉冲多普勒和连续多普勒等<br>C.脉冲多普勒有距离选通功能<br>D.连续多普勒无距离选通功能<br>E.彩色多普勒是半定量显示</td>
      <td>A.脉冲多普勒能测高速血流</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>18. 在本周的PBL学习案例中, 戴安娜ingested Accutane (a retinoic acid derivative) for her acne. Recalling the mechanism of action of retinoic acid, Accutane would act via binding to (2.0分)</td>
      <td>A.Intracellular nuclear receptor<br>B.Cell surface membrane receptor<br>C.retinoic acid response element (RARE)<br>D.Tyrosine kinase receptor</td>
      <td>A.Intracellular nuclear receptor</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>19. 以下关于青春发育延迟错误的说法是：(2.0分)</td>
      <td>A.体质性青春发育延迟一般多见于男孩<br>B.下丘脑-垂体-性腺轴的病变可造成青春发育延迟<br>C.染色体异常造成的性发育延迟不属于青春发育延迟<br>D.Turner综合征属于高促性腺激素性性发育不良的一种<br>E.过度运动和消瘦也会造成青春发育延迟</td>
      <td>C.染色体异常造成的性发育延迟不属于青春发育延迟</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>20. 下列关于胎儿期的描述，错误的是(2.0分)</td>
      <td>A.预防感染是预防胎儿畸形、先天发育不全的关键保健措施之一<br>B.妊娠3-8周是胚胎细胞高度分化期，极易受环境不良因素干扰而导致流产、死胎、畸形<br>C.胎儿期从受精卵形成至胎儿娩出，可以分为3个阶段，其中妊娠早期为胎龄16周之前<br>D.至28周时，胎儿肺泡发育基本完善，已具有气体交换功能<br>E.孕期经常饮酒可能导致胎儿中枢神经系统发育障碍、颜面畸形和生长迟缓</td>
      <td>C.胎儿期从受精卵形成至胎儿娩出，可以分为3个阶段，其中妊娠早期为胎龄16周之前</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>21. 电泳过程，DNA样品的迁移方向为： (2.0分)</td>
      <td>A.从正极到负极<br>B.从上到下<br>C.从负极到正极<br>D.从左到右</td>
      <td>C.从负极到正极</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>22. Chris and his brother Todd both have Duchnne muscular dystrophy. There is a maternal history of this disorder. Jean, the boy's maternal aunt, is interested in beginning a family. What is the probability that she is a heterozygous carrier of the disease ge(2.0分)</td>
      <td>A.3/8<br>B.1/8<br>C.1/4<br>D.Virtually 0<br>E.1/2</td>
      <td>E.1/2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>23. 生理性体重下降一般发生在(2.0分)</td>
      <td>A.出生后第3周内<br>B.出生后第2周内<br>C.出生后第1周内<br>D.出生后第4周内<br>E.出生后1个月</td>
      <td>C.出生后第1周内</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>24. Which of following action is acceptable in medical genetics practice? (2.0分)</td>
      <td>A.Put all the information on the internet and call for people to support the known name patients<br>B.Discuss the cases with your friend because she is very interested in anything funny<br>C.Put all the patient genetic testing reports at the front desk and let the patients search for their own ones because it is easy<br>D.Discuss the cases with your colleagues in the hallway<br>E.None of the above</td>
      <td>E.None of the above</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>25. 以下哪一项是新生儿期的特征？ (2.0分)</td>
      <td>A.生理功能已逐渐成熟，不会再出现胎儿循环<br>B.容易受外界不良因素影响而发生畸形、发育不全、生长迟缓<br>C.体格生长速度相对婴儿期较慢<br>D.经历了依赖于母体生存向独立生存的巨大变化，发病率和死亡率均很高<br>E.新生儿的免疫功能发育不成熟，尤其是细胞免疫功能</td>
      <td>D.经历了依赖于母体生存向独立生存的巨大变化，发病率和死亡率均很高</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>26. If both parents are affected with the same autosomal recessive disorder then the probability that each of their children will be affected equals ___. (2.0分)</td>
      <td>A.1/2<br>B.1/4<br>C.3/4<br>D.2/3<br>E.1</td>
      <td>E.1</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>27. 关于压电效应那种说法正确?(2.0分)</td>
      <td>A.正压电效应(产生)<br>B.在交变电场的作用导致压电晶体厚度的交替改变从而产生声振动，即由电能转变为声能。<br>C.逆压电效应(接收)<br>D.由压电晶体自主产生超声波</td>
      <td>B.在交变电场的作用导致压电晶体厚度的交替改变从而产生声振动，即由电能转变为声能。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>28. 双链DNA迁移率与下列哪种因素无关： (2.0分)</td>
      <td>A.凝胶浓度<br>B.电压<br>C.DNA长度<br>D.电泳时间</td>
      <td>D.电泳时间</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>29. DMD基因定位于(2.0分)</td>
      <td>A.1q22.2-22.3<br>B.Xq21.2-21.3<br>C.3p21.2-21.3<br>D.Xq22.2-22.3</td>
      <td>B.Xq21.2-21.3</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>30. 是超声首先观察到的妊娠标志。(2.0分)</td>
      <td>A. "胎儿"<br>B.卵黄囊（yolk sac）<br>C.胚芽（fetal pole）<br>D. "胚胎"<br>E.妊娠囊（gestational sac）</td>
      <td>E.妊娠囊（gestational sac）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>31. 超声诊断仪的显示模式等哪项描述是错误的？(2.0分)</td>
      <td>A.D型测速原理和海军声纳是一样的<br>B.A超回声波幅的高低、多少反映界面的声阻抗差异大小<br>C.M型是最早用于心脏检查的<br>D.B超就是超声波的统称<br>E.1842年Christian Joham Doppler观察天体时发现多普勒效应</td>
      <td>D.B超就是超声波的统称</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>32. Bob has hypophosphatemic rickets（抗维生素D佝偻病）. He and his wife Jill come to the genetics for counseling because they would like to have children. What can you tell them about the likelihood that any daughters will be affected? Any sons? (2.0分)</td>
      <td>A.100% daughters, 50% sons<br>B.100% daughters, 50% sons<br>C.100% daughters, 0% sons<br>D.0% daughters, 100% sons<br>E.50% daughters, 100% sons</td>
      <td>C.100% daughters, 0% sons</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>33. 女孩第二性征发育顺序依次为(2.0分)</td>
      <td>A.乳房-阴毛-初潮-腋毛<br>B.阴毛-乳房-初潮-腋毛<br>C.腋毛-乳房-阴毛-初潮<br>D.乳房-腋毛-初潮-阴毛<br>E.乳房-阴毛-腋毛-初潮</td>
      <td>A.乳房-阴毛-初潮-腋毛</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>34. 一3周岁男孩，体检发现前囟未闭，约1.5×1.5cm, 平坦，无饱满或隆起，头围49.5cm, 应考虑的可能疾病是(2.0分)</td>
      <td>A.脱水<br>B.脑发育不良<br>C.甲状腺功能低下<br>D.脑积水<br>E.以上都不是</td>
      <td>C.甲状腺功能低下</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>35. G分带核型的D组染色体包括：(2.0分)</td>
      <td>A.21-22染色体<br>B.4-5号染色体<br>C.6-12号染色体<br>D.13-15号染色体</td>
      <td>D.13-15号染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>36. A 21-year-old man requests genetic testing for Huntington disease. Family history includes a grandmother who had been affected. Which of the following describes the most direct diagnostic procedure for this patient? (2.0分)</td>
      <td>A.Polyglutamine（多谷氨酰胺）analysis<br>B.Gene deletion analysis<br>C.Missense mutation analysis<br>D.CAG repeat analysis<br>E.Protein concentration analysis</td>
      <td>D.CAG repeat analysis</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>37. Mutations in homeotic genes often cause (2.0分)</td>
      <td>A.the absence of structures.<br>B.the deletion of segments.<br>C.too many segments.<br>D.structures to appear in the wrong place.</td>
      <td>D.structures to appear in the wrong place.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>38. 彩色血流显像中对向探头的湍流血流颜色应为 (2.0分)</td>
      <td>A.混色血流<br>B.红色血流<br>C.以红色为主的五彩镶嵌血流<br>D.兰色血流<br>E.以兰色为主五彩镶嵌血流</td>
      <td>C.以红色为主的五彩镶嵌血流</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>39. 一男孩，出生体重3.3kg, 目前体检体重8.9kg, 身长72cm, 前囟1×1cm, 乳牙1枚。 头围45cm, 尚不会独站。最可能的年龄是： (2.0分)</td>
      <td>A.12月龄<br>B.6月龄<br>C.9月龄<br>D.3月龄<br>E.15月龄</td>
      <td>C.9月龄</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>40. 一刚出生的新生儿，出生体重2.3Kg,男孩， 出生时皮肤红，有少许脱皮，头发分条清楚，耳廓软骨发育好、耳舟成形，指趾甲超过指、趾端，足纹遍及整个足底，乳腺结节较大>4mm,阴囊皱褶多。该新生儿最可能是： (2.0分)</td>
      <td>A.早产儿，大于胎龄儿<br>B.早产，低出生体重儿<br>C.过期产儿<br>D.正常足月儿<br>E.足月小样儿(小于胎龄儿)</td>
      <td>E.足月小样儿(小于胎龄儿)</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>41. DNA载样缓冲液的性能不包括： (2.0分)</td>
      <td>A.含有的溴酚蓝（某些还含有二甲苯青），示踪DNA分子在凝胶中的电泳迁移。<br>B.可以使待电泳样品沉在点样孔底部，避免样品漂浮。<br>C.溴酚蓝的迁移位置大约相当于70 bp左右的线性DNA分子的迁移位置。<br>D.紫外光照射凝胶会增加DNA条带的亮度。</td>
      <td>D.紫外光照射凝胶会增加DNA条带的亮度。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>42. Many disorders are not caused by single gene inheritance, but are multifactorial. In counseling situations involving these disorders, how are recurrence risks identified?(2.0分)</td>
      <td>A.Bayes theorem is applied, using modifications of "prior" risk calculation utilized among single-gene defects<br>B.Recurrence risks cannot determined for non-Mendelian disorders<br>C. Single gene inheritance risks are multiplied by a factorial fraction, chosen to represent the contribution from other genetic factors plus the environmental influence<br>D.The risks are determined empirically, based on previous observations of disease recurrence among actual families<br>E.All above is wrong</td>
      <td>D.The risks are determined empirically, based on previous observations of disease recurrence among actual families</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>43. 一婴儿出生时孕28周，出生体重为750克。考虑该新生儿为(2.0分)</td>
      <td>A.低出生体重儿，小于胎龄儿<br>B.低出生体重儿，适于胎龄儿<br>C.极低出生体重儿，适于胎龄儿<br>D.极低出生体重儿，小于胎龄儿<br>E.极低出生体重儿，大于胎龄儿</td>
      <td>D.极低出生体重儿，小于胎龄儿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>44. 小儿胸椎后凸出现的时间为： (2.0分)</td>
      <td>A.8月会爬时<br>B.3个月会抬头时<br>C.6个月会坐时<br>D.出生后即出现<br>E.1岁会走时</td>
      <td>C.6个月会坐时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>45. 一足月出生男婴，以下哪一项提示为异常？ (2.0分)</td>
      <td>A.拥抱反射未引出<br>B.巴彬斯基征阳性<br>C.提睾反射未引出<br>D.可引出觅食反射<br>E.克氏征阳性</td>
      <td>A.拥抱反射未引出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>46. Which of the following is, in most cases, inherited as a complex genetic trait? (2.0分)</td>
      <td>A.Neurofibromatosis神经纤维瘤病<br>B.Cystic fibrosis<br>C.Neural tube defects<br>D.Down syndrome<br>E.Duchenne muscular dystrophy</td>
      <td>C.Neural tube defects</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>47. 下列那一项描述错误? D(2.0分)</td>
      <td>A.传播方向和振动方向相互垂直的称横波<br>B.波的传播方向与质点振动方向一致的,称为纵波<br>C.振动质点在媒质内传播产生周期性疏密波称声波<br>D.声波可以在真空中传播<br>E.光波可以在真空中传播</td>
      <td>D.声波可以在真空中传播</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>48. 了解儿童的生长速度及其生长发育趋势，最直观的评价方法是(2.0分)</td>
      <td>A.均值离差法<br>B.生长发育图评价法<br>C.标准差的离差法<br>D.百分位数法<br>E.中位数法</td>
      <td>B.生长发育图评价法</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>49. 在本周的PBL学习案例中, 贾贝贝 was born with microcephaly, micrognathia, and microtia. The type of morphogenesis that these exemplify is (2.0分)</td>
      <td>A.Deformation<br>B.Disruption<br>C.Malformation<br>D.Dysplasia<br>E.Normal</td>
      <td>C.Malformation</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2008</td>
      <td>50. 下列关于婴幼儿骨骼和牙齿发育的描述，正确的是： (2.0分)</td>
      <td>A.生后6个月出现腰椎前凸<br>B.后囟在生后1-1.5岁闭合<br>C.前囟在生后6-8周闭合<br>D.乳牙一般在4-10个月开始萌出<br>E.儿童在8岁左右开始出第一颗恒牙</td>
      <td>D.乳牙一般在4-10个月开始萌出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>1. 对环境雌激素的评价，以下错误的一项是：(2.0分)</td>
      <td>A.儿童对环境雌激素更具易感性<br>B.环境雌激素有抗天然雄激素效应<br>C.环境雌激素对儿童神经系统无损害<br>D.有些植物雌激素对健康有益</td>
      <td>C.环境雌激素对儿童神经系统无损害</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>2. 在家庭教育氛围中，父母受教育程度与儿童的心理发展一般来说：(2.0分)</td>
      <td>A.是呈正相关<br>B.是呈负相关<br>C.正、负向相关相等<br>D.不一定有相关性</td>
      <td>A.是呈正相关</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>3. 黑种人跑步快的遗传特点是：(2.0分)</td>
      <td>A.骨骼肌特别发达<br>B.驱干和四肢的比例特殊<br>C.体成份中脂肪含量少<br>D.日照使骨骼发育佳</td>
      <td>B.驱干和四肢的比例特殊</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>4. 氟对于人体来说:(2.0分)</td>
      <td>A.氟仅仅对保护牙齿有益<br>B.体内积存越多对机体越有益<br>C.体内不需要氟的存在<br>D.体内微量存在对机体有益</td>
      <td>D.体内微量存在对机体有益</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>5. 遗传因素对生长发育的影响来源于：(2.0分)</td>
      <td>A.家族性与种族性<br>B.家族性与血缘性<br>C.家族性与地域性<br>D.种族性与迁徙性</td>
      <td>A.家族性与种族性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>6. 环境因素决定了生长发育的：(2.0分)</td>
      <td>A.可能性<br>B.现实性<br>C.潜力性<br>D.程度性</td>
      <td>B.现实性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>7. 环境因素对个体生长发育的影响起始于：(2.0分)</td>
      <td>A.出生后<br>B.胎儿期<br>C.父母生殖细胞形成时<br>D.受精卵形成时</td>
      <td>C.父母生殖细胞形成时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>8. 生长长期变化的趋势：(2.0分)</td>
      <td>A.不会停滞的<br>B.一定是正向的<br>C.可以是正、负向的<br>D.达到一定程度会停滞的</td>
      <td>D.达到一定程度会停滞的</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>9. 双生子是研究儿童生长发育影响因素的天然素材是基于：(2.0分)</td>
      <td>A.同卵双生子的基因相同而环境不同<br>B.同卵双生子的基因相同且环境相同<br>C.同卵双生子的基因相同<br>D.同卵双生子与异卵双生子的基因不同</td>
      <td>C.同卵双生子的基因相同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>10. 平衡膳食是指：(2.0分)</td>
      <td>A.营养素摄入与人体需求的平衡<br>B.各种营养素间的平衡<br>C.一日三餐的平衡<br>D.主副食及荤素的平衡</td>
      <td>A.营养素摄入与人体需求的平衡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>11. 有关超声波的特性下列正确的是：(2.0分)</td>
      <td>A.大于16Hz的机械纵波<br>B.16--20MHz的机械纵波<br>C.大于20M Hz的机械纵波<br>D.大于20M Hz的机械横波<br>E.小于16Hz的机械横波</td>
      <td>C.大于20M Hz的机械纵波</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>12. 有关超声多普勒以下哪项错误：(2.0分)</td>
      <td>A.有彩色多普勒、脉冲多普勒和连续多普勒等<br>B.脉冲多普勒能测高速血流<br>C.脉冲多普勒有距离选通功能<br>D.连续多普勒无距离选通功能<br>E.彩色多普勒是半定量显示</td>
      <td>B.脉冲多普勒能测高速血流</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>13. 在扫描中，清楚地分辨物体，能够测定其结构间最小距离，决定于声束的 (2.0分)</td>
      <td>A.强度<br>B.波长<br>C.衰减<br>D.速度<br>E.波幅</td>
      <td>B.波长</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>14. 描述超声图像特征的四个参数不包括 (2.0分)</td>
      <td>A.亮度<br>B.灰度<br>C.反射度<br>D.对比度<br>E.分辨率</td>
      <td>C.反射度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>15. （ ）是超声首先观察到的妊娠标志。(2.0分)</td>
      <td>A.卵黄囊（yolk sac）<br>B. "胎儿"<br>C.胚芽（fetal pole）<br>D. "胚胎"<br>E.妊娠囊（gestational sac）</td>
      <td>E.妊娠囊（gestational sac）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>16. 连续多普勒的特点为：(2.0分)</td>
      <td>A.速度分辨力差，距离分辨力亦差<br>B.速度分辨力差，距离分辨力佳<br>C.速度分辨力佳, 距离分辨力差<br>D.速度分辨力佳, 距离分辨力亦佳<br>E.以上都错误</td>
      <td>C.速度分辨力佳, 距离分辨力差</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>17. 液体属于声学类型中的 (2.0分)</td>
      <td>A.少反射型<br>B.无反射型<br>C.多反射型<br>D.全反射型<br>E.混合反射型</td>
      <td>B.无反射型</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>18. 彩色血流显像中对向探头的湍流血流颜色应为 (2.0分)</td>
      <td>A.红色血流<br>B. 兰色血流<br>C.混色血流<br>D.以红色为主的五彩镶嵌血流<br>E.以兰色为主五彩镶嵌血流</td>
      <td>D.以红色为主的五彩镶嵌血流</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>19. 对湍流状态的血流作出定量诊断，需依靠：(2.0分)</td>
      <td>A.ＣＤＦＩ<br>B.ＣＷＤ<br>C.ＰＷＤ<br>D.２－ＤＥ<br>E.Ｍ－ＭＯＤＥ</td>
      <td>B.ＣＷＤ</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>20. 关于压电效应那种说法正确?(2.0分)</td>
      <td>A.逆压电效应(接收)<br>B.在交变电场的作用导致压电晶体厚度的交替改变从而产生声振动，即由电能转变为声能。<br>C.正压电效应(产生)<br>D.由压电晶体自主产生超声波</td>
      <td>B.在交变电场的作用导致压电晶体厚度的交替改变从而产生声振动，即由电能转变为声能。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>21. 梯度磁场的目的是 (2.0分)</td>
      <td>A.增加磁场的均匀性<br>B.减少磁场强度<br>C.帮助空间定位<br>D.增加磁场强度<br>E.减小伪影</td>
      <td>C.帮助空间定位</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>22. 相位编码将导致Y轴上的像素：(2.0分)</td>
      <td>A.相位不同 频率不同<br>B.相位不同 频率相同<br>C.相位相同 频率不同<br>D.相位相同 频率相同<br>E.与频率无关</td>
      <td>B.相位不同 频率相同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>23. 梯度回波序列的主要优点是 (2.0分)</td>
      <td>A.减低噪声<br>B.提高对比分辨率<br>C.提高图像信噪比<br>D.提高空间分辨率<br>E.缩短扫描时间</td>
      <td>E.缩短扫描时间</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>24. 自旋回波（SE）序列中去相位是指 (2.0分)</td>
      <td>A.180°脉冲激励后<br>B.180°脉冲激励时<br>C.90°脉冲激励后<br>D.磁场不均匀所致的相位差别<br>E.以上都不对</td>
      <td>B.180°脉冲激励时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>25. 影响图像对比度的主要成像参数是 (2.0分)</td>
      <td>A.脉冲序列<br>B.磁场系统<br>C.纵向磁化矢量<br>D.横向磁化矢量<br>E.以上都不对</td>
      <td>D.横向磁化矢量</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>26. 对CT而言，MRI的优点包括以下几方面，错误的是 (2.0分)</td>
      <td>A.直接的多平面成像<br>B.多参数成像，信息量大<br>C.密度分辨率高<br>D.空间分辨率高<br>E.无碘过敏危险</td>
      <td>D.空间分辨率高</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>27. 一3周岁男孩，体检发现前囟未闭，约1.5×1.5cm, 平坦，无饱满或隆起，头围49.5cm, 乳牙12颗, 身体的上部量较长, 应考虑的可能疾病是(2.0分)</td>
      <td>A.脑发育不良<br>B.甲状腺功能低下<br>C.脑积水<br>D.脱水<br>E.以上都不是</td>
      <td>B.甲状腺功能低下</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>28. 一健康女婴，营养状况好，测量头围42cm，前囟1.5cm×1.2cm，身长65cm，勉强扶坐，出牙1颗，最可能的年龄是 (2.0分)</td>
      <td>A.3~4个月<br>B.5~6个月<br>C.7~8个月<br>D.8~9个月<br>E.10~12个月</td>
      <td>B.5~6个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>29. 这个女孩，下列反射哪项应该已经不存在 (2.0分)</td>
      <td>A.拥抱反射<br>B.膝反射<br>C.跟腱反射<br>D.腹壁反射<br>E.巴氏征阳性</td>
      <td>A.拥抱反射</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>30. 下列关于婴幼儿骨骼和牙齿发育的描述，正确的是： (2.0分)</td>
      <td>A.前囟在生后6-8周闭合<br>B.后囟在生后1-1.5岁闭合<br>C.生后6个月出现腰椎前凸<br>D.乳牙一般在4-10个月开始萌出<br>E.儿童在8岁左右开始出第一颗恒牙</td>
      <td>D.乳牙一般在4-10个月开始萌出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>31. 小儿胸椎后凸出现的时间为： (2.0分)</td>
      <td>A.出生后即出现<br>B.3个月会抬头时<br>C.6个月会坐时<br>D.8月会爬时<br>E.1岁会走时</td>
      <td>C.6个月会坐时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>32. 下列关于胎儿期的描述，错误的是 (2.0分)</td>
      <td>A.胎儿期从受精卵形成至胎儿娩出，可以分为3个阶段，其中妊娠早期为胎龄16周之前<br>B.妊娠3-8周是胚胎细胞高度分化期，极易受环境不良因素干扰而导致流产、死胎、畸形<br>C.预防感染是预防胎儿畸形、先天发育不全的关键保健措施之一<br>D.至28周时，胎儿肺泡发育基本完善，已具有气体交换功能<br>E.孕期经常饮酒可能导致胎儿中枢神经系统发育障碍、颜面畸形和生长迟缓</td>
      <td>A.胎儿期从受精卵形成至胎儿娩出，可以分为3个阶段，其中妊娠早期为胎龄16周之前</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>33. 我国围生期的定义是(2.0分)</td>
      <td>A.胎龄满28周至出生后7天内<br>B.胎龄满40周至出生后7天内<br>C.胎龄满28周至出生后2周内<br>D.胎龄满40周至出生后2周内<br>E.胎龄满28 至出生后28天内</td>
      <td>A.胎龄满28周至出生后7天内</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>34. 新生儿体温调节的特点，哪一项是正确的？ (2.0分)</td>
      <td>A.新生儿体温调节功能不完善，靠棕色脂肪代偿产热<br>B.早产儿日龄越小，体重越低，所需中性环境温度也越低<br>C.环境温度高时，早产儿可通过出汗而蒸发散热<br>D.将新生儿置于预热后的辐射床，可避免蒸发散热<br>E.将辐射床置于通风对流的过道，不会影响新生儿的体温</td>
      <td>A.新生儿体温调节功能不完善，靠棕色脂肪代偿产热</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>35. 一足月出生男婴，以下哪一项提示为异常？ (2.0分)</td>
      <td>A.可引出觅食反射<br>B.巴彬斯基征阳性<br>C.提睾反射未引出<br>D.拥抱反射未引出<br>E.克氏征阳性</td>
      <td>D.极低出生体重儿，小于胎龄儿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>36. 一婴儿出生时孕28周，出生体重为750克。考虑该新生儿为(2.0分)</td>
      <td>A.低出生体重儿，适于胎龄儿<br>B.低出生体重儿，小于胎龄儿<br>C.极低出生体重儿，适于胎龄儿<br>D.极低出生体重儿，小于胎龄儿<br>E.极低出生体重儿，大于胎龄儿</td>
      <td>D.Y染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>37. 下列哪染色体是近端着丝粒染色体： (2.0分)</td>
      <td>A.3号染色体<br>B.8号染色体<br>C.X染色体<br>D.Y染色体</td>
      <td>D.?-地中海贫血</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>38. 人类染色体核型分析不适合诊断下列哪些遗传病： (2.0分)</td>
      <td>A.21三体综合征<br>B.猫叫综合征<br>C.特纳氏综合征<br>D.?-地中海贫血</td>
      <td>D.电泳时间</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>39. 双链DNA迁移率与下列哪种因素无关： (2.0分)</td>
      <td>A.DNA长度<br>B.电压<br>C.凝胶浓度<br>D.电泳时间</td>
      <td>D.分子量精确，每个条带间隔100bp</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>40. 以下对核酸分子量标准描述不正确的是：(2.0分)</td>
      <td>A.是一组分子量大小已知的DNA片段混合物<br>B.用做对比来检测琼脂糖凝胶电泳的PCR产物长度<br>C.可直接电泳，使用方便<br>D.分子量精确，每个条带间隔100bp</td>
      <td>A.与DNA结合后促进DNA的复制和转录</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>41. 溴化乙锭的性能不包括：(2.0分)</td>
      <td>A.与DNA结合后促进DNA的复制和转录<br>B.能嵌入到双链核酸碱基对平面之间<br>C.250～310 nm波长的紫外光激发其发出橙红色光，常用于检测核酸分子。<br>D.是一种强诱变剂，有致癌作用。</td>
      <td>A.Xq21.2-21.3</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>42. DMD基因定位于： (2.0分)</td>
      <td>A.Xq21.2-21.3<br>B.1q22.2-22.3<br>C.3p21.2-21.3<br>D.Xq22.2-22.3</td>
      <td>D.Malformation</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>43. 在本周的PBL学习案例中, 贾贝贝 was born with microcephaly, micrognathia, and microtia. The type of morphogenesis that these exemplify is (2.0分)</td>
      <td>A.Deformation<br>B.Disruption<br>C.Dysplasia<br>D.Malformation<br>E.Normal</td>
      <td>C.Intracellular nuclear receptor</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>44. 在本周的PBL学习案例中, 戴安娜ingested Accutane (a retinoic acid derivative) for her acne. Recalling the mechanism of action of retinoic acid, Accutane would act via binding to (2.0分)</td>
      <td>A.retinoic acid response element (RARE)<br>B.Cell surface membrane receptor<br>C.Intracellular nuclear receptor<br>D.Tyrosine kinase receptor</td>
      <td>B.40%</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>45. The pedigree shows your patient, Marsha, who is affected with a single gene, autosomal dominant disorder that shows 80% penetrance, and her two children, Michael and Marcus. Michael is also clinically affected with the disorder. The probability that Marcus will have the clinical signs with the disorder is closet to which of the following choices? (2.0分)</td>
      <td>A.20%<br>B.40%<br>C.50%<br>D.80%<br>E.100%</td>
      <td>E.1/2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>46. Chris and his brother Todd both have Duchnne muscular dystrophy. There is a maternal history of this disorder. Jean, the boy's maternal aunt, is interested in beginning a family. What is the probability that she is a heterozygous carrier of the disease gene? (2.0分)</td>
      <td>A. Virtually 0<br>B.1/8<br>C.1/4<br>D.3/8<br>E.1/2</td>
      <td>D.Ligand-binding domains</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>47. A severe birth defect syndrome called retinoic acid embryopathy (OMIM: 242440) is caused by medications such as isotretinoin (Accutane) when taken by pregnant women for treatment of acne. Retinoic acid and steroid hormones are group I signals that cross the cell membrane to interact with cytosolic or nuclear receptors. Which of the structural domains of such receptors would interact with retinoic acid? (2.0分)</td>
      <td>A.Response elements<br>B.Antirepressor domains<br>C.Transcription-activating domains<br>D.Ligand-binding domains<br>E.DNA-binding domains</td>
      <td>E.None of the above</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>48. Which of following action is acceptable in medical genetics practice? (2.0分)</td>
      <td>A.Discuss the cases with your colleagues in the hallway<br>B.Discuss the cases with your friend because she is very interested in anything funny<br>C.Put all the patient genetic testing reports at the front desk and let the patients search for their own ones because it is easy<br>D.Put all the information on the internet and call for people to support the known name patients<br>E.None of the above</td>
      <td>E.Good counselling should not be measured by the patient's/client's ability to remember genetic risks</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2009</td>
      <td>49. About genetic counselling (2.0分)</td>
      <td>A. The individual who seeks genetic counselling is the proband<br>B.Genetic counselling is all about recurrence risk<br>C.Genetic disorders are accidents of nature, so guilt feelings are rare<br>D.Patient support groups have little value given that modern medical genetics is so technically complex<br>E.Good counselling should not be measured by the patient's/client's ability to remember genetic risks</td>
      <td>D.100% daughters, 0% sons</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>1. 一男婴，体重7.5kg，身长66cm，头围44cm，左腕骨骨化中心2个。此婴儿最可能的月龄是 (2.5分)</td>
      <td>A.2个月<br>B.4个月<br>C.6个月<br>D.10个月<br>E.12个月</td>
      <td>C.6个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>2. 关于生长发育的规律，下列哪项是错误的 (2.5分)</td>
      <td>A.由上到下<br>B.由粗到细<br>C.由低级到高级<br>D.由简单到复杂<br>E.由远到近</td>
      <td>E.由远到近</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>3. 以下关于青春发育延迟错误的说法是：(2.5分)</td>
      <td>A.下丘脑-垂体-性腺轴的病变可造成青春发育延迟<br>B.体质性青春发育延迟一般多见于男孩<br>C. 染色体异常造成的性发育延迟不属于青春发育延迟<br>D.Turner综合征属于高促性腺激素性性发育不良的一种<br>E.过度运动和消瘦也会造成青春发育延迟</td>
      <td>C. 染色体异常造成的性发育延迟不属于青春发育延迟</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>4. 以下不是46 XX DSD （性分化异常）病因的为：(2.5分)</td>
      <td>A.分泌雄激素的肿瘤<br>B.母亲高雄激素血症<br>C.先天性肾上腺皮质增生症 21羟化酶缺乏<br>D.雄激素受体不敏感综合征<br>E.以上都不是</td>
      <td>D.雄激素受体不敏感综合征</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>5. 下列关于青春期发育的知识正确的是：(2.5分)</td>
      <td>A.男孩生长发育第二高峰比女孩晚1岁<br>B.青春期发育时一般先有骨龄的加速，然后再有线性生长的加速<br>C.男孩进入青春期发育的标志为喉结突出<br>D.女孩进入青春发育的标志为初潮<br>E.神经内分泌调节趋于稳定</td>
      <td>B.青春期发育时一般先有骨龄的加速，然后再有线性生长的加速</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>6. MRI成像基础是：(2.5分)</td>
      <td>A.组织间吸收系数的差别<br>B.组织间密度高低的差别<br>C.组织间形态的差别<br>D.组织间驰豫时间的差别</td>
      <td>D.组织间驰豫时间的差别</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>7. 自旋回波（SE）序列中去相位是指：(2.5分)</td>
      <td>A.180°脉冲激励后<br>B.180°脉冲激励时<br>C.90°脉冲激励后<br>D.磁场不均匀所致的相位差别<br>E.以上都不对</td>
      <td>B.180°脉冲激励时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>8. 已知某核的旋磁比，今欲使其发生磁共振，则外加磁场B0和射频脉冲RF的关系是：(2.5分)</td>
      <td>A.只有当B0=1T，才能发生磁共振<br>B.只有当B0=2T，才能发生磁共振<br>C.只有当B0=3T，才能发生磁共振<br>D.只要B0与满足拉莫尔公式，就可能发生磁共振<br>E.只要B0与满足拉莫尔公式，就一定发生磁共振</td>
      <td>D.只要B0与满足拉莫尔公式，就可能发生磁共振</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>9. 影响图像对比度的主要成像参数是：(2.5分)</td>
      <td>A.脉冲序列<br>B.磁场系统<br>C.纵向磁化矢量<br>D.横向磁化矢量<br>E.以上都不对</td>
      <td>D.横向磁化矢量</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>10. 有关小儿年龄分期，以下哪一项是错误的？ (2.5分)</td>
      <td>A.新生儿期：自胎儿娩出脐带结扎至28天的时期。<br>B.婴儿期；自满28天到1周岁之前为婴儿期。<br>C.幼儿期：自1岁至满3周岁之前为幼儿期。<br>D.青春期：青春期年龄范围一般从11岁～20岁，女孩的青春期开始年龄和结束年龄都比男孩早2年左右。<br>E.根据不同年龄及其生理特点，分为7个期。</td>
      <td>B.婴儿期；自满28天到1周岁之前为婴儿期。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>11. 一刚出生的新生儿，出生体重2.3Kg,男孩， 出生时皮肤红，有少许脱皮，头发分条清楚，耳廓软骨发育好、耳舟成形，指趾甲超过指、趾端，足纹遍及整个足底，乳腺结节较大>4mm,阴囊皱褶多。该新生儿最可能是： (2.5分)</td>
      <td>A.正常足月儿<br>B.早产，低出生体重儿<br>C.过期产儿<br>D.早产儿，大于胎龄儿<br>E.足月小样儿(小于胎龄儿)</td>
      <td>E.足月小样儿(小于胎龄儿)</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>12. 新生儿体温调节的特点，哪一项是正确的？(2.5分)</td>
      <td>A.新生儿体温调节功能不完善，靠棕色脂肪代偿产热<br>B.早产儿日龄越小，体重越低，所需中性环境温度也越低<br>C.环境温度高时，早产儿可通过出汗而蒸发散热<br>D.将新生儿置于预热后的辐射床，可避免蒸发散热<br>E.将辐射床置于通风对流的过道，不会影响新生儿的体温</td>
      <td>A.新生儿体温调节功能不完善，靠棕色脂肪代偿产热</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>13. 一婴儿出生时孕28周，出生体重为750克。考虑该新生儿为(2.5分)</td>
      <td>A.低出生体重儿，适于胎龄儿<br>B.低出生体重儿，小于胎龄儿<br>C.极低出生体重儿，适于胎龄儿<br>D.极低出生体重儿，小于胎龄儿<br>E.极低出生体重儿，大于胎龄儿</td>
      <td>D.极低出生体重儿，小于胎龄儿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>14. 生理性体重下降一般发生在 (2.5分)</td>
      <td>A.出生后第1周内<br>B.出生后第2周内<br>C.出生后第3周内<br>D.出生后第4周内<br>E.出生后1个月</td>
      <td>A.出生后第1周内</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>15. 一12月龄男孩，前来进行儿童健康体检，在体格测量后，进行的体格发育评价不包括(2.5分)</td>
      <td>A.骨龄评价<br>B.发育水平评价<br>C.生长速度评价<br>D.体型匀称性评价<br>E.身材匀称度评价</td>
      <td>A.骨龄评价</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>16. 一健康女婴，营养状况好，测量头围42cm，前囟1.5cm×1.2cm，身长65cm，勉强扶坐，出牙1颗，最可能的年龄是(2.5分)</td>
      <td>A.3~4个月<br>B.5~6个月<br>C.7~8个月<br>D.8~9个月<br>E.10~12个月</td>
      <td>B.5~6个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>17. 单链DNA迁移率与下列哪种因素无关： (2.5分)</td>
      <td>A.DNA长度<br>B.DNA的碱基序列<br>C.凝胶浓度<br>D.电泳时间</td>
      <td>D.电泳时间</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>18. SSCP的电泳结果应分析哪种形态的DNA： (2.5分)</td>
      <td>A.单链<br>B.双链<br>C.三链<br>D.单链和双链</td>
      <td>A.单链</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>19. 下哪项不能作为判断G带制备好坏的标准： (2.5分)</td>
      <td>A.细胞完整，轮廓清晰，染色体在同一平面上均匀分布<br>B.染色体形态和分散良好，无重叠现象，即使染色体个别重叠，也要能明显辨别<br>C.所观察的染色体长短大致一样，处于同一有丝分裂时期<br>D.在所观察的染色体周围有多个散在的染色体</td>
      <td>D.在所观察的染色体周围有多个散在的染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>20. PCR产物大小由下列哪种因素决定： (2.5分)</td>
      <td>A.模板量<br>B.退火温度<br>C.引物序列<br>D.变性温度</td>
      <td>C.引物序列</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>21. 若发现视野没有分裂相，二个主要原因有： (2.5分)</td>
      <td>A.秋水仙素浓度或处理时间不合适<br>B.胰酶消化时间过长<br>C.Giemsa染色时间不够<br>D.低渗时间太短</td>
      <td>A.秋水仙素浓度或处理时间不合适</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>22. A 21-year-old man requests genetic testing for Huntington disease. Family history includes a grandmother who had been affected. Which of the following describes the most direct diagnostic procedure for this patient?(2.5分)</td>
      <td>A.CAG repeat analysis<br>B.Gene deletion analysis<br>C.Missense mutation analysis<br>D.Polyglutamine（多谷氨酰胺）analysis<br>E.Protein concentration analysis</td>
      <td>A.CAG repeat analysis</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>23. Which of following action is acceptable in medical genetics practice（医学遗传学实践）?(2.5分)</td>
      <td>A.Discuss the cases with your colleagues in the hallway（过道）<br>B.Discuss the cases with your friend because she is very interested in anything funny<br>C.Put all the patient genetic testing reports at the front desk and let the patients search for their own ones because it is easy<br>D.Put all the information on the internet and call for people to support the known name patients<br>E.None of the above</td>
      <td>E.None of the above</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>24. About genetic counselling（关于遗传咨询）(2.5分)</td>
      <td>A.The individual who seeks genetic counselling is the proband（先证者）<br>B.Genetic counselling is all about recurrence risk（再发风险）<br>C.Genetic disorders are accidents of nature（天生的）, so guilt feelings are rare<br>D.Patient support groups have little value given that modern medical genetics is so technically complex<br>E.Good counselling should not be measured by the patient's/client's ability to remember genetic risks</td>
      <td>E.Good counselling should not be measured by the patient's/client's ability to remember genetic risks</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>25. If both parents are affected with the same autosomal recessive disorder then the probability that each of their children will be affected equals ___.(2.5分)</td>
      <td>A.3/4<br>B.1/4<br>C.1/2<br>D.2/3<br>E.1</td>
      <td>E.1</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>26. 在本周的PBL学习案例中, 戴安娜ingested Accutane (异维A酸。a retinoic acid derivative) for her acne（痤疮）. Recalling the mechanism of action of retinoic acid（视黄酸）, Accutane would act via binding to(2.5分)</td>
      <td>A.retinoic acid response element (RARE)<br>B.Cell surface membrane receptor（细胞表面膜受体）<br>C.Intracellular nuclear receptor（胞内细胞核受体）<br>D.Tyrosine kinase receptor（酪氨酸激酶受体）<br>E.mRNA</td>
      <td>C.Intracellular nuclear receptor（胞内细胞核受体）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>27. Mutations in homeotic genes（同源异型基因） often cause(2.5分)</td>
      <td>A.the deletion of segments.<br>B.the absence of structures.<br>C.too many segments.<br>D.structures to appear in the wrong place.<br>E.DMD</td>
      <td>D.structures to appear in the wrong place.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>28. Which is true? Transcription factors（转录因子）:(2.5分)</td>
      <td>A.Are RNA sequences that interfere（干扰） with translation in the ribosomes<br>B.Their only function is to switch off（关闭） genes in development<br>C.When mutated in Drosophila body segments（果蝇的体节） may NOT be completely reorganized<br>D.Are not involved in defects of laterality（偏侧化）<br>E.Include genes that have a zinc finger motif（锌指基序）</td>
      <td>E.Include genes that have a zinc finger motif（锌指基序）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>29. 有关超声波的特性下列正确的是(2.5分)</td>
      <td>A.大于16Hz的机械纵波<br>B.16--20MHz的机械纵波<br>C.大于20M Hz的机械纵波<br>D.大于20M Hz的机械横波<br>E.小于16Hz的机械横波</td>
      <td>C.大于20M Hz的机械纵波</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>30. 连续多普勒的特点为：(2.5分)</td>
      <td>A.速度分辨力差，距离分辨力亦差<br>B.速度分辨力差，距离分辨力佳<br>C.速度分辨力佳, 距离分辨力差<br>D.速度分辨力佳, 距离分辨力亦佳<br>E.以上都错误</td>
      <td>C.速度分辨力佳, 距离分辨力差</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>31. 在扫描中，清楚地分辨物体，能够测定其结构间最小距离，决定于声束的 (2.5分)</td>
      <td>A.强度<br>B.波长<br>C.衰减<br>D.速度<br>E.波幅</td>
      <td>B.波长</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>32. 彩色血流显像中对向探头的湍流血流颜色应为： (2.5分)</td>
      <td>A.红色血流<br>B.兰色血流<br>C.混色血流<br>D.以红色为主的五彩镶嵌血流<br>E.以兰色为主五彩镶嵌血流</td>
      <td>D.以红色为主的五彩镶嵌血流</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>33. 关于压电效应那种说法正确的是：(2.5分)</td>
      <td>A.逆压电效应(接收)<br>B.在交变电场的作用导致压电晶体厚度的交替改变从而产生声振动，即由电能转变为声能。<br>C.正压电效应(产生)<br>D.由压电晶体自主产生超声波</td>
      <td>B.在交变电场的作用导致压电晶体厚度的交替改变从而产生声振动，即由电能转变为声能。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>34. 超声波安全标准那条描述不正确？(2.5分)</td>
      <td>A.人体紧要部位超声强度限定值《FDA规定》<br>B.超声生物效应与安全指标Ispta有关<br>C.国际电工委员会（ICE1157-92）规定胎Ispta<1Mw/cm2<br>D.Ispta的概念:脉冲能量集中在T2时间段内,脉冲周期时间为T1,脉冲能量被T1 平均称为Ispta，<br>E.器官的Ispta依其重要性和敏感程度有不同要求</td>
      <td>C.国际电工委员会（ICE1157-92）规定胎Ispta<1Mw/cm2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>35. 超声反射率由什么决定？(2.5分)</td>
      <td>A.声阻抗直接决定<br>B.声吸收<br>C.反射面前后声阻抗之差决定<br>D.Doppler信号强弱<br>E.波长</td>
      <td>C.反射面前后声阻抗之差决定</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>36. 描述超声图像特征的四个参数不包括 (2.5分)</td>
      <td>A.亮度<br>B.灰度<br>C.反射度<br>D.对比度<br>E.分辨率</td>
      <td>C.反射度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>37. 双顶径（biaparietal diameter,BPD）那个说法正确(2.5分)</td>
      <td>A.妊娠12周末以前测<br>B.测量的标准平面是丘脑平面<br>C.测量方法：从顶骨的内侧缘至对侧顶骨的内侧缘<br>D.中期妊娠双顶径的增长较慢，妊娠晚期相对快<br>E.31周前平均每周增长1mm</td>
      <td>B.测量的标准平面是丘脑平面</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>38. DICOM 3的含义是什么? (2.5分)</td>
      <td>A.PACS（图像存挡和通信系统）<br>B.直接通过视频连接超声仪器的标准<br>C.前国际上己制订出必需共同遵守的传输协议<br>D.Doppler国际标准<br>E.彩色血流的国际标准</td>
      <td>C.前国际上己制订出必需共同遵守的传输协议</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>39. 下列哪项不是幼儿期的特点？ (2.5分)</td>
      <td>A.生长速度较婴儿期减慢<br>B.智能发育加速<br>C.活动范围增加，容易发生意外伤害<br>D.食物转为固体，应注意膳食营养<br>E.体质增强，感染、传染性疾病减少</td>
      <td>E.体质增强，感染、传染性疾病减少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2010</td>
      <td>40. 一3周岁男孩，体检发现前囟未闭，约1.5×1.5cm, 平坦，无饱满或隆起，头围49.5cm, 乳牙12颗, 身体的上部量较长, 应考虑的可能疾病是 (2.5分)</td>
      <td>A.脑发育不良<br>B.甲状腺功能低下<br>C.脑积水<br>D.脱水<br>E.以上都不是</td>
      <td>B.甲状腺功能低下</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>1. 已知某核的旋磁比，今欲使其发生磁共振，则外加磁场B0和射频脉冲RF的关系是：(2.5分)</td>
      <td>A.只有当B0=1T，才能发生磁共振<br>B.只有当B0=2T，才能发生磁共振<br>C.只有当B0=3T，才能发生磁共振<br>D.只要B0与满足拉莫尔公式，就可能发生磁共振<br>E.只要B0与满足拉莫尔公式，就一定发生磁共振</td>
      <td>D.只要B0与满足拉莫尔公式，就可能发生磁共振</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>2. 自旋回波（SE）序列中去相位是指(2.5分)</td>
      <td>A.180°脉冲激励后<br>B.180°脉冲激励时<br>C.90°脉冲激励后<br>D.磁场不均匀所致的相位差别<br>E.以上都不对</td>
      <td>B.180°脉冲激励时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>3. 下列何种情况下的病人绝对禁止行MRI检查(2.5分)</td>
      <td>A.装有人工股骨头<br>B.装有心脏起搏器<br>C.宫内节育器<br>D.幽闭恐惧综合症<br>E.对比剂过敏</td>
      <td>B.装有心脏起搏器</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>4. 有关磁共振信号强度的描述，错误的是(2.5分)</td>
      <td>A.T1值越大，信号强度越大<br>B.T2值越大，信号强度越大<br>C.TR越长，信号强度越大<br>D.TE越短，信号强度越大<br>E.质子密度越大，信号强度越大</td>
      <td>A.T1值越大，信号强度越大</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>5. 影响图像对比度的主要成像参数是(2.5分)</td>
      <td>A.脉冲序列<br>B. 磁场系统<br>C.纵向磁化矢量<br>D.横向磁化矢量<br>E.以上都不对</td>
      <td>D.横向磁化矢量</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>6. Which of the following is, in most cases, inherited as a complex genetic trait（复杂遗传性状）?(2.5分)</td>
      <td>A.Cystic fibrosis<br>B.Down syndrome<br>C.Neurofibromatosis（神经纤维瘤病）<br>D.Neural tube defects（神经管缺陷）<br>E.Duchenne muscular dystrophy（DMD）</td>
      <td>D.Neural tube defects（神经管缺陷）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>7. Many disorders are not caused by single gene inheritance, but are multifactorial. In counseling situations involving these disorders, how are recurrence risks（再发风险） identified?(2.5分)</td>
      <td>A.Single gene inheritance risks are multiplied by a factorial fraction, chosen to represent the contribution from other genetic factors plus the environmental influence（通过阶乘分数得到单基因遗传的风险，再乘以其他遗传因素和环境因素造成的风险）<br>B.Bayes theorem（Bayes定理） is applied, using modifications of "prior" risk calculation（前概率风险计算） utilized among single-gene defects<br>C.The risks are determined empirically, based on previous observations of disease recurrence among actual families（主要依据经验风险）<br>D.Recurrence risks cannot determined for non-Mendelian disorders<br>E.All above is wrong</td>
      <td>C.The risks are determined empirically, based on previous observations of disease recurrence among actual families（主要依据经验风险）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>8. About genetic counselling（关于遗传咨询）(2.5分)</td>
      <td>A.The individual who seeks genetic counselling is the proband（先证者）<br>B.Genetic counselling is all about recurrence risk（再发风险）<br>C.Genetic disorders are accidents of nature（天生的）, so guilt feelings are rare<br>D.Patient support groups have little value given that modern medical genetics is so technically complex<br>E.Good counselling should not be measured by the patient's/client's ability to remember genetic risks</td>
      <td>E.Good counselling should not be measured by the patient's/client's ability to remember genetic risks</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>9. If both parents are affected with the same autosomal recessive disorder then the probability that each of their children will be affected equals ___.(2.5分)</td>
      <td>A.42067<br>B.42008<br>C.42006<br>D.42038<br>E.1</td>
      <td>E.1</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>10. 在本周的PBL学习案例中, 贾贝贝 was born with microcephaly（小头）, micrognathia（小颌）, and microtia（小耳畸形）. The type of morphogenesis（形态发生） that these exemplify is(2.5分)</td>
      <td>A.Deformation（变形）<br>B.Disruption（畸化）<br>C.Dysplasia（发育异常）<br>D.Malformation（畸形）<br>E.Normal</td>
      <td>D.Malformation（畸形）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>11. 在本周的PBL学习案例中, 戴安娜ingested Accutane (异维A酸。a retinoic acid derivative) for her acne（痤疮）. Recalling the mechanism of action of retinoic acid（视黄酸）, Accutane would act via binding to(2.5分)</td>
      <td>A.retinoic acid response element (RARE)<br>B.Cell surface membrane receptor（细胞表面膜受体）<br>C.Intracellular nuclear receptor（胞内细胞核受体）<br>D.Tyrosine kinase receptor（酪氨酸激酶受体）<br>E.mRNA</td>
      <td>C.Intracellular nuclear receptor（胞内细胞核受体）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>12. Which is false? In development, HOX genes:(2.5分)</td>
      <td>A.Function as transcription factors（转录因子）<br>B.Only a few malformation syndromes（畸形综合征） can be directly attributed to HOX gene mutations at present, probably because of paralogous（旁系同源基因）compensation（补偿）<br>C.Show very divergent（趋异进化） structures across different species<br>D.Are functionally redundant（冗余） in postnatal（出生后） life<br>E.Individually can be important in the normal development of widely different body systems</td>
      <td>C.Show very divergent（趋异进化） structures across different species</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>13. Dysmorphology（畸形学）classifies congenital anatomic malformations according to pathophysiology. This classification includes malformations（畸形）, deformations（变形）, and disruptions（畸化）. A fourth type exists in which there is abnormal organization of cells into tissues with its morphologic consequences. This would be defined as(2.5分)</td>
      <td>A.dysautonomia<br>B.dysdiadokinesis<br>C.distichiasis<br>D.dysergia<br>E.dysplasia</td>
      <td>E.dysplasia</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>14. A severe birth defect syndrome called retinoic acid embryopathy (视黄酸胚胎病。OMIM: 242440) is caused by medications such as isotretinoin (Accutane。异维A酸) when taken by pregnant women for treatment of acne（痤疮）. Retinoic acid and steroid hormones（类固醇激素） are group I signals（信号分子） that cross the cell membrane to interact with cytosolic（细胞溶质） or nuclear receptors. Which of the structural domains（结构域） of such receptors would interact with retinoic acid?(2.5分)</td>
      <td>A.Response elements（反应元件）<br>B.Antirepressor domains（抗阻抑物功能域）<br>C.Transcription-activating domains（转录活化域）<br>D.Ligand-binding domains（配体结合域）<br>E.DNA-binding domains（DNA结合域）</td>
      <td>D.Ligand-binding domains（配体结合域）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>15. 下列关于胎儿期的描述，错误的是 (2.5分)</td>
      <td>A.胎儿期从受精卵形成至胎儿娩出, 共40周；<br>B.妊娠3-8周是胚胎细胞高度分化期，极易受环境不良因素干扰而导致流产、死胎、畸形<br>C.预防感染是预防胎儿畸形、先天发育不全的关键保健措施之一<br>D.至26周时，胎儿肺泡发育基本完善，PS已达肺成熟水平，具有气体交换功能<br>E.孕期经常饮酒可能导致胎儿中枢神经系统发育障碍、颜面畸形和生长迟缓</td>
      <td>D.至26周时，胎儿肺泡发育基本完善，PS已达肺成熟水平，具有气体交换功能</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>16. 一刚出生的新生儿，出生体重2.3Kg,男孩， 出生时皮肤红，有少许脱皮，头发分条清楚，耳廓软骨发育好、耳舟成形，指趾甲超过指、趾端，足纹遍及整个足底，乳腺结节较大>4mm,阴囊皱褶多。该新生儿最可能是： (2.5分)</td>
      <td>A.正常足月儿<br>B.早产，低出生体重儿<br>C.过期产儿<br>D.早产儿，大于胎龄儿<br>E.足月小样儿(小于胎龄儿)</td>
      <td>E.足月小样儿(小于胎龄儿)</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>17. 新生儿体温调节的特点，哪一项是正确的？ (2.5分)</td>
      <td>A.新生儿体温调节功能不完善，靠棕色脂肪代偿产热<br>B.早产儿日龄越小，体重越低，所需中性环境温度也越低<br>C.环境温度高时，早产儿可通过出汗而蒸发散热<br>D.将新生儿置于预热后的辐射床，可避免蒸发散热<br>E.将辐射床置于通风对流的过道，不会影响新生儿的体温</td>
      <td>A.新生儿体温调节功能不完善，靠棕色脂肪代偿产热</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>18. 下列哪项不是幼儿期的特点？ (2.5分)</td>
      <td>A.生长速度较婴儿期减慢<br>B.智能发育加速<br>C.活动范围增加，容易发生意外伤害<br>D.食物转为固体，应注意膳食营养<br>E.体质增强，感染、传染性疾病减少</td>
      <td>E.体质增强，感染、传染性疾病减少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>19. 下列关于婴幼儿骨骼和牙齿发育的描述，正确的是： (2.5分)</td>
      <td>A.前囟在生后6-8周闭合<br>B.后囟在生后1-1.5岁闭合<br>C.生后9个月出现胸椎前凸<br>D.乳牙一般在4-10个月开始萌出<br>E.儿童在8岁左右开始出第一颗恒牙</td>
      <td>D.乳牙一般在4-10个月开始萌出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>20. 一足月出生男婴，以下哪一项提示为异常？ (2.5分)</td>
      <td>A.可引出觅食反射<br>B.巴彬斯基征阳性<br>C.提睾反射未引出<br>D.拥抱反射未引出<br>E.克氏征阳性</td>
      <td>C.9月龄</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>21. 一男孩，出生体重3.3kg, 目前体检体重8.9kg, 身长72cm, 前囟1×1cm, 乳牙1枚。 头围45cm, 尚不会独站。最可能的年龄是： (2.5分)</td>
      <td>A.3月龄<br>B.6月龄<br>C.9月龄<br>D.12月龄<br>E.15月龄</td>
      <td>B.甲状腺功能低下</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>22. 一3周岁男孩，体检发现前囟未闭，约1.5×1.5cm, 平坦，无饱满或隆起，头围49.5cm, 乳牙12颗, 身体的上部量较长, 应考虑的可能疾病是 (2.5分)</td>
      <td>A.脑发育不良<br>B.甲状腺功能低下<br>C.脑积水<br>D.脱水<br>E.以上都不是</td>
      <td>C.生长曲线图评价法</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>23. 了解儿童的生长速度及其生长发育趋势，最直观的评价方法是 (2.5分)</td>
      <td>A.百分位数法<br>B.均值离差法<br>C.生长曲线图评价法<br>D.标准差的离差法<br>E.中位数法</td>
      <td>C.常出现周期性呼吸，即呼吸停止<20秒，伴有心率缓慢及发绀</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>24. 一早产新生儿，以下哪项生理或生化指标是异常的？ (2.5分)</td>
      <td>A.出生时平均血容量为90ml/kg<br>B.平均心率为140次/分<br>C.常出现周期性呼吸，即呼吸停止<20秒，伴有心率缓慢及发绀<br>D.血红蛋白（Hb）高达170g/L<br>E.拥抱反射不完全引出</td>
      <td>B.8岁</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>25. 一男孩，体重28kg，身长128cm，左腕骨骨化中心9个。此男孩最可能的年龄是 (2.5分)</td>
      <td>A.6岁<br>B.8岁<br>C.10岁<br>D.12岁<br>E.以上均不是</td>
      <td>A.婴儿期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>26. 小儿年龄阶段中哪一期体格发育最快 (2.5分)</td>
      <td>A.婴儿期<br>B.幼儿期<br>C.学龄前期<br>D.学龄期<br>E.青春期</td>
      <td>D. 雄激素受体不敏感综合征</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>27. 以下不是46 XX DSD （性分化异常）病因的为：(2.5分)</td>
      <td>A. 分泌雄激素的肿瘤<br>B. 母亲高雄激素血症<br>C. 先天性肾上腺皮质增生症 21羟化酶缺乏<br>D. 雄激素受体不敏感综合征<br>E. 以上都不是</td>
      <td>B.高肾素性高血压（DOC ）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>28. 17羟化酶缺乏症(17-OHD,17 hydroxylase deficiency)不会出现下列哪项表现(2.5分)</td>
      <td>A.男性假两性畸形<br>B.高肾素性高血压（DOC ）<br>C.血皮质醇降低<br>D.皮质酮、DOC、ACTH、孕酮升高<br>E.血Na增高，血K降低（血浆PRA及Aldo水平下降），碱中毒</td>
      <td>C.关键时刻无AMH或睾酮作用，则内生殖管道分化为男性结构</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>29. 以下有关性决定和性分化的叙述错误的是：(2.5分)</td>
      <td>A.胚胎的性决定和性分化具有关键的时间窗<br>B.关键的调控基因需在"正确"的关键时刻准确合适的表达才能使性分化正确进行。<br>C.关键时刻无AMH或睾酮作用，则内生殖管道分化为男性结构<br>D.45XO综合征是最常见的性染色体畸变综合征<br>E.性分化发育异常的诊断过程是性别鉴定和病因诊断的过程</td>
      <td>C.染色体异常造成的性发育延迟不属于青春发育延迟</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>30. 以下关于青春发育延迟错误的说法是：(2.5分)</td>
      <td>A.下丘脑-垂体-性腺轴的病变可造成青春发育延迟<br>B.体质性青春发育延迟一般多见于男孩<br>C.染色体异常造成的性发育延迟不属于青春发育延迟<br>D.Turner综合征属于高促性腺激素性性发育不良的一种<br>E.过度运动和消瘦也会造成青春发育延迟</td>
      <td>E.由远到近</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>31. 关于生长发育的规律，下列哪项是错误的 (2.5分)</td>
      <td>A.由上到下<br>B.由粗到细<br>C.由低级到高级<br>D.由简单到复杂<br>E.由远到近</td>
      <td>C.大于20M Hz的机械纵波</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>32. 有关超声波的特性下列正确的是：(2.5分)</td>
      <td>A.大于16Hz的机械纵波<br>B.16--20MHz的机械纵波<br>C.大于20M Hz的机械纵波<br>D.大于20M Hz的机械横波<br>E.小于16Hz的机械横波</td>
      <td>B.波长</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>33. 在扫描中，清楚地分辨物体，能够测定其结构间最小距离，决定于声束的 (2.5分)</td>
      <td>A.强度<br>B.波长<br>C.衰减<br>D.速度<br>E.波幅</td>
      <td>C.速度分辨力佳, 距离分辨力差</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>34. 连续多普勒的特点为：(2.5分)</td>
      <td>A.速度分辨力差，距离分辨力亦差<br>B.速度分辨力差，距离分辨力佳<br>C.速度分辨力佳, 距离分辨力差<br>D.速度分辨力佳, 距离分辨力亦佳<br>E.以上都错误</td>
      <td>D.声波可以在真空中传播</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>35. 下列那一项描述错误? (2.5分)</td>
      <td>A.振动质点在媒质内传播产生周期性疏密波称声波<br>B.波的传播方向与质点振动方向一致的,称为纵波<br>C.传播方向和振动方向相互垂直的称横波<br>D.声波可以在真空中传播<br>E.光波可以在真空中传播</td>
      <td>C.前国际上己制订出必需共同遵守的传输协议</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>36. DICOM 3的含义是什么? (2.5分)</td>
      <td>A.PACS（图像存挡和通信系统）<br>B.直接通过视频连接超声仪器的标准<br>C.前国际上己制订出必需共同遵守的传输协议<br>D.Doppler国际标准<br>E.彩色血流的国际标准</td>
      <td>A.无反射型常见于空气。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>37. 超声波的反射类型根据组织声阻抗的大小与组织结构内部均匀程度可分型，哪项是错误的？ (2.5分)</td>
      <td>A.无反射型常见于空气。<br>B.少反引型：常见心壁 ；<br>C.多反射型：如瓣膜等；<br>D.全反射型：肠交界。<br>E.血液表现为无反射型。</td>
      <td>B.测量的标准平面是丘脑平面</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>38. 双顶径（biaparietal diameter,BPD）哪个说法正确 (2.5分)</td>
      <td>A.妊娠12周末以前测<br>B.测量的标准平面是丘脑平面<br>C.测量方法：从顶骨的内侧缘至对侧顶骨的内侧缘<br>D.中期妊娠双顶径的增长较慢，妊娠晚期相对快<br>E.31周前平均每周增长1mm</td>
      <td>A.B超就是超声波的统称</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2011</td>
      <td>39. 超声诊断仪的显示模式等哪项描述是错误的？(2.5分)</td>
      <td>A.B超就是超声波的统称<br>B.M型是最早用于心脏检查的<br>C.D型测速原理和海军声纳是一样的<br>D.A超回声波幅的高低、多少反映界面的声阻抗差异大小<br>E.1842年Christian Joham Doppler观察天体时发现多普勒效应</td>
      <td>D.以红色为主的五彩镶嵌血流</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>1. 有关超声多普勒以下哪项错误：(2.5分)</td>
      <td>A.有彩色多普勒、脉冲多普勒和连续多普勒等<br>B.脉冲多普勒能测高速血流<br>C.脉冲多普勒有距离选通功能<br>D.连续多普勒无距离选通功能<br>E.彩色多普勒是半定量显示</td>
      <td>B.脉冲多普勒能测高速血流</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>2. 波的峰压或高度称 (2.5分)</td>
      <td>A.周期<br>B.频率<br>C.波幅<br>D.波长<br>E.速度</td>
      <td>C.波幅</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>3. 连续多普勒的特点为：(2.5分)</td>
      <td>A.速度分辨力差，距离分辨力亦差<br>B.速度分辨力差，距离分辨力佳<br>C.速度分辨力佳, 距离分辨力差<br>D.速度分辨力佳, 距离分辨力亦佳<br>E.以上都错误</td>
      <td>C.速度分辨力佳, 距离分辨力差</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>4. 液体属于声学类型中的 (2.5分)</td>
      <td>A.少反射型<br>B.无反射型<br>C.多反射型<br>D.全反射型<br>E.混合反射型</td>
      <td>B.无反射型</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>5. 关于压电效应那种说法正确? (2.5分)</td>
      <td>A.逆压电效应(接收)<br>B.在交变电场的作用导致压电晶体厚度的交替改变从而产生声振动，即由电能转变为声能。<br>C.正压电效应(产生)<br>D.由压电晶体自主产生超声波</td>
      <td>B.在交变电场的作用导致压电晶体厚度的交替改变从而产生声振动，即由电能转变为声能。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>6. 下列那一项描述错误? (2.5分)</td>
      <td>A.振动质点在媒质内传播产生周期性疏密波称声波<br>B.波的传播方向与质点振动方向一致的,称为纵波<br>C.传播方向和振动方向相互垂直的称横波<br>D.声波可以在真空中传播<br>E.光波可以在真空中传播</td>
      <td>D.声波可以在真空中传播</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>7. 超声反射率由什么决定?(2.5分)</td>
      <td>A.声阻抗直接决定<br>B.声吸收<br>C.反射面前后声阻抗之差决定<br>D.Doppler信号强弱<br>E.波长</td>
      <td>C.反射面前后声阻抗之差决定</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>8. 物理定律紧绕声波和组织相互作用，作用过程涉及四大物理定律，期中哪项是错误的?(2.5分)</td>
      <td>A.吸收定律<br>B.反射定律<br>C.压电定律<br>D.衍射定律<br>E.多普勒定律</td>
      <td>C.压电定律</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>9. 是超声首先观察到的妊娠标志。(2.5分)</td>
      <td>A.卵黄囊（yolk sac）<br>B. "胎儿"<br>C.胚芽（fetal pole）<br>D. "胚胎"<br>E.妊娠囊（gestational sac）</td>
      <td>E.妊娠囊（gestational sac）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>10. A 21-year-old man requests genetic testing for Huntington disease. Family history includes a grandmother who had been affected. Which of the following describes the most direct diagnostic procedure for this patient?(2.5分)</td>
      <td>A.CAG repeat analysis<br>B.Gene deletion analysis<br>C.Missense mutation analysis<br>D.Polyglutamine（多谷氨酰胺）analysis<br>E.Protein concentration analysis</td>
      <td>A.CAG repeat analysis</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>11. Chris and his brother Todd both have Duchnne muscular dystrophy（DMD）. There is a maternal（母系） history of this disorder. Jean, the boy's maternal aunt, is interested in beginning a family. What is the probability（概率） that she is a heterozygous carrier（杂合子携带者） of the disease gene?(2.5分)</td>
      <td>A.Virtually 0<br>B.42377<br>C.42373<br>D.3/8<br>E.1/2</td>
      <td>D.3/8</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>12. About genetic counselling（关于遗传咨询）(2.5分)</td>
      <td>A.The individual who seeks genetic counselling is the proband（先证者）<br>B.Genetic counselling is all about recurrence risk（再发风险）<br>C.Genetic disorders are accidents of nature（天生的）, so guilt feelings are rare<br>D.Patient support groups have little value given that modern medical genetics is so technically complex<br>E.Good counselling should not be measured by the patient's/client's ability to remember genetic risks</td>
      <td>D.Patient support groups have little value given that modern medical genetics is so technically complex</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>13. The maternal serum level of alpha-fetoprotein (AFP 甲胎蛋白) is lower than average in which situation?(2.5分)</td>
      <td>A.Down syndrome<br>B.Exomphalos（脐疝）<br>C.Neural tube defects（神经管缺陷）<br>D.Twin pregnancies<br>E.Huntington disease</td>
      <td>A.Down syndrome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>14. Hox genes encode proteins with which of the following properties（特性）?(2.5分)</td>
      <td>A.Presence of DNA-binding domain（DNA-结合功能域）<br>B.Transport to lysosome（溶酶体）<br>C.Binding of extracellular ligands（细胞外配体） in the cell membrane<br>D.Secretion from the cell<br>E.Transport to Golgi complex（高尔基复合体）</td>
      <td>A.Presence of DNA-binding domain（DNA-结合功能域）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>15. Mutations in homeotic genes（同源异型基因） often cause(2.5分)</td>
      <td>A.the deletion of segments.<br>B.the absence of structures.<br>C.too many segments.<br>D.structures to appear in the wrong place.<br>E.DMD</td>
      <td>D.structures to appear in the wrong place.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>16. A severe birth defect syndrome（出生缺陷综合征） called retinoic acid embryopathy (视黄酸胚胎病。OMIM: 242440) is caused by medications such as isotretinoin (Accutane。异维A酸) when taken by pregnant women for treatment of acne（痤疮）. Retinoic acid and steroid hormones（类固醇激素） are group I signals（信号分子） that cross the cell membrane to interact with cytosolic（细胞溶质） or nuclear receptors. Which of the structural domains（结构域） of such receptors would interact with retinoic acid?(2.5分)</td>
      <td>A.Response elements（反应元件）<br>B.Antirepressor domains（抗阻抑物功能域）<br>C.Transcription-activating domains（转录活化域）<br>D.Ligand-binding domains（配体结合域）<br>E.DNA-binding domains（DNA结合域）</td>
      <td>D.Ligand-binding domains（配体结合域）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>17. Which is true? Transcription factors（转录因子）(2.5分)</td>
      <td>A.Are RNA sequences that interfere（干扰） with translation in the ribosomes<br>B.Their only function is to switch off（关闭） genes in development<br>C.When mutated in Drosophila body segments（果蝇的体节） may NOT be completely reorganized<br>D.Are not involved in defects of laterality（偏侧化）<br>E.Include genes that have a zinc finger motif（锌指基序）</td>
      <td>E.Include genes that have a zinc finger motif（锌指基序）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>18. Birth defects(2.5分)</td>
      <td>A.are uncommon（非常见的） disorders that most practitioners will rarely see.<br>B.in general are decreasing in frequency.<br>C.are often associated with infant mortality（婴儿死亡率）.<br>D.are less common in the South as compared to the rest of the US.<br>E.rarely are seen with more than one anomaly（异常） per person.</td>
      <td>C.are often associated with infant mortality（婴儿死亡率）.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>19. MRI的成像基础是(2.5分)</td>
      <td>A.组织间吸收系数的差别<br>B.组织间密度高低的差别<br>C.组织间形态的差别<br>D.组织间驰豫时间的差别<br>E.组织间解剖结构的差异</td>
      <td>D.组织间驰豫时间的差别</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>20. 梯度磁场的目的是(2.5分)</td>
      <td>A.增加磁场的均匀性<br>B.减少磁场强度<br>C.帮助空间定位<br>D.增加磁场强度<br>E.减小伪影</td>
      <td>C.帮助空间定位</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>21. 下列造影技术中，哪些不属于MR水成像范畴(2.5分)</td>
      <td>A.MR胰胆管造影<br>B.MR泪道造影<br>C.MR尿路造影<br>D.MR血管造影<br>E.MR腮腺管造影</td>
      <td>B.MR泪道造影</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>22. 下列常用的临床检查方法中无电离辐射的是(2.5分)</td>
      <td>A.CT和PET<br>B.超声和CT<br>C.超声和MRI<br>D.CT和MRI<br>E.PET和MRI</td>
      <td>C.超声和MRI</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>23. 有关磁共振信号强度的描述，错误的是(2.5分)</td>
      <td>A.T1值越大，信号强度越大<br>B.T2值越大，信号强度越大<br>C.TR越长，信号强度越大<br>D.TE越短，信号强度越大<br>E.质子密度越大，信号强度越大</td>
      <td>A.T1值越大，信号强度越大</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>24. 下列关于胎儿期的描述，错误的是 (2.5分)</td>
      <td>A.妊娠3-8周是胚胎细胞高度分化期，极易受环境不良因素干扰而导致流产、 死胎、畸形<br>B.预防感染是预防胎儿畸形、先天发育不全的关键保健措施之一<br>C.胎儿期从受精卵形成至胎儿娩出，可以分为3个阶段，其中妊娠早期为胎龄16周之前<br>D.至28周时，胎儿肺泡发育基本完善，已具有气体交换功能<br>E.孕期经常饮酒可能导致胎儿中枢神经系统发育障碍、颜面畸形和生长迟缓</td>
      <td>C.胎儿期从受精卵形成至胎儿娩出，可以分为3个阶段，其中妊娠早期为胎龄16周之前</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>25. 以下哪一项是新生儿期的特征? (2.5分)</td>
      <td>A.容易受外界不良因素影响而发生畸形、发育不全、生长迟缓<br>B.经历了依赖于母体生存向独立生存的巨大变化，发病率和死亡率均很高<br>C.体格生长速度相对婴儿期较慢<br>D.生理功能已逐渐成熟，不会再出现胎儿循环<br>E.新生儿的免疫功能发育不成熟，尤其细胞免疫功能</td>
      <td>B.经历了依赖于母体生存向独立生存的巨大变化，发病率和死亡率均很高</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>26. 一刚出生的新生儿，出生体重1.8Kg,男孩， 出生时皮肤红，有少许脱皮，头发分条清楚，耳廓软骨发育好、耳舟成形，指趾甲超过指、趾端，足纹遍及整个足底，乳腺结节较大>4mm,阴囊皱褶多。该新生儿最可能是： (2.5分)</td>
      <td>A.正常足月儿<br>B.早产，低出生体重儿<br>C.足月小样儿(小于胎龄儿)<br>D.过期产儿<br>E.早产儿，小于胎龄儿</td>
      <td>C.足月小样儿(小于胎龄儿)</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>27. 新生儿体温调节的特点，哪一项是正确的? (2.5分)</td>
      <td>A.新生儿体温调节功能不完善，靠棕色脂肪代偿产热<br>B.早产儿日龄越小，体重越低，所需中性环境温度也越低<br>C.环境温度高时，早产儿可通过出汗而蒸发散热<br>D.将新生儿置于预热后的辐射床，可避免蒸发散热<br>E.将辐射床置于通风对流的过道，不会影响新生儿的体温</td>
      <td>A.新生儿体温调节功能不完善，靠棕色脂肪代偿产热</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>28. 一婴儿出生时孕28周，出生体重为750克。考虑该新生儿为(2.5分)</td>
      <td>A.早产低出生体重儿，适于胎龄儿<br>B.早产低出生体重儿，小于胎龄儿<br>C.早产极低出生体重儿，适于胎龄儿<br>D.早产极低出生体重儿，小于胎龄儿<br>E.早产极低出生体重儿，大于胎龄儿</td>
      <td>D.早产极低出生体重儿，小于胎龄儿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>29. 学龄前期是指 (2.5分)</td>
      <td>A.自胎儿娩出脐带结扎至生后28天<br>B.自胎儿娩出脐带结扎至1周岁<br>C.满1周岁至3周岁<br>D.自满3周岁至6~7岁<br>E.自6~7岁至青春期前</td>
      <td>D.自满3周岁至6~7岁</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>30. 小儿胸椎后凸出现的时间为(2.5分)</td>
      <td>A.出生后即出现<br>B.3个月会抬头时<br>C.6个月会坐时<br>D.8月会爬时<br>E.1岁会走时</td>
      <td>C.6个月会坐时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>31. 生理性体重下降一般发生在(2.5分)</td>
      <td>A.出生后第1周内<br>B.出生后第2周内<br>C.出生后第3周内<br>D.出生后第4周内<br>E.出生后1个月</td>
      <td>A.出生后第1周内</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>32. 一3周岁男孩，体检发现前囟未闭，约1.5×1.5cm, 平坦，无饱满或隆起，头围49.5cm, 乳牙12颗, 身体的上部量较长, 应考虑的可能疾病是 (2.5分)</td>
      <td>A.脑发育不良<br>B.甲状腺功能低下<br>C.脑积水<br>D.脱水<br>E.以上都不是</td>
      <td>B.甲状腺功能低下</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>33. 一健康女婴，营养状况好，测量头围42cm，前囟1.5cm×1.2cm，身长65cm，勉强扶坐，出牙1颗，最可能的年龄是 (2.5分)</td>
      <td>A.3~4个月<br>B.5~6个月<br>C.7~8个月<br>D.8~9个月<br>E.10~12个月</td>
      <td>B.5~6个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>34. 正常小儿头围46cm时几个月? (2.5分)</td>
      <td>A.6个月<br>B.10个月<br>C.12个月<br>D.24个月<br>E.60个月</td>
      <td>C.12个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>35. 一健康女婴，能独坐一会儿，能用手摇玩具，能认识熟人及生人，脊柱出现了第二个生理性弯曲，其年龄大约为(2.5分)</td>
      <td>A.4个月<br>B.6个月<br>C.8个月<br>D.9个月<br>E.以上均不是</td>
      <td>B.6个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>36. 关于生长发育的规律，下列哪项是错误的 (2.5分)</td>
      <td>A.由上到下<br>B.由粗到细<br>C.由低级到高级<br>D.由简单到复杂<br>E.由远到近</td>
      <td>E.由远到近</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>37. 青春期增长最快的是(2.5分)</td>
      <td>A.头部<br>B.颈部<br>C.脊柱<br>D.上肢<br>E.下肢</td>
      <td>E.下肢</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>38. 下列关于青春期发育的知识正确的是(2.5分)</td>
      <td>A.男孩生长发育第二高峰比女孩晚1岁<br>B.青春期发育时一般先有骨龄的加速，然后再有线性生长的加速<br>C.男孩进入青春期发育的标志为喉结突出<br>D.女孩进入青春发育的标志为初潮<br>E.神经内分泌调节趋于稳定</td>
      <td>B.青春期发育时一般先有骨龄的加速，然后再有线性生长的加速</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>39. 以下有关性决定和性分化的叙述错误的是(2.5分)</td>
      <td>A.胚胎的性决定和性分化具有关键的时间窗<br>B.关键的调控基因需在"正确"的关键时刻准确合适的表达才能使性分化正确进行。<br>C.关键时刻无AMH或睾酮作用，则内生殖管道分化为男性结构<br>D.45XO综合征是最常见的性染色体畸变综合征<br>E.性分化发育异常的诊断过程是性别鉴定和病因诊断的过程</td>
      <td>C.关键时刻无AMH或睾酮作用，则内生殖管道分化为男性结构</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2012</td>
      <td>40. A 8-year-old boy was admitted to hospital with the complaint of pubic hair development. His height was 128cm and weight was 26kg. His bone age is about 9.5 years old. Which test of the following should be done first? (2.5分)</td>
      <td>A.Growth hormone stimulation test<br>B.Gonadotropin-releasing hormone stimulation test<br>C.Oral glucose tolerance test<br>D.Dexamethasone suppression test<br>E.Human chorionic gonadotropin stimulation test</td>
      <td>B.Gonadotropin-releasing hormone stimulation test</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>1. 有关超声多普勒以下哪项错误：(2.5分)</td>
      <td>A.有彩色多普勒、脉冲多普勒和连续多普勒等<br>B.脉冲多普勒能测高速血流<br>C.脉冲多普勒有距离选通功能<br>D.连续多普勒无距离选通功能<br>E.彩色多普勒是半定量显示</td>
      <td>B.脉冲多普勒能测高速血流</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>2. 波的峰压或高度称 (2.5分)</td>
      <td>A.周期<br>B.频率<br>C.波幅<br>D.波长<br>E.速度</td>
      <td>C.波幅</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>3. 连续多普勒的特点为：(2.5分)</td>
      <td>A.速度分辨力差，距离分辨力亦差<br>B.速度分辨力差，距离分辨力佳<br>C.速度分辨力佳, 距离分辨力差<br>D.速度分辨力佳, 距离分辨力亦佳<br>E.以上都错误</td>
      <td>C.速度分辨力佳, 距离分辨力差</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>4. 液体属于声学类型中的 (2.5分)</td>
      <td>A.少反射型<br>B.无反射型<br>C.多反射型<br>D.全反射型<br>E.混合反射型</td>
      <td>B.无反射型</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>5. 关于压电效应那种说法正确? (2.5分)</td>
      <td>A.逆压电效应(接收)<br>B.在交变电场的作用导致压电晶体厚度的交替改变从而产生声振动，即由电能转变为声能。<br>C.正压电效应(产生)<br>D.由压电晶体自主产生超声波</td>
      <td>B.在交变电场的作用导致压电晶体厚度的交替改变从而产生声振动，即由电能转变为声能。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>6. 下列那一项描述错误? (2.5分)</td>
      <td>A.振动质点在媒质内传播产生周期性疏密波称声波<br>B.波的传播方向与质点振动方向一致的,称为纵波<br>C.传播方向和振动方向相互垂直的称横波<br>D.声波可以在真空中传播<br>E.光波可以在真空中传播</td>
      <td>D.声波可以在真空中传播</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>7. 超声反射率由什么决定?(2.5分)</td>
      <td>A.声阻抗直接决定<br>B.声吸收<br>C.反射面前后声阻抗之差决定<br>D.Doppler信号强弱<br>E.波长</td>
      <td>C.反射面前后声阻抗之差决定</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>8. 物理定律紧绕声波和组织相互作用，作用过程涉及四大物理定律，期中哪项是错误的?(2.5分)</td>
      <td>A.吸收定律<br>B.反射定律<br>C.压电定律<br>D.衍射定律<br>E.多普勒定律</td>
      <td>C.压电定律</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>9. 是超声首先观察到的妊娠标志。(2.5分)</td>
      <td>A.卵黄囊（yolk sac）<br>B. "胎儿"<br>C.胚芽（fetal pole）<br>D. "胚胎"<br>E.妊娠囊（gestational sac）</td>
      <td>E.妊娠囊（gestational sac）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>10. Which of the following is, in most cases, inherited as a complex genetic trait（复杂遗传性状）?(2.5分)</td>
      <td>A.Cystic fibrosis<br>B.Down syndrome<br>C.Neurofibromatosis（神经纤维瘤病）<br>D.Neural tube defects（神经管缺陷）<br>E.Duchenne muscular dystrophy（DMD）</td>
      <td>D.Neural tube defects（神经管缺陷）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>11. Chris and his brother Todd both have Duchnne muscular dystrophy（DMD）. There is a maternal（母系） history of this disorder. Jean, the boy's maternal aunt, is interested in beginning a family. What is the probability（概率） that she is a heterozygous carrier（杂合子携带者） of the disease gene?(2.5分)</td>
      <td>A.Virtually 0<br>B.42743<br>C.42739<br>D.3/8<br>E.1/2</td>
      <td>E.1/2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>12. About genetic counselling（关于遗传咨询）(2.5分)</td>
      <td>A.The individual who seeks genetic counselling is the proband（先证者）<br>B.Genetic counselling is all about recurrence risk（再发风险）<br>C.Genetic disorders are accidents of nature（天生的）, so guilt feelings are rare<br>D.Patient support groups have little value given that modern medical genetics is so technically complex<br>E.Good counselling should not be measured by the patient's/client's ability to remember genetic risks</td>
      <td>E.Good counselling should not be measured by the patient's/client's ability to remember genetic risks</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>13. If both parents are affected with the same autosomal recessive disorder then the probability that each of their children will be affected equals ___.(2.5分)</td>
      <td>A.42798<br>B.42739<br>C.42737<br>D.42769<br>E.1</td>
      <td>E.1</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>14. Hox genes encode proteins with which of the following properties（特性）?(2.5分)</td>
      <td>A.Presence of DNA-binding domain（DNA-结合功能域）<br>B.Transport to lysosome（溶酶体）<br>C.Binding of extracellular ligands（细胞外配体） in the cell membrane<br>D.Secretion from the cell<br>E.Transport to Golgi complex（高尔基复合体）</td>
      <td>A.Presence of DNA-binding domain（DNA-结合功能域）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>15. Mutations in homeotic genes（同源异型基因） often cause(2.5分)</td>
      <td>A.the deletion of segments.<br>B.the absence of structures.<br>C.too many segments.<br>D.structures to appear in the wrong place.<br>E.DMD</td>
      <td>D.structures to appear in the wrong place.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>16. A severe birth defect syndrome（出生缺陷综合征） called retinoic acid embryopathy (视黄酸胚胎病。OMIM: 242440) is caused by medications such as isotretinoin (Accutane。异维A酸) when taken by pregnant women for treatment of acne（痤疮）. Retinoic acid and steroid hormones（类固醇激素） are group I signals（信号分子） that cross the cell membrane to interact with cytosolic（细胞溶质） or nuclear receptors. Which of the structural domains（结构域） of such receptors would interact with retinoic acid?(2.5分)</td>
      <td>A.Response elements（反应元件）<br>B.Antirepressor domains（抗阻抑物功能域）<br>C.Transcription-activating domains（转录活化域）<br>D.Ligand-binding domains（配体结合域）<br>E.DNA-binding domains（DNA结合域）</td>
      <td>D.Ligand-binding domains（配体结合域）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>17. Which is true? Transcription factors（转录因子）(2.5分)</td>
      <td>A.Are RNA sequences that interfere（干扰） with translation in the ribosomes<br>B.Their only function is to switch off（关闭） genes in development<br>C.When mutated in Drosophila body segments（果蝇的体节） may NOT be completely reorganized<br>D.Are not involved in defects of laterality（偏侧化）<br>E.Include genes that have a zinc finger motif（锌指基序）</td>
      <td>E.Include genes that have a zinc finger motif（锌指基序）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>18. Birth defects(2.5分)</td>
      <td>A.are uncommon（非常见的） disorders that most practitioners will rarely see.<br>B.in general are decreasing in frequency.<br>C.are often associated with infant mortality（婴儿死亡率）.<br>D.are less common in the South as compared to the rest of the US.<br>E.rarely are seen with more than one anomaly（异常） per person.</td>
      <td>C.are often associated with infant mortality（婴儿死亡率）.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>19. MRI的成像基础是(2.5分)</td>
      <td>A.组织间吸收系数的差别<br>B.组织间密度高低的差别<br>C.组织间形态的差别<br>D.组织间驰豫时间的差别<br>E.组织间解剖结构的差异</td>
      <td>D.组织间驰豫时间的差别</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>20. 能同时评价儿童少年心肺功能和多个系统训练水平的理想指标是 (2.5分)</td>
      <td>A.肺活量、脉搏<br>B.最大耗氧量<br>C.呼吸差、肺活量<br>D.脉搏、血压<br>E.体重</td>
      <td>B.最大耗氧量</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>21. 下列造影技术中，哪些不属于MR水成像范畴(2.5分)</td>
      <td>A.MR胰胆管造影<br>B.MR泪道造影<br>C.MR尿路造影<br>D.MR血管造影<br>E.MR腮腺管造影</td>
      <td>D.MR血管造影</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>22. 以下关于全国学生体质健康调研错误的说法是(2.5分)</td>
      <td>A.全国学生体质健康调研是一种追踪调查，用于建立生长发育指标<br>B.由教育部五部委领导，在1979-2010年间，每5年开展一次<br>C.样本采用按照省（自治区、直辖市），城乡男女四群体，以及按社会经济水平好、中、差三片三级整群抽样<br>D.调研的对象要有较强的代表性</td>
      <td>A.全国学生体质健康调研是一种追踪调查，用于建立生长发育指标</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>23. 梯度回波序列与自旋回波序列的不同，以下哪句论述是正确的(2.5分)</td>
      <td>A.梯度回波信号没有自由感应衰减<br>B.梯度回波只使用90°射频脉冲<br>C.梯度回波采用翻转梯度场产生回波而不使用180°脉冲<br>D.梯度回波扫描时间长<br>E.梯度回波信号比SE序列成像速度慢</td>
      <td>C.梯度回波采用翻转梯度场产生回波而不使用180°脉冲</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>24. 有一妇女准备怀孕，了解关于胎儿期的信息，以下错误的是 (2.5分)</td>
      <td>A.妊娠3-8周是胚胎细胞高度分化期，极易受环境不良因素干扰而导致流 产、 死胎、畸形<br>B.预防感染是预防胎儿畸形、先天发育不全的关键保健措施之一<br>C.胎儿期从受精卵形成至胎儿娩出，可以分为3个阶段，其中妊娠早期为胎龄16周之前<br>D.至28周时，胎儿肺泡发育基本完善，已具有气体交换功能<br>E.孕期经常饮酒可能导致胎儿中枢神经系统发育障碍、颜面畸形和生长迟缓</td>
      <td>C.胎儿期从受精卵形成至胎儿娩出，可以分为3个阶段，其中妊娠早期为胎龄16周之前</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>25. 以下哪一项是新生儿期的特征? (2.5分)</td>
      <td>A.容易受外界不良因素影响而发生畸形、发育不全、生长迟缓<br>B.经历了依赖于母体生存向独立生存的巨大变化，发病率和死亡率均很高<br>C.体格生长速度相对婴儿期较慢<br>D.生理功能已逐渐成熟，不会再出现胎儿循环<br>E.新生儿的免疫功能发育不成熟，尤其细胞免疫功能</td>
      <td>B.经历了依赖于母体生存向独立生存的巨大变化，发病率和死亡率均很高</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>26. 一刚出生的新生儿，出生体重1.8Kg,男孩， 出生时皮肤红，有少许脱皮，头发分条清楚，耳廓软骨发育好、耳舟成形，指趾甲超过指、趾端，足纹遍及整个足底，乳腺结节较大>4mm,阴囊皱褶多。该新生儿最可能是： (2.5分)</td>
      <td>A.正常足月儿<br>B.早产，低出生体重儿<br>C.足月小样儿(小于胎龄儿)<br>D.过期产儿<br>E.早产儿，小于胎龄儿</td>
      <td>C.足月小样儿(小于胎龄儿)</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>27. 有一早产儿转运至新生儿病房，其体温调节的特点，哪一项是正确的(2.5分)</td>
      <td>A.新生儿体温调节功能不完善，靠棕色脂肪代偿产热<br>B.早产儿日龄越小，体重越低，所需中性环境温度也越低<br>C.环境温度高时，早产儿可通过出汗而蒸发散热<br>D.将早产儿置于预热后的辐射床，可避免蒸发散热<br>E.将辐射床置于通风对流的过道，不会影响早产儿的体温</td>
      <td>A.新生儿体温调节功能不完善，靠棕色脂肪代偿产热</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>28. 一婴儿出生时孕28周，出生体重为750克。考虑该新生儿为(2.5分)</td>
      <td>A.早产低出生体重儿，适于胎龄儿<br>B.早产低出生体重儿，小于胎龄儿<br>C.早产极低出生体重儿，适于胎龄儿<br>D.早产极低出生体重儿，小于胎龄儿<br>E.早产极低出生体重儿，大于胎龄儿</td>
      <td>D.早产极低出生体重儿，小于胎龄儿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>29. 学龄前期是指 (2.5分)</td>
      <td>A.自胎儿娩出脐带结扎至生后28天<br>B.自胎儿娩出脐带结扎至1周岁<br>C.满1周岁至3周岁<br>D.自满3周岁至6~7岁<br>E.自6~7岁至青春期前</td>
      <td>D.自满3周岁至6~7岁</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>30. 小儿胸椎后凸出现的时间为(2.5分)</td>
      <td>A.出生后即出现<br>B.3个月会抬头时<br>C.6个月会坐时<br>D.8月会爬时<br>E.1岁会走时</td>
      <td>C.6个月会坐时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>31. 生理性体重下降一般发生在(2.5分)</td>
      <td>A.出生后第1周内<br>B.出生后第2周内<br>C.出生后第3周内<br>D.出生后第4周内<br>E.出生后1个月</td>
      <td>A.出生后第1周内</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>32. 一3周岁男孩，体检发现前囟未闭，约1.5×1.5cm, 平坦，无饱满或隆起，头围49.5cm, 乳牙12颗, 身体的上部量较长, 应考虑的可能疾病是 (2.5分)</td>
      <td>A.脑发育不良<br>B.甲状腺功能低下<br>C.脑积水<br>D.脱水<br>E.以上都不是</td>
      <td>B.甲状腺功能低下</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>33. 一健康女婴，营养状况好，测量头围42cm，前囟1.5cm×1.2cm，身长65cm，勉强扶坐，出牙1颗，最可能的年龄是 (2.5分)</td>
      <td>A.3~4个月<br>B.5~6个月<br>C.7~8个月<br>D.8~9个月<br>E.10~12个月</td>
      <td>B.5~6个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>34. 正常小儿头围46cm时几个月? (2.5分)</td>
      <td>A.6个月<br>B.10个月<br>C.12个月<br>D.24个月<br>E.60个月</td>
      <td>C.12个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>35. 一健康女婴，能独坐一会儿，能用手摇玩具，能认识熟人及生人，脊柱出现了第二个生理性弯曲，其年龄大约为(2.5分)</td>
      <td>A.4个月<br>B.6个月<br>C.8个月<br>D.9个月<br>E.以上均不是</td>
      <td>B.6个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>36. 关于气候、季节对儿童体格发育影响的叙述，哪项是不正确的 (2.5分)</td>
      <td>A.身高春季增长快<br>B.体重秋冬季增长快<br>C.季节对儿童身高的增长有影响，而与体重增长无关<br>D.气候的影响是综合性的，不单是不同气温的影响</td>
      <td>C.季节对儿童身高的增长有影响，而与体重增长无关</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>37. 以下说法错误的是(2.5分)</td>
      <td>A.儿童佝偻病和成人的骨质疏松症，与维生素D缺乏有关<br>B.维生素B2缺乏易导致夜盲症<br>C.铁缺乏导致易疲劳，抗病能力下降，学习效率低下和贫血等<br>D.必需脂肪酸对儿童身体发育和智力发展必不可少</td>
      <td>B.维生素B2缺乏易导致夜盲症</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>38. 个体儿童生长检测的目的(2.5分)</td>
      <td>A.完善管理档案<br>B.对小儿进行体格测量<br>C.以早期发现异常，及时调整<br>D.评价保健措施<br>E.便于父母了解小儿的发育情况</td>
      <td>C.以早期发现异常，及时调整</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>39. 以下有关性决定和性分化的叙述错误的是(2.5分)</td>
      <td>A.胚胎的性决定和性分化具有关键的时间窗<br>B.关键的调控基因需在"正确"的关键时刻准确合适的表达才能使性分化正确进行。<br>C.关键时刻无AMH或睾酮作用，则内生殖管道分化为男性结构<br>D.45XO综合征是最常见的性染色体畸变综合征<br>E.性分化发育异常的诊断过程是性别鉴定和病因诊断的过程</td>
      <td>C.关键时刻无AMH或睾酮作用，则内生殖管道分化为男性结构</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2013</td>
      <td>40. A 8-year-old boy was admitted to hospital with the complaint of pubic hair development. His height was 128cm and weight was 26kg. His bone age is about 9.5 years old. Which test of the following should be done first? (2.5分)</td>
      <td>A.Growth hormone stimulation test<br>B.Gonadotropin-releasing hormone stimulation test<br>C.Oral glucose tolerance test<br>D.Dexamethasone suppression test<br>E.Human chorionic gonadotropin stimulation test</td>
      <td>B.Gonadotropin-releasing hormone stimulation test</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>1. 有关超声波的特性下列正确的是：(2.5分)</td>
      <td>A.大于16Hz的机械纵波<br>B.16--20MHz的机械纵波<br>C.大于20M Hz的机械纵波<br>D.大于20M Hz的机械横波<br>E.小于16Hz的机械横波</td>
      <td>C.大于20M Hz的机械纵波</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>2. 在扫描中，清楚地分辨物体，能够测定其结构间最小距离，决定于声束的 (2.5分)</td>
      <td>A.强度<br>B.波长<br>C.衰减<br>D.速度<br>E.波幅</td>
      <td>B.波长</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>3. 频率增大，穿透将 (2.5分)</td>
      <td>A.减小<br>B.增大<br>C.增大十倍<br>D.不变<br>E.减小十倍</td>
      <td>A.减小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>4. 连续多普勒的特点为：(2.5分)</td>
      <td>A.速度分辨力差，距离分辨力亦差<br>B.速度分辨力差，距离分辨力佳<br>C.速度分辨力佳, 距离分辨力差<br>D.速度分辨力佳, 距离分辨力亦佳<br>E.以上都错误</td>
      <td>C.速度分辨力佳, 距离分辨力差</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>5. 下列那一项描述错误? (2.5分)</td>
      <td>A.振动质点在媒质内传播产生周期性疏密波称声波<br>B.波的传播方向与质点振动方向一致的,称为纵波<br>C.传播方向和振动方向相互垂直的称横波<br>D.声波可以在真空中传播<br>E.光波可以在真空中传播</td>
      <td>D.声波可以在真空中传播</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>6. DICOM 3的含义是什么? (2.5分)</td>
      <td>A.PACS（图像存挡和通信系统）<br>B.直接通过视频连接超声仪器的标准<br>C.前国际上己制订出必需共同遵守的传输协议<br>D.Doppler国际标准<br>E.彩色血流的国际标准</td>
      <td>C.前国际上己制订出必需共同遵守的传输协议</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>7. 超声反射率由什么决定？(2.5分)</td>
      <td>A.声阻抗直接决定<br>B.声吸收<br>C.反射面前后声阻抗之差决定<br>D.Doppler信号强弱<br>E.波长</td>
      <td>C.反射面前后声阻抗之差决定</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>8. 物理定律紧绕声波和组织相互作用，作用过程涉及四大物理定律，期中哪项是错误的？(2.5分)</td>
      <td>A.吸收定律<br>B.反射定律<br>C.压电定律<br>D.衍射定律<br>E.多普勒定律</td>
      <td>C.压电定律</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>9. 双顶径（biaparietal diameter,BPD）那个说法正确 (2.5分)</td>
      <td>A.妊娠12周末以前测<br>B.测量的标准平面是丘脑平面<br>C.测量方法：从顶骨的内侧缘至对侧顶骨的内侧缘<br>D.中期妊娠双顶径的增长较慢，妊娠晚期相对快<br>E.31周前平均每周增长1mm</td>
      <td>B.测量的标准平面是丘脑平面</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>10. 下列常用的临床检查方法中无电离辐射的是 (2.5分)</td>
      <td>A.CT和PET<br>B.超声和CT<br>C.超声和MRI<br>D.CT和MRI<br>E.PET和MRI</td>
      <td>C.超声和MRI</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>11. 下列哪一项不是MRI成像的优点 (2.5分)</td>
      <td>A.有较高的软组织分辨力<br>B.对钙化灶显示敏感<br>C.可多参数成像<br>D.能多方位成像<br>E.不受骨骼伪影的干扰</td>
      <td>B.对钙化灶显示敏感</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>12. 对外加静磁场 B0 中质子磁矩的描述，不正确的是： (2.5分)</td>
      <td>A.质子磁矩是矢量，具有方向和大小<br>B.具有磁矩的原子核有一定的质量和大小<br>C.磁矩的方向总是与外加磁场( B0 ) 的方向相反<br>D.当磁矩受到破坏后，其恢复需要一定的时间<br>E.磁矩在 B0 中是随质子运动的不同而变化的</td>
      <td>C.磁矩的方向总是与外加磁场( B0 ) 的方向相反</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>13. 下列成像技术中，哪些属于MR水成像范畴 (2.5分)</td>
      <td>A.MR弥散成像<br>B.MR波谱成像<br>C.MR灌注成像<br>D.MR血管造影成像<br>E.MR尿路造影</td>
      <td>E.MR尿路造影</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>14. 下列何种情况下的病人绝对禁止行MRI检查 (2.5分)</td>
      <td>A.装有人工股骨头<br>B.装有心脏起搏器<br>C.宫内节育器<br>D.幽闭恐惧综合症<br>E.对比剂过敏</td>
      <td>B.装有心脏起搏器</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>15. 关于梯度磁场的描述，正确的是 (2.5分)</td>
      <td>A.实现空间定位<br>B.影响图像分辨力<br>C.影响图像信噪比<br>D.梯度场强越高越好<br>E.可引起周围神经剌激症状</td>
      <td>A.实现空间定位</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>16. 目前公认的 MRI 设备相对安全的范围是 (2.5分)</td>
      <td>A.0.5 高斯线区域外<br>B.1 高斯线区域外<br>C.1.5 高斯线区域外<br>D.3 高斯线区域外<br>E.5 高斯线区域外</td>
      <td>E.5 高斯线区域外</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>17. 孕妇与胎儿进行磁共振检查时，以下说法哪一项是错误的？ (2.5分)</td>
      <td>A.不使用对比剂<br>B.不使用各种门控（如呼吸和心电门控）<br>C.不进行多平面扫描<br>D.不要求屏气扫描<br>E.不使用镇静剂</td>
      <td>C.不进行多平面扫描</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>18. 目前能够进行活体组织内化学物质无创性检测的方法是： (2.5分)</td>
      <td>A.灌注成像<br>B.扩散成像<br>C.MR 波谱<br>D.MR 动态增强<br>E.MR 血管成像</td>
      <td>C.MR 波谱</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>19. 有关小儿年龄分期，以下哪一项是错误的？ (2.5分)</td>
      <td>A.新生儿期：自胎儿娩出脐带结扎至28天的时期。<br>B.婴儿期；自满28天到1周岁之前为婴儿期。<br>C.幼儿期：自1岁至满3周岁之前为幼儿期。<br>D.青春期：青春期年龄范围一般从11岁～20岁，女孩的青春期开始年龄和结束年龄都比男孩早2年左右。<br>E.根据不同年龄及其生理特点，分为7个期。</td>
      <td>B.婴儿期；自满28天到1周岁之前为婴儿期。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>20. 以下哪一项是新生儿期的特征？ (2.5分)</td>
      <td>A.容易受外界不良因素影响而发生畸形、发育不全、生长迟缓<br>B.经历了依赖于母体生存向独立生存的巨大变化，发病率和死亡率均很高<br>C.体格生长速度相对婴儿期较慢<br>D.生理功能已逐渐成熟，不会再出现胎儿循环<br>E.新生儿的免疫功能发育不成熟，尤其细胞免疫功能</td>
      <td>B.经历了依赖于母体生存向独立生存的巨大变化，发病率和死亡率均很高</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>21. 一刚出生的新生儿，出生体重1.8Kg,男孩， 出生时皮肤红，有少许脱皮，头发分条清楚，耳廓软骨发育好、耳舟成形，指趾甲超过指、趾端，足纹遍及整个足底，乳腺结节较大>4mm,阴囊皱褶多。该新生儿最可能是：(2.5分)</td>
      <td>A.正常足月儿<br>B.早产，低出生体重儿<br>C.足月小样儿(小于胎龄儿)<br>D.过期产儿<br>E.早产儿，小于胎龄儿</td>
      <td>C.足月小样儿(小于胎龄儿)</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>22. 有一早产儿转运至新生儿病房，其体温调节的特点，哪一项是正确的？ (2.5分)</td>
      <td>A.新生儿体温调节功能不完善，靠棕色脂肪代偿产热<br>B.早产儿日龄越小，体重越低，所需中性环境温度也越低<br>C.环境温度高时，早产儿可通过出汗而蒸发散热<br>D.将早产儿置于预热后的辐射床，可避免蒸发散热<br>E.将辐射床置于通风对流的过道，不会影响早产儿的体温</td>
      <td>A.新生儿体温调节功能不完善，靠棕色脂肪代偿产热</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>23. 小儿胸椎后凸出现的时间为： (2.5分)</td>
      <td>A.出生后即出现<br>B.3个月会抬头时<br>C.6个月会坐时<br>D.8月会爬时<br>E.1岁会走时</td>
      <td>C.6个月会坐时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>24. 一12月龄男孩，前来进行儿童健康体检，在体格测量后，进行的体格发育评价不包括 (2.5分)</td>
      <td>A.骨龄评价<br>B.发育水平评价<br>C.生长速度评价<br>D.体型匀称性评价<br>E.身材匀称度评价</td>
      <td>A.骨龄评价</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>25. 一健康女婴，营养状况好，测量头围42cm，前囟1.5cm×1.2cm，身长65cm，可两手支撑或靠坐一会，出牙1颗，最可能的年龄是 (2.5分)</td>
      <td>A.3~4个月<br>B.5~6个月<br>C.7~8个月<br>D.8~9个月<br>E.10~12个月</td>
      <td>B.5~6个月</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>26. 一18月龄小儿前来体检，以下哪项不符合该年龄段的特点？ (2.5分)</td>
      <td>A.生长速度较婴儿期减慢<br>B.智能发育加速<br>C.活动范围增加，容易发生意外伤害<br>D.食物转为固体，应注意膳食营养<br>E.体质增强，感染、传染性疾病减少</td>
      <td>E.体质增强，感染、传染性疾病减少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>27. 以下有关性决定和性分化的叙述错误的是：(2.5分)</td>
      <td>A.胚胎的性决定和性分化具有关键的时间窗<br>B.关键的调控基因需在"正确"的关键时刻准确合适的表达才能使性分化正确进行。<br>C.关键时刻无AMH或睾酮作用，则内生殖管道分化为男性结构<br>D.45XO综合征是最常见的性染色体畸变综合征<br>E.性分化发育异常的诊断过程是性别鉴定和病因诊断的过程</td>
      <td>C.关键时刻无AMH或睾酮作用，则内生殖管道分化为男性结构</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>28. 男性青春期前睾丸保持婴儿状态，体积不大于(2.5分)</td>
      <td>A.2.0 mL<br>B.2.5 mL<br>C.3.0 mL<br>D.3.5 mL<br>E.4.0 mL</td>
      <td>C.3.0 mL</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>29. 11青春期生长调控的激素有许多，除了(2.5分)</td>
      <td>A.促生长激素激素释放激素<br>B.胰岛素<br>C.IGF-1 （胰岛素样生长因子）<br>D.性激素<br>E.生长抑素</td>
      <td>B.胰岛素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>30. 以下关于青春发育的说法哪项是错误的？(2.5分)</td>
      <td>A.启动的年龄、发育速度、 成熟年龄及发育程度有个体间的差异<br>B.有明显的种族、性别间的差异<br>C.情绪会影响青春发育的时间<br>D.青春发育的年龄在逐年提前<br>E.颅脑外伤、感染等不会影响青春发育时间</td>
      <td>E.颅脑外伤、感染等不会影响青春发育时间</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>31. 曾生育过一个或几个遗传病患儿，再生育本病患儿的风险或概率，称为(2.5分)</td>
      <td>A.再现风险<br>B.患病率<br>C.发病率<br>D.条件概率<br>E.遗传风险</td>
      <td>A.再现风险</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>32. Chris and his brother Todd both have Duchnne muscular dystrophy（DMD）. There is a maternal（母系） history of this disorder. Jean, the boy's maternal aunt, is interested in beginning a family. What is the probability（概率） that she is a heterozygous carrier（杂合子携带者） of the disease gene?(2.5分)</td>
      <td>A.Virtually 0<br>B.1/8<br>C.1/4<br>D.3/8<br>E.1/2</td>
      <td>E.1/2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>33. If both parents are affected with the same autosomal recessive disorder then the probability that each of their children will be affected equals ___.(2.5分)</td>
      <td>A.3/4<br>B.1/4<br>C.1/2<br>D.2/3<br>E.1</td>
      <td>E.1</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>34. Birth defects(2.5分)</td>
      <td>A.are uncommon（非常见的） disorders that most practitioners will rarely see.<br>B.in general are decreasing in frequency.<br>C.are often associated with infant mortality（婴儿死亡率）.<br>D.are less common in the South as compared to the rest of the US.<br>E.rarely are seen with more than one anomaly（异常） per person.</td>
      <td>C.are often associated with infant mortality（婴儿死亡率）.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>35. 以下哪一种不需要做胎儿宫内诊断？(2.5分)</td>
      <td>A.孕早期服用过致畸药物<br>B.长期处于污染环境及羊水过多或过少的孕妇<br>C.接触过较多射线<br>D.多次发生自然流产、死胎、死产的孕妇<br>E.注射过狂犬疫苗的孕妇</td>
      <td>E.注射过狂犬疫苗的孕妇</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>36. 如果用骨龄与时间年龄的差异来区分成熟类型时，早熟儿童通常表现为(2.5分)</td>
      <td>A.骨龄大于时间年龄<br>B.骨龄等于时间年龄<br>C.骨龄小于时间年龄<br>D.骨龄与时间年龄无关<br>E.无法判断</td>
      <td>A.骨龄大于时间年龄</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>37. 能较客观、精确反映发育成熟程度的是(2.5分)</td>
      <td>A.第二性征年龄<br>B.齿龄<br>C.骨龄<br>D.体重<br>E.身高</td>
      <td>C.骨龄</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>38. 以下说法错误的是(2.5分)</td>
      <td>A.等级评价法中中等标准落在平均值正负一个方差值内<br>B.曲线法可用于分析长期趋势，用一张图可以同时分析男女生的生长趋势。<br>C.如身高测量值小于百分位数法中的P3，说明该生测定值处于下等。<br>D.Z分法优点是不论使用什么指标，在群体中均一Z值表示，因而可在不同个体和群体间进行横向和纵向比较。</td>
      <td>B.曲线法可用于分析长期趋势，用一张图可以同时分析男女生的生长趋势。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>39. 关于遗传对儿童体格发育影响的叙述，哪项是不正确的？ (2.5分)</td>
      <td>A.遗传决定了儿童生长发育程度的可能性，潜力或最大限度<br>B.矮小父母的孩子身高不可能超过同年龄的平均身高。<br>C.人的体形、躯干和四肢主要受种族遗传的影响<br>D.相对来说，遗传对儿童生长发育的影响要大于环境因素</td>
      <td>B.矮小父母的孩子身高不可能超过同年龄的平均身高。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>2</td>
      <td>2014</td>
      <td>40. 以下说法的错误是(2.5分)</td>
      <td>A.营养和体育锻炼是影响生长发育最重要的环境因素。<br>B.不良生活作息行为和环境污染是影响儿童健康的重要因素。<br>C.网络和电视是双刃剑，带来好处的同时，可能会影响儿童的生长发育。<br>D.富裕家庭的孩子身体发育状况都要好于贫困家庭的孩子。</td>
      <td>D.富裕家庭的孩子身体发育状况都要好于贫困家庭的孩子。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>1. 决定药物每天用药次数的主要因素是(2.0分)</td>
      <td>A.血浆蛋白结合率<br>B.作用强弱<br>C.消除速度<br>D.吸收速度<br>E.起效快慢</td>
      <td>C.消除速度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>2. 按一级动力学消除的药物，其血浆半衰期（t1/2）等于（注：Ke = 消除速率常数）(2.0分)</td>
      <td>A.Ke/2.303<br>B.0.693/Ke<br>C.Ke/0.693<br>D.2.303/Ke<br>E.0.301/Ke</td>
      <td>B.0.693/Ke</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>3. 药物吸收到达血浆稳态浓度时意味着 (2.0分)</td>
      <td>A.药物作用最强<br>B.药物的吸收过程已完成<br>C.药物的吸收速度与消除速度达到平衡<br>D.药物的消除过程正开始<br>E.药物在体内分布达到平衡</td>
      <td>C.药物的吸收速度与消除速度达到平衡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>4. 某药物在口服和静脉注射相同剂量后的时量曲线下面积(AUC)相等，这意味着(2.0分)</td>
      <td>A.口服吸收完全<br>B.口服吸收迅速<br>C.口服和静脉注射可以取得同样生物效应<br>D.口服药物未经肝门脉吸收<br>E.属一房室分布模型</td>
      <td>A.口服吸收完全</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>5. 绝对口服生物利用度等于(2.0分)</td>
      <td>A. (静脉注射一定量药物后AUC / 口服等量药物后AUC) × 100％<br>B. (口服一定量药物后AUC / 静脉注射等量药物后AUC) × 100％<br>C. (静脉注射一定量药物后Cmax / 口服等量药物后Cmax) × 100％<br>D. (口服一定量药物后Cmax / 静脉注射等量药物后Cmax) × 100％<br>E. (口服一定量药物后Tmax / 静脉注射等量药物后Tmax) × 100％</td>
      <td>B. (口服一定量药物后AUC / 静脉注射等量药物后AUC) × 100％</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>6. 某药的表观分布容积为40 L，如欲立即达到4 mg/L。的稳态血药浓度，应给的负荷剂量是(2.0分)</td>
      <td>A.100 mg<br>B.25 mg<br>C.50 mg<br>D.13 mg<br>E.160 mg</td>
      <td>E.160 mg</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>7. 某药在体内按一级动力学消除，在其吸收达高峰后抽血两次，测其血浆浓度分别为150 g/ml及18.75 g/ml，两次抽血间隔9小时，该药的血浆半衰期是 (2.0分)</td>
      <td>A.1小时<br>B.1.5小时<br>C.3小时<br>D.2小时<br>E.4小时</td>
      <td>C.3小时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>8. 某催眠药的消除速率常数（Ke）为0.35/h，设静脉注射后病人入睡时血药浓度为l mg/L，当病人醒转时血药浓度为0.125 mg/L，问病人大约睡了多久？(2.0分)</td>
      <td>A.9小时<br>B.6小时<br>C.8小时<br>D.4小时<br>E.10小时</td>
      <td>B.6小时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>9. 某药消除符合一级动力学，t1/2为4小时，在固定间隔固定剂量多次给药后，经过下述哪一时间即可达到血浆稳态浓度?(2.0分)</td>
      <td>A.约40小时<br>B.约30小时<br>C.约10小时<br>D.约20小时<br>E.约50小时</td>
      <td>D.约20小时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>10. 负荷剂量是(2.0分)</td>
      <td>A.一半有效血药浓度的剂量<br>B.一半稳态血药浓度的剂量<br>C.达到有效血药浓度的剂量<br>D.达到一定血药浓度的剂量<br>E.维持有效血药浓度的剂量</td>
      <td>C.达到有效血药浓度的剂量</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>11. 一级动力学消除的药物，如按恒定的剂量每隔1个半衰期给药1次时，为了迅速达到稳态血浓度可将首次剂量 (2.0分)</td>
      <td>A.增加0.5倍<br>B.增加3倍<br>C.增加2倍<br>D.增加1倍<br>E.增加4倍</td>
      <td>D.增加1倍</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>12. 有关特异质反应说法正确的是 (2.0分)</td>
      <td>A.多数反应比较轻微<br>B.发生与否取决于药物剂量<br>C.通常与遗传变异有关<br>D.是一种常见的不良反应<br>E.是一种免疫反应</td>
      <td>C.通常与遗传变异有关</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>13. 安慰剂一般指(2.0分)</td>
      <td>A.由药理活性较弱的物质制成的制剂<br>B.由本身没有特殊药理活性的物质（乳糖、淀粉等）制成的外形似药的制剂<br>C.本身没有特殊作用的医疗措施（如假手术等）<br>D.有一定治疗作用的医疗措施<br>E.对病人做的安慰、鼓励等心理治疗</td>
      <td>B.由本身没有特殊药理活性的物质（乳糖、淀粉等）制成的外形似药的制剂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>14. 关于药物相互作用说法不正确的是(2.0分)</td>
      <td>A.有时表现为毒性反应的增强<br>B.在两种或两种以上药物同时应用时出现<br>C.可改变药物的体内过程<br>D.可能表现为药理作用的改变<br>E.机体对药物的反应性改变</td>
      <td>C.可改变药物的体内过程</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>15. 反复多次用药后，人体对该药的反应性逐渐降低，称为 (2.0分)</td>
      <td>A.耐药性<br>B.成瘾性<br>C.依赖性<br>D.耐受性<br>E.个体差异性</td>
      <td>D.耐受性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>16. 长期用药后病人对药物产生主观和客观上需要连续用药的现象，称为 (2.0分)</td>
      <td>A.耐受性<br>B.依赖性<br>C.快速耐受性<br>D.耐药性<br>E.个体差异性</td>
      <td>B.依赖性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>17. 药物是 (2.0分)</td>
      <td>A.能影响机体生理功能的物质<br>B.能干扰细胞代谢活动的化学物质<br>C.一种化学物质<br>D.用以防治及诊断疾病的物质<br>E.有滋补营养、保健作用的物质</td>
      <td>D.用以防治及诊断疾病的物质</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>18. 药理学是研究(2.0分)</td>
      <td>A.药物效应动力学<br>B.药物的学科<br>C.药物代谢动力学<br>D.药物与机体相互作用的规律与原理<br>E.与药物有关的生理科学</td>
      <td>D.药物与机体相互作用的规律与原理</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>19. 药效学是研究(2.0分)</td>
      <td>A.影响药效的因素<br>B.药物在体内的过程<br>C.药物对机体的作用规律<br>D.药物的疗效<br>E.药物的作用规律</td>
      <td>C.药物对机体的作用规律</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>20. 多数药物只影响机体的少数生理功能，这种特性称为 (2.0分)</td>
      <td>A.安全性<br>B.有效性<br>C.选择性<br>D.耐受性<br>E.敏感性</td>
      <td>C.选择性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>21. 药物的选择作用取决于 (2.0分)</td>
      <td>A.三者均对<br>B.药动学特性<br>C.药物化学特性<br>D.药效学特性<br>E.三者均不对</td>
      <td>D.药效学特性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>22. 药物作用的两重性指 (2.0分)</td>
      <td>A.既有治疗作用，又有不良反应<br>B.既有对因治疗作用，又有对症治疗作用<br>C.既有局部作用，又有全身作用<br>D.既有副作用，又有毒性作用<br>E.既有原发作用，又有继发作用</td>
      <td>A.既有治疗作用，又有不良反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>23. 副作用是指(2.0分)</td>
      <td>A.用药后给病人带来的不舒适的反应<br>B.用药量过大或用药时间过久引起的反应<br>C.与治疗目的无关的作用<br>D.在治疗剂量出现与治疗目的无关的作用<br>E.停药后，残存药物引起的反应</td>
      <td>D.在治疗剂量出现与治疗目的无关的作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>24. 药物的副作用是指(2.0分)</td>
      <td>A.治疗量时出现的变态反应<br>B.治疗量时出现的与治疗目的无关的作用<br>C.用药量过大引起的不良反应<br>D.药物对老年及儿童的有害作用<br>E.用药时间过长引起机体损害</td>
      <td>B.治疗量时出现的与治疗目的无关的作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>25. 药物的副作用是(2.0分)</td>
      <td>A.在治疗范围内所产生的与治疗目的无关，但无多大危害的作用<br>B.因用量过大所致<br>C.一种过敏反应<br>D.指剧毒药所产生的毒性<br>E.由于病人高度敏感所致</td>
      <td>A.在治疗范围内所产生的与治疗目的无关，但无多大危害的作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>26. 药物的毒性反应是(2.0分)</td>
      <td>A.一种过敏反应<br>B.一种遗传性生化机制异常所产生的特异反应<br>C.因用量过大（或机体对该药特别敏感）所发生的对机体有损害的反应<br>D.在使用治疗用量时所产生的与治疗目的无关的反应<br>E.指剧毒药所产生的毒性作用</td>
      <td>C.因用量过大（或机体对该药特别敏感）所发生的对机体有损害的反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>27. 量效曲线可以为用药提供什么参考(2.0分)</td>
      <td>A.药物的安全范围<br>B.药物的毒性性质<br>C.药物的疗效大小<br>D.药物的给药方案<br>E.药物的体内分布过程</td>
      <td>D.药物的给药方案</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>28. 药物的量反应是指(2.0分)</td>
      <td>A.以数量的分级来表示个体反应的效应强度<br>B.在某一群体中某一效应出现的频率<br>C.以数量的分级来表示群体中某一效应出现的频率<br>D.以数量的分级来表示群体反应的效应强度<br>E.在某一群体中某一效应出现的个数</td>
      <td>A.以数量的分级来表示个体反应的效应强度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>29. 药物的质反应是指 (2.0分)</td>
      <td>A.不良反应发生与否<br>B.某种反应发生与否<br>C.药物效应程度的大小<br>D.药物效应的定量测定<br>E.药物效应的个体差异</td>
      <td>B.某种反应发生与否</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>30. 药物的效价强度（potency）是指同一类型药物之间 (2.0分)</td>
      <td>A.产生治疗作用与不良反应的比值<br>B.在足够大的剂量时产生最大效应的强弱<br>C.引起毒性剂量的大小<br>D.产生相同效应时需要的剂量的不同<br>E.以上都不是</td>
      <td>D.产生相同效应时需要的剂量的不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>31. Ion channels in cell membranes (2.0分)</td>
      <td>A.may open in response to a change in potential difference across the membrane.<br>B.Both are nonspecific and may open in response to a change in potential difference across the membrane are correct.<br>C.are nonspecific.<br>D.may open in response to binding a ligand.<br>E.Both may open in response to a change in potential difference across the membrane and may open in response to binding a ligand are correct.</td>
      <td>E.Both may open in response to a change in potential difference across the membrane and may open in response to binding a ligand are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>32. The concentration of (2.0分)</td>
      <td>A.Both positively charged substances within cells is greater than the concentration of negatively charged substances and sodium and chloride ions in the extracellular fluid is greater than that in the cytosol of cells are correct.<br>B.sodium and chloride ions in the extracellular fluid is greater than that in the cytosol of cells.<br>C.potassium and calcium ions in the cytosol of cells is greater than that in the extracellular fluid.<br>D.positively charged substances within cells is greater than the concentration of negatively charged substances.<br>E.Both sodium and chloride ions in the extracellular fluid is greater than that in the cytosol of cells and potassium and calcium ions in the cytosol of cells is greater than that in the extracellular fluid are correct.</td>
      <td>B.sodium and chloride ions in the extracellular fluid is greater than that in the cytosol of cells.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>33. Mediated transport across cell membranes(2.0分)</td>
      <td>A.is characterized by saturable carriers and a maximum velocity of transport.<br>B.refers both to diffusion and to the active transport of molecules.<br>C.refers to the movement of ions through protein channels.<br>D.Both refers to the movement of ions through protein channels and refers both to diffusion and to the active transport of molecules are correct.<br>E.Both refers both to diffusion and to the active transport of molecules and is characterized by saturable carriers and a maximum velocity of transport are correct.</td>
      <td>A.is characterized by saturable carriers and a maximum velocity of transport.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>34. Carrier-mediated transport (2.0分)</td>
      <td>A.always requires the direct expenditure of energy.<br>B.always involves the movement of substances against a concentration gradient.<br>C.involves a specific membrane protein that functions as a carrier molecule.<br>D.Both involves a specific membrane protein that functions as a carrier molecule and always involves the movement of substances against a concentration gradient are correct.<br>E.All of the choices are correct.</td>
      <td>C.involves a specific membrane protein that functions as a carrier molecule.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>35. Which of the following is a feature that distinguishes active transport from facilitated diffusion? (2.0分)</td>
      <td>A.specificity<br>B.requirement for a carrier molecule<br>C.saturability<br>D.presence of a transport maximum<br>E.requirement for metabolic energy</td>
      <td>E.requirement for metabolic energy</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>36. If a cell is placed into an unknown solution and it shrinks, what can be concluded about the unknown solution? (2.0分)</td>
      <td>A.Its nonpenetrating solute concentration was less than that of the cell.<br>B.Its nonpenetrating solute concentration was greater than that of the cell.<br>C.Its nonpenetrating solute concentration was equal to that of the cell.<br>D.Any of the choices are possible.</td>
      <td>B.Its nonpenetrating solute concentration was greater than that of the cell.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>37. The resting membrane potential (2.0分)</td>
      <td>A.is the same in all cells.<br>B.requires very few ions to be distributed unevenly.<br>C.is oriented so that the cell's interior is positive with respect to the extracellular fluid.<br>D.occurs only in nerve and muscle cells.<br>E.None of the choices are correct.</td>
      <td>B.requires very few ions to be distributed unevenly.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>38. In a resting neuron, (2.0分)</td>
      <td>A.the concentration of sodium ion is greater inside the cell than outside.<br>B.the permeability of the plasma membrane to potassium ion is about 50 times greater than its permeability to sodium ion.<br>C.the plasma membrane is completely impermeable to sodium ion.<br>D.the plasma membrane is freely permeable to sodium ion.<br>E.None of the choices are true.</td>
      <td>B.the permeability of the plasma membrane to potassium ion is about 50 times greater than its permeability to sodium ion.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>39. The membrane potential of most neurons at rest is (2.0分)</td>
      <td>A.equal to the equilibrium potential of potassium ion.<br>B.slightly more positive than the equilibrium potential of potassium ion.<br>C.slightly more negative than the equilibrium potential of potassium ion.<br>D.equal to the equilibrium potential of sodium ion.<br>E.Both equal to the equilibrium potential of sodium ion and slightly more negative than the equilibrium potential of potassium ion.</td>
      <td>B.slightly more positive than the equilibrium potential of potassium ion.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>40. The diffusion potential for Na+ across a nerve cell membrane (2.0分)</td>
      <td>A.favors its movement into the cell at resting potential.<br>B.is in the same direction as the diffusion potential for potassium.<br>C.is equal and opposite to the electrical potential acting on sodium at resting potential.<br>D.favors its movement out of the cell at resting potential.<br>E.is both favors its movement into the cell at resting potential and is equal and opposite to the electrical potential acting on sodium at resting potential.</td>
      <td>A.favors its movement into the cell at resting potential.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>41. An increase in the extracellular concentration of K+ above normal would result in(2.0分)</td>
      <td>A.an increase in intracellular Na+.<br>B.an increase in intracellular K+.<br>C.a decrease in intracellular Na+.<br>D.a decrease in intracellular K+.<br>E.no change in intracellular ion concentrations.</td>
      <td>B.an increase in intracellular K+.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>42. If the concentration of ATP were depleted in a typical nerve cell, the(2.0分)</td>
      <td>A.resting membrane potential would eventually become positive, inside with respect to outside.<br>B.concentration gradient for Na+ would remain the same.<br>C.resting membrane potential would increase (become more negative).<br>D.resting membrane potential would decrease (become less negative).<br>E.None of the choices are correct.</td>
      <td>D.resting membrane potential would decrease (become less negative).</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>43. Which of the following statements about the refractory period of a membrane is true? (2.0分)</td>
      <td>A.The refractory period places an upper limit on the frequency with which a nerve cell can conduct action potentials.<br>B.The refractory period prevents the action potential from spreading back over the part of the membrane that just underwent an action potential.<br>C.The absolute refractory period refers to the period of time during which another action potential cannot be initiated in that part of the membrane that has just undergone an action potential, no matter how great the strength of the stimulus.<br>D.The relative refractory period refers to the period of time during which another action potential can be initiated in that part of the membrane that has just undergone an action potential, if the stimulus is strong enough.<br>E.All of the choices are correct.</td>
      <td>E.All of the choices are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>44. Which of the following statements concerning the rate of action potential propagation is true? (2.0分)</td>
      <td>A.It is faster in myelinated nerve fibers than in nonmyelinated ones.<br>B.It is faster for a strong stimulus than for a weak one.<br>C.It is faster in large-diameter axons than in small-diameter ones.<br>D.Both it is faster in large-diameter axons than in small-diameter ones and it is faster in myelinated nerve fibers than in nonmyelinated ones are true.<br>E.All of the choices are true.</td>
      <td>D.Both it is faster in large-diameter axons than in small-diameter ones and it is faster in myelinated nerve fibers than in nonmyelinated ones are true.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>45. An action potential does not restimulate the adjacent membrane that was previously depolarized because (2.0分)</td>
      <td>A.stimulation is inhibited by the myelin sheath.<br>B.it is impossible for an action potential to be propagated along an axon toward the nerve cell body.<br>C.the resting membrane potential of the axon is too low.<br>D.the resting membrane potential of the axon is too high.<br>E.this area of membrane is absolutely refractory to depolarization.</td>
      <td>E.this area of membrane is absolutely refractory to depolarization.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>46. The regions of axon membrane that lie between regions of myelin are the (2.0分)</td>
      <td>A.nodes of Ranvier.<br>B.islets of Langerhans.<br>C.synaptic membranes.<br>D.glial cells.<br>E.dendrites.</td>
      <td>A.nodes of Ranvier.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>47. Exocytosis of neurotransmitter into the synaptic cleft is triggered by an influx of ______ in response to the arrival of an action potential in the axon terminal. (2.0分)</td>
      <td>A.ATP<br>B.K+<br>C.Na+<br>D.Ca2+<br>E.Cl-</td>
      <td>D.Ca2+</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>48. When a solute, X, is placed in compartment A of a two compartment container and allowed to diffuse to compartment B and attain diffusion equilibrium, then (2.0分)</td>
      <td>A.solutes will be moving in both directions equally.<br>B.there will no longer be any movement of solutes between compartments.<br>C.solutes will only continue to move from A to B.<br>D.solutes will only continue to move from B to A.<br>E.solutes will continue to move to the side with the higher concentration.</td>
      <td>A.solutes will be moving in both directions equally.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>49. Which of the following statements regarding the diffusion of nonpolar solutes across cell membranes is correct? (2.0分)</td>
      <td>A.At equilibrium for solute X, the net flux of X across cell membranes is zero.<br>B.At equilibrium for solute X, the concentration of X inside the cell is equal to its concentration outside the cell.<br>C.Both at equilibrium for solute X, the flux of X across cell membranes is zero and at equilibrium for solute X, the concentration of X inside the cell is equal to its concentration outside the cell are correct.<br>D.At equilibrium for solute X, the flux of X across cell membranes is zero.<br>E.Both at equilibrium for solute X, the net flux of X across cell membranes is zero and at equilibrium for solute X, the concentration of X inside the cell is equal to its concentration outside the cell are correct.</td>
      <td>E.Both at equilibrium for solute X, the net flux of X across cell membranes is zero and at equilibrium for solute X, the concentration of X inside the cell is equal to its concentration outside the cell are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2007</td>
      <td>50. The net flux of a penetrating solute into a cell will increase if the (2.0分)</td>
      <td>A.permeability constant for that solute increases.<br>B.concentration of that solute in the extracellular fluid increases.<br>C.temperature increases.<br>D.Both permeability constant for that solute increases and concentration of that solute in the extracellular fluid increases are correct.<br>E.All of the choices are correct.</td>
      <td>E.All of the choices are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>1. 按一级动力学消除的药物，其血浆半衰期（t1/2）等于（注：Ke = 消除速率常数）(2.0分)</td>
      <td>A.Ke/2.303<br>B.Ke/0.693<br>C.2.303/Ke<br>D.0.693/Ke<br>E.0.301/Ke</td>
      <td>D.0.693/Ke</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>2. 下列哪项为经导管栓塞术(2.0分)</td>
      <td>A.脑动脉溶栓术<br>B.肝癌TACE术<br>C.颈动脉支架植入<br>D.TIPSS<br>E.肾动脉成形术</td>
      <td>B.肝癌TACE术</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>3. Which of the following statements regarding the active transport of molecules across cell membranes is correct? (2.0分)</td>
      <td>A.In secondary active-transport systems in which Na ions are bound to carriers, the actively transported solute always follows Na ions across the membrane.<br>B.Both primary and secondary active transport are dependent upon energy derived from ATP.<br>C.In secondary active-transport systems in which Na ions are bound to carriers, the actively transported solute always moves across the membrane in the direction opposite of Na ion movement.<br>D.Both primary and secondary active transport are dependent upon energy derived from ATP and in secondary active-transport systems in which Na ions are bound to carriers, the actively transported solute always follows Na ions across the membrane are correct.<br>E.Both primary and secondary active transport are dependent upon energy derived from ATP and in secondary active-transport systems in which Na ions are bound to carriers, the actively transported solute always moves across the membrane in the direction opposite of Na ion movement are correct.</td>
      <td>B.Both primary and secondary active transport are dependent upon energy derived from ATP.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>4. Which of the following is not a difference between primary active transport and secondary active transport? (2.0分)</td>
      <td>A.Primary active transport uses a carrier that is phosphorylated whereas the latter does not.<br>B.Primary active transport uses a carrier that is an ATPase whereas the latter does not.<br>C.Primary active transport uses energy derived from ATP whereas secondary active transport does not.<br>D.Primary active transport uses a carrier whose binding affinity for the solute is modified by covalent modulation whereas the latter does not.<br>E.None of the choices are correct.</td>
      <td>C.Primary active transport uses energy derived from ATP whereas secondary active transport does not.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>5. During the active transport of glucose across an epithelium, energy is used to (2.0分)</td>
      <td>A.synthesize insulin, which is necessary for glucose reabsorption.<br>B.power the Na -glucose cotransporter.<br>C.power the Na,K-ATPase pump.<br>D.maintain the transport maximum for glucose.<br>E.power the facilitated diffusion of glucose across the basolateral membrane of the epithelial cell.</td>
      <td>B.power the Na -glucose cotransporter.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>6. If all other conditions remain the same and the concentration of a nonpenetrating solute increases inside a cell, (2.0分)</td>
      <td>A.water will tend to leave the cell because the interior has a decreased osmolarity.<br>B.water will tend to leave the cell because the interior has an increased osmolarity.<br>C.water will tend to enter the cell because the interior has a decreased osmolarity.<br>D.water will tend to enter the cell because the interior has an increased osmolarity.<br>E.the non-penetrating solute will diffuse across the membrane until its concentration is equal on both sides of the membrane.</td>
      <td>D.water will tend to enter the cell because the interior has an increased osmolarity.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>7. 治疗外伤引起的剧烈疼痛时，皮下注射Morphine 10 mg与皮下注射Pethidine 100 mg的疗效相同，因此 (2.0分)</td>
      <td>A.Morphine的效能比Pethidine强10倍<br>B.Morphine的效价强度比Pethidine强10倍<br>C.Pethidine的效应效价强度比Morphine强10倍<br>D.Pethidine的效能比Morphine强10倍<br>E.Morphine的安全性比Pethidine高10倍</td>
      <td>B.Morphine的效价强度比Pethidine强10倍</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>8. 药物吸收到达血浆稳态浓度时意味着 (2.0分)</td>
      <td>A.药物的吸收速度与消除速度达到平衡<br>B.药物的吸收过程已完成<br>C.药物的消除过程正开始<br>D.药物作用最强<br>E.药物在体内分布达到平衡</td>
      <td>A.药物的吸收速度与消除速度达到平衡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>9. If the concentration of ATP were depleted in a typical nerve cell, the(2.0分)</td>
      <td>A.resting membrane potential would decrease (become less negative).<br>B.resting membrane potential would increase (become more negative).<br>C.concentration gradient for Na+ would remain the same.<br>D.resting membrane potential would eventually become positive, inside with respect to outside.<br>E.None of the choices are correct.</td>
      <td>A.resting membrane potential would decrease (become less negative).</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>10. 某药在体内按一级动力学消除，在其吸收达高峰后抽血两次，测其血浆浓度分别为150 g/ml及18.75 g/ml，两次抽血间隔9小时，该药的血浆半衰期是(2.0分)</td>
      <td>A.3小时<br>B.1.5小时<br>C.2小时<br>D.1小时<br>E.4小时</td>
      <td>A.3小时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>11. 药物的最大效应（效能，maximum efficacy）是指 (2.0分)</td>
      <td>A.产生相同效应时需要的剂量的不同<br>B.引起毒性剂量的大小<br>C.在足够大的剂量时产生效应的强弱<br>D.产生治疗作用与不良反应的比值<br>E.以上都不是</td>
      <td>C.在足够大的剂量时产生效应的强弱</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>12. Ion channels in cell membranes (2.0分)</td>
      <td>A.Both are nonspecific and may open in response to a change in potential difference across the membrane are correct.<br>B.may open in response to a change in potential difference across the membrane.<br>C.may open in response to binding a ligand.<br>D.are nonspecific.<br>E.Both may open in response to a change in potential difference across the membrane and may open in response to binding a ligand are correct.</td>
      <td>E.Both may open in response to a change in potential difference across the membrane and may open in response to binding a ligand are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>13. 一级动力学消除的药物，如按恒定的剂量每隔1个半衰期给药1次时，为了迅速达到稳态血浓度可将首次剂量 (2.0分)</td>
      <td>A.增加2倍<br>B.增加3倍<br>C.增加1倍<br>D.增加0.5倍<br>E.增加4倍</td>
      <td>C.增加1倍</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>14. If the ATP-generating mechanisms in a cell are poisoned and the cell has depleted its ATP reserves, (2.0分)</td>
      <td>A.secondary active transport of molecules would cease immediately.<br>B.primary active transport of molecules would cease immediately.<br>C.eventually there will be no potential difference across the membrane.<br>D.primary active transport of molecules would cease immediately and secondary active transport of molecules would cease immediately are correct.<br>E.primary active transport of molecules would cease immediately and eventually there will be no potential difference across the membrane are correct.</td>
      <td>E.primary active transport of molecules would cease immediately and eventually there will be no potential difference across the membrane are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>15. An increase in the extracellular concentration of K+ above normal would result in(2.0分)</td>
      <td>A.an increase in intracellular K+.<br>B.an increase in intracellular Na+.<br>C.a decrease in intracellular K+.<br>D.a decrease in intracellular Na+.<br>E.no change in intracellular ion concentrations.</td>
      <td>A.an increase in intracellular K+.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>16. 利用X线进行放射治疗主要利用X线(2.0分)</td>
      <td>A.荧光效应<br>B.感光效应<br>C.电离效应<br>D.穿透作用<br>E.光学特性</td>
      <td>C.电离效应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>17. 量效曲线可以为用药提供什么参考(2.0分)</td>
      <td>A.药物的疗效大小<br>B.药物的毒性性质<br>C.药物的给药方案<br>D.药物的安全范围<br>E.药物的体内分布过程</td>
      <td>C.药物的给药方案</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>18. 绝对口服生物利用度等于 (2.0分)</td>
      <td>A. (静脉注射一定量药物后AUC / 口服等量药物后AUC) × 100％<br>B. (口服一定量药物后AUC / 静脉注射等量药物后AUC) × 100％<br>C. (静脉注射一定量药物后Cmax / 口服等量药物后Cmax) × 100％<br>D. (口服一定量药物后Cmax / 静脉注射等量药物后Cmax) × 100％<br>E. (口服一定量药物后Tmax / 静脉注射等量药物后Tmax) × 100％</td>
      <td>B. (口服一定量药物后AUC / 静脉注射等量药物后AUC) × 100％</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>19. X线透视的基础是(2.0分)</td>
      <td>A.荧光作用<br>B.感光作用<br>C.生物作用<br>D.穿透作用<br>E.光学特性</td>
      <td>A.荧光作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>20. The equilibrium potential of K ions in nerve cells is about -90 mV. The membrane potential of typical nerve cells at rest is -70 mV. Therefore (2.0分)</td>
      <td>A.increasing the membrane potential of a nerve cell would slow the diffusion of K ions out of it.<br>B.in nerve cells at rest, there is a net diffusion of K ions out of the cell.<br>C.increasing the permeability of a resting neuronal membrane to K ions will increase the membrane potential (that is, make it more negative, inside with respect to outside).<br>D.potassium is not the only permeant ion at rest.<br>E.All of the choices are true.</td>
      <td>E.All of the choices are true.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>21. 消化道常用造影剂是：(2.0分)</td>
      <td>A.优维显<br>B.泛影葡胺<br>C.碘化油<br>D.硫酸钡<br>E.Gd-DTPA</td>
      <td>D.硫酸钡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>22. 在人体组织中X线穿透力由强到弱，依次为 (2.0分)</td>
      <td>A.气体＞液体及软组织＞脂肪<br>B.气体＞脂肪＞液体及软组织<br>C.骨骼＞脂肪＞液体及软组织<br>D.液体及软组织＞骨骼＞脂肪<br>E.脂肪＞气体＞骨骼、液体及软组织</td>
      <td>B.气体＞脂肪＞液体及软组织</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>23. 血管性病变的诊断的金标准为(2.0分)</td>
      <td>A.MRI<br>B.X线平片<br>C.DSA<br>D.CT<br>E.B超</td>
      <td>C.DSA</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>24. An action potential in a neuronal membrane differs from a graded potential in that (2.0分)</td>
      <td>A.an action potential requires the opening of Ca+2 channels, whereas a graded potential does not.<br>B.an action potential is propagated without decrement, whereas a graded potential is not.<br>C.Both an action potential requires the opening of Ca+2 channels, whereas a graded potential does not and an action potential is propagated without decrement, whereas a graded potential is not are correct.<br>D.an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is not all-or-none.<br>E.Both an action potential is propagated without decrement, whereas a graded potential is not and an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is not all-or-none are correct.</td>
      <td>E.Both an action potential is propagated without decrement, whereas a graded potential is not and an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is not all-or-none are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>25. 药物的量反应是指(2.0分)</td>
      <td>A.以数量的分级来表示个体反应的效应强度<br>B.在某一群体中某一效应出现的频率<br>C.以数量的分级来表示群体中某一效应出现的频率<br>D.以数量的分级来表示群体反应的效应强度<br>E.在某一群体中某一效应出现的个数</td>
      <td>A.以数量的分级来表示个体反应的效应强度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>26. 决定药物每天用药次数的主要因素是(2.0分)</td>
      <td>A.作用强弱<br>B.吸收速度<br>C.消除速度<br>D.血浆蛋白结合率<br>E.起效快慢</td>
      <td>C.消除速度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>27. Which of the following is a feature that distinguishes active transport from facilitated diffusion?(2.0分)</td>
      <td>A.presence of a transport maximum<br>B.requirement for a carrier molecule<br>C.specificity<br>D.saturability<br>E.requirement for metabolic energy</td>
      <td>E.requirement for metabolic energy</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>28. 有关特异质反应说法正确的是 (2.0分)</td>
      <td>A.多数反应比较轻微<br>B.是一种常见的不良反应<br>C.发生与否取决于药物剂量<br>D.通常与遗传变异有关<br>E.是一种免疫反应</td>
      <td>D.通常与遗传变异有关</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>29. 某药物在口服和静脉注射相同剂量后的时量曲线下面积(AUC)相等，这意味着 (2.0分)</td>
      <td>A.口服和静脉注射可以取得同样生物效应<br>B.口服药物未经肝门脉吸收<br>C.口服吸收完全<br>D.口服吸收迅速<br>E.属一房室分布模型</td>
      <td>C.口服吸收完全</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>30. Which of the following statements about the refractory period of a membrane is true? (2.0分)</td>
      <td>A.The refractory period prevents the action potential from spreading back over the part of the membrane that just underwent an action potential.<br>B.The refractory period places an upper limit on the frequency with which a nerve cell can conduct action potentials.<br>C.The relative refractory period refers to the period of time during which another action potential can be initiated in that part of the membrane that has just undergone an action potential, if the stimulus is strong enough.<br>D.The absolute refractory period refers to the period of time during which another action potential cannot be initiated in that part of the membrane that has just undergone an action potential, no matter how great the strength of the stimulus.<br>E.All of the choices are correct.</td>
      <td>E.All of the choices are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>31. 某药的表观分布容积为40 L，如欲立即达到4 mg/L。的稳态血药浓度，应给的负荷剂量是(2.0分)</td>
      <td>A.13 mg<br>B.50 mg<br>C.25 mg<br>D.100 mg<br>E.160 mg</td>
      <td>E.160 mg</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>32. An action potential does not restimulate the adjacent membrane that was previously depolarized because (2.0分)</td>
      <td>A.it is impossible for an action potential to be propagated along an axon toward the nerve cell body.<br>B.the resting membrane potential of the axon is too high.<br>C.the resting membrane potential of the axon is too low.<br>D.stimulation is inhibited by the myelin sheath.<br>E.this area of membrane is absolutely refractory to depolarization.</td>
      <td>E.this area of membrane is absolutely refractory to depolarization.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>33. 某催眠药的消除速率常数（Ke）为0.35/h，设静脉注射后病人入睡时血药浓度为l mg/L，当病人醒转时血药浓度为0.125 mg/L，问病人大约睡了多久？(2.0分)</td>
      <td>A.6小时<br>B.4小时<br>C.8小时<br>D.9小时<br>E.10小时</td>
      <td>A.6小时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>34. 某药消除符合一级动力学，t1/2为4小时，在固定间隔固定剂量多次给药后，经过下述哪一时间即可达到血浆稳态浓度? (2.0分)</td>
      <td>A.约10小时<br>B.约20小时<br>C.约40小时<br>D.约30小时<br>E.约50小时</td>
      <td>B.约20小时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>35. 负荷剂量是(2.0分)</td>
      <td>A.一半稳态血药浓度的剂量<br>B.达到有效血药浓度的剂量<br>C.一半有效血药浓度的剂量<br>D.达到一定血药浓度的剂量<br>E.维持有效血药浓度的剂量</td>
      <td>B.达到有效血药浓度的剂量</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>36. 关于DSA优点，描述错误的是(2.0分)</td>
      <td>A.适用于各种图像处理技术<br>B.造影剂用量少<br>C.密度分辨率高<br>D.没有骨骼软组织影重叠<br>E.不需用造影剂</td>
      <td>E.不需用造影剂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>37. X线成像的基础为(2.0分)</td>
      <td>A.荧光作用<br>B.感光作用<br>C.生物作用<br>D.穿透作用<br>E.光学特性</td>
      <td>D.穿透作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>38. When an axon is stimulated to threshold, the voltage-gated(2.0分)</td>
      <td>A.Na+ channels are activated and then inactivated.<br>B.K+ channels open before the voltage-gated Na+ channels.<br>C.K+ channels open at the same time as the voltage-gated Na+ channels.<br>D.K+ channels are opened when Na+ binds to the channel.<br>E.All of the choices are correct.</td>
      <td>A.Na+ channels are activated and then inactivated.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>39. 药物的半数致死量(LD50)是指 (2.0分)</td>
      <td>A.引起半数实验动物严重毒性反应的剂量<br>B.抗寄生虫药杀死一半寄生虫的剂量<br>C.抗生素杀死一半病原菌的剂量<br>D.引起半数实验动物死亡的剂量<br>E.致死量的一半</td>
      <td>D.引起半数实验动物死亡的剂量</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>40. X线透视荧光影像形成的错误叙述 (2.0分)</td>
      <td>A.依赖于人体组织的密度差别<br>B.需有X线的对比度<br>C.X线的穿透能力<br>D.依赖于人体组织的厚度差别<br>E.透过射线具有相同的强度</td>
      <td>E.透过射线具有相同的强度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>41. 药物的质反应是指 (2.0分)</td>
      <td>A.某种反应发生与否<br>B.药物效应的定量测定<br>C.药物效应程度的大小<br>D.不良反应发生与否<br>E.药物效应的个体差异</td>
      <td>A.某种反应发生与否</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>42. 药物的效价强度（potency）是指同一类型药物之间 (2.0分)</td>
      <td>A.引起毒性剂量的大小<br>B.在足够大的剂量时产生最大效应的强弱<br>C.产生相同效应时需要的剂量的不同<br>D.产生治疗作用与不良反应的比值<br>E.以上都不是</td>
      <td>C.产生相同效应时需要的剂量的不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>43. 经皮肝胆管造影的英文缩写为(2.0分)</td>
      <td>A.ERCP<br>B.PTC<br>C.MRCP<br>D.IVP<br>E.TIPSS</td>
      <td>B.PTC</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>44. 药物引起最大效应50%所需的浓度（EC50）用以表示 (2.0分)</td>
      <td>A.分布范围的大小<br>B.最大效应的大小<br>C.安全性的大小<br>D.效价强度的大小<br>E.毒性的大小</td>
      <td>D.效价强度的大小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>45. 药物的毒性反应是(2.0分)</td>
      <td>A.一种遗传性生化机制异常所产生的特异反应<br>B.在使用治疗用量时所产生的与治疗目的无关的反应<br>C.因用量过大（或机体对该药特别敏感）所发生的对机体有损害的反应<br>D.一种过敏反应<br>E.指剧毒药所产生的毒性作用</td>
      <td>C.因用量过大（或机体对该药特别敏感）所发生的对机体有损害的反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>46. 半数致死量(LD50)是指 (2.0分)</td>
      <td>A.能使群体中有50个个体出现某一效应的剂量<br>B.能使群体中有一半以上个体死亡的剂量<br>C.能使群体中有半数个体出现某一效应的剂量<br>D.能使群体中有一半个体死亡的剂量<br>E.能使群体中半数个体出现疗效的剂量</td>
      <td>D.能使群体中有一半个体死亡的剂量</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>47. Which of the following statements regarding action potentials generated in a membrane is not true? (2.0分)</td>
      <td>A.Action potentials travel decrementally down the membrane.<br>B.The first action potential generated is the same size as the action potential ultimately generated at the end of the membrane.<br>C.An action potential generates a local current that depolarizes adjacent membrane to threshold potential.<br>D.An action potential generates a new action potential in an adjacent area of membrane.<br>E.An action potential generated by a threshold stimulus is the same size as one generated by a supra-threshold stimulus.</td>
      <td>A.Action potentials travel decrementally down the membrane.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>48. 药物的治疗指数是指(2.0分)</td>
      <td>A.治疗量/半数致死量<br>B.治愈率/不良反应发生率<br>C.LD50/ED50<br>D.ED50/LD50<br>E.ED95/LD5</td>
      <td>C.LD50/ED50</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>49. 药物的非特异性作用包括 (2.0分)</td>
      <td>A.酶抑制药抑制酶的活性<br>B.受体阻断药抑制受体激活<br>C.离子通道阻滞药干扰离子跨膜转运<br>D.利尿药抑制肾小管Na+-K+交换<br>E.抗酸药对胃酸的中和作用</td>
      <td>E.抗酸药对胃酸的中和作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2008</td>
      <td>50. 药物的内在活性(效应力)是指 (2.0分)</td>
      <td>A.药物水溶性大小<br>B.药物激动受体的能力<br>C.药物穿透生物膜的能力<br>D.药物对受体亲和力高低<br>E.药物脂溶性强弱</td>
      <td>B.药物激动受体的能力</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>1. 在碱性尿液中弱酸性药物(2.0分)</td>
      <td>A.解离多，重吸收少，排泄快<br>B.解离少，重吸收多，排泄快<br>C.解离多，重吸收多，排泄快<br>D.解离少，重吸收多，排泄慢<br>E.解离多，重吸收少，排泄慢</td>
      <td>A.解离多，重吸收少，排泄快</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>2. 易化扩散是 (2.0分)</td>
      <td>A.依赖载体（药物转运体）逆浓度梯度跨膜转运<br>B.不依赖载体顺浓度梯度跨膜转运<br>C.依赖载体顺浓度梯度跨膜转运<br>D.不依赖载体逆浓度梯度跨膜转运<br>E.主动转运</td>
      <td>C.依赖载体顺浓度梯度跨膜转运</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>3. 主动转运的特点是(2.0分)</td>
      <td>A.通过载体（药物转运体）转运，不需耗能<br>B.通过载体转运，需要耗能<br>C.不通过载体转运，不需耗能<br>D.不通过载体转运，需要耗能<br>E.包括易化扩散</td>
      <td>B.通过载体转运，需要耗能</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>4. 药物的首关消除（首过消除）是指(2.0分)</td>
      <td>A.药物口服后，部分未经吸收即从肠道排出<br>B.药物静脉注射后，部分迅速经肾排泄<br>C.药物口服后，部分迅速经肾排泄<br>D.药物经静脉注射，进入体循环之后，部分在肝脏内消除<br>E.药物口服后，进入体循环之前，部分先在肝脏内消除</td>
      <td>D.药物经静脉注射，进入体循环之后，部分在肝脏内消除</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>5. 关于药物与血浆蛋白结合的描述，下述哪一点是错误的？(2.0分)</td>
      <td>A.药物与血浆蛋白结合一般是可逆的<br>B.同时用两个药物可能会发生置换现象<br>C.血浆蛋白减少可使结合型药物减少<br>D.结合型药物有较强的药理活性<br>E.结合型药物一般难以分布到全身组织</td>
      <td>D.结合型药物有较强的药理活性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>6. 零级消除动力学的特点是(2.0分)</td>
      <td>A.体内药物过多时，以最大能力消除药物的方式<br>B.血浆消除半衰期随血浆药物浓度高低而增减<br>C.t1/2＝0.5C0 / K<br>D.单位时间内体内药量以恒定的量消除<br>E.以上都正确</td>
      <td>E.以上都正确</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>7. 在等剂量时，Vd小的药物比Vd大的药物(2.0分)</td>
      <td>A.血浆浓度较低<br>B.血浆蛋白结合较少<br>C.组织内药物浓度较低<br>D.生物利用度较小<br>E.能达到的稳态血药浓度较低</td>
      <td>A.血浆浓度较低</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>8. 静脉注射2 g磺胺药，其血药浓度为100 mg/L，其表观分布容积为 (2.0分)</td>
      <td>A.0.05 L<br>B.2 L<br>C.5 L<br>D.20 L<br>E.200 L</td>
      <td>D.20 L</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>9. 绝对口服生物利用度等于 (2.0分)</td>
      <td>A. (静脉注射一定量药物后AUC / 口服等量药物后AUC) × 100％<br>B. (口服一定量药物后AUC / 静脉注射等量药物后AUC) × 100％<br>C. (口服一定量药物后Cmax / 静脉注射等量药物后Cmax) × 100％<br>D. (静脉注射一定量药物后Cmax / 口服等量药物后Cmax) × 100％<br>E. (口服一定量药物后Tmax / 静脉注射等量药物后Tmax) × 100％</td>
      <td>B. (口服一定量药物后AUC / 静脉注射等量药物后AUC) × 100％</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>10. 药物的血浆tl/2是指 (2.0分)</td>
      <td>A.药物的稳态血浓度下降一半的时间<br>B.药物的有效血浓度下降一半的时间<br>C.药物的组织浓度下降一半的时间<br>D.药物的血浆浓度下降一半的时间<br>E.药物的血浆蛋白结合率下降一半的时间</td>
      <td>D.药物的血浆浓度下降一半的时间</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>11. 药效学是研究(2.0分)</td>
      <td>A.药物的疗效<br>B.药物在体内的过程<br>C.药物对机体的作用规律<br>D.影响药效的因素<br>E.药物的作用规律</td>
      <td>C.药物对机体的作用规律</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>12. 多数药物只影响机体的少数生理功能，这种特性称为 (2.0分)</td>
      <td>A.安全性<br>B.有效性<br>C.耐受性<br>D.选择性<br>E.敏感性</td>
      <td>D.选择性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>13. 药物作用的两重性指(2.0分)</td>
      <td>A.既有对因治疗作用，又有对症治疗作用<br>B.既有副作用，又有毒性作用<br>C.既有治疗作用，又有不良反应<br>D.既有局部作用，又有全身作用<br>E.既有原发作用，又有继发作用</td>
      <td>C.既有治疗作用，又有不良反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>14. 药物的副作用是指 (2.0分)</td>
      <td>A.用药量过大引起的不良反应<br>B.治疗量时出现的与治疗目的无关的作用<br>C.治疗量时出现的变态反应<br>D.药物对老年及儿童的有害作用<br>E.用药时间过长引起机体损害</td>
      <td>B.治疗量时出现的与治疗目的无关的作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>15. 药物的毒性反应是(2.0分)</td>
      <td>A.一种过敏反应<br>B.在使用治疗用量时所产生的与治疗目的无关的反应<br>C.因用量过大（或机体对该药特别敏感）所发生的对机体有损害的反应<br>D.一种遗传性生化机制异常所产生的特异反应<br>E.指剧毒药所产生的毒性作用</td>
      <td>C.因用量过大（或机体对该药特别敏感）所发生的对机体有损害的反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>16. 激动药是指对受体 (2.0分)</td>
      <td>A.有亲和力而无内在活性的药物<br>B.有亲和力而内在活性较弱的药物<br>C.有亲和力又有内在活性的药物<br>D.无亲和力但有较强内在活性的药物<br>E.既无亲和力也无内在活性的药物</td>
      <td>C.有亲和力又有内在活性的药物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>17. 拮抗药（阻断药）是指对受体 (2.0分)</td>
      <td>A.有亲和力而无内在活性的药物<br>B.有亲和力而内在活性较弱的药物<br>C.有亲和力又有内在活性的药物<br>D.无亲和力但有较强内在活性的药物<br>E.既无亲和力也无内在活性的药物</td>
      <td>A.有亲和力而无内在活性的药物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>18. 部分激动药是指对受体(2.0分)</td>
      <td>A.有亲和力而无内在活性的药物<br>B.有亲和力而内在活性较弱的药物<br>C.有亲和力又有内在活性的药物<br>D.无亲和力但有较强内在活性的药物<br>E.既无亲和力也无内在活性的药物</td>
      <td>B.有亲和力而内在活性较弱的药物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>19. 关于药物相互作用说法不正确的是(2.0分)</td>
      <td>A.在两种或两种以上药物同时应用时出现<br>B.可能表现为药理作用的改变<br>C.诱导用药者的遗传异常<br>D.有时表现为毒性反应的增强<br>E.可改变药物的体内过程</td>
      <td>C.诱导用药者的遗传异常</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>20. 联合应用两种药物时，药物的作用可能发生(2.0分)</td>
      <td>A.疗效上的协同<br>B.疗效上的拮抗<br>C.两者或其中之一的毒性增强<br>D.两者或其中之一的毒性减弱<br>E.以上都是</td>
      <td>E.以上都是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>21. 利用X线进行放射治疗主要利用X线 (2.0分)</td>
      <td>A.穿透作用<br>B.感光效应<br>C.电离效应<br>D.荧光效应<br>E.光学特性</td>
      <td>C.电离效应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>22. 在人体组织中X线穿透力由强到弱，依次为 (2.0分)</td>
      <td>A.气体＞脂肪＞液体及软组织<br>B.气体＞液体及软组织＞脂肪<br>C.骨骼＞脂肪＞液体及软组织<br>D.液体及软组织＞骨骼＞脂肪<br>E.脂肪＞气体＞骨骼、液体及软组织</td>
      <td>A.气体＞脂肪＞液体及软组织</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>23. X线成像的基础为 (2.0分)</td>
      <td>A.穿透作用<br>B.感光作用<br>C.生物作用<br>D.荧光作用<br>E.光学特性</td>
      <td>A.穿透作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>24. X线透视的基础是 (2.0分)</td>
      <td>A.穿透作用<br>B.感光作用<br>C.生物作用<br>D.荧光作用<br>E.光学特性</td>
      <td>D.荧光作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>25. X线透视荧光影像形成的错误叙述 (2.0分)</td>
      <td>A.依赖于人体组织的密度差别<br>B.依赖于人体组织的厚度差别<br>C.X线的穿透能力<br>D.需有X线的对比度<br>E.透过射线具有相同的强度</td>
      <td>E.透过射线具有相同的强度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>26. 消化道常用造影剂是：(2.0分)</td>
      <td>A.碘化油<br>B.泛影葡胺<br>C.优维显<br>D.硫酸钡<br>E.Gd-DTPA</td>
      <td>D.硫酸钡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>27. 关于DSA优点，描述错误的是 (2.0分)</td>
      <td>A.密度分辨率高<br>B.造影剂用量少<br>C.适用于各种图像处理技术<br>D.没有骨骼软组织影重叠<br>E.不需用造影剂</td>
      <td>E.不需用造影剂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>28. 血管性病变的诊断的金标准为(2.0分)</td>
      <td>A.X线平片<br>B.CT<br>C.MRI<br>D.DSA<br>E.B超</td>
      <td>D.DSA</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>29. 经皮肝胆管造影的英文缩写为 (2.0分)</td>
      <td>A.PTC<br>B.ERCP<br>C.MRCP<br>D.IVP<br>E.TIPSS</td>
      <td>A.PTC</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>30. 下列哪项为经导管栓塞术(2.0分)</td>
      <td>A.TIPSS<br>B.肝癌TACE术<br>C.颈动脉支架植入<br>D.脑动脉溶栓术<br>E.肾动脉成形术</td>
      <td>B.肝癌TACE术</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>31. Ion channels in cell membranes (2.0分)</td>
      <td>A.are nonspecific.<br>B.may open in response to a change in potential difference across the membrane.<br>C.may open in response to binding a ligand.<br>D.Both are nonspecific and may open in response to a change in potential difference across the membrane are correct.<br>E. Both may open in response to a change in potential difference across the membrane and may open in response to binding a ligand are correct.</td>
      <td>E. Both may open in response to a change in potential difference across the membrane and may open in response to binding a ligand are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>32. Which of the following is a feature that distinguishes active transport from facilitated diffusion? (2.0分)</td>
      <td>A.saturability<br>B.requirement for a carrier molecule<br>C.specificity<br>D.presence of a transport maximum<br>E.requirement for metabolic energy</td>
      <td>E.requirement for metabolic energy</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>33. Which of the following statements regarding the active transport of molecules across cell membranes is correct? (2.0分)</td>
      <td>A.Both primary and secondary active transport are dependent upon energy derived from ATP.<br>B.In secondary active-transport systems in which Na ions are bound to carriers, the actively transported solute always follows Na ions across the membrane.<br>C.In secondary active-transport systems in which Na ions are bound to carriers, the actively transported solute always moves across the membrane in the direction opposite of Na ion movement.<br>D.Both primary and secondary active transport are dependent upon energy derived from ATP and in secondary active-transport systems in which Na ions are bound to carriers, the actively transported solute always follows Na ions across the membrane are correct.<br>E. Both primary and secondary active transport are dependent upon energy derived from ATP and in secondary active-transport systems in which Na ions are bound to carriers, the actively transported solute always moves across the membrane in the direction opposite of Na ion movement are correct.</td>
      <td>A.Both primary and secondary active transport are dependent upon energy derived from ATP.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>34. Which of the following is not a difference between primary active transport and secondary active transport? (2.0分)</td>
      <td>A.Primary active transport uses energy derived from ATP whereas secondary active transport does not.<br>B. Primary active transport uses a carrier that is an ATPase whereas the latter does not.<br>C.Primary active transport uses a carrier that is phosphorylated whereas the latter does not.<br>D.Primary active transport uses a carrier whose binding affinity for the solute is modified by covalent modulation whereas the latter does not.<br>E.None of the choices are correct.</td>
      <td>A.Primary active transport uses energy derived from ATP whereas secondary active transport does not.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>35. If the ATP-generating mechanisms in a cell are poisoned and the cell has depleted its ATP reserves, (2.0分)</td>
      <td>A.primary active transport of molecules would cease immediately.<br>B.secondary active transport of molecules would cease immediately.<br>C.eventually there will be no potential difference across the membrane.<br>D.primary active transport of molecules would cease immediately and secondary active transport of molecules would cease immediately are correct.<br>E.primary active transport of molecules would cease immediately and eventually there will be no potential difference across the membrane are correct.</td>
      <td>E.primary active transport of molecules would cease immediately and eventually there will be no potential difference across the membrane are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>36. If all other conditions remain the same and the concentration of a nonpenetrating solute increases inside a cell(2.0分)</td>
      <td>A.water will tend to enter the cell because the interior has an increased osmolarity.<br>B.water will tend to leave the cell because the interior has an increased osmolarity.<br>C.water will tend to enter the cell because the interior has a decreased osmolarity.<br>D.water will tend to leave the cell because the interior has a decreased osmolarity.<br>E.the non-penetrating solute will diffuse across the membrane until its concentration is equal on both sides of the membrane.</td>
      <td>A.water will tend to enter the cell because the interior has an increased osmolarity.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>37. The reason solutions for injection or infusion into people normally contain either 150 mM NaCl or 300 mM glucose is that these (2.0分)</td>
      <td>A.solutes are necessary for metabolism.<br>B.solutions are hypertonic to the blood and cells.<br>C.solutions are hypoosmotic to the blood and cells.<br>D.solutions are isotonic to the blood and cells.<br>E.solutions contain penetrating solutes.</td>
      <td>D.solutions are isotonic to the blood and cells.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>38. During the active transport of glucose across an epithelium, energy is used to (2.0分)</td>
      <td>A.power the Na,K-ATPase pump.<br>B.power the Na -glucose cotransporter.<br>C.synthesize insulin, which is necessary for glucose reabsorption.<br>D.maintain the transport maximum for glucose.<br>E.power the facilitated diffusion of glucose across the basolateral membrane of the epithelial cell.</td>
      <td>B.power the Na -glucose cotransporter.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>39. Exocrine glands differ from endocrine glands in that the former (2.0分)</td>
      <td>A.are formed from infoldings of embryonic epithelium whereas the latter are not.<br>B.are specialized for secretion whereas the latter are not.<br>C.secrete their products into ducts whereas the latter do not.<br>D.secrete hormones whereas the latter do not.<br>E.None of the choices are correct.</td>
      <td>A.are formed from infoldings of embryonic epithelium whereas the latter are not.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>40. An increase in the extracellular concentration of K+ above normal would result in(2.0分)</td>
      <td>A.a decrease in intracellular K+.<br>B.an increase in intracellular K+.<br>C.a decrease in intracellular Na+.<br>D.an increase in intracellular Na+.<br>E. no change in intracellular ion concentrations.</td>
      <td>B.an increase in intracellular K+.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>41. If the concentration of ATP were depleted in a typical nerve cell, the (2.0分)</td>
      <td>A.resting membrane potential would increase (become more negative).<br>B.resting membrane potential would decrease (become less negative).<br>C.concentration gradient for Na+ would remain the same.<br>D. resting membrane potential would eventually become positive, inside with respect to outside.<br>E.None of the choices are correct.</td>
      <td>B.resting membrane potential would decrease (become less negative).</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>42. The equilibrium potential of K ions in nerve cells is about -90 mV. The membrane potential of typical nerve cells at rest is -70 mV. Therefore (2.0分)</td>
      <td>A. increasing the permeability of a resting neuronal membrane to K ions will increase the membrane potential (that is, make it more negative, inside with respect to outside).<br>B.in nerve cells at rest, there is a net diffusion of K ions out of the cell.<br>C. increasing the membrane potential of a nerve cell would slow the diffusion of K ions out of it.<br>D.potassium is not the only permeant ion at rest.<br>E.All of the choices are true.</td>
      <td>E.All of the choices are true.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>43. An action potential in a neuronal membrane differs from a graded potential in that (2.0分)</td>
      <td>A.an action potential requires the opening of Ca+2 channels, whereas a graded potential does not.<br>B. an action potential is propagated without decrement, whereas a graded potential is not.<br>C.an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is not all-or-none.<br>D.Both an action potential requires the opening of Ca+2 channels, whereas a graded potential does not and an action potential is propagated without decrement, whereas a graded potential is not are correct.<br>E.Both an action potential is propagated without decrement, whereas a graded potential is not and an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is not all-or-none are correct.</td>
      <td>E.Both an action potential is propagated without decrement, whereas a graded potential is not and an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is not all-or-none are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>44. Which of the following statements about the refractory period of a membrane is true? (2.0分)</td>
      <td>A.The absolute refractory period refers to the period of time during which another action potential cannot be initiated in that part of the membrane that has just undergone an action potential, no matter how great the strength of the stimulus.<br>B.The relative refractory period refers to the period of time during which another action potential can be initiated in that part of the membrane that has just undergone an action potential, if the stimulus is strong enough.<br>C. The refractory period prevents the action potential from spreading back over the part of the membrane that just underwent an action potential.<br>D.The refractory period places an upper limit on the frequency with which a nerve cell can conduct action potentials.<br>E.All of the choices are correct.</td>
      <td>E.All of the choices are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>45. Which of the following statements regarding action potentials generated in a membrane is not true? (2.0分)</td>
      <td>A.Action potentials travel decrementally down the membrane.<br>B. An action potential generates a new action potential in an adjacent area of membrane.<br>C.An action potential generates a local current that depolarizes adjacent membrane to threshold potential.<br>D.The first action potential generated is the same size as the action potential ultimately generated at the end of the membrane.<br>E.An action potential generated by a threshold stimulus is the same size as one generated by a supra-threshold stimulus.</td>
      <td>A.Action potentials travel decrementally down the membrane.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>46. An action potential does not restimulate the adjacent membrane that was previously depolarized because (2.0分)</td>
      <td>A.stimulation is inhibited by the myelin sheath.<br>B.it is impossible for an action potential to be propagated along an axon toward the nerve cell body.<br>C. the resting membrane potential of the axon is too high.<br>D. the resting membrane potential of the axon is too low.<br>E.this area of membrane is absolutely refractory to depolarization.</td>
      <td>E.this area of membrane is absolutely refractory to depolarization.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>47. When an axon is stimulated to threshold, the voltage-gated (2.0分)</td>
      <td>A.K+ channels open before the voltage-gated Na+ channels.<br>B.Na+ channels are activated and then inactivated.<br>C.K+ channels open at the same time as the voltage-gated Na+ channels.<br>D.K+ channels are opened when Na+ binds to the channel.<br>E.All of the choices are correct.</td>
      <td>B.Na+ channels are activated and then inactivated.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>48. During the rising (depolarizing) phase of an action potential, (2.0分)</td>
      <td>A. PK+ becomes much greater than PNa+.<br>B.PNa+ becomes much greater than PK+.<br>C. PK+ is the same as PNa+.<br>D. Na+ efflux (flow out of the cell) occurs.<br>E. none of the choices occur.</td>
      <td>B.PNa+ becomes much greater than PK+.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>49. Exocytosis of neurotransmitter into the synaptic cleft is triggered by an influx of ______ in response to the arrival of an action potential in the axon terminal. (2.0分)</td>
      <td>A.K+<br>B.Na+<br>C.Ca2+<br>D.ATP<br>E.Cl-</td>
      <td>C.Ca2+</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2009</td>
      <td>50. Once formed inside of the cell most endocytic vesicle will fuse with which organelle for sorting? (2.0分)</td>
      <td>A. endoplasmic reticulum<br>B. Golgi apparatus<br>C.endosome<br>D. nucleus<br>E.mitochondria</td>
      <td>C.endosome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>1. Equal concentrations of two solutes, A and B, are placed into the same beaker at the same time. Solute A reaches diffusion equilibrium faster than solute B. What is the most likely explanation for this observation? (3.0分)</td>
      <td>A.The temperature was greater for solute A than solute B.<br>B.The concentration gradient for A was greater than B.<br>C.Solute A is smaller than solute B.<br>D.Solute A traveled a shorter distance than solute B.<br>E.All of the choices are logical explanations.</td>
      <td>C.Solute A is smaller than solute B.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>2. If it takes solute A 1 second to diffuse 1 millimeter, how long will it take solute A to diffuse 10 millimeters under the same conditions? (3.0分)</td>
      <td>A.1 second<br>B.10 seconds<br>C.50 seconds<br>D.100 seconds</td>
      <td>D.100 seconds</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>3. The permeability of the plasma membrane to mineral ions (3.0分)</td>
      <td>A.is dependent upon channels formed by proteins.<br>B.varies from one cell to another.<br>C.is affected by differences in electrical charge on the two sides of the membrane.<br>D.Both is dependent upon channels formed by proteins and is affected by differences in electrical charge on the two sides of the membrane are correct.<br>E.All of the choices are correct.</td>
      <td>E.All of the choices are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>4. Which of the following is a feature that distinguishes active transport from facilitated diffusion? (3.0分)</td>
      <td>A.saturability<br>B.requirement for a carrier molecule<br>C.specificity<br>D.presence of a transport maximum<br>E.requirement for metabolic energy</td>
      <td>E.requirement for metabolic energy</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>5. Which of the following is not a difference between primary active transport and secondary active transport? (3.0分)</td>
      <td>A.Primary active transport uses energy derived from ATP whereas secondary active transport does not.<br>B.Primary active transport uses a carrier that is an ATPase whereas the latter does not.<br>C.Primary active transport uses a carrier that is phosphorylated whereas the latter does not.<br>D.Primary active transport uses a carrier whose binding affinity for the solute is modified by covalent modulation whereas the latter does not.<br>E.None of the choices are correct.</td>
      <td>A.Primary active transport uses energy derived from ATP whereas secondary active transport does not.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>6. If pure water and a solution containing a nonpenetrating solute are separated by a membrane that is permeable only to water, (3.0分)</td>
      <td>A.water will diffuse by osmosis until the water concentrations in the two compartments become equal.<br>B.both water and the solute will diffuse across the membrane down their concentration gradients until a state of equilibrium is established.<br>C.water will diffuse by osmosis until stopped by opposing hydrostatic pressure.<br>D.no movement will occur between the compartments.<br>E.none of the choices will occur.</td>
      <td>C.water will diffuse by osmosis until stopped by opposing hydrostatic pressure.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>7. Which of the following statements about epithelial cells and epithelial transport is correct? (4.0分)</td>
      <td>A.Epithelial cells are polarized.<br>B.Epithelial cells lining the small intestine have Na,K-ATPase pumps only in their basolateral membranes.<br>C.The "active" component of active transport across epithelial cells occurs only from the lumen side into the cells.<br>D.Both epithelial cells are polarized and epithelial cells lining the small intestine have Na, K -ATPase pumps only in their basolateral membranes are correct.<br>E.Both epithelial cells are polarized and the "active" component of active transport across epithelial cells occurs only from the lumen side into the cells are correct.</td>
      <td>D.Both epithelial cells are polarized and epithelial cells lining the small intestine have Na, K -ATPase pumps only in their basolateral membranes are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>8. Compartments A and B are separated by a membrane that is permeable to K+ but not to Cl-. At time zero, a solution of KCl is poured into compartment A and pure H2O is poured into compartment B. At equilibrium, (3.0分)</td>
      <td>A.the concentration of K+ in A will be lower than it was at time zero.<br>B.diffusion of K+ from A to B will be equal to the diffusion of K+ from B to A.<br>C.here will be a potential difference across the membrane, with side A negative relative to side B.<br>D.the electrical and diffusion potentials for K+ will be equal in magnitude and opposite in direction<br>E.All of the choices are correct</td>
      <td>E.All of the choices are correct</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>9. The equilibrium potential of K ions in nerve cells is about -90 mV. The membrane potential of typical nerve cells at rest is -70 mV. Therefore (3.0分)</td>
      <td>A.increasing the permeability of a resting neuronal membrane to K ions will increase the membrane potential (that is, make it more negative, inside with respect to outside).<br>B.in nerve cells at rest, there is a net diffusion of K ions out of the cell.<br>C.increasing the membrane potential of a nerve cell would slow the diffusion of K ions out of it.<br>D.potassium is not the only permeant ion at rest.<br>E.All of the choices are true</td>
      <td>E.All of the choices are true</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>10. A threshold stimulus applied to an excitable membrane is one that is just sufficient to (3.0分)</td>
      <td>A. trigger a graded potential in the membrane.<br>B.cause a change in membrane potential.<br>C.cause net inward movement of positive charge through the membrane.<br>D.be conducted to the axon hillock.<br>E.depolarize a dendrite.</td>
      <td>C.cause net inward movement of positive charge through the membrane.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>11. Action potentials are said to be "all-or-none" in character because (3.0分)</td>
      <td>A.the rate of propagation of an action potential down an axon is independent of stimulus strength.<br>B.they are associated with an absolute refractory period.<br>C.a supra-threshold stimulus is required to stimulate an action potential during the relative refractory period.<br>D.the amplitude of an action potential generated in any given neuron is the same, regardless of the stimulus strength.<br>E.All of these statements describe the "all-or-none" character of action potentials.</td>
      <td>D.the amplitude of an action potential generated in any given neuron is the same, regardless of the stimulus strength.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>12. Which of the following statements regarding action potentials generated in a membrane is not true? (3.0分)</td>
      <td>A.Action potentials travel decrementally down the membrane.<br>B.An action potential generates a new action potential in an adjacent area of membrane.<br>C.An action potential generates a local current that depolarizes adjacent membrane to threshold potential.<br>D.The first action potential generated is the same size as the action potential ultimately generated at the end of the membrane.<br>E.An action potential generated by a threshold stimulus is the same size as one generated by a supra-threshold stimulus.</td>
      <td>A.Action potentials travel decrementally down the membrane.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>13. Which of the following statements regarding the phases of an action potential is correct? (3.0分)</td>
      <td>A.During the depolarizing phase, the permeability of the membrane to Na+ is greater than its permeability at rest.<br>B.During the repolarizing phase, the permeability of the membrane to K+ is greater than its permeability at rest.<br>C.The relative refractory period of the membrane coincides with the hyperpolarized and second repolarizing phases.<br>D.Both During the depolarizing phase, the permeability of the membrane to Na+ is greater than its permeability at rest and During the repolarizing phase, the permeability of the membrane to K+ is greater than its permeability at rest are correct.<br>E.All of the choices are correct.</td>
      <td>E.All of the choices are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>14. 下列关于药物主动转运的叙述，哪一项是错误的？ (3.0分)</td>
      <td>A.需要消耗能量<br>B.可受其他化学品的干扰<br>C.有化学结构特异性<br>D.比被动转运较快达到平衡<br>E.转运速度有饱和限制</td>
      <td>D.比被动转运较快达到平衡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>15. pKa < 4的弱碱性药物如地西泮，在胃肠道pH范围内基本都是 (3.0分)</td>
      <td>A.离子型，吸收快而完全<br>B.非离子型，吸收快而完全<br>C.离子型，吸收慢而不完全<br>D.非离子型，吸收慢而不完全<br>E.离子型和非离子型相等</td>
      <td>B.非离子型，吸收快而完全</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>16. 关于药物与血浆蛋白结合的描述，下述哪一点是错误的？ (3.0分)</td>
      <td>A.药物与血浆蛋白结合一般是可逆的<br>B.同时用两个药物可能会发生置换现象<br>C.血浆蛋白减少可使结合型药物减少<br>D.结合型药物有较强的药理活性<br>E.结合型药物一般难以分布到全身组织</td>
      <td>D.结合型药物有较强的药理活性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>17. 药物在肝脏内代谢转化后都会 (3.0分)</td>
      <td>A.毒性减小或消失<br>B.经胆汁排泄<br>C.极性（水溶性）增高<br>D.脂/水分布系数增大<br>E.分子量减小</td>
      <td>C.极性（水溶性）增高</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>18. 口服苯妥英钠几周后又加服氯霉素，测得苯妥英钠血浓度明显升高，这现象是因为 (3.0分)</td>
      <td>A.氯霉素使苯妥英钠吸收增加<br>B.氯霉素增加苯妥英钠的生物利用度<br>C.氯霉素与苯妥英钠竞争与血红蛋白结合，使苯妥英钠游离增加<br>D.氯霉素抑制肝药酶，使苯妥英钠代谢减少<br>E.氯霉素诱导肝药酶，使苯妥英钠代谢增加</td>
      <td>D.氯霉素抑制肝药酶，使苯妥英钠代谢减少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>19. 一级消除动力学的特点是 (3.0分)</td>
      <td>A.血浆消除半衰期随血浆药物浓度高低而增减<br>B.血浆消除半衰期随给药量大小而增减<br>C.单位时间内体内药量以恒定的百分比消除<br>D.单位时间内体内药量以恒定的量消除<br>E.体内药物过多时，以最大能力消除药物</td>
      <td>C.单位时间内体内药量以恒定的百分比消除</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>20. 药物代谢动力学参数不包括 (3.0分)</td>
      <td>A.消除速率常数<br>B.表观分布容积<br>C.半衰期<br>D.半数致死量<br>E.血浆清除率</td>
      <td>D.半数致死量</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>21. 绝对口服生物利用度等于 (3.0分)</td>
      <td>A. (静脉注射一定量药物后AUC / 口服等量药物后AUC) × 100％<br>B. (口服一定量药物后AUC / 静脉注射等量药物后AUC) × 100％<br>C. (口服一定量药物后Cmax / 静脉注射等量药物后Cmax) × 100％<br>D. (静脉注射一定量药物后Cmax / 口服等量药物后Cmax) × 100％<br>E. (口服一定量药物后Tmax / 静脉注射等量药物后Tmax) × 100％</td>
      <td>B. (口服一定量药物后AUC / 静脉注射等量药物后AUC) × 100％</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>22. 某药的表观分布容积为40 L，如欲立即达到4 mg/L。的稳态血药浓度，应给的负荷剂量是 (3.0分)</td>
      <td>A.13 mg<br>B.25 mg<br>C.50 mg<br>D.100 mg<br>E.160 mg</td>
      <td>E.160 mg</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>23. 药物作用的两重性指 (3.0分)</td>
      <td>A.既有对因治疗作用，又有对症治疗作用<br>B.既有副作用，又有毒性作用<br>C.既有治疗作用，又有不良反应<br>D.既有局部作用，又有全身作用<br>E.既有原发作用，又有继发作用</td>
      <td>C.既有治疗作用，又有不良反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>24. 量效曲线可以为用药提供什么参考 (3.0分)</td>
      <td>A.药物的疗效大小<br>B.药物的毒性性质<br>C.药物的安全范围<br>D.药物的给药方案<br>E.药物的体内分布过程</td>
      <td>D.药物的给药方案</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>25. 药物的效价强度（potency）是指同一类型药物之间 (3.0分)</td>
      <td>A.产生治疗作用与不良反应的比值<br>B.在足够大的剂量时产生最大效应的强弱<br>C.产生相同效应时需要的剂量的不同<br>D.引起毒性剂量的大小<br>E.以上都不是</td>
      <td>C.产生相同效应时需要的剂量的不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>26. 治疗外伤引起的剧烈疼痛时，皮下注射Morphine （吗啡）10 mg与皮下注射Pethidine （哌替丁）100 mg的疗效相同，因此 (3.0分)</td>
      <td>A.Morphine的效能比Pethidine强10倍<br>B.Morphine的效价强度比Pethidine强10倍<br>C.Pethidine的效能比Morphine强10倍<br>D.Pethidine的效应效价强度比Morphine强10倍<br>E.Morphine的安全性比Pethidine高10倍</td>
      <td>B.Morphine的效价强度比Pethidine强10倍</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>27. 药物的非特异性作用包括 (3.0分)</td>
      <td>A.离子通道阻滞药干扰离子跨膜转运<br>B.受体阻断药抑制受体激活<br>C.酶抑制药抑制酶的活性<br>D.利尿药抑制肾小管Na+-K+交换<br>E.抗酸药对胃酸的中和作用</td>
      <td>E.抗酸药对胃酸的中和作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>28. 拮抗药（阻断药）是指对受体 (3.0分)</td>
      <td>A.有亲和力而无内在活性的药物<br>B.有亲和力而内在活性较弱的药物<br>C.有亲和力又有内在活性的药物<br>D.无亲和力但有较强内在活性的药物<br>E.既无亲和力也无内在活性的药物</td>
      <td>A.有亲和力而无内在活性的药物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>29. 关于药物相互作用说法，不正确的是 (3.0分)</td>
      <td>A.在两种或两种以上药物同时应用时出现<br>B.可能表现为药理作用的改变<br>C.有时表现为毒性反应的增强<br>D.不改变每一药物的体内过程<br>E.机体对药物的反应性改变</td>
      <td>D.不改变每一药物的体内过程</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>30. 有关年龄对药物效应的影响说法正确的是 (3.0分)</td>
      <td>A.仅少部分药物在老年人中作用会减弱<br>B.药物的t1/2不会随着年龄的增长而延长<br>C.新生儿和老年人药物排泄功能减弱<br>D.新生儿的药物结合代谢能力相对较强<br>E.在老年人应用降压药物后，不容易引起直立性低血压</td>
      <td>C.新生儿和老年人药物排泄功能减弱</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>31. 在人体组织中X线穿透力由强到弱，依次为 (3.0分)</td>
      <td>A.气体＞脂肪＞液体及软组织<br>B.气体＞液体及软组织＞脂肪<br>C.骨骼＞脂肪＞液体及软组织<br>D.液体及软组织＞骨骼＞脂肪<br>E.脂肪＞气体＞骨骼、液体及软组织</td>
      <td>A.气体＞脂肪＞液体及软组织</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>32. 关于DSA优点，描述错误的是 (3.0分)</td>
      <td>A.密度分辨率高<br>B.造影剂用量少<br>C.适用于各种图像处理技术<br>D.没有骨骼软组织影重叠<br>E.不需用造影剂</td>
      <td>E.不需用造影剂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2010</td>
      <td>33. 下列哪项为经导管栓塞术(3.0分)</td>
      <td>A.TIPSS<br>B.肝癌TACE术<br>C.颈动脉支架植入<br>D.脑动脉溶栓术<br>E.肾动脉成形术</td>
      <td>B.肝癌TACE术</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>1. Equal concentrations of two solutes, A and B, are placed into the same beaker at the same time. Solute A reaches diffusion equilibrium faster than solute B. What is the most likely explanation for this observation? (3.0分)</td>
      <td>A.The temperature was greater for solute A than solute B.<br>B.The concentration gradient for A was greater than B.<br>C.Solute A is smaller than solute B.<br>D.Solute A traveled a shorter distance than solute B.<br>E.All of the choices are logical explanations.</td>
      <td>C.Solute A is smaller than solute B.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>2. Which of the following statements regarding the movement of molecules across cell membranes is correct? (3.0分)</td>
      <td>A.The diffusion of molecules across a cell membrane occurs at a rate that is influenced by the surface area of the membrane and the magnitude of the concentration difference across it.<br>B.The net flux of molecules that cross cell membranes by diffusion is always from regions of lower concentration to regions of higher concentration.<br>C.Molecules that enter a cell by diffusion must directly permeate the lipid portion of the plasma membrane, whereas those that enter by facilitated diffusion utilize membrane-bound proteins.<br>D.Both the diffusion of molecules across a cell membrane occurs at a rate that is influenced by the surface area of the membrane and the magnitude of the concentration difference across it and the net flux of molecules that cross cell membranes by diffusion is always from regions of lower concentration to regions of higher concentration are correct.<br>E.Both the diffusion of molecules across a cell membrane occurs at a rate that is influenced by the surface area of the membrane and the magnitude of the concentration difference across it and molecules that enter a cell by diffusion must directly permeate the lipid portion of the plasma membrane, whereas those that enter by facilitated diffusion utilize membrane-bound proteins are correct.</td>
      <td>E.Both the diffusion of molecules across a cell membrane occurs at a rate that is influenced by the surface area of the membrane and the magnitude of the concentration difference across it and molecules that enter a cell by diffusion must directly permeate the lipid portion of the plasma membrane, whereas those that enter by facilitated diffusion utilize membrane-bound proteins are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>3. Mediated transport across cell membranes (3.0分)</td>
      <td>A.refers to the movement of ions through protein channels.<br>B.refers both to diffusion and to the active transport of molecules.<br>C.is characterized by saturable carriers and a maximum velocity of transport.<br>D.Both refers to the movement of ions through protein channels and refers both to diffusion and to the active transport of molecules are correct.<br>E.Both refers both to diffusion and to the active transport of molecules and is characterized by saturable carriers and a maximum velocity of transport are correct.</td>
      <td>C.is characterized by saturable carriers and a maximum velocity of transport.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>4. If the ATP-generating mechanisms in a cell are poisoned and the cell has depleted its ATP reserves(3.0分)</td>
      <td>A.primary active transport of molecules would cease immediately.<br>B.secondary active transport of molecules would cease immediately.<br>C.eventually there will be no potential difference across the membrane.<br>D.primary active transport of molecules would cease immediately and secondary active transport of molecules would cease immediately are correct.<br>E.primary active transport of molecules would cease immediately and eventually there will be no potential difference across the membrane are correct.</td>
      <td>E.primary active transport of molecules would cease immediately and eventually there will be no potential difference across the membrane are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>5. If a cell is placed into an unknown solution and it shrinks, what can be concluded about the unknown solution? (3.0分)</td>
      <td>A.Its nonpenetrating solute concentration was greater than that of the cell.<br>B.Its nonpenetrating solute concentration was less than that of the cell.<br>C.Its nonpenetrating solute concentration was equal to that of the cell.<br>D.Any of the choices are possible</td>
      <td>A.Its nonpenetrating solute concentration was greater than that of the cell.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>6. Which of the following statements about epithelial cells and epithelial transport is correct? (3.0分)</td>
      <td>A.Epithelial cells are polarized.<br>B.Epithelial cells lining the small intestine have Na,K-ATPase pumps only in their basolateral membranes.<br>C.The "active" component of active transport across epithelial cells occurs only from the lumen side into the cells.<br>D.Both epithelial cells are polarized and epithelial cells lining the small intestine have Na, K -ATPase pumps only in their basolateral membranes are correct.<br>E.Both epithelial cells are polarized and the "active" component of active transport across epithelial cells occurs only from the lumen side into the cells are correct.</td>
      <td>D.Both epithelial cells are polarized and epithelial cells lining the small intestine have Na, K -ATPase pumps only in their basolateral membranes are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>7. Which of the following are possible combinations of mechanisms for transport of a particle against a concentration gradient across an epithelial cell? (3.0分)</td>
      <td>A.Passive diffusion from a lumen into the cell followed by facilitated diffusion from the cell into the blood.<br>B.Passive diffusion on the apical side into the cell followed by primary active transport on the basolateral side.<br>C.Secondary active transport on the mucosal side followed by facilitated diffusion on the serosal side.<br>D.Both passive diffusion from a lumen into the cell followed by facilitated diffusion from the cell into the blood and passive diffusion on the apical side into the cell followed by primary active transport on the basolateral side are correct.<br>E.Both passive diffusion on the apical side into the cell followed by primary active transport on the basolateral side and secondary active transport on the mucosal side followed by facilitated diffusion on the serosal side are correct.</td>
      <td>E.Both passive diffusion on the apical side into the cell followed by primary active transport on the basolateral side and secondary active transport on the mucosal side followed by facilitated diffusion on the serosal side are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>8. Compartments A and B are separated by a membrane that is permeable to K+ but not to Cl-. At time zero, a solution of KCl is poured into compartment A and pure H2O is poured into compartment B. Now they are emptied and the membrane replaced with one that is permeable to both K+ and Cl-, but no other ions. At time zero, a solution of NaCl is poured into compartment A and a solution of KA (A is an anion other than Cl-) is poured into compartment B. At equilibrium, (3.0分)</td>
      <td>A.compartment A will be negatively charged relative to B.<br>B.there is a net flux of K+ from B to A.<br>C.there is a concentration gradient favoring Cl- diffusion from A to B and this gradient is balanced by an electric force favoring diffusion from B to A.<br>D.Both there is a net flux of K+ from B to A and there is a concentration gradient favoring Cl- diffusion from A to B and this gradient is balanced by an electric force favoring diffusion from B to A are correct.<br>E.All of the choices are correct.</td>
      <td>D.Both there is a net flux of K+ from B to A and there is a concentration gradient favoring Cl- diffusion from A to B and this gradient is balanced by an electric force favoring diffusion from B to A are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>9. The diffusion potential for Na+ across a nerve cell membrane (3.0分)</td>
      <td>A.favors its movement into the cell at resting potential.<br>B.favors its movement out of the cell at resting potential.<br>C.is equal and opposite to the electrical potential acting on sodium at resting potential.<br>D.is in the same direction as the diffusion potential for potassium.<br>E.is both favors its movement into the cell at resting potential and is equal and opposite to the electrical potential acting on sodium at resting potential.</td>
      <td>A.favors its movement into the cell at resting potential.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>10. The equilibrium potential of K ions in nerve cells is about -90 mV. The membrane potential of typical nerve cells at rest is -70 mV. Therefore (3.0分)</td>
      <td>A.increasing the permeability of a resting neuronal membrane to K ions will increase the membrane potential (that is, make it more negative, inside with respect to outside).<br>B.in nerve cells at rest, there is a net diffusion of K ions out of the cell.<br>C.increasing the membrane potential of a nerve cell would slow the diffusion of K ions out of it.<br>D.potassium is not the only permeant ion at rest.<br>E.All of the choices are true.</td>
      <td>E.All of the choices are true.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>11. An action potential in a neuronal membrane differs from a graded potential in that (3.0分)</td>
      <td>A.an action potential requires the opening of Ca+2 channels, whereas a graded potential does not.<br>B.an action potential is propagated without decrement, whereas a graded potential is not.<br>C.an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is not all-or-none.<br>D.Both an action potential requires the opening of Ca+2 channels, whereas a graded potential does not and an action potential is propagated without decrement, whereas a graded potential is not are correct.<br>E.Both an action potential is propagated without decrement, whereas a graded potential is not and an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is not all-or-none are correct.</td>
      <td>E.Both an action potential is propagated without decrement, whereas a graded potential is not and an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is not all-or-none are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>12. Action potentials are said to be "all-or-none" in character because (4.0分)</td>
      <td>A.the rate of propagation of an action potential down an axon is independent of stimulus strength.<br>B.they are associated with an absolute refractory period.<br>C.a supra-threshold stimulus is required to stimulate an action potential during the relative refractory period.<br>D.the amplitude of an action potential generated in any given neuron is the same, regardless of the stimulus strength.<br>E.All of these statements describe the "all-or-none" character of action potentials.</td>
      <td>D.the amplitude of an action potential generated in any given neuron is the same, regardless of the stimulus strength.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>13. Which of the following statements regarding the phases of an action potential is correct? (3.0分)</td>
      <td>A.During the depolarizing phase, the permeability of the membrane to Na+ is greater than its permeability at rest.<br>B.During the repolarizing phase, the permeability of the membrane to K+ is greater than its permeability at rest.<br>C.The relative refractory period of the membrane coincides with the hyperpolarized and second repolarizing phases.<br>D.Both During the depolarizing phase, the permeability of the membrane to Na+ is greater than its permeability at rest and During the repolarizing phase, the permeability of the membrane to K+ is greater than its permeability at rest are correct.<br>E.All of the choices are correct.</td>
      <td>E.All of the choices are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>14. Which of the following statements regarding action potentials generated in a membrane is not true? (3.0分)</td>
      <td>A.Action potentials travel decrementally down the membrane.<br>B.An action potential generates a new action potential in an adjacent area of membrane.<br>C.An action potential generates a local current that depolarizes adjacent membrane to threshold potential.<br>D.The first action potential generated is the same size as the action potential ultimately generated at the end of the membrane.<br>E.An action potential generated by a threshold stimulus is the same size as one generated by a supra-threshold stimulus.</td>
      <td>A.Action potentials travel decrementally down the membrane.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>15. Which of the following statements concerning the rate of action potential propagation is true? (3.0分)</td>
      <td>A.It is faster in large-diameter axons than in small-diameter ones.<br>B.It is faster for a strong stimulus than for a weak one.<br>C.It is faster in myelinated nerve fibers than in nonmyelinated ones.<br>D.Both it is faster in large-diameter axons than in small-diameter ones and it is faster in myelinated nerve fibers than in nonmyelinated ones are true.<br>E.All of the choices are true.</td>
      <td>D.Both it is faster in large-diameter axons than in small-diameter ones and it is faster in myelinated nerve fibers than in nonmyelinated ones are true.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>16. If pure water and a solution containing a nonpenetrating solute are separated by a membrane that is permeable only to water, (3.0分)</td>
      <td>A.water will diffuse by osmosis until the water concentrations in the two compartments become equal.<br>B.both water and the solute will diffuse across the membrane down their concentration gradients until a state of equilibrium is established.<br>C.water will diffuse by osmosis until stopped by opposing hydrostatic pressure.<br>D.no movement will occur between the compartments.<br>E.none of the choices will occur.</td>
      <td>C.water will diffuse by osmosis until stopped by opposing hydrostatic pressure.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>17. 下列关于细胞信号转导的叙述哪项是不正确的？(3.0分)</td>
      <td>A.不同的信号转导通路之间具有相互联系作用<br>B.细胞受体分为膜受体和核受体<br>C.酪氨酸蛋白激酶型受体属于核受体<br>D.细胞信号转导过程是由细胞内一系列信号转导蛋白的构象、活性或功能变化来实现的<br>E.细胞内信使分子能激活细胞内受体和蛋白激酶</td>
      <td>C.酪氨酸蛋白激酶型受体属于核受体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>18. II型糖尿病的发生机制主要累及以下哪个环节(3.0分)</td>
      <td>A.细胞信号或配体<br>B.受体<br>C.细胞内信号通路<br>D.信号终止环节<br>E.信号放大过程</td>
      <td>B.受体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>19. 有关G蛋白叙述哪项是不正确的？(3.0分)</td>
      <td>A.G蛋白是指与鸟嘌呤核苷酸可逆性结合的蛋白质家族<br>B.G蛋白是由αβγ亚单位组成的异三聚体<br>C.Gα上的GTP被GDP取代，这是G蛋白激活的关键步骤<br>D.小分子G蛋白只具有G蛋白α亚基的功能<br>E.G蛋白偶联受体由单一肽链7次穿越细胞膜</td>
      <td>C.Gα上的GTP被GDP取代，这是G蛋白激活的关键步骤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>20. 下列关于炎症中信号转导错误的是(3.0分)</td>
      <td>A.TLR4是LPS-LBP-CD14的特异性受体<br>B.NF-kB和MAPK信号通路参与了LPS诱导炎症因子生成的过程<br>C.TNF通路不参与炎症中细胞因子级联反应<br>D.细胞粘附分子介导的信号转导通路参与了炎症细胞向感染部位的迁移<br>E.TLR4下游通路包括MYD88依赖及非依赖途径</td>
      <td>C.TNF通路不参与炎症中细胞因子级联反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>21. 关于表观分布容积小的药物，下列哪项是正确的？(3.0分)</td>
      <td>A.与血浆蛋白结合少，较集中于血浆<br>B.与血浆蛋白结合多，较集中于血浆<br>C.与血浆蛋白结合少，多在细胞内液<br>D.与血浆蛋白结合多，多在细胞内液<br>E.与血浆蛋白结合多，多在细胞间液</td>
      <td>B.与血浆蛋白结合多，较集中于血浆</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>22. pKa =8.2的弱酸性药物如戊巴比妥，在胃内pH范围内基本都是 (3.0分)</td>
      <td>A.离子型，吸收快而完全<br>B.非离子型，吸收快而完全<br>C.离子型，吸收慢而不完全<br>D.非离子型，吸收慢而不完全<br>E.离子型和非离子型相等</td>
      <td>B.非离子型，吸收快而完全</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>23. 药物的首关消除（首过消除）是指 (3.0分)</td>
      <td>A.药物口服后，部分未经吸收即从肠道排出<br>B.药物静脉注射后，部分迅速经肾排泄<br>C.药物口服后，部分迅速经肾排泄<br>D.药物经静脉注射，进入体循环之后，部分在肝脏内消除<br>E.药物口服后，进入体循环之前，部分先在肝脏内消除</td>
      <td>E.药物口服后，进入体循环之前，部分先在肝脏内消除</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>24. 绝对口服生物利用度等于(3.0分)</td>
      <td>A.(静脉注射一定量药物后AUC / 口服等量药物后AUC) × 100％<br>B.(口服一定量药物后AUC / 静脉注射等量药物后AUC) × 100％<br>C.(口服一定量药物后Cmax / 静脉注射等量药物后Cmax) × 100％<br>D.(静脉注射一定量药物后Cmax / 口服等量药物后Cmax) × 100％<br>E.(口服一定量药物后Tmax / 静脉注射等量药物后Tmax) × 100％</td>
      <td>B.(口服一定量药物后AUC / 静脉注射等量药物后AUC) × 100％</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>25. 苯巴比妥可使氯丙嗪血药浓度明显降低，这是因为苯巴比妥(3.0分)</td>
      <td>A.减少氯丙嗪的吸收<br>B.增加氯丙嗪与血浆蛋白结合<br>C.诱导肝药酶，使氯丙嗪代谢增加<br>D.降低氯丙嗪的生物利用度<br>E.扩大氯丙嗪的分布</td>
      <td>C.诱导肝药酶，使氯丙嗪代谢增加</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>26. 下列关于药物主动转运的叙述，哪一项是错误的？ (3.0分)</td>
      <td>A.需要消耗能量<br>B.可受其他化学品的干扰<br>C.有化学结构特异性<br>D.比被动转运较快达到平衡<br>E.转运速度有饱和限制</td>
      <td>D.比被动转运较快达到平衡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>27. 某药在体内按一级动力学消除，在其吸收达高峰后抽血两次，测其血浆浓度分别为150 ?g/ml及18.75 ?g/ml，两次抽血间隔9小时，该药的血浆半衰期是(3.0分)</td>
      <td>A.1小时<br>B.1.5小时<br>C.2小时<br>D.3小时<br>E.4小时</td>
      <td>D.3小时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>28. 药物吸收到达血浆稳态浓度时意味着 (3.0分)</td>
      <td>A.药物作用最强<br>B.药物的吸收过程已完成<br>C.药物的消除过程正开始<br>D.药物的吸收速度与消除速度达到平衡<br>E.药物在体内分布达到平衡</td>
      <td>D.药物的吸收速度与消除速度达到平衡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>29. 负荷剂量是 (3.0分)</td>
      <td>A.一半有效血药浓度的剂量<br>B.一半稳态血药浓度的剂量<br>C.达到一定血药浓度的剂量<br>D.达到有效血药浓度的剂量<br>E.维持有效血药浓度的剂量</td>
      <td>D.达到有效血药浓度的剂量</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>30. 安慰剂一般指(3.0分)</td>
      <td>A.由本身没有特殊药理活性的物质（乳糖、淀粉等）制成的外形似药的制剂<br>B.由药理活性较弱的物质制成的制剂<br>C.本身没有特殊作用的医疗措施（如假手术等）<br>D.有一定治疗作用的医疗措施<br>E.对病人做的安慰、鼓励等心理治疗</td>
      <td>A.由本身没有特殊药理活性的物质（乳糖、淀粉等）制成的外形似药的制剂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>31. 关于药物相互作用说法不正确的是(3.0分)</td>
      <td>A.在两种或两种以上药物同时应用时出现<br>B.可能表现为药理作用的改变<br>C.有时表现为毒性反应的增强<br>D.可改变药物的体内过程<br>E.机体对药物的反应性改变</td>
      <td>D.可改变药物的体内过程</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>32. 有关特异质反应说法正确的是 (3.0分)</td>
      <td>A.是一种常见的不良反应<br>B.多数反应比较轻微<br>C.发生与否取决于药物剂量<br>D.通常与遗传变异有关<br>E.是一种免疫反应</td>
      <td>D.通常与遗传变异有关</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2011</td>
      <td>33. 某药消除符合一级动力学，t1/2为4小时，在固定间隔固定剂量多次给药后，经过下述哪一时间即可达到血浆稳态浓度? (3.0分)</td>
      <td>A.约10小时<br>B.约20小时<br>C.约30小时<br>D.约40小时<br>E.约50小时</td>
      <td>B.约20小时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>1. Which of the following statements regarding the diffusion of nonpolar solutes across cell membranes is correct? (3.0分)</td>
      <td>A.At equilibrium for solute X, the flux of X across cell membranes is zero.<br>B.At equilibrium for solute X, the net flux of X across cell membranes is zero.<br>C.At equilibrium for solute X, the concentration of X inside the cell is equal to its concentration outside the cell.<br>D. Both at equilibrium for solute X, the flux of X across cell membranes is zero and at equilibrium for solute X, the concentration of X inside the cell is equal to its concentration outside the cell are correct.<br>E.Both at equilibrium for solute X, the net flux of X across cell membranes is zero and at equilibrium for solute X, the concentration of X inside the cell is equal to its concentration outside the cell are correct.</td>
      <td>E.Both at equilibrium for solute X, the net flux of X across cell membranes is zero and at equilibrium for solute X, the concentration of X inside the cell is equal to its concentration outside the cell are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>2. If it takes solute A 1 second to diffuse 1 millimeter, how long will it take solute A to diffuse 10 millimeters under the same conditions? (3.0分)</td>
      <td>A.1 second<br>B.10 seconds<br>C.50 seconds<br>D.100 seconds</td>
      <td>D.100 seconds</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>3. The permeability of the plasma membrane to mineral ions (3.0分)</td>
      <td>A.is dependent upon channels formed by proteins.<br>B.varies from one cell to another.<br>C.is affected by differences in electrical charge on the two sides of the membrane.<br>D.Both is dependent upon channels formed by proteins and is affected by differences in electrical charge on the two sides of the membrane are correct.<br>E.All of the choices are correct.</td>
      <td>E.All of the choices are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>4. Ion channels in cell membranes (3.0分)</td>
      <td>A.are nonspecific.<br>B.may open in response to a change in potential difference across the membrane.<br>C.may open in response to binding a ligand.<br>D.Both are nonspecific and may open in response to a change in potential difference across the membrane are correct.<br>E.Both may open in response to a change in potential difference across the membrane and may open in response to binding a ligand are correct.</td>
      <td>E.Both may open in response to a change in potential difference across the membrane and may open in response to binding a ligand are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>5. Carrier-mediated transport (3.0分)</td>
      <td>A.involves a specific membrane protein that functions as a carrier molecule.<br>B.always involves the movement of substances against a concentration gradient.<br>C.always requires the direct expenditure of energy.<br>D.Both involves a specific membrane protein that functions as a carrier molecule and always involves the movement of substances against a concentration gradient are correct.<br>E.All of the choices are correct.</td>
      <td>A.involves a specific membrane protein that functions as a carrier molecule.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>6. Osmosis refers to the movement of across semi-permeable membranes. (3.0分)</td>
      <td>A.glucose<br>B.charged particles<br>C.lipid molecules<br>D.water<br>E.any substance</td>
      <td>D.water</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>7. If all other conditions remain the same and the concentration of a nonpenetrating solute increases inside a cell, (3.0分)</td>
      <td>A.water will tend to enter the cell because the interior has an increased osmolarity.<br>B.water will tend to leave the cell because the interior has an increased osmolarity.<br>C.water will tend to enter the cell because the interior has a decreased osmolarity.<br>D.water will tend to leave the cell because the interior has a decreased osmolarity.<br>E.the non-penetrating solute will diffuse across the membrane until its concentration is equal on both sides of the membrane.</td>
      <td>A.water will tend to enter the cell because the interior has an increased osmolarity.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>8. Which of the following statements about epithelial cells and epithelial transport is correct? (3.0分)</td>
      <td>A.Epithelial cells are polarized.<br>B.Epithelial cells lining the small intestine have Na,K-ATPase pumps only in their basolateral membranes.<br>C.The "active" component of active transport across epithelial cells occurs only from the lumen side into the cells.<br>D.Both epithelial cells are polarized and epithelial cells lining the small intestine have Na, K -ATPase pumps only in their basolateral membranes are correct.<br>E.Both epithelial cells are polarized and the "active" component of active transport across epithelial cells occurs only from the lumen side into the cells are correct.</td>
      <td>D.Both epithelial cells are polarized and epithelial cells lining the small intestine have Na, K -ATPase pumps only in their basolateral membranes are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>9. During the active transport of glucose across an epithelium, energy is used to (3.0分)</td>
      <td>A.power the Na,K-ATPase pump.<br>B.power the Na -glucose cotransporter.<br>C.synthesize insulin, which is necessary for glucose reabsorption.<br>D.maintain the transport maximum for glucose.<br>E.power the facilitated diffusion of glucose across the basolateral membrane of the epithelial cell.</td>
      <td>B.power the Na -glucose cotransporter.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>10. Compartments A and B are separated by a membrane that is permeable to K+ but not to Cl-. At time zero, a solution of KCl is poured into compartment A and pure H2O is poured into compartment B. At equilibrium, (3.0分)</td>
      <td>A.the concentration of K+ in A will be lower than it was at time zero.<br>B.diffusion of K+ from A to B will be equal to the diffusion of K+ from B to A.<br>C.there will be a potential difference across the membrane, with side A negative relative to side B.<br>D.the electrical and diffusion potentials for K+ will be equal in magnitude and opposite in direction<br>E.All of the choices are correct.</td>
      <td>E.All of the choices are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>11. The resting membrane potential (4.0分)</td>
      <td>A.requires very few ions to be distributed unevenly.<br>B.is the same in all cells.<br>C.is oriented so that the cell's interior is positive with respect to the extracellular fluid.<br>D.occurs only in nerve and muscle cells.<br>E.None of the choices are correct.</td>
      <td>A.requires very few ions to be distributed unevenly.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>12. An increase in the extracellular concentration of K+ above normal would result in (3.0分)</td>
      <td>A.depolarization of resting nerve cells.<br>B.hyperpolarization of resting nerve cells.<br>C.no change in the resting membrane potential.</td>
      <td>A.depolarization of resting nerve cells.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>13. The Na,K-ATPase in a nerve cell (3.0分)</td>
      <td>A.maintains an electrical gradient such that the inside is negative with respect to the outside.<br>B.maintains a concentration gradient for K+ such that diffusion forces favor movement of K+ into the cell.<br>C.maintains an electrical gradient at the equilibrium potential of K+.<br>D.transports an equal number of sodium and potassium ions<br>E.Both maintains an electrical gradient such that the inside is negative with respect to the outside and transports an equal number of sodium and potassium ions are correct.</td>
      <td>A.maintains an electrical gradient such that the inside is negative with respect to the outside.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>14. The equilibrium potential of K ions in nerve cells is about -90 mV. The membrane potential of typical nerve cells at rest is -70 mV. Therefore (3.0分)</td>
      <td>A.increasing the permeability of a resting neuronal membrane to K ions will increase the membrane potential (that is, make it more negative, inside with respect to outside).<br>B.in nerve cells at rest, there is a net diffusion of K ions out of the cell.<br>C.increasing the membrane potential of a nerve cell would slow the diffusion of K ions out of it.<br>D.potassium is not the only permeant ion at rest.<br>E.All of the choices are true.</td>
      <td>E.All of the choices are true.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>15. An action potential in a neuronal membrane differs from a graded potential in that (3.0分)</td>
      <td>A.an action potential requires the opening of Ca+2 channels, whereas a graded potential does not.<br>B.an action potential is propagated without decrement, whereas a graded potential is not.<br>C.an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is not all-or-none.<br>D.Both an action potential requires the opening of Ca+2 channels, whereas a graded potential does not and an action potential is propagated without decrement, whereas a graded potential is not are correct.<br>E.Both an action potential is propagated without decrement, whereas a graded potential is not and an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is not all-or-none are correct.</td>
      <td>E.Both an action potential is propagated without decrement, whereas a graded potential is not and an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is not all-or-none are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>16. Action potentials are said to be "all-or-none" in character because (3.0分)</td>
      <td>A.the rate of propagation of an action potential down an axon is independent of stimulus strength.<br>B.they are associated with an absolute refractory period.<br>C.a supra-threshold stimulus is required to stimulate an action potential during the relative refractory period.<br>D.the amplitude of an action potential generated in any given neuron is the same, regardless of the stimulus strength.<br>E.All of these statements describe the "all-or-none" character of action potentials.</td>
      <td>D.the amplitude of an action potential generated in any given neuron is the same, regardless of the stimulus strength.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>17. Which of the following statements concerning the rate of action potential propagation is true? (3.0分)</td>
      <td>A.It is faster in large-diameter axons than in small-diameter ones.<br>B.It is faster for a strong stimulus than for a weak one.<br>C.It is faster in myelinated nerve fibers than in nonmyelinated ones.<br>D.Both it is faster in large-diameter axons than in small-diameter ones and it is faster in myelinated nerve fibers than in nonmyelinated ones are true.<br>E.All of the choices are true.</td>
      <td>D.Both it is faster in large-diameter axons than in small-diameter ones and it is faster in myelinated nerve fibers than in nonmyelinated ones are true.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>18. 下列关于细胞信号转导的叙述哪项是不正确的？(3.0分)</td>
      <td>A.不同的信号转导通路之间具有相互联系作用<br>B.细胞受体分为膜受体和核受体<br>C.酪氨酸蛋白激酶型受体属于核受体<br>D.细胞信号转导过程是由细胞内一系列信号转导蛋白的构象、活性或功能变化来实现的<br>E.细胞内信使分子能激活细胞内受体和蛋白激酶</td>
      <td>C.酪氨酸蛋白激酶型受体属于核受体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>19. 信号转导通路对靶蛋白调节最重要的方式是(3.0分)</td>
      <td>A.通过G蛋白调节<br>B.通过可逆性磷酸化调节<br>C.通过配体调节<br>D.通过受体数量调节<br>E.通过受体亲和力调节</td>
      <td>B.通过可逆性磷酸化调节</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>20. 重症肌无力的主要信号转导障碍是(3.0分)</td>
      <td>A.Ach分泌减少<br>B.体内产生抗n-Ach受体的抗体<br>C.Na+通道障碍<br>D.抗体与n-Ach受体结合<br>E.Ach与其受体结合障碍</td>
      <td>B.体内产生抗n-Ach受体的抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>21. 下列关于炎症中信号转导错误的是(3.0分)</td>
      <td>A.TLR4是LPS-LBP-CD14的特异性受体<br>B.NF-kB和MAPK信号通路参与了LPS诱导炎症因子生成的过程<br>C.TNF通路不参与炎症中细胞因子级联反应<br>D.细胞粘附分子介导的信号转导通路参与了炎症细胞向感染部位的迁移<br>E.TLR4下游通路包括MYD88依赖及非依赖途径</td>
      <td>C.TNF通路不参与炎症中细胞因子级联反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>22. 下列关于药物主动转运的叙述，哪一项是错误的？ ( ) (3.0分)</td>
      <td>A.需要消耗能量<br>B.可受其他化学品的干扰<br>C.有化学结构特异性<br>D.比被动转运较快达到平衡<br>E.转运速度有饱和限制</td>
      <td>D.比被动转运较快达到平衡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>23. 药物的pKa是指 ( ) (3.0分)</td>
      <td>A.药物完全解离时的pH<br>B.药物50％解离时的pH<br>C.药物30％解离时的pH<br>D.药物80％解离时的pH<br>E.药物全部不解离时的pH</td>
      <td>B.药物50％解离时的pH</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>24. 在碱性尿液中弱碱性药物 ( ) (3.0分)</td>
      <td>A.解离多，重吸收少，排泄快<br>B.解离少，重吸收多，排泄快<br>C.解离多，重吸收多，排泄快<br>D.解离少，重吸收多，排泄慢<br>E.解离多，重吸收少，排泄慢</td>
      <td>D.解离少，重吸收多，排泄慢</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>25. 同一药物血药浓度达峰值最快的给药途径是 ( ) (3.0分)</td>
      <td>A.口服给药<br>B.静脉给药<br>C.肌内给药<br>D.经皮给药<br>E.舌下给药</td>
      <td>B.静脉给药</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>26. 药物的首关消除（首过消除）是指 ( ) (3.0分)</td>
      <td>A.药物口服后，部分未经吸收即从肠道排出<br>B.药物静脉注射后，部分迅速经肾排泄<br>C.药物口服后，部分迅速经肾排泄<br>D.药物经静脉注射，进入体循环之后，部分在肝脏内消除<br>E.药物口服后，进入体循环之前，部分先在肝脏内消除</td>
      <td>E.药物口服后，进入体循环之前，部分先在肝脏内消除</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>27. 药物A与药物B竞争结合血浆蛋白，合用后药物A( ) (3.0分)</td>
      <td>A.效应增强<br>B.效应减弱<br>C.不影响药物B的效应<br>D.应当加量使用<br>E.用量不必调整</td>
      <td>A.效应增强</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>28. 药物通过肝脏代谢后不会发生 ( ) (3.0分)</td>
      <td>A.毒性降低或消失<br>B.作用降低或消失<br>C.分子量减少<br>D.极性增高<br>E.脂溶性加大</td>
      <td>E.脂溶性加大</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>29. 苯巴比妥可使氯丙嗪血药浓度明显降低，这是因为苯巴比妥 ( )(3.0分)</td>
      <td>A.减少氯丙嗪的吸收<br>B.增加氯丙嗪与血浆蛋白结合<br>C.诱导肝药酶，使氯丙嗪代谢增加<br>D.降低氯丙嗪的生物利用度<br>E.扩大氯丙嗪的分布</td>
      <td>C.诱导肝药酶，使氯丙嗪代谢增加</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>30. 决定药物每天用药次数的主要因素是 ( )(3.0分)</td>
      <td>A.血浆蛋白结合率<br>B.吸收速度<br>C.消除速度<br>D.作用强弱<br>E.起效快慢</td>
      <td>C.消除速度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>31. 某药物在口服和静脉注射相同剂量后的时量曲线下面积(AUC)相等，这意味着 ( )(3.0分)</td>
      <td>A.口服吸收迅速<br>B.口服吸收完全<br>C.口服和静脉注射可以取得同样生物效应<br>D.口服药物未经肝门脉吸收<br>E.属一房室分布模型</td>
      <td>B.口服吸收完全</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>32. 某药的表观分布容积为40 L，如欲立即达到4 mg/L。的稳态血药浓度，应给的负荷剂量是 ( )(3.0分)</td>
      <td>A.13 mg<br>B.25 mg<br>C.50 mg<br>D.100 mg<br>E.160 mg</td>
      <td>E.160 mg</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2012</td>
      <td>33. 某药在体内按一级动力学消除，在其吸收达高峰后抽血两次，测其血浆浓度分别为150 g/ml及18.75 g/ml，两次抽血间隔9小时，该药的血浆半衰期是 ( )(3.0分)</td>
      <td>A.1小时<br>B.1.5小时<br>C.2小时<br>D.3小时<br>E.4小时</td>
      <td>D.3小时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>1. 药物的非特异性作用包括 (2.5分)</td>
      <td>A.离子通道阻滞药干扰离子跨膜转运<br>B.受体阻断药抑制受体激活<br>C.酶抑制药抑制酶的活性<br>D.利尿药抑制肾小管Na+-K+交换<br>E.抗酸药对胃酸的中和作用</td>
      <td>E.抗酸药对胃酸的中和作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>2. 药物的半数致死量(LD50)是指 (2.5分)</td>
      <td>A.抗生素杀死一半病原菌的剂量<br>B.抗寄生虫药杀死一半寄生虫的剂量<br>C.引起半数实验动物严重毒性反应的剂量<br>D.引起半数实验动物死亡的剂量<br>E.致死量的一半</td>
      <td>D.引起半数实验动物死亡的剂量</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>3. 已确定的第二信使不包括(2.5分)</td>
      <td>A.cAMP<br>B.cGMP<br>C.磷酸肌醇<br>D.甘油二酯<br>E.二氧化碳</td>
      <td>E.二氧化碳</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>4. 某口服降压药物用量为10 mg/day.因病人误服用量达到100 mg/day 引起的低血压休克属于 (2.5分)</td>
      <td>A.药物的副作用<br>B.药物的疗效<br>C.药物的特异质作用<br>D.药物的毒性<br>E.药物的停药反应</td>
      <td>D.药物的毒性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>5. 下列属于药物的质反应的是 (2.5分)</td>
      <td>A.心率次数<br>B.死亡个数<br>C.血压毫米汞柱值<br>D.尿量毫升数<br>E.体重千克数</td>
      <td>B.死亡个数</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>6. Which of the following statements regarding the diffusion of nonpolar solutes across cell membranes is correct? (2.5分)</td>
      <td>A.At equilibrium for solute X, the flux of X across cell membranes is zero.<br>B.At equilibrium for solute X, the net flux of X across cell membranes is zero.<br>C.At equilibrium for solute X, the concentration of X inside the cell is equal to its concentration outside the cell.<br>D.Both at equilibrium for solute X, the flux of X across cell membranes is zero and at equilibrium for solute X, the concentration of X inside the cell is equal to its concentration outside the cell are correct.<br>E.Both at equilibrium for solute X, the net flux of X across cell membranes is zero and at equilibrium for solute X, the concentration of X inside the cell is equal to its concentration outside the cell are correct.</td>
      <td>E.Both at equilibrium for solute X, the net flux of X across cell membranes is zero and at equilibrium for solute X, the concentration of X inside the cell is equal to its concentration outside the cell are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>7. If it takes solute A 1 second to diffuse 1 millimeter, how long will it take solute A to diffuse 10 millimeters under the same conditions? (2.5分)</td>
      <td>A.1 second<br>B.10 seconds<br>C.50 seconds<br>D.100 seconds</td>
      <td>D.100 seconds</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>8. The permeability of the plasma membrane to mineral ions (2.5分)</td>
      <td>A.is dependent upon channels formed by proteins.<br>B.varies from one cell to another.<br>C.is affected by differences in electrical charge on the two sides of the membrane.<br>D.Both is dependent upon channels formed by proteins and is affected by differences in electrical charge on the two sides of the membrane are correct.<br>E.All of the choices are correct.</td>
      <td>E.All of the choices are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>9. Ion channels in cell membranes (2.5分)</td>
      <td>A.are nonspecific.<br>B.may open in response to a change in potential difference across the membrane.<br>C.may open in response to binding a ligand.<br>D.Both are nonspecific and may open in response to a change in potential difference across the membrane are correct.<br>E.Both may open in response to a change in potential difference across the membrane and may open in response to binding a ligand are correct.</td>
      <td>E.Both may open in response to a change in potential difference across the membrane and may open in response to binding a ligand are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>10. Carrier-mediated transport (2.5分)</td>
      <td>A.involves a specific membrane protein that functions as a carrier molecule.<br>B.always involves the movement of substances against a concentration gradient.<br>C.always requires the direct expenditure of energy.<br>D.Both involves a specific membrane protein that functions as a carrier molecule and always involves the movement of substances against a concentration gradient are correct.<br>E.All of the choices are correct.</td>
      <td>A.involves a specific membrane protein that functions as a carrier molecule.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>11. Osmosis refers to the movement of across semi-permeable membranes. (2.5分)</td>
      <td>A.glucose<br>B.charged particles<br>C.lipid molecules<br>D.water<br>E.any substance</td>
      <td>D.water</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>12. If all other conditions remain the same and the concentration of a nonpenetrating solute increases inside a cell, (2.5分)</td>
      <td>A.water will tend to enter the cell because the interior has an increased osmolarity.<br>B.water will tend to leave the cell because the interior has an increased osmolarity.<br>C.water will tend to enter the cell because the interior has a decreased osmolarity.<br>D.water will tend to leave the cell because the interior has a decreased osmolarity.<br>E.the non-penetrating solute will diffuse across the membrane until its concentration is equal on both sides of the membrane.</td>
      <td>A.water will tend to enter the cell because the interior has an increased osmolarity.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>13. Which of the following statements about epithelial cells and epithelial transport is correct? (2.5分)</td>
      <td>A.Epithelial cells are polarized.<br>B.Epithelial cells lining the small intestine have Na,K-ATPase pumps only in their basolateral membranes.<br>C.The "active" component of active transport across epithelial cells occurs only from the lumen side into the cells.<br>D.Both epithelial cells are polarized and epithelial cells lining the small intestine have Na, K -ATPase pumps only in their basolateral membranes are correct.<br>E.Both epithelial cells are polarized and the "active" component of active transport across epithelial cells occurs only from the lumen side into the cells are correct.</td>
      <td>D.Both epithelial cells are polarized and epithelial cells lining the small intestine have Na, K -ATPase pumps only in their basolateral membranes are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>14. During the active transport of glucose across an epithelium, energy is used to (2.5分)</td>
      <td>A.power the Na,K-ATPase pump.<br>B.power the Na -glucose cotransporter.<br>C.synthesize insulin, which is necessary for glucose reabsorption.<br>D.maintain the transport maximum for glucose.<br>E.power the facilitated diffusion of glucose across the basolateral membrane of the epithelial cell.</td>
      <td>B.power the Na -glucose cotransporter.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>15. Compartments A and B are separated by a membrane that is permeable to K+ but not to Cl-. At time zero, a solution of KCl is poured into compartment A and pure H2O is poured into compartment B. At equilibrium, (2.5分)</td>
      <td>A.the concentration of K+ in A will be lower than it was at time zero.<br>B.diffusion of K+ from A to B will be equal to the diffusion of K+ from B to A.<br>C.there will be a potential difference across the membrane, with side A negative relative to side B.<br>D.the electrical and diffusion potentials for K+ will be equal in magnitude and opposite in direction<br>E.All of the choices are correct.</td>
      <td>E.All of the choices are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>16. The resting membrane potential (2.5分)</td>
      <td>A.requires very few ions to be distributed unevenly.<br>B.is the same in all cells.<br>C.is oriented so that the cell's interior is positive with respect to the extracellular fluid.<br>D.occurs only in nerve and muscle cells.<br>E.None of the choices are correct.</td>
      <td>A.requires very few ions to be distributed unevenly.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>17. An increase in the extracellular concentration of K+ above normal would result in (2.5分)</td>
      <td>A.depolarization of resting nerve cells.<br>B.hyperpolarization of resting nerve cells.<br>C.no change in the resting membrane potential.</td>
      <td>A.depolarization of resting nerve cells.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>18. The Na,K-ATPase in a nerve cell (2.5分)</td>
      <td>A.maintains an electrical gradient such that the inside is negative with respect to the outside.<br>B.maintains a concentration gradient for K+ such that diffusion forces favor movement of K+ into the cell.<br>C.maintains an electrical gradient at the equilibrium potential of K+.<br>D.transports an equal number of sodium and potassium ions<br>E.Both maintains an electrical gradient such that the inside is negative with respect to the outside and transports an equal number of sodium and potassium ions are correct.</td>
      <td>A.maintains an electrical gradient such that the inside is negative with respect to the outside.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>19. The equilibrium potential of K ions in nerve cells is about -90 mV. The membrane potential of typical nerve cells at rest is -70 mV. Therefore (2.5分)</td>
      <td>A.increasing the permeability of a resting neuronal membrane to K ions will increase the membrane potential (that is, make it more negative, inside with respect to outside).<br>B.in nerve cells at rest, there is a net diffusion of K ions out of the cell.<br>C.increasing the membrane potential of a nerve cell would slow the diffusion of K ions out of it.<br>D.potassium is not the only permeant ion at rest.<br>E.All of the choices are true.</td>
      <td>E.All of the choices are true.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>20. An action potential in a neuronal membrane differs from a graded potential in that (2.5分)</td>
      <td>A.an action potential requires the opening of Ca+2 channels, whereas a graded potential does not.<br>B.an action potential is propagated without decrement, whereas a graded potential is not.<br>C.an action potential has a threshold and is an all-or-none phenomenon,whereas a graded potential does not have a threshold and is not all-or-none.<br>D.Both an action potential requires the opening of Ca+2 channels, whereas a graded potential does not and an action potential is propagated without decrement, whereas a graded potential is not are correct.<br>E.Both an action potential is propagated without decrement, whereas a graded potential is not and an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is not all-or-none are correct.</td>
      <td>E.Both an action potential is propagated without decrement, whereas a graded potential is not and an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is not all-or-none are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>21. Action potentials are said to be "all-or-none" in character because (2.5分)</td>
      <td>A.the rate of propagation of an action potential down an axon is independent of stimulus strength.<br>B.they are associated with an absolute refractory period.<br>C.a supra-threshold stimulus is required to stimulate an action potential during the relative refractory period.<br>D.the amplitude of an action potential generated in any given neuron is the same, regardless of the stimulus strength.<br>E.All of these statements describe the "all-or-none" character of action potentials.</td>
      <td>D.the amplitude of an action potential generated in any given neuron is the same, regardless of the stimulus strength.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>22. Which of the following statements concerning the rate of action potential propagation is true? (2.5分)</td>
      <td>A.It is faster in large-diameter axons than in small-diameter ones.<br>B.It is faster for a strong stimulus than for a weak one.<br>C.It is faster in myelinated nerve fibers than in nonmyelinated ones.<br>D.Both it is faster in large-diameter axons than in small-diameter ones and it is faster in myelinated nerve fibers than in nonmyelinated ones are true.<br>E.All of the choices are true.</td>
      <td>D.Both it is faster in large-diameter axons than in small-diameter ones and it is faster in myelinated nerve fibers than in nonmyelinated ones are true.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>23. 下列关于细胞信号转导的叙述哪项是不正确的？(2.5分)</td>
      <td>A.不同的信号转导通路之间具有相互联系作用<br>B.细胞受体分为膜受体和核受体<br>C.酪氨酸蛋白激酶型受体属于核受体<br>D.细胞信号转导过程是由细胞内一系列信号转导蛋白的构象、活性或功能变化来实现的<br>E.细胞内信使分子能激活细胞内受体和蛋白激酶</td>
      <td>C.酪氨酸蛋白激酶型受体属于核受体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>24. 信号转导通路对靶蛋白调节最重要的方式是(2.5分)</td>
      <td>A.通过G蛋白调节<br>B.通过可逆性磷酸化调节<br>C.通过配体调节<br>D.通过受体数量调节<br>E.通过受体亲和力调节</td>
      <td>B.通过可逆性磷酸化调节</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>25. 重症肌无力的主要信号转导障碍是(2.5分)</td>
      <td>A.Ach分泌减少<br>B.体内产生抗n-Ach受体的抗体<br>C.Na+通道障碍<br>D.抗体与n-Ach受体结合<br>E.Ach与其受体结合障碍</td>
      <td>B.体内产生抗n-Ach受体的抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>26. 下列关于炎症中信号转导错误的是(2.5分)</td>
      <td>A.TLR4是LPS-LBP-CD14的特异性受体<br>B.NF-kB和MAPK信号通路参与了LPS诱导炎症因子生成的过程<br>C.TNF通路不参与炎症中细胞因子级联反应<br>D.细胞粘附分子介导的信号转导通路参与了炎症细胞向感染部位的迁移<br>E.TLR4下游通路包括MYD88依赖及非依赖途径</td>
      <td>C.TNF通路不参与炎症中细胞因子级联反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>27. 下列关于药物主动转运的叙述，哪一项是错误的？ (2.5分)</td>
      <td>A.需要消耗能量<br>B.可受其他化学品的干扰<br>C.有化学结构特异性<br>D.比被动转运较快达到平衡<br>E.转运速度有饱和限制</td>
      <td>D.比被动转运较快达到平衡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>28. 药物的pKa是指 (2.5分)</td>
      <td>A.药物完全解离时的pH<br>B.药物50％解离时的pH<br>C.药物30％解离时的pH<br>D.药物80％解离时的pH<br>E.药物全部不解离时的pH</td>
      <td>B.药物50％解离时的pH</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>29. 在碱性尿液中弱碱性药物 (2.5分)</td>
      <td>A.解离多，重吸收少，排泄快<br>B.解离少，重吸收多，排泄快<br>C.解离多，重吸收多，排泄快<br>D.解离少，重吸收多，排泄慢<br>E.解离多，重吸收少，排泄慢</td>
      <td>D.解离少，重吸收多，排泄慢</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>30. 药物引起最大效应50%所需的浓度（EC50）用以表示 (2.5分)</td>
      <td>A.效价强度的大小<br>B.最大效应的大小<br>C.安全性的大小<br>D.分布范围的大小<br>E.毒性的大小</td>
      <td>A.效价强度的大小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>31. 药物的首关消除（首过消除）是指 (2.5分)</td>
      <td>A.药物口服后，部分未经吸收即从肠道排出<br>B.药物静脉注射后，部分迅速经肾排泄<br>C.药物口服后，部分迅速经肾排泄<br>D.药物经静脉注射，进入体循环之后，部分在肝脏内消除<br>E.药物口服后，进入体循环之前，部分先在肝脏内消除</td>
      <td>E.药物口服后，进入体循环之前，部分先在肝脏内消除</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>32. 药物A与药物B竞争结合血浆蛋白，合用后药物A (2.5分)</td>
      <td>A.效应增强<br>B.效应减弱<br>C.不影响药物B的效应<br>D.应当加量使用<br>E.用量不必调整</td>
      <td>A.效应增强</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>33. 药物通过肝脏代谢后不会发生 (2.5分)</td>
      <td>A.毒性降低或消失<br>B.作用降低或消失<br>C.分子量减少<br>D.极性增高<br>E.脂溶性加大</td>
      <td>E.脂溶性加大</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>34. 苯巴比妥可使氯丙嗪血药浓度明显降低，这是因为苯巴比妥 (2.5分)</td>
      <td>A.减少氯丙嗪的吸收<br>B.增加氯丙嗪与血浆蛋白结合<br>C.诱导肝药酶，使氯丙嗪代谢增加<br>D.降低氯丙嗪的生物利用度<br>E.扩大氯丙嗪的分布</td>
      <td>C.诱导肝药酶，使氯丙嗪代谢增加</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>35. 部分激动药是指对受体(2.5分)</td>
      <td>A.有亲和力而无内在活性的药物<br>B.有亲和力而内在活性较弱的药物<br>C.有亲和力又有内在活性的药物<br>D.无亲和力但有较强内在活性的药物<br>E.既无亲和力也无内在活性的药物</td>
      <td>B.有亲和力而内在活性较弱的药物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>36. 某药物在口服和静脉注射相同剂量后的时量曲线下面积(AUC)相等，这意味着(2.5分)</td>
      <td>A.口服吸收迅速<br>B.口服吸收完全<br>C.口服和静脉注射可以取得同样生物效应<br>D.口服药物未经肝门脉吸收<br>E.属一房室分布模型</td>
      <td>B.口服吸收完全</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>37. 关于药物的选择性,正确的表述是 (2.5分)</td>
      <td>A.与药物剂量无关<br>B.与药物本身的化学结构有关<br>C.选择性低的药物针对性强<br>D.选择性高的药物副作用多<br>E.选择性与组织亲和力无关</td>
      <td>B.与药物本身的化学结构有关</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>38. 某药在体内按一级动力学消除，在其吸收达高峰后抽血两次，测其血浆浓度分别为150 ?g/ml及18.75 ?g/ml，两次抽血间隔9小时，该药的血浆半衰期是(2.5分)</td>
      <td>A.1小时<br>B.1.5小时<br>C.2小时<br>D.3小时<br>E.4小时</td>
      <td>D.3小时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>39. 负荷剂量是(2.5分)</td>
      <td>A.一半有效血药浓度的剂量<br>B.一半稳态血药浓度的剂量<br>C.达到一定血药浓度的剂量<br>D.达到有效血药浓度的剂量<br>E.维持有效血药浓度的剂量</td>
      <td>D.达到有效血药浓度的剂量</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2013</td>
      <td>40. 安慰剂一般指(2.5分)</td>
      <td>A.由本身没有特殊药理活性的物质（乳糖、淀粉等）制成的外形似药的制剂<br>B.由药理活性较弱的物质制成的制剂<br>C.本身没有特殊作用的医疗措施（如假手术等）<br>D.有一定治疗作用的医疗措施<br>E.对病人做的安慰、鼓励等心理治疗</td>
      <td>A.由本身没有特殊药理活性的物质（乳糖、淀粉等）制成的外形似药的制剂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>1. 核素显像与其它医学影像相比，最大的特点是：(2.5分)</td>
      <td>A.图像质量不同<br>B.价格不同<br>C.显示器官及病变组织的解剖结构和代谢，功能相结合的图象<br>D.计算机不同</td>
      <td>C.显示器官及病变组织的解剖结构和代谢，功能相结合的图象</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>2. TIA的诊断，灵敏度最高的是：(2.5分)</td>
      <td>A.CT<br>B.MRI<br>C.脑灌注显像<br>D.脑脊液显像</td>
      <td>C.脑灌注显像</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>3. 甲状腺显像利用的是：(2.5分)</td>
      <td>A.γ射线<br>B.β射线<br>C.α射线<br>D.γ射线和β射线</td>
      <td>A.γ射线</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>4. 地塞米松抑制试验第一次肾上腺皮质显影增强，第2次与第1次显像比较无明显变化，考虑为：(2.5分)</td>
      <td>A.肾上腺皮质增生<br>B.肾上腺皮质腺瘤<br>C.肾上腺髓质增生<br>D.嗜铬细胞瘤</td>
      <td>B.肾上腺皮质腺瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>5. 既往有完全性左束支传导阻滞(LBBB)病人疑有心肌梗死出现时，既能明确诊断又能了解梗死部位和范围的检查方法是：(2.5分)</td>
      <td>A.心电图<br>B.冠状动脉造影<br>C.亲心肌梗死显像<br>D.心肌酶学检查</td>
      <td>C.亲心肌梗死显像</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>6. Which of the following statements regarding the diffusion of nonpolar solutes across cell membranes is correct? (2.5分)</td>
      <td>A.At equilibrium for solute X, the flux of X across cell membranes is zero.<br>B.At equilibrium for solute X, the net flux of X across cell membranes is zero.<br>C.At equilibrium for solute X, the concentration of X inside the cell is equal to its concentration outside the cell.<br>D.Both at equilibrium for solute X, the flux of X across cell membranes is zero and at equilibrium for solute X, the concentration of X inside the cell is equal to its concentration outside the cell are correct.<br>E.Both at equilibrium for solute X, the net flux of X across cell membranes is zero and at equilibrium for solute X, the concentration of X inside the cell is equal to its concentration outside the cell are correct.</td>
      <td>E.Both at equilibrium for solute X, the net flux of X across cell membranes is zero and at equilibrium for solute X, the concentration of X inside the cell is equal to its concentration outside the cell are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>7. If it takes solute A 1 second to diffuse 1 millimeter, how long will it take solute A to diffuse 10 millimeters under the same conditions? (2.5分)</td>
      <td>A.1 second<br>B.10 seconds<br>C.50 seconds<br>D.100 seconds</td>
      <td>D.100 seconds</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>8. The permeability of the plasma membrane to mineral ions (2.5分)</td>
      <td>A.is dependent upon channels formed by proteins.<br>B.varies from one cell to another.<br>C.is affected by differences in electrical charge on the two sides of the membrane.<br>D.Both is dependent upon channels formed by proteins and is affected by differences in electrical charge on the two sides of the membrane are correct.<br>E.All of the choices are correct.</td>
      <td>E.All of the choices are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>9. Ion channels in cell membranes (2.5分)</td>
      <td>A.are nonspecific.<br>B.may open in response to a change in potential difference across the membrane.<br>C.may open in response to binding a ligand.<br>D.Both are nonspecific and may open in response to a change in potential difference across the membrane are correct.<br>E.Both may open in response to a change in potential difference across the membrane and may open in response to binding a ligand are correct.</td>
      <td>E.Both may open in response to a change in potential difference across the membrane and may open in response to binding a ligand are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>10. Carrier-mediated transport (2.5分)</td>
      <td>A.involves a specific membrane protein that functions as a carrier molecule.<br>B.always involves the movement of substances against a concentration gradient.<br>C.always requires the direct expenditure of energy.<br>D.Both involves a specific membrane protein that functions as a carrier molecule and always involves the movement of substances against a concentration gradient are correct.<br>E.All of the choices are correct.</td>
      <td>A.involves a specific membrane protein that functions as a carrier molecule.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>11. Osmosis refers to the movement of across semi-permeable membranes. (2.5分)</td>
      <td>A.glucose<br>B.charged particles<br>C.lipid molecules<br>D.water<br>E.any substance</td>
      <td>D.water</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>12. If all other conditions remain the same and the concentration of a nonpenetrating solute increases inside a cell, (2.5分)</td>
      <td>A.water will tend to enter the cell because the interior has an increased osmolarity.<br>B.water will tend to leave the cell because the interior has an increased osmolarity.<br>C.water will tend to enter the cell because the interior has a decreased osmolarity.<br>D.water will tend to leave the cell because the interior has a decreased osmolarity.<br>E.the non-penetrating solute will diffuse across the membrane until its concentration is equal on both sides of the membrane.</td>
      <td>A.water will tend to enter the cell because the interior has an increased osmolarity.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>13. Which of the following statements about epithelial cells and epithelial transport is correct? (2.5分)</td>
      <td>A.Epithelial cells are polarized.<br>B.Epithelial cells lining the small intestine have Na,K-ATPase pumps only in their basolateral membranes.<br>C.The "active" component of active transport across epithelial cells occurs only from the lumen side into the cells.<br>D.Both epithelial cells are polarized and epithelial cells lining the small intestine have Na, K -ATPase pumps only in their basolateral membranes are correct.<br>E.Both epithelial cells are polarized and the "active" component of active transport across epithelial cells occurs only from the lumen side into the cells are correct.</td>
      <td>D.Both epithelial cells are polarized and epithelial cells lining the small intestine have Na, K -ATPase pumps only in their basolateral membranes are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>14. During the active transport of glucose across an epithelium, energy is used to (2.5分)</td>
      <td>A.power the Na,K-ATPase pump.<br>B.power the Na -glucose cotransporter.<br>C.synthesize insulin, which is necessary for glucose reabsorption.<br>D.maintain the transport maximum for glucose.<br>E.power the facilitated diffusion of glucose across the basolateral membrane of the epithelial cell.</td>
      <td>B.power the Na -glucose cotransporter.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>15. Compartments A and B are separated by a membrane that is permeable to K+ but not to Cl-. At time zero, a solution of KCl is poured into compartment A and pure H2O is poured into compartment B. At equilibrium, (2.5分)</td>
      <td>A.the concentration of K+ in A will be lower than it was at time zero.<br>B.diffusion of K+ from A to B will be equal to the diffusion of K+ from B to A.<br>C.there will be a potential difference across the membrane, with side A negative relative to side B.<br>D.the electrical and diffusion potentials for K+ will be equal in magnitude and opposite in direction<br>E.All of the choices are correct.</td>
      <td>E.All of the choices are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>16. The resting membrane potential (2.5分)</td>
      <td>A.requires very few ions to be distributed unevenly.<br>B.is the same in all cells.<br>C.is oriented so that the cell's interior is positive with respect to the extracellular fluid.<br>D.occurs only in nerve and muscle cells.<br>E.None of the choices are correct.</td>
      <td>A.requires very few ions to be distributed unevenly.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>17. An increase in the extracellular concentration of K+ above normal would result in (2.5分)</td>
      <td>A.depolarization of resting nerve cells.<br>B.hyperpolarization of resting nerve cells.<br>C.no change in the resting membrane potential.</td>
      <td>A.depolarization of resting nerve cells.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>18. The Na,K-ATPase in a nerve cell (2.5分)</td>
      <td>A.maintains an electrical gradient such that the inside is negative with respect to the outside.<br>B.maintains a concentration gradient for K+ such that diffusion forces favor movement of K+ into the cell.<br>C.maintains an electrical gradient at the equilibrium potential of K+.<br>D.transports an equal number of sodium and potassium ions<br>E.Both maintains an electrical gradient such that the inside is negative with respect to the outside and transports an equal number of sodium and potassium ions are correct.</td>
      <td>A.maintains an electrical gradient such that the inside is negative with respect to the outside.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>19. The equilibrium potential of K ions in nerve cells is about -90 mV. The membrane potential of typical nerve cells at rest is -70 mV. Therefore (2.5分)</td>
      <td>A.increasing the permeability of a resting neuronal membrane to K ions will increase the membrane potential (that is, make it more negative, inside with respect to outside).<br>B.in nerve cells at rest, there is a net diffusion of K ions out of the cell.<br>C.increasing the membrane potential of a nerve cell would slow the diffusion of K ions out of it.<br>D.potassium is not the only permeant ion at rest.<br>E.All of the choices are true.</td>
      <td>E.All of the choices are true.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>20. An action potential in a neuronal membrane differs from a graded potential in that (2.5分)</td>
      <td>A.an action potential requires the opening of Ca+2 channels, whereas a graded potential does not.<br>B.an action potential is propagated without decrement, whereas a graded potential is not.<br>C.an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is not all-or-none.<br>D.Both an action potential requires the opening of Ca+2 channels, whereas a graded potential does not and an action potential is propagated without decrement, whereas a graded potential is not are correct.<br>E.Both an action potential is propagated without decrement, whereas a graded potential is not and an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is no all-or-none are correct.</td>
      <td>E.Both an action potential is propagated without decrement, whereas a graded potential is not and an action potential has a threshold and is an all-or-none phenomenon, whereas a graded potential does not have a threshold and is no all-or-none are correct.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>21. Action potentials are said to be "all-or-none" in character because (2.5分)</td>
      <td>A.the rate of propagation of an action potential down an axon is independent of stimulus strength.<br>B.they are associated with an absolute refractory period.<br>C.a supra-threshold stimulus is required to stimulate an action potential during the relative refractory period.<br>D.the amplitude of an action potential generated in any given neuron is the same, regardless of the stimulus strength.<br>E.All of these statements describe the "all-or-none" character of action potentials.</td>
      <td>D.the amplitude of an action potential generated in any given neuron is the same, regardless of the stimulus strength.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>22. Which of the following statements concerning the rate of action potential propagation is true? (2.5分)</td>
      <td>A.It is faster in large-diameter axons than in small-diameter ones.<br>B.It is faster for a strong stimulus than for a weak one.<br>C.It is faster in myelinated nerve fibers than in nonmyelinated ones.<br>D.Both it is faster in large-diameter axons than in small-diameter ones and it is faster in myelinated nerve fibers than in nonmyelinated ones are true.<br>E.All of the choices are true.</td>
      <td>D.Both it is faster in large-diameter axons than in small-diameter ones and it is faster in myelinated nerve fibers than in nonmyelinated ones are true.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>23. 下列关于细胞信号转导的叙述哪项是不正确的？(2.5分)</td>
      <td>A.不同的信号转导通路之间具有相互联系作用<br>B.细胞受体分为膜受体和核受体<br>C.酪氨酸蛋白激酶型受体属于核受体<br>D.细胞信号转导过程是由细胞内一系列信号转导蛋白的构象、活性或功能变化来实现的<br>E.细胞内信使分子能激活细胞内受体和蛋白激酶</td>
      <td>C.酪氨酸蛋白激酶型受体属于核受体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>24. 信号转导通路对靶蛋白调节最重要的方式是(2.5分)</td>
      <td>A.通过G蛋白调节<br>B.通过可逆性磷酸化调节<br>C.通过配体调节<br>D.通过受体数量调节<br>E.通过受体亲和力调节</td>
      <td>B.通过可逆性磷酸化调节</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>25. 重症肌无力的主要信号转导障碍是(2.5分)</td>
      <td>A.Ach分泌减少<br>B.体内产生抗n-Ach受体的抗体<br>C.Na+通道障碍<br>D.抗体与n-Ach受体结合<br>E.Ach与其受体结合障碍</td>
      <td>B.体内产生抗n-Ach受体的抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>26. 下列关于炎症中信号转导错误的是(2.5分)</td>
      <td>A.TLR4是LPS-LBP-CD14的特异性受体<br>B.NF-kB和MAPK信号通路参与了LPS诱导炎症因子生成的过程<br>C.TNF通路不参与炎症中细胞因子级联反应<br>D.细胞粘附分子介导的信号转导通路参与了炎症细胞向感染部位的迁移<br>E.TLR4下游通路包括MYD88依赖及非依赖途径</td>
      <td>C.TNF通路不参与炎症中细胞因子级联反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>27. 下列关于药物主动转运的叙述，哪一项是错误的？ (2.5分)</td>
      <td>A.需要消耗能量<br>B.可受其他化学品的干扰<br>C.有化学结构特异性<br>D.比被动转运较快达到平衡<br>E.转运速度有饱和限制</td>
      <td>D.比被动转运较快达到平衡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>28. 药物的pKa是指 (2.5分)</td>
      <td>A.药物完全解离时的pH<br>B.药物50％解离时的pH<br>C.药物30％解离时的pH<br>D.药物80％解离时的pH<br>E.药物全部不解离时的pH</td>
      <td>B.药物50％解离时的pH</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>29. 在碱性尿液中弱碱性药物 (2.5分)</td>
      <td>A.解离多，重吸收少，排泄快<br>B.解离少，重吸收多，排泄快<br>C.解离多，重吸收多，排泄快<br>D.解离少，重吸收多，排泄慢<br>E.解离多，重吸收少，排泄慢</td>
      <td>D.解离少，重吸收多，排泄慢</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>30. 药物引起最大效应50%所需的浓度（EC50）用以表示 (2.5分)</td>
      <td>A.效价强度的大小<br>B.最大效应的大小<br>C.安全性的大小<br>D.分布范围的大小<br>E.毒性的大小</td>
      <td>A.效价强度的大小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>31. 药物的首关消除（首过消除）是指 (2.5分)</td>
      <td>A.药物口服后，部分未经吸收即从肠道排出<br>B.药物静脉注射后，部分迅速经肾排泄<br>C.药物口服后，部分迅速经肾排泄<br>D.药物经静脉注射，进入体循环之后，部分在肝脏内消除<br>E.药物口服后，进入体循环之前，部分先在肝脏内消除</td>
      <td>E.药物口服后，进入体循环之前，部分先在肝脏内消除</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>32. 药物A与药物B竞争结合血浆蛋白，合用后药物A (2.5分)</td>
      <td>A.效应增强<br>B.效应减弱<br>C.不影响药物B的效应<br>D.应当加量使用<br>E.用量不必调整</td>
      <td>A.效应增强</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>33. 药物通过肝脏代谢后不会发生 (2.5分)</td>
      <td>A.毒性降低或消失<br>B.作用降低或消失<br>C.分子量减少<br>D.极性增高<br>E.脂溶性加大</td>
      <td>E.脂溶性加大</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>34. 苯巴比妥可使氯丙嗪血药浓度明显降低，这是因为苯巴比妥(2.5分)</td>
      <td>A.减少氯丙嗪的吸收<br>B.增加氯丙嗪与血浆蛋白结合<br>C.诱导肝药酶，使氯丙嗪代谢增加<br>D.降低氯丙嗪的生物利用度<br>E.扩大氯丙嗪的分布</td>
      <td>C.诱导肝药酶，使氯丙嗪代谢增加</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>35. 部分激动药是指对受体(2.5分)</td>
      <td>A.有亲和力而无内在活性的药物<br>B.有亲和力而内在活性较弱的药物<br>C.有亲和力又有内在活性的药物<br>D.无亲和力但有较强内在活性的药物<br>E.既无亲和力也无内在活性的药物</td>
      <td>B.有亲和力而内在活性较弱的药物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>36. 某药物在口服和静脉注射相同剂量后的时量曲线下面积(AUC)相等，这意味着(2.5分)</td>
      <td>A.口服吸收迅速<br>B.口服吸收完全<br>C.口服和静脉注射可以取得同样生物效应<br>D.口服药物未经肝门脉吸收<br>E.属一房室分布模型</td>
      <td>B.口服吸收完全</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>37. 关于药物的选择性,正确的表述是 (2.5分)</td>
      <td>A.与药物剂量无关<br>B.与药物本身的化学结构有关<br>C.选择性低的药物针对性强<br>D.选择性高的药物副作用多<br>E.选择性与组织亲和力无关</td>
      <td>B.与药物本身的化学结构有关</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>38. 某药在体内按一级动力学消除，在其吸收达高峰后抽血两次，测其血浆浓度分别为150g/ml及18.75 ?g/ml，两次抽血间隔9小时，该药的血浆半衰期是(2.5分)</td>
      <td>A.1小时<br>B.1.5小时<br>C.2小时<br>D.3小时<br>E.4小时</td>
      <td>D.3小时</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>39. 负荷剂量是(2.5分)</td>
      <td>A.一半有效血药浓度的剂量<br>B.一半稳态血药浓度的剂量<br>C.达到一定血药浓度的剂量<br>D.达到有效血药浓度的剂量<br>E.维持有效血药浓度的剂量</td>
      <td>D.达到有效血药浓度的剂量</td>
    </tr>
    <tr>
      <td>1</td>
      <td>3</td>
      <td>2014</td>
      <td>40. 安慰剂一般指(2.5分)</td>
      <td>A.由本身没有特殊药理活性的物质（乳糖、淀粉等）制成的外形似药的制剂<br>B.由药理活性较弱的物质制成的制剂<br>C.本身没有特殊作用的医疗措施（如假手术等）<br>D.有一定治疗作用的医疗措施<br>E.对病人做的安慰、鼓励等心理治疗</td>
      <td>A.由本身没有特殊药理活性的物质（乳糖、淀粉等）制成的外形似药的制剂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>1. 关于萎缩哪项是错误的： (2.0分)</td>
      <td>A.营养缺乏供血不足等均可引起萎缩<br>B.凡是比正常小的器官组织或细胞<br>C.可以恢复<br>D.间质不减少，有时可增生<br>E.重量减轻</td>
      <td>B.凡是比正常小的器官组织或细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>2. 全身营养不良时，首先发生萎缩的组织是 (2.0分)</td>
      <td>A.脂肪组织<br>B.肝实质<br>C.骨骼肌<br>D.心肌<br>E.脑组织</td>
      <td>A.脂肪组织</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>3. 下列哪项属生理性萎缩？ (2.0分)</td>
      <td>A.垂体功能低下引起的肾上腺萎缩<br>B.垂体坏死引起的乳腺萎缩<br>C.授乳后乳腺组织的复旧<br>D.小儿麻痹症引起的下肢萎缩<br>E.动脉粥样硬化引起的脑萎缩</td>
      <td>C.授乳后乳腺组织的复旧</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>4. 萎缩是指： (2.0分)</td>
      <td>A.细胞体积比正常小<br>B.由于器官、组织发育不良致器官体积比正常小<br>C.由于组织、细胞大量破坏而体积缩小<br>D.器官体积比正常小<br>E.发育正常的器官、组织、细胞体积变小</td>
      <td>E.发育正常的器官、组织、细胞体积变小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>5. 脂褐素的形成累及哪一个细胞器？(2.0分)</td>
      <td>A.线粒体<br>B.粗面内质网<br>C.高尔基器<br>D.光面内质网<br>E.溶酶体</td>
      <td>E.溶酶体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>6. 下列哪项属代偿性肥大？(2.0分)</td>
      <td>A.哺乳期乳腺<br>B.妊娠子宫<br>C.甲状腺机能亢进患者的甲状腺肿大<br>D.地方性甲状腺肿<br>E.一侧肾切除、对侧肾肿大</td>
      <td>E.一侧肾切除、对侧肾肿大</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>7. 下列那项属代偿性肥大？ (2.0分)</td>
      <td>A.慢性扁桃体炎时的扁桃体肥大<br>B.缺碘所致的甲状腺肥大<br>C.老年性前列腺肥大<br>D.高血压时左心室向心性肥大<br>E.肺气肿时肺体积增大</td>
      <td>D.高血压时左心室向心性肥大</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>8. 支气管粘膜上皮出现鳞状上皮属于？(2.0分)</td>
      <td>A.分化不良<br>B.不完全再生<br>C.不典型增生<br>D.癌初期改变<br>E.适应性改变</td>
      <td>E.适应性改变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>9. 一种分化成熟的组织转变为另一种分化成熟的组织称(2.0分)</td>
      <td>A.再生<br>B.增生<br>C.机化<br>D.分化<br>E.化生</td>
      <td>E.化生</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>10. 男，50岁，有长期吸烟史，因发热咳痰入院。痰检发现，痰内脱落的气管粘膜上皮部分为鳞状上皮，细胞无异型性，此病变可能为：(2.0分)</td>
      <td>A.气管上皮的鳞状化生<br>B.气管上皮的异型增生<br>C.气管上皮先天性发育异常<br>D.气管上皮的食管上皮化生<br>E.以上都不是</td>
      <td>A.气管上皮的鳞状化生</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>11. 细胞和组织的损伤性变化是： (2.0分)</td>
      <td>A.化生<br>B.增生<br>C.肥大<br>D.变性<br>E.再生</td>
      <td>D.变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>12. 男, 28岁，因肝肿大, 肝功能异常而入院。 临床诊断为急性普通型肝炎, 此时患者肝的病变最可能是： (2.0分)</td>
      <td>A.肝细胞透明变性<br>B.肝细胞大片坏死<br>C.肝细胞气球样变<br>D.肝细胞碎片状坏死<br>E.以上都不是</td>
      <td>C.肝细胞气球样变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>13. 下列哪一种变性最轻:(2.0分)</td>
      <td>A.细胞水肿<br>B.脂肪变性<br>C.粘液样变性<br>D.纤维素样变性<br>E.玻璃样变性</td>
      <td>A.细胞水肿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>14. 肾近曲小管细胞水肿时，细胞浆内细小颗粒是：(2.0分)</td>
      <td>A.扩张的高尔基体<br>B.脱落的核糖体<br>C.凝固的蛋白质<br>D.增多的溶酶体<br>E.肿胀的线粒体和扩张的内质网</td>
      <td>E.肿胀的线粒体和扩张的内质网</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>15. 最常见的变性是：(2.0分)</td>
      <td>A.脂肪变性<br>B.细胞水肿<br>C.玻璃样变性<br>D.纤维素样变性<br>E.粘液样变性</td>
      <td>B.细胞水肿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>16. 细胞水肿和脂肪变性主要发生在： (2.0分)</td>
      <td>A.心，肝，肾<br>B.肺，脾，肾<br>C.肝，肾，脾<br>D.心，脾，肺<br>E.心，肝，胃</td>
      <td>A.心，肝，肾</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>17. 细胞水肿常见于：(2.0分)</td>
      <td>A.肝细胞<br>B.脂肪细胞<br>C.纤维细胞<br>D.神经细胞<br>E.中性粒细胞</td>
      <td>A.肝细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>18. 气球样变的肝细胞中，下列哪项改变是错误的 (2.0分)</td>
      <td>A.内质网扩张囊泡变<br>B.细胞内糖原增多<br>C.细胞内水分增多<br>D.线粒体肿胀，嵴消失<br>E.核蛋白体颗粒脱失</td>
      <td>B.细胞内糖原增多</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>19. 易发生干性坏疽的器官是(2.0分)</td>
      <td>A.肠道<br>B.四肢<br>C.心肌<br>D.肺<br>E.子宫</td>
      <td>B.四肢</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>20. 电镜下，脂肪变性的脂滴形成于 (2.0分)</td>
      <td>A.溶酶体内<br>B.线粒体内<br>C.高尔基器内<br>D.内质网中<br>E.胞核中</td>
      <td>D.内质网中</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>21. 梗死后液化性坏死常见于 (2.0分)</td>
      <td>A.心<br>B.肾<br>C.脑<br>D.肺<br>E.肝</td>
      <td>C.脑</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>22. 虎斑心是指：(2.0分)</td>
      <td>A.心肌细胞脂肪变性<br>B.心肌细胞水样变性<br>C.心肌细胞凝固性坏死<br>D.心肌间脂肪组织浸润<br>E.心肌细胞内脂褐素沉着</td>
      <td>A.心肌细胞脂肪变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>23. 脂肪变性时,苏丹Ⅲ染色可将细胞内的脂滴染成:-(2.0分)</td>
      <td>A.黑色<br>B.橘红色<br>C.蓝色<br>D.黄色<br>E.棕色</td>
      <td>B.橘红色</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>24. 玻璃样变性不会发生于：(2.0分)</td>
      <td>A.肾小球肾炎的近曲小管上皮细胞<br>B.高血压病人的细动脉壁<br>C.纤维化的肾小球<br>D.陈旧的纤维瘢痕组织<br>E.以上都不是</td>
      <td>E.以上都不是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>25. 关于玻璃样变性, 下列哪项是错误的? (2.0分)</td>
      <td>A.可发生于浆细胞<br>B.可发生于血管壁<br>C.可发生于结缔组织<br>D.可发生于肝细胞<br>E.可发生于肾远曲小管上皮细胞</td>
      <td>E.可发生于肾远曲小管上皮细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>26. 血管壁的玻璃样变性主要发生在：(2.0分)</td>
      <td>A.小动脉<br>B.大动脉<br>C.中等动脉<br>D.静脉<br>E.细动脉</td>
      <td>E.细动脉</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>27. 关于结缔组织玻璃样变, 下列哪项是错误的?-(2.0分)</td>
      <td>A.可见于粥瘤<br>B. 常见于瘢痕组织<br>C.可见于纤维化肾小球<br>D.胶原纤维融合为梁状透明样物质<br>E.纤维母细胞增多</td>
      <td>E.纤维母细胞增多</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>28. 女, 40岁, 有数十年肾炎病史, 近来症状加重, 多尿,夜尿,查体患者呈贫血貌,高血压。此时肾小球可能出现何种病变: (2.0分)</td>
      <td>A.弥漫性肾小球内细胞增生<br>B.部分肾小球纤维化玻璃样变性<br>C.弥漫性肾小球系膜细胞和基质增生<br>D.肾小球基底膜增厚<br>E.以上都不是</td>
      <td>B.部分肾小球纤维化玻璃样变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>29. 风湿病结缔组织病变是:(2.0分)</td>
      <td>A.玻璃样变性<br>B.纤维素样坏死<br>C.水样变性<br>D.脂肪变性<br>E.嗜酸性变性</td>
      <td>B.纤维素样坏死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>30. 结核病坏死属于:(2.0分)</td>
      <td>A.纤维素样坏死<br>B.液化性坏死<br>C.干酪样坏死<br>D.凝固性坏死<br>E.溶解坏死</td>
      <td>A.纤维素样坏死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>31. 坏死细胞结构消失，但早期组织结构的轮廓依然存在，这种改变称为：(2.0分)</td>
      <td>A.液化性坏死<br>B.干酪样坏死<br>C.脂肪坏死<br>D.坏疽<br>E.凝固性坏死</td>
      <td>E.凝固性坏死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>32. 不属于液化性坏死的有：(2.0分)</td>
      <td>A.阿米巴肝脓肿<br>B.脂肪坏死<br>C.心肌梗死<br>D.脑梗死<br>E.葡萄球菌引起的脓肿</td>
      <td>C.心肌梗死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>33. 下述哪项不符合干酪样坏死?(2.0分)</td>
      <td>A.淡黄色、质地松软<br>B.镜下呈红染、颗粒状、无结构的物质<br>C.含有多量脂质<br>D.由结核杆菌引起<br>E.可见原有组织结构轮廓</td>
      <td>E.可见原有组织结构轮廓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>34. 下列哪种坏死后果严重, 需紧急处理? (2.0分)</td>
      <td>A.下肢干性坏疽<br>B.乳房脂肪坏死<br>C.臀部气性坏疽<br>D.肾局灶性梗死<br>E.脾梗死</td>
      <td>C.臀部气性坏疽</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>35. 男, 70岁, 有长期高血压病史，近几年来经常发生心前区疼痛，诊断为心绞痛。现出现跛行,左下肢第一足趾渐变黑、变硬、变干，此足趾病变可能为:(2.0分)</td>
      <td>A.出血性梗死<br>B.干性坏疽<br>C.液化性坏死<br>D.黑色素瘤<br>E.以上都不是</td>
      <td>B.干性坏疽</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>36. 区别组织坏死和死后自溶的可靠根据是(2.0分)</td>
      <td>A.电镜下细胞器破坏与否<br>B.细胞体积是否肿胀<br>C.组织轮廓存在与否<br>D.细胞核是否溶解消失<br>E.病变周围有无炎症反应</td>
      <td>E.病变周围有无炎症反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>37. 坏死和坏疽的主要区别在于：(2.0分)</td>
      <td>A.动脉阻塞的程度<br>B.有无腐败菌感染<br>C.静脉有无淤血<br>D.发生部位<br>E.病变深</td>
      <td>B.有无腐败菌感染</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>38. 关于坏死组织本身的结局，下列哪种是错误的？ (2.0分)</td>
      <td>A.分离排出<br>B.机化<br>C.溶解吸收<br>D.化生<br>E.包裹钙化</td>
      <td>D.化生</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>39. 判断组织或细胞是否坏死的主要依据是：(2.0分)</td>
      <td>A.细胞膜的改变<br>B.细胞核的改变<br>C.细胞间质的改变<br>D.细胞浆的改变<br>E.细胞器的改变</td>
      <td>B.细胞核的改变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>40. 关于坏死, 下列哪项是正确的?(2.0分)</td>
      <td>A.坏死是指活体内局部组织、细胞死亡后出现的形态学改变<br>B.坏死类型之一是细胞凋亡<br>C.坏死是指局部组织、细胞的死亡<br>D.坏死是指机体死亡后组织、细胞出现的形态学改变<br>E.坏死是可复性改变</td>
      <td>A.坏死是指活体内局部组织、细胞死亡后出现的形态学改变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>41. 关于脂肪变性记述中，下列哪一项是正确的：(2.0分)</td>
      <td>A.贫血时心肌脂肪变性呈弥漫分布<br>B.脂性肾病，肾小管上皮脂肪变性不明显<br>C.磷中毒时肝脂肪变性主要分布于小叶中央区<br>D.慢性肝淤血脂肪变性首先位于小叶中央区<br>E.白喉外毒素不能引起心肌弥漫性脂肪变性</td>
      <td>D.慢性肝淤血脂肪变性首先位于小叶中央区</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>42. 细胞脂肪变可用下列何种特殊染色加以证明? (2.0分)</td>
      <td>A.PAS<br>B.苏丹III<br>C.抗酸染色<br>D.刚果红<br>E.von Gieson染色</td>
      <td>B.苏丹III</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>43. 下列哪种器官的坏死容易发生液化？ (2.0分)</td>
      <td>A.肾<br>B.心<br>C.脑<br>D.肝<br>E.脾</td>
      <td>C.脑</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>44. 脂肪坏死常见于(2.0分)</td>
      <td>A.丙型肝炎<br>B.急性胰腺炎<br>C.糖尿病<br>D.风湿性心肌炎<br>E.甲状腺髓样癌</td>
      <td>B.急性胰腺炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>45. 下列病变发生于心肌细胞的是(2.0分)</td>
      <td>A.玻璃样变<br>B.纤维蛋白样变<br>C.脂肪心<br>D.粘液样变<br>E.虎斑心</td>
      <td>E.虎斑心</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>46. 形态上不属于玻璃样变者(2.0分)</td>
      <td>A.高血压细动脉硬化<br>B.Mallory小体<br>C.瘢痕<br>D.II型糖尿病胰岛间出现均质红染物质<br>E.Russell小体</td>
      <td>D.II型糖尿病胰岛间出现均质红染物质</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>47. 凝固性坏死的形态特点不包括(2.0分)</td>
      <td>A.细胞核消失<br>B.好发于肠、脑等<br>C.一定时间内细胞与组织轮廓保留<br>D.好发于心肌、脾、肾等<br>E.病灶周围可有炎性充血出血反应</td>
      <td>B.好发于肠、脑等</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>48. 干性坏疽与湿性坏疽的区别不包括 (2.0分)</td>
      <td>A.腐败性改变轻<br>B.多发生于同皮肤或与外界相通的内脏器官<br>C.病变干燥，<br>D.动脉阻塞，而静脉回流通畅<br>E.与周围组织有明显分界</td>
      <td>B.多发生于同皮肤或与外界相通的内脏器官</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>49. 鉴别组织坏死和死后自溶的主要形态学依据(2.0分)</td>
      <td>A.是否伴有炎症反应<br>B.是否伴有腐败菌感染<br>C.组织的基本轮廓是否保留<br>D.细胞核消失与否<br>E.形态改变的范围</td>
      <td>A.是否伴有炎症反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2007</td>
      <td>50. 胆囊粘膜固有层内大量泡沫细胞聚集，称为(2.0分)</td>
      <td>A.脂肪变<br>B.脂斑<br>C.脂性肉芽肿<br>D.胆固醇沉积症<br>E.黄色瘤</td>
      <td>D.胆固醇沉积症</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>1. 在细胞周期运行过程中的"分子警察"指的是 (3.0分)</td>
      <td>A.Fas<br>B.Bcl-2<br>C.p53<br>D.Fas-L<br>E.Bcl-XL</td>
      <td>C.p53</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>2. 细胞增殖周期的顺序依次是 (3.0分)</td>
      <td>A.G1→M→G2→S<br>B.G1→G2→M→S<br>C.M→G1→G2→S<br>D.S→G1→M→G2<br>E.G1→S→G2→M</td>
      <td>E.G1→S→G2→M</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>3. CDK的中文全称是 (3.0分)</td>
      <td>A.周期素<br>B.周期素依赖性激酶<br>C. 周期素依赖性激酶抑制因子<br>D. 泛素<br>E. 细胞因子</td>
      <td>B.周期素依赖性激酶</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>4. 与儿童的视网膜母细胞瘤的发生密切相关的基因是 (3.0分)</td>
      <td>A. P53<br>B. Myc<br>C. P16<br>D. RB<br>E.Ras</td>
      <td>D. RB</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>5. Cyclin发挥作用是作为 (3.0分)</td>
      <td>A.调节亚基<br>B.催化亚基<br>C.细胞微环境<br>D.检查点<br>E.增殖细胞核抗原（PCNA）</td>
      <td>A.调节亚基</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>6. 转化生长因子β（TGF-β）属于 (3.0分)</td>
      <td>A. 细胞周期的驱动力改变<br>B. 增殖抑制信号<br>C.增殖信号<br>D.肿瘤<br>E.CDK活性增高</td>
      <td>B. 增殖抑制信号</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>7. 属于癌基因表达产物的是 (3.0分)</td>
      <td>A.Cyclin<br>B.P27kip1<br>C. CDI<br>D. P53<br>E. P21kip1</td>
      <td>A.Cyclin</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>8. 有关细胞调亡的特征下列哪一项是错误的 (3.0分)</td>
      <td>A.由较弱刺激触发，可见于生理或病理情况<br>B.DNA片段化电泳时呈"梯"状条带<br>C.溶酶体相对完整，局部无炎症反应<br>D.主动过程，耗能，无需新蛋白合成<br>E.胞膜皱缩内陷，分割胞浆成凋亡小体</td>
      <td>D.主动过程，耗能，无需新蛋白合成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>9. 下列分子不参与死亡受体通路的有(3.0分)</td>
      <td>A.Fas<br>B.FADD<br>C.caspase-8<br>D.caspase-3<br>E.AIF</td>
      <td>E.AIF</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>10. 下述哪个过程属于细胞凋亡现象(3.0分)</td>
      <td>A.开水引起的皮肤烫伤<br>B.人胚胎过程中指/趾间隙的形成<br>C.毒物中毒引起的细胞死亡<br>D.强酸、强碱引起的损伤<br>E.急性缺血时细胞的死亡</td>
      <td>B.人胚胎过程中指/趾间隙的形成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>11. 细胞凋亡过度性疾病有 (3.0分)</td>
      <td>A.老年性痴呆<br>B.肺癌<br>C.原发性肝癌<br>D.自身免疫病<br>E.疱疹病毒感染</td>
      <td>A.老年性痴呆</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>12. 肾近曲小管细胞水肿时，细胞浆内细小颗粒是：(3.0分)</td>
      <td>A.扩张的高尔基体<br>B.脱落的核糖体<br>C.增多的溶酶体<br>D.凝固的蛋白质<br>E.肿胀的线粒体和扩张的内质网</td>
      <td>E.肿胀的线粒体和扩张的内质网</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>13. 水样变性和脂肪变性主要发生在：(3.0分)</td>
      <td>A.肺，脾，肾<br>B.心，肝，肾<br>C.肝，肾，脾<br>D.心，脾，肺<br>E.心，肝，胃</td>
      <td>B.心，肝，肾</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>14. 气球样变的肝细胞中，下列哪项改变是错误的：(3.0分)</td>
      <td>A.细胞内水分增多<br>B.细胞内糖原增多<br>C.内质网扩张囊泡变<br>D.线粒体肿胀，嵴消失<br>E.核蛋白体颗粒脱失</td>
      <td>B.细胞内糖原增多</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>15. 易发生干性坏疽的器官是：(4.0分)</td>
      <td>A.肺<br>B.四肢<br>C.心肌<br>D.肠道<br>E.子宫</td>
      <td>B.四肢</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>16. 下列哪一种变性最轻: (3.0分)</td>
      <td>A.细胞水肿<br>B.粘液样变性<br>C.脂肪变性<br>D.纤维素样变性<br>E.玻璃样变性</td>
      <td>A.细胞水肿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>17. 梗死后液化性坏死常见于 (3.0分)</td>
      <td>A.肺<br>B.肾<br>C.脑<br>D.心<br>E.肝</td>
      <td>C.脑</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>18. 虎斑心是指：(3.0分)</td>
      <td>A.心肌细胞凝固性坏死<br>B.心肌细胞水样变性<br>C.心肌细胞脂肪变性<br>D.心肌间脂肪组织浸润<br>E.心肌细胞内脂褐素沉着</td>
      <td>C.心肌细胞脂肪变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>19. 脂肪变性时,苏丹Ⅲ染色可将细胞内的脂滴染成: (3.0分)</td>
      <td>A.黑色<br>B.蓝色<br>C.橘红色<br>D.黄色<br>E.棕色</td>
      <td>C.橘红色</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>20. 玻璃样变性不会发生于：(3.0分)</td>
      <td>A.陈旧的纤维瘢痕组织<br>B.高血压病人的细动脉壁<br>C.纤维化的肾小球<br>D.肾小球肾炎的近曲小管上皮细胞<br>E.以上都不是</td>
      <td>E.以上都不是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>21. 下述哪项不符合干酪样坏死? (3.0分)</td>
      <td>A.由结核杆菌引起<br>B.淡黄色、质地松软<br>C.镜下呈红染、颗粒状、无结构的物质<br>D.含有多量脂质<br>E.可见原有组织结构轮廓</td>
      <td>E.可见原有组织结构轮廓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>22. 结核病坏死属于:(3.0分)</td>
      <td>A.凝固性坏死<br>B.液化性坏死<br>C.干酪样坏死<br>D.纤维素样坏死<br>E.溶解坏死</td>
      <td>C.干酪样坏死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>23. 区别组织坏死和死后自溶的可靠根据是 (3.0分)</td>
      <td>A.组织轮廓存在与否<br>B.细胞体积是否肿胀<br>C.电镜下细胞器破坏与否<br>D.细胞核是否溶解消失<br>E.病变周围有无炎症反应</td>
      <td>E.病变周围有无炎症反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>24. 营养不良时,首先发生萎缩的组织或器官是(3.0分)</td>
      <td>A.肌肉组织<br>B.脂肪组织<br>C.肝、肾<br>D.脑<br>E.心肌</td>
      <td>B.脂肪组织</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>25. 心肌细胞不会发生(3.0分)</td>
      <td>A.萎缩<br>B.变性<br>C.坏死<br>D.增生<br>E.肥大</td>
      <td>D.增生</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>26. 脂肪心和虎斑心的区别在于(3.0分)</td>
      <td>A.脂肪的质不同<br>B.脂肪的量不同<br>C.脂肪存在的部位不同<br>D.脂肪的质和量均不同<br>E. 一与脂肪代谢有关，一与脂肪代谢无关</td>
      <td>C.脂肪存在的部位不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>27. 细胞水肿好发生于肝 心、 肾，这是由于这些脏器(3.0分)</td>
      <td>A.容易发生缺氧<br>B.容易发生中毒<br>C.容易发生感染<br>D.实质细胞富于溶酶体<br>E.实质细胞富于线粒体,代谢旺盛</td>
      <td>E.实质细胞富于线粒体,代谢旺盛</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>28. 老年性色素为(3.0分)</td>
      <td>A.含铁血黄素<br>B.脂褐素<br>C.黑色素<br>D.外源性色素<br>E.胆红素</td>
      <td>B.脂褐素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>29. 不属于细胞、组织的适应性变化的病变是(3.0分)</td>
      <td>A.萎缩<br>B.发育不全<br>C.肥大<br>D.增生<br>E.化生</td>
      <td>B.发育不全</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>30. 下述哪种肿瘤的发生可能与化生有关(3.0分)</td>
      <td>A.皮肤鳞状细胞癌<br>B.肾盂移行细胞癌<br>C.大肠黏液腺癌<br>D.肝胆管上皮癌<br>E.肠型胃癌</td>
      <td>E.肠型胃癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>31. 肉眼观察肉芽组织呈颗粒状是因为 (3.0分)</td>
      <td>A.大量炎细胞灶性聚集<br>B.新生的毛细血管灶性聚集<br>C.表面的毛细血管网呈袢状弯曲<br>D.感染、炎性水肿引起<br>E.成纤维细胞灶性聚集</td>
      <td>C.表面的毛细血管网呈袢状弯曲</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>32. 病理性钙化病灶肉眼观察时，下列哪项描述是正确的(3.0分)</td>
      <td>A.灰白色颗粒状<br>B.暗红色颗粒状<br>C.蓝色颗粒状<br>D.黑色炭末样<br>E.土黄色颗粒状</td>
      <td>A.灰白色颗粒状</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2009</td>
      <td>33. Metaplasia, the transformation of fully differentiated tissue into another, is not detected in:(3.0分)</td>
      <td>A.connective tissue elements<br>B.the gastrointestinal tract<br>C.the central nervous system<br>D.the biliary system<br>E.the urothelium</td>
      <td>C.the central nervous system</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>1. 细胞周期运行过程中的"分子警察"指的是 (3.0分)</td>
      <td>A.Fas<br>B.Bcl-2<br>C.p53<br>D.Fas-L<br>E.Bcl-XL</td>
      <td>C.p53</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>2. 属于癌基因表达产物的是(3.0分)</td>
      <td>A.Cyclin<br>B.P27kip1<br>C.CDI<br>D.P53<br>E.P21kip1</td>
      <td>A.Cyclin</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>3. 下述哪个过程属于细胞凋亡现象 (3.0分)</td>
      <td>A.开水引起的皮肤烫伤<br>B.人胚胎过程中指/趾间隙的形成<br>C.毒物中毒引起的细胞死亡<br>D.强酸、强碱引起的损伤<br>E.急性缺血时细胞的死亡</td>
      <td>B.人胚胎过程中指/趾间隙的形成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>4. CDK的中文全称是(3.0分)</td>
      <td>A.周期素<br>B.周期素依赖性激酶<br>C.周期素依赖性激酶抑制因子<br>D.泛素<br>E.细胞因子</td>
      <td>B.周期素依赖性激酶</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>5. 有关细胞调亡的特征下列哪一项是错误的 (3.0分)</td>
      <td>A.由较弱刺激触发，可见于生理或病理情况<br>B.DNA片段化电泳时呈"梯"状条带<br>C.溶酶体相对完整，局部无炎症反应<br>D.主动过程，耗能，无需新蛋白合成<br>E.胞膜皱缩内陷，分割胞浆成凋亡小体</td>
      <td>D.主动过程，耗能，无需新蛋白合成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>6. 肾近曲小管细胞水肿时，细胞浆内细小颗粒是(3.0分)</td>
      <td>A.扩张的高尔基体<br>B.脱落的核糖体<br>C.增多的溶酶体<br>D.凝固的蛋白质<br>E.肿胀的线粒体和扩张的内质网</td>
      <td>E.肿胀的线粒体和扩张的内质网</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>7. 气球样变的肝细胞中，下列哪项改变是错误的： (3.0分)</td>
      <td>A.细胞内水分增多<br>B.细胞内糖原增多<br>C.内质网扩张囊泡变<br>D.线粒体肿胀，嵴消失<br>E.核蛋白体颗粒脱失</td>
      <td>B.细胞内糖原增多</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>8. 玻璃样变性不会发生于： (3.0分)</td>
      <td>A.陈旧的纤维瘢痕组织<br>B.高血压病人的细动脉壁<br>C.纤维化的肾小球<br>D.肾小球肾炎的近曲小管上皮细胞<br>E.以上都不是</td>
      <td>E.以上都不是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>9. 结核病坏死属于: (3.0分)</td>
      <td>A.凝固性坏死<br>B.液化性坏死<br>C.干酪样坏死<br>D.纤维素样坏死<br>E.溶解坏死</td>
      <td>C.干酪样坏死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>10. 脂肪心和虎斑心的区别在于(3.0分)</td>
      <td>A.脂肪的质不同<br>B.脂肪的量不同<br>C.脂肪存在的部位不同<br>D.脂肪的质和量均不同<br>E.一与脂肪代谢有关，一与脂肪代谢无关</td>
      <td>C.脂肪存在的部位不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>11. 病理性钙化病灶肉眼观察时，下列哪项描述是正确的 (4.0分)</td>
      <td>A.灰白色颗粒状<br>B.暗红色颗粒状<br>C.蓝色颗粒状<br>D.黑色炭末样<br>E.土黄色颗粒状</td>
      <td>A.灰白色颗粒状</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>12. Metaplasia, the transformation of fully differentiated tissue into another, is not detected in:(3.0分)</td>
      <td>A. A.connective tissue elements<br>B. B.the gastrointestinal tract<br>C. C.the central nervous system<br>D. D.the biliary system<br>E. E.the urothelium</td>
      <td>C. C.the central nervous system</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>13. 细胞水肿好发生于肝 心、 肾，这是由于这些脏器(3.0分)</td>
      <td>A.容易发生缺氧<br>B.容易发生中毒<br>C.容易发生感染<br>D.实质细胞富于溶酶体<br>E.实质细胞富于线粒体,代谢旺盛</td>
      <td>E.实质细胞富于线粒体,代谢旺盛</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>14. 下列哪项属生理性萎缩？ (3.0分)</td>
      <td>A.授乳后乳腺组织的复旧<br>B.垂体坏死引起的乳腺萎缩<br>C.垂体功能低下引起的肾上腺萎缩<br>D.小儿麻痹症引起的下肢萎缩<br>E.动脉粥样硬化引起的脑萎缩</td>
      <td>A.授乳后乳腺组织的复旧</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>15. 下列那项属代偿性肥大？ (3.0分)</td>
      <td>A.老年性前列腺肥大<br>B.缺碘所致的甲状腺肥大<br>C.慢性扁桃体炎时的扁桃体肥大<br>D.高血压时左心室向心性肥大<br>E.肺气肿时肺体积增大</td>
      <td>D.高血压时左心室向心性肥大</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>16. 男，50岁，有长期吸烟史，因发热咳痰入院。痰检发现，痰内脱落的气管粘膜上皮部分为鳞状上皮，细胞无异型性，此病变可能为： (3.0分)</td>
      <td>A.气管上皮的鳞状化生<br>B.气管上皮的食管上皮化生<br>C.气管上皮先天性发育异常<br>D.气管上皮的异型增生<br>E.以上都不是</td>
      <td>A.气管上皮的鳞状化生</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>17. 男, 28岁，因肝肿大, 肝功能异常而入院。 临床诊断为急性普通型肝炎, 此时患者肝的病变最可能是：(3.0分)</td>
      <td>A.肝细胞气球样变<br>B.肝细胞大片坏死<br>C.肝细胞透明变性<br>D.肝细胞碎片状坏死<br>E.以上都不是</td>
      <td>A.肝细胞气球样变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>18. 玻璃样变性不会发生于： (3.0分)</td>
      <td>A.陈旧的纤维瘢痕组织<br>B.B.高血压病人的细动脉壁<br>C.C.纤维化的肾小球<br>D.肾小球肾炎的近曲小管上皮细胞<br>E.以上都不是</td>
      <td>E.以上都不是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>19. 关于结缔组织玻璃样变, 下列哪项是错误的? (3.0分)</td>
      <td>A.常见于瘢痕组织<br>B.可见于纤维化肾小球<br>C.胶原纤维融合为梁状透明样物质<br>D.可见于粥瘤<br>E.纤维母细胞增多</td>
      <td>E.纤维母细胞增多</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>20. 女, 40岁, 有数十年肾炎病史, 近来症状加重, 多尿,夜尿,查体患者呈贫血貌,高血压。此时肾小球可能出现何种病变:(3.0分)</td>
      <td>A.部分肾小球纤维化玻璃样变性<br>B.弥漫性肾小球内细胞增生<br>C.弥漫性肾小球系膜细胞和基质增生<br>D.肾小球基底膜增厚<br>E.以上都不是</td>
      <td>A.部分肾小球纤维化玻璃样变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>21. 风湿病结缔组织病变是: (3.0分)</td>
      <td>A.玻璃样变性<br>B.纤维素样坏死<br>C.脂肪变性<br>D.水样变性<br>E.嗜酸性变性</td>
      <td>B.纤维素样坏死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>22. 坏死细胞结构消失，但早期组织结构的轮廓依然存在，这种改变称为： (3.0分)</td>
      <td>A.坏疽<br>B.液化性坏死<br>C.干酪样坏死<br>D.脂肪坏死<br>E.凝固性坏死</td>
      <td>E.凝固性坏死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>23. 下述哪项不符合干酪样坏死? (3.0分)</td>
      <td>A.由结核杆菌引起<br>B.淡黄色、质地松软<br>C.镜下呈红染、颗粒状、无结构的物质<br>D.含有多量脂质<br>E.可见原有组织结构轮廓</td>
      <td>E.可见原有组织结构轮廓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>24. 下列哪种坏死后果严重, 需紧急处理? (3.0分)</td>
      <td>A.乳房脂肪坏死<br>B.下肢干性坏疽<br>C.臀部气性坏疽<br>D.肾局灶性梗死<br>E.脾梗死</td>
      <td>C.臀部气性坏疽</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>25. 判断组织或细胞是否坏死的主要依据是：(3.0分)</td>
      <td>A.细胞浆的改变<br>B.细胞核的改变<br>C.细胞间质的改变<br>D.细胞膜的改变<br>E.细胞器的改变</td>
      <td>B.细胞核的改变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>26. 关于脂肪变性记述中，下列哪一项是正确的：(3.0分)</td>
      <td>A.慢性肝淤血脂肪变性首先位于小叶中央区<br>B.磷中毒时肝脂肪变性主要分布于小叶中央区<br>C.贫血时心肌脂肪变性呈弥漫分布<br>D.脂性肾病，肾小管上皮脂肪变性不明显<br>E.白喉外毒素不能引起心肌弥漫性脂肪变性</td>
      <td>A.慢性肝淤血脂肪变性首先位于小叶中央区</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>27. 支气管粘膜上皮出现鳞状上皮属于？ (3.0分)</td>
      <td>A.分化不良<br>B.不典型增生<br>C.不完全再生<br>D.癌初期改变<br>E.适应性改变</td>
      <td>E.适应性改变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>28. 萎缩是指： (3.0分)</td>
      <td>A.细胞体积比正常小<br>B.器官体积比正常小<br>C.由于组织、细胞大量破坏而体积缩小<br>D.由于器官、组织发育不良致器官体积比正常小<br>E.发育正常的器官、组织、细胞体积变小</td>
      <td>E.发育正常的器官、组织、细胞体积变小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>29. 电镜下，脂肪变性的脂滴形成于 (3.0分)</td>
      <td>A.线粒体内<br>B.内质网中<br>C.溶酶体内<br>D.高尔基器内<br>E.胞核中</td>
      <td>B.内质网中</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>30. 老年性色素为(3.0分)</td>
      <td>A.含铁血黄素<br>B.脂褐素<br>C.黑色素<br>D.外源性色素<br>E.胆红素</td>
      <td>B.脂褐素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>31. 转化生长因子β（TGF-β）属于(3.0分)</td>
      <td>A.细胞周期的驱动力改变<br>B.增殖抑制信号<br>C.增殖信号<br>D.肿瘤<br>E.CDK活性增高</td>
      <td>B.增殖抑制信号</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>32. 下列分子不参与死亡受体通路的有 (3.0分)</td>
      <td>A.Fas<br>B.FADD<br>C.caspase-8<br>D.caspase-3<br>E.AIF</td>
      <td>E.AIF</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2010</td>
      <td>33. 不属于液化性坏死的有(3.0分)</td>
      <td>A.脑梗死<br>B.脂肪坏死<br>C.心肌梗死<br>D.阿米巴肝脓肿<br>E.葡萄球菌引起的脓肿</td>
      <td>C.心肌梗死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>1. 营养不良时,首先发生萎缩的组织或器官是(3.0分)</td>
      <td>A.肌肉组织<br>B.脂肪组织<br>C.肝、肾<br>D.脑<br>E.心肌</td>
      <td>B.脂肪组织</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>2. 脂肪心和虎斑心的区别在于(3.0分)</td>
      <td>A.脂肪的质不同<br>B.脂肪的量不同<br>C.脂肪存在的部位不同<br>D.脂肪的质和量均不同<br>E.一与脂肪代谢有关，一与脂肪代谢无关</td>
      <td>C.脂肪存在的部位不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>3. 下列组织中未见发生化生者为(3.0分)</td>
      <td>A.结缔组织成分<br>B.胃肠道<br>C.中枢神经系统<br>D.胆道系统<br>E.泌尿道上皮</td>
      <td>C.中枢神经系统</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>4. 细胞缺氧、线粒体氧化磷酸化降低、细胞膜钠-钾泵功能降低，导致细胞内(3.0分)</td>
      <td>A.钠多、钾多、水多<br>B.钠少、钾少、水少<br>C.钠多、钾少、水多<br>D.钠多、钾少、水少<br>E.钠少、钾多、水多</td>
      <td>C.钠多、钾少、水多</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>5. 未见于凝固性坏死的改变是(3.0分)</td>
      <td>A.保持组织结构的轮廓<br>B.嗜酸性染色<br>C.周围有充血、出血带环绕<br>D.组织软化、甚至形成空洞<br>E.细胞核消失</td>
      <td>D.组织软化、甚至形成空洞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>6. 萎缩是指：(4.0分)</td>
      <td>A.细胞体积比正常小<br>B.器官体积比正常小<br>C.由于组织、细胞大量破坏而体积缩小<br>D.由于器官、组织发育不良致器官体积比正常小<br>E.发育正常的器官、组织、细胞体积变小</td>
      <td>E.发育正常的器官、组织、细胞体积变小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>7. 支气管粘膜上皮出现鳞状上皮属于？ (3.0分)</td>
      <td>A.分化不良<br>B.不典型增生<br>C.不完全再生<br>D.癌初期改变<br>E.适应性改变</td>
      <td>E.适应性改变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>8. 肾近曲小管细胞水肿时，细胞浆内细小颗粒是： (3.0分)</td>
      <td>A.扩张的高尔基体<br>B.脱落的核糖体<br>C.增多的溶酶体<br>D.凝固的蛋白质<br>E.肿胀的线粒体和扩张的内质网</td>
      <td>E.肿胀的线粒体和扩张的内质网</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>9. 最常见的变性是 (3.0分)</td>
      <td>A.细胞水肿<br>B.脂肪变性<br>C.玻璃样变性<br>D.纤维素样变性<br>E.粘液样变性</td>
      <td>E.粘液样变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>10. 脂肪变性时,苏丹Ⅲ染色可将细胞内的脂滴染成 (3.0分)</td>
      <td>A.黑色<br>B.蓝色<br>C.橘红色<br>D.黄色<br>E.棕色</td>
      <td>C.橘红色</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>11. 下述哪项不符合干酪样坏死?(3.0分)</td>
      <td>A.由结核杆菌引起<br>B.淡黄色、质地松软<br>C.镜下呈红染、颗粒状、无结构的物质<br>D.含有多量脂质<br>E.可见原有组织结构轮廓</td>
      <td>E.可见原有组织结构轮廓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>12. 脂肪坏死常见于(3.0分)</td>
      <td>A.急性胰腺炎<br>B.糖尿病<br>C.肝脂肪变性<br>D.脂性肾病<br>E.脂肪心</td>
      <td>A.急性胰腺炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>13. 区别坏死与组织死后自溶的可靠依据： (3.0分)</td>
      <td>A.溶酶体膜破坏，酶释放到胞质<br>B.细胞器溶解<br>C.周围有无炎症反应<br>D.细胞核固缩、碎裂、溶解<br>E.是否保存细胞轮廓</td>
      <td>C.周围有无炎症反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>14. 下列对肺淤血组织学特点的描述中哪一项是错误的？ (3.0分)</td>
      <td>A.肺泡壁毛细血管扩张<br>B.肺泡腔内有水肿液<br>C.肺泡腔内有大量中性粒细胞和纤维素渗出<br>D.肺泡腔内有多少不等的红细胞<br>E.肺泡腔内可见心力衰竭细胞</td>
      <td>C.肺泡腔内有大量中性粒细胞和纤维素渗出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>15. Decompression sickness usually refers to: (3.0分)</td>
      <td>A.oxygen embolism<br>B.nitrogen gas embolism<br>C.carbon dioxide embolism<br>D.fat embolism<br>E.amniotic fluid embolism</td>
      <td>B.nitrogen gas embolism</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>16. 以下哪项不是梗死形成的原因和条件： (3.0分)</td>
      <td>A.血管内血栓形成阻塞管腔<br>B.血管受压闭塞<br>C.动脉痉挛<br>D.无有效的侧枝循环<br>E.毒物的毒性作用</td>
      <td>E.毒物的毒性作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>17. 引起发热的炎症介质是 (3.0分)</td>
      <td>A.组胺<br>B.缓激肽<br>C.前列腺素<br>D.补体C3a<br>E.阳离子蛋白</td>
      <td>C.前列腺素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>18. 18. 下列哪一种病变不属于肉芽肿性炎 (3.0分)</td>
      <td>A.结核结节<br>B.树胶肿<br>C.风湿小体<br>D.伤寒小结<br>E.宫颈息肉</td>
      <td>E.宫颈息肉</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>19. 癌与肉瘤的最主要区别是 (3.0分)</td>
      <td>A.瘤细胞的分布方式不同<br>B.发生的年龄不同<br>C.肿瘤内血管多少不同<br>D.转移的途径不同<br>E.组织来源不同</td>
      <td>E.组织来源不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>20. 一个典型的恶性肿瘤的自然生长史可以分为几个阶段，依次是： (3.0分)</td>
      <td>A.局部浸润，远处转移，一个细胞的恶性转化，转化细胞的克隆性增生<br>B.一个细胞的恶性转化，局部浸润，远处转移，转化细胞的克隆性增生<br>C.一个细胞的恶性转化，远处转移，局部浸润，转化细胞的克隆性增生<br>D.一个细胞的恶性转化，转化细胞的克隆性增生，局部浸润，远处转移<br>E.一个细胞的恶性转化，转化细胞的克隆性增生，远处转移，局部浸润</td>
      <td>D.一个细胞的恶性转化，转化细胞的克隆性增生，局部浸润，远处转移</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>21. 萎缩的心肌细胞内常可出现: (3.0分)</td>
      <td>A.橙色血质<br>B.脂褐素<br>C.疟色素<br>D.含铁血黄素<br>E.黑色素</td>
      <td>B.脂褐素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>22. 肉眼观察心脏标本，判断其萎缩的最主要根据是 (3.0分)</td>
      <td>A.体积小<br>B.颜色呈棕褐色<br>C.心脏外形不变，表面血管弯曲<br>D.心脏变形，表面血管绷直<br>E.心肌质地硬韧</td>
      <td>C.心脏外形不变，表面血管弯曲</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>23. 光镜下见细胞核缩小，染色质凝聚，呈深蓝色的是(3.0分)</td>
      <td>A.核碎裂<br>B.核分裂<br>C.核固缩<br>D.核溶解<br>E.凋亡小体</td>
      <td>C.核固缩</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>24. 结缔组织、血管壁及细胞内透明变性的共同点是：(3.0分)</td>
      <td>A.发病机制相似<br>B.肉眼观形态相似<br>C.组织学形态相似<br>D.后果相似<br>E.全部都是蛋白质蓄积所致</td>
      <td>C.组织学形态相似</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>25. 下列哪种情况不属于化生？ (3.0分)</td>
      <td>A.柱状上皮变为复层鳞状上皮<br>B.胃粘膜上皮变为肠型上皮<br>C.肉芽组织变为瘢痕组织<br>D.纤维组织变为骨组织<br>E.结缔组织软骨化</td>
      <td>C.肉芽组织变为瘢痕组织</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>26. 脂肪变性是指 (3.0分)</td>
      <td>A.脂肪细胞内出现了脂肪滴<br>B.组织内出现了脂肪细胞<br>C.正常不见或仅见少量脂滴的细胞质内出现脂滴或脂滴增多<br>D.脂肪组织中脂滴增多<br>E.器官内出现了脂肪细胞</td>
      <td>C.正常不见或仅见少量脂滴的细胞质内出现脂滴或脂滴增多</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>27. "虎斑心"的组织学改变是(3.0分)</td>
      <td>A.心肌纤维间大量淋巴细胞浸润<br>B.心肌纤维间出现脂肪沉积<br>C.心肌细胞中出现脂肪沉积<br>D.心肌细胞中出现透明小体<br>E.心肌细胞中出现淀粉样变性</td>
      <td>C.心肌细胞中出现脂肪沉积</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>28. 细动脉壁的透明变性最常发于(3.0分)</td>
      <td>A.急进性高血压<br>B.缓进性高血压<br>C.急性弥漫性增生性肾小球肾炎<br>D.急性肾盂肾炎<br>E.嗜铬细胞癌</td>
      <td>B.缓进性高血压</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>29. 肝细胞内透明变性，可见(3.0分)</td>
      <td>A.Russell body<br>B.Negri body<br>C.Verocay body<br>D.Aschoff body<br>E.Mallory body</td>
      <td>E.Mallory body</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>30. 最能代表细胞坏死的三种改变是(3.0分)</td>
      <td>A.核膜破裂、核碎裂、胞质浓缩<br>B.核溶解、胞质少和胞膜破裂<br>C.核溶解、胞质浓缩和胞膜破裂<br>D.核固缩、核质固缩、细胞膜皱缩<br>E.核固缩、核碎裂、核溶解</td>
      <td>E.核固缩、核碎裂、核溶解</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>31. 凝固性坏死好发于下列器官，除外(3.0分)</td>
      <td>A.心<br>B.肝<br>C.脾<br>D.肾<br>E.脑</td>
      <td>E.脑</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>32. 干酪样坏死的本质是(3.0分)</td>
      <td>A.纤维蛋白样坏死<br>B.脂肪坏死<br>C.液化性坏死<br>D.彻底的凝固性坏死<br>E.干性坏疽</td>
      <td>D.彻底的凝固性坏死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2012</td>
      <td>33. 关于湿性坏疽的叙述，下列哪项是不正确的？(3.0分)</td>
      <td>A.常见于肠、胆囊及子宫<br>B.坏死组织与周围分界不清楚<br>C.新鲜标本有恶臭<br>D.常是动脉、静脉循环均有障碍<br>E.全身中毒症状不明显</td>
      <td>E.全身中毒症状不明显</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>1. 营养不良时,首先发生萎缩的组织或器官是：(2.5分)</td>
      <td>A.肌肉组织<br>B.脂肪组织<br>C.肝、肾<br>D.脑<br>E.心肌</td>
      <td>B.脂肪组织</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>2. 脂肪心和虎斑心的区别在于：(2.5分)</td>
      <td>A.脂肪的质不同<br>B.脂肪的量不同<br>C.脂肪存在的部位不同<br>D.脂肪的质和量均不同<br>E.一与脂肪代谢有关，一与脂肪代谢无关</td>
      <td>C.脂肪存在的部位不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>3. 下列组织中未见发生化生者为：(2.5分)</td>
      <td>A.结缔组织成分<br>B.胃肠道<br>C.中枢神经系统<br>D.胆道系统<br>E.泌尿道上皮</td>
      <td>C.中枢神经系统</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>4. 细胞缺氧、线粒体氧化磷酸化降低、细胞膜钠-钾泵功能降低，导致细胞内：(2.5分)</td>
      <td>A.钠多、钾多、水多<br>B.钠少、钾少、水少<br>C.钠多、钾少、水多<br>D.钠多、钾少、水少<br>E.钠少、钾多、水多</td>
      <td>C.钠多、钾少、水多</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>5. 未见于凝固性坏死的改变是：(2.5分)</td>
      <td>A.保持组织结构的轮廓<br>B.嗜酸性染色<br>C.周围有充血、出血带环绕<br>D.组织软化、甚至形成空洞<br>E.细胞核消失</td>
      <td>D.组织软化、甚至形成空洞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>6. 萎缩是指：(2.5分)</td>
      <td>A.细胞体积比正常小<br>B.器官体积比正常小<br>C.由于组织、细胞大量破坏而体积缩小<br>D.由于器官、组织发育不良致器官体积比正常小<br>E.发育正常的器官、组织、细胞体积变小</td>
      <td>E.发育正常的器官、组织、细胞体积变小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>7. 支气管粘膜上皮出现鳞状上皮属于:(2.5分)</td>
      <td>A.分化不良<br>B.不典型增生<br>C.不完全再生<br>D.癌初期改变<br>E.适应性改变</td>
      <td>E.适应性改变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>8. 肾近曲小管细胞水肿时，细胞浆内细小颗粒是： (2.5分)</td>
      <td>A.扩张的高尔基体<br>B.脱落的核糖体<br>C.增多的溶酶体<br>D.凝固的蛋白质<br>E.肿胀的线粒体和扩张的内质网</td>
      <td>E.肿胀的线粒体和扩张的内质网</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>9. 最常见的变性是： (2.5分)</td>
      <td>A.细胞水肿<br>B.脂肪变性<br>C.玻璃样变性<br>D.纤维素样变性<br>E.粘液样变性</td>
      <td>E.粘液样变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>10. 脂肪变性时,苏丹Ⅲ染色可将细胞内的脂滴染成: (2.5分)</td>
      <td>A.黑色<br>B.蓝色<br>C.橘红色<br>D.黄色<br>E.棕色</td>
      <td>C.橘红色</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>11. 下述哪项不符合干酪样坏死:(2.5分)</td>
      <td>A.由结核杆菌引起<br>B.淡黄色、质地松软<br>C.镜下呈红染、颗粒状、无结构的物质<br>D.含有多量脂质<br>E.可见原有组织结构轮廓</td>
      <td>E.可见原有组织结构轮廓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>12. 脂肪坏死常见于:(2.5分)</td>
      <td>A.急性胰腺炎<br>B.糖尿病<br>C.肝脂肪变性<br>D.脂性肾病<br>E.脂肪心</td>
      <td>A.急性胰腺炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>13. 区别坏死与组织死后自溶的可靠依据： (2.5分)</td>
      <td>A.溶酶体膜破坏，酶释放到胞质<br>B.细胞器溶解<br>C.周围有无炎症反应<br>D.细胞核固缩、碎裂、溶解<br>E.是否保存细胞轮廓</td>
      <td>C.周围有无炎症反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>14. 下列对肺淤血组织学特点的描述中哪一项是错误的: (2.5分)</td>
      <td>A.肺泡壁毛细血管扩张<br>B.肺泡腔内有水肿液<br>C.肺泡腔内有大量中性粒细胞和纤维素渗出<br>D.肺泡腔内有多少不等的红细胞<br>E.肺泡腔内可见心力衰竭细胞</td>
      <td>C.肺泡腔内有大量中性粒细胞和纤维素渗出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>15. Decompression sickness usually refers to: (2.5分)</td>
      <td>A.oxygen embolism<br>B.nitrogen gas embolism<br>C.carbon dioxide embolism<br>D.fat embolism<br>E.amniotic fluid embolism</td>
      <td>B.nitrogen gas embolism</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>16. 以下哪项不是梗死形成的原因和条件： (2.5分)</td>
      <td>A.血管内血栓形成阻塞管腔<br>B.血管受压闭塞<br>C.动脉痉挛<br>D.无有效的侧枝循环<br>E.毒物的毒性作用</td>
      <td>E.毒物的毒性作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>17. 引起发热的炎症介质是: (2.5分)</td>
      <td>A.组胺<br>B.缓激肽<br>C.前列腺素<br>D.补体C3a<br>E.阳离子蛋白</td>
      <td>C.前列腺素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>18. 下列哪一种病变不属于肉芽肿性炎: (2.5分)</td>
      <td>A.结核结节<br>B.树胶肿<br>C.风湿小体<br>D.伤寒小结<br>E.宫颈息肉</td>
      <td>E.宫颈息肉</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>19. 癌与肉瘤的最主要区别是: (2.5分)</td>
      <td>A.瘤细胞的分布方式不同<br>B.发生的年龄不同<br>C.肿瘤内血管多少不同<br>D.转移的途径不同<br>E.组织来源不同</td>
      <td>E.组织来源不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>20. 一个典型的恶性肿瘤的自然生长史可以分为几个阶段，依次是： (2.5分)</td>
      <td>A.局部浸润，远处转移，一个细胞的恶性转化，转化细胞的克隆性增生<br>B.一个细胞的恶性转化，局部浸润，远处转移，转化细胞的克隆性增生<br>C.一个细胞的恶性转化，远处转移，局部浸润，转化细胞的克隆性增生<br>D.一个细胞的恶性转化，转化细胞的克隆性增生，局部浸润，远处转移<br>E.一个细胞的恶性转化，转化细胞的克隆性增生，远处转移，局部浸润</td>
      <td>D.一个细胞的恶性转化，转化细胞的克隆性增生，局部浸润，远处转移</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>21. 下列哪项不符合结缔组织玻璃样变性:(2.5分)</td>
      <td>A.常见于瘢痕组织及动脉粥样硬化的斑块等<br>B.病变组织灰白色、半透明<br>C.镜下纤维细胞明显减少<br>D.纤维化的肾小球<br>E.胶原纤维崩解融合</td>
      <td>E.胶原纤维崩解融合</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>22. 下列哪项不正确: (2.5分)</td>
      <td>A.病理性色素沉着包括含铁血黄素、脂褐素和黑色素等<br>B.含铁血黄素是红细胞的血红蛋白分解转化而成<br>C.脂褐素是细胞内未能被消化的残留体<br>D.脂褐素常出现在代谢旺盛的肝、心肌等细胞内<br>E.黑色素是一种深褐色无折光性颗粒状色素，常见于阿狄森氏病及黑色素痣等</td>
      <td>D.脂褐素常出现在代谢旺盛的肝、心肌等细胞内</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>23. 下列哪项不属于细胞和组织的适应性反应:(2.5分)</td>
      <td>A.肥大<br>B.增生<br>C.萎缩<br>D.变性<br>E.化生</td>
      <td>D.变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>24. 细胞水肿发生的机制主要是由于:(2.5分)</td>
      <td>A.内质网受损<br>B.高尔基体受损<br>C.中心体受损<br>D.线粒体肿大和内质网扩张断裂<br>E.核糖体受损</td>
      <td>D.线粒体肿大和内质网扩张断裂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>25. 关于含铁血黄素，下列哪项是对的：(2.5分)</td>
      <td>A.棕黄色，折光性弱<br>B.是铁蛋白微粒集合而成的颗粒<br>C.在吞噬细胞内产生，故在间质中见不到<br>D.在脾、肝内出现，就说明该处曾有出血<br>E.出现全身含铁血黄素沉着时，只说明曾有大量红细胞破坏</td>
      <td>B.是铁蛋白微粒集合而成的颗粒</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>26. 下列哪种情况不属于化生: (2.5分)</td>
      <td>A.柱状上皮变为复层鳞状上皮<br>B.胃粘膜上皮变为肠型上皮<br>C.肉芽组织变为瘢痕组织<br>D.纤维组织变为骨组织<br>E.结缔组织软骨化</td>
      <td>C.肉芽组织变为瘢痕组织</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>27. 营养不良性钙化和转移性钙化的主要区别点是: (2.5分)</td>
      <td>A.发生部位不同<br>B.钙盐性质不同<br>C.染色性质不同<br>D.血钙浓度不同<br>E.对机体的影响不同</td>
      <td>D.血钙浓度不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>28. 选择下列错误的一项:(2.5分)</td>
      <td>A.粘液样变性是组织间质出现粘液样物质的积聚<br>B.淀粉样变性是由于组织内有淀粉物沉积<br>C.粘液样变性常见于急性风湿病时心血管的结缔组织、动脉粥样硬化的动脉壁<br>D.淀粉样变性常见于骨髓瘤、结核病等<br>E.淀粉样变性物质在HE染色中呈淡红色</td>
      <td>B.淀粉样变性是由于组织内有淀粉物沉积</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>29. 细动脉壁的透明变性最常发于:(2.5分)</td>
      <td>A.急进性高血压<br>B.缓进性高血压<br>C.急性弥漫性增生性肾小球肾炎<br>D.急性肾盂肾炎<br>E.嗜铬细胞癌</td>
      <td>B.缓进性高血压</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>30. 干性坏疽的叙述，下列哪项是正确的:(2.5分)</td>
      <td>A.发生机制为动脉闭塞而静脉回流受阻<br>B.腐败菌感染一般较重<br>C.全身中毒症状重<br>D.坏死区与周围组织没有界线<br>E.多见于四肢末端</td>
      <td>D.坏死区与周围组织没有界线</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>31. 最能代表细胞坏死的三种改变是(2.5分)</td>
      <td>A.核膜破裂、核碎裂、胞质浓缩<br>B.核溶解、胞质少和胞膜破裂<br>C.核溶解、胞质浓缩和胞膜破裂<br>D.核固缩、核质固缩、细胞膜皱缩<br>E.核固缩、核碎裂、核溶解</td>
      <td>E.核固缩、核碎裂、核溶解</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>32. 下列哪种病变不属于细胞、组织的适应性变化:(2.5分)</td>
      <td>A.萎缩<br>B.肥大<br>C.发育不全<br>D.增生<br>E.化生</td>
      <td>C.发育不全</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>33. 干酪样坏死的本质是(2.5分)</td>
      <td>A.纤维蛋白样坏死<br>B.脂肪坏死<br>C.液化性坏死<br>D.彻底的凝固性坏死<br>E.干性坏疽</td>
      <td>D.彻底的凝固性坏死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>34. 关于湿性坏疽的叙述，下列哪项是不正确的？(2.5分)</td>
      <td>A.常见于肠、胆囊及子宫<br>B.坏死组织与周围分界不清楚<br>C.新鲜标本有恶臭<br>D.常是动脉、静脉循环均有障碍<br>E.全身中毒症状不明显</td>
      <td>E.全身中毒症状不明显</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>35. 下列萎缩中不属于病理性萎缩的是:(2.5分)</td>
      <td>A.晚期食管癌患者的肝<br>B.晚期原发性高血压病人的肾<br>C.老年女性的卵巢<br>D.截瘫病人的双下肢</td>
      <td>C.老年女性的卵巢</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>36. 气球样变的细胞最常见于:(2.5分)</td>
      <td>A.心<br>B.肝<br>C.肾<br>D.脑<br>E.脾</td>
      <td>B.肝</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>37. 下列那项属代偿性肥大:(2.5分)</td>
      <td>A.老年性前列腺肥大<br>B.缺碘所致的甲状腺肥大<br>C.慢性扁桃体炎时的扁桃体肥大<br>D.高血压时左心室向心性肥大<br>E.肺气肿时肺体积增大</td>
      <td>D.高血压时左心室向心性肥大</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>38. 女, 40岁, 有数十年肾炎病史, 近来症状加重, 多尿,夜尿,查体患者呈贫血貌,高血压。此时肾小球可能出现何种病变: (2.5分)</td>
      <td>A.部分肾小球纤维化玻璃样变性<br>B.弥漫性肾小球内细胞增生<br>C.弥漫性肾小球系膜细胞和基质增生<br>D.肾小球基底膜增厚<br>E.以上都不是</td>
      <td>A.部分肾小球纤维化玻璃样变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>39. 不属于液化性坏死的有： (2.5分)</td>
      <td>A.脑梗死<br>B.脂肪坏死<br>C.心肌梗死<br>D.阿米巴肝脓肿<br>E.葡萄球菌引起的脓肿</td>
      <td>C.心肌梗死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2013</td>
      <td>40. 关于脂肪变性记述中，下列哪一项是正确的： (2.5分)</td>
      <td>A.慢性肝淤血脂肪变性首先位于小叶中央区<br>B.磷中毒时肝脂肪变性主要分布于小叶中央区<br>C.贫血时心肌脂肪变性呈弥漫分布<br>D.脂性肾病，肾小管上皮脂肪变性不明显<br>E.白喉外毒素不能引起心肌弥漫性脂肪变性</td>
      <td>A.慢性肝淤血脂肪变性首先位于小叶中央区</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>1. 肝淤血的主要病变是： (2.5分)</td>
      <td>A.肝小叶中央静脉及肝窦扩张充血，肝细胞变性、萎缩<br>B.肝小叶间静脉扩张充血，肝细胞变性、萎缩<br>C.肝小叶间静脉扩张充血，小叶间结缔组织增生<br>D.肝窦扩张充血，小叶间胆管和结缔组织增生<br>E.肝小叶间动静脉淤血，小叶间结缔组织增生</td>
      <td>A.肝小叶中央静脉及肝窦扩张充血，肝细胞变性、萎缩</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>2. 新生的血管穿过阻塞的血栓，从而使阻塞两端血流重新恢复，称为： (2.5分)</td>
      <td>A.血栓溶解<br>B.再通<br>C.透明变性<br>D.液化性坏死<br>E.纤维蛋白溶解</td>
      <td>B.再通</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>3. 下列有关肝淤血的叙述中，哪项不正确： (2.5分)</td>
      <td>A.中央静脉扩张<br>B.肝细胞脂肪变性<br>C.小叶间静脉扩张<br>D.肝细胞萎缩<br>E.肝窦扩张</td>
      <td>C.小叶间静脉扩张</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>4. 下列肺淤血的叙述中，哪项是错误的？(2.5分)</td>
      <td>A.肺泡壁毛细血管扩张<br>B.肺泡腔内中性白细胞和纤维素渗出<br>C.肺泡腔内有水肿液<br>D.可发生漏出性出血<br>E.常可见心力衰竭细胞</td>
      <td>B.肺泡腔内中性白细胞和纤维素渗出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>5. 心衰细胞见于 (2.5分)</td>
      <td>A.左心衰时肺泡腔内<br>B.右心衰时肺泡腔内<br>C.肺水肿时肺泡腔内<br>D.肝淤血时肝脏内<br>E.脾淤血时脾脏内</td>
      <td>A.左心衰时肺泡腔内</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>6. 脾、肾梗死灶肉眼检查的主要特点为(2.5分)</td>
      <td>A.多呈地图状、灰白色、界限清楚<br>B.多呈不规则形、暗红色、界限不清<br>C.多呈楔形、暗红色、界限不清<br>D.多呈地图状、暗红色、界限不清<br>E.多呈楔形、灰白色、界限清楚</td>
      <td>E.多呈楔形、灰白色、界限清楚</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>7. 风湿性心脏病二尖瓣上的疣状赘生物是 (2.5分)</td>
      <td>A.白色血栓<br>B.红色血栓<br>C.混合血栓<br>D.透明血栓<br>E.血凝块</td>
      <td>A.白色血栓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>8. 混合血栓是由下列哪些成分组成的？(2.5分)</td>
      <td>A.血小板梁及其之间的纤维蛋白网，网眼内网罗大量红细胞<br>B.纤维蛋白、红细胞、白细胞、血小板<br>C.纤维蛋白和红细胞<br>D.血栓头及尾<br>E.血小板和白细胞</td>
      <td>A.血小板梁及其之间的纤维蛋白网，网眼内网罗大量红细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>9. 最常见的变性是： (2.5分)</td>
      <td>A.细胞水肿<br>B.脂肪变性<br>C.玻璃样变性<br>D.纤维素样变性<br>E.粘液样变性</td>
      <td>E.粘液样变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>10. 下列哪一种不是渗出性炎症?(2.5分)</td>
      <td>A.卡他性炎症<br>B.乙型脑炎<br>C.流行性脑膜炎<br>D.肾盂肾炎<br>E.脓肿</td>
      <td>B.乙型脑炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>11. 下述哪项不符合干酪样坏死:(2.5分)</td>
      <td>A.由结核杆菌引起<br>B.淡黄色、质地松软<br>C.镜下呈红染、颗粒状、无结构的物质<br>D.含有多量脂质<br>E.可见原有组织结构轮廓</td>
      <td>E.可见原有组织结构轮廓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>12. 脂肪坏死常见于:(2.5分)</td>
      <td>A.急性胰腺炎<br>B.糖尿病<br>C.肝脂肪变性<br>D.脂性肾病<br>E.脂肪心</td>
      <td>A.急性胰腺炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>13. 区别坏死与组织死后自溶的可靠依据： (2.5分)</td>
      <td>A.溶酶体膜破坏，酶释放到胞质<br>B.细胞器溶解<br>C.周围有无炎症反应<br>D.细胞核固缩、碎裂、溶解<br>E.是否保存细胞轮廓</td>
      <td>C.周围有无炎症反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>14. 下列对肺淤血组织学特点的描述中哪一项是错误的: (2.5分)</td>
      <td>A.肺泡壁毛细血管扩张<br>B.肺泡腔内有水肿液<br>C.肺泡腔内有大量中性粒细胞和纤维素渗出<br>D.肺泡腔内有多少不等的红细胞<br>E.肺泡腔内可见心力衰竭细胞</td>
      <td>C.肺泡腔内有大量中性粒细胞和纤维素渗出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>15. 下列哪一项不属于渗出性炎症?(2.5分)</td>
      <td>A.卡他性炎症<br>B.阿米巴肝脓肿<br>C.假膜性炎<br>D.绒毛心<br>E.大叶性肺炎</td>
      <td>B.阿米巴肝脓肿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>16. 以下哪项不是梗死形成的原因和条件： (2.5分)</td>
      <td>A.血管内血栓形成阻塞管腔<br>B.血管受压闭塞<br>C.动脉痉挛<br>D.无有效的侧枝循环<br>E.毒物的毒性作用</td>
      <td>E.毒物的毒性作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>17. 下列关于炎症描述，哪一项不正确?(2.5分)</td>
      <td>A.嗜中性粒细胞浸润通常是急性炎症的标志<br>B.慢性炎症细胞主要是淋巴细胞、巨噬细胞和浆细胞<br>C.淋巴细胞浸润并非总是慢性炎症的特征<br>D.嗜中性粒细胞游出后必然引起局部单核细胞增多<br>E.白细胞渗出只见于急性炎症早期</td>
      <td>E.白细胞渗出只见于急性炎症早期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>18. 炎症的渗出主要由于：(2.5分)</td>
      <td>A.血液动力学改变<br>B.血管壁通透性改变<br>C.小静脉血栓形成<br>D.循环血量增加<br>E.组织间液比重降低</td>
      <td>B.血管壁通透性改变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>19. 巨噬细胞、纤维母细胞和淋巴细胞最常见于：(2.5分)</td>
      <td>A.急性炎症<br>B.肉芽组织<br>C.伤口愈合处<br>D.慢性炎症<br>E.化脓性炎症</td>
      <td>D.慢性炎症</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>20. 以变质为主的炎症，其实质细胞的主要变化是：(2.5分)</td>
      <td>A.增生和再生<br>B.萎缩和变性<br>C.变性和坏死<br>D.增生和变性<br>E.坏死和萎缩</td>
      <td>C.变性和坏死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>21. 关于血管壁玻璃样变，错误的描述是(2.5分)</td>
      <td>A.常见于高血压<br>B.常见于肾、脑、脾、视网膜细动脉<br>C.血管壁变硬、管腔狭窄<br>D.可引起组织缺血<br>E.玻璃样物质由免疫球蛋白和基底膜样物构成</td>
      <td>E.玻璃样物质由免疫球蛋白和基底膜样物构成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>22. 下列哪项不正确: (2.5分)</td>
      <td>A.病理性色素沉着包括含铁血黄素、脂褐素和黑色素等<br>B.含铁血黄素是红细胞的血红蛋白分解转化而成<br>C.脂褐素是细胞内未能被消化的残留体<br>D.脂褐素常出现在代谢旺盛的肝、心肌等细胞内<br>E.黑色素是一种深褐色无折光性颗粒状色素，常见于阿狄森氏病及黑色素痣等</td>
      <td>D.脂褐素常出现在代谢旺盛的肝、心肌等细胞内</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>23. 下列不符合液化性坏死的描述是：(2.5分)</td>
      <td>A.局部蛋白质含量少<br>B.局部蛋白酶丰富<br>C.局部脂质含量多<br>D.局部化脓<br>E.脂肪坏死不属于液化性坏死</td>
      <td>A.局部蛋白质含量少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>24. 细胞水肿发生的机制主要是由于:(2.5分)</td>
      <td>A.内质网受损<br>B.高尔基体受损<br>C.中心体受损<br>D.线粒体肿大和内质网扩张断裂<br>E.核糖体受损</td>
      <td>D.线粒体肿大和内质网扩张断裂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>25. 关于含铁血黄素，下列哪项是对的：(2.5分)</td>
      <td>A.棕黄色，折光性弱<br>B.是铁蛋白微粒集合而成的颗粒<br>C.在吞噬细胞内产生，故在间质中见不到<br>D.在脾、肝内出现，就说明该处曾有出血<br>E.出现全身含铁血黄素沉着时，只说明曾有大量红细胞破坏</td>
      <td>B.是铁蛋白微粒集合而成的颗粒</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>26. 下列哪种情况不属于化生: (2.5分)</td>
      <td>A.柱状上皮变为复层鳞状上皮<br>B.胃粘膜上皮变为肠型上皮<br>C.肉芽组织变为瘢痕组织<br>D.纤维组织变为骨组织<br>E.结缔组织软骨化</td>
      <td>C.肉芽组织变为瘢痕组织</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>27. 干性坏疽常发生于：(2.5分)</td>
      <td>A.足<br>B.肠道<br>C.肺<br>D.大脑<br>E.脾脏</td>
      <td>A.足</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>28. 与细胞水肿的发生密切的细胞器是：(2.5分)</td>
      <td>A.溶酶体<br>B.线粒体<br>C.高尔基体<br>D.内质网<br>E.核糖体</td>
      <td>B.线粒体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>29. 细动脉壁的透明变性最常发于:(2.5分)</td>
      <td>A.急进性高血压<br>B.缓进性高血压<br>C.急性弥漫性增生性肾小球肾炎<br>D.急性肾盂肾炎<br>E.嗜铬细胞癌</td>
      <td>B.缓进性高血压</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>30. 下列符合干性坏疽的描述是： (2.5分)</td>
      <td>A.坏死合并腐败菌感染<br>B.常伴有全身中毒症状<br>C.局部肿胀明显<br>D.坏死组织与健康组织之间界限不清楚<br>E.坏死部位动脉和静脉血流均受</td>
      <td>A.坏死合并腐败菌感染</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>31. 最能代表细胞坏死的三种改变是(2.5分)</td>
      <td>A.核膜破裂、核碎裂、胞质浓缩<br>B.核溶解、胞质少和胞膜破裂<br>C.核溶解、胞质浓缩和胞膜破裂<br>D.核固缩、核质固缩、细胞膜皱缩<br>E.核固缩、核碎裂、核溶解</td>
      <td>E.核固缩、核碎裂、核溶解</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>32. 下列哪种病变不属于细胞、组织的适应性变化:(2.5分)</td>
      <td>A.萎缩<br>B.肥大<br>C.发育不全<br>D.增生<br>E.化生</td>
      <td>C.发育不全</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>33. 干酪样坏死的本质是(2.5分)</td>
      <td>A.纤维蛋白样坏死<br>B.脂肪坏死<br>C.液化性坏死<br>D.彻底的凝固性坏死<br>E.干性坏疽</td>
      <td>D.彻底的凝固性坏死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>34. 关于湿性坏疽的叙述，下列哪项是不正确的？(2.5分)</td>
      <td>A.常见于肠、胆囊及子宫<br>B.坏死组织与周围分界不清楚<br>C.新鲜标本有恶臭<br>D.常是动脉、静脉循环均有障碍<br>E.全身中毒症状不明显</td>
      <td>E.全身中毒症状不明显</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>35. 下列萎缩中不属于病理性萎缩的是:(2.5分)</td>
      <td>A.晚期食管癌患者的肝<br>B.晚期原发性高血压病人的肾<br>C.老年女性的卵巢<br>D.截瘫病人的双下肢</td>
      <td>C.老年女性的卵巢</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>36. 气球样变的细胞最常见于:(2.5分)</td>
      <td>A.心<br>B.肝<br>C.肾<br>D.脑<br>E.脾</td>
      <td>B.肝</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>37. 细胞内线粒体肿大、内质网扩张常见于(2.5分)</td>
      <td>A.水变性<br>B.脂肪变性<br>C.玻璃样变性<br>D.纤维素样变性<br>E.钙化</td>
      <td>A.水变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>38. 男性，60岁，因胃癌广泛转移而死亡。尸体解剖检查，心脏重200g。切片检查心肌细胞核两侧可见黄褐色细颗粒状色素，此色素可能是：(2.5分)</td>
      <td>A.黑色素<br>B.胆色素<br>C.含铁血黄素<br>D.脂褐素<br>E.前角蛋白聚集</td>
      <td>D.脂褐素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>39. 不属于液化性坏死的有： (2.5分)</td>
      <td>A.脑梗死<br>B.脂肪坏死<br>C.心肌梗死<br>D.阿米巴肝脓肿<br>E.葡萄球菌引起的脓肿</td>
      <td>C.心肌梗死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>4</td>
      <td>2014</td>
      <td>40. 下列属于完全性再生的是： (2.5分)</td>
      <td>A.胃溃疡愈合<br>B.皮肤溃疡愈合<br>C.肺空洞愈合<br>D.肝细胞点、灶状坏死愈合<br>E.心肌梗死灶的修复</td>
      <td>B.皮肤溃疡愈合</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>1. 细胞水肿常见于： (2.0分)</td>
      <td>A.脂肪细胞<br>B.纤维细胞<br>C.肝细胞<br>D.神经细胞<br>E.中性粒细胞</td>
      <td>C.肝细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>2. 下列哪一种变性最轻:(2.0分)</td>
      <td>A.细胞水肿<br>B.粘液样变性<br>C.纤维素样变性<br>D.脂肪变性<br>E.玻璃样变性</td>
      <td>A.细胞水肿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>3. 脑萎缩的大体特征是(2.0分)</td>
      <td>A.脑沟变窄，脑回增宽<br>B.脑沟变窄，脑回变窄<br>C.脑沟加深，脑回增宽<br>D.脑沟加深，脑回变窄<br>E.脑沟变浅，脑回变窄</td>
      <td>D.脑沟加深，脑回变窄</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>4. 易发生干性坏疽的器官是： (2.0分)</td>
      <td>A.肠道<br>B.四肢<br>C.心肌<br>D.肺<br>E.子宫</td>
      <td>B.四肢</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>5. 细胞水肿和脂肪变性主要发生在： (2.0分)</td>
      <td>A.肺，脾，肾<br>B.心，肝，肾<br>C.心，脾，肺<br>D.肝，肾，脾<br>E.心，肝，胃</td>
      <td>B.心，肝，肾</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>6. 下列那项属废用性萎缩(2.0分)</td>
      <td>A.食管癌病人全身消瘦<br>B.神经损伤及肌肉萎缩<br>C.骨折固定后相应肌肉萎缩<br>D.良性肿瘤邻近组织萎缩<br>E.脑髓体病变引起性腺萎缩</td>
      <td>C.骨折固定后相应肌肉萎缩</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>7. 脂褐素电镜下为 (2.0分)</td>
      <td>A.脂质小体<br>B.Russell小体<br>C.Mallory小体<br>D.Councillman小体<br>E.残存小体</td>
      <td>E.残存小体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>8. 下述哪种肿瘤的发生可能与化生有关 (2.0分)</td>
      <td>A.肠黏液腺癌<br>B.肾盂移行细胞癌<br>C.皮肤鳞状细胞癌<br>D.肝胆管上皮癌<br>E.肠型胃癌</td>
      <td>E.肠型胃癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>9. 关于玻璃样变性, 下列哪项是错误的? (2.0分)</td>
      <td>A.可发生于血管壁<br>B.可发生于浆细胞<br>C.可发生于肝细胞<br>D.可发生于结缔组织<br>E.可发生于肾远曲小管上皮细胞</td>
      <td>E.可发生于肾远曲小管上皮细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>10. 下述哪项不是心脏萎缩的肉眼特点(2.0分)</td>
      <td>A.心脏表面血管弯曲<br>B.心肌质地硬韧<br>C.体积小<br>D.呈褐色<br>E.心脏表面血管增粗</td>
      <td>E.心脏表面血管增粗</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>11. 不属于细胞、组织的适应性变化的病变是(2.0分)</td>
      <td>A.发育不全<br>B.萎缩<br>C.肥大<br>D.增生<br>E.化生</td>
      <td>A.发育不全</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>12. 下列哪种组织再生能力最强？ (2.0分)</td>
      <td>A.神经元<br>B.骨骼肌<br>C.神经胶质细胞<br>D.心肌<br>E.软骨</td>
      <td>E.软骨</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>13. 判断组织或细胞是否坏死的主要依据是 (2.0分)</td>
      <td>A.细胞间质的改变<br>B.细胞核的改变<br>C.细胞浆的改变<br>D.细胞膜的改变<br>E.细胞器的改变</td>
      <td>B.细胞核的改变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>14. 坏死和坏疽的主要区别在于： (2.0分)</td>
      <td>A.动脉阻塞的程度<br>B.有无腐败菌感染<br>C.静脉有无淤血<br>D.发生部位<br>E.病变深</td>
      <td>B.有无腐败菌感染</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>15. 肾近曲小管细胞水肿时，细胞浆内细小颗粒是(2.0分)</td>
      <td>A.增多的溶酶体<br>B.凝固的蛋白质<br>C.脱落的核糖体<br>D.扩张的高尔基体<br>E.肿胀的线粒体和扩张的内质网</td>
      <td>E.肿胀的线粒体和扩张的内质网</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>16. 水样变性和脂肪变性主要发生在(2.0分)</td>
      <td>A.肝，肾，脾<br>B.心，肝，肾<br>C.肺，脾，肾<br>D.心，脾，肺<br>E.心，肝，胃</td>
      <td>B.心，肝，肾</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>17. 气球样变的肝细胞中，下列哪项改变是错误的(2.0分)</td>
      <td>A.线粒体肿胀，嵴消失<br>B.细胞内糖原增多<br>C.内质网扩张囊泡变<br>D.细胞内水分增多<br>E.核蛋白体颗粒脱失</td>
      <td>B.细胞内糖原增多</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>18. 易发生干性坏疽的器官是(2.0分)</td>
      <td>A.心肌<br>B.四肢<br>C.肺<br>D.肠道<br>E.子宫</td>
      <td>B.四肢</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>19. 男, 28岁，因肝肿大, 肝功能异常而入院。 临床诊断为急性普通型肝炎, 此时患者肝的病变最可能是： (2.0分)</td>
      <td>A.肝细胞碎片状坏死<br>B.肝细胞气球样变<br>C.肝细胞大片坏死<br>D.肝细胞透明变性<br>E.以上都不是</td>
      <td>B.肝细胞气球样变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>20. 电镜下，脂肪变性的脂滴形成于 (2.0分)</td>
      <td>A.内质网中<br>B.线粒体内<br>C.溶酶体内<br>D.高尔基器内<br>E.胞核中</td>
      <td>A.内质网中</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>21. 虎斑心是指： (2.0分)</td>
      <td>A.心肌细胞凝固性坏死<br>B.心肌间脂肪组织浸润<br>C.心肌细胞脂肪变性<br>D.心肌细胞水样变性<br>E.心肌细胞内脂褐素沉着</td>
      <td>C.心肌细胞脂肪变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>22. 脂肪变性时,苏丹Ⅲ染色可将细胞内的脂滴染成: (2.0分)</td>
      <td>A.黄色<br>B.橘红色<br>C.黑色<br>D.蓝色<br>E.棕色</td>
      <td>B.橘红色</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>23. 大块疤痕可引起(2.0分)</td>
      <td>A.腔室狭窄<br>B.器官变形<br>C.器官表面凹陷<br>D.关节运动障碍<br>E.以上均可</td>
      <td>E.以上均可</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>24. 下述哪项不符合干酪样坏死? (2.0分)</td>
      <td>A.淡黄色、质地松软<br>B.由结核杆菌引起<br>C.镜下呈红染、颗粒状、无结构的物质<br>D.含有多量脂质<br>E.可见原有组织结构轮廓</td>
      <td>E.可见原有组织结构轮廓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>25. 结核病坏死属于: (2.0分)</td>
      <td>A.凝固性坏死<br>B.纤维素样坏死<br>C.干酪样坏死<br>D.液化性坏死<br>E.溶解坏死</td>
      <td>C.干酪样坏死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>26. 结核病坏死属于 (2.0分)</td>
      <td>A.液化性坏死<br>B.纤维素样坏死<br>C.凝固性坏死<br>D.干酪样坏死<br>E.溶解坏死</td>
      <td>B.纤维素样坏死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>27. 一种分化成熟的组织转变为另一种分化成熟的组织称： (2.0分)</td>
      <td>A.增生<br>B.再生<br>C.分化<br>D.机化<br>E.化生</td>
      <td>E.化生</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>28. 不属于液化性坏死的有： (2.0分)</td>
      <td>A.阿米巴肝脓肿<br>B.脂肪坏死<br>C.心肌梗死<br>D.脑梗死<br>E.葡萄球菌引起的脓肿</td>
      <td>C.心肌梗死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>29. 细胞和组织的损伤性变化是 (2.0分)</td>
      <td>A.肥大<br>B.变性<br>C.化生<br>D.增生<br>E.再生</td>
      <td>B.变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>30. 肉芽组织是由----组成(2.0分)</td>
      <td>A.新生毛细血管和单核细胞<br>B.新生毛细血管和成纤维细胞<br>C.吞噬细胞和成纤维细胞<br>D.新生毛细血管和吞噬细胞<br>E.以上均不是</td>
      <td>B.新生毛细血管和成纤维细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>31. 下列哪一种变性最轻: (2.0分)</td>
      <td>A.脂肪变性<br>B.粘液样变性<br>C.细胞水肿<br>D.纤维素样变性<br>E.玻璃样变性</td>
      <td>C.细胞水肿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>32. 血管壁的玻璃样变性主要发生在 (2.0分)</td>
      <td>A.静脉<br>B.中等动脉<br>C.大动脉<br>D.小动脉<br>E.细动脉</td>
      <td>E.细动脉</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>33. 下列哪项不符合一期愈合? (2.0分)</td>
      <td>A.5-6天胶原纤维形成<br>B.炎症反应重<br>C.凝血块少<br>D.创缘整齐<br>E.约2-3周完全愈合</td>
      <td>B.炎症反应重</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>34. 区别组织坏死和死后自溶的可靠根据是 (2.0分)</td>
      <td>A.细胞核是否溶解消失<br>B.细胞体积是否肿胀<br>C.电镜下细胞器破坏与否<br>D.组织轮廓存在与否<br>E.病变周围有无炎症反应</td>
      <td>E.病变周围有无炎症反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>35. 男, 18岁, 阑尾炎行外科手术切除, 此时手术刀口属(2.0分)</td>
      <td>A.一期愈合<br>B.二期愈合<br>C.痂下愈合<br>D.完全再生<br>E.以上都不是</td>
      <td>A.一期愈合</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>36. 气球样变的肝细胞中，下列哪项改变是错误的 (2.0分)</td>
      <td>A.内质网扩张囊泡变<br>B.细胞内糖原增多<br>C.细胞内水分增多<br>D.线粒体肿胀，嵴消失<br>E.核蛋白体颗粒脱失</td>
      <td>B.细胞内糖原增多</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>37. 梗死后液化性坏死常见于(2.0分)</td>
      <td>A.脑<br>B.肾<br>C.肺<br>D.心<br>E.肝</td>
      <td>A.脑</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>38. 下列哪项属生理性萎缩？ (2.0分)</td>
      <td>A.垂体功能低下引起的肾上腺萎缩<br>B.垂体坏死引起的乳腺萎缩<br>C.授乳后乳腺组织的复旧<br>D.小儿麻痹症引起的下肢萎缩<br>E.动脉粥样硬化引起的脑萎缩</td>
      <td>C.授乳后乳腺组织的复旧</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>39. 区别组织坏死和死后自溶的可靠根据是 (2.0分)</td>
      <td>A.细胞体积是否肿胀<br>B.组织轮廓存在与否<br>C.电镜下细胞器破坏与否<br>D.细胞核是否溶解消失<br>E.病变周围有无炎症反应</td>
      <td>E.病变周围有无炎症反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>40. 最常见的变性是： (2.0分)</td>
      <td>A.玻璃样变性<br>B.纤维素样变性<br>C.脂肪变性<br>D.细胞水肿<br>E.粘液样变性</td>
      <td>D.细胞水肿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>41. 关于坏死组织本身的结局，下列哪种是错误的？ (2.0分)</td>
      <td>A.化生<br>B.分离排出<br>C.溶解吸收<br>D.机化<br>E.包裹钙化</td>
      <td>A.化生</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>42. 坏死细胞结构消失，但早期组织结构的轮廓依然存在，这种改变称为 (2.0分)</td>
      <td>A.坏疽<br>B.脂肪坏死<br>C.干酪样坏死<br>D.液化性坏死<br>E.凝固性坏死</td>
      <td>E.凝固性坏死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>43. 下列那项改变含代偿性肥大(2.0分)</td>
      <td>A.肺气肿肺体积增大<br>B.慢性扁桃体炎扁桃体增大<br>C.老年人前列腺增大<br>D.高血压病左心室增大<br>E.妊娠期子宫增大</td>
      <td>E.妊娠期子宫增大</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>44. 病理性钙化病灶肉眼观察时，下列哪项描述是正确的(2.0分)</td>
      <td>A.灰白色颗粒状<br>B.黑色炭末样<br>C.蓝色颗粒状<br>D.暗红色颗粒状<br>E.土黄色颗粒状</td>
      <td>A.灰白色颗粒状</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>45. 玻璃样变性不会发生于 (2.0分)</td>
      <td>A.纤维化的肾小球<br>B.高血压病人的细动脉壁<br>C.陈旧的纤维瘢痕组织<br>D.肾小球肾炎的近曲小管上皮细胞<br>E.以上都不是</td>
      <td>E.以上都不是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>46. 肾近曲小管细胞水肿时，细胞浆内细小颗粒是： (2.0分)</td>
      <td>A.扩张的高尔基体<br>B.凝固的蛋白质<br>C.增多的溶酶体<br>D.脱落的核糖体<br>E.肿胀的线粒体和扩张的内质网</td>
      <td>E.肿胀的线粒体和扩张的内质网</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>47. 男，50岁，有长期吸烟史，因发热咳痰入院。痰检发现，痰内脱落的气管粘膜上皮部分为鳞状上皮，细胞无异型性，此病变可能为：(2.0分)</td>
      <td>A.气管上皮先天性发育异常<br>B.气管上皮的食管上皮化生<br>C.气管上皮的鳞状化生<br>D.气管上皮的异型增生<br>E.以上都不是</td>
      <td>C.气管上皮的鳞状化生</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>48. 风湿病结缔组织病变是 (2.0分)</td>
      <td>A.脂肪变性<br>B.纤维素样坏死<br>C.玻璃样变性<br>D.水样变性<br>E.嗜酸性变性</td>
      <td>B.纤维素样坏死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>49. 肉眼观察肉芽组织呈颗粒状是因为(2.0分)</td>
      <td>A.新生的毛细血管灶性聚集<br>B.感染、炎性水肿引起<br>C.大量炎细胞灶性聚集<br>D.表面的毛细血管网呈袢状弯曲<br>E.成纤维细胞灶性聚集</td>
      <td>D.表面的毛细血管网呈袢状弯曲</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2008</td>
      <td>50. 关于坏死, 下列哪项是正确的? (2.0分)</td>
      <td>A.坏死是指机体死亡后组织、细胞出现的形态学改变<br>B.坏死是指活体内局部组织、细胞死亡后出现的形态学改变<br>C.坏死是指局部组织、细胞的死亡<br>D.坏死类型之一是细胞凋亡<br>E.坏死是可复性改变</td>
      <td>B.坏死是指活体内局部组织、细胞死亡后出现的形态学改变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>1. 细胞因子不具备的特点是：(2.0分)</td>
      <td>A.通过与相应受体结合发挥作用<br>B.作用具有高效性和多效性<br>C.作用具有重叠性和网络性<br>D.主要是在局部起持久作用<br>E.主要通过自分泌和旁分泌发挥作用</td>
      <td>D.主要是在局部起持久作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>2. IFN-γ：(2.0分)</td>
      <td>A.主要由成纤维细胞产生<br>B.主要由白细胞产生<br>C.其抗病毒功能强于免疫调节功能<br>D.又称为I型干扰素<br>E.具有干扰病毒复制的功能</td>
      <td>E.具有干扰病毒复制的功能</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>3. 能够用细胞增殖法检测的细胞因子是 (2.0分)</td>
      <td>A.CSF<br>B.TNF<br>C.IFN<br>D.IL-6<br>E.IL-8</td>
      <td>D.IL-6</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>4. 产生IL-1细胞主要是：(2.0分)</td>
      <td>A.肥大细胞、中性粒细胞<br>B.Mo/Mφ、树突状细胞<br>C.Th2细胞<br>D.Th1细胞<br>E.淋巴细胞</td>
      <td>B.Mo/Mφ、树突状细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>5. 可诱导产生IgE的细胞因子是(2.0分)</td>
      <td>A.IL-5<br>B.IL-4<br>C.IL-2<br>D.IFN-γ<br>E.CSF</td>
      <td>B.IL-4</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>6. 刺激淋巴细胞增殖的细胞因子主要是(2.0分)</td>
      <td>A.IL-1<br>B.IL-5<br>C.IL-2<br>D.IFN-γ<br>E.IL-3</td>
      <td>C.IL-2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>7. 对炎症反应有明显促进作用的白细胞介素是(2.0分)</td>
      <td>A.IL-2、IL-4、IL-5、IL-6<br>B.IL-2、IL-10、IL-12<br>C.IL-3、IL-7、IL-11<br>D.IL-1、IL-6、IL-8<br>E.IL-1、IL-2、IL-12、IL-15</td>
      <td>D.IL-1、IL-6、IL-8</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>8. 兄弟姐妹间进行器官移植，引起排斥反应的抗原是(2.0分)</td>
      <td>A.异种抗原<br>B.同种异型抗原<br>C.异嗜性抗原<br>D.自身抗原<br>E.感染的微生物抗原</td>
      <td>B.同种异型抗原</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>9. 以下有关TAP基因的叙述哪项是错误的(2.0分)</td>
      <td>A.它编码产物是抗原肽转运体<br>B.它包括TAP1和TAP2两个基因座位<br>C.它位于HLA I类基因区<br>D.其编码产物主要参与内源性抗原肽的转运<br>E.其编码产物参与抗原肽由胞质进入内质网的转运</td>
      <td>C.它位于HLA I类基因区</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>10. 人类MHC的染色体定位于 (2.0分)</td>
      <td>A.17号染色体<br>B.6号染色体<br>C.9号染色体<br>D.2号染色体</td>
      <td>B.6号染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>11. 与强直性脊柱炎有关的HLA抗原是(2.0分)</td>
      <td>A.HLA-CW6<br>B.HLA-B27<br>C.HLA-DR3<br>D.HLA-DR4<br>E.HLA-A1</td>
      <td>B.HLA-B27</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>12. HLA单元型是(2.0分)</td>
      <td>A.在同一条染色体上存在的全套MHC等位基因<br>B.MHC基因座的特殊片段<br>C.促进排斥的在MHC基因座以外的基因<br>D.HLA-B的一个等位基因</td>
      <td>A.在同一条染色体上存在的全套MHC等位基因</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>13. 下列哪一个不是由MHC基因编码(2.0分)</td>
      <td>A.β2-微球蛋白<br>B.I类HLA抗原<br>C.II类HLA抗原<br>D.C4<br>E.HSP70</td>
      <td>A.β2-微球蛋白</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>14. 人或动物体内代表个体特异性的能引起强烈而迅速排斥反应的抗原系统称为(2.0分)</td>
      <td>A.组织相容性抗原<br>B.移植抗原<br>C.白细胞抗原<br>D.主要组织相容性抗原系统<br>E.主要组织相容性复合体</td>
      <td>D.主要组织相容性抗原系统</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>15. MHC-I类分子的经典功能(2.0分)</td>
      <td>A.为CD8+杀伤性T细胞的识别分子<br>B.参与外源性抗原呈递<br>C.参与内源性抗原呈递<br>D.A十B<br>E.A十C</td>
      <td>E.A十C</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>16. 下列对肺淤血组织学特点的描述中哪一项是错误的？(2.0分)</td>
      <td>A. 肺泡壁毛细血管扩张<br>B. 肺泡腔内有水肿液<br>C. 肺泡腔内有大量中性粒细胞和纤维素渗出<br>D. 肺泡腔内有多少不等的红细胞<br>E. 肺泡腔内可见心力衰竭细胞</td>
      <td>C. 肺泡腔内有大量中性粒细胞和纤维素渗出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>17. 下列对肝淤血脂肪变的病变特点的描述中哪一项是错误的？(2.0分)</td>
      <td>A.肝脏体积增大，表面和切面呈暗红色<br>B.肝小叶中央静脉肝窦明显扩张充血<br>C.肝小叶中央静脉周围肝细胞高度脂肪变性<br>D. 肝小叶周边肝细胞高度脂肪变性<br>E. 肝小叶中央肝细胞坏死、崩解</td>
      <td>C.肝小叶中央静脉周围肝细胞高度脂肪变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>18. 44岁男患，车祸时发生右大腿骨粉碎性及开放性骨折，在送往医院途中，该患者出现面部青紫，呼吸困难，口吐白沫而亡，其最可能的死因是：(2.0分)</td>
      <td>A.心肌梗死<br>B. 气体栓塞<br>C. 脂肪栓塞<br>D. 脑出血<br>E.气胸</td>
      <td>C. 脂肪栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>19. 以下哪种说法是错误的？(2.0分)</td>
      <td>A.白色血栓可单独出现于动脉内膜上<br>B.白色血栓可参与构成静脉血栓<br>C.红色血栓组成与血凝块无异<br>D.透明血栓是静脉血栓的组分之一<br>E. 混合血栓是静脉血栓的主体</td>
      <td>D.透明血栓是静脉血栓的组分之一</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>20. 以下哪种类型的栓塞最为常见和重要？(2.0分)</td>
      <td>A. 血栓栓塞<br>B. 气体栓塞<br>C. 羊水栓塞<br>D. 脂肪栓塞<br>E. 肿瘤细胞栓塞</td>
      <td>A. 血栓栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>21. 某心衰患者下肢深静脉内的血栓脱落后最有可能引起以下哪种病变：(2.0分)</td>
      <td>A. 脑梗死<br>B. 心肌梗死<br>C. 肺梗死<br>D. 肾梗死<br>E. 肠梗死</td>
      <td>C. 肺梗死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>22. 某患者患急性感染性心内膜炎，其二尖瓣瓣膜上出现一黄豆大的赘生物，此赘生物脱落后将不会引起以下哪种栓塞：(2.0分)</td>
      <td>A. 脑动脉栓塞<br>B. 脾动脉栓塞<br>C. 肺动脉栓塞<br>D. 肾动脉栓塞<br>E. 肠系膜动脉栓塞</td>
      <td>C. 肺动脉栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>23. 梗死灶的形状取决于：(2.0分)</td>
      <td>A. 该器官的组织致密程度<br>B. 该器官的血管分布方式<br>C. 该器官的侧枝循环状态<br>D. 该器官是否有淤血<br>E. 该器官的蛋白含量</td>
      <td>B. 该器官的血管分布方式</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>24. 以下哪种类型的梗死一般不是贫血性梗死？(2.0分)</td>
      <td>A. 肾梗死<br>B. 脾梗死<br>C. 脑梗死<br>D. 肠梗死<br>E. 心肌梗死</td>
      <td>D. 肠梗死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>25. 以下哪项不是出血性梗死发生的条件：(2.0分)</td>
      <td>A. 组织疏松<br>B. 侧枝循环丰富<br>C. 器官高度淤血<br>D. 器官内蛋白含量较少<br>E. 动静脉同时受压</td>
      <td>D. 器官内蛋白含量较少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>26. 某男车祸后股骨骨折入院，急救后情况稳定，第2天突发呼吸急促、呼吸困难和心动过速，终因右心衰竭死亡，该患者的死亡原因最有可能为：(2.0分)</td>
      <td>A.血栓栓塞<br>B.肺脂肪栓塞<br>C.肺气体栓塞<br>D.肺骨髓组织栓塞<br>E.肺受伤动脉破裂出血</td>
      <td>B.肺脂肪栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>27. 引起肺褐色硬化的最常见疾病是：(2.0分)</td>
      <td>A.二尖瓣狭窄'<br>B.肺动脉瓣狭窄<br>C.三尖瓣狭窄<br>D.主动脉瓣闭锁不全<br>E.肺动脉栓塞</td>
      <td>A.二尖瓣狭窄'</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>28. 心力衰竭细胞最常见于：(2.0分)</td>
      <td>A.冠心病<br>B.肺心病<br>C.右心衰竭<br>D.慢性肺淤血<br>E.肺褐色硬化</td>
      <td>D.慢性肺淤血</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>29. 脂肪栓塞病人死亡原因常见于下列哪一种情况： (2.0分)</td>
      <td>A.急性右心衰竭<br>B.急性左心衰竭<br>C.肾功能衰竭<br>D.心肌梗死</td>
      <td>A.急性右心衰竭</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>30. 下列哪种情况不易发生气体栓塞： (2.0分)</td>
      <td>A.颈部外伤和手术<br>B.胸部外伤和手术<br>C.锁骨下静脉外伤<br>D.胎盘早期剥离<br>E.大隐静脉插管输液</td>
      <td>E.大隐静脉插管输液</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>31. 纤维素性炎最常由下列哪种病原微生物引起：(2.0分)</td>
      <td>A.溶血性链球菌<br>B.痢疾杆菌<br>C.真菌<br>D.大肠杆菌</td>
      <td>B.痢疾杆菌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>32. 关于炎症的概念，较恰当的解释是：(2.0分)</td>
      <td>A.所有活体组织对损伤因子所发生的防御反应<br>B.具有完整神经系统的生物对损防因子所发生的局部反应<br>C.具有血管系统的活体组织对损伤因子所发生的防御反应<br>D.全身出现红、肿、热、痛现象</td>
      <td>C.具有血管系统的活体组织对损伤因子所发生的防御反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>33. 有关外周血中性白细胞核右移，下列那项不正确： (2.0分)</td>
      <td>A.核分叶、增多<br>B.以衰老中性白细胞为多<br>C.反映病人对感染抵抗力较强<br>D.提示病人反应力低下</td>
      <td>C.反映病人对感染抵抗力较强</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>34. 下列配对哪项明显错误：(2.0分)</td>
      <td>A.皮肤表层水泡-化脓性炎<br>B.大叶性肺炎-纤维素性炎<br>C.风湿性关节炎-浆液性炎<br>D.结核病-肉芽肿性炎</td>
      <td>A.皮肤表层水泡-化脓性炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>35. 葡萄球菌和链球菌感染时局部以下列那种是细胞浸润为主： (2.0分)</td>
      <td>A.嗜酸性粒细胞<br>B.中性粒细胞<br>C.巨噬细胞<br>D.淋巴细胞</td>
      <td>B.中性粒细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>36. 解热镇痛抗炎药物的共同作用机制是 (2.0分)</td>
      <td>A.抑制细胞间黏附因子的合成<br>B.抑制肿瘤坏死因子的合成<br>C.抑制前列腺素的合成<br>D.抑制白介素的合成<br>E.抑制血栓素的合成</td>
      <td>C.抑制前列腺素的合成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>37. Aspirin的用途不包括以下哪一项？ (2.0分)</td>
      <td>A.预防脑血栓形成<br>B.治疗感冒引起的头痛<br>C.治疗风湿性关节炎<br>D.用于低温麻醉<br>E.缓解牙痛</td>
      <td>D.用于低温麻醉</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>38. Aspirin的不良反应不包括 (2.0分)</td>
      <td>A.胃肠道反应<br>B.凝血障碍<br>C.成瘾性<br>D.过敏反应<br>E.水杨酸反应</td>
      <td>C.成瘾性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>39. 对风湿性关节炎，非甾体抗炎药的作用是 (2.0分)</td>
      <td>A.缩短疗程<br>B.可根治风湿性关节炎<br>C.阻止肉芽组织及瘢痕形成<br>D.对症治疗（缓解症状）<br>E.对因治疗（消除病因）</td>
      <td>D.对症治疗（缓解症状）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>40. 有关塞来昔布，下列说法正确的是 (2.0分)</td>
      <td>A.不影响前列腺素合成<br>B.治疗剂量可影响血栓素A2的合成<br>C.是非选择性环氧酶-2抑制药<br>D.是选择性环氧酶-2抑制药<br>E.不良反应多</td>
      <td>D.是选择性环氧酶-2抑制药</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>41. 糖皮质激素抗炎作用的基本机制是 (2.0分)</td>
      <td>A.稳定溶酶体膜<br>B.抑制毛细血管和纤维母细胞的增生<br>C.减轻渗出、水肿、毛细血管扩张等炎症反应<br>D.影响了参与炎症的一些基因转录<br>E.增加肥大细胞颗粒的稳定性</td>
      <td>D.影响了参与炎症的一些基因转录</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>42. 糖皮质激素用于急性炎症的主要目的在于 (2.0分)</td>
      <td>A.加快消除致病因素，促进炎症消退<br>B.增强机体防御功能，促进炎症消退<br>C.降低血管通透性，减轻肿胀、疼痛等症状<br>D.改善葡萄糖、蛋白质、水盐代谢，提高机体抗病能力<br>E.抑制肉芽组织生长，防止粘连和疤痕形成，减轻后遗症</td>
      <td>C.降低血管通透性，减轻肿胀、疼痛等症状</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>43. 糖皮质激素用于慢性炎症的目的在于 (2.0分)</td>
      <td>A.具有强大抗炎作用，促进炎症消散<br>B.抑制花生四烯酸释放，使炎症介质PG合成减少<br>C.促进炎症区的血管收缩，降低其通透性<br>D.稳定溶酶体膜，减少蛋白水解酶的释放<br>E.抑制肉芽组织生长，防止粘连和疤痕</td>
      <td>E.抑制肉芽组织生长，防止粘连和疤痕</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>44. 糖皮质激素和抗生素合用治疗严重感染的目的是 (2.0分)</td>
      <td>A.增强机体免疫能力<br>B.用激素缓解症状，度过危险期，用抗生素控制感染<br>C.对抗抗生素的某些不良反应<br>D.增强机体防御能力<br>E.增强抗生素的抗菌作用</td>
      <td>B.用激素缓解症状，度过危险期，用抗生素控制感染</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>45. 糖皮质激素诱发和加重感染的主要原因是 (2.0分)</td>
      <td>A.用量不足，无法控制症状而造成<br>B.病人对激素不敏感而未反映出相应的疗效<br>C.促使许多病原微生物繁殖所致<br>D.抑制炎症反应和免疫反应，降低机体的防御能力<br>E.抑制促肾上腺皮质激素的释放</td>
      <td>D.抑制炎症反应和免疫反应，降低机体的防御能力</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>46. 下列哪项与炎症渗出液无关(2.0分)</td>
      <td>A.血管通透性增高<br>B.液体比重高<br>C.液体静置后凝固<br>D.液体内含纤维蛋白<br>E.液体内含极少细胞</td>
      <td>E.液体内含极少细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>47. 在过敏反应炎症中，组胺来源于(2.0分)</td>
      <td>A.嗜酸性粒细胞<br>B.淋巴细胞<br>C.浆细胞<br>D.肥大细胞<br>E.单核细胞</td>
      <td>D.肥大细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>48. 较多嗜酸性粒细胞浸润见于(2.0分)</td>
      <td>A.伤寒杆菌感染<br>B.变态反应或寄生虫感染<br>C.乙脑病毒感染<br>D.溶血性链球菌感染<br>E.葡萄球菌感染</td>
      <td>B.变态反应或寄生虫感染</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>49. 关于炎症细胞的描述，下列哪项不正确(2.0分)</td>
      <td>A.中性粒细胞浸润通常是急性炎症的标志<br>B.慢性炎症细胞主要是淋巴细胞，巨噬细胞和浆细胞<br>C.淋巴细胞并非总是慢性炎症的特征<br>D.中性粒细胞游出后常引起局部单核细胞的渗出<br>E.白细胞的渗出只见于急性炎症早期</td>
      <td>E.白细胞的渗出只见于急性炎症早期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2009</td>
      <td>50. 以下不具防御作用的反应是 (2.0分)</td>
      <td>A.纤维蛋白渗出<br>B.白细胞游出<br>C.炎性增生<br>D.红细胞漏出<br>E.血浆渗出</td>
      <td>D.红细胞漏出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>1. IFN-γ：(2.5分)</td>
      <td>A.主要由成纤维细胞产生<br>B.主要由白细胞产生<br>C.其抗病毒功能强于免疫调节功能<br>D.又称为I型干扰素<br>E.具有干扰病毒复制的功能</td>
      <td>D.又称为I型干扰素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>2. 对炎症反应有明显促进作用的白细胞介素是：(2.5分)</td>
      <td>A.IL-2、IL-4、IL-5、IL-6<br>B.IL-2、IL-10、IL-12<br>C.IL-3、IL-7、IL-11<br>D.IL-1、IL-6、IL-8<br>E.IL-1、IL-2、IL-12、IL-15</td>
      <td>D.IL-1、IL-6、IL-8</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>3. 主要介导同型细胞间的黏附作用，对组织和器官的发育及完整组织结构的维持起重要作用的黏附分子家族是：(2.5分)</td>
      <td>A.免疫球蛋白超家族<br>B.选择素家族<br>C.钙黏蛋白家族<br>D.整合素家族<br>E.未归类黏附分子</td>
      <td>C.钙黏蛋白家族</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>4. 以下关于CD4的说法哪项是错误的：(2.5分)</td>
      <td>A.成熟的T细胞表面都有CD4表达<br>B.CD4不直接参与特异性识别抗原<br>C.CD4属于免疫球蛋白超家族成员<br>D.CD4可与Ag-MHCII分子复合体结合<br>E.可用抗CD4单抗对辅助性T细胞进行检测</td>
      <td>A.成熟的T细胞表面都有CD4表达</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>5. 属于趋化因子的是：(2.5分)</td>
      <td>A.IL-8<br>B.IL-1<br>C.IL-2<br>D.TGF-β<br>E.TNF-β</td>
      <td>A.IL-8</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>6. 与B细胞活化有关的膜分子：(2.5分)</td>
      <td>A.CD3和CD2<br>B.CD4和CD8<br>C.CD4和CD40<br>D.CD21和CD19<br>E.CD56和CD16</td>
      <td>D.CD21和CD19</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>7. 主要介导细胞与细胞外基质结合的黏附分子家族是：(2.5分)</td>
      <td>A.免疫球蛋白超家族<br>B.选择素家族<br>C.整合素家族<br>D.钙黏蛋白家族<br>E.未归类黏附分子</td>
      <td>C.整合素家族</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>8. 慢性肝淤血时，通常不会出现(2.5分)</td>
      <td>A.肝细胞萎缩<br>B.肝细胞脂肪变性<br>C.肝纤维支架的破坏<br>D.纤维组织增生<br>E.中央静脉和肝血窦扩张淤血</td>
      <td>C.肝纤维支架的破坏</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>9. 左冠状动脉回旋支栓塞可引起 (2.5分)</td>
      <td>A.左心室前壁心肌梗死<br>B.左心室后壁心肌梗死<br>C.左心室侧壁心肌梗死<br>D.室间隔前1/3心肌梗死<br>E.右心室心肌梗死</td>
      <td>C.左心室侧壁心肌梗死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>10. 下列哪项不是肺梗死的特点 (2.5分)</td>
      <td>A.梗死灶呈不规则形<br>B.梗死灶呈暗红色<br>C.为凝固性坏死<br>D.可继发感染引起坏疽<br>E.累及胸膜脏层时可引起胸痛</td>
      <td>A.梗死灶呈不规则形</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>11. 慢性肺淤血不包括(2.5分)</td>
      <td>A.肺水肿<br>B.肺出血<br>C.肺泡壁毛细血管扩张充血<br>D.肺泡间隔增宽<br>E.肺内支气管明显扩张</td>
      <td>E.肺内支气管明显扩张</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>12. 下列哪种梗死可发生软化并形成囊腔 (2.5分)</td>
      <td>A.肺梗死<br>B.肠梗死<br>C.脾梗死<br>D.脑梗死<br>E.肾梗死</td>
      <td>D.脑梗死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>13. 下列对肺淤血组织学特点的描述中哪一项是错误的？ (2.5分)</td>
      <td>A. 肺泡壁毛细血管扩张<br>B. 肺泡腔内有水肿液<br>C. 肺泡腔内有大量中性粒细胞和纤维素渗出<br>D. 肺泡腔内有多少不等的红细胞<br>E. 肺泡腔内可见心力衰竭细胞</td>
      <td>C. 肺泡腔内有大量中性粒细胞和纤维素渗出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>14. 44岁男患，车祸时发生右大腿骨粉碎性及开放性骨折，在送往医院途中，该患者出现面部青紫，呼吸困难，口吐白沫而亡，其最可能的死因是：(2.5分)</td>
      <td>A.心肌梗死<br>B.气体栓塞<br>C.脂肪栓塞<br>D.脑出血<br>E.气胸</td>
      <td>C.脂肪栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>15. 某心衰患者下肢深静脉内的血栓脱落后最有可能引起以下哪种病变： (2.5分)</td>
      <td>A. 脑梗死<br>B. 心肌梗死<br>C. 肺梗死<br>D. 肾梗死<br>E. 肠梗死</td>
      <td>C. 肺梗死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>16. 梗死灶的形状取决于：(2.5分)</td>
      <td>A. 该器官的组织致密程度<br>B. 该器官的血管分布方式<br>C. 该器官的侧枝循环状态<br>D. 该器官是否有淤血<br>E. 该器官的蛋白含量</td>
      <td>B. 该器官的血管分布方式</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>17. 男，61岁，以四肢瘫痪，失语10天入院，入院当天血压下降，呼吸衰竭，次晨死亡。尸体解剖发现胰腺粘液癌，局部淋巴结转移,胃、小肠、大肠、肝转移。以下哪项可能是该患者的直接死亡原因。(2.5分)</td>
      <td>A.恶病质<br>B. 淋巴结粘液癌转移<br>C. 脑广泛性微梗死形成<br>D. 肾多发性梗死<br>E. 肺微循环内血栓形成</td>
      <td>E. 肺微循环内血栓形成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>18. 引起肺褐色硬化的最常见疾病是：(2.5分)</td>
      <td>A.二尖瓣狭窄' F. Q L6 q* k<br>B.肺动脉瓣狭窄<br>C.三尖瓣狭窄<br>D.主动脉瓣闭锁不全<br>E..肺动脉栓塞</td>
      <td>A.二尖瓣狭窄' F. Q L6 q* k</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>19. 关于严重肺淤血的叙述，下列哪项是错误的：0 f9 \' y6 \5 `7 J4 m(2.5分)</td>
      <td>A.肺泡腔内有水肿液<br>B.可见心力衰竭细胞<br>C.可发生漏出性出血# W6 {3 d1 N) V<br>D.肺泡壁毛细血管扩张充血<br>E.肺泡腔内见有白细胞和纤维蛋白</td>
      <td>E.肺泡腔内见有白细胞和纤维蛋白</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>20. 下列有关梗死叙述中，哪一项是不正确的：(2.5分)</td>
      <td>A.双重血循环的器官不易发生梗死<br>B.全身血液循环状态对梗死发生无影响<br>C.动脉痉挛促进梗死发生<br>D.有效的侧枝循环的建立可防止梗死发生<br>E.梗死多由动脉阻塞引起</td>
      <td>B.全身血液循环状态对梗死发生无影响</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>21. 羊水栓塞时，病理诊断的主要依据是：(2.5分)</td>
      <td>A.肺小动脉和毛细血管内有羊水成分<br>B.微血管内透明血栓% q$ |, W1 D" U<br>C.肺泡腔内有角化上皮和胎粪小体等. o. I4 L8 B( {) D<br>D.肺水肿和出血<br>E.肺透明膜形成* C0 u8 B( S4 ^& k, E/ m5 O- ^1</td>
      <td>A.肺小动脉和毛细血管内有羊水成分</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>22. 下列哪种情况不易发生气体栓塞：" |8 ^8 d. Q6 B2 I1 V(2.5分)</td>
      <td>A.颈部外伤和手术<br>B.胸部外伤和手术<br>C.锁骨下静脉外伤<br>D.胎盘早期剥离<br>E.大隐静脉插管输液# o' p* R! `. N* e" Y</td>
      <td>E.大隐静脉插管输液# o' p* R! `. N* e" Y</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>23. 肺动脉栓塞引起猝死的原因不包括哪一项：(2.5分)</td>
      <td>A.肺动脉痉挛<br>B.支气管动脉痉挛4 S5 G2 u' E+ b; x# N: p<br>C.支气管痉挛<br>D.肺出血性梗死, n8 x' F/ K' W4 ], J( Q3 F# K<br>E.心冠状动脉痉挛</td>
      <td>D.肺出血性梗死, n8 x' F/ K' W4 ], J( Q3 F# K</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>24. 淤血器官的形态特征是：, y8 q- Q* Z& J$ H- a(2.5分)</td>
      <td>A.色暗红，体积增大，切面湿润，功能增强，温度降低<br>B.色暗红，体积缩小，切面干燥，功能增强，温度降低<br>C.色暗红，体积增大，切面湿润，功能减退，温度降低<br>D.色鲜红，体积增大，切面干燥，功能减退，温度降低<br>E.色鲜红，体积缩小，切面湿润，功能增强，温度降低</td>
      <td>C.色暗红，体积增大，切面湿润，功能减退，温度降低</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>25. 下列心脏病很少引起肺淤血的是：(2.5分)</td>
      <td>A.高血压性心脏病<br>B.肺源性心脏病<br>C.风湿性心脏病二尖瓣狭窄<br>D.梅毒性心脏病<br>E.冠心病</td>
      <td>B.肺源性心脏病</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>26. 某患者患急性感染性心内膜炎，其二尖瓣瓣膜上出现一黄豆大的赘生物，此赘生物脱落后将不会引起以下哪种栓塞：(2.5分)</td>
      <td>A.脑动脉栓塞<br>B.脾动脉栓塞<br>C.肺动脉栓塞<br>D.肾动脉栓塞<br>E.肠系膜动脉栓塞</td>
      <td>C.肺动脉栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>27. 一位18岁的病人，其脚部因冻伤出现水泡，以下诊断正确的是：(2.5分)</td>
      <td>A.纤维素性炎症<br>B.浆液性炎症<br>C.脓肿<br>D.蜂窝织炎</td>
      <td>B.浆液性炎症</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>28. 关于炎症的概念，较恰当的解释是：(2.5分)</td>
      <td>A.所有活体组织对损伤因子所发生的防御反应<br>B.具有完整神经系统的生物对损防因子所发生的局部反应<br>C.具有血管系统的活体组织对损伤因子所发生的防御反应<br>D.全身出现红、肿、热、痛现象</td>
      <td>C.具有血管系统的活体组织对损伤因子所发生的防御反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>29. 脓肿主要由下列哪种细菌引起：(2.5分)</td>
      <td>A.金黄色葡萄球菌<br>B.溶血性链球莲<br>C.大肠肝菌<br>D.绿脓杆菌</td>
      <td>B.溶血性链球莲</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>30. 形成漏出液的主要原因是(2.5分)</td>
      <td>A.主要由局部血管通透性升高所致<br>B.主要由白细胞主动游出所致<br>C.主要由静脉回流受阻所致<br>D.主要由局部血管内渗透升高所致</td>
      <td>C.主要由静脉回流受阻所致</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>31. 炎性假瘤指的是：(2.5分)</td>
      <td>A.炎性增生形成的肿瘤样团场块<br>B.上皮增生形成的良性肿瘤<br>C.间叶组织形成的恶性肿瘤<br>D.局限性的化脓性炎</td>
      <td>A.炎性增生形成的肿瘤样团场块</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>32. 一患者有明显全身中毒症状，还出现皮肤粘膜的多发性出血斑点和脾及全身淋巴结肿 大、血中查到病原菌，应考虑为：(2.5分)</td>
      <td>A.败血症<br>B.菌血症<br>C.脓毒血症<br>D.毒血症</td>
      <td>A.败血症</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>33. 与疼痛明显有关的炎症介质是(2.5分)</td>
      <td>A.甲状腺素<br>B.C3a<br>C.前列腺素<br>D.C5a</td>
      <td>C.前列腺素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>34. 炎症时白细胞游出的部位是： (2.5分)</td>
      <td>A.细静脉与毛细血管<br>B.细动脉与细静脉<br>C.中静脉与细静脉<br>D.小动脉与细动脉</td>
      <td>A.细静脉与毛细血管</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>35. 炎症时，血液动力学变化一般按以下顺序发生(2.5分)</td>
      <td>A.细动脉短暂收缩→主动性充血→血流速度减慢→白细胞靠边、附壁<br>B.白细胞靠边附壁→血流速度减慢→主动性充血→细动态短暂收缩<br>C.细动脉短暂收缩→白细胞靠边附壁→主动性充血→血流速度变慢<br>D.细动脉短暂收缩→主动性充血→白细胞靠边附壁→血流速度减慢</td>
      <td>A.细动脉短暂收缩→主动性充血→血流速度减慢→白细胞靠边、附壁</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>36. 阿司匹林（aspirin）的不良反应中，与抑制PG合成酶无关是 (2.5分)</td>
      <td>A.阿司匹林哮喘<br>B.水杨酸反应<br>C.抑制血小板聚集<br>D.导致胃溃疡、胃出血<br>E.损伤肾功能</td>
      <td>B.水杨酸反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>37. 糖皮质激素的不良反应不包括 (2.5分)</td>
      <td>A.类肾上腺皮质功能亢进综合征<br>B.诱发或加重感染<br>C.诱发或加重支气管哮喘<br>D.诱发或加重溃疡病<br>E.骨质疏松、肌肉萎缩</td>
      <td>C.诱发或加重支气管哮喘</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>38. 糖皮质激素用于急性炎症的主要目的在于 (2.5分)</td>
      <td>A.加快消除致病因素，促进炎症消退<br>B.增强机体防御功能，促进炎症消退<br>C.降低血管通透性，减轻肿胀、疼痛等症状<br>D.改善葡萄糖、蛋白质、水盐代谢，提高机体抗病能力<br>E.抑制肉芽组织生长，防止粘连和疤痕形成，减轻后遗症</td>
      <td>C.降低血管通透性，减轻肿胀、疼痛等症状</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>39. 解热镇痛作用强而抗炎作用很弱的药物是 (2.5分)</td>
      <td>A.吲哚美辛<br>B.布洛芬<br>C.双氯芬酸<br>D.吡罗昔康<br>E.对乙酰氨基酚</td>
      <td>E.对乙酰氨基酚</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2010</td>
      <td>40. 关于炎症的概念，较确切的说法是(2.5分)</td>
      <td>A.白细胞对细菌的一种作用<br>B.由损伤引起的细胞变化<br>C.细胞生长异常的一种形式<br>D.充血、水肿的一种形式<br>E.组织对损伤的一种防御为主的反应</td>
      <td>E.组织对损伤的一种防御为主的反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>1. 细胞因子不具备的特点是：(4.0分)</td>
      <td>A.通过与相应受体结合发挥作用<br>B.作用具有高效性和多效性<br>C.作用具有重叠性和网络性<br>D.主要是在局部起持久作用<br>E.主要通过自分泌和旁分泌发挥作用</td>
      <td>D.主要是在局部起持久作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>2. 以下关于CD4的说法哪项是错误的：(4.0分)</td>
      <td>A.成熟的T细胞表面都有CD4表达<br>B.CD4不直接参与特异性识别抗原<br>C.CD4属于免疫球蛋白超家族成员<br>D.CD4可与Ag-MHCII分子复合体结合<br>E.可用抗CD4单抗对辅助性T细胞进行检测</td>
      <td>A.成熟的T细胞表面都有CD4表达</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>3. 主要介导细胞与细胞外基质结合的黏附分子家族是：(3.0分)</td>
      <td>A.免疫球蛋白超家族<br>B.选择素家族<br>C.整合素家族<br>D.钙黏蛋白家族<br>E.未归类黏附分子</td>
      <td>C.整合素家族</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>4. 与B细胞活化有关的膜分子：(4.0分)</td>
      <td>A.CD3和CD2<br>B.CD4和CD8<br>C.CD4和CD40<br>D.CD21和CD19<br>E.CD56和CD16</td>
      <td>D.CD21和CD19</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>5. 对炎症反应有明显促进作用的白细胞介素是：(3.0分)</td>
      <td>A.IL-2、IL-4、IL-5、IL-6<br>B.IL-2、IL-10、IL-12<br>C.IL-3、IL-7、IL-11<br>D.IL-1、IL-6、IL-8<br>E.IL-1、IL-2、IL-12、IL-15</td>
      <td>D.IL-1、IL-6、IL-8</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>6. IFN-γ：(4.0分)</td>
      <td>A.主要由成纤维细胞产生<br>B.主要由白细胞产生<br>C.其抗病毒功能强于免疫调节功能<br>D.又称为I型干扰素<br>E.具有干扰病毒复制的功能</td>
      <td>E.具有干扰病毒复制的功能</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>7. TNF缺乏以下哪种功能：(3.0分)</td>
      <td>A.抑制炎症反应<br>B.激活中性粒细胞和Mo/Mφ 功能<br>C.内源性致热原<br>D.诱导细胞凋亡<br>E.对肿瘤细胞有毒性作用</td>
      <td>A.抑制炎症反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>8. 主要介导白细胞与内皮细胞结合，参与炎症及淋巴细胞归巢的黏附分子家族是：(4.0分)</td>
      <td>A.整合素家族<br>B.选择素家族<br>C.钙黏蛋白家族<br>D.免疫球蛋白超家族<br>E.未归类黏附分子</td>
      <td>B.选择素家族</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>9. L-选择素、E-选择素、P-选择素中的L、E、P分别表示：(3.0分)</td>
      <td>A.淋巴细胞、血小板、内皮细胞<br>B.血小板、内皮细胞、白细胞<br>C.淋巴细胞、内皮细胞、神经细胞<br>D.白细胞、内皮细胞、血小板<br>E.白细胞、血小板、神经细胞</td>
      <td>D.白细胞、内皮细胞、血小板</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>10. 白色血栓主要由下列哪些成分构成(4.0分)</td>
      <td>A.白细胞、纤维素和血小板<br>B.血小板和纤维素<br>C.红细胞和白细胞<br>D.红细胞和纤维素<br>E.血小板和红细胞</td>
      <td>B.血小板和纤维素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>11. 下述关于梗死的叙述中，哪一项是错误的： (3.0分)</td>
      <td>A.双重血液循环的器官不易发生梗死<br>B.全身血液循环状态对梗死的形成无影响<br>C.动脉痉挛促进梗死的形成<br>D.有效的侧支循环的建立可防止梗死的发生<br>E.梗死多由动脉阻塞引起</td>
      <td>B.全身血液循环状态对梗死的形成无影响</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>12. 脾、肾梗死灶肉眼检查的主要特点为： (4.0分)</td>
      <td>A.多呈楔形、灰白色、界限清楚<br>B.多呈不规则形、暗红色、界限不清<br>C.多呈楔形、暗红色、界限不清<br>D.多呈地图形、暗红色、界限不清<br>E.多呈地图状、灰白色、界限清楚</td>
      <td>A.多呈楔形、灰白色、界限清楚</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>13. 槟榔肝是由____引起的(3.0分)</td>
      <td>A.肝脂肪变<br>B.肝水样变性<br>C.门脉性肝硬化<br>D.慢性肝淤血<br>E.坏死后性肝硬化</td>
      <td>D.慢性肝淤血</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>14. 炎症的基本病变是(3.0分)</td>
      <td>A.组织细胞的变性坏死<br>B.组织的炎性充血和水肿<br>C.变质，渗出，增生<br>D.红，肿，热，痛，功能障碍<br>E.周围血液中白细胞增多和体温升高</td>
      <td>C.变质，渗出，增生</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>15. 伪膜性炎症发生后对患者危害最大的部位在(4.0分)</td>
      <td>A.心包<br>B.胸膜<br>C.腹膜<br>D.气管<br>E.结肠</td>
      <td>B.胸膜</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>16. 有关炎症的定义，下列哪项最准确： (3.0分)</td>
      <td>A.是机体对损伤所发生的反应<br>B.是活体组织对损伤因子所发生的反应<br>C.是活体组织对损伤因子所发生的防御反应<br>D.具有血管系统的活体组织对损伤因子所发生的反应<br>E.具有血管系统的活体组织对损伤因子所发生的防御反应</td>
      <td>E.具有血管系统的活体组织对损伤因子所发生的防御反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>17. 蜂窝织炎的概念应为： (4.0分)</td>
      <td>A.是发生于疏松结缔组织及阑尾的急性炎症<br>B.是以中性粒细胞渗出为主的炎症<br>C.是发生在疏松结缔组织的一种弥漫性化脓性炎症<br>D.由链球菌感染所引起的化脓性炎症<br>E.没有明显坏死的渗出性炎症</td>
      <td>C.是发生在疏松结缔组织的一种弥漫性化脓性炎症</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>18. 下列哪项最符合脓肿的含义： (3.0分)</td>
      <td>A.可形成空腔的变质性炎<br>B.常见于实质性脏器的化脓性炎症<br>C.伴有明显组织坏死溶解的化脓性炎症<br>D.有组织坏死，经溶解后形成脓腔的局限性化脓性炎症<br>E.愈合后常有瘢痕形成的化脓性炎症</td>
      <td>D.有组织坏死，经溶解后形成脓腔的局限性化脓性炎症</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>19. 糖皮质激素和抗生素合用治疗严重感染的目的是 (4.0分)</td>
      <td>A.增强机体防御<br>B.增强抗生素抗菌作用<br>C.拮抗抗生素的不良反应<br>D.增强机体应激性<br>E.激素缓解症状，度过危险期，抗生素控制感染</td>
      <td>E.激素缓解症状，度过危险期，抗生素控制感染</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>20. 对乙酰氨基酚没有明显抗炎、抗风湿作用是因为 (3.0分)</td>
      <td>A.对外周PGs合成酶抑制作用较强<br>B.对中枢PGs合成酶抑制作用较强<br>C.对中枢PGs合成酶抑制作用较弱<br>D.对外周PGs合成酶抑制作用较弱<br>E.对白三烯抑制作用弱</td>
      <td>B.对中枢PGs合成酶抑制作用较强</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>21. 关于罗非昔布的说法错误的是 (4.0分)</td>
      <td>A.对COX-2有高度的选择性抑制作用<br>B.抑制血小板聚集<br>C.口服吸收良好<br>D.主要用于骨关节炎治疗<br>E.胃肠道反应较轻</td>
      <td>C.口服吸收良好</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>22. 近年来出现的选择性COX-2抑制剂的严重不良反应是 (3.0分)</td>
      <td>A.胃肠道反应<br>B.心血管系统不良反应<br>C.血液系统反应<br>D.肝肾功能损伤<br>E.皮肤反应</td>
      <td>B.心血管系统不良反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>23. 糖皮质激素对血液和造血系统的作用是 (4.0分)</td>
      <td>A.刺激骨髓造血功能<br>B.使红细胞与血红蛋白减少<br>C.使中性粒细胞减少<br>D.使血小板减少<br>E.使淋巴细胞增加</td>
      <td>C.使中性粒细胞减少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>24. 不属于阿司匹林禁忌症的是 (4.0分)</td>
      <td>A.维生素K缺乏症<br>B.支气管哮喘<br>C.溃疡病<br>D.冠心病<br>E.低凝血酶原血症</td>
      <td>D.冠心病</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>25. 结构上有β3链整合素家族成员属于(4.0分)</td>
      <td>A.VLA组<br>B.钙黏蛋白组<br>C.补体调节蛋白组<br>D.血小板糖蛋白组<br>E.白细胞黏附受体组</td>
      <td>D.血小板糖蛋白组</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>26. 主要介导同型细胞间的黏附作用，对组织和器官的发育及完整组织结构的维持起重要作用的黏附分子家族是(4.0分)</td>
      <td>A.免疫球蛋白超家族<br>B.选择素家族<br>C.钙黏蛋白家族<br>D.整合素家族<br>E.未归类黏附分子</td>
      <td>C.钙黏蛋白家族</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>27. 刺激淋巴细胞增殖的细胞因子主要是(3.0分)</td>
      <td>A.IL-1<br>B.IL-5<br>C.IL-2<br>D.IFN-γ<br>E.IL-3</td>
      <td>C.IL-2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2011</td>
      <td>28. 产生IL-1细胞主要是(4.0分)</td>
      <td>A.肥大细胞、中性粒细胞<br>B.Mo/Mφ、树突状细胞<br>C.Th2细胞<br>D.Th1细胞<br>E.淋巴细胞</td>
      <td>B.Mo/Mφ、树突状细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>1. 妊娠后期的妇女往往出现下肢或足背皮下水肿，引起水肿的原因为：(2.5分)</td>
      <td>A.下肢动脉生理性充血<br>B.下肢血管的炎症性充血<br>C.下肢动脉的减压后充血<br>D.下肢静脉的淤血<br>E.下肢血管的出血</td>
      <td>D.下肢静脉的淤血</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>2. 下列对肺淤血组织学特点的描述中哪一项是错误的？ (2.5分)</td>
      <td>A.肺泡壁毛细血管扩张<br>B.肺泡腔内有水肿液<br>C.肺泡腔内有大量中性粒细胞和纤维素渗出<br>D.肺泡腔内有多少不等的红细胞<br>E.肺泡腔内可见心力衰竭细胞</td>
      <td>C.肺泡腔内有大量中性粒细胞和纤维素渗出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>3. 44岁男患，车祸时发生右大腿骨粉碎性及开放性骨折，在送往医院途中，该患者出现面部青紫，呼吸困难，口吐白沫而亡，其最可能的死因是：(2.5分)</td>
      <td>A.心肌梗死<br>B.气体栓塞<br>C.脂肪栓塞<br>D.脑出血<br>E.气胸</td>
      <td>C.脂肪栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>4. 关于白色血栓，下列哪项描述不正确？ (2.5分)</td>
      <td>A.白色血栓构成静脉血栓的头部<br>B.白色血栓主要由血小板和纤维素组成<br>C.白色血栓可见于风湿性心内膜炎<br>D.白色血栓常含有大量的中性粒细胞，故肉眼呈白色<br>E.白色血栓机化可致心瓣膜变形</td>
      <td>D.白色血栓常含有大量的中性粒细胞，故肉眼呈白色</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>5. 以下哪种类型的栓塞最为常见和重要？ (2.5分)</td>
      <td>A.血栓栓塞<br>B.气体栓塞<br>C.羊水栓塞<br>D.脂肪栓塞<br>E.肿瘤细胞栓塞</td>
      <td>A.血栓栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>6. 某患者患急性感染性心内膜炎，其二尖瓣瓣膜上出现一黄豆大的赘生物，此赘生物脱落后将不会引起以下哪种栓塞：(2.5分)</td>
      <td>A.脑动脉栓塞<br>B.脾动脉栓塞<br>C.肺动脉栓塞<br>D.肾动脉栓塞<br>E.肠系膜动脉栓塞</td>
      <td>C.肺动脉栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>7. 梗死灶的形状取决于：(2.5分)</td>
      <td>A.该器官的组织致密程度<br>B.该器官的血管分布方式<br>C.该器官的侧枝循环状态<br>D.该器官是否有淤血<br>E.该器官的蛋白含量</td>
      <td>B.该器官的血管分布方式</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>8. 男，61岁，以四肢瘫痪，失语10天入院，入院当天血压下降，呼吸衰竭，次晨死亡。尸体解剖发现胰腺粘液癌，局部淋巴结转移,胃、小肠、大肠、肝转移。以下哪项可能是该患者的直接死亡原因。(2.5分)</td>
      <td>A.恶病质<br>B.淋巴结粘液癌转移<br>C.脑广泛性微梗死形成<br>D.肾多发性梗死<br>E.肺微循环内血栓形成</td>
      <td>E.肺微循环内血栓形成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>9. 引起肺褐色硬化的最常见疾病是：(2.5分)</td>
      <td>A.二尖瓣狭窄<br>B.肺动脉瓣狭窄<br>C.三尖瓣狭窄<br>D.主动脉瓣闭锁不全<br>E.肺动脉栓塞</td>
      <td>A.二尖瓣狭窄</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>10. 关于严重肺淤血的叙述，下列哪项是错误的(2.5分)</td>
      <td>A.肺泡腔内有水肿液<br>B.可见心力衰竭细胞<br>C.可发生漏出性出血<br>D.肺泡壁毛细血管扩张充血<br>E.肺泡腔内见有白细胞和纤维蛋白</td>
      <td>E.肺泡腔内见有白细胞和纤维蛋白</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>11. 易发生贫血性梗死的器官是(2.5分)</td>
      <td>A.心、脑、肠<br>B.肾、肠、脑<br>C.心、脾、肾<br>D.脾、心、肺<br>E.肾、心、肺</td>
      <td>C.心、脾、肾</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>12. 下列哪种情况不易发生气体栓塞：(2.5分)</td>
      <td>A.颈部外伤和手术<br>B.胸部外伤和手术<br>C.锁骨下静脉外伤<br>D.胎盘早期剥离<br>E.大隐静脉插管输液</td>
      <td>E.大隐静脉插管输液</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>13. 透明血栓最常见于：(2.5分)</td>
      <td>A.小动脉<br>B.小静脉<br>C.毛细血管<br>D.中静脉<br>E.中动脉</td>
      <td>C.毛细血管</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>14. 下述关于梗死的叙述中，哪一项是错误的: (2.5分)</td>
      <td>A.双重血液循环的器官不易发生梗死<br>B.全身血液循环状态对梗死的形成无影响<br>C.动脉痉挛促进梗死的形成<br>D.有效的侧支循环的建立可防止梗死的发生<br>E.梗死多由动脉阻塞引起</td>
      <td>B.全身血液循环状态对梗死的形成无影响</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>15. 诊断羊水栓塞的证据主要是在下何处发现羊水成分：(2.5分)</td>
      <td>A.脑动脉酸性粒细胞<br>B.子宫腔内<br>C.肺泡腔内<br>D.细支气管内<br>E.肺小动脉和毛细血管</td>
      <td>E.肺小动脉和毛细血管</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>16. Which of the following cytokines does not belong to Th2 type (2.5分)</td>
      <td>A.IL-4<br>B.IL-5<br>C.IL-6<br>D.IL-13<br>E.IFN-γ</td>
      <td>E.IFN-γ</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>17. Which of the following cytokines can mediate anti-virus effect (2.5分)</td>
      <td>A.IL-1<br>B.IL-6<br>C.IL-8<br>D.IFN-α<br>E.GM-CSF</td>
      <td>D.IFN-α</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>18. 细胞因子不具备的特点是：(2.5分)</td>
      <td>A.通过与相应受体结合发挥作用<br>B.作用具有高效性和多效性<br>C.作用具有重叠性和网络性<br>D.主要是在局部起持久作用<br>E.主要通过自分泌和旁分泌发挥作用</td>
      <td>D.主要是在局部起持久作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>19. Which of the following description can happen in patients of X-linked severe combined immunodeficiency (2.5分)</td>
      <td>A.Normal numbers of T cells<br>B.Normal numbers of NK cells<br>C.Normal numbers of B cells<br>D.Normal classes of immunoglobulins<br>E.Normal responses of T cells to mitogen</td>
      <td>C.Normal numbers of B cells</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>20. The T cell receptor complex comprises the following molecules(2.5分)</td>
      <td>A.TCR and CD3<br>B.TCR and CD2<br>C.TCR and one MHC molecule<br>D.TCR and CD4<br>E.TCR and CD8</td>
      <td>A.TCR and CD3</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>21. 与T细胞活化有关的重要膜分子：(2.5分)</td>
      <td>A.CD4和CD2<br>B.ITAM和CD8<br>C.p56lck<br>D.CD21和CD19<br>E.CD56和CD16</td>
      <td>A.CD4和CD2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>22. Which of the following surface markers can be considered as B cell-specific marker(2.5分)</td>
      <td>A.CD80/86<br>B.CD40<br>C.CD19<br>D.CTLA4<br>E.CD40L</td>
      <td>C.CD19</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>23. Which of the following surface molecules on B cells is critical for the formation of germinal center(2.5分)</td>
      <td>A.CD81<br>B.CD80<br>C.CD19<br>D.CD40<br>E.ICAM-1</td>
      <td>D.CD40</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>24. 炎症的发生和发展取决于：(2.5分)</td>
      <td>A.种族与损伤因子<br>B.机体的反应性与年龄<br>C.损伤因子与机体的反应性<br>D.性别与年龄<br>E.细菌及其他微生物</td>
      <td>C.损伤因子与机体的反应性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>25. 深部脓肿自体表穿破，形成一端排脓的盲管称：(2.5分)</td>
      <td>A.导管<br>B.窦道<br>C.瘘管<br>D.溃疡<br>E.脓腔</td>
      <td>B.窦道</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>26. 纤维素性炎最常由下列哪种病原微生物引起：(2.5分)</td>
      <td>A.溶血性链球菌<br>B.痢疾杆菌<br>C.真菌<br>D.大肠杆菌<br>E.金黄色葡萄球菌</td>
      <td>B.痢疾杆菌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>27. 关于炎症的概念，最准确的解释是：(2.5分)</td>
      <td>A.所有活体组织对损伤因子所发生的防御反应<br>B.具有完整神经系统的生物对损防因子所发生的局部反应<br>C.具有血管系统的活体组织对损伤因子所发生的防御反应<br>D.具有导管系统的活体组织对损伤因子所发生的防御反应<br>E.具有淋巴管系统的活体组织对损伤因子所发生的防御反应</td>
      <td>C.具有血管系统的活体组织对损伤因子所发生的防御反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>28. 下列配对哪项明显错误：(2.5分)</td>
      <td>A.皮肤表层水泡-化脓性炎<br>B.大叶性肺炎-纤维素性炎<br>C.风湿性关节炎-浆液性炎<br>D.结核病-肉芽肿性炎<br>E.炎性假瘤---非特异性炎</td>
      <td>D.结核病-肉芽肿性炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>29. 葡萄球菌和链球菌感染时局部以下列哪种细胞浸润为主：(2.5分)</td>
      <td>A.嗜酸性粒细胞<br>B.中性粒细胞<br>C.巨噬细胞<br>D.淋巴细胞<br>E.嗜碱性粒细胞</td>
      <td>B.中性粒细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>30. 血管活性胺主要存在于：(2.5分)</td>
      <td>A.浆细胞与淋巴细胞<br>B.肥大细胞与嗜碱性细胞<br>C.中性白细胞与嗜酸性的细胞<br>D.中性白细胞与巨噬细胞<br>E.嗜酸性的细胞</td>
      <td>B.肥大细胞与嗜碱性细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>31. 皮肤化脓性炎伴体内多数小脓肿形成应考虑为：(2.5分)</td>
      <td>A.败血症<br>B.菌血症<br>C.脓毒血症<br>D.毒血症<br>E.脓毒败血症</td>
      <td>E.脓毒败血症</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>32. 有关变质，下列哪项不正确：(2.5分)</td>
      <td>A.变质只发生在实质细胞<br>B.实质细胞可出现水肿<br>C.可出现脂肪变性<br>D.可出现凝固性坏死<br>E.可出现液化性坏死</td>
      <td>A.变质只发生在实质细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>33. 有关渗出液与漏出液，下列哪项正确：(2.5分)</td>
      <td>A.渗出液只形成浆膜腔积液<br>B.漏出液只造成间质水肿<br>C.渗出液与漏出液均可造成间质水肿与浆膜腔积液<br>D.渗出液与漏出液均不会造成间质水肿与浆膜腔积液<br>E.渗出液比漏出液成分含量少</td>
      <td>C.渗出液与漏出液均可造成间质水肿与浆膜腔积液</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>34. 炎症时白细胞游出的部位是：(2.5分)</td>
      <td>A.细静脉与毛细血管<br>B.细动脉与细静脉<br>C.中静脉与细静脉<br>D.小动脉与细动脉<br>E.小静脉与细静脉</td>
      <td>A.细静脉与毛细血管</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>35. 下列哪种物质不属于炎症介质：(2.5分)</td>
      <td>A.前列腺素<br>B.血管紧张素<br>C.血管活性胺<br>D.一些补体成分<br>E.细胞因子</td>
      <td>B.血管紧张素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>36. 糖皮质激素和抗生素合用治疗严重感染的目的是 (2.5分)</td>
      <td>A.增强机体防御力<br>B.增强抗生素抗菌作用<br>C.拮抗抗生素的不良反应<br>D.增强机体应激性<br>E.激素缓解症状，度过危险期，抗生素控制感染</td>
      <td>E.激素缓解症状，度过危险期，抗生素控制感染</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>37. 糖皮质激素对血液和造血系统的作用是 (2.5分)</td>
      <td>A.刺激骨髓造血功能<br>B.使红细胞与血红蛋白减少<br>C.使中性粒细胞减少<br>D.使血小板减少<br>E.使淋巴细胞增加</td>
      <td>A.刺激骨髓造血功能</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>38. 不属于阿司匹林禁忌症的是 (2.5分)</td>
      <td>A.维生素K缺乏症<br>B.支气管哮喘<br>C.溃疡病<br>D.冠心病<br>E.低凝血酶原血症</td>
      <td>D.冠心病</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>39. 对乙酰氨基酚没有明显抗炎、抗风湿作用是因为 (2.5分)</td>
      <td>A.对外周PGs合成酶抑制作用较强<br>B.对中枢PGs合成酶抑制作用较强<br>C.对中枢PGs合成酶抑制作用较弱<br>D.对外周PGs合成酶抑制作用较弱<br>E.对白三烯抑制作用弱</td>
      <td>D.对外周PGs合成酶抑制作用较弱</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2012</td>
      <td>40. 近年来出现的选择性COX-2抑制剂的严重不良反应是 (2.5分)</td>
      <td>A.胃肠道反应<br>B.心血管系统不良反应<br>C.血液系统反应<br>D.肝肾功能损伤<br>E.皮肤反应</td>
      <td>B.心血管系统不良反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>1. 妊娠后期的妇女往往出现下肢或足背皮下水肿，引起水肿的原因为：(2.5分)</td>
      <td>A.下肢动脉生理性充血<br>B.下肢血管的炎症性充血<br>C.下肢动脉的减压后充血<br>D.下肢静脉的淤血<br>E.下肢血管的出血</td>
      <td>D.下肢静脉的淤血</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>2. 淤血（congestion）不会引起 (2.5分)</td>
      <td>A.水肿<br>B.出血<br>C.局部缺氧<br>D.实质细胞增生<br>E.胶原纤维增生</td>
      <td>D.实质细胞增生</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>3. 44岁男患，车祸时发生右大腿骨粉碎性及开放性骨折，在送往医院途中，该患者出现面部青紫，呼吸困难，口吐白沫而亡，其最可能的死因是：(2.5分)</td>
      <td>A.心肌梗死<br>B.气体栓塞<br>C.脂肪栓塞<br>D.脑出血<br>E.气胸</td>
      <td>C.脂肪栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>4. 关于白色血栓，下列哪项描述不正确？ (2.5分)</td>
      <td>A.白色血栓构成静脉血栓的头部<br>B.白色血栓主要由血小板和纤维素组成<br>C.白色血栓可见于风湿性心内膜炎<br>D.白色血栓常含有大量的中性粒细胞，故肉眼呈白色<br>E.白色血栓机化可致心瓣膜变形</td>
      <td>D.白色血栓常含有大量的中性粒细胞，故肉眼呈白色</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>5. 槟榔肝（nutmeq liver）的典型病变是：(2.5分)</td>
      <td>A.肝小叶结构破坏<br>B.肝细胞萎缩<br>C.肝细胞坏死<br>D.门静脉分支扩张淤血<br>E.肝血窦扩张淤血，肝细胞脂肪变性</td>
      <td>E.肝血窦扩张淤血，肝细胞脂肪变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>6. 混合血栓（mixed thrombus）常发生于：(2.5分)</td>
      <td>A.静脉血栓尾部<br>B.动脉血栓头部<br>C.静脉血栓体部<br>D.毛细血管内<br>E.心瓣膜闭锁缘</td>
      <td>C.静脉血栓体部</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>7. 弥漫性血管内凝血（DIC）时微血管内的血栓称为：(2.5分)</td>
      <td>A.赘生物<br>B.透明血栓<br>C.附壁血栓<br>D.白色血栓<br>E.红色血栓</td>
      <td>B.透明血栓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>8. 休克死亡者，其某些脏器的组织切片中可见：(2.5分)</td>
      <td>A.白色血栓<br>B.混合血栓<br>C.红色血栓<br>D.附壁血栓<br>E.透明血栓</td>
      <td>E.透明血栓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>9. 血循环中血凝块随血流运行发生远处血管阻塞的过程称为：(2.5分)</td>
      <td>A.血栓<br>B.血栓形成<br>C.血栓栓塞<br>D.梗死<br>E.血栓转移</td>
      <td>C.血栓栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>10. 光镜下诊断羊水栓塞的主要依据是：(2.5分)</td>
      <td>A.小动脉内有血栓<br>B.小静脉内有血栓<br>C.毛细血管内有透明血栓<br>D.小动脉内有粘液<br>E.小动脉和毛细血管内有角化上皮W* _, s) v; N/ w/ g</td>
      <td>E.小动脉和毛细血管内有角化上皮W* _, s) v; N/ w/ g</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>11. 肺动脉栓塞不会引起：(2.5分)</td>
      <td>A.猝死<br>B.间质性肺炎<br>C.肺梗死<br>D.肺动脉高压<br>E.右心室扩张</td>
      <td>B.间质性肺炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>12. 梗死最常见的原因是：(2.5分)</td>
      <td>A.动脉血栓形成<br>B.静脉血栓形成<br>C.动脉痉挛<br>D.动脉受压<br>E.静脉受压R! `. N* e" Y</td>
      <td>A.动脉血栓形成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>13. 肝淤血的主要病变是： (2.5分)</td>
      <td>A.肝小叶中央静脉及肝窦扩张充血，肝细胞变性、萎缩<br>B.肝小叶间静脉扩张充血，肝细胞变性、萎缩<br>C.肝小叶间静脉扩张充血，小叶间结缔组织增生<br>D.肝窦扩张充血，小叶间胆管和结缔组织增生<br>E.肝小叶间动静脉淤血，小叶间结缔组织增生9 L) u) |- |# |6 I</td>
      <td>A.肝小叶中央静脉及肝窦扩张充血，肝细胞变性、萎缩</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>14. 心衰细胞见于： (2.5分)</td>
      <td>A.左心衰时肺泡腔内<br>B.右心衰时肺泡腔内<br>C.肺水肿时肺泡腔内<br>D.肝淤血时肝脏内<br>E.脾淤血时脾脏内</td>
      <td>A.左心衰时肺泡腔内</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>15. 混合血栓（mixed thrombus）通常不见：(2.5分)</td>
      <td>A.质脆<br>B.无光泽<br>C.Zahn线<br>D.湿润<br>E.与血管壁粘着</td>
      <td>D.湿润</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>16. 主要介导细胞与细胞外基质结合的黏附分子家族是：(2.5分)</td>
      <td>A.免疫球蛋白超家族<br>B.选择素家族<br>C.整合素家族<br>D.钙黏蛋白家族<br>E.未归类黏附分子</td>
      <td>C.整合素家族</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>17. L-选择素、E-选择素、P-选择素中的L、E、P分别表示：(2.5分)</td>
      <td>A.淋巴细胞、血小板、内皮细胞<br>B.血小板、内皮细胞、白细胞<br>C.淋巴细胞、内皮细胞、神经细胞<br>D.白细胞、内皮细胞、血小板<br>E.白细胞、血小板、神经细胞</td>
      <td>D.白细胞、内皮细胞、血小板</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>18. 细胞因子不具备的特点是：(2.5分)</td>
      <td>A.通过与相应受体结合发挥作用<br>B.作用具有高效性和多效性<br>C.作用具有重叠性和网络性<br>D.主要是在局部起持久作用<br>E.主要通过自分泌和旁分泌发挥作用</td>
      <td>D.主要是在局部起持久作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>19. IFN无以下哪种功能：(2.5分)</td>
      <td>A.抗病毒<br>B.增强巨噬细胞功能<br>C.增强NK细胞功能<br>D.诱导LAK细胞产生<br>E.抑制肿瘤细胞生长</td>
      <td>D.诱导LAK细胞产生</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>20. 产生IL-1细胞主要是：(2.5分)</td>
      <td>A.肥大细胞、中性粒细胞<br>B.Mo/Mφ、树突状细胞<br>C.Th2细胞<br>D.Th1细胞<br>E.淋巴细胞</td>
      <td>B.Mo/Mφ、树突状细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>21. 与T细胞活化有关的重要膜分子：(2.5分)</td>
      <td>A.CD4和CD2<br>B.ITAM和CD8<br>C.p56lck<br>D.CD21和CD19<br>E.CD56和CD16</td>
      <td>A.CD4和CD2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>22. 以下关于CD4的说法哪项是错误的：(2.5分)</td>
      <td>A.成熟的T细胞表面都有CD4表达<br>B.CD4不直接参与特异性识别抗原<br>C.CD4属于免疫球蛋白超家族成员<br>D.CD4可与Ag-MHCII分子复合体结合<br>E.可用抗CD4单抗对辅助性T细胞进行检测</td>
      <td>A.成熟的T细胞表面都有CD4表达</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>23. EB病毒的受体是：(2.5分)</td>
      <td>A.CD2<br>B.CD8<br>C.CD4<br>D.CD28<br>E.CD21</td>
      <td>E.CD21</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>24. 肾梗死区的坏死多为：(2.5分)</td>
      <td>A.液化性坏死<br>B.凝固性坏死<br>C.坏疽<br>D.干酪样坏死<br>E.脂肪坏死</td>
      <td>B.凝固性坏死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>25. 病毒感染的炎症灶中主要出现哪种炎症细胞：(2.5分)</td>
      <td>A.淋巴细胞<br>B.巨噬细胞<br>C.浆细胞<br>D.嗜中性粒细胞<br>E.嗜酸性粒细胞</td>
      <td>A.淋巴细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>26. 炎症灶中某些化学物质吸引中性粒细胞定向游走的现象称为：(2.5分)</td>
      <td>A.游出<br>B.趋化<br>C.吞噬<br>D.渗出<br>E.识别</td>
      <td>B.趋化</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>27. 急性炎症时引起组织肿胀的主要原因是：(2.5分)</td>
      <td>A.组织增生<br>B.动脉扩张<br>C.静脉阻塞<br>D.富含蛋白的液体进入组织间隙<br>E.小静脉痉挛</td>
      <td>D.富含蛋白的液体进入组织间隙</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>28. 炎症局部疼痛的主要原因是：(2.5分)</td>
      <td>A.细胞增生压迫神经末稍<br>B.静脉阻塞<br>C.局部充血<br>D.渗出物压迫及炎症介质作用<br>E.组织变性坏死</td>
      <td>D.渗出物压迫及炎症介质作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>29. 吞噬细胞与异物接触后，伸出伪足，包围异物，并将其摄入胞浆内则形成：(2.5分)</td>
      <td>A.吞噬溶酶体<br>B.残体<br>C.吞噬体<br>D.初级溶酶体<br>E.自噬体</td>
      <td>C.吞噬体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>30. 脓细胞是指： (2.5分)</td>
      <td>A.变性坏死的中性粒细胞<br>B.脓液中的所有细胞<br>C.化脓病灶中死亡的上皮细胞<br>D.变性坏死的白细胞<br>E.变性坏死的单核细胞</td>
      <td>A.变性坏死的中性粒细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>31. 金黄色葡萄球菌感染常引起：(2.5分)</td>
      <td>A.脓性卡他性炎<br>B.蜂窝织炎<br>C.纤维蛋白性炎<br>D.出血性炎<br>E.脓肿</td>
      <td>E.脓肿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>32. 钩端螺旋体病属下列哪种类型炎症：(2.5分)</td>
      <td>A.浆液性炎<br>B.化脓性炎<br>C.蜂窝织炎<br>D.增生性炎<br>E.出血性炎</td>
      <td>E.出血性炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>33. 下列哪一种不是渗出性炎症?(2.5分)</td>
      <td>A.卡他性炎症<br>B.乙型脑炎<br>C.流行性脑膜炎<br>D.肾盂肾炎<br>E.脓肿</td>
      <td>B.乙型脑炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>34. 炎症的渗出主要由于：(2.5分)</td>
      <td>A.血液动力学改变<br>B.血管壁通透性改变<br>C.小静脉血栓形成<br>D.循环血量增加</td>
      <td>B.血管壁通透性改变</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>35. 下列关于炎症描述，哪一项不正确?(2.5分)</td>
      <td>A.嗜中性粒细胞浸润通常是急性炎症的标志<br>B.慢性炎症细胞主要是淋巴细胞、巨噬细胞和浆细胞<br>C.淋巴细胞浸润并非总是慢性炎症的特征<br>D.嗜中性粒细胞游出后必然引起局部单核细胞增多<br>E.白细胞渗出只见于急性炎症早期</td>
      <td>E.白细胞渗出只见于急性炎症早期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>36. Which one of the following drugs has a high adsorptive capacity and inhibits the absorption of toxins? (2.5分)</td>
      <td>A.Activated charcoal<br>B.Syrup of ipecac<br>C.Ethanol<br>D.Atropine</td>
      <td>A.Activated charcoal</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>37. Which poison may cause acute liver failure? (2.5分)</td>
      <td>A.Cocaine<br>B.Digitalis<br>C.Acetaminophen<br>D.Theophylline</td>
      <td>C.Acetaminophen</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>38. Aspirin can induce all of the following effect EXCEPT (2.5分)</td>
      <td>A.reducing fever<br>B.reducing prostaglandin synthesis in inflamed tissue<br>C.stimulating respiratory when taken in toxic dosage<br>D.reducing leukotrienes</td>
      <td>D.reducing leukotrienes</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>39. Mechanism of action of prednisone: (2.5分)</td>
      <td>A.Inhibition of purine synthesis<br>B.Inhibition of the enzyme calcineurin<br>C.Inhibition of pyrimidine<br>D.Inhibition of phospholipase A2</td>
      <td>D.Inhibition of phospholipase A2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2013</td>
      <td>40. The main mechanism under the anti-platelet role of aspirin is? (2.5分)</td>
      <td>A.The inhibition of COX and the reduction of TXA2 synthesis.<br>B.Inhibit the thrombin formation<br>C.Antagonize the effect of Vitamin K<br>D.Activate the anti-thrombin III (AT III)</td>
      <td>A.The inhibition of COX and the reduction of TXA2 synthesis.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>1. 下列对肺淤血组织学特点的描述中哪一项是错误的？ (2.5分)</td>
      <td>A.肺泡壁毛细血管扩张<br>B.肺泡腔内有水肿液<br>C.肺泡腔内有大量中性粒细胞和纤维素渗出<br>D.肺泡腔内有多少不等的红细胞<br>E.肺泡腔内可见心力衰竭细胞</td>
      <td>C.肺泡腔内有大量中性粒细胞和纤维素渗出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>2. 以下哪种类型的栓塞最为常见和重要？ (2.5分)</td>
      <td>A.血栓栓塞<br>B.气体栓塞<br>C.羊水栓塞<br>D.脂肪栓塞<br>E.肿瘤细胞栓塞</td>
      <td>A.血栓栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>3. 某心衰患者下肢深静脉内的血栓脱落后最有可能引起以下哪种病变： (2.5分)</td>
      <td>A.脑梗死<br>B.心肌梗死<br>C.肺梗死<br>D.肾梗死<br>E.肠梗死</td>
      <td>C.肺梗死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>4. 某患者患急性感染性心内膜炎，其二尖瓣瓣膜上出现一黄豆大的赘生物，此赘生物脱落后将不会引起以下哪种栓塞：(2.5分)</td>
      <td>A.脑动脉栓塞<br>B.脾动脉栓塞<br>C.肺动脉栓塞<br>D.肾动脉栓塞<br>E.肠系膜动脉栓塞</td>
      <td>C.肺动脉栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>5. 以下哪项不是梗死形成的原因和条件：(2.5分)</td>
      <td>A.血管内血栓形成阻塞管腔<br>B.血管受压闭塞<br>C.动脉痉挛<br>D.无有效的侧枝循环<br>E.毒物的毒性作用</td>
      <td>E.毒物的毒性作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>6. 关于严重肺淤血的叙述，下列哪项是错误的：(2.5分)</td>
      <td>A.肺泡腔内有水肿液<br>B.可见心力衰竭细胞<br>C.可发生漏出性出血<br>D.肺泡壁毛细血管扩张充血<br>E.肺泡腔内见有白细胞和纤维蛋白</td>
      <td>E.肺泡腔内见有白细胞和纤维蛋白</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>7. 易发生贫血性梗死的器官是(2.5分)</td>
      <td>A.心、脑、肠<br>B.肾、肠、脑<br>C.心、脾、肾<br>D.脾、心、肺<br>E.肾、心、肺</td>
      <td>C.心、脾、肾</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>8. 血液循环中血栓随血流运行发生相应的血管阻塞的过程称之为：(2.5分)</td>
      <td>A.梗死<br>B.血栓形成<br>C.血栓运行<br>D.血栓栓塞<br>E.栓子</td>
      <td>D.血栓栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>9. 淤血指的是：(2.5分)</td>
      <td>A.毛细血管性充血<br>B.静脉系统性充血<br>C.C.动脉性充血<br>D.减压性充血<br>E.小静脉和毛细血管扩张充血</td>
      <td>E.小静脉和毛细血管扩张充血</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>10. 引起肺出血性梗死的主要原因是： (2.5分)</td>
      <td>A.肺静脉淤血，肺动脉阻塞，侧枝循环不能建立<br>B.肺静脉阻塞，肺动脉淤血，侧枝循环不能建立<br>C.左心衰竭、肺静脉回流受阻<br>D.肺动脉及支气管动脉同时阻塞<br>E.肺静脉及支气管动脉同时阻</td>
      <td>A.肺静脉淤血，肺动脉阻塞，侧枝循环不能建立</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>11. 延续性血栓的形成顺序为: (2.5分)</td>
      <td>A.白色血栓、混合血栓、红色血栓<br>B.混合血栓、红色血栓、白色血栓<br>C.红色血栓、白色血栓、混合血栓<br>D.混合血栓、白色血栓、红色血栓<br>E.红色血栓、混合血栓、白色血栓</td>
      <td>A.白色血栓、混合血栓、红色血栓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>12. 血栓的结局不包括: (2.5分)</td>
      <td>A.梗死<br>B.溶解、吸收<br>C.钙化<br>D.机化<br>E.再通</td>
      <td>A.梗死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>13. 在葡萄球菌感染的炎症反应中所见到的主要细胞是：(2.5分)</td>
      <td>A.淋巴细胞<br>B.单核细胞<br>C.嗜酸性粒细胞<br>D.肥大细胞<br>E.嗜中性粒细胞</td>
      <td>E.嗜中性粒细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>14. 下列哪项不属于渗出性炎症?(2.5分)</td>
      <td>A.假膜性炎症<br>B.大叶性肺炎<br>C.卡他性炎症<br>D.阿米巴肝脓肿<br>E.流脑</td>
      <td>D.阿米巴肝脓肿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>15. 溶血性链球菌最常引起：(2.5分)</td>
      <td>A.蜂窝织炎<br>B.假膜性炎<br>C.坏死性炎<br>D.脓肿<br>E.出血性炎</td>
      <td>A.蜂窝织炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>16. 细胞因子不具备的特点是：(2.5分)</td>
      <td>A.通过与相应受体结合发挥作用<br>B.作用具有高效性和多效性<br>C.作用具有重叠性和网络性<br>D.主要是在局部起持久作用<br>E.主要通过自分泌和旁分泌发挥作用</td>
      <td>D.主要是在局部起持久作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>17. 产生IL-1细胞主要是：(2.5分)</td>
      <td>A.肥大细胞、中性粒细胞<br>B.树突状细胞<br>C.Th2细胞<br>D.Th1细胞<br>E.淋巴细胞</td>
      <td>B.树突状细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>18. 对炎症反应有明显促进作用的白细胞介素是：(2.5分)</td>
      <td>A.IL-2、IL-4、IL-5、IL-6<br>B.IL-2、IL-10、IL-12<br>C.IL-3、IL-7、IL-11<br>D.IL-1、IL-6、IL-8<br>E.IL-1、IL-2、IL-12、IL-15</td>
      <td>D.IL-1、IL-6、IL-8</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>19. TNF缺乏以下哪种功能：(2.5分)</td>
      <td>A.抑制炎症反应<br>B.激活中性粒细胞和功能<br>C.内源性致热原<br>D.诱导细胞凋亡<br>E.对肿瘤细胞有毒性作用</td>
      <td>A.抑制炎症反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>20. 与B细胞活化有关的膜分子：(2.5分)</td>
      <td>A.CD3和CD2<br>B.CD4和CD8<br>C.CD4和CD40<br>D.CD21和CD19<br>E.CD56和CD16</td>
      <td>D.CD21和CD19</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>21. 主要介导同型细胞间的黏附作用，对组织和器官的发育及完整组织结构的维持起重要作用的黏附分子家族是：(2.5分)</td>
      <td>A.免疫球蛋白超家族<br>B.选择素家族<br>C.钙黏蛋白家族<br>D.整合素家族<br>E.未归类黏附分子</td>
      <td>C.钙黏蛋白家族</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>22. Which of the following is usually NOT the adverse effects of glucocorticoid drugs? (2.5分)</td>
      <td>A.Central obesity<br>B.Increasing susceptibility to infections<br>C.Hypertension<br>D.Myopathy and osteoporosis<br>E.Allergic reactions</td>
      <td>E.Allergic reactions</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>23. Which of the following drug is COX-2-selective agents?(2.5分)</td>
      <td>A.ibuprofen.<br>B.celecoxib,<br>C.piroxicam,<br>D.acetaminophen<br>E.sodium salicylate</td>
      <td>B.celecoxib,</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>24. 以下不属于糖皮质激素的抗炎作用是(2.5分)</td>
      <td>A.抑制炎症细胞的浸润<br>B.降低毛细血管通透性<br>C.抑制肉芽组织增生<br>D.直接杀灭病原菌<br>E.减少炎症因子的释放</td>
      <td>D.直接杀灭病原菌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>25. 长期使用糖皮质激素后的停药反应不包括：(2.5分)</td>
      <td>A.对应激反应减弱<br>B.肾上腺皮质功能亢进<br>C.原有病情复发或恶化<br>D.肾上腺皮质功能不全<br>E.肾上腺皮质萎缩</td>
      <td>B.肾上腺皮质功能亢进</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>26. 炎症过程中，液体渗出最主要的机制是 (2.5分)</td>
      <td>A.血管通透性增加<br>B.血管外胶体渗透压降低<br>C.血管外胶体渗透压增高<br>D.血管内流体静压增高<br>E.血管内流体静压降低</td>
      <td>A.血管通透性增加</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>27. 血管通透性增加的机制不包括(2.5分)</td>
      <td>A.内皮细胞收缩<br>B.新生毛细血管壁的高通透性<br>C.穿胞作用减弱<br>D.白细胞介导的内皮细胞损伤<br>E.直接内皮细胞损伤</td>
      <td>C.穿胞作用减弱</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>28. 血管通透性增加的机制不包括(2.5分)</td>
      <td>A.内皮细胞收缩<br>B.新生毛细血管壁的高通透性<br>C.穿胞作用减弱<br>D.白细胞介导的内皮细胞损伤<br>E.直接内皮细胞损伤</td>
      <td>C.穿胞作用减弱</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>29. 可以引起血管通透性增高的炎症介质不包括(2.5分)</td>
      <td>A.5-羟色胺<br>B.组胺<br>C.C3b<br>D.白细胞三烯<br>E.缓激肽</td>
      <td>C.C3b</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>30. 炎症最重要的特征是(2.5分)</td>
      <td>A.血管通透性增加<br>B.液体渗出<br>C.血流变缓<br>D.红细胞漏出<br>E.白细胞渗出</td>
      <td>E.白细胞渗出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>31. 补体C3b具有以下哪种炎症介质效应(2.5分)</td>
      <td>A.趋化作用<br>B.具有调理素作用<br>C.促进白细胞与内皮细胞之间的黏附<br>D.血管通透性增高<br>E.发热</td>
      <td>B.具有调理素作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>32. 下列关于浆液性炎的叙述，错误的是(2.5分)</td>
      <td>A.常见于急性炎症的早期<br>B.渗出的浆液含有3%-5%白蛋白和少量纤维蛋白<br>C.对机体的影响一般较小<br>D.渗出的浆液多混浊、黏稠、不透明<br>E.常发生于疏松组织、浆膜、黏膜和皮肤</td>
      <td>D.渗出的浆液多混浊、黏稠、不透明</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>33. 下列哪项描述最能反映脓肿的本质(2.5分)</td>
      <td>A.局限性化脓性炎<br>B.脓肿膜可以局限炎症<br>C.大量中性粒细胞渗出<br>D.急性脓肿可以转变为慢性脓肿<br>E.有脓液形成</td>
      <td>A.局限性化脓性炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>34. 下列哪项描述最能反映脓肿的本质(2.5分)</td>
      <td>A.局限性化脓性炎<br>B.脓肿膜可以局限炎症<br>C.大量中性粒细胞渗出<br>D.急性脓肿可以转变为慢性脓肿<br>E.有脓液形成</td>
      <td>A.局限性化脓性炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>35. 脓肿膜主要由以下哪种成分构成(2.5分)</td>
      <td>A.炎性坏死组织<br>B.肉芽肿<br>C.纤维肉芽组织<br>D.纤维蛋白网<br>E.被挤压的正常组织</td>
      <td>C.纤维肉芽组织</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>36. 慢性炎症的病理特点不包括(2.5分)</td>
      <td>A.渗出炎细胞以淋巴细胞、浆细胞和单核巨噬细胞为主<br>B.变质改变一般不突出<br>C.成纤维细胞和血管增生较为明显<br>D.较多中性粒细胞浸润<br>E.实质细胞增生可以增生</td>
      <td>D.较多中性粒细胞浸润</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>37. 上皮样细胞不具有下述哪项特点(2.5分)</td>
      <td>A.胞质丰富<br>B.胞质界限不清<br>C.吞噬力强<br>D.形态与上皮细胞相似<br>E.胞质呈淡粉色</td>
      <td>C.吞噬力强</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>38. 下列哪种疾病无肉芽肿形成(2.5分)</td>
      <td>A.风湿病<br>B.硅肺<br>C.梅毒<br>D.麻风病<br>E.溃疡性结肠炎</td>
      <td>E.溃疡性结肠炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>39. 菌血症见于(2.5分)</td>
      <td>A.炎症的缓解期<br>B.炎症的慢性期<br>C.炎症的早期<br>D.炎症的中期<br>E.炎症的晚期</td>
      <td>C.炎症的早期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>5</td>
      <td>2014</td>
      <td>40. 关于蜂窝织炎的叙述，正确的是(2.5分)</td>
      <td>A.常见的发病部位是内脏器官、肌肉和阑尾<br>B.与细菌分泌的透明质酸酶、链激酶有关<br>C.金黄色葡萄球菌是主要的致病菌<br>D.炎症局限<br>E.组织坏死通常较明显</td>
      <td>B.与细菌分泌的透明质酸酶、链激酶有关</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>1. 与B细胞活化有关的膜分子：(2.0分)</td>
      <td>A.CD3和CD2<br>B.CD4和CD40<br>C.CD4和CD8<br>D.CD21和CD19<br>E.CD56和CD16</td>
      <td>D.CD21和CD19</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>2. CD2的配体是：(2.0分)</td>
      <td>A.CD3<br>B.CD79α和CD79β<br>C.LFA-3<br>D.LFA-2<br>E.羊红细胞受体</td>
      <td>C.LFA-3</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>3. 以下关于CD4的说法哪项是错误的：(2.0分)</td>
      <td>A.CD4属于免疫球蛋白超家族成员<br>B.CD4不直接参与特异性识别抗原<br>C.成熟的T细胞表面都有CD4表达<br>D.CD4可与Ag-MHCII分子复合体结合<br>E.可用抗CD4单抗对辅助性T细胞进行检测</td>
      <td>C.成熟的T细胞表面都有CD4表达</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>4. EB病毒的受体是：(2.0分)</td>
      <td>A.CD28<br>B.CD8<br>C.CD4<br>D.CD2<br>E.CD21</td>
      <td>E.CD21</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>5. 能与CD80结合的是(2.0分)</td>
      <td>A.CD4<br>B.CD8<br>C.CD2<br>D.CD28<br>E.CD21</td>
      <td>D.CD28</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>6. 主要介导细胞与细胞外基质结合的黏附分子家族是：(2.0分)</td>
      <td>A.免疫球蛋白超家族<br>B.整合素家族<br>C.选择素家族<br>D.钙黏蛋白家族<br>E.未归类黏附分子</td>
      <td>B.整合素家族</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>7. 结构上有β3链整合素家族成员属于： (2.0分)</td>
      <td>A.VLA组<br>B.血小板糖蛋白组<br>C.补体调节蛋白组<br>D.钙黏蛋白组<br>E.白细胞黏附受体组</td>
      <td>B.血小板糖蛋白组</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>8. 主要介导白细胞与内皮细胞结合，参与炎症及淋巴细胞归巢的黏附分子家族是：(2.0分)</td>
      <td>A.选择素家族<br>B.整合素家族<br>C.钙黏蛋白家族<br>D.免疫球蛋白超家族<br>E.未归类黏附分子</td>
      <td>A.选择素家族</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>9. 主要介导同型细胞间的黏附作用，对组织和器官的发育及完整组织结构的维持起重要作用的黏附分子家族是：(2.0分)</td>
      <td>A.整合素家族<br>B.钙黏蛋白家族<br>C.免疫球蛋白超家族<br>D.选择素家族<br>E.未归类黏附分子</td>
      <td>B.钙黏蛋白家族</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>10. L-选择素、E-选择素、P-选择素中的L、E、P分别表示：(2.0分)</td>
      <td>A.白细胞、内皮细胞、血小板<br>B.血小板、内皮细胞、白细胞<br>C.淋巴细胞、内皮细胞、神经细胞<br>D.淋巴细胞、血小板、内皮细胞<br>E.白细胞、血小板、神经细胞</td>
      <td>A.白细胞、内皮细胞、血小板</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>11. 有关渗出液与漏出液，下列哪项正确：(2.0分)</td>
      <td>A.漏出液只造成间质水肿<br>B.渗出液只形成浆膜腔积液<br>C.渗出液与漏出液均可造成间质水肿与浆膜腔积液<br>D.渗出液与漏出液均不会造成间质水肿与浆膜腔积液</td>
      <td>C.渗出液与漏出液均可造成间质水肿与浆膜腔积液</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>12. 炎症局部主要由巨噬细胞增生形成境界清楚的结节状病灶称：(2.0分)</td>
      <td>A.结节<br>B.肉芽肿<br>C.炎性息肉<br>D.炎性假瘤</td>
      <td>B.肉芽肿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>13. 下列哪项不是由细胞释放的炎症介质：(2.0分)</td>
      <td>A.组胺与5羟色胺<br>B.白细胞三烯<br>C.前列腺素<br>D.缓激肽</td>
      <td>D.缓激肽</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>14. 炎症时白细胞游出的部位是：(2.0分)</td>
      <td>A.细动脉与细静脉<br>B.细静脉与毛细血管<br>C.中静脉与细静脉<br>D.小动脉与细动脉</td>
      <td>B.细静脉与毛细血管</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>15. 局限性的化脓性炎且形成含脓的腔称：(2.0分)</td>
      <td>A.表面化脓<br>B.蜂窝织炎<br>C.脓肿<br>D.纤维素性炎</td>
      <td>C.脓肿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>16. 葡萄球菌和链球菌感染时局部以下列那种是细胞浸润为主：(2.0分)</td>
      <td>A.巨噬细胞<br>B.中性粒细胞<br>C.嗜酸性粒细胞<br>D.淋巴细胞</td>
      <td>B.中性粒细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>17. 形成漏出液的主要原因是：(2.0分)</td>
      <td>A.主要由白细胞主动游出所致<br>B.主要由局部血管通透性升高所致<br>C.主要由静脉回流受阻所致<br>D.主要由局部血管内渗透升高所致</td>
      <td>C.主要由静脉回流受阻所致</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>18. 有关纤维素性炎的好发部位，下列哪项错误：(2.0分)</td>
      <td>A.浆膜<br>B.肝<br>C.浆粘膜<br>D.肺</td>
      <td>B.肝</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>19. 一患者有明显全身中毒症状，还出现皮肤粘膜的多发性出血斑点和脾及全身淋巴结肿 大、血中查到病原菌，应考虑为：(2.0分)</td>
      <td>A.菌血症<br>B.败血症<br>C.脓毒血症<br>D.毒血症</td>
      <td>B.败血症</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>20. 血管活性胺主要存在于：(2.0分)</td>
      <td>A.肥大细胞与嗜碱性细胞<br>B.浆细胞与淋巴细胞<br>C.中性白细胞与嗜酸性的细胞<br>D.中性白细胞与巨噬细胞</td>
      <td>A.肥大细胞与嗜碱性细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>21. 局部器官或组织内动脉血输入量异常增多的现象称为(2.0分)</td>
      <td>A.被动性充血<br>B.炎性充血<br>C.淤血<br>D.生理性充血<br>E.主动性充血</td>
      <td>E.主动性充血</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>22. 淤血器官(2.0分)</td>
      <td>A.色暗红，体积增大，切面湿润，功能减退，温度降低<br>B.色苍白，体积增大，切面干燥，功能减退，温度降低<br>C.色暗红，体积增大，切面湿润，功能增强，温度降低<br>D.色暗红，体积增大，切面干燥，功能增强，温度降低<br>E.色苍白，体积缩小，切面湿润，功能增强，温度升高</td>
      <td>A.色暗红，体积增大，切面湿润，功能减退，温度降低</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>23. 心衰细胞见于(2.0分)</td>
      <td>A.左心衰竭时肺泡腔内<br>B.肝淤血时肝脏内<br>C.肺水肿时肺泡腔内<br>D.右心衰竭时肺泡腔内<br>E.脾淤血时脾脏内</td>
      <td>A.左心衰竭时肺泡腔内</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>24. 微循环血管壁通透性增高引起的出血是 (2.0分)</td>
      <td>A.外出血<br>B.漏出性出血<br>C.体腔积血<br>D.破裂性出血<br>E.渗出性出血</td>
      <td>B.漏出性出血</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>25. 下列哪种疾病引起的出血属于漏出性出血？(2.0分)</td>
      <td>A.主动脉瘤<br>B.胃溃疡<br>C.子宫颈癌<br>D.肺结核<br>E.血小板减少性紫癜</td>
      <td>E.血小板减少性紫癜</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>26. 静脉性充血时局部静脉血液回流 (2.0分)</td>
      <td>A.减少<br>B.增多和减少交替进行<br>C.增多<br>D.不变<br>E.减少，同时伴有左心衰竭</td>
      <td>A.减少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>27. 右心衰竭可导致 (2.0分)</td>
      <td>A.肝出血性梗死<br>B.槟榔肝<br>C.肝细胞透明变性<br>D.肝贫血性梗死<br>E.坏死后性肝硬化</td>
      <td>B.槟榔肝</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>28. 槟榔肝的形成是由于(2.0分)</td>
      <td>A.肝小叶间静脉淤血和结缔组织增生<br>B.中央静脉及肝窦淤血和肝细胞脂肪变性<br>C.肝细胞坏死和结缔组织增生<br>D.肝脏出血和肝细胞坏死<br>E.小胆管和结缔组织增生</td>
      <td>B.中央静脉及肝窦淤血和肝细胞脂肪变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>29. 右心衰竭引起淤血的器官主要是 (2.0分)</td>
      <td>A.肺、脑及胃肠道<br>B.肺、肝及胃肠道<br>C.肝、脾及胃肠道<br>D.肾、肺及胃肠道<br>E.脾、肺及胃肠道</td>
      <td>C.肝、脾及胃肠道</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>30. 肺淤血时痰液中出现胞质中含有棕黄色色素颗粒的巨噬细胞称为(2.0分)</td>
      <td>A.肺泡上皮细胞<br>B.异物巨细胞<br>C.单核细胞<br>D.支气管黏膜上皮细胞<br>E.心衰细胞</td>
      <td>E.心衰细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>31. 根据定义，组织间隙或体腔内过量的体液潴留称为 (2.0分)</td>
      <td>A.胸腔积液<br>B.漏出<br>C.水肿<br>D.渗出<br>E.腹腔积液</td>
      <td>C.水肿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>32. 严重肝实质疾病引起出血的原因是 (2.0分)</td>
      <td>A.凝血因子消耗过多<br>B.凝血因子合成减少<br>C.红细胞破坏<br>D.血小板生成减少<br>E.凝血因子无功能</td>
      <td>B.凝血因子合成减少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>33. 水肿组织的肉眼病变特点是(2.0分)</td>
      <td>A.体积缩小，色苍白，重量增加<br>B.体积缩小，色暗红，重量减轻<br>C.体积增大，色苍白，重量增加<br>D.体积增大，色暗红，重量增加<br>E.体积不变，色苍白，重量减轻</td>
      <td>C.体积增大，色苍白，重量增加</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>34. 在HE染色切片上见到肺泡腔内有粉红色液体成分，可诊断为(2.0分)</td>
      <td>A.肺水肿<br>B.肺气肿<br>C.肺结核<br>D.肺出血<br>E.肺羊水吸入</td>
      <td>A.肺水肿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>35. 健康孕妇在分娩时突然出现发绀、呼吸困难、休克，应考虑为 (2.0分)</td>
      <td>A.羊水栓塞<br>B.过敏性休克<br>C.心力衰竭<br>D.肺水肿<br>E.血型不合引起急性溶血</td>
      <td>A.羊水栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>36. 引起脾、肾、肺梗死最常见的原因是(2.0分)</td>
      <td>A.动脉痉挛<br>B.动脉受压闭塞<br>C.动脉栓塞<br>D.血栓形成<br>E.动脉粥样硬化</td>
      <td>C.动脉栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>37. 慢性肺淤血的特点不包括(2.0分)</td>
      <td>A.切面暗红色<br>B.肺泡间隔增宽<br>C.肺泡壁毛细血管扩张充血<br>D.肺泡腔内有心衰细胞<br>E.肺内支气管扩张</td>
      <td>E.肺内支气管扩张</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>38. 下列哪项不属于病理性充血？(2.0分)</td>
      <td>A.减压后充血<br>B.侧支性充血<br>C.炎性充血<br>D.理化因素引起的充血<br>E.器官组织活动增强时引起的充血</td>
      <td>E.器官组织活动增强时引起的充血</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>39. 槟榔肝的特点不包括 (2.0分)</td>
      <td>A.肝细胞脂肪变性<br>B.肝细胞萎缩<br>C.肝小叶中央静脉和肝窦扩张充血<br>D.胆小管增生<br>E.肉眼观察切面呈红黄相间的花纹状</td>
      <td>D.胆小管增生</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>40. 关于腘静脉内血栓脱落引起的栓塞，下列叙述哪项不正确？(2.0分)</td>
      <td>A.大多栓塞于肺<br>B.均要发生出血性梗死<br>C.伴有左心衰竭时可发生相应部位的出血性梗死<br>D.如栓塞于肺动脉主干常引起猝死<br>E.如有室间隔缺损亦可栓塞于脑</td>
      <td>B.均要发生出血性梗死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>41. 下列疾病以增生性炎症为特征的是(2.0分)</td>
      <td>A.气性坏疽<br>B.大叶性肺炎<br>C.伤寒<br>D.急性病毒性肝炎<br>E.流行性乙型脑炎</td>
      <td>C.伤寒</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>42. 下列哪项不属于纤维蛋白性炎?(2.0分)</td>
      <td>A.白喉<br>B.尿毒症假膜性肠炎<br>C.肠阿米巴痢疾<br>D.风湿性心外膜炎<br>E.大叶性肺炎</td>
      <td>C.肠阿米巴痢疾</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>43. 关于浆液性炎，下列哪项叙述不正确？(2.0分)</td>
      <td>A.发生于关节时，可引起关节腔积液<br>B.可表现为炎性水肿，水疱，<br>C.损害较轻，易于消退，不会致命<br>D.常发生于粘膜，浆膜和疏松结缔组织，<br>E.发生于粘膜时，可表现为卡他性炎</td>
      <td>C.损害较轻，易于消退，不会致命</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>44. 下列炎症性疾病中并发恶性肿瘤可能性较高的是(2.0分)</td>
      <td>A.肝脓肿<br>B.慢性菌痢<br>C.肠阿米巴病<br>D.肺结核病<br>E.溃疡性结肠炎</td>
      <td>E.溃疡性结肠炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>45. 肉芽肿可以主要由下列成分组成，除外(2.0分)</td>
      <td>A.泡沫细胞<br>B.巨噬细胞<br>C.类上皮细胞<br>D.成纤维细胞<br>E.异物巨细胞</td>
      <td>D.成纤维细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>46. 淤血时扩张充盈的血管主要是(2.0分)</td>
      <td>A.静脉<br>B.动脉<br>C.小动脉和毛细血管<br>D.小静脉和毛细血管<br>E.毛细血管、小动脉和小静脉</td>
      <td>D.小静脉和毛细血管</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>47. 左心衰竭主要引起： (2.0分)</td>
      <td>A.脑淤血水肿<br>B.肝淤血水肿<br>C.肺淤血水肿<br>D.肾淤血水肿<br>E.脾淤血水肿</td>
      <td>C.肺淤血水肿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>48. 混合血栓可见于 (2.0分)</td>
      <td>A.风湿性心内膜炎的疣状血栓<br>B.静脉血栓头部<br>C.心室内附壁血栓<br>D.肾小球毛细血管内<br>E.动脉血栓头部</td>
      <td>C.心室内附壁血栓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>49. 混合血栓最常发生的部位是(2.0分)</td>
      <td>A.左心室<br>B.主动脉<br>C.心瓣膜<br>D.中、小动脉<br>E.下肢静脉</td>
      <td>E.下肢静脉</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2007</td>
      <td>50. 下列哪项出血不属于破裂性出血? (2.0分)</td>
      <td>A.慢性空洞型肺结核大咯血<br>B.肾小球肾炎血尿<br>C.十二指肠溃疡柏油样便<br>D.肝硬化食道静脉曲张大呕血<br>E.直肠癌便血</td>
      <td>B.肾小球肾炎血尿</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>1. 以下哪项不是梗死形成的原因和条件：(2.0分)</td>
      <td>A.血管受压闭塞<br>B.血管内血栓形成阻塞管腔<br>C.动脉痉挛<br>D.无有效的侧枝循环<br>E.毒物的毒性作用</td>
      <td>E.毒物的毒性作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>2. 能够用细胞增殖法检测的细胞因子是(2.0分)</td>
      <td>A.TNF<br>B.CSF<br>C.IFN<br>D.IL-6<br>E.IL-8</td>
      <td>D.IL-6</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>3. 慢性炎症病灶内浸润的炎细胞主要是 (2.0分)</td>
      <td>A.中性粒细胞和浆细胞<br>B.单核和淋巴细胞<br>C.嗜酸性和嗜碱性粒细胞<br>D.淋巴和嗜碱性粒细胞<br>E.中性粒细胞和嗜酸性粒细胞</td>
      <td>B.单核和淋巴细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>4. 糖皮质激素诱发和加重感染的主要原因是(2.0分)</td>
      <td>A.促使许多病原微生物繁殖所致<br>B.病人对激素不敏感而未反映出相应的疗效<br>C.用量不足，无法控制症状而造成<br>D.抑制炎症反应和免疫反应，降低机体的防御能力<br>E.抑制促肾上腺皮质激素的释放</td>
      <td>D.抑制炎症反应和免疫反应，降低机体的防御能力</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>5. 下列有关脾梗死病理特点的叙述哪一项是错误的(2.0分)</td>
      <td>A.多由血栓栓塞所致<br>B.属出血性梗死<br>C.交界处有明显的充血、出血带<br>D.梗死灶呈灰白色，锥体形<br>E.梗死组织呈凝固性坏死</td>
      <td>B.属出血性梗死</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>6. 急性炎症时组织变红的主要原因是(2.0分)</td>
      <td>A.肉芽组织形成<br>B.静脉性充血<br>C.动脉性充血<br>D.血管内血栓形成<br>E.血管扩张</td>
      <td>C.动脉性充血</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>7. 下列对肺淤血组织学特点的描述中哪一项是错误的？(2.0分)</td>
      <td>A.肺泡壁毛细血管扩张<br>B.肺泡腔内有大量中性粒细胞和纤维素渗出<br>C.肺泡腔内有水肿液<br>D.肺泡腔内有多少不等的红细胞<br>E.肺泡腔内可见心力衰竭细胞</td>
      <td>B.肺泡腔内有大量中性粒细胞和纤维素渗出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>8. 有关外周血中性白细胞核右移，下列那项不正确：(2.0分)</td>
      <td>A.以衰老中性白细胞为多<br>B.核分叶、增多<br>C.反映病人对感染抵抗力较强<br>D.提示病人反应力低下</td>
      <td>C.反映病人对感染抵抗力较强</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>9. 深部脓肿向体表或体腔穿破，形成一个一端为盲端的排脓管道称为(2.0分)</td>
      <td>A.瘘管<br>B.窦道<br>C.溃疡<br>D.空洞<br>E.积脓</td>
      <td>B.窦道</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>10. 急性炎症时组织肿胀的主要原因是 (2.0分)</td>
      <td>A.富于蛋白的液体进入组织内<br>B.动脉痉挛<br>C.静脉阻塞<br>D.组织增生<br>E.肉芽组织形成</td>
      <td>A.富于蛋白的液体进入组织内</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>11. 炎症最重要的标志是：(2.0分)</td>
      <td>A.变性<br>B.变质<br>C.渗出<br>D.增生</td>
      <td>C.渗出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>12. 产生IL-1细胞主要是：(2.0分)</td>
      <td>A.肥大细胞、中性粒细胞<br>B.Th1细胞<br>C.Th2细胞<br>D.Mo/Mφ、树突状细胞<br>E.淋巴细胞</td>
      <td>D.Mo/Mφ、树突状细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>13. 下列细胞中MHC II类分子主要存在于： (2.0分)</td>
      <td>A.红细胞<br>B.DC细胞<br>C.NK细胞<br>D.嗜酸性粒细胞<br>E.T淋巴细胞</td>
      <td>B.DC细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>14. 以下不具防御作用的反应是(2.0分)</td>
      <td>A.白细胞游出<br>B.纤维蛋白渗出<br>C.炎性增生<br>D.红细胞漏出<br>E.血浆渗出</td>
      <td>D.红细胞漏出</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>15. 下列病变中不属于肉芽肿性病变的是(2.0分)</td>
      <td>A.伤寒小结<br>B.Aschoff小体<br>C.结核结节<br>D.肝硬化时的再生结节<br>E.假结核结节</td>
      <td>D.肝硬化时的再生结节</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>16. 慢性肺淤血不包括(2.0分)</td>
      <td>A.肺泡间隔增宽<br>B.肺出血<br>C.肺泡壁毛细血管扩张充血<br>D.肺水肿<br>E.肺内支气管明显扩张</td>
      <td>E.肺内支气管明显扩张</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>17. 皮肤、黏膜和浆膜少而广泛的出血灶称为 (2.0分)</td>
      <td>A.凝血块<br>B.积血<br>C.淤血<br>D.血肿<br>E.瘀点</td>
      <td>E.瘀点</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>18. 下列哪一个不是由MHC基因编码(2.0分)</td>
      <td>A.I类HLA抗原<br>B.β2-微球蛋白<br>C.II类HLA抗原<br>D.C4<br>E.HSP70</td>
      <td>B.β2-微球蛋白</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>19. 出血性梗死最常发生在哪一个器官？ (2.0分)</td>
      <td>A.肺<br>B.肾<br>C.脑<br>D.脾<br>E.心</td>
      <td>A.肺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>20. 下列哪一项为近年来出现的选择性COX-2抑制药的严重不良反应？ (2.0分)</td>
      <td>A.血液系统反应<br>B.心血管系统不良反应<br>C.胃肠道反应<br>D.肝肾功能损伤<br>E.皮肤反应</td>
      <td>B.心血管系统不良反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>21. 脓肿主要由下列哪种细菌引起：(2.0分)</td>
      <td>A.金黄色葡萄球菌<br>B.大肠肝菌<br>C.溶血性链球莲<br>D.绿脓杆菌</td>
      <td>C.溶血性链球莲</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>22. 下列炎症中哪一种是化脓性炎症? (2.0分)</td>
      <td>A.急性细菌性心内膜炎<br>B.冷脓肿<br>C.风湿性心内膜炎<br>D.嗜酸性脓肿<br>E.病毒性肝炎</td>
      <td>A.急性细菌性心内膜炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>23. 引起肺褐色硬化的最常见疾病是：(2.0分)</td>
      <td>A.二尖瓣狭窄<br>B.主动脉瓣闭锁不全<br>C.三尖瓣狭窄<br>D.肺动脉瓣狭窄<br>E.肺动脉栓塞</td>
      <td>A.二尖瓣狭窄</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>24. 葡萄球菌和链球菌感染时局部以下列那种是细胞浸润为主：(2.0分)</td>
      <td>A.嗜酸性粒细胞<br>B.巨噬细胞<br>C.中性粒细胞<br>D.淋巴细胞</td>
      <td>C.中性粒细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>25. 一患者有明显全身中毒症状，还出现皮肤粘膜的多发性出血斑点和脾及全身淋巴结肿 大、血中查到病原菌，应考虑为：(2.0分)</td>
      <td>A.脓毒血症<br>B.菌血症<br>C.败血症<br>D.毒血症</td>
      <td>C.败血症</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>26. MHC-I类分子的经典功能(2.0分)</td>
      <td>A.A十B<br>B.参与外源性抗原呈递<br>C.参与内源性抗原呈递<br>D.为CD8+杀伤性T细胞的识别分子<br>E.A十C</td>
      <td>E.A十C</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>27. 细胞因子不具备的特点是：(2.0分)</td>
      <td>A.作用具有高效性和多效性<br>B.通过与相应受体结合发挥作用<br>C.作用具有重叠性和网络性<br>D.主要是在局部起持久作用<br>E.主要通过自分泌和旁分泌发挥作用</td>
      <td>D.主要是在局部起持久作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>28. 流行性脑膜炎属于(2.0分)</td>
      <td>A.肉芽肿性炎<br>B.渗出性炎<br>C.增生性炎<br>D.变质性炎<br>E.出血性炎</td>
      <td>B.渗出性炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>29. 人或动物体内代表个体特异性的能引起强烈而迅速排斥反应的抗原系统称为(2.0分)</td>
      <td>A.主要组织相容性抗原系统<br>B.移植抗原<br>C.白细胞抗原<br>D.组织相容性抗原<br>E.主要组织相容性复合体</td>
      <td>A.主要组织相容性抗原系统</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>30. 某男车祸后股骨骨折入院，急救后情况稳定，第2天突发呼吸急促、呼吸困难和心动过速，终因右心衰竭死亡，该患者的死亡原因最有可能为：(2.0分)</td>
      <td>A. 血栓栓塞<br>B.肺骨髓组织栓塞<br>C.肺气体栓塞<br>D.肺脂肪栓塞<br>E.肺受伤动脉破裂出血</td>
      <td>D.肺脂肪栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>31. 某患者患急性感染性心内膜炎，其二尖瓣瓣膜上出现一黄豆大的赘生物，此赘生物脱落后将不会引起以下哪种栓塞：(2.0分)</td>
      <td>A.肺动脉栓塞<br>B.脾动脉栓塞<br>C.脑动脉栓塞<br>D.肾动脉栓塞<br>E.肠系膜动脉栓塞</td>
      <td>A.肺动脉栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>32. 下列配对哪项明显错误：(2.0分)</td>
      <td>A.大叶性肺炎-纤维素性炎<br>B.皮肤表层水泡-化脓性炎<br>C.风湿性关节炎-浆液性炎<br>D.结核病-肉芽肿性炎</td>
      <td>B.皮肤表层水泡-化脓性炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>33. 梗死灶的形状取决于(2.0分)</td>
      <td>A.该器官的血管分布方式<br>B.该器官的组织致密程度<br>C.该器官的侧枝循环状态<br>D.该器官是否有淤血<br>E.该器官的蛋白含量</td>
      <td>A.该器官的血管分布方式</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>34. 炎症介质的主要作用是 (2.0分)</td>
      <td>A.阳离子浓度降低<br>B.细胞酶活性障碍<br>C.实质细胞变性、坏死<br>D.血管扩张、通透性升高<br>E.组织分解代谢增强</td>
      <td>D.血管扩张、通透性升高</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>35. 与强直性脊柱炎有关的HLA抗原是(2.0分)</td>
      <td>A.HLA-DR4<br>B.HLA-B27<br>C.HLA-DR3<br>D.HLA-CW6<br>E.HLA-A1</td>
      <td>B.HLA-B27</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>36. 心力衰竭细胞最常见于：(2.0分)</td>
      <td>A..冠心病<br>B.肺心病<br>C.慢性肺淤血<br>D.右心衰竭<br>E.肺褐色硬化</td>
      <td>C.慢性肺淤血</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>37. 肉芽组织和肉芽肿的区别在于(2.0分)</td>
      <td>A.组成成分不同<br>B.是否为慢性炎症<br>C.是否导致纤维化<br>D.是否由急性转化而来<br>E.有无感染</td>
      <td>A.组成成分不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>38. 刺激淋巴细胞增殖的细胞因子主要是：(2.0分)</td>
      <td>A.IL-5<br>B.IL-1<br>C.IL-2<br>D.IFN-γ<br>E.IL-3</td>
      <td>C.IL-2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>39. 糖皮质激素抗炎作用的基本机制是 (2.0分)</td>
      <td>A.影响了参与炎症的一些基因转录<br>B.抑制毛细血管和纤维母细胞的增生<br>C.减轻渗出、水肿、毛细血管扩张等炎症反应<br>D.稳定溶酶体膜<br>E.增加肥大细胞颗粒的稳定性</td>
      <td>A.影响了参与炎症的一些基因转录</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>40. 对急性风湿性关节炎，解热镇痛药的作用是 (2.0分)</td>
      <td>A.可根治风湿性关节炎<br>B.缩短疗程<br>C.阻止肉芽组织及瘢痕形成<br>D.对症治疗<br>E.对因治疗</td>
      <td>D.对症治疗</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>41. 编码HLA-I类分子基因位点(2.0分)</td>
      <td>A.HLA-A、B位点<br>B.HLA-DR、DP、DQ位点<br>C.HLA-DR位点<br>D.HLA-A、B、C位点<br>E.C4、C2、TNF、21经化酶基因位点</td>
      <td>D.HLA-A、B、C位点</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>42. 44岁男患，车祸时发生右大腿骨粉碎性及开放性骨折，在送往医院途中，该患者出现面部青紫，呼吸困难，口吐白沫而亡，其最可能的死因是：(2.0分)</td>
      <td>A.脑出血<br>B.气体栓塞<br>C.脂肪栓塞<br>D.心肌梗死<br>E.气胸</td>
      <td>C.脂肪栓塞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>43. 深部脓肿一侧向体表穿破，一侧向体腔穿破，形成一沟通两侧的病理性通道 称 (2.0分)</td>
      <td>A.瘘管<br>B.窦道<br>C.导管<br>D.溃疡</td>
      <td>A.瘘管</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>44. IFN-γ：(2.0分)</td>
      <td>A.其抗病毒功能强于免疫调节功能<br>B.主要由白细胞产生<br>C.主要由成纤维细胞产生<br>D.又称为I型干扰素<br>E.具有干扰病毒复制的功能</td>
      <td>E.具有干扰病毒复制的功能</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>45. 静脉血栓的尾部是(2.0分)</td>
      <td>A.透明血栓<br>B.混合血栓<br>C.红色血栓<br>D.白色血栓<br>E.层状血栓</td>
      <td>C.红色血栓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>46. 下列有关aspirin的体内过程叙述错误的是 (2.0分)</td>
      <td>A.不能分布到脑脊液和胎盘屏障<br>B.口服吸收迅速，1～2小时后达到血药浓度峰值<br>C.尿液pH的变化对其排泄量影响不大<br>D.小剂量时按一级动力学消除<br>E.大剂量时按零级动力学消除</td>
      <td>C.尿液pH的变化对其排泄量影响不大</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>47. 可诱导产生IgE的细胞因子是：(2.0分)</td>
      <td>A.IFN-γ<br>B.IL-4<br>C.IL-2<br>D.IL-5<br>E.CSF</td>
      <td>B.IL-4</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>48. 下列对肝淤血脂肪变的病变特点的描述中哪一项是错误的(2.0分)</td>
      <td>A.肝脏体积增大，表面和切面呈暗红色<br>B.肝小叶中央静脉肝窦明显扩张充血<br>C.肝小叶周边肝细胞高度脂肪变性<br>D.肝小叶中央静脉周围肝细胞高度脂肪变性<br>E.肝小叶中央肝细胞坏死、崩解</td>
      <td>D.肝小叶中央静脉周围肝细胞高度脂肪变性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>49. 对炎症反应有明显促进作用的白细胞介素是：(2.0分)</td>
      <td>A.IL-3、IL-7、IL-11<br>B.IL-2、IL-10、IL-12<br>C.IL-2、IL-4、IL-5、IL-6<br>D.IL-1、IL-6、IL-8<br>E.IL-1、IL-2、IL-12、IL-15</td>
      <td>D.IL-1、IL-6、IL-8</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2008</td>
      <td>50. TNF缺乏以下哪种功能：(2.0分)</td>
      <td>A.诱导细胞凋亡<br>B.激活中性粒细胞和Mo/Mφ 功能<br>C.内源性致热原<br>D.抑制炎症反应<br>E.对肿瘤细胞有毒性作用</td>
      <td>D.抑制炎症反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>1. 在间接凝集反应中，要求所用载体与免疫无关，主要是指(2.0分)</td>
      <td>A.所用载体不能影响相应的抗原抗体反应<br>B.载体不能是免疫学研究对象<br>C.载体不用于吸附可溶性抗原或抗体<br>D.载体不参与凝集物的形成</td>
      <td>A.所用载体不能影响相应的抗原抗体反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>2. 关于效价，正确的是(2.0分)</td>
      <td>A.通常以"++++"的血清最高稀释度作为试验效价<br>B.凝集效价作为半定量指标，可以反映待检血清中抗体的相对浓度<br>C.效价和滴度是两个完全无关的概念<br>D.相同试验条件下的两份待检标本，效价分别是1:160和1:640；可以认为在前一份标本中待检物浓度更高</td>
      <td>B.凝集效价作为半定量指标，可以反映待检血清中抗体的相对浓度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>3. 致敏载体是下述哪种类型免疫反应中的概念(2.0分)</td>
      <td>A.沉淀反应<br>B.免疫标记技术<br>C.直接凝集反应<br>D.间接凝集反应</td>
      <td>D.间接凝集反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>4. 在协同凝集反应中，载体是(2.0分)</td>
      <td>A.金黄色葡萄球菌<br>B.乳胶颗粒<br>C.红细胞<br>D.蛋白质</td>
      <td>A.金黄色葡萄球菌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>5. 和金黄色葡萄球菌A蛋白结合的是(2.0分)</td>
      <td>A.IgG的Fc段<br>B.IgG的Fab段<br>C.IgG的CDR区（complementarity determining region）<br>D.IgG的轻链</td>
      <td>A.IgG的Fc段</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>6. 巨噬细胞缺乏以下哪种受体(2.0分)</td>
      <td>A.IgG的Fc受体<br>B.PHA受体<br>C.TLR<br>D.补体C3b受体<br>E.清道夫受体</td>
      <td>B.PHA受体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>7. 以下哪项关于外周免疫器官的叙述是错误的(2.0分)</td>
      <td>A.脾脏中以B淋巴细胞为主<br>B.淋巴结中以B淋巴细胞为主<br>C.脾脏有血液过滤作用<br>D.脾脏是人体最大的免疫器官<br>E.脾脏是产生抗体的主要器官</td>
      <td>B.淋巴结中以B淋巴细胞为主</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>8. B细胞发育成熟的场所是(2.0分)</td>
      <td>A.骨髓<br>B.胸腺<br>C.扁桃腺<br>D.淋巴结<br>E.脾</td>
      <td>A.骨髓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>9. 宿主的天然抵抗力(2.0分)</td>
      <td>A.经遗传而获得<br>B.感染病原微生物而获得<br>C.接种菌苗或疫苗而获得<br>D.母体的抗体(IgG)通过胎盘给婴儿而获得<br>E.给宿主转输致敏巴细胞而获得</td>
      <td>A.经遗传而获得</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>10. 慢性肉芽肿病发病原因是(2.0分)</td>
      <td>A.红细胞内酶缺陷<br>B.T细胞功能缺陷<br>C.B细胞功能缺陷<br>D.中性粒细胞功能缺陷<br>E.补体功能缺陷</td>
      <td>D.中性粒细胞功能缺陷</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>11. 半抗原(2.0分)</td>
      <td>A.既有免疫原性，又有抗原性<br>B.只有免疫原性，而无抗原性<br>C.只有抗原性，而无免疫原性<br>D.既无免疫原性，又无抗原性<br>E.只有与蛋白质载体结合后才能与相应抗体结合</td>
      <td>C.只有抗原性，而无免疫原性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>12. 兄弟姐妹间进行器官移植，引起排斥反应的抗原是(2.0分)</td>
      <td>A.异种抗原<br>B.同种异型抗原<br>C.异嗜性抗原<br>D.自身抗原<br>E.感染的微生物抗原</td>
      <td>B.同种异型抗原</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>13. 在特异性免疫应答中首先接触TD-Ag的细胞是(2.0分)</td>
      <td>A.T细胞<br>B.B细胞<br>C.APC细胞<br>D.肥大细胞<br>E.中性粒细胞</td>
      <td>C.APC细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>14. 决定抗原分子特异性的是(2.0分)</td>
      <td>A.抗原分子的物理性状<br>B.抗原分子量的大小<br>C.抗原分子中的特殊化学基团<br>D.抗原分子的化学成分<br>E.抗原分子内部结构的复杂性</td>
      <td>C.抗原分子中的特殊化学基团</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>15. 植物血凝素PHA可刺激哪种细胞转化(2.0分)</td>
      <td>A.B细胞<br>B.K细胞<br>C.T细胞<br>D.NK细胞</td>
      <td>C.T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>16. 抗体发挥中和作用主要依赖于(2.0分)</td>
      <td>A.激活补体经典途径<br>B.ADCC作用<br>C. 调理作用<br>D.V区作用<br>E. C区作用</td>
      <td>D.V区作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>17. 具有激活初始T细胞能力的APC是 (2.0分)</td>
      <td>A.巨噬细胞<br>B.B细胞<br>C.树突状细胞<br>D.单核细胞<br>E.肥大细胞</td>
      <td>C.树突状细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>18. 下列哪种细胞因子具有刺激Th1细胞生成的能力(2.0分)</td>
      <td>A.IL-1<br>B.IL-12<br>C.TNF-alpha<br>D.G-CSF<br>E.Erythropoietin</td>
      <td>B.IL-12</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>19. 直接特异杀伤靶细胞的是(2.0分)</td>
      <td>A.巨噬细胞<br>B.Th细胞<br>C.NK细胞<br>D.Tc细胞<br>E.B细胞</td>
      <td>D.Tc细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>20. 在特异性免疫应答中首先接触TD-Ag的细胞是(2.0分)</td>
      <td>A.T细胞<br>B.B细胞<br>C.APC细胞<br>D.肥大细胞<br>E.中性粒细胞</td>
      <td>C.APC细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>21. 以下有关抗体描述错误的是： (2.0分)</td>
      <td>A.IgM激活补体的能力最强<br>B.IgM升高提示处于感染早期<br>C.IgE是I型过敏反应中的主要免疫球蛋白<br>D.IgG、IgA和IgE都能够通过胎盘<br>E.分泌片成分可以保护IgA避免被蛋白酶降解，分布在乳汁和粘膜表面</td>
      <td>D.IgG、IgA和IgE都能够通过胎盘</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>22. 自然调节T细胞主要是指(2.0分)</td>
      <td>A.CD4+CD25+T细胞<br>B.CD4+ Th1细胞<br>C.CD4+Th2细胞<br>D.CD4+ Th3细胞<br>E.CD4+ Tr1细胞</td>
      <td>A.CD4+CD25+T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>23. CD8+CTL细胞的功能有： (2.0分)</td>
      <td>A.通过ADCC作用杀伤肿瘤细胞<br>B.通过结合MHC-II-抗原肽复合物被激活，释放细胞因子促进抗体产生<br>C.通过结合MHC-I-抗原肽复合物被激活，释放穿孔素与淋巴毒素杀伤靶细胞<br>D.释放MAC杀伤靶细胞<br>E.通过MAC攻击杀伤</td>
      <td>C.通过结合MHC-I-抗原肽复合物被激活，释放穿孔素与淋巴毒素杀伤靶细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>24. BCR与下列哪种分子结合形成复合物(2.0分)</td>
      <td>A.CD4<br>B.CD8<br>C.Ig<br>D.TNF 受体<br>E.IL-2受体</td>
      <td>C.Ig</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>25. 具有局部粘膜抗感染作用的免疫球蛋白是(2.0分)</td>
      <td>A.IgG<br>B.IgM<br>C.IgA<br>D.sIgA<br>E.IgE</td>
      <td>D.sIgA</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>26. 抗体初次应答的特征是 (2.0分)</td>
      <td>A.抗体以IgG为主<br>B.IgG与IgM几乎同时产生<br>C.抗体含量较高<br>D.抗体亲和力低</td>
      <td>D.抗体亲和力低</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>27. 主要介导同型细胞间的黏附作用，对组织和器官的发育及完整组织结构的维持起重要作用的黏附分子家族是： (2.0分)</td>
      <td>A.免疫球蛋白超家族<br>B.选择素家族<br>C.钙黏蛋白家族<br>D.整合素家族<br>E.未归类黏附分子</td>
      <td>C.钙黏蛋白家族</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>28. 能使B细胞表面BCR与FcγIIR－B 交联的抗体(2.0分)</td>
      <td>A.抗γ链独特型IgG类抗体<br>B.抗δ链独特型IgG类抗体<br>C.抗μ链独特型IgM类抗体<br>D.抗μ链独特型IgG类抗体<br>E.抗μ链独特型IgM类抗体</td>
      <td>D.抗μ链独特型IgG类抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>29. 受抗原刺激后，机体最先产生的抗体是(2.0分)</td>
      <td>A.IgG<br>B.IgM<br>C.IgD<br>D.IgA<br>E.IgE</td>
      <td>B.IgM</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>30. 主要介导白细胞与内皮细胞结合，参与炎症及淋巴细胞归巢的黏附分子家族是(2.0分)</td>
      <td>A.整合素家族<br>B.选择素家族<br>C.钙黏蛋白家族<br>D.免疫球蛋白超家族<br>E.未归类黏附分子</td>
      <td>B.选择素家族</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>31. 下列有关B细胞的表述中哪项正确(2.0分)</td>
      <td>A.成熟B细胞表面仅表达mIgM<br>B.成熟B细胞既无mIgM，又无mIgE<br>C.成熟B细胞既有mIgM，又有mIgD<br>D.阴性选择发生在骨髓中的成熟B细胞发育后<br>E.阴性选择发生在骨髓中的前B细胞发育时期</td>
      <td>C.成熟B细胞既有mIgM，又有mIgD</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>32. T细胞发育成熟的免疫器官是(2.0分)</td>
      <td>A.骨髓<br>B.胸腺<br>C.腔上囊<br>D.淋巴结</td>
      <td>B.胸腺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>33. 结构上有β3链整合素家族成员属于：(2.0分)</td>
      <td>A.VLA组<br>B.钙黏蛋白组<br>C.补体调节蛋白组<br>D.血小板糖蛋白组<br>E.白细胞黏附受体组</td>
      <td>D.血小板糖蛋白组</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>34. IgG经胃蛋白酶水解后，得到有抗体活性的片段是(2.0分)</td>
      <td>A.Fab<br>B. Fc<br>C.F（ab'）<br>D.F（ab'）2</td>
      <td>D.F（ab'）2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>35. 主要介导细胞与细胞外基质结合的黏附分子家族是：(2.0分)</td>
      <td>A.免疫球蛋白超家族<br>B.选择素家族<br>C.整合素家族<br>D.钙黏蛋白家族<br>E.未归类黏附分子</td>
      <td>C.整合素家族</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>36. 下述哪个器官或细胞可对抗原识别与应答(2.0分)</td>
      <td>A.脑<br>B.浆细胞<br>C.NK细胞<br>D.脾脏和淋巴结中的巨噬细胞<br>E.脾脏和淋巴结中的B细胞</td>
      <td>E.脾脏和淋巴结中的B细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>37. 未成熟B细胞(2.0分)</td>
      <td>A.只产生μ链<br>B.是T、B细胞的前体<br>C.表面同时表达IgM和IgD<br>D.在其发育的某一阶段与抗原接触后可导致无反应性<br>E.必须经过胸腺才能成熟</td>
      <td>D.在其发育的某一阶段与抗原接触后可导致无反应性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>38. 下列哪种物质是T细胞表面最重要的共刺激分子： (2.0分)</td>
      <td>A.CD28<br>B.ICAM-1<br>C.CD40<br>D.CD4<br>E.CD8</td>
      <td>A.CD28</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>39. 下列哪种物质是B细胞表面最重要的共刺激分子： (2.0分)</td>
      <td>A.CD28<br>B.CD40<br>C.ICAM-1<br>D.CD4<br>E.CD8</td>
      <td>B.CD40</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>40. IgG3的分子量比所有其他IgG亚类的分子量高的原因是(2.0分)</td>
      <td>A.C区有4个功能区<br>B.有与羧基端结合的J链<br>C.分子发生聚合<br>D.较长的铰链区<br>E.碳水化合物含量高</td>
      <td>D.较长的铰链区</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>41. 能与CD80结合的是：(2.0分)</td>
      <td>A.CD2<br>B.CD8<br>C.CD4<br>D.CD28<br>E.CD21</td>
      <td>D.CD28</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>42. 在生发中心聚集的非吞噬性单个核细胞中有发育很好的内质网存在提示这些细胞是 (2.0分)</td>
      <td>A.T细胞<br>B.B细胞<br>C.记忆细胞<br>D.浆细胞<br>E.无标记细胞</td>
      <td>D.浆细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>43. EB病毒的受体是：(2.0分)</td>
      <td>A.CD2<br>B.CD8<br>C.CD4<br>D.CD28<br>E.CD21</td>
      <td>E.CD21</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>44. 参与免疫应答的细胞都带有(2.0分)</td>
      <td>A.抗原受体<br>B.SmIg<br>C.有丝分裂受体<br>D.SRBC受体<br>E.MHC编码产物</td>
      <td>E.MHC编码产物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>45. 关于记忆细胞的错误理解是(2.0分)</td>
      <td>A.已接受抗原刺激<br>B.仅限于B细胞<br>C.可生存数月到数年<br>D.参加淋巴细胞再循环<br>E.再次遇到抗原时能迅速增殖和分化</td>
      <td>B.仅限于B细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>46. MHC限制性表现于(2.0分)</td>
      <td>A.NK细胞的杀伤作用<br>B.ADCC<br>C.T细胞的抗原识别过程<br>D.B细胞对TI抗原的应答<br>E.补体依赖细胞毒作用</td>
      <td>C.T细胞的抗原识别过程</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>47. 抗体能破坏病毒感染的细胞，通过(2.0分)</td>
      <td>A.直接中和细胞内病毒颗粒<br>B.诱导非感染T细胞释放抗病毒物质<br>C.防止病毒脱落<br>D.与细胞表面病毒诱导的抗原决定簇结合并活化补体<br>E.调理作用并导致吞噬作用</td>
      <td>D.与细胞表面病毒诱导的抗原决定簇结合并活化补体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>48. 下述不属于固有免疫的特点是(2.0分)</td>
      <td>A.缺少特异性<br>B.由刺激物激活<br>C.涉及多种免疫细胞的参与<br>D.有记忆性</td>
      <td>D.有记忆性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>49. 以下有关抗体描述错误的是(2.0分)</td>
      <td>A.IgM激活补体的能力最强<br>B.IgM升高提示处于感染早期<br>C.IgE是I型过敏反应中的主要免疫球蛋白<br>D.IgG、IgA和IgE都能够通过胎盘<br>E.分泌片成分可以保护IgA避免被蛋白酶降解，分布在乳汁和粘膜表面</td>
      <td>D.IgG、IgA和IgE都能够通过胎盘</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2009</td>
      <td>50. 唯一能激发初次免疫应答的APC是(2.0分)</td>
      <td>A.B细胞<br>B.单核-巨噬细胞<br>C.血管内皮细胞<br>D.树突状细胞<br>E.胸腺上皮细胞</td>
      <td>D.树突状细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>1. When using ProtParam to analyze the structure of one protein, from its output" number of amino acids (2322), theoretical pI (5.27), total number of atoms (35191), instability index (44.80) , grand average of hydropathicity (GRAVY)( -0.157)" we can conclude that: (2.5分)</td>
      <td>A.this protein stable and hydrophilic.<br>B.this protein is unstable and hydrophobic.<br>C.this protein is stable and hydrophobic.<br>D.this protein is unstable and hydrophilic.</td>
      <td>D.this protein is unstable and hydrophilic.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>2. When trying to compare the similarity between two protein sequences using protein database, which "blast" should be chosen?(2.5分)</td>
      <td>A.blastn<br>B.blastp<br>C.tblastn<br>D.blastx</td>
      <td>B.blastp</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>3. 在间接凝集反应中，要求所用载体与免疫无关，主要是指(2.5分)</td>
      <td>A.所用载体不能影响相应的抗原抗体反应<br>B.载体不能是免疫学研究对象<br>C.载体不用于吸附可溶性抗原或抗体<br>D.载体不参与凝集物的形成</td>
      <td>A.所用载体不能影响相应的抗原抗体反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>4. 关于吞噬试验，不正确的是(2.5分)</td>
      <td>A.吞噬百分率和吞噬指数是反映吞噬细胞吞噬功能的指标<br>B.吞噬细胞是组成机体非特异性免疫的成分之一<br>C.核深染且分叶的是巨噬细胞<br>D.试验中，若吞噬时间过长，会造成吞噬率偏低，因为部分被吞噬物可能已被消化而不能被计数</td>
      <td>C.核深染且分叶的是巨噬细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>5. 关于ABO血型鉴定试验，不正确的是(2.5分)</td>
      <td>A.指尖或耳垂通常作为取血部位<br>B.先加分型试剂（抗A或抗B），再加入待检者血球混悬液，是为了防止漏加分型试剂（抗A和抗B）<br>C.采血针一人一针，防止交叉感染<br>D.待检标本是血球混悬液，不能直接用血液</td>
      <td>D.待检标本是血球混悬液，不能直接用血液</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>6. 类风湿因子作为一种抗体，其对应的抗原是(2.5分)</td>
      <td>A.红细胞<br>B.人类自身变性IgG<br>C.T细胞<br>D.软骨组织</td>
      <td>B.人类自身变性IgG</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>7. 下列有关B细胞的表述中哪项正确 (2.5分)</td>
      <td>A.成熟B细胞表面仅表达mIgM<br>B.成熟B细胞既无mIgM，又无mIgE<br>C. 成熟B细胞既有mIgM，又有mIgD<br>D.阴性选择发生在骨髓中的成熟B细胞发育后<br>E.阴性选择发生在骨髓中的前B细胞发育时期</td>
      <td>C. 成熟B细胞既有mIgM，又有mIgD</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>8. 未成熟B细胞(2.5分)</td>
      <td>A.只产生μ链<br>B.是T、B细胞的前体<br>C.表面同时表达IgM和IgD<br>D.在其发育的某一阶段与抗原接触后可导致无反应性<br>E.必须经过胸腺才能成熟</td>
      <td>B.是T、B细胞的前体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>9. 在生发中心聚集的非吞噬性单个核细胞中有发育很好的内质网存在提示这些细胞是 (2.5分)</td>
      <td>A.T细胞<br>B.B细胞<br>C.记忆细胞<br>D.浆细胞<br>E.无标记细胞</td>
      <td>D.浆细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>10. 下列哪种物质是B细胞表面最重要的共刺激分子： (2.5分)</td>
      <td>A.CD28<br>B.CD40<br>C.ICAM-1<br>D.CD4<br>E.CD8</td>
      <td>B.CD40</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>11. 关于记忆细胞的错误理解是(2.5分)</td>
      <td>A.已接受抗原刺激<br>B.仅限于B细胞<br>C.可生存数月到数年<br>D.参加淋巴细胞再循环<br>E.再次遇到抗原时能迅速增殖和分化</td>
      <td>B.仅限于B细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>12. 抗体能破坏病毒感染的细胞，通过(2.5分)</td>
      <td>A.直接中和细胞内病毒颗粒<br>B.诱导非感染T细胞释放抗病毒物质<br>C.防止病毒脱落<br>D.与细胞表面病毒诱导的抗原决定簇结合并活化补体<br>E.调理作用并导致吞噬作用</td>
      <td>D.与细胞表面病毒诱导的抗原决定簇结合并活化补体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>13. 与B细胞活化有关的膜分子：(2.5分)</td>
      <td>A.CD3和CD2<br>B.CD4和CD8<br>C.CD4和CD40<br>D.CD21和CD19<br>E.CD56和CD16</td>
      <td>D.CD21和CD19</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>14. 下列关于B细胞活化的错误的是： (2.5分)</td>
      <td>A.CD21/CD19/CD81是B细胞表面最重要的共刺激分子<br>B.需要双信号，一是BCR/Ig 传递抗原信号；二与Th细胞相互作用，通过CD40传递共刺激信号<br>C.在骨髓发育不需要抗原刺激<br>D.受体编辑也是自身反应性B细胞清除的机制之一<br>E.对TD抗原的再次应答需Th细胞辅助</td>
      <td>A.CD21/CD19/CD81是B细胞表面最重要的共刺激分子</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>15. 在胸腺细胞发生阴性选择时，发生凋亡的细胞是：(2.5分)</td>
      <td>A.不能与MHC有效结合的双阳性细胞<br>B.与MHC亲和力过高的双阳性细胞<br>C.与MHC有效结合的单阳性细胞<br>D.不与MHC-自身抗原肽发生结合的单阳性细胞<br>E.与MHC-自身抗原肽有高亲和力的单阳性细胞</td>
      <td>E.与MHC-自身抗原肽有高亲和力的单阳性细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>16. 致敏TC细胞的作用特点是(2.5分)</td>
      <td>A.无抗原特异性<br>B.受MHC-Ⅱ类分子限制<br>C.可通过释放TNF杀伤靶细胞<br>D.可通过ADCC作用杀伤靶细胞<br>E.可通过分泌细胞毒性物质杀伤靶细胞</td>
      <td>E.可通过分泌细胞毒性物质杀伤靶细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>17. MHC限制性表现于(2.5分)</td>
      <td>A.NK细胞的杀伤作用<br>B.ADCC<br>C.T细胞的抗原识别过程<br>D.B细胞对TI抗原的应答<br>E.补体依赖细胞毒作用</td>
      <td>C.T细胞的抗原识别过程</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>18. 下列哪种细胞因子具有刺激Th1细胞生成的能力(2.5分)</td>
      <td>A.IL-1<br>B.IL-12<br>C.TNF-alpha<br>D.G-CSF<br>E.Erythropoietin</td>
      <td>B.IL-12</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>19. 以下关于CD4的说法哪项是错误的：(2.5分)</td>
      <td>A.成熟的T细胞表面都有CD4表达<br>B.CD4不直接参与特异性识别抗原<br>C.CD4属于免疫球蛋白超家族成员<br>D.CD4可与Ag-MHCII分子复合体结合<br>E.可用抗CD4单抗对辅助性T细胞进行检测</td>
      <td>A.成熟的T细胞表面都有CD4表达</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>20. 免疫应答过程不包括(2.5分)</td>
      <td>A.巨噬细胞对抗原的加工和提呈<br>B.B细胞对抗原的特异性识别<br>C.T细胞在胸腺内的分化成熟<br>D.T、B细胞的活化、增殖、分化<br>E.效应细胞和效应分子的产生和作用</td>
      <td>C.T细胞在胸腺内的分化成熟</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>21. 下列哪项不是活化T细胞释放的细胞因子： (2.5分)</td>
      <td>A.IL-10<br>B.IL-2<br>C.IL-4<br>D.TNF-β<br>E.IL-1</td>
      <td>E.IL-1</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>22. 下列关于T细胞介导的适应性免疫应答的说法，哪项是错误的(2.5分)</td>
      <td>A.对TD抗原的应答都产生记忆<br>B.对TD抗原的应答需APC提呈抗原<br>C.CTL杀伤靶细胞受MHC I类限制<br>D.均能形成免疫耐受<br>E.效应产物的效应均具有特异性</td>
      <td>E.效应产物的效应均具有特异性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>23. 与细胞免疫应答无关的免疫反应是(2.5分)</td>
      <td>A.外毒素中和作用<br>B.抗肿瘤免疫作用<br>C.移植排斥反应<br>D.接触性皮炎<br>E.结核结节形成</td>
      <td>A.外毒素中和作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>24. 半抗原(2.5分)</td>
      <td>A.既有免疫原性，又有抗原反应性<br>B.只有免疫原性，而无抗原反应性<br>C.只有抗原反应性，而无免疫原性<br>D.既无免疫原性，又无抗原反应性<br>E.只有与蛋白质载体结合后才能与相应抗体结合</td>
      <td>C.只有抗原反应性，而无免疫原性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>25. 下列哪种物质不是TD-Ag：(2.5分)</td>
      <td>A.血清蛋白<br>B.细菌外毒素<br>C.类毒素<br>D.细菌脂多糖<br>E.IgM</td>
      <td>D.细菌脂多糖</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>26. 用牛血清白蛋白-二硝基苯-卵清蛋白（BSA-DNP-OA）免疫过的动物，注射下列哪种物质，产生抗DNP抗体的量最少： (2.5分)</td>
      <td>A.用牛血清白蛋白-二硝基苯<br>B.二硝基苯-卵清蛋白<br>C.牛血清白蛋白-二硝基苯-卵清蛋白<br>D.鸡丙种球蛋白-二硝基苯<br>E. 鸡丙种球蛋白-苯胺</td>
      <td>E. 鸡丙种球蛋白-苯胺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>27. 佐剂是这样一种物质(2.5分)</td>
      <td>A.能增加免疫原的大小<br>B.增强半抗原的免疫原性<br>C.增加免疫原的化学复杂性<br>D.增强机体对免疫原的免疫应答<br>E.增强免疫原的交叉反应性</td>
      <td>D.增强机体对免疫原的免疫应答</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>28. 动物来源的破伤风抗毒素对人而言是(2.5分)</td>
      <td>A.半抗原<br>B.抗体<br>C.抗原<br>D.既是抗原又是抗体<br>E.超抗原</td>
      <td>D.既是抗原又是抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>29. 决定抗原分子特异性的是(2.5分)</td>
      <td>A.抗原分子的物理性状<br>B.抗原分子量的大小<br>C.抗原分子中的特殊化学基团<br>D.抗原分子的化学成分<br>E.抗原分子内部结构的复杂性</td>
      <td>C.抗原分子中的特殊化学基团</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>30. 抗原提呈细胞所不具备的作用是：(2.5分)</td>
      <td>A.降解蛋白质抗原为小分子肽段<br>B.促进T细胞表达特异性抗原受体<br>C.可为T细胞活化提供第一信号<br>D.可为T细胞活化提供第二信号<br>E.以抗原肽-MHC复合体的形式提呈抗原</td>
      <td>B.促进T细胞表达特异性抗原受体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>31. B细胞摄取抗原的方式是：(2.5分)</td>
      <td>A.非特异性抗原受体介导的吞噬作用<br>B.特异性抗原受体介导的吞饮作用<br>C.非特异性抗原受体介导的吞饮作用<br>D.特异性抗原受体介导的内吞作用和非特异性抗原受体介导的吞饮作用<br>E.特异性抗原受体介导的内吞作用和非特异性吞饮作用</td>
      <td>E.特异性抗原受体介导的内吞作用和非特异性吞饮作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>32. DC成熟后(2.5分)</td>
      <td>A.其MHC分子、共刺激分子和黏附分子表达显著提高<br>B.体外激发MLR能力很弱<br>C.摄取抗原能力增强<br>D.加工处理抗原能力增强<br>E.提呈抗原能力减弱</td>
      <td>A.其MHC分子、共刺激分子和黏附分子表达显著提高</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>33. 专职APC细胞与T细胞之间相互作用受MHC-Ⅱ类分子限制的是(2.5分)</td>
      <td>A.病毒感染细胞与Th细胞<br>B.病毒感染细胞与Tc细胞<br>C.巨噬细胞和Th细胞<br>D.肿瘤细胞与Th细胞<br>E.肿瘤细胞和Tc细胞</td>
      <td>C.巨噬细胞和Th细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>34. 能使B细胞表面BCR与FcγIIR－B 交联的抗体(2.5分)</td>
      <td>A.抗γ链独特型IgG类抗体<br>B.抗α链独特型IgG类抗体<br>C.抗μ链独特型IgM类抗体<br>D.抗μ链独特型IgG类抗体<br>E.抗γ链独特型IgM类抗体</td>
      <td>D.抗μ链独特型IgG类抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>35. 来自母体能引起新生儿溶血症的Rh抗体是： (2.5分)</td>
      <td>A.IgA类抗体<br>B.IgM类抗体<br>C.IgG类抗体<br>D.IgE类抗体<br>E. IgD类抗体</td>
      <td>C.IgG类抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>36. 以下有关抗体描述错误的是： (2.5分)</td>
      <td>A.IgM激活补体的能力最强<br>B.IgM升高提示处于感染早期<br>C.IgE是I型过敏反应中的主要免疫球蛋白<br>D.IgG、IgA和IgE都能够通过胎盘<br>E.分泌片成分可以保护IgA避免被蛋白酶降解，分布在乳汁和粘膜表面</td>
      <td>D.IgG、IgA和IgE都能够通过胎盘</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>37. 淋巴结的下述哪个区域为胸腺依赖区(2.5分)</td>
      <td>A.副皮质区<br>B.浅皮质区<br>C.髓索<br>D.淋巴小结<br>E.次级淋巴滤泡</td>
      <td>A.副皮质区</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>38. 关于淋巴细胞再循环，以下哪项描述是错误的(2.5分)</td>
      <td>A.参与再循环的淋巴细胞主要是T细胞<br>B.淋巴细胞再循环可使体内淋巴细胞分布更趋合理<br>C.淋巴细胞再循环可增加与抗原、抗原提呈细胞接触的机会<br>D.淋巴细胞再循环是淋巴细胞经HEV离开血循环选择性进入并定居于外周免疫器官相应区域<br>E.淋巴细胞再循环是维持机体正常免疫应答的必要条件</td>
      <td>D.淋巴细胞再循环是淋巴细胞经HEV离开血循环选择性进入并定居于外周免疫器官相应区域</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>39. 宿主的天然抵抗力(2.5分)</td>
      <td>A.经遗传而获得<br>B.感染病原微生物而获得<br>C.接种菌苗或疫苗而获得<br>D.母体的抗体(IgG)通过胎盘给婴儿而获得<br>E.给宿主转输致敏巴细胞而获得</td>
      <td>A.经遗传而获得</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2010</td>
      <td>40. 巨噬细胞缺乏以下哪种受体(2.5分)</td>
      <td>A.IgG的Fc受体<br>B.PHA受体<br>C.TLR<br>D.补体C3b受体<br>E.清道夫受体</td>
      <td>B.PHA受体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>1. CD8+CTL细胞的功能有： (2.5分)</td>
      <td>A.通过ADCC作用杀伤肿瘤细胞<br>B.通过结合MHC-II-抗原肽复合物被激活，释放细胞因子促进抗体产生<br>C.通过结合MHC-I-抗原肽复合物被激活，释放穿孔素与淋巴毒素杀伤靶细胞<br>D.释放MAC杀伤靶细胞</td>
      <td>C.通过结合MHC-I-抗原肽复合物被激活，释放穿孔素与淋巴毒素杀伤靶细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>2. 在胸腺细胞发生阴性选择时，发生凋亡的细胞是(2.5分)</td>
      <td>A.不能与MHC有效结合的双阳性细胞<br>B.与MHC亲和力过高的双阳性细胞<br>C.与MHC有效结合的单阳性细胞<br>D.不与MHC-自身抗原肽发生结合的单阳性细胞<br>E.与MHC-自身抗原肽有高亲和力的单阳性细胞</td>
      <td>E.与MHC-自身抗原肽有高亲和力的单阳性细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>3. 以下关于CD4的说法哪项是错误的(2.5分)</td>
      <td>A.成熟的T细胞表面都有CD4表达<br>B.CD4不直接参与特异性识别抗原<br>C.CD4属于免疫球蛋白超家族成员<br>D.CD4可与Ag-MHCII分子复合体结合<br>E.可用抗CD4单抗对辅助性T细胞进行检测</td>
      <td>A.成熟的T细胞表面都有CD4表达</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>4. 致敏TC细胞的作用特点是(2.5分)</td>
      <td>A.无抗原特异性<br>B.受MHC-Ⅱ类分子限制<br>C.可通过释放TNF杀伤靶细胞<br>D.可通过ADCC作用杀伤靶细胞<br>E.可通过分泌细胞毒性物质杀伤靶细胞</td>
      <td>E.可通过分泌细胞毒性物质杀伤靶细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>5. Diversity is an important feature of the immune system. Which one of the following statements about it is INCORRECT? (2.5分)</td>
      <td>A.Humans can make antibodies with about 108 different VH X VL combinations.<br>B.A single cell can synthesize IgM antibody, then switch to IgA antibody.<br>C.The hematopoietic stem cell carries the genetic potential to create more than 104 immunoglobulin genes.<br>D.A single B lymphocyte can produce antibodies of many different specificities, but a plasma cell is monospecific.</td>
      <td>D.A single B lymphocyte can produce antibodies of many different specificities, but a plasma cell is monospecific.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>6. In the immune response to a hapten-protein conjugate, in order to get anti-hapten antibodies it is essential that (2.5分)</td>
      <td>A.the hapten be recognized by helper T cells.<br>B.the protein be recognized by helper T cells.<br>C.the protein be recognized by B cells.<br>D.the hapten be recognized by suppressor T cells.</td>
      <td>B.the protein be recognized by helper T cells.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>7. Which one of the following is NOT true of the gene segments that combine to make up a heavy-chain gene? (2.5分)</td>
      <td>A.Many V region segments are available.<br>B.Several J segments and several D segments are available.<br>C.V, D, and J segments combine to encode the antigen-binding site.<br>D.A V segment and a J segment are preselected by an antigen to make up the variable-region portion of the gene.</td>
      <td>D.A V segment and a J segment are preselected by an antigen to make up the variable-region portion of the gene.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>8. Isotype switching of immunoglobulin classes by B cells involves(2.5分)</td>
      <td>A.simultaneous insertion of VH genes adjacent to each CH gene.<br>B.successive insertion of a single VH gene adjacent to different CH genes.<br>C.activation of homologous genes on chromosome 6.<br>D.switching of light-chain types (kappa and lambda).</td>
      <td>B.successive insertion of a single VH gene adjacent to different CH genes.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>9. 半抗原(2.5分)</td>
      <td>A.既有免疫原性，又有抗原反应性<br>B.只有免疫原性，而无抗原反应性<br>C.只有抗原反应性，而无免疫原性<br>D.既无免疫原性，又无抗原反应性<br>E.只有与蛋白质载体结合后才能与相应抗体结合</td>
      <td>C.只有抗原反应性，而无免疫原性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>10. 胸腺依赖性抗原的特点之一是(2.5分)</td>
      <td>A.分子较大，结构复杂，需T细胞的辅助<br>B.分子较小，结构复杂，需T细胞的辅助<br>C.分子较大，结构复杂，直接激活B细胞<br>D.结构简单，含有许多重复的抗原决定簇，无需T细胞的辅助<br>E.只产生IgM</td>
      <td>A.分子较大，结构复杂，需T细胞的辅助</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>11. 用牛血清白蛋白-二硝基苯-卵清蛋白（BSA-DNP-OA）免疫过的动物，注射下列哪种物质，产生抗DNP抗体的量最少(2.5分)</td>
      <td>A.用牛血清白蛋白-二硝基苯<br>B.二硝基苯-卵清蛋白<br>C.牛血清白蛋白-二硝基苯-卵清蛋白<br>D.鸡丙种球蛋白-二硝基苯<br>E.鸡丙种球蛋白-苯胺</td>
      <td>E.鸡丙种球蛋白-苯胺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>12. 接种牛痘后产生对天花的抵抗性，这反映了(2.5分)</td>
      <td>A.抗原的特异性<br>B.抗原的交叉反应<br>C.病毒的超感染<br>D.先天免疫<br>E.主动保护</td>
      <td>B.抗原的交叉反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>13. 关于淋巴细胞再循环，以下哪项描述是错误的(2.5分)</td>
      <td>A.参与再循环的淋巴细胞主要是T细胞<br>B.淋巴细胞再循环可使体内淋巴细胞分布更趋合理<br>C.淋巴细胞再循环可增加与抗原、抗原提呈细胞接触的机会<br>D.淋巴细胞再循环是淋巴细胞经HEV离开血循环选择性进入并定居于外周免疫器官相应区域<br>E.淋巴细胞再循环是维持机体正常免疫应答的必要条件</td>
      <td>D.淋巴细胞再循环是淋巴细胞经HEV离开血循环选择性进入并定居于外周免疫器官相应区域</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>14. 宿主的天然抵抗力(2.5分)</td>
      <td>A.经遗传而获得<br>B.感染病原微生物而获得<br>C.接种菌苗或疫苗而获得<br>D.母体的抗体(IgG)通过胎盘给婴儿而获得<br>E.给宿主转输致敏巴细胞而获得</td>
      <td>A.经遗传而获得</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>15. 以下哪项不是脾脏的重要功能(2.5分)</td>
      <td>A.产生致敏淋巴细胞<br>B.产生抗体<br>C.血液过滤作用<br>D.淋巴液过滤作用<br>E.进行特异性免疫应答</td>
      <td>D.淋巴液过滤作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>16. 免疫的概念是(2.5分)</td>
      <td>A.机体排除病原微生物的功能<br>B.机体清除自身衰老、死亡细胞的功能<br>C.机体抗感染的防御功能<br>D.机体免疫系统识别和排除抗原性异物的功能<br>E.机体清除自身突变细胞的功能</td>
      <td>D.机体免疫系统识别和排除抗原性异物的功能</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>17. 在间接凝集反应中，要求所用载体与免疫无关，主要是指(2.5分)</td>
      <td>A.所用载体不能影响相应的抗原抗体反应<br>B.载体不能是免疫学研究对象<br>C.载体不用于吸附可溶性抗原或抗体<br>D.载体不参与凝集物的形成</td>
      <td>A.所用载体不能影响相应的抗原抗体反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>18. 关于吞噬试验，不正确的是(2.5分)</td>
      <td>A.吞噬百分率和吞噬指数是反映吞噬细胞吞噬功能的指标<br>B.吞噬细胞是组成机体非特异性免疫的成分之一<br>C.核深染且分叶的是巨噬细胞<br>D.试验中，若吞噬时间过长，会造成吞噬率偏低，因为部分被吞噬物可能已被消化而不能被计数</td>
      <td>C.核深染且分叶的是巨噬细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>19. 关于ABO血型鉴定试验，不正确的是(2.5分)</td>
      <td>A.指尖或耳垂通常作为取血部位<br>B.先加分型试剂（抗A或抗B），再加入待检者血球混悬液，是为了防止漏加分型试剂（抗A和抗B）<br>C.采血针一人一针，防止交叉感染<br>D.待检标本是血球混悬液，不能直接用血液</td>
      <td>D.待检标本是血球混悬液，不能直接用血液</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>20. 关于效价，正确的是(2.5分)</td>
      <td>A.通常以"++++"的血清最高稀释度作为试验效价<br>B.凝集效价作为半定量指标，可以反映待检血清中抗体的相对浓度<br>C.效价和滴度是两个完全无关的概念<br>D.相同试验条件下的两份待检标本，效价分别是1:160和1:640；可以认为在前一份标本中待检物浓度更高</td>
      <td>B.凝集效价作为半定量指标，可以反映待检血清中抗体的相对浓度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>21. 免疫应答过程不包括(2.5分)</td>
      <td>A.巨噬细胞对抗原的加工和提呈<br>B.B细胞对抗原的特异性识别<br>C.T细胞在胸腺内的分化成熟<br>D.T、B细胞的活化、增殖、分化<br>E.效应细胞和效应分子的产生和作用</td>
      <td>C.T细胞在胸腺内的分化成熟</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>22. TCR识别抗原的信号传递是通过哪项进行传递的(2.5分)</td>
      <td>A.CD2<br>B.SmIg<br>C.CD3<br>D.Igα，Igβ<br>E.MHC I/II类分子</td>
      <td>C.CD3</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>23. 下列关于T细胞介导的适应性免疫应答的说法，哪项是错误的(2.5分)</td>
      <td>A.对TD抗原的应答都产生记忆<br>B.对TD抗原的应答需APC提呈抗原<br>C.CTL杀伤靶细胞受MHC I类限制<br>D.均能形成免疫耐受<br>E.效应产物的效应均具有特异性</td>
      <td>E.效应产物的效应均具有特异性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>24. 与细胞免疫应答无关的免疫反应是(2.5分)</td>
      <td>A.外毒素中和作用<br>B.抗肿瘤免疫作用<br>C.移植排斥反应<br>D.接触性皮炎<br>E.结核结节形成</td>
      <td>A.外毒素中和作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>25. DC成熟后(2.5分)</td>
      <td>A.其MHC分子、共刺激分子和黏附分子表达显著提高<br>B.体外激发MLR能力很弱<br>C.摄取抗原能力增强<br>D.加工处理抗原能力增强<br>E.提呈抗原能力减弱</td>
      <td>A.其MHC分子、共刺激分子和黏附分子表达显著提高</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>26. 专职APC细胞与T细胞之间相互作用受MHC-Ⅱ类分子限制的是(2.5分)</td>
      <td>A.病毒感染细胞与Th细胞<br>B.病毒感染细胞与Tc细胞<br>C.巨噬细胞和Th细胞<br>D.肿瘤细胞与Th细胞<br>E.肿瘤细胞和Tc细胞</td>
      <td>C.巨噬细胞和Th细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>27. B细胞摄取抗原的方式是(2.5分)</td>
      <td>A.非特异性抗原受体介导的吞噬作用<br>B.特异性抗原受体介导的吞饮作用<br>C.非特异性抗原受体介导的吞饮作用<br>D.特异性抗原受体介导的内吞作用和非特异性抗原受体介导的吞饮作用<br>E.特异性抗原受体介导的内吞作用和非特异性吞饮作用</td>
      <td>E.特异性抗原受体介导的内吞作用和非特异性吞饮作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>28. 抗原提呈细胞所不具备的作用是(2.5分)</td>
      <td>A.降解蛋白质抗原为小分子肽段<br>B.促进T细胞表达特异性抗原受体<br>C.可为T细胞活化提供第一信号<br>D.可为T细胞活化提供第二信号<br>E.以抗原肽-MHC复合体的形式提呈抗原</td>
      <td>B.促进T细胞表达特异性抗原受体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>29. 通过自然被动免疫的Ig是(2.5分)</td>
      <td>A.sIgA、IgG<br>B.IgM、sIgA<br>C.IgG、IgD<br>D.IgD、IgE<br>E.IgE、IgA</td>
      <td>A.sIgA、IgG</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>30. 能使B细胞表面BCR与FcγIIR－B 交联的抗体(2.5分)</td>
      <td>A.抗γ链独特型IgG类抗体<br>B.抗α链独特型IgG类抗体<br>C.抗μ链独特型IgM类抗体<br>D.抗μ链独特型IgG类抗体<br>E.抗γ链独特型IgM类抗体</td>
      <td>D.抗μ链独特型IgG类抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>31. 受抗原刺激后，机体最先产生的抗体是(2.5分)</td>
      <td>A.IgG<br>B.IgM<br>C.IgD<br>D.IgA<br>E.IgE</td>
      <td>B.IgM</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>32. 下列关于MHC I类抗原的描述错误的是(2.5分)</td>
      <td>A.由HLA复合体的A、B、C区基因编码<br>B.其抗原肽结合槽由 1和 1组成，结合肽的长度为13-17氨基酸<br>C.其抗原肽结合槽由 1和 2组成，结合肽的长度为9-11氨基酸<br>D.具有高度多态性，由 链决定<br>E.所有有核细胞都表达</td>
      <td>B.其抗原肽结合槽由 1和 1组成，结合肽的长度为13-17氨基酸</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>33. 以下有关TAP基因的叙述哪项是错误的(2.5分)</td>
      <td>A.它编码产物是抗原肽转运体<br>B.它包括TAP1和TAP2两个基因座位<br>C.它位于HLA I类基因区<br>D.其编码产物主要参与内源性抗原肽的转运<br>E.其编码产物参与抗原肽由胞质进入内质网的转运</td>
      <td>C.它位于HLA I类基因区</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>34. HLA单元型是）(2.5分)</td>
      <td>A.在同一条染色体上存在的全套MHC等位基因<br>B.MHC基因座的特殊片段<br>C.促进排斥的在MHC基因座以外的基因<br>D.HLA-B的一个等位基因</td>
      <td>A.在同一条染色体上存在的全套MHC等位基因</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>35. 人或动物体内代表个体特异性的能引起强烈而迅速排斥反应的抗原系统称为(2.5分)</td>
      <td>A.组织相容性抗原<br>B.移植抗原<br>C.白细胞抗原<br>D.主要组织相容性抗原系统<br>E.主要组织相容性复合体</td>
      <td>D.主要组织相容性抗原系统</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>36. 金黄色葡萄球菌协同凝集反应，也属于(2.5分)</td>
      <td>A.正向间接凝集反应<br>B.反向间接凝集反应<br>C.直接凝集反应<br>D.正向被动凝集反应</td>
      <td>B.反向间接凝集反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>37. 关于效价，正确的是(2.5分)</td>
      <td>A.通常以"++++"的血清最高稀释度作为试验效价<br>B.凝集效价作为半定量指标，可以反映待检血清中抗体的相对浓度<br>C.效价和滴度是两个完全无关的概念<br>D.相同试验条件下的两份待检标本，效价分别是1:160和1: 640；可以认为在前一份标本中待检物浓度更高</td>
      <td>B.凝集效价作为半定量指标，可以反映待检血清中抗体的相对浓度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>38. 关于ABO血型鉴定试验，不正确的是(2.5分)</td>
      <td>A.指尖或耳垂通常作为取血部位<br>B.先加分型试剂（抗A或抗B），再加入待检者血球混悬液，是为了防止漏加分型试剂（抗A和抗B）<br>C.采血针一人一针，防止交叉感染<br>D.待检标本是血球混悬液，不能直接用血液</td>
      <td>D.待检标本是血球混悬液，不能直接用血液</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>39. 关于吞噬试验，正确的是(2.5分)</td>
      <td>A.吞噬百分率和吞噬指数是反映吞噬细胞吞噬功能的指标<br>B.吞噬细胞是组成机体特异性免疫的成分之一<br>C.核深染且分叶的是巨噬细胞<br>D.试验中，若吞噬时间过长，会造成吞噬率偏高，因为部分被吞噬物可能已被消化而不能被计数</td>
      <td>A.吞噬百分率和吞噬指数是反映吞噬细胞吞噬功能的指标</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2011</td>
      <td>40. 关于直接凝集反应，不正确的是(2.5分)</td>
      <td>A.可溶性抗原参与<br>B.颗粒性抗原参与<br>C.形成肉眼可见的抗原抗体复合物<br>D.参与反应抗体也称为凝集素</td>
      <td>A.可溶性抗原参与</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>1. 切除胸腺的新生鼠的淋巴结中缺乏何种细胞(2.5分)</td>
      <td>A.巨噬细胞<br>B.T淋巴细胞<br>C.B淋巴细胞<br>D.干细胞<br>E.粒细胞</td>
      <td>B.T淋巴细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>2. 下述不属于固有免疫的特点是(2.5分)</td>
      <td>A.缺少特异性<br>B.长期进化形成<br>C.涉及多种免疫细胞的参与<br>D.有记忆性<br>E.早期、快速</td>
      <td>D.有记忆性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>3. 关于淋巴细胞再循环，以下哪项描述是错误的(2.5分)</td>
      <td>A.参与再循环的淋巴细胞主要是T细胞<br>B.淋巴细胞再循环可使体内淋巴细胞分布更趋合理<br>C.淋巴细胞再循环可增加与抗原、抗原提呈细胞接触的机会<br>D.淋巴细胞再循环是淋巴细胞经HEV离开血循环选择性进入并定居于外周免疫器官相应区域<br>E.淋巴细胞再循环是维持机体正常免疫应答的必要条件</td>
      <td>D.淋巴细胞再循环是淋巴细胞经HEV离开血循环选择性进入并定居于外周免疫器官相应区域</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>4. 以下哪项不是脾脏的重要功能(2.5分)</td>
      <td>A.产生致敏淋巴细胞<br>B.产生抗体<br>C.血液过滤作用<br>D.淋巴液过滤作用<br>E.进行特异性免疫应答</td>
      <td>D.淋巴液过滤作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>5. 在特异性免疫应答中首先接触TD-Ag的细胞是(2.5分)</td>
      <td>A.T细胞<br>B.B细胞<br>C.APC细胞<br>D.肥大细胞<br>E.中性粒细胞</td>
      <td>C.APC细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>6. 接种牛痘后产生对天花的抵抗性，这反映了(2.5分)</td>
      <td>A.抗原的特异性<br>B.抗原的交叉反应<br>C.病毒的超感染<br>D.先天免疫<br>E.主动保护</td>
      <td>B.抗原的交叉反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>7. 用牛血清白蛋白-二硝基苯-卵清蛋白（BSA-DNP-OA）免疫过的动物，注射下列哪种物质，产生抗DNP抗体的量最少(2.5分)</td>
      <td>A.用牛血清白蛋白-二硝基苯<br>B.二硝基苯-卵清蛋白<br>C.牛血清白蛋白-二硝基苯-卵清蛋白<br>D.鸡丙种球蛋白-二硝基苯<br>E.鸡丙种球蛋白-苯胺</td>
      <td>E.鸡丙种球蛋白-苯胺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>8. 抗体发挥中和作用主要依赖于(2.5分)</td>
      <td>A.激活补体经典途径<br>B.ADCC作用<br>C.调理作用<br>D. V区作用<br>E.C区作用</td>
      <td>D. V区作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>9. 以下有关抗体描述错误的是(2.5分)</td>
      <td>A.IgM激活补体的能力最强<br>B.IgM升高提示处于感染早期<br>C.IgE是I型过敏反应中的主要免疫球蛋白<br>D.IgG、IgA和IgE都能够通过胎盘<br>E.分泌片成分可以保护IgA避免被蛋白酶降解，分布在乳汁和粘膜表面</td>
      <td>D.IgG、IgA和IgE都能够通过胎盘</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>10. 能使B细胞表面BCR与FcγIIR－B 交联的抗体(2.5分)</td>
      <td>A.抗γ链独特型IgG类抗体<br>B.抗α链独特型IgG类抗体<br>C.抗μ链独特型IgM类抗体<br>D.抗μ链独特型IgG类抗体<br>E.抗γ链独特型IgM类抗体</td>
      <td>D.抗μ链独特型IgG类抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>11. 来自母体能引起新生儿溶血症的Rh抗体是(2.5分)</td>
      <td>A.IgA类抗体<br>B.IgM类抗体<br>C.IgG类抗体<br>D.IgE类抗体<br>E.IgD类抗体</td>
      <td>C.IgG类抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>12. 与强直性脊柱炎有关的HLA抗原是(2.5分)</td>
      <td>A.HLA-CW6<br>B.HLA-B27<br>C.HLA-DR3<br>D.HLA-DR4<br>E.HLA-A1</td>
      <td>B.HLA-B27</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>13. 下列哪一个不是由MHC基因编码(2.5分)</td>
      <td>A.β2-微球蛋白<br>B.I类HLA抗原<br>C.II类HLA抗原<br>D.C4<br>E.HSP70</td>
      <td>A.β2-微球蛋白</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>14. MHC-Ⅰ类分子的经典功能(2.5分)</td>
      <td>A.为CD8+杀伤性T细胞的识别分子<br>B.参与外源性抗原呈递<br>C.参与内源性抗原呈递<br>D.A和B<br>E.A和C</td>
      <td>E.A和C</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>15. 下列细胞中MHC Ⅱ类分子主要存在于(2.5分)</td>
      <td>A.嗜酸性粒细胞<br>B.DC细胞<br>C.NK细胞<br>D.红细胞<br>E.T淋巴细胞</td>
      <td>B.DC细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>16. 能显著刺激初始T细胞的APC是(2.5分)</td>
      <td>A.巨噬细胞<br>B.B细胞<br>C.DC<br>D.Th细胞<br>E.NK细胞</td>
      <td>C.DC</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>17. 在内源性抗原降解中发挥重要作用的是(2.5分)</td>
      <td>A.proteasome<br>B.endocytosis<br>C.pinocytosis<br>D.internalization<br>E.exocytosis</td>
      <td>A.proteasome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>18. B细胞摄取抗原的方式是(2.5分)</td>
      <td>A.非特异性抗原受体介导的吞噬作用<br>B.特异性抗原受体介导的吞饮作用<br>C.非特异性抗原受体介导的吞饮作用<br>D.特异性抗原受体介导的内吞作用和非特异性抗原受体介导的吞饮作用<br>E.特异性抗原受体介导的内吞作用和非特异性吞饮作用</td>
      <td>E.特异性抗原受体介导的内吞作用和非特异性吞饮作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>19. 下列哪种细胞因子具有刺激Th1细胞生成的能力(2.5分)</td>
      <td>A.IL-1<br>B.IL-12<br>C.TNF-alpha<br>D.G-CSF<br>E.Erythropoietin</td>
      <td>B.IL-12</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>20. 自然调节T细胞主要是指(2.5分)</td>
      <td>A.CD4+CD25+T细胞<br>B.CD4+ Th1细胞<br>C.CD4+Th2细胞<br>D.CD4+ Th3细胞<br>E.CD4+ Tr1细胞</td>
      <td>A.CD4+CD25+T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>21. MHC限制性表现于(2.5分)</td>
      <td>A.NK细胞的杀伤作用<br>B.ADCC<br>C.T细胞的抗原识别过程<br>D.B细胞对TI抗原的应答<br>E.补体依赖细胞毒作用</td>
      <td>C.T细胞的抗原识别过程</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>22. 人类T细胞不具备的受体是(2.5分)</td>
      <td>A.E受体<br>B.抗原受体<br>C.C3b受体<br>D.PHA受体<br>E.IL-2受体</td>
      <td>C.C3b受体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>23. 免疫应答过程不包括(2.5分)</td>
      <td>A.巨噬细胞对抗原的加工和提呈<br>B.B细胞对抗原的特异性识别<br>C.T细胞在胸腺内的分化成熟<br>D.T、B细胞的活化、增殖、分化<br>E.效应细胞和效应分子的产生和作用</td>
      <td>C.T细胞在胸腺内的分化成熟</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>24. 辅助性T细胞不能诱导(2.5分)</td>
      <td>A.B细胞增殖<br>B.B细胞分化成浆细胞<br>C.记忆性B细胞的扩增<br>D.轻链V、J的连接<br>E.B细胞产生抗体的类别转换</td>
      <td>D.轻链V、J的连接</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>25. 下列关于T细胞介导的适应性免疫应答的说法，哪项是错误的(2.5分)</td>
      <td>A.对TD抗原的应答都产生记忆<br>B.对TD抗原的应答需APC提呈抗原<br>C.CTL杀伤靶细胞受MHC I类限制<br>D.均能形成免疫耐受<br>E.效应产物的效应均具有特异性</td>
      <td>E.效应产物的效应均具有特异性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>26. 下列哪项不是活化T细胞释放的细胞因子(2.5分)</td>
      <td>A.IL-10<br>B.IL-2<br>C.IL-4<br>D.TNF-β<br>E.IL-1</td>
      <td>E.IL-1</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>27. Diversity is an important feature of the immune system. Which one of the following statements about it is INCORRECT?(2.5分)</td>
      <td>A.Humans can make antibodies with about 108 different VH X VL combinations.<br>B.A single cell can synthesize IgM antibody, then switch to IgA antibody.<br>C.The hematopoietic stem cell carries the genetic potential to create more than 104 immunoglobulin genes.<br>D.A single B lymphocyte can produce antibodies of many different specificities, but a plasma cell is monospecific.</td>
      <td>D.A single B lymphocyte can produce antibodies of many different specificities, but a plasma cell is monospecific.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>28. The membrane IgM and IgD on the surface of an individual B cell(2.5分)</td>
      <td>A.have identical heavy chains but different light chains<br>B.are identical except for their CH regions<br>C.are identical except for their VH regions<br>D.have different VH and VL regions</td>
      <td>B.are identical except for their CH regions</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>29. In the immune response to a hapten-protein conjugate, in order to get anti-hapten antibodies it is essential that(2.5分)</td>
      <td>A.the hapten be recognized by helper T cells.<br>B.the protein be recognized by helper T cells.<br>C.the protein be recognized by B cells.<br>D.the hapten be recognized by suppressor T cells.</td>
      <td>B.the protein be recognized by helper T cells.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>30. A primary immune response in an adult human requires approximately how much time to produce detectable antibody levels in the blood?(2.5分)</td>
      <td>A.12 hours<br>B.3 days<br>C.1 week<br>D.3 weeks</td>
      <td>C.1 week</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>31. Which one of the following can be directly used for protein sequence search? (2.5分)</td>
      <td>A.GENBANK<br>B.SWISS-MODEL<br>C.UniProt<br>D.Map Viewer</td>
      <td>C.UniProt</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>32. When using ProtParam to analyze the structure of one protein, from its output" number of amino acids (2322), theoretical pI (5.27), total number of atoms (35191), instability index (44.80) , grand average of hydropathicity (GRAVY)( -0.157)" we can conclude that: (2.5分)</td>
      <td>A.this protein stable and hydrophilic.<br>B.this protein is unstable and hydrophobic.<br>C.this protein is stable and hydrophobic.<br>D.this protein is unstable and hydrophilic.</td>
      <td>D.this protein is unstable and hydrophilic.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>33. Which of following is NOT used for visualization of protein structure? (2.5分)</td>
      <td>A.PyMol<br>B.RasMol<br>C.Cn3D<br>D.ProtParam</td>
      <td>D.ProtParam</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>34. 参与直接凝集反应的抗原是(2.5分)</td>
      <td>A.可溶性抗原<br>B.颗粒性抗原<br>C.蛋白质抗原<br>D.凝集素</td>
      <td>B.颗粒性抗原</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>35. 关于效价，正确的是(2.5分)</td>
      <td>A.通常以"+++"的血清最高稀释度作为试验效价<br>B.凝集效价作为半定量指标，可以反映待检血清中抗体的相对浓度<br>C.效价和滴度是两个完全无关的概念<br>D.相同试验条件下的两份待检标本，效价分别是1:160和1:640；可以认为在前一份标本中待检物浓度更高</td>
      <td>B.凝集效价作为半定量指标，可以反映待检血清中抗体的相对浓度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>36. 关于吞噬试验，不正确的是（ ）(2.5分)</td>
      <td>A.吞噬百分率和吞噬指数是反映吞噬细胞吞噬功能的指标<br>B.吞噬细胞是组成机体非特异性免疫的成分之一<br>C.核深染且分叶的是巨噬细胞<br>D.试验中，若吞噬时间过长，会造成吞噬率偏低，因为部分被吞噬物可能已被消化而不能被计数</td>
      <td>C.核深染且分叶的是巨噬细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>37. 在ABO血型鉴定试验中，与抗A抗体、抗B抗体均不凝集的是 （ ）(2.5分)</td>
      <td>A.A型血<br>B.B型血<br>C.AB型血<br>D.O型血</td>
      <td>D.O型血</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>38. 在间接凝集反应中，常被用作载体的细胞是(2.5分)</td>
      <td>A.红细胞<br>B.NK细胞<br>C.T细胞<br>D.B细胞</td>
      <td>A.红细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>39. 类风湿因子作为一种抗体，其对应的抗原是(2.5分)</td>
      <td>A.红细胞<br>B.人类自身变性IgG<br>C.T细胞<br>D.软骨组织</td>
      <td>B.人类自身变性IgG</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2012</td>
      <td>40. 金黄色葡萄球菌协同凝集反应中，和SPA结合的是(2.5分)</td>
      <td>A.IgG<br>B.IgM<br>C.IgA<br>D.IgE</td>
      <td>A.IgG</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>1. 切除胸腺的新生鼠的淋巴结中缺乏何种细胞(2.5分)</td>
      <td>A.巨噬细胞<br>B.T淋巴细胞<br>C.B淋巴细胞<br>D.干细胞<br>E.粒细胞</td>
      <td>B.T淋巴细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>2. 下述不属于固有免疫的特点是(2.5分)</td>
      <td>A.缺少特异性<br>B.长期进化形成<br>C.涉及多种免疫细胞的参与<br>D.有记忆性<br>E.早期、快速</td>
      <td>D.有记忆性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>3. 关于淋巴细胞再循环，以下哪项描述是错误的(2.5分)</td>
      <td>A.参与再循环的淋巴细胞主要是T细胞<br>B.淋巴细胞再循环可使体内淋巴细胞分布更趋合理<br>C.淋巴细胞再循环可增加与抗原、抗原提呈细胞接触的机会<br>D.淋巴细胞再循环是淋巴细胞经HEV离开血循环选择性进入并定居于外周免疫器官相应区域<br>E.淋巴细胞再循环是维持机体正常免疫应答的必要条件</td>
      <td>D.淋巴细胞再循环是淋巴细胞经HEV离开血循环选择性进入并定居于外周免疫器官相应区域</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>4. 以下哪项不是脾脏的重要功能(2.5分)</td>
      <td>A.产生致敏淋巴细胞<br>B.产生抗体<br>C.血液过滤作用<br>D.淋巴液过滤作用<br>E.进行特异性免疫应答</td>
      <td>D.淋巴液过滤作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>5. 半抗原(2.5分)</td>
      <td>A.既有免疫原性，又有抗原反应性<br>B.只有免疫原性，而无抗原反应性<br>C.只有抗原反应性，而无免疫原性<br>D.既无免疫原性，又无抗原反应性<br>E.只有与蛋白质载体结合后才能与相应抗体结合</td>
      <td>C.只有抗原反应性，而无免疫原性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>6. 接种牛痘后产生对天花的抵抗性，这反映了(2.5分)</td>
      <td>A.抗原的特异性<br>B.抗原的交叉反应<br>C.病毒的超感染<br>D.先天免疫<br>E.主动保护</td>
      <td>B.抗原的交叉反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>7. 用牛血清白蛋白-二硝基苯-卵清蛋白（BSA-DNP-OA）免疫过的动物，注射下列哪种物质，产生抗DNP抗体的量最少(2.5分)</td>
      <td>A.用牛血清白蛋白-二硝基苯<br>B.二硝基苯-卵清蛋白<br>C.牛血清白蛋白-二硝基苯-卵清蛋白<br>D.鸡丙种球蛋白-二硝基苯<br>E.鸡丙种球蛋白-苯胺</td>
      <td>E.鸡丙种球蛋白-苯胺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>8. 抗体发挥中和作用主要依赖于(2.5分)</td>
      <td>A.激活补体经典途径<br>B.ADCC作用<br>C.调理作用<br>D.V区作用<br>E.C区作用</td>
      <td>D.V区作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>9. 以下有关抗体描述错误的是(2.5分)</td>
      <td>A.IgM激活补体的能力最强<br>B.IgM升高提示处于感染早期<br>C.IgE是I型过敏反应中的主要免疫球蛋白<br>D.IgG、IgA和IgE都能够通过胎盘<br>E.分泌片成分可以保护IgA避免被蛋白酶降解，分布在乳汁和粘膜表面</td>
      <td>D.IgG、IgA和IgE都能够通过胎盘</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>10. 能使B细胞表面BCR与FcγIIR－B 交联的抗体 (2.5分)</td>
      <td>A.抗γ链独特型IgG类抗体<br>B.抗α链独特型IgG类抗体<br>C.抗μ链独特型IgM类抗体<br>D.抗μ链独特型IgG类抗体<br>E.抗γ链独特型IgM类抗体</td>
      <td>D.抗μ链独特型IgG类抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>11. 来自母体能引起新生儿溶血症的Rh抗体是(2.5分)</td>
      <td>A.IgA类抗体<br>B.IgM类抗体<br>C.IgG类抗体<br>D.IgE类抗体<br>E.IgD类抗体</td>
      <td>C.IgG类抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>12. 与强直性脊柱炎有关的HLA抗原是(2.5分)</td>
      <td>A.HLA-CW6<br>B.HLA-B27<br>C.HLA-DR3<br>D.HLA-DR4<br>E.HLA-A1</td>
      <td>B.HLA-B27</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>13. 下列哪一个不是由MHC基因编码(2.5分)</td>
      <td>A.β2-微球蛋白<br>B.I类HLA抗原<br>C.II类HLA抗原<br>D.C4<br>E.HSP70</td>
      <td>A.β2-微球蛋白</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>14. MHC-Ⅰ类分子的经典功能(2.5分)</td>
      <td>A.为CD8+杀伤性T细胞的识别分子<br>B.参与外源性抗原呈递<br>C.参与内源性抗原呈递<br>D.A和B<br>E.A和C</td>
      <td>E.A和C</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>15. 下列细胞中MHC Ⅱ类分子主要存在于(2.5分)</td>
      <td>A.嗜酸性粒细胞<br>B.DC细胞<br>C.NK细胞<br>D.红细胞<br>E.T淋巴细胞</td>
      <td>B.DC细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>16. 能显著刺激初始T细胞的APC是(2.5分)</td>
      <td>A.巨噬细胞<br>B.B细胞<br>C.DC<br>D.Th细胞<br>E.NK细胞</td>
      <td>C.DC</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>17. 与 DC功能无关的是(2.5分)</td>
      <td>A.提呈抗原功能最强<br>B.树突状突起<br>C.活化B细胞<br>D.表达CD40<br>E.吞噬功能</td>
      <td>C.活化B细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>18. B细胞摄取抗原的方式是(2.5分)</td>
      <td>A.非特异性抗原受体介导的吞噬作用<br>B.特异性抗原受体介导的吞饮作用<br>C.非特异性抗原受体介导的吞饮作用<br>D.特异性抗原受体介导的内吞作用和非特异性抗原受体介导的吞饮作用<br>E.特异性抗原受体介导的内吞作用和非特异性吞饮作用</td>
      <td>E.特异性抗原受体介导的内吞作用和非特异性吞饮作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>19. 下列哪种细胞因子具有刺激Th1细胞生成的能力(2.5分)</td>
      <td>A.IL-1<br>B.IL-12<br>C.TNF-alpha<br>D.G-CSF<br>E.Erythropoietin</td>
      <td>B.IL-12</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>20. 自然调节T细胞主要是指(2.5分)</td>
      <td>A.CD4+CD25+T细胞<br>B.CD4+ Th1细胞<br>C.CD4+Th2细胞<br>D.CD4+ Th3细胞<br>E.CD4+ Tr1细胞</td>
      <td>A.CD4+CD25+T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>21. MHC限制性表现于(2.5分)</td>
      <td>A.NK细胞的杀伤作用<br>B.ADCC<br>C.T细胞的抗原识别过程<br>D.B细胞对TI抗原的应答<br>E.补体依赖细胞毒作用</td>
      <td>C.T细胞的抗原识别过程</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>22. 致敏TC细胞的作用特点是(2.5分)</td>
      <td>A.无抗原特异性<br>B.受MHC-Ⅱ类分子限制<br>C.可通过释放TNF杀伤靶细胞<br>D.可通过ADCC作用杀伤靶细胞<br>E.可通过分泌细胞毒性物质杀伤靶细胞</td>
      <td>E.可通过分泌细胞毒性物质杀伤靶细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>23. 免疫应答过程不包括(2.5分)</td>
      <td>A.巨噬细胞对抗原的加工和提呈<br>B.B细胞对抗原的特异性识别<br>C.T细胞在胸腺内的分化成熟<br>D.T、B细胞的活化、增殖、分化<br>E.效应细胞和效应分子的产生和作用</td>
      <td>C.T细胞在胸腺内的分化成熟</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>24. CD4+ T细胞活化的第2信号是(2.5分)</td>
      <td>A.CD64与IgG<br>B.CD64与IgG<br>C.CD4 与MHC II类分子<br>D.CD28与B7<br>E.TCR与CD3</td>
      <td>D.CD28与B7</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>25. 下列关于T细胞介导的适应性免疫应答的说法，哪项是错误的(2.5分)</td>
      <td>A.对TD抗原的应答都产生记忆<br>B.对TD抗原的应答需APC提呈抗原<br>C.CTL杀伤靶细胞受MHC I类限制<br>D.均能形成免疫耐受<br>E.效应产物的效应均具有特异性</td>
      <td>E.效应产物的效应均具有特异性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>26. 与 CTL 杀伤无关的是(2.5分)</td>
      <td>A.穿孔素<br>B.颗粒酶<br>C.ADCC<br>D.FasL/Fas<br>E.CD8</td>
      <td>C.ADCC</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>27. Diversity is an important feature of the immune system. Which one of the following statements about it is INCORRECT?(2.5分)</td>
      <td>A.Humans can make antibodies with about 108 different VH X VL combinations.<br>B.A single cell can synthesize IgM antibody, then switch to IgA antibody.<br>C.he hematopoietic stem cell carries the genetic potential to create more than 104 immunoglobulin genes.<br>D.A single B lymphocyte can produce antibodies of many different specificities, but a plasma cell is monospecific.</td>
      <td>D.A single B lymphocyte can produce antibodies of many different specificities, but a plasma cell is monospecific.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>28. The membrane IgM and IgD on the surface of an individual B cell(2.5分)</td>
      <td>A.have identical heavy chains but different light chains<br>B.are identical except for their CH regions<br>C.are identical except for their VH regions<br>D.have different VH and VL regions</td>
      <td>B.are identical except for their CH regions</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>29. In the immune response to a hapten-protein conjugate, in order to get anti-hapten antibodies it is essential that(2.5分)</td>
      <td>A.the hapten be recognized by helper T cells.<br>B.the protein be recognized by helper T cells.<br>C.the protein be recognized by B cells.<br>D.the hapten be recognized by suppressor T cells.</td>
      <td>B.the protein be recognized by helper T cells.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>30. A primary immune response in an adult human requires approximately how much time to produce detectable antibody levels in the blood?(2.5分)</td>
      <td>A.12 hours<br>B.3 days<br>C.1 week<br>D.3 weeks</td>
      <td>C.1 week</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>31. Which one of the following can be directly used for protein sequence search? (2.5分)</td>
      <td>A.GENBANK<br>B.SWISS-MODEL<br>C.UniProt<br>D.Map Viewer</td>
      <td>C.UniProt</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>32. Which one of the following can be used for protein three-dimension structure prediction? (2.5分)</td>
      <td>A.SWISS-MODEL<br>B.SignalP<br>C.PDB<br>D.TargetP</td>
      <td>A.SWISS-MODEL</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>33. When trying to compare the similarity between two protein sequences using protein database, which "blast" should be chosen? (2.5分)</td>
      <td>A.blastn<br>B.blastp<br>C.tblastn<br>D.blastx</td>
      <td>B.blastp</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>34. 参与直接凝集反应的抗原是(2.5分)</td>
      <td>A.可溶性抗原<br>B.颗粒性抗原<br>C.蛋白质抗原<br>D.凝集素</td>
      <td>B.颗粒性抗原</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>35. 关于效价，正确的是(2.5分)</td>
      <td>A.通常以"+++"的血清最高稀释度作为试验效价<br>B.凝集效价作为半定量指标，可以反映待检血清中抗体的相对浓度<br>C.效价和滴度是两个完全无关的概念<br>D.相同试验条件下的两份待检标本，效价分别是1:160和1:640；可以认为在前一份标本中待检物浓度更高</td>
      <td>B.凝集效价作为半定量指标，可以反映待检血清中抗体的相对浓度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>36. 关于吞噬试验，不正确的是(2.5分)</td>
      <td>A.吞噬百分率和吞噬指数是反映吞噬细胞吞噬功能的指标<br>B.吞噬细胞是组成机体非特异性免疫的成分之一<br>C.核深染且分叶的是巨噬细胞<br>D.试验中，若吞噬时间过长，会造成吞噬率偏低，因为部分被吞噬物可能已被消化而不能被计数</td>
      <td>C.核深染且分叶的是巨噬细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>37. 凝集反应出现肉眼可见的抗原抗体复合物，不正确的是(2.5分)</td>
      <td>A.抗原与抗体需对应<br>B.参与抗原可能是颗粒性抗原<br>C.抗原抗体比例要合适，且需适量电解质<br>D.抗体过剩</td>
      <td>D.抗体过剩</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>38. 类风湿因子，不正确的是 (2.5分)</td>
      <td>A.出现于所有类风湿关节炎患者，且只出现于类风湿关节炎患者<br>B.是抗患者自身IgG的抗体<br>C.参与类风湿关节炎发病<br>D.可能是IgM，IgG，或IgA</td>
      <td>A.出现于所有类风湿关节炎患者，且只出现于类风湿关节炎患者</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>39. 金黄色葡萄球菌协同凝集反应中，和IgGFc段结合的是金黄色葡萄球菌的(2.5分)</td>
      <td>A.荚膜多糖<br>B.葡萄球菌A蛋白（SPA）<br>C.肠毒素<br>D.脂多糖（LPS）</td>
      <td>B.葡萄球菌A蛋白（SPA）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2013</td>
      <td>40. 关于吞噬试验，不正确的是(2.5分)</td>
      <td>A.吞噬百分率和吞噬指数是反映吞噬细胞吞噬功能的指标<br>B.吞噬细胞是组成机体非特异性免疫的成分之一<br>C.巨噬细胞的吞噬作用也称为大吞噬<br>D.试验中，若吞噬时间过长，会造成吞噬率偏高，因为部分被吞噬物可能已被消化而不能被计数</td>
      <td>D.试验中，若吞噬时间过长，会造成吞噬率偏高，因为部分被吞噬物可能已被消化而不能被计数</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>1. 切除胸腺的新生鼠的淋巴结中缺乏何种细胞(2.5分)</td>
      <td>A.巨噬细胞<br>B.T淋巴细胞<br>C.B淋巴细胞<br>D.干细胞<br>E.粒细胞</td>
      <td>B.T淋巴细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>2. 关于淋巴细胞再循环，以下哪项描述是错误的(2.5分)</td>
      <td>A.参与再循环的淋巴细胞主要是T细胞<br>B.淋巴细胞再循环可使体内淋巴细胞分布更趋合理<br>C.淋巴细胞再循环可增加与抗原、抗原提呈细胞接触的机会<br>D.淋巴细胞再循环是淋巴细胞经HEV离开血循环选择性进入并定居于外周 免疫器官相应区域<br>E.淋巴细胞再循环是维持机体正常免疫应答的必要条件</td>
      <td>D.淋巴细胞再循环是淋巴细胞经HEV离开血循环选择性进入并定居于外周 免疫器官相应区域</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>3. 宿主的天然抵抗力(2.5分)</td>
      <td>A.经遗传而获得<br>B.感染病原微生物而获得<br>C.接种菌苗或疫苗而获得<br>D.母体的抗体(IgG)通过胎盘给婴儿而获得<br>E.给宿主转输致敏巴细胞而获得</td>
      <td>A.经遗传而获得</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>4. 淋巴结的下述哪个区域为胸腺依赖区(2.5分)</td>
      <td>A.副皮质区<br>B.浅皮质区<br>C.髓索<br>D.淋巴小结<br>E.次级淋巴滤泡</td>
      <td>A.副皮质区</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>5. 半抗原(2.5分)</td>
      <td>A.既有免疫原性，又有抗原反应性<br>B.只有免疫原性，而无抗原反应性<br>C.只有抗原反应性，而无免疫原性<br>D.既无免疫原性，又无抗原反应性<br>E.只有与蛋白质载体结合后才能与相应抗体结合</td>
      <td>C.只有抗原反应性，而无免疫原性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>6. 接种牛痘后产生对天花的抵抗性，这反映了(2.5分)</td>
      <td>A.抗原的特异性<br>B.抗原的交叉反应<br>C.病毒的超感染<br>D.先天免疫<br>E.主动保护</td>
      <td>B.抗原的交叉反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>7. 用牛血清白蛋白-二硝基苯-卵清蛋白（BSA-DNP-OA）免疫过的动物，注射下列哪种物质，产生抗DNP抗体的量最少(2.5分)</td>
      <td>A.用牛血清白蛋白-二硝基苯<br>B.二硝基苯-卵清蛋白<br>C.牛血清白蛋白-二硝基苯-卵清蛋白<br>D.鸡丙种球蛋白-二硝基苯<br>E.鸡丙种球蛋白-苯胺</td>
      <td>E.鸡丙种球蛋白-苯胺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>8. 抗体发挥中和作用主要依赖于(2.5分)</td>
      <td>A.激活补体经典途径<br>B.ADCC作用<br>C.调理作用<br>D.V区作用<br>E.C区作用</td>
      <td>D.V区作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>9. 能与肥大细胞表面FcR结合，并介导I型超敏反应的Ig是(2.5分)</td>
      <td>A.IgA<br>B.IgM<br>C.IgG<br>D.IgE<br>E.IgD</td>
      <td>D.IgE</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>10. 能使B细胞表面BCR与FcγIIR－B 交联的抗体(2.5分)</td>
      <td>A.抗γ链独特型IgG类抗体<br>B.抗α链独特型IgG类抗体<br>C.抗μ链独特型IgM类抗体<br>D.抗μ链独特型IgG类抗体<br>E.抗γ链独特型IgM类抗体</td>
      <td>D.抗μ链独特型IgG类抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>11. 人类MHC的染色体定位于 (2.5分)</td>
      <td>A.17号染色体<br>B.6号染色体<br>C.9号染色体<br>D.2号染色体</td>
      <td>B.6号染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>12. 下列哪一个不是由MHC基因编码(2.5分)</td>
      <td>A.β2-微球蛋白<br>B.I类HLA抗原<br>C.II类HLA抗原<br>D.C4<br>E.HSP70</td>
      <td>A.β2-微球蛋白</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>13. 下列细胞中MHC Ⅱ类分子主要存在于(2.5分)</td>
      <td>A.嗜酸性粒细胞<br>B.DC细胞<br>C.NK细胞<br>D.红细胞<br>E.T淋巴细胞</td>
      <td>B.DC细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>14. 能显著刺激初始T细胞的APC是(2.5分)</td>
      <td>A.巨噬细胞<br>B.B细胞<br>C.DC<br>D.Th细胞<br>E.NK细胞</td>
      <td>C.DC</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>15. 抗原提呈细胞所不具备的作用是(2.5分)</td>
      <td>A.降解蛋白质抗原为小分子肽段<br>B.促进T细胞表达特异性抗原受体<br>C.可为T细胞活化提供第一信号<br>D.可为T细胞活化提供第二信号<br>E.以抗原肽-MHC复合体的形式提呈抗原</td>
      <td>B.促进T细胞表达特异性抗原受体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>16. 与 DC功能无关的是(2.5分)</td>
      <td>A.提呈抗原功能最强<br>B.树突状突起<br>C.活化B细胞<br>D.表达CD40<br>E.吞噬功能</td>
      <td>C.活化B细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>17. 自然调节T细胞主要是指(2.5分)</td>
      <td>A.CD4+CD25+T细胞<br>B.CD4+ Th1细胞<br>C.CD4+Th2细胞<br>D.CD4+ Th3细胞<br>E.CD4+ Tr1细胞</td>
      <td>A.CD4+CD25+T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>18. MHC限制性表现于(2.5分)</td>
      <td>A.NK细胞的杀伤作用<br>B.ADCC<br>C.T细胞的抗原识别过程<br>D.B细胞对TI抗原的应答<br>E.补体依赖细胞毒作用</td>
      <td>C.T细胞的抗原识别过程</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>19. Tfh细胞主要分泌的细胞因子是(2.5分)</td>
      <td>A.IL-2<br>B.IL-17<br>C.TGF-β<br>D.IL-21<br>E.IL-22</td>
      <td>D.IL-21</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>20. TCR识别抗原的信号传递是通过哪个分子进行传递的(2.5分)</td>
      <td>A.CD2<br>B.SmIg<br>C.CD3<br>D.Igα，Igβ<br>E.MHC I/II类分子</td>
      <td>C.CD3</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>21. 下列关于T细胞介导的适应性免疫应答的说法，哪项是错误的(2.5分)</td>
      <td>A.对TD抗原的应答都产生记忆<br>B.对TD抗原的应答需APC提呈抗原<br>C.CTL杀伤靶细胞受MHC I类限制<br>D.均能形成免疫耐受<br>E.效应产物的效应均具有特异性</td>
      <td>E.效应产物的效应均具有特异性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>22. 与 CTL 杀伤无关的是(2.5分)</td>
      <td>A.穿孔素<br>B.颗粒酶<br>C.ADCC<br>D.FasL/Fas<br>E.CD8</td>
      <td>C.ADCC</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>23. 以下关于CD4的说法哪项是错误的(2.5分)</td>
      <td>A.成熟的T细胞表面都有CD4表达<br>B.CD4不直接参与特异性识别抗原<br>C.CD4属于免疫球蛋白超家族成员<br>D.CD4可与Ag-MHCII分子复合体结合<br>E.可用抗CD4单抗对辅助性T细胞进行检测</td>
      <td>A.成熟的T细胞表面都有CD4表达</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>24. 与细胞免疫应答无关的免疫反应是(2.5分)</td>
      <td>A.外毒素中和作用<br>B.抗肿瘤免疫作用<br>C.移植排斥反应<br>D.接触性皮炎<br>E.结核结节形成</td>
      <td>A.外毒素中和作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>25. Diversity is an important feature of the immune system. Which one of the following statements about it is INCORRECT?(2.5分)</td>
      <td>A.Humans can make antibodies with about 108 different VH X VL combinations.<br>B.A single cell can synthesize IgM antibody, then switch to IgA antibody.<br>C.The hematopoietic stem cell carries the genetic potential to create more than 104 immunoglobulin genes.<br>D.A single B lymphocyte can produce antibodies of many different specificities, but a plasma cell is monospecific.</td>
      <td>D.A single B lymphocyte can produce antibodies of many different specificities, but a plasma cell is monospecific.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>26. During the maturation of a B lymphocyte, the first immunoglobulin heavy chain synthesized is the(2.5分)</td>
      <td>A.Mu chain.<br>B.gamma chain.<br>C.epsilon chain.<br>D.alpha chain.</td>
      <td>A.Mu chain.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>27. Which one of the following is NOT true of the gene segments that combine to make up a heavy-chain gene?(2.5分)</td>
      <td>A.Many V region segments are available.<br>B.Several J segments and several D segments are available.<br>C.V, D, and J segments combine to encode the antigen-binding site.<br>D.V segment and a J segment are preselected by an antigen to make up the variable-region portion of the gene.</td>
      <td>D.V segment and a J segment are preselected by an antigen to make up the variable-region portion of the gene.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>28. In the immune response to a hapten-protein conjugate, in order to get anti-hapten antibodies it is essential that(2.5分)</td>
      <td>A.the hapten be recognized by helper T cells.<br>B.the protein be recognized by helper T cells.<br>C.the protein be recognized by B cells.<br>D.the hapten be recognized by suppressor T cells.</td>
      <td>B.the protein be recognized by helper T cells.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>29. A primary immune response in an adult human requires approximately how much time to produce detectable antibody levels in the blood?(2.5分)</td>
      <td>A.12 hours<br>B.3 days<br>C.1 week<br>D.3 weeks</td>
      <td>C.1 week</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>30. An antibody directed against the idiotypic determinants of a human IgG antibody would react with(2.5分)</td>
      <td>A.the Fc part of the IgG.<br>B.an IgM antibody produced by the same plasma cell that produced the IgG.<br>C.all human kappa chains.<br>D.all human gamma chains.</td>
      <td>B.an IgM antibody produced by the same plasma cell that produced the IgG.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>31. When using ProtParam to analyze the structure of one protein, from its output" number of amino acids (2322), theoretical pI (5.27), total number of atoms (35191), instability index (44.80) , grand average of hydropathicity (GRAVY)( -0.157)" we can conclude that: (2.5分)</td>
      <td>A.this protein stable and hydrophilic.<br>B.this protein is unstable and hydrophobic.<br>C.this protein is stable and hydrophobic.<br>D.this protein is unstable and hydrophilic.</td>
      <td>D.this protein is unstable and hydrophilic.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>32. Which one of the following can be used for protein three-dimension structure prediction?(2.5分)</td>
      <td>A.SWISS-MODEL<br>B.SignalP<br>C.PDB<br>D.TargetP</td>
      <td>A.SWISS-MODEL</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>33. Which of following is NOT used for visualization of protein structure? (2.5分)</td>
      <td>A.PyMol<br>B.RasMol<br>C.Cn3D<br>D.ProtParam</td>
      <td>D.ProtParam</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>34. 关于效价，正确的是(2.5分)</td>
      <td>A.通常以"+++"的血清最高稀释度作为试验效价<br>B.凝集效价作为半定量指标，可以反映待检血清中抗体的相对浓度<br>C.效价和滴度是两个完全无关的概念<br>D.相同试验条件下的两份待检标本，效价分别是1:160和1:640；可以认为在前一份标本中待检物浓度更高</td>
      <td>B.凝集效价作为半定量指标，可以反映待检血清中抗体的相对浓度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>35. 和金黄色葡萄球菌A蛋白结合的是(2.5分)</td>
      <td>A.IgG的Fc段<br>B.IgG的Fab段<br>C.IgG的CDR区（complementarity determining region）<br>D.IgG的轻链</td>
      <td>A.IgG的Fc段</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>36. 关于ABO血型鉴定试验，不正确的是(2.5分)</td>
      <td>A.指尖或耳垂通常作为取血部位<br>B.先加分型试剂（抗A或抗B），再加入待检者血球混悬液，是为了防止漏加分型试剂（抗A和抗B）<br>C.采血针一人一针，防止交叉感染<br>D.待检标本是血球混悬液，不能直接用血液</td>
      <td>D.待检标本是血球混悬液，不能直接用血液</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>37. 直接凝集反应，参与抗原为(2.5分)</td>
      <td>A.蛋白质分子<br>B.多糖分子<br>C.可溶性抗原<br>D.颗粒性抗原</td>
      <td>D.颗粒性抗原</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>38. 类风湿因子，作为抗体，其对应的抗原是 (2.5分)</td>
      <td>A.患者关节滑膜抗原<br>B.患者自身IgG<br>C.甲状腺球蛋白<br>D.乙酰胆碱受体</td>
      <td>B.患者自身IgG</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>39. 关于吞噬试验，不正确的是(2.5分)</td>
      <td>A.吞噬百分率和吞噬指数是反映吞噬细胞吞噬功能的指标<br>B.吞噬细胞是组成机体非特异性免疫的成分之一<br>C.巨噬细胞的吞噬作用也称为大吞噬<br>D.试验中，若吞噬时间过长，会造成吞噬率偏高，因为部分被吞噬物可能已被消化而不能被计数</td>
      <td>D.试验中，若吞噬时间过长，会造成吞噬率偏高，因为部分被吞噬物可能已被消化而不能被计数</td>
    </tr>
    <tr>
      <td>1</td>
      <td>6</td>
      <td>2014</td>
      <td>40. 核深染且分叶的吞噬细胞是(2.5分)</td>
      <td>A.肥大细胞<br>B.巨噬细胞<br>C.中性粒细胞<br>D.单核细胞</td>
      <td>C.中性粒细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>1. 抗体发挥中和作用主要依赖于(2.0分)</td>
      <td>A.ADCC作用<br>B.激活补体经典途径<br>C.调理作用<br>D.V区作用<br>E.C区作用</td>
      <td>D.V区作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>2. 半抗原(2.0分)</td>
      <td>A.既有免疫原性，又有抗原性<br>B.既无免疫原性，又无抗原性<br>C.只有抗原性，而无免疫原性<br>D.只有免疫原性，而无抗原性<br>E.只有与蛋白质载体结合后才能与相应抗体结合</td>
      <td>C.只有抗原性，而无免疫原性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>3. 兄弟姐妹间进行器官移植，引起排斥反应的抗原是(2.0分)</td>
      <td>A.异嗜性抗原<br>B.同种异型抗原<br>C.异种抗原<br>D.自身抗原<br>E.感染的微生物抗原</td>
      <td>B.同种异型抗原</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>4. 直接特异杀伤靶细胞的是(2.0分)</td>
      <td>A.NK细胞<br>B.Th细胞<br>C.巨噬细胞<br>D.Tc细胞<br>E.B细胞</td>
      <td>D.Tc细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>5. 在特异性免疫应答中首先接触TD-Ag的细胞是(2.0分)</td>
      <td>A.肥大细胞<br>B.B细胞<br>C.APC细胞<br>D.T细胞<br>E.中性粒细胞</td>
      <td>C.APC细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>6. 禽类新生期切除腔上囊的后果是(2.0分)</td>
      <td>A.细胞免疫功能和体液免疫功能均正常<br>B.细胞免疫功能正常，体液免疫功能缺陷<br>C.细胞免疫功能缺陷，体液免疫功能正常<br>D.细胞免疫功能和体液免疫功能均有缺陷</td>
      <td>D.细胞免疫功能和体液免疫功能均有缺陷</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>7. 自然调节T细胞主要是指(2.0分)</td>
      <td>A.CD4+CD25+T细胞<br>B.CD4+ Th1细胞<br>C.CD4+ Th3细胞<br>D.CD4+Th2细胞<br>E.CD4+ Tr1细胞</td>
      <td>A.CD4+CD25+T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>8. 以下有关TAP基因的叙述哪项是错误的(2.0分)</td>
      <td>A.其编码产物主要参与内源性抗原肽的转运<br>B.它包括TAP1和TAP2两个基因座位<br>C.它位于HLA I类基因区<br>D.它编码产物是抗原肽转运体<br>E.其编码产物参与抗原肽由胞质进入内质网的转运</td>
      <td>C.它位于HLA I类基因区</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>9. 决定抗原分子特异性的是(2.0分)</td>
      <td>A.抗原分子的化学成分<br>B.抗原分子量的大小<br>C.抗原分子中的特殊化学基团<br>D.抗原分子的物理性状<br>E.抗原分子内部结构的复杂性</td>
      <td>C.抗原分子中的特殊化学基团</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>10. 具有局部粘膜抗感染作用的免疫球蛋白是(2.0分)</td>
      <td>A.IgM<br>B.sIgA<br>C.IgG<br>D.IgA<br>E.IgE</td>
      <td>B.sIgA</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>11. 下述哪个器官或细胞可对抗原识别与应答(2.0分)</td>
      <td>A.NK细胞<br>B.浆细胞<br>C.脑<br>D.脾脏和淋巴结中的巨噬细胞<br>E.脾脏和淋巴结中的B细胞</td>
      <td>E.脾脏和淋巴结中的B细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>12. 未成熟B细胞(2.0分)</td>
      <td>A.在其发育的某一阶段与抗原接触后可导致无反应性<br>B.是T、B细胞的前体<br>C.表面同时表达IgM和IgD<br>D.只产生μ链<br>E.必须经过胸腺才能成熟</td>
      <td>A.在其发育的某一阶段与抗原接触后可导致无反应性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>13. 下列哪种物质一般不能引起免疫应答(2.0分)</td>
      <td>A.多糖<br>B.类脂<br>C.蛋白质<br>D.核酸<br>E.糖类-蛋白质复合体</td>
      <td>B.类脂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>14. 接种牛痘后产生对天花的抵抗性，这反映了(2.0分)</td>
      <td>A.抗原的交叉反应<br>B.抗原的特异性<br>C.病毒的超感染<br>D.先天免疫<br>E.主动保护</td>
      <td>A.抗原的交叉反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>15. IgG3的分子量比所有其他IgG亚类的分子量高的原因是(2.0分)</td>
      <td>A.有与羧基端结合的J链<br>B.C区有4个功能区<br>C.分子发生聚合<br>D.较长的铰链区<br>E.碳水化合物含量高</td>
      <td>D.较长的铰链区</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>16. 下列哪一个不是由MHC基因编码(2.0分)</td>
      <td>A.C4<br>B.β2-微球蛋白<br>C.I类HLA抗原<br>D.II类HLA抗原<br>E.HSP70</td>
      <td>B.β2-微球蛋白</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>17. 在生发中心聚集的非吞噬性单个核细胞中有发育很好的内质网存在提示这些细胞是 (2.0分)</td>
      <td>A.T细胞<br>B.记忆细胞<br>C.B细胞<br>D.奖细胞<br>E.无标记细胞</td>
      <td>D.奖细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>18. 不表达HLA I类抗原的细胞包括(2.0分)</td>
      <td>A.皮肤细胞<br>B.B淋巴细胞<br>C.单核细胞<br>D.T淋巴细胞<br>E.横纹肌细胞</td>
      <td>E.横纹肌细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>19. 参与免疫应答的细胞都带有(2.0分)</td>
      <td>A.抗原受体<br>B.SmIg<br>C.SRBC受体<br>D.有丝分裂受体<br>E.MHC编码产物</td>
      <td>E.MHC编码产物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>20. 关于记忆细胞的错误理解是(2.0分)</td>
      <td>A.仅限于B细胞<br>B.已接受抗原刺激<br>C.可生存数月到数年<br>D.参加淋巴细胞再循环<br>E.再次遇到抗原时能迅速增殖和分化</td>
      <td>A.仅限于B细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>21. B细胞发育成熟的场所是(2.0分)</td>
      <td>A.扁桃腺<br>B.胸腺<br>C.骨髓<br>D.淋巴结<br>E.脾</td>
      <td>C.骨髓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>22. 人类T细胞不具备的受体是(2.0分)</td>
      <td>A.E受体<br>B.C3b受体<br>C.抗原受体<br>D.PHA受体<br>E.IL-2受体</td>
      <td>B.C3b受体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>23. 关于IgA下述哪项是正确的(2.0分)</td>
      <td>A.sIgA是膜局部免疫的最重要因素<br>B.sIgA具有免疫排除功能<br>C.IgA1主要存在于血清中<br>D.二聚体IgA结合抗原的亲合力，高于单体IgA<br>E.以上均正确</td>
      <td>E.以上均正确</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>24. 与类风湿因子有关的Ig是(2.0分)</td>
      <td>A.IgG<br>B.IgA<br>C.IgD<br>D.IgM<br>E.IgE</td>
      <td>D.IgM</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>25. 惟一能通过胎盘的Ig是(2.0分)</td>
      <td>A.IgD<br>B.IgA<br>C.IgM<br>D.IgG<br>E.IgE</td>
      <td>D.IgG</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>26. 决定Ig的类和亚类的部位是(2.0分)</td>
      <td>A.铰链区<br>B.VL十CL<br>C.VL十VH<br>D.CH<br>E.CL</td>
      <td>D.CH</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>27. 各种单体抗体分子都有的特性是(2.0分)</td>
      <td>A.分子量在100 KDa以下<br>B.H链与L链借非共价键相联<br>C.具有两个完全相同的抗原结合部位<br>D.能结合补体<br>E.能促进吞噬</td>
      <td>C.具有两个完全相同的抗原结合部位</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>28. 单克隆抗体的应用不包括(2.0分)</td>
      <td>A.激素水平测定<br>B.肿瘤的治疗<br>C.血清Cl-含量测定<br>D.肿瘤的诊断<br>E.细胞受体测定</td>
      <td>C.血清Cl-含量测定</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>29. 宿主的天然抵抗力(2.0分)</td>
      <td>A.感染病原微生物而获得<br>B.经遗传而获得<br>C.接种菌苗或疫苗而获得<br>D.母体的抗体(IgG)通过胎盘给婴儿而获得<br>E.给宿主转输致敏巴细胞而获得</td>
      <td>B.经遗传而获得</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>30. 5种免疫球蛋白的划分是根据(2.0分)</td>
      <td>A.H链不同<br>B.V区不同<br>C.L链不同<br>D.H链和L链均不同<br>E.连接H链的二硫键位置和数目不同</td>
      <td>A.H链不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>31. 下列关于MHC I类抗原的描述错误的是： (2.0分)</td>
      <td>A.具有高度多态性，由 链决定<br>B.其抗原肽结合槽由 1和 1组成，结合肽的长度为13-17氨基酸<br>C.其抗原肽结合槽由 1和 2组成，结合肽的长度为9-11氨基酸<br>D.由HLA复合体的A、B、C区基因编码<br>E.所有有核细胞都表达</td>
      <td>C.DC细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>32. 下列细胞中MHC II类分子主要存在于： (2.0分)</td>
      <td>A.NK细胞<br>B.红细胞<br>C.DC细胞<br>D.嗜酸性粒细胞<br>E.T淋巴细胞</td>
      <td>B.通过结合MHC-I-抗原肽复合物被激活，释放穿孔素与淋巴毒素杀伤靶细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>33. CD8+CTL细胞的功能有： (2.0分)</td>
      <td>A.通过结合MHC-II-抗原肽复合物被激活，释放细胞因子促进抗体产生<br>B.通过结合MHC-I-抗原肽复合物被激活，释放穿孔素与淋巴毒素杀伤靶细胞<br>C.释放MAC杀伤靶细胞<br>D.通过ADCC作用杀伤肿瘤细胞<br>E.通过MAC攻击杀伤</td>
      <td>A.Ig</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>34. BCR与下列哪种分子结合形成复合物： (2.0分)</td>
      <td>A.Ig<br>B.CD8<br>C.CD4<br>D.TNF 受体<br>E.IL-2受体</td>
      <td>A.成熟B细胞既有mIgM，又有mIgD</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>35. 下列有关B细胞的表述中哪项正确 (2.0分)</td>
      <td>A.成熟B细胞既有mIgM，又有mIgD<br>B.成熟B细胞既无mIgM，又无mIgE<br>C.成熟B细胞表面仅表达mIgM<br>D.阴性选择发生在骨髓中的成熟B细胞发育后<br>E.阴性选择发生在骨髓中的前B细胞发育时期</td>
      <td>A.CD40</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>36. 下列哪种物质是B细胞表面最重要的共刺激分子： (2.0分)</td>
      <td>A.CD40<br>B.CD4<br>C.CD28<br>D.ICAM-1<br>E.CD8</td>
      <td>B.CD21/CD19/CD81是B细胞表面最重要的共刺激分子</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>37. 下列关于B细胞活化的错误的是： (2.0分)</td>
      <td>A.受体编辑也是自身反应性B细胞清除的机制之一<br>B.CD21/CD19/CD81是B细胞表面最重要的共刺激分子<br>C.需要双信号，一BCR/Ig 传递抗原信号；二与Th细胞相互作用，通过CD40传递共刺激信号<br>D.在骨髓发育不需要抗原刺激<br>E.对TD抗原的再次应答需Th细胞辅助</td>
      <td>B.CD28</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>38. 下列哪种物质是T细胞表面最重要的共刺激分子： (2.0分)</td>
      <td>A.ICAM-1<br>B.CD28<br>C.CD40<br>D.CD4<br>E.CD8</td>
      <td>A.树突状细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>39. 具有激活初始T细胞能力的APC是 (2.0分)</td>
      <td>A.树突状细胞<br>B.B细胞<br>C.巨噬细胞<br>D.单核细胞<br>E.肥大细胞</td>
      <td>B.IL-12</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>40. 下列哪种细胞因子具有刺激Th1细胞生成的能力(2.0分)</td>
      <td>A.G-CSF<br>B.IL-12<br>C.TNF-alpha<br>D.IL-1<br>E.Erythropoietin</td>
      <td>B.颗粒性抗原</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>41. 可以概括参与直接凝集反应的抗原的特点的是(2.0分)</td>
      <td>A.蛋白质抗原<br>B.颗粒性抗原<br>C.可溶性抗原<br>D.凝集素</td>
      <td>C.所用载体不能影响相应的抗原抗体反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>42. 在间接凝集反应中，要求所用载体与免疫无关，主要是指(2.0分)</td>
      <td>A.载体不用于吸附可溶性抗原或抗体<br>B.载体不能是免疫学研究对象<br>C.所用载体不能影响相应的抗原抗体反应<br>D.载体不参与凝集物的形成</td>
      <td>C.凝集效价作为半定量指标，可以反映待检血清中抗体的相对浓度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>43. 关于效价，正确的是(2.0分)</td>
      <td>A.通常以"++++"的血清最高稀释度作为试验效价<br>B.效价和滴度是两个完全无关的概念<br>C.凝集效价作为半定量指标，可以反映待检血清中抗体的相对浓度<br>D.相同试验条件下的两份待检标本，效价分别是1:160和1:640；可以认为在前一份标本中待检物浓度更高</td>
      <td>D.间接凝集反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>44. 致敏载体是下述哪种类型免疫反应中的概念(2.0分)</td>
      <td>A.沉淀反应<br>B.直接凝集反应<br>C.免疫标记技术<br>D.间接凝集反应</td>
      <td>B.金黄色葡萄球菌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>45. 在协同凝集反应中，载体是(2.0分)</td>
      <td>A.乳胶颗粒<br>B.金黄色葡萄球菌<br>C.红细胞<br>D.蛋白质</td>
      <td>C.IgG的Fc段</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>46. 和金黄色葡萄球菌A蛋白结合的是(2.0分)</td>
      <td>A.IgG的CDR区（complementarity determining region）<br>B.IgG的Fab段<br>C.IgG的Fc段<br>D.IgG的轻链</td>
      <td>C.核深染且分叶的是巨噬细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>47. 关于吞噬试验，不正确的是(2.0分)</td>
      <td>A.吞噬细胞是组成机体非特异性免疫的成分之一<br>B.吞噬百分率和吞噬指数是反映吞噬细胞吞噬功能的指标<br>C.核深染且分叶的是巨噬细胞<br>D.试验中，若吞噬时间过长，会造成吞噬率偏低，因为部分被吞噬物可能已被消化而不能被计数</td>
      <td>B.红细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>48. 在间接凝集反应中，常被用作载体的细胞是(2.0分)</td>
      <td>A.NK细胞<br>B.红细胞<br>C.T细胞<br>D.B细胞</td>
      <td>D.待检标本是血球混悬液，不能直接用血液</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2007</td>
      <td>49. 关于ABO血型鉴定试验，不正确的是(2.0分)</td>
      <td>A.采血针一人一针，防止交叉感染<br>B.先加分型试剂（抗A或抗B），再加入待检者血球混悬液，是为了防止漏加分型试剂（抗A和抗B）<br>C.指尖或耳垂通常作为取血部位<br>D.待检标本是血球混悬液，不能直接用血液</td>
      <td>B.阴性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>1. 和金黄色葡萄球菌A蛋白结合的是(2.0分)</td>
      <td>A.IgG的CDR区（complementarity determining region）<br>B.IgG的Fab段<br>C.IgG的Fc段<br>D.IgG的轻链</td>
      <td>C.IgG的Fc段</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>2. 半抗原(2.0分)</td>
      <td>A.既无免疫原性，又无抗原性<br>B.只有抗原性，而无免疫原性<br>C.既有免疫原性，又有抗原性<br>D.只有免疫原性，而无抗原性<br>E.只有与蛋白质载体结合后才能与相应抗体结合</td>
      <td>B.只有抗原性，而无免疫原性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>3. 下列数据库中属蛋白质序列数据库的是(2.0分)</td>
      <td>A.Swiss-prot<br>B.GENBANK<br>C.SCOP<br>D. OMIN</td>
      <td>A.Swiss-prot</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>4. 关于效价，正确的是(2.0分)</td>
      <td>A.效价和滴度是两个完全无关的概念<br>B.凝集效价作为半定量指标，可以反映待检血清中抗体的相对浓度<br>C.通常以"++++"的血清最高稀释度作为试验效价<br>D.相同试验条件下的两份待检标本，效价分别是1:160和1:640；可以认为在前一份标本中待检物浓度更高</td>
      <td>B.凝集效价作为半定量指标，可以反映待检血清中抗体的相对浓度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>5. 先天性丙种球蛋白缺乏症患者反复持久的细菌感染常发生在(2.0分)</td>
      <td>A.学龄期儿童<br>B.出生半年内<br>C.出生半年后<br>D.新生儿期<br>E.青少年期</td>
      <td>C.出生半年后</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>6. 下列软件哪一个不属于蛋白结构显示软件 (2.0分)</td>
      <td>A. ProtParam<br>B. RasMOl<br>C.PyMol<br>D. Cn3D</td>
      <td>A. ProtParam</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>7. 主要介导同型细胞间的黏附作用，对组织和器官的发育及完整组织结构的维持起重要作用的黏附分子家族是： (2.0分)</td>
      <td>A.整合素家族<br>B.选择素家族<br>C.钙黏蛋白家族<br>D.免疫球蛋白超家族<br>E.未归类黏附分子</td>
      <td>C.钙黏蛋白家族</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>8. 与T细胞活化有关的重要膜分子：(2.0分)</td>
      <td>A.ITAM和CD8<br>B.CD4和CD2<br>C.p56lck<br>D.CD21和CD19<br>E.CD56和CD16</td>
      <td>B.CD4和CD2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>9. 受抗原刺激后，机体最先产生的抗体是(2.0分)</td>
      <td>A.IgA<br>B.IgM<br>C.IgD<br>D.IgG<br>E.IgE</td>
      <td>B.IgM</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>10. IgG3的分子量比所有其他IgG亚类的分子量高的原因是(2.0分)</td>
      <td>A.有与羧基端结合的J链<br>B.C区有4个功能区<br>C.分子发生聚合<br>D.较长的铰链区<br>E.碳水化合物含量高</td>
      <td>D.较长的铰链区</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>11. 寄生虫感染时明显水平升高的Ig是(2.0分)</td>
      <td>A.IgA<br>B.IgG<br>C.IgM<br>D.IgD<br>E.IgE</td>
      <td>E.IgE</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>12. 在特异性免疫应答中首先接触TD-Ag的细胞是(2.0分)</td>
      <td>A.APC细胞<br>B.B细胞<br>C.T细胞<br>D.肥大细胞<br>E.中性粒细胞</td>
      <td>A.APC细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>13. 下列哪种物质一般不能引起免疫应答(2.0分)</td>
      <td>A.核酸<br>B.类脂<br>C.多糖<br>D.蛋白质<br>E.糖类-蛋白质复合体</td>
      <td>B.类脂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>14. 参与直接凝集反应的抗原是(2.0分)</td>
      <td>A.可溶性抗原<br>B.蛋白质抗原<br>C.颗粒性抗原<br>D.凝集素</td>
      <td>C.颗粒性抗原</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>15. B细胞能识别特异性抗原，因其表面有(2.0分)</td>
      <td>A.C3受体<br>B.Fc受体<br>C.IPS受体<br>D.E受体<br>E.SmIg</td>
      <td>E.SmIg</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>16. 未成熟B细胞(2.0分)</td>
      <td>A.表面同时表达IgM和IgD<br>B.是T、B细胞的前体<br>C.只产生μ链<br>D.在其发育的某一阶段与抗原接触后可导致无反应性<br>E.必须经过胸腺才能成熟</td>
      <td>D.在其发育的某一阶段与抗原接触后可导致无反应性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>17. 抗体能破坏病毒感染的细胞，通过(2.0分)</td>
      <td>A.直接中和细胞内病毒颗粒<br>B.诱导非感染T细胞释放抗病毒物质<br>C.与细胞表面病毒诱导的抗原决定簇结合并活化补体<br>D.防止病毒脱落<br>E.调理作用并导致吞噬作用</td>
      <td>C.与细胞表面病毒诱导的抗原决定簇结合并活化补体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>18. 抗体发挥中和作用主要依赖于(2.0分)</td>
      <td>A.ADCC作用<br>B.调理作用<br>C.V区作用<br>D.激活补体经典途径<br>E. C区作用</td>
      <td>C.V区作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>19. 佐剂是这样一种物质(2.0分)</td>
      <td>A.增加免疫原的化学复杂性<br>B.增强半抗原的免疫原性<br>C.能增加免疫原的大小<br>D.增强机体对免疫原的免疫应答<br>E.增强免疫原的交叉反应性</td>
      <td>D.增强机体对免疫原的免疫应答</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>20. 兄弟姐妹间进行器官移植，引起排斥反应的抗原是(2.0分)</td>
      <td>A.异种抗原<br>B.同种异型抗原<br>C.自身抗原<br>D.异嗜性抗原<br>E.感染的微生物抗原</td>
      <td>B.同种异型抗原</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>21. B细胞发育成熟的场所是(2.0分)</td>
      <td>A.淋巴结<br>B.胸腺<br>C.扁桃腺<br>D.骨髓<br>E.脾</td>
      <td>D.骨髓</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>22. 人类T细胞不具备的受体是(2.0分)</td>
      <td>A.C3b受体<br>B.抗原受体<br>C.E受体<br>D.PHA受体<br>E.IL-2受体</td>
      <td>A.C3b受体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>23. 在蛋白质序列数据库中比较查询蛋白质序列，应使用(2.0分)</td>
      <td>A.Tblastn<br>B.Blastp<br>C.Blastn<br>D.blastx</td>
      <td>B.Blastp</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>24. 下述哪个器官或细胞可对抗原识别与应答(2.0分)</td>
      <td>A.浆细胞<br>B.脑<br>C.NK细胞<br>D.脾脏和淋巴结中的巨噬细胞<br>E.脾脏和淋巴结中的B细胞</td>
      <td>E.脾脏和淋巴结中的B细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>25. 惟一能通过胎盘的Ig是(2.0分)</td>
      <td>A.IgG<br>B.IgA<br>C.IgD<br>D.IgM<br>E.IgE</td>
      <td>A.IgG</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>26. IgG (2.0分)</td>
      <td>A.IgG半衰期相对较短<br>B.IgG4固定补体的能力最强<br>C.IgG以单体形式存在，广泛分布于体液中<br>D.为天然血型抗体<br>E.不参与ADCC反应</td>
      <td>C.IgG以单体形式存在，广泛分布于体液中</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>27. 下列哪一类细胞产生IgE(2.0分)</td>
      <td>A.B淋巴细胞<br>B.T淋巴细胞<br>C.巨噬细胞<br>D.肥大细胞<br>E.嗜碱粒细胞</td>
      <td>A.B淋巴细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>28. 能使B细胞表面BCR与FcγIIR－B 交联的抗体 (2.0分)</td>
      <td>A.抗δ链独特型IgG类抗体<br>B.抗γ链独特型IgG类抗体<br>C.抗μ链独特型IgM类抗体<br>D.抗μ链独特型IgG类抗体<br>E.抗μ链独特型IgM类抗体</td>
      <td>D.抗μ链独特型IgG类抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>29. 慢性肉芽肿病发病原因是(2.0分)</td>
      <td>A.T细胞功能缺陷<br>B.红细胞内酶缺陷<br>C.B细胞功能缺陷<br>D.中性粒细胞功能缺陷<br>E.补体功能缺陷</td>
      <td>D.中性粒细胞功能缺陷</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>30. 以下关于CD4的说法哪项是错误的(2.0分)</td>
      <td>A.CD4属于免疫球蛋白超家族成员<br>B.CD4可与Ag-MHCII分子复合体结合<br>C.CD4不直接参与特异性识别抗原<br>D.成熟的T细胞表面都有CD4表达<br>E.可用抗CD4单抗对辅助性T细胞进行检测</td>
      <td>D.成熟的T细胞表面都有CD4表达</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>31. 关于ABO血型鉴定试验，不正确的是(2.0分)</td>
      <td>A.先加分型试剂（抗A或抗B），再加入待检者血球混悬液，是为了防止漏加分型试剂（抗A和抗B）<br>B.指尖或耳垂通常作为取血部位<br>C.采血针一人一针，防止交叉感染<br>D.待检标本是血球混悬液，不能直接用血液</td>
      <td>D.待检标本是血球混悬液，不能直接用血液</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>32. 下述不属于固有免疫的特点是(2.0分)</td>
      <td>A.缺少特异性<br>B.涉及多种免疫细胞的参与<br>C.由刺激物激活<br>D.有记忆性</td>
      <td>D.有记忆性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>33. MHC-I类分子的经典功能(2.0分)</td>
      <td>A.参与外源性抗原呈递<br>B.为CD8+杀伤性T细胞的识别分子<br>C.参与内源性抗原呈递<br>D.A十B<br>E.A十C</td>
      <td>E.A十C</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>34. 直接特异杀伤靶细胞的是(2.0分)</td>
      <td>A.NK细胞<br>B.Th细胞<br>C.巨噬细胞<br>D.Tc细胞<br>E.B细胞</td>
      <td>D.Tc细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>35. 与B细胞活化有关的膜分子：(2.0分)</td>
      <td>A.CD4和CD8<br>B.CD4和CD40<br>C.CD21和CD19<br>D.CD3和CD2<br>E.CD56和CD16</td>
      <td>C.CD21和CD19</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>36. 主要介导白细胞与内皮细胞结合，参与炎症及淋巴细胞归巢的黏附分子家族是: (2.0分)</td>
      <td>A.整合素家族<br>B.免疫球蛋白超家族<br>C.钙黏蛋白家族<br>D.选择素家族<br>E.未归类黏附分子</td>
      <td>D.选择素家族</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>37. 下列数据库中属结构数据库的有(2.0分)</td>
      <td>A.Tr-EMB<br>B.Uniprot<br>C. PDB<br>D.PubMed</td>
      <td>C. PDB</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>38. MHC限制性表现于(2.0分)</td>
      <td>A.T细胞的抗原识别过程<br>B.NK细胞的杀伤作用<br>C.B细胞对TI抗原的应答<br>D.ADCC<br>E.补体依赖细胞毒作用</td>
      <td>A.T细胞的抗原识别过程</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>39. 接种牛痘后产生对天花的抵抗性，这反映了(2.0分)</td>
      <td>A.抗原的交叉反应<br>B.抗原的特异性<br>C.病毒的超感染<br>D.先天免疫<br>E.主动保护</td>
      <td>A.抗原的交叉反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>40. 在协同凝集反应中，载体是(2.0分)</td>
      <td>A.红细胞<br>B.乳胶颗粒<br>C.金黄色葡萄球菌<br>D.蛋白质</td>
      <td>C.金黄色葡萄球菌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>41. 关于IgA下述哪项是正确的(2.0分)</td>
      <td>A.IgA1主要存在于血清中<br>B.二聚体IgA结合抗原的亲合力，高于单体IgA<br>C.sIgA是膜局部免疫的最重要因素<br>D.sIgA具有免疫排除功能<br>E.以上均正确</td>
      <td>E.以上均正确</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>42. 关于吞噬试验，不正确的是(2.0分)</td>
      <td>A.吞噬百分率和吞噬指数是反映吞噬细胞吞噬功能的指标<br>B.核深染且分叶的是巨噬细胞<br>C.吞噬细胞是组成机体非特异性免疫的成分之一<br>D.试验中，若吞噬时间过长，会造成吞噬率偏低，因为部分被吞噬物可能已被消化而不能被计数</td>
      <td>B.核深染且分叶的是巨噬细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>43. 与类风湿因子有关的Ig是(2.0分)</td>
      <td>A.IgG<br>B.IgA<br>C.IgD<br>D.IgM<br>E.IgE</td>
      <td>D.IgM</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>44. 在间接凝集反应中，要求所用载体与免疫无关，主要是指(2.0分)</td>
      <td>A.载体不能是免疫学研究对象<br>B.所用载体不能影响相应的抗原抗体反应<br>C.载体不用于吸附可溶性抗原或抗体<br>D.载体不参与凝集物的形成</td>
      <td>B.所用载体不能影响相应的抗原抗体反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>45. 在血清类风湿因子测定试验（间接血球凝集试验）中，若V型微量反应板某孔中，所有红细胞紧密集中于孔中央，成为一暗红色点，正确的凝集程度判断是 (2.0分)</td>
      <td>A.++<br>B.++++<br>C.阴性<br>D.+</td>
      <td>C.阴性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>46. 在间接凝集反应中，常被用作载体的细胞是(2.0分)</td>
      <td>A.NK细胞<br>B.红细胞<br>C.T细胞<br>D.B细胞</td>
      <td>B.红细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>47. 致敏载体是下述哪种类型免疫反应中的概念(2.0分)</td>
      <td>A.直接凝集反应<br>B.免疫标记技术<br>C.沉淀反应<br>D.间接凝集反应</td>
      <td>D.间接凝集反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>48. 抗体初次应答的特征是 (2.0分)</td>
      <td>A.抗体以IgG为主<br>B.抗体含量较高<br>C.IgG与IgM几乎同时产生<br>D.抗体亲和力低</td>
      <td>D.抗体亲和力低</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>49. 唯一能激发初次免疫应答的APC是(2.0分)</td>
      <td>A.B细胞<br>B.树突状细胞<br>C.血管内皮细胞<br>D.单核-巨噬细胞<br>E.胸腺上皮细胞</td>
      <td>B.树突状细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2008</td>
      <td>50. 下列哪一种说法不正确 (2.0分)</td>
      <td>A.蛋白质数据库可分为一维数据库，二维数据库，三维数据库，四维数据库<br>B.蛋白质数据库大体可分为序列数据库，模体及结构域数据库，结构数据库和分类数据库。<br>C.蛋白数据库可分为初级数据库和二级数据库</td>
      <td>A.蛋白质数据库可分为一维数据库，二维数据库，三维数据库，四维数据库</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>1. 对细胞免疫应答起负调节作用的细胞因子是 (2.0分)</td>
      <td>A.IL-2、IL-4、IL-10<br>B.IL-4、TGF-β、IL-10<br>C.IL-1、IL-8、TGF-β<br>D.IL-4、IL-8、IL-10<br>E.IL-12、IFN-γ、TNF-α</td>
      <td>B.IL-4、TGF-β、IL-10</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>2. 关于免疫调节的正确叙述是 (2.0分)</td>
      <td>A.协同刺激分子受体分为高亲合性的CD28和低亲合性的<br>B.协同刺激分子与CTLA-4结合促进免疫应答<br>C.CTLA-4的表达密度大于CD28<br>D.活化的T细胞才能表达CTLA-4<br>E.协同刺激分子与CD28结合抑制免疫应答</td>
      <td>D.活化的T细胞才能表达CTLA-4</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>3. 关于免疫细胞调节作用的正确叙述是 (2.0分)</td>
      <td>A.单核-巨噬细胞参与免疫应答的调节<br>B.Th1细胞辅助体液免疫应答<br>C.Th1细胞产生IL-10抑制Th2细胞的增殖<br>D.Th2细胞产生IFN-γ抑制Th1细胞的增殖<br>E.NK细胞与免疫应答调节无关</td>
      <td>A.单核-巨噬细胞参与免疫应答的调节</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>4. NK细胞在免疫调节中的作用体现在(2.0分)</td>
      <td>A.分泌IL-4和IL-6抑制T<br>B.分泌IFN-γ增强Mφ功能<br>C.发挥靶细胞杀伤作用时受MHC限制<br>D.分泌IL-3等细胞因子抑制血细胞发育<br>E.对异体骨髓移植排斥能力弱，但对异体实体</td>
      <td>B.分泌IFN-γ增强Mφ功能</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>5. AICD (2.0分)</td>
      <td>A.是一种程序性被动死亡<br>B.对免疫应答的终止有调节作用<br>C.在免疫应答过程中只有细胞杀伤作用，而无免疫调节作用<br>D.在免疫应答过程中只有免疫调节作用，而无细胞杀伤作用<br>E.主要通过淋巴细胞释放细胞毒颗粒实现的</td>
      <td>B.对免疫应答的终止有调节作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>6. 以下哪种不属于抑制性受体 (2.0分)</td>
      <td>A.Fc R<br>B.CTLA4<br>C.CD28<br>D.PD-1<br>E.KIR</td>
      <td>C.CD28</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>7. 用于检测细胞免疫的免疫学技术是(2.0分)</td>
      <td>A.对流免疫电泳<br>B.E玫瑰花环形成实验<br>C.溶血空斑实验<br>D.直接凝集反应<br>E.协同凝集实验</td>
      <td>B.E玫瑰花环形成实验</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>8. 抗原-抗体反应的适宜酸碱度是 (2.0分)</td>
      <td>A.pH=2<br>B.pH=9<br>C.pH=5<br>D.pH=10<br>E.pH=7</td>
      <td>E.pH=7</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>9. 双抗体夹心法检测血清中的甲胎蛋白（AFP），应选择的固相包被物是 (2.0分)</td>
      <td>A.纯化的AFP<br>B.抗AFP抗体<br>C.酶标抗AFP抗体<br>D.酶标记AFP<br>E.同位素标记AFP抗体</td>
      <td>B.抗AFP抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>10. 凝集反应和沉淀反应的本质区别在于(2.0分)</td>
      <td>A.所用的溶液不同<br>B.支持物不同<br>C.检测的抗体不同<br>D.检测的抗原物理性质不同<br>E.需要的辅助试剂不同</td>
      <td>D.检测的抗原物理性质不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>11. 检测人类B细胞功能的实验是(2.0分)</td>
      <td>A. E花环试验<br>B.溶血空斑试验<br>C.肥达氏反应<br>D.结核菌素试验<br>E.锡克试验</td>
      <td>B.溶血空斑试验</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>12. 应用直接免疫荧光技术鉴别特异性传染原时，荧光素是被结合到 (2.0分)</td>
      <td>A.微生物<br>B.针对人γ―球蛋白的特异性抗体<br>C.针对微生物的特异性抗体<br>D.针对特异性抗体的抗体<br>E.针对微生物的非特异性抗体</td>
      <td>C.针对微生物的特异性抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>13. 给机体注射疫苗使其获得免疫力的方式称为 (2.0分)</td>
      <td>A.人工自动免疫<br>B.人工被动免疫<br>C.非特异性免疫<br>D.天然自动免疫<br>E.天然被动免疫</td>
      <td>A.人工自动免疫</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>14. IgG通过胎盘使胎儿获得的免疫力称为 (2.0分)</td>
      <td>A.人工自动免疫<br>B.人工被动免疫<br>C.非特异性免疫<br>D.天然自动免疫<br>E.天然被动免疫</td>
      <td>E.天然被动免疫</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>15. 属于活疫苗的是(2.0分)</td>
      <td>A.乙型脑炎疫苗<br>B.卡介苗<br>C.霍乱疫苗<br>D.狂犬疫苗<br>E.乙型肝炎血源疫苗</td>
      <td>B.卡介苗</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>16. 属于自然被动免疫的是(2.0分)</td>
      <td>A.隐性感染后获得的免疫<br>B.患传染病后获得的免疫<br>C.通过胎盘获得的免疫<br>D.接受血清丙种球蛋白制剂获得的免疫<br>E.注射类毒素后获得的免疫</td>
      <td>C.通过胎盘获得的免疫</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>17. 属于自然主动免疫的是(2.0分)</td>
      <td>A.隐性感染后获得的免疫<br>B.胎儿从母体获得IgG而建立的免疫<br>C.注射血清丙种球蛋白制剂获得的免疫<br>D.注射抗毒素后获得的免疫<br>E.注射类毒素后获得的免疫</td>
      <td>A.隐性感染后获得的免疫</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>18. 患传染病后获得的免疫 (2.0分)</td>
      <td>A.自然免疫<br>B.人工自动免疫<br>C.自然自动免疫<br>D.自然被动免疫<br>E.人工被动免疫</td>
      <td>C.自然自动免疫</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>19. 预防乙肝病毒感染可采用的生物制品是(2.0分)</td>
      <td>A.抗毒素<br>B.抗病毒血清<br>C.丙种球蛋白<br>D.类毒素<br>E.乙肝病毒基因工程疫苗</td>
      <td>E.乙肝病毒基因工程疫苗</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>20. 免疫增强疗法不应用于(2.0分)</td>
      <td>A.抗移植排斥<br>B.恶性肿瘤<br>C.免疫缺陷病<br>D.病毒感染<br>E.真菌感染</td>
      <td>A.抗移植排斥</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>21. 哪个补体片段具有调理作用? (2.0分)</td>
      <td>A.C3b<br>B.C2a<br>C.C3a<br>D.C5a<br>E.C5b</td>
      <td>A.C3b</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>22. 具有趋化中性粒细胞作用的补体成分是(2.0分)</td>
      <td>A.C4b<br>B.C5b<br>C.C5a<br>D.C1<br>E.C2a</td>
      <td>C.C5a</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>23. 某孕妇为Rh-，第一胎分娩Rh+ 胎儿，为防止再次妊娠的Rh+ 胎儿产生溶血症，应给Rh-母亲注射(2.0分)</td>
      <td>A.抗Rh抗体<br>B.Rh抗原<br>C.免疫抑制剂<br>D.免疫增强剂<br>E.以上都不是</td>
      <td>A.抗Rh抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>24. 能够通过经典途径激活补体的是(2.0分)</td>
      <td>A.IgM<br>B.IgD<br>C.IgE<br>D.IgA</td>
      <td>A.IgM</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>25. 哪个是补体旁路途径的C3转化酶 (2.0分)</td>
      <td>A.C4b2a<br>B.C3bBb<br>C.C4b2a3b<br>D.C3bBb3b</td>
      <td>B.C3bBb</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>26. 体液中的补体抑制因子是(2.0分)</td>
      <td>A.C1q<br>B.IgG1<br>C.IL-2<br>D.H因子<br>E.B因子</td>
      <td>D.H因子</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>27. 补体经典激活途径中各成分的激活顺序为(2.0分)</td>
      <td>A.C123456789<br>B.C124536789<br>C.C145236789<br>D.C124356789<br>E.C142356789</td>
      <td>E.C142356789</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>28. 下列哪种成分无酶活性(2.0分)</td>
      <td>A.C1s<br>B.C1r<br>C.P因子<br>D.D因子<br>E.I因子</td>
      <td>E.I因子</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>29. 参与溶菌作用的补体成分是(2.0分)</td>
      <td>A.C3<br>B.C42<br>C.C1<br>D.C56789<br>E.C423</td>
      <td>D.C56789</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>30. 血管神经性水肿主要由于下列哪个成分缺陷所引起(2.0分)</td>
      <td>A.H因子<br>B.I因子<br>C.C1INH<br>D.S蛋白<br>E.C4bp</td>
      <td>C.C1INH</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>31. 介导I型超敏反应的主要细胞类型-(2.0分)</td>
      <td>A.T淋巴细胞<br>B.NK细胞<br>C.巨噬细胞<br>D.肥大细胞<br>E.树突状细胞</td>
      <td>D.肥大细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>32. 超敏反应中不是由抗体直接参与的型别为(2.0分)</td>
      <td>A.I型<br>B.II型<br>C.III型<br>D.IV型</td>
      <td>D.IV型</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>33. 高亲和性的可结合到肥大细胞上的IgE分子部位是(2.0分)</td>
      <td>A.Fab段<br>B.CH2功能区<br>C.H链恒定区<br>D.HVR区<br>E.Fc段</td>
      <td>E.Fc段</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>34. DTH皮肤试验阳性与下列物质有关(2.0分)</td>
      <td>A.抗体、补体和CK<br>B.抗原、抗原致敏的T淋巴细胞和巨噬细胞<br>C.抗原抗体复合物、补体和中性粒细胞<br>D.IgG抗体、抗原和肥大细胞<br>E.抗原、巨噬细胞和补体</td>
      <td>B.抗原、抗原致敏的T淋巴细胞和巨噬细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>35. 关于IV 型超敏反应错误的是(2.0分)</td>
      <td>A.以IgG抗体介导为主<br>B.反应速度慢<br>C.炎症区以单个核细胞浸润为主<br>D.效应Tc细胞参与</td>
      <td>A.以IgG抗体介导为主</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>36. 自噬的生理意义中下列哪个表述是错误的? (2.0分)</td>
      <td>A.使细胞活化<br>B.清除衰老的细胞器<br>C.代谢应激<br>D.维持染色体的稳定<br>E.使细胞发生程序性死亡</td>
      <td>A.使细胞活化</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>37. 目前的研究已经发现，自噬参与调控免疫应答的过程，包括以下哪个方面(2.0分)</td>
      <td>A.抗原的提呈<br>B.TLR信号途径的调节<br>C.微生物感染和炎症过程<br>D.以上全部</td>
      <td>D.以上全部</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>38. 自噬是指从粗面内质网的无核糖体附着区脱落的双层膜包裹部分胞质和细胞内需降解的细胞器、蛋白质等成分形成。(2.0分)</td>
      <td>A.抗体<br>B.autophagosome<br>C.复合物<br>D.lysosome<br>E.以上都不是</td>
      <td>B.autophagosome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>39. 细胞自噬能引起细胞死亡的方式是。(2.0分)</td>
      <td>A.Necrosis<br>B.Lysis<br>C.Programmed cell death<br>D. Necroptosis<br>E.Pyroptosis</td>
      <td>C.Programmed cell death</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>40. 分子伴侣介导的自噬是 (2.0分)</td>
      <td>A.由内质网来源的膜包绕待降解物形成自噬体，然后与溶酶体融合并降解其内容物;<br>B.细胞外的异物蛋白被吞噬后，与溶酶体融合后被消化<br>C.溶酶体的膜直接包裹长寿命蛋白等，并在溶酶体内降解<br>D.胞质内蛋白结合到分子伴侣后被转运到溶酶体腔中，然后被溶酶体酶消化<br>E.内体与溶酶体的融合过程</td>
      <td>D.胞质内蛋白结合到分子伴侣后被转运到溶酶体腔中，然后被溶酶体酶消化</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>41. 治疗肾移植排斥反应的药物不包括 (2.0分)</td>
      <td>A.mycophenolate mofetil（霉酚酸酯）<br>B.methylprednisolone (甲泼尼松龙)<br>C.cyclosporine (CsA, 环孢素)<br>D.levamisole (左旋咪唑 )<br>E.tacrolimus (FK506, 他克莫司)</td>
      <td>D.levamisole (左旋咪唑 )</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>42. Rapamycin (雷帕霉素, sirolimus 西罗莫司)属于 (2.0分)</td>
      <td>A.糖皮质激素<br>B.钙调磷酸酶抑制剂<br>C.抗增殖/抗代谢药<br>D.抗体类药物<br>E.中药成分</td>
      <td>C.抗增殖/抗代谢药</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>43. Cyclosporine (CsA, 环孢素)属于 (2.0分)</td>
      <td>A.糖皮质激素<br>B.钙调磷酸酶抑制剂<br>C.抗增殖/抗代谢药<br>D.抗体类药物<br>E.中药成分</td>
      <td>B.钙调磷酸酶抑制剂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>44. 免疫缺陷综合征（immunodeficient diseases）不应使用 (2.0分)</td>
      <td>A.胸腺素<br>B.白介素-2（IL-2）<br>C.干扰素<br>D.环孢素<br>E.异丙肌苷</td>
      <td>D.环孢素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>45. 环孢素（cyclosporine）的毒性包括 (2.0分)</td>
      <td>A.肾损害<br>B.肝损害<br>C.中枢神经系统毒性<br>D.增加对感染的敏感性<br>E.以上均是</td>
      <td>E.以上均是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>46. 化学治疗药（化疗药）不包括 (2.0分)</td>
      <td>A.抗寄生虫药物<br>B.抗糖尿病药物<br>C.抗菌药物<br>D.抗生素<br>E.抗病毒药</td>
      <td>B.抗糖尿病药物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>47. 抗菌药物是 (2.0分)</td>
      <td>A.对病原菌有杀灭作用的药物<br>B.对病原菌有抑制作用的药物<br>C.对病原菌有杀灭或抑制作用的药物<br>D.能用于预防细菌性感染的药物<br>E.能治疗细菌性感染的药物</td>
      <td>C.对病原菌有杀灭或抑制作用的药物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>48. 抗菌谱是 (2.0分)</td>
      <td>A.药物的治疗指数<br>B.药物的抗菌范围<br>C.药物的抗菌能力<br>D.抗菌药的治疗效果<br>E.抗菌药的适应证</td>
      <td>B.药物的抗菌范围</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>49. 下列药物中，化疗指数最大的是 (2.0分)</td>
      <td>A.LD50＝50 mg，ED50＝100 mg<br>B.LD50＝100 mg，ED50 50 mg<br>C.LD50＝500 mg，ED50 = 250 mg<br>D.LD50＝50 mg，ED50＝10 mg<br>E.LD50＝100 mg，ED50＝25 mg</td>
      <td>D.LD50＝50 mg，ED50＝10 mg</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2009</td>
      <td>50. 最低抑菌浓度（MIC）是指 (2.0分)</td>
      <td>A.杀灭细菌50%所需的浓度<br>B.抑制细菌生长50%所需的浓度<br>C.抑制细菌生长90%所需的浓度<br>D.杀灭细菌所需的最低浓度<br>E.抑制细菌生长所需的最低浓度</td>
      <td>E.抑制细菌生长所需的最低浓度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>1. 关于免疫应答的调节，下列哪项是错误的？(3.0分)</td>
      <td>A.免疫应答不受遗传基因的制约<br>B.免疫调节的机制决定了免疫应答的发生及应答的强弱<br>C.免疫应答的调节可分为基因、细胞和分子三种水平的调节<br>D.神经-内分泌免疫网络参与免疫应答的调节<br>E.免疫调节机制失控或异常可导致免疫疾病的发生</td>
      <td>A.免疫应答不受遗传基因的制约</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>2. 自然调节性T细胞的特异性转录因子是哪个分子？(3.0分)</td>
      <td>A.BCL-2<br>B.T-bet<br>C.STAT3<br>D.Foxp3<br>E.GATA3</td>
      <td>D.Foxp3</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>3. 群体水平免疫调节的基础主要是：(3.0分)</td>
      <td>A. MHC多态性<br>B.神经内分泌免疫网络的调节<br>C.AICD对特异性应答的反馈调节<br>D.独特型网络的调节<br>E.免疫细胞激活信号转导中的反馈调节</td>
      <td>B.神经内分泌免疫网络的调节</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>4. 关于抗毒素的使用，哪项是错误的？(3.0分)</td>
      <td>A.可能发生过敏反应<br>B.治疗时要早期足量<br>C.可作为免疫增强剂给儿童多次注射<br>D.对过敏机体应采取脱敏疗法<br>E.只能用于紧急预防或治疗</td>
      <td>C.可作为免疫增强剂给儿童多次注射</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>5. 下列哪项指标可以评价AIDS患者的细胞免疫功能？(3.0分)</td>
      <td>A.CD2+/CD3+细胞比值<br>B.CD3+/CD4+细胞比值<br>C.CD3+/CD8+细胞比值<br>D.CD4+/CD8+细胞比值<br>E.CD2+/CD4+细胞比值</td>
      <td>D.CD4+/CD8+细胞比值</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>6. 肿瘤疫苗与传统疫苗的主要区别是：(3.0分)</td>
      <td>A.肿瘤疫苗主要用于肿瘤的预防<br>B.传统疫苗主要用于疾病的治疗<br>C.肿瘤疫苗主要用于肿瘤的治疗<br>D.肿瘤疫苗是免疫重建疗法<br>E.肿瘤疫苗是人工被动免疫疗法</td>
      <td>C.肿瘤疫苗主要用于肿瘤的治疗</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>7. 沉淀反应中，形成肉眼可见的沉淀线或沉淀物的条件不包括(3.0分)</td>
      <td>A.抗原抗体比例合适<br>B.适量电解质存在<br>C.抗体过剩<br>D.抗原抗体的量足够多</td>
      <td>C.抗体过剩</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>8. 对流免疫电泳，正确的是(3.0分)</td>
      <td>A.与双向琼脂扩散相比，更不敏感<br>B.与双向琼脂扩散相比，试验时间更长<br>C.在一对抗原抗体孔中，抗体通常置于靠近阳极的孔，抗原置于靠近阴极的孔<br>D.在一对抗原抗体孔中，抗体通常置于靠近阴极的孔，抗原置于靠近阳极的孔</td>
      <td>C.在一对抗原抗体孔中，抗体通常置于靠近阳极的孔，抗原置于靠近阴极的孔</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>9. 下列哪项组合绵羊红细胞最有可能出现溶血现象(3.0分)</td>
      <td>A.绵羊红细胞，溶血素<br>B.绵羊红细胞，补体<br>C.绵羊红细胞，溶血素，补体<br>D.绵羊红细胞，豚鼠血清</td>
      <td>C.绵羊红细胞，溶血素，补体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>10. ELISA双抗体夹心法的设计是用于检测(4.0分)</td>
      <td>A.抗体<br>B.抗原<br>C.抗原或抗体<br>D.底物</td>
      <td>B.抗原</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>11. 斑点免疫层析试验中，下列哪种结果是阴性结果(3.0分)</td>
      <td>A.出现两条红线，颜色有深浅<br>B.出现一条红线（在参照区）<br>C.出现两条红线，颜色深浅相近<br>D.没有红线出现</td>
      <td>B.出现一条红线（在参照区）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>12. 关于密度梯度离心法分离外周血单个核细胞，正确的是(3.0分)</td>
      <td>A.水平离心<br>B.淋巴细胞分离液密度介于红细胞和中性粒细胞之间<br>C.被分离的外周血无需抗凝处理<br>D.非水平离心</td>
      <td>A.水平离心</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>13. 模式识别受体可识别：(3.0分)</td>
      <td>A.细菌表面的甘露糖残基<br>B.肿瘤相关抗原<br>C.肿瘤特异性抗原<br>D.MHC I类分子<br>E.MHC II类分子</td>
      <td>A.细菌表面的甘露糖残基</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>14. NK细胞所不具备的作用和特征是：(3.0分)</td>
      <td>A.表达杀伤活化受体<br>B.具有免疫调节作用<br>C.表达IgFc受体<br>D.具有吞噬杀伤作用<br>E.表达杀伤抑制受体</td>
      <td>D.具有吞噬杀伤作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>15. 固有免疫细胞所不具备的免疫应答特点是：(3.0分)</td>
      <td>A.直接识别病原体某些共有配体分子<br>B.识别相应配体后，立即产生免疫应答<br>C.经克隆扩增和分化后，产生免疫应答<br>D.通常没有免疫记忆功能，不能引起再次应答<br>E.免疫应答维持时间较短</td>
      <td>C.经克隆扩增和分化后，产生免疫应答</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>16. NK细胞表面能够识别HLA I类分子的杀伤抑制性受体是 (3.0分)</td>
      <td>A.KIR2DL<br>B.KIR3DS<br>C.CD94/NKG2C<br>D.NKG2D<br>E.NKp30</td>
      <td>A.KIR2DL</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>17. 某孕妇为Rh-，第一胎分娩Rh+ 胎儿，为防止再次妊娠的Rh+ 胎儿产生溶血症，应给Rh-母亲注射(3.0分)</td>
      <td>A.抗Rh抗体<br>B.Rh抗原<br>C.免疫抑制剂<br>D.免疫增强剂<br>E.以上都不是</td>
      <td>A.抗Rh抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>18. 下列哪种成分无酶活性(3.0分)</td>
      <td>A.C1s<br>B.C1r<br>C.P因子<br>D.D因子<br>E.I因子</td>
      <td>E.I因子</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>19. 初次注入大量抗毒素的马血清所引起血清病的发病机理属于(3.0分)</td>
      <td>A.Ⅰ型变态反应<br>B.Ⅱ型变态反应<br>C.Ⅲ型变态反应<br>D.Ⅳ型变态反应<br>E.Ⅴ型变态反应</td>
      <td>C.Ⅲ型变态反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>20. Ⅲ型超敏反应重要病理学特征是(3.0分)</td>
      <td>A.红细胞浸润<br>B.巨噬细胞浸润<br>C.淋巴细胞浸润<br>D.嗜酸性粒细胞浸润<br>E.中性粒细胞浸润</td>
      <td>E.中性粒细胞浸润</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>21. DTH皮肤试验阳性与下列物质有关(3.0分)</td>
      <td>A.抗体、补体和CK<br>B.抗原、抗原致敏的T淋巴细胞和巨噬细胞<br>C.抗原抗体复合物、补体和中性粒细胞<br>D.IgG抗体、抗原和肥大细胞<br>E.抗原、巨噬细胞和补体</td>
      <td>B.抗原、抗原致敏的T淋巴细胞和巨噬细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>22. 当IgE结合于肥大细胞表面的FcεR后，下列哪些因素可使肥大细胞脱颗粒(3.0分)</td>
      <td>A.变应原再次进入<br>B.抗IgE的IgG Fab段<br>C.抗IgE的IgG Fc段<br>D.IgM</td>
      <td>C.抗IgE的IgG Fc段</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>23. 抗菌药物的作用机制不包括(3.0分)</td>
      <td>A.抑制细菌细胞壁的合成<br>B.破坏细菌细胞壁结构<br>C.对药物产生灭活酶<br>D.抑制菌体蛋白质合成<br>E.抑制细菌叶酸代谢</td>
      <td>C.对药物产生灭活酶</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>24. 产生钝化酶的细菌往往对下列哪一类抗生素发生耐药？ (3.0分)</td>
      <td>A.青霉素类抗生素<br>B.B．头孢菌素类抗生素<br>C.C. 氨基苷类抗生素<br>D.D．大环内酯类抗生素<br>E.E．四环素类抗生素</td>
      <td>C.C. 氨基苷类抗生素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>25. 抗菌药物是 (3.0分)</td>
      <td>A.对病原菌有杀灭作用的药物<br>B.对病原菌有抑制作用的药物<br>C.对病原菌有杀灭或抑制作用的药物<br>D.能用于预防细菌性感染的药物<br>E.能治疗细菌性感染的药物</td>
      <td>C.对病原菌有杀灭或抑制作用的药物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>26. 红霉素等大环内酯类的抗菌作用机制是 (3.0分)</td>
      <td>A.与细菌胞浆膜结合，破坏胞浆膜结构<br>B.破坏细胞壁使水分内渗<br>C.抑制DNA多聚酶，影响DNA的合成<br>D.与转肽酶结合，阻止细胞壁粘肽合成<br>E.抑制菌体蛋白的合成</td>
      <td>E.抑制菌体蛋白的合成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>27. Which of the following information can NOT be achieved by oncomine?(3.0分)</td>
      <td>A.Differential expression of a given gene in cancer vs normal<br>B.coexpression analysis of a given gene in cell lines<br>C.pathway analysis<br>D.DNA copy gain in medulloblastoma clinical specimens</td>
      <td>C.pathway analysis</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>28. Where you can get the boxplots of the expression of a given gene ? (3.0分)</td>
      <td>A.The datasets tab<br>B.The concepts tab<br>C.The visualize<br>D.The filters</td>
      <td>C.The visualize</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>29. How to do comparing analysis? (3.0分)</td>
      <td>A.select the datasets tab<br>B.select the desired analyses by clicking the checkboxes next to them<br>C.click the Compare link near the top of the tab<br>D.all the above steps</td>
      <td>D.all the above steps</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>30. 关于AICD，下列哪项是错误的？ (3.0分)</td>
      <td>A.AICD是指FAS启动的效应细胞的凋亡<br>B.AICD参与CTL等细胞对靶细胞的杀伤<br>C.AICD在免疫调节中主要起正反馈作用<br>D.AICD能够抑制受到抗原活化并发生克窿扩增的T淋巴细胞<br>E.AICD可以使特异性的细胞免疫和体液免疫应答同时受到下调</td>
      <td>C.AICD在免疫调节中主要起正反馈作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>31. 免疫毒素指的是(3.0分)</td>
      <td>A.抗肿瘤单抗与毒素的交联物<br>B.抗肿瘤单抗与抗癌药物的交联物<br>C.抗肿瘤单抗与放射性核素的交联物<br>D.抗肿瘤单抗与特定细胞因子的交联物<br>E.抗肿瘤单抗与肿瘤疫苗的交联物</td>
      <td>A.抗肿瘤单抗与毒素的交联物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>32. 可用于免疫抑制疗法的是： (3.0分)</td>
      <td>A.环孢素A、FK-506<br>B.卡介苗<br>C.短小棒状杆菌<br>D.多糖<br>E.胞壁酰二肽</td>
      <td>A.环孢素A、FK-506</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2010</td>
      <td>33. 关于ELISA中的封闭步骤，正确的是 (3.0分)</td>
      <td>A.封闭是用无关蛋白封闭非特异性位点<br>B.无论何种情况下封闭均必不可少<br>C.即使封闭不当，也不可能使阴性本底增高<br>D.封闭后无需洗板就可加待检标本</td>
      <td>A.封闭是用无关蛋白封闭非特异性位点</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>1. 关于免疫应答的调节，下列哪项是错误的？(2.0分)</td>
      <td>A.免疫应答不受遗传基因的制约<br>B.免疫调节的机制决定了免疫应答的发生及应答的强弱<br>C.免疫应答的调节可分为基因、细胞和分子三种水平的调节<br>D.神经-内分泌免疫网络参与免疫应答的调节<br>E.免疫调节机制失控或异常可导致免疫疾病的发生</td>
      <td>D.神经-内分泌免疫网络参与免疫应答的调节</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>2. 下列哪项指标可以评价AIDS患者的细胞免疫功能？ (2.0分)</td>
      <td>A.CD2+/CD3+细胞比值<br>B.CD3+/CD4+细胞比值<br>C.CD3+/CD8+细胞比值<br>D.CD4+/CD8+细胞比值<br>E.CD2+/CD4+细胞比值</td>
      <td>D.CD4+/CD8+细胞比值</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>3. 用免疫荧光技术间接法检测组织中的抗原，应将荧光素标记：(2.0分)</td>
      <td>A.抗原<br>B.相应抗体<br>C.抗免疫球蛋白抗体<br>D.抗原抗体复合物<br>E.抗C3抗体</td>
      <td>B.相应抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>4. 常用的检测细胞毒效应的方法是： (2.0分)</td>
      <td>A.3H-TdR掺入法<br>B.125I释放法<br>C.51Cr释放<br>D.形态学检测<br>E.移动抑制试验</td>
      <td>C.51Cr释放</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>5. 用ELISA双抗体夹心法检测抗原A时，固相载体的包被物是： (2.0分)</td>
      <td>A.酶标抗A抗体<br>B.未标记的抗A抗体<br>C.酶标抗原A<br>D.未标记的抗球蛋白抗体<br>E.酶标抗球蛋白抗体</td>
      <td>B.未标记的抗A抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>6. 沉淀反应中，扩散试验与电泳结合，产生多种方法，不包括(2.0分)</td>
      <td>A.对流免疫电泳<br>B.交叉免疫电泳<br>C.火箭免疫电泳<br>D.双向琼脂扩散</td>
      <td>D.双向琼脂扩散</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>7. 对流免疫电泳，正确的是（ C ）(2.0分)</td>
      <td>A.与双向琼脂扩散相比，更不敏感<br>B.与双向琼脂扩散相比，试验时间更长<br>C.在一对抗原抗体孔中，抗体通常置于靠近阳极的孔，抗原置于靠近阴极的孔<br>D.在一对抗原抗体孔中，抗体通常置于靠近阴极的孔，抗原置于靠近阳极的孔</td>
      <td>C.在一对抗原抗体孔中，抗体通常置于靠近阳极的孔，抗原置于靠近阴极的孔</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>8. 对流免疫电泳的注意事项，不正确的是(2.0分)</td>
      <td>A.琼脂浓度要高，以大于3%为宜<br>B.电泳时电流不宜过大，以免蛋白变性<br>C.抗原抗体电极方向不能搞错<br>D.抗原抗体浓度要适当，抗原太浓或太稀都不易出现沉淀线</td>
      <td>A.琼脂浓度要高，以大于3%为宜</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>9. 关于ELISA中的封闭步骤，正确的是(2.0分)</td>
      <td>A.封闭是用无关蛋白封闭非特异性位点<br>B.无论何种情况下封闭均必不可少<br>C.即使封闭不当，也不可能使阴性本底增高<br>D.封闭后无需洗板就可加待检标本</td>
      <td>A.封闭是用无关蛋白封闭非特异性位点</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>10. 密度梯度离心法分离外周血单个核细胞，离心后悬浮于淋巴细胞分离液层和血浆层之间的是(2.0分)</td>
      <td>A.外周血单个核细胞（淋巴细胞和单核细胞）<br>B.中性粒细胞<br>C.红细胞<br>D.红细胞和中性粒细胞</td>
      <td>A.外周血单个核细胞（淋巴细胞和单核细胞）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>11. 淋巴细胞转化试验（形态学检查法）中，典型淋巴母细胞的特征不包括(2.0分)</td>
      <td>A.体积明显增大<br>B.可见1~4个明显核仁<br>C.胞浆嗜碱性，有伪足样突出<br>D.可见成堆或散在的染色体</td>
      <td>D.可见成堆或散在的染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>12. 斑点免疫层析试验中，下列哪种结果是阴性结果(3.0分)</td>
      <td>A.出现两条红线，颜色有深浅<br>B.出现一条红线（在参照区）<br>C.出现两条红线，颜色深浅相近<br>D.没有红线出现</td>
      <td>B.出现一条红线（在参照区）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>13. 下面哪个数据库可以进行抗原表位的预测分析(2.0分)</td>
      <td>A.IGMT<br>B.IEDB<br>C.IPD<br>D.ImmPort</td>
      <td>B.IEDB</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>14. 固有免疫细胞所不具备的免疫应答特点是(2.0分)</td>
      <td>A.直接识别病原体某些共有配体分子<br>B.识别相应配体后，立即产生免疫应答<br>C.经克隆扩增和分化后，产生免疫应答<br>D.通常没有免疫记忆功能，不能引起再次应答<br>E.免疫应答维持时间较短</td>
      <td>C.经克隆扩增和分化后，产生免疫应答</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>15. 模式识别受体可识别：(3.0分)</td>
      <td>A.细菌表面的甘露糖残基<br>B.肿瘤相关抗原<br>C.肿瘤特异性抗原<br>D.MHC I类分子<br>E.MHC II类分子</td>
      <td>A.细菌表面的甘露糖残基</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>16. Toll样受体中能与病毒单链RNA结合的是(2.0分)</td>
      <td>A.TLR2<br>B.TLR3<br>C.TLR5<br>D.TLR8<br>E.TLR9</td>
      <td>D.TLR8</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>17. NK细胞表面能够识别HLA I类分子的杀伤抑制性受体是(2.0分)</td>
      <td>A.KIR2DL<br>B.KIR3DS<br>C.CD94/NKG2C<br>D.NKG2D<br>E.NKp30</td>
      <td>A.KIR2DL</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>18. 某孕妇为Rh-，第一胎分娩Rh+ 胎儿，为防止再次妊娠的Rh+ 胎儿产生溶血症，应给Rh-母亲注射(2.0分)</td>
      <td>A.抗Rh抗体<br>B.Rh抗原<br>C.免疫抑制剂<br>D.免疫增强剂<br>E.以上都不是</td>
      <td>A.抗Rh抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>19. 补体经典激活途径中各成分的激活顺序为(2.0分)</td>
      <td>A.C123456789<br>B.C124536789<br>C.C145236789<br>D.C124356789<br>E.C142356789</td>
      <td>E.C142356789</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>20. 血管神经性水肿主要由于下列哪个成分缺陷所引起(2.0分)</td>
      <td>A.H因子<br>B.I因子<br>C.C1INH<br>D.S蛋白<br>E.C4bp</td>
      <td>C.C1INH</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>21. 初次注入大量抗毒素的马血清所引起血清病的发病机理属于(2.0分)</td>
      <td>A.Ⅰ型变态反应<br>B.Ⅱ型变态反应<br>C.Ⅲ型变态反应<br>D.Ⅳ型变态反应<br>E.Ⅴ型变态反应</td>
      <td>C.Ⅲ型变态反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>22. I型变态反应可通过下列哪种成分转移给正常人(2.0分)</td>
      <td>A.患者的致敏淋巴细胞<br>B.患者的血清<br>C.致敏淋巴细胞释放的转移因子<br>D.巨噬细胞释放的淋巴细胞激活因子<br>E.以上均不是</td>
      <td>B.患者的血清</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>23. DTH皮肤试验阳性与下列物质有关(2.0分)</td>
      <td>A.抗体、补体和CK<br>B.抗原、抗原致敏的T淋巴细胞和巨噬细胞<br>C.抗原抗体复合物、补体和中性粒细胞<br>D.IgG抗体、抗原和肥大细胞<br>E.抗原、巨噬细胞和补体</td>
      <td>B.抗原、抗原致敏的T淋巴细胞和巨噬细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>24. III型超敏反应性疾病中引起组织损伤作用最强的细胞是 (B)(2.0分)</td>
      <td>A.补体<br>B.中性粒细胞<br>C.T淋巴细胞<br>D.单核细胞<br>E.血小板</td>
      <td>B.中性粒细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>25. 当IgE结合于肥大细胞表面的FcεR后，下列哪些因素可使肥大细胞脱颗粒 (2.0分)</td>
      <td>A.变应原再次进入<br>B.抗IgE的IgG Fab段<br>C.抗IgE的IgG Fc段<br>D.IgM<br>E.IgA</td>
      <td>A.变应原再次进入</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>26. 迟发型超敏反应主要是由下列因素介导(3.0分)</td>
      <td>A.IgE 结合到肥大细胞上<br>B.IgG 和IgM结合到组织抗原上<br>C.免疫复合物沉积在基底膜<br>D.CD4+ 和CD8+ T细胞<br>E.浆细胞</td>
      <td>D.CD4+ 和CD8+ T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>27. 关于IV 型超敏反应错误的是(2.0分)</td>
      <td>A.以IgG抗体介导为主<br>B.反应速度慢<br>C.炎症区以单个核细胞浸润为主<br>D.效应Tc细胞参与<br>E.结核杆菌感染可以发生</td>
      <td>A.以IgG抗体介导为主</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>28. 在特异性变应原脱敏疗法中，诱导机体产生的封闭抗体的是(2.0分)</td>
      <td>A.IgM<br>B.IgG<br>C.IgE<br>D.IgD<br>E.IgA</td>
      <td>B.IgG</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>29. 具有趋化中性粒细胞作用的补体成分是(2.0分)</td>
      <td>A.C4b<br>B.C5b<br>C.C5a<br>D.C1<br>E.C2a</td>
      <td>C.C5a</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>30. NK细胞所不具备的作用和特征是(2.0分)</td>
      <td>A.表达杀伤活化受体<br>B.具有免疫调节作用<br>C.表达IgFc受体<br>D.具有吞噬杀伤作用<br>E.表达杀伤抑制受体</td>
      <td>D.具有吞噬杀伤作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>31. 属于自然主动免疫的是(2.0分)</td>
      <td>A.隐性感染后获得的免疫<br>B.胎儿从母体获得IgG而建立的免疫<br>C.注射血清丙种球蛋白制剂获得的免疫<br>D.注射抗毒素后获得的免疫<br>E.注射类毒素后获得的免疫</td>
      <td>A.隐性感染后获得的免疫</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>32. 预防新生儿发生破伤风的最佳方法是(2.0分)</td>
      <td>A.给新生儿注射破伤风抗毒素<br>B.给新生儿注射破伤风类毒素<br>C.给新生儿注射破伤风抗毒素和类毒素<br>D.怀孕早期给母亲注射破伤风类毒素进行免疫<br>E.分娩前给母亲注射破伤风类毒素</td>
      <td>E.分娩前给母亲注射破伤风类毒素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>33. 免疫增强疗法不应用于(2.0分)</td>
      <td>A.抗移植排斥<br>B.恶性肿瘤<br>C.免疫缺陷病<br>D.病毒感染<br>E.真菌感染</td>
      <td>A.抗移植排斥</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>34. 下列不属于被动免疫治疗的是(2.0分)</td>
      <td>A.注射经射线照射致死的自身肿瘤细胞加BCG<br>B.输注LAK细胞<br>C.输注活化的TIL细胞<br>D.注射IL-2<br>E.注射IFN-α</td>
      <td>A.注射经射线照射致死的自身肿瘤细胞加BCG</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>35. 属于活疫苗的是(2.0分)</td>
      <td>A.乙型脑炎疫苗<br>B.卡介苗<br>C.霍乱疫苗<br>D.狂犬疫苗<br>E.乙型肝炎血源疫苗</td>
      <td>B.卡介苗</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>36. 下列不属于免疫增强剂的是(2.0分)</td>
      <td>A.左旋咪唑<br>B.西咪替丁<br>C.卡介苗<br>D.烷化剂<br>E.短小棒状杆菌</td>
      <td>D.烷化剂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>37. Which of the following information can NOT be achieved by oncomine? (2.0分)</td>
      <td>A.Differential expression of a given gene in cancer vs normal<br>B.coexpression analysis of a given gene in cell lines<br>C.pathway analysis<br>D.DNA copy gain in medulloblastoma clinical specimens</td>
      <td>C.pathway analysis</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>38. How to remove filters ? (2.0分)</td>
      <td>A.clicking them in the browse tree<br>B.Click the red X next to the term in the filter box or click the gray X at the top pf the filter box to remove all your filters<br>C.click the arrow at the top of the filters<br>D.none of the above</td>
      <td>B.Click the red X next to the term in the filter box or click the gray X at the top pf the filter box to remove all your filters</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>39. Where you can get the boxplots of the expression of a given gene ?(2.0分)</td>
      <td>A.The datasets tab<br>B.The concepts tab<br>C.The visualize<br>D.The filters</td>
      <td>C.The visualize</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>40. 治疗肾移植排斥反应的药物不包括(2.0分)</td>
      <td>A.mycophenolate mofetil（霉酚酸酯）<br>B.methylprednisolone (甲泼尼松龙)<br>C.cyclosporine (CsA, 环孢素)<br>D.levamisole (左旋咪唑 )<br>E.tacrolimus (FK506, 他克莫司)</td>
      <td>D.levamisole (左旋咪唑 )</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>41. Mycophenolate mofetil（霉酚酸酯）的作用主要是(2.0分)</td>
      <td>A.抑制次黄嘌呤单核苷磷酸脱氢酶（IMPDH）<br>B.增强次黄嘌呤单核苷磷酸脱氢酶<br>C.抑制钙调磷酸酶<br>D.增强钙调磷酸酶<br>E.抑制mTOR信号通路</td>
      <td>A.抑制次黄嘌呤单核苷磷酸脱氢酶（IMPDH）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>42. 有免疫增强作用的药物不包括(2.0分)</td>
      <td>A.卡介苗（BCG）<br>B.白介素-2（IL-2）<br>C.硫唑嘌呤（azathioprine, Aza）<br>D.干扰素（interferons）<br>E.左旋咪唑（levamisole）</td>
      <td>C.硫唑嘌呤（azathioprine, Aza）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>43. Cyclosporine (CsA, 环孢素)属于 (2.0分)</td>
      <td>A.糖皮质激素<br>B.钙调磷酸酶抑制剂<br>C.抗增殖/抗代谢药<br>D.抗体类药物<br>E.中药成分</td>
      <td>B.钙调磷酸酶抑制剂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>44. 有关化疗指数(CI)的描述中错误的是 (2.0分)</td>
      <td>A.CI反映药物的安全性<br>B.LD50/ED50反映CI<br>C.CI大说明药物临床应用不安全<br>D.CI小说明药物临床应用不安全<br>E.化疗药安全性也可用LD5／ED95反映</td>
      <td>C.CI大说明药物临床应用不安全</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>45. 抗菌药物的作用机制不包括 (2.0分)</td>
      <td>A.抑制细菌细胞壁的合成<br>B.破坏细菌细胞壁结构<br>C.对药物产生灭活酶<br>D.抑制菌体蛋白质合成<br>E.抑制细菌叶酸代谢</td>
      <td>C.对药物产生灭活酶</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>46. 产生钝化酶的细菌往往对下列哪一类抗生素发生耐药？ (3.0分)</td>
      <td>A.青霉素类抗生素<br>B.头孢菌素类抗生素<br>C.氨基苷类抗生素<br>D.大环内酯类抗生素<br>E.四环素类抗生素</td>
      <td>C.氨基苷类抗生素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>47. 红霉素等大环内酯类的抗菌作用机制是(2.0分)</td>
      <td>A.与细菌胞浆膜结合，破坏胞浆膜结构<br>B.破坏细胞壁使水分内渗<br>C.抑制DNA多聚酶，影响DNA的合成<br>D.与转肽酶结合，阻止细胞壁粘肽合成<br>E.抑制菌体蛋白的合成</td>
      <td>E.抑制菌体蛋白的合成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2011</td>
      <td>48. 化学治疗药（化疗药）不包括(2.0分)</td>
      <td>A.抗寄生虫药物<br>B.抗糖尿病药物<br>C.抗菌药物<br>D.抗生素<br>E.抗病毒药</td>
      <td>B.抗糖尿病药物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>1. 下列淋巴细胞中，不属于固有免疫细胞的是：(2.5分)</td>
      <td>A.gdT细胞<br>B.abT细胞<br>C.NK T细胞<br>D.NK细胞<br>E.B1细胞</td>
      <td>B.abT细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>2. 固有免疫细胞所不具备的免疫应答特点是：(2.5分)</td>
      <td>A.直接识别病原体某些共有配体分子<br>B.识别相应配体后，立即产生免疫应答<br>C.经克隆扩增和分化后，产生免疫应答<br>D.通常没有免疫记忆功能，不能引起再次应答<br>E.免疫应答维持时间较短</td>
      <td>C.经克隆扩增和分化后，产生免疫应答</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>3. 模式识别受体可识别：(2.5分)</td>
      <td>A.细菌表面的甘露糖残基<br>B.肿瘤相关抗原<br>C.肿瘤特异性抗原<br>D.MHC I类分子<br>E.MHC II类分子</td>
      <td>A.细菌表面的甘露糖残基</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>4. Toll样受体中能与病毒单链RNA结合的是：(2.5分)</td>
      <td>A.TLR2<br>B.TLR3<br>C.TLR5<br>D.TLR8<br>E.TLR9</td>
      <td>D.TLR8</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>5. 不具吞噬功能，可通过ADCC效应杀伤肿瘤细胞的固有免疫细胞是：(2.5分)</td>
      <td>A.巨噬细胞<br>B. T细胞<br>C.NK细胞<br>D.NKT细胞<br>E. T细胞</td>
      <td>C.NK细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>6. NK细胞表面能够识别HLA I类分子的杀伤抑制性受体是:(2.5分)</td>
      <td>A.KIR2DL<br>B.KIR3DS<br>C.CD94/NKG2C<br>D.NKG2D<br>E.NKp30</td>
      <td>A.KIR2DL</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>7. 具有趋化中性粒细胞作用的补体成分是：(2.5分)</td>
      <td>A.C4b<br>B.C5b<br>C.C5a<br>D.C1<br>E.C2a</td>
      <td>C.C5a</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>8. 某孕妇为Rh-，第一胎分娩Rh+ 胎儿，为防止再次妊娠的Rh+ 胎儿产生溶血症，应给Rh-母亲注射:(2.5分)</td>
      <td>A.抗Rh抗体<br>B.Rh抗原<br>C.免疫抑制剂<br>D.免疫增强剂<br>E.以上都不是</td>
      <td>A.抗Rh抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>9. 体液中的补体抑制因子是:(2.5分)</td>
      <td>A.C1q<br>B.IgG1<br>C.IL-2<br>D.H因子<br>E.B因子</td>
      <td>D.H因子</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>10. 下列哪种成分无酶活性:(2.5分)</td>
      <td>A.C1s<br>B.C1r<br>C.P因子<br>D.D因子<br>E.I因子</td>
      <td>E.I因子</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>11. 参与溶菌作用的补体成分是:(2.5分)</td>
      <td>A.C3<br>B.C42<br>C.C1<br>D.C56789<br>E.C423</td>
      <td>D.C56789</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>12. 初次注入大量抗毒素的马血清所引起血清病的发病机理属于:(2.5分)</td>
      <td>A.Ⅰ型变态反应<br>B.Ⅱ型变态反应<br>C.Ⅲ型变态反应<br>D.Ⅳ型变态反应<br>E.Ⅴ型变态反应</td>
      <td>C.Ⅲ型变态反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>13. Ⅲ型超敏反应重要病理学特征是:(2.5分)</td>
      <td>A.红细胞浸润<br>B.巨噬细胞浸润<br>C.淋巴细胞浸润<br>D.嗜酸性粒细胞浸润<br>E.中性粒细胞浸润</td>
      <td>E.中性粒细胞浸润</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>14. 与类风湿因子有关的最主要的Ig是:(2.5分)</td>
      <td>A.IgG<br>B.IgA<br>C.IgM<br>D.IgD<br>E.IgE</td>
      <td>C.IgM</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>15. 下列哪一类细胞产生IgE：(2.5分)</td>
      <td>A.T淋巴细胞<br>B.B淋巴细胞<br>C.巨噬细胞<br>D.肥大细胞<br>E.嗜碱粒细胞</td>
      <td>B.B淋巴细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>16. 介导I型超敏反应的主要细胞类型:(2.5分)</td>
      <td>A.T淋巴细胞<br>B.NK细胞<br>C.巨噬细胞<br>D.肥大细胞<br>E.树突状细胞</td>
      <td>D.肥大细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>17. DTH皮肤试验阳性与下列物质有关:(2.5分)</td>
      <td>A.抗体、补体和CK<br>B.抗原、抗原致敏的T淋巴细胞和巨噬细胞<br>C.抗原抗体复合物、补体和中性粒细胞<br>D.IgG抗体、抗原和肥大细胞<br>E.抗原、巨噬细胞和补体</td>
      <td>B.抗原、抗原致敏的T淋巴细胞和巨噬细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>18. 不属于I型超敏反应的疾病是:(2.5分)</td>
      <td>A.荨麻疹<br>B.支气管哮喘<br>C.血清过敏性休克<br>D.过敏性鼻炎<br>E.链球菌感染后的肾小球肾炎</td>
      <td>E.链球菌感染后的肾小球肾炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>19. 当IgE结合于肥大细胞表面的FcεR后，下列哪些因素可使肥大细胞脱颗粒:(2.5分)</td>
      <td>A.变应原再次进入<br>B.抗IgE的IgG Fab段<br>C.抗IgE的IgG Fc段<br>D.IgM<br>E.IgA</td>
      <td>A.变应原再次进入</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>20. 迟发型超敏反应主要是由下列因素介导:(2.5分)</td>
      <td>A.IgE 结合到肥大细胞上<br>B.IgG 和IgM结合到组织抗原上<br>C.免疫复合物沉积在基底膜<br>D.CD4+ 和CD8+ T细胞<br>E.浆细胞</td>
      <td>D.CD4+ 和CD8+ T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>21. 关于免疫应答的调节，下列哪项是错误的？(2.5分)</td>
      <td>A.免疫应答不受遗传基因的制约<br>B.免疫调节的机制决定了免疫应答的发生及应答的强弱<br>C.免疫应答的调节可分为基因、细胞和分子三种水平的调节<br>D.神经-内分泌免疫网络参与免疫应答的调节<br>E.免疫调节机制失控或异常可导致免疫疾病的发生</td>
      <td>A.免疫应答不受遗传基因的制约</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>22. 关于AICD，下列哪项是错误的？(2.5分)</td>
      <td>A.AICD是指FAS启动的效应细胞的凋亡<br>B.AICD参与CTL等细胞对靶细胞的杀伤<br>C.AICD在免疫调节中主要起正反馈作用<br>D.AICD能够抑制受到抗原活化并发生克窿扩增的T淋巴细胞<br>E.AICD可以使特异性的细胞免疫和体液免疫应答同时受到下调</td>
      <td>C.AICD在免疫调节中主要起正反馈作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>23. 以下哪些细胞因子可增强NK细胞的活性? (2.5分)</td>
      <td>A. IL-2、IL-8<br>B.IL-2、IFN-γ、IL-12<br>C.IL-2、IL-4<br>D.IL-10、IFN-γ<br>E.IL-3、IL-4</td>
      <td>B.IL-2、IFN-γ、IL-12</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>24. 下列哪个补体调节分子缺陷可导致血管神经性水肿?(2.5分)</td>
      <td>A.C1INH<br>B.C4BP<br>C.I因子<br>D.C3b<br>E.CD59</td>
      <td>A.C1INH</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>25. 沉淀反应中，形成肉眼可见的沉淀线或沉淀物的条件不包括:(2.5分)</td>
      <td>A.抗原抗体比例合适<br>B.适量电解质存在<br>C.抗体过剩<br>D.抗原抗体的量足够多</td>
      <td>C.抗体过剩</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>26. 单向琼脂扩散可用于:(2.5分)</td>
      <td>A.定性检测<br>B.定量检测<br>C.检测抗原抗体纯度<br>D.快速诊断</td>
      <td>B.定量检测</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>27. 对流免疫电泳，正确的是:(2.5分)</td>
      <td>A.与双向琼脂扩散相比，更不敏感<br>B.与双向琼脂扩散相比，试验时间更长<br>C.在一对抗原抗体孔中，抗体通常置于靠近阳极的孔，抗原置于靠近阴极的孔<br>D.在一对抗原抗体孔中，抗体通常置于靠近阴极的孔，抗原置于靠近阳极的孔</td>
      <td>C.在一对抗原抗体孔中，抗体通常置于靠近阳极的孔，抗原置于靠近阴极的孔</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>28. 下列哪项组合绵羊红细胞最有可能出现溶血现象:(2.5分)</td>
      <td>A.绵羊红细胞，溶血素<br>B.绵羊红细胞，补体<br>C.绵羊红细胞，溶血素，补体<br>D.绵羊红细胞，豚鼠血清</td>
      <td>C.绵羊红细胞，溶血素，补体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>29. 免疫标记技术常用标记物不包括:(2.5分)</td>
      <td>A.荧光素<br>B.酶<br>C.放射性同位素<br>D.绵羊红细胞</td>
      <td>D.绵羊红细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>30. ELISA双抗体夹心法的设计是用于检测:(2.5分)</td>
      <td>A.抗体<br>B.抗原<br>C.抗原或抗体<br>D.底物</td>
      <td>B.抗原</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>31. （采用淋巴细胞分离液进行的）密度梯度离心法分离得到的细胞是:(2.5分)</td>
      <td>A.外周血单个核细胞（PBMC）<br>B.淋巴细胞和中性粒<br>C.只有淋巴细胞<br>D.血小板</td>
      <td>A.外周血单个核细胞（PBMC）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>32. 淋巴细胞转化试验（形态学检查法）中，不计入转化的淋巴细胞的是:(2.5分)</td>
      <td>A.淋巴母细胞<br>B.过渡型淋巴细胞<br>C.小淋巴细胞<br>D.核分裂相细胞</td>
      <td>C.小淋巴细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>33. Which of the following is not a quality of an effective vaccine?(2.5分)</td>
      <td>A.It should require periodic boosters to maintains its effectiveness.<br>B.It should stimulate the production of memory cells.<br>C.It should stimulate both a humoral and cell-mediated immune response.<br>D.It should protect against the natural form of the pathogen.<br>E.It should be easy to administer.</td>
      <td>A.It should require periodic boosters to maintains its effectiveness.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>34. A small protein subunit used in a vaccine may fail to stimulate T-cell immunity because of:(2.5分)</td>
      <td>A.Lack of glycosylation<br>B.Lack of conformation<br>C.Lack of carrier determinants<br>D.HLA-related unresponsiveness<br>E.Inherently insufficient antigen concentration</td>
      <td>C.Lack of carrier determinants</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>35. Artificially acquired passive immunity could be the result of _____ injection. (2.5分)</td>
      <td>A.antigen<br>B.toxoid<br>C.gamma globulin<br>D.cortisone</td>
      <td>C.gamma globulin</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>36. A new employee in the SPCA was bitten by a rabid dog. The worker was brought to the Emergency Department even though he had been inoculated for tetanus, only three days before he was bitten. The attending physician ordered treatment with anti-rabies immune human globulin. Which one of the following describes the type of immunization the patient received in the emergency unit?(2.5分)</td>
      <td>A.Active natural immunity.<br>B.Active artificial immunity.<br>C.Passive natural immunity.<br>D.Passive artifical immunity.<br>E.None of the above.</td>
      <td>A.Active natural immunity.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>37. 治疗肾移植排斥反应的药物不包括:(2.5分)</td>
      <td>A.mycophenolate mofetil（霉酚酸酯）<br>B.methylprednisolone (甲泼尼松龙)<br>C.cyclosporine (CsA, 环孢素)<br>D.levamisole (左旋咪唑 )<br>E.tacrolimus (FK506, 他克莫司)</td>
      <td>D.levamisole (左旋咪唑 )</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>38. 免疫缺陷综合征（immunodeficient diseases）不应使用:(2.5分)</td>
      <td>A.胸腺素<br>B.白介素-2（IL-2）<br>C.干扰素<br>D.环孢素<br>E.异丙肌苷</td>
      <td>D.环孢素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>39. 抗菌药物是:(2.5分)</td>
      <td>A.对病原菌有杀灭作用的药物<br>B.对病原菌有抑制作用的药物<br>C.对病原菌有杀灭或抑制作用的药物<br>D.能用于预防细菌性感染的药物<br>E.能治疗细菌性感染的药物</td>
      <td>C.对病原菌有杀灭或抑制作用的药物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2012</td>
      <td>40. 最低抑菌浓度（MIC）是指:(2.5分)</td>
      <td>A.杀灭细菌50%所需的浓度<br>B.抑制细菌生长50%所需的浓度<br>C.抑制细菌生长90%所需的浓度<br>D.杀灭细菌所需的最低浓度</td>
      <td>D.杀灭细菌所需的最低浓度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>1. 下列淋巴细胞中，不属于固有免疫细胞的是：(2.5分)</td>
      <td>A.T细胞<br>B.T细胞<br>C.NK T细胞<br>D.NK细胞<br>E.B1细胞</td>
      <td>B.T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>2. 固有免疫分子不包括：(2.5分)</td>
      <td>A.防御素<br>B.补体系统<br>C.细胞因子<br>D.溶菌酶<br>E.抗毒素</td>
      <td>E.抗毒素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>3. 模式识别受体可识别：(2.5分)</td>
      <td>A.细菌表面的甘露糖残基<br>B.肿瘤相关抗原<br>C.肿瘤特异性抗原<br>D.MHC I类分子<br>E.MHC II类分子</td>
      <td>A.细菌表面的甘露糖残基</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>4. Toll样受体中能与病毒单链RNA结合的是：(2.5分)</td>
      <td>A.TLR2<br>B.TLR3<br>C.TLR5<br>D.TLR8<br>E.TLR9</td>
      <td>D.TLR8</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>5. 不具吞噬功能，可通过ADCC效应杀伤肿瘤细胞的固有免疫细胞是：(2.5分)</td>
      <td>A.巨噬细胞<br>B.T细胞<br>C.NK细胞<br>D.NKT细胞<br>E.T细胞</td>
      <td>C.NK细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>6. NK细胞表面能够识别HLA I类分子的杀伤抑制性受体是:(2.5分)</td>
      <td>A.KIR2DL<br>B.KIR3DS<br>C.CD94/NKG2C<br>D.NKG2D<br>E.NKp30</td>
      <td>A.KIR2DL</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>7. 具有趋化中性粒细胞作用的补体成分是：(2.5分)</td>
      <td>A.C4b<br>B.C5b<br>C.C5a<br>D.C1<br>E.C2a</td>
      <td>C.C5a</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>8. 某孕妇为Rh-，第一胎分娩Rh+ 胎儿，为防止再次妊娠的Rh+ 胎儿产生溶血症，应给Rh-母亲注射:(2.5分)</td>
      <td>A.抗Rh抗体<br>B.Rh抗原<br>C.免疫抑制剂<br>D.免疫增强剂<br>E.以上都不是</td>
      <td>A.抗Rh抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>9. 补体经典激活途径中各成分的激活顺序为:(2.5分)</td>
      <td>A.C123456789<br>B.C124536789<br>C.C145236789<br>D.C124356789<br>E.C142356789</td>
      <td>E.C142356789</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>10. 下列哪种成分无酶活性:(2.5分)</td>
      <td>A.C1s<br>B.C1r<br>C.P因子<br>D.D因子<br>E.I因子</td>
      <td>E.I因子</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>11. 血管神经性水肿主要由于下列哪个成分缺陷所引起:(2.5分)</td>
      <td>A.H因子<br>B.I因子<br>C.C1INH<br>D.S蛋白<br>E.C4bp</td>
      <td>C.C1INH</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>12. 初次注入大量抗毒素的马血清所引起血清病的发病机理属于:(2.5分)</td>
      <td>A.Ⅰ型变态反应<br>B.Ⅱ型变态反应<br>C.Ⅲ型变态反应<br>D.Ⅳ型变态反应<br>E.Ⅴ型变态反应</td>
      <td>C.Ⅲ型变态反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>13. Ⅲ型超敏反应重要病理学特征是:(2.5分)</td>
      <td>A.红细胞浸润<br>B.巨噬细胞浸润<br>C.淋巴细胞浸润<br>D.嗜酸性粒细胞浸润<br>E.中性粒细胞浸润</td>
      <td>E.中性粒细胞浸润</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>14. 与输血反应有关的是： (2.5分)</td>
      <td>A.Ⅰ型超敏反应<br>B.Ⅱ型超敏反应<br>C.Ⅲ型超敏反应<br>D.Ⅳ型超敏反应<br>E.都不是</td>
      <td>B.Ⅱ型超敏反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>15. 下列哪一类细胞产生IgE：(2.5分)</td>
      <td>A.T淋巴细胞<br>B.B淋巴细胞<br>C.巨噬细胞<br>D.肥大细胞<br>E.嗜碱粒细胞</td>
      <td>B.B淋巴细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>16. 介导I型超敏反应的主要细胞类型:(2.5分)</td>
      <td>A.T淋巴细胞<br>B.NK细胞<br>C.巨噬细胞<br>D.肥大细胞<br>E.树突状细胞</td>
      <td>D.肥大细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>17. DTH皮肤试验阳性与下列物质有关:(2.5分)</td>
      <td>A.抗体、补体和CK<br>B.抗原、抗原致敏的T淋巴细胞和巨噬细胞<br>C.抗原抗体复合物、补体和中性粒细胞<br>D.IgG抗体、抗原和肥大细胞<br>E.抗原、巨噬细胞和补体</td>
      <td>B.抗原、抗原致敏的T淋巴细胞和巨噬细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>18. 不属于I型超敏反应的疾病是:(2.5分)</td>
      <td>A.荨麻疹<br>B.支气管哮喘<br>C.血清过敏性休克<br>D.过敏性鼻炎<br>E.链球菌感染后的肾小球肾炎</td>
      <td>E.链球菌感染后的肾小球肾炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>19. 当IgE结合于肥大细胞表面的FcεR后，下列哪些因素可使肥大细胞脱颗粒:(2.5分)</td>
      <td>A.变应原再次进入<br>B.抗IgE的IgG Fab段<br>C.抗IgE的IgG Fc段<br>D.IgM<br>E.IgA</td>
      <td>A.变应原再次进入</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>20. 迟发型超敏反应主要是由下列因素介导:(2.5分)</td>
      <td>A.IgE 结合到肥大细胞上<br>B.IgG 和IgM结合到组织抗原上<br>C.免疫复合物沉积在基底膜<br>D.CD4+ 和CD8+ T细胞<br>E.浆细胞</td>
      <td>D.CD4+ 和CD8+ T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>21. 关于免疫应答的调节，下列哪项是错误的？(2.5分)</td>
      <td>A.免疫应答不受遗传基因的制约<br>B.免疫调节的机制决定了免疫应答的发生及应答的强弱<br>C.免疫应答的调节可分为基因、细胞和分子三种水平的调节<br>D.神经-内分泌免疫网络参与免疫应答的调节<br>E.免疫调节机制失控或异常可导致免疫疾病的发生</td>
      <td>A.免疫应答不受遗传基因的制约</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>22. 影响抗原抗体反应的因素有:(2.5分)</td>
      <td>A.电解质、pH值和反应体积<br>B.温度、pH值和反应体积<br>C.温度、电解质和反应体积<br>D.抗原抗体比例、电解质、pH值和温度<br>E.温度、电解质、pH值和反应体积</td>
      <td>D.抗原抗体比例、电解质、pH值和温度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>23. 以下哪些细胞因子可增强NK细胞的活性? (2.5分)</td>
      <td>A.IL-2、IL-8<br>B.IL-2、IFN-γ、IL-12<br>C.IL-2、IL-4<br>D.IL-10、IFN-γ<br>E.IL-3、IL-4</td>
      <td>B.IL-2、IFN-γ、IL-12</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>24. 预防新生儿发生破伤风的最佳方法是?(2.5分)</td>
      <td>A.给新生儿注射破伤风抗毒素<br>B.给新生儿注射破伤风类毒素<br>C.给新生儿注射破伤风抗毒素和类毒素<br>D.怀孕早期给母亲注射破伤风类毒素进行免疫<br>E.分娩前给母亲注射破伤风类毒素</td>
      <td>E.分娩前给母亲注射破伤风类毒素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>25. 沉淀反应和凝集反应共同之处在于:(2.5分)</td>
      <td>A.参与抗原均为可溶性抗原<br>B.参与抗原均为颗粒性抗原<br>C.均可在半固体凝胶中进行<br>D.形成肉眼可见的抗原抗体复合物</td>
      <td>D.形成肉眼可见的抗原抗体复合物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>26. 单向琼脂扩散可用于:(2.5分)</td>
      <td>A.定性检测<br>B.定量检测<br>C.检测抗原抗体纯度<br>D.快速诊断</td>
      <td>B.定量检测</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>27. 对流免疫电泳，正确的是:(2.5分)</td>
      <td>A.与双向琼脂扩散相比，更不敏感<br>B.与双向琼脂扩散相比，试验时间更长<br>C.在一对抗原抗体孔中，抗体通常置于靠近阳极的孔，抗原置于靠近阴极的孔<br>D.在一对抗原抗体孔中，抗体通常置于靠近阴极的孔，抗原置于靠近阳极的孔</td>
      <td>C.在一对抗原抗体孔中，抗体通常置于靠近阳极的孔，抗原置于靠近阴极的孔</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>28. 对流免疫电泳的注意事项，不正确的是: (2.5分)</td>
      <td>A.琼脂浓度要高，以大于3%为宜<br>B.电泳时电流不宜过大，以免蛋白变性<br>C.抗原抗体电极方向不能搞错<br>D.抗原抗体浓度要适当，抗原太浓或太稀都不易出现沉淀线</td>
      <td>A.琼脂浓度要高，以大于3%为宜</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>29. 免疫标记技术常用标记物不包括:(2.5分)</td>
      <td>A.荧光素<br>B.酶<br>C.放射性同位素<br>D.绵羊红细胞</td>
      <td>D.绵羊红细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>30. 关于ELISA中的封闭步骤，正确的是:(2.5分)</td>
      <td>A.封闭是用无关蛋白封闭非特异性位点<br>B.无论何种情况下封闭均必不可少<br>C.即使封闭不当，也不可能使阴性本底增高<br>D.封闭后无需洗板就可加待检标本</td>
      <td>A.封闭是用无关蛋白封闭非特异性位点</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>31. （采用淋巴细胞分离液进行的）密度梯度离心法分离得到的细胞是:(2.5分)</td>
      <td>A.外周血单个核细胞（PBMC）<br>B.淋巴细胞和中性粒<br>C.只有淋巴细胞<br>D.血小板</td>
      <td>A.外周血单个核细胞（PBMC）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>32. 淋巴细胞转化试验（形态学检查法）中，典型淋巴母细胞的特征不包括:(2.5分)</td>
      <td>A.体积明显增大<br>B.可见1~4个明显核仁<br>C.胞浆嗜碱性，有伪足样突出<br>D.可见成堆或散在的染色体</td>
      <td>D.可见成堆或散在的染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>33. E玫瑰花环试验中，形成花环的细胞通常是:(2.5分)</td>
      <td>A.T细胞<br>B.B细胞<br>C.中性粒细胞<br>D.巨噬细胞</td>
      <td>A.T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>34. 患传染病后获得的免疫: (2.5分)</td>
      <td>A.自然免疫<br>B.人工自动免疫<br>C.自然自动免疫<br>D.自然被动免疫<br>E.人工被动免疫</td>
      <td>C.自然自动免疫</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>35. Which of the following description is not true about innate immunity: (2.5分)</td>
      <td>A.It provides the early line of defense against microbes.<br>B.It consists of cellular and biochemical defense mechanisms that are in place even before infection and are poised to respond rapidly to infections.<br>C.The components of innate immunity include physical and chemical barriers<br>D.Cytokines regulate and coordinate many of the activities of the cells of innate immunity.<br>E.The mechanisms of innate immunity can specifically distinguish fine differences between microbes.</td>
      <td>E.The mechanisms of innate immunity can specifically distinguish fine differences between microbes.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>36. Which of the following is not the adverse effect of cyclosporine: (2.5分)</td>
      <td>A.nephrotoxicity<br>B.neurotoxicity<br>C.hirsutism<br>D.hyperglycemia</td>
      <td>D.hyperglycemia</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>37. Which one belongs to macrolides(2.5分)</td>
      <td>A.Vancomycin<br>B.Carbenicillin<br>C.Erythromycin<br>D.Amikacin</td>
      <td>C.Erythromycin</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>38. The most serious adverse reaction for Penicillin G is (2.5分)</td>
      <td>A.ototoxicity<br>B.nephrotoxicity<br>C.hepatic toxicity<br>D.anaphylactic shock</td>
      <td>D.anaphylactic shock</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>39. 影响细菌蛋白质合成的药物是：(2.5分)</td>
      <td>A.阿莫西林<br>B.红霉素<br>C.多粘霉素<br>D.氨苄西林</td>
      <td>B.红霉素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2013</td>
      <td>40. Immunosuppressive drugs can be used to treat: (2.5分)</td>
      <td>A.Serious infection and rejection after organ transplantation<br>B.Autoimmune disorders and rejection after organ transplantation<br>C.Allergic disease and AIDS<br>D.Serious infection and cancer</td>
      <td>B.Autoimmune disorders and rejection after organ transplantation</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>1. Which of the following description is not true about innate immunity: (2.5分)</td>
      <td>A.It provides the early line of defense against microbes.<br>B.It consists of cellular and biochemical defense mechanisms that are in place even before infection and are poised to respond rapidly to infections.<br>C.The components of innate immunity include physical and chemical barriers<br>D.Cytokines regulate and coordinate many of the activities of the cells of innate immunity.<br>E.The mechanisms of innate immunity can specifically distinguish fine differences between microbes.</td>
      <td>E.The mechanisms of innate immunity can specifically distinguish fine differences between microbes.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>2. 固有免疫分子不包括：(2.5分)</td>
      <td>A.防御素<br>B.补体系统<br>C.细胞因子<br>D.溶菌酶<br>E.抗毒素</td>
      <td>E.抗毒素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>3. 模式识别受体可识别：(2.5分)</td>
      <td>A.细菌表面的甘露糖残基<br>B.肿瘤相关抗原<br>C.肿瘤特异性抗原<br>D.MHC I类分子<br>E.MHC II类分子</td>
      <td>A.细菌表面的甘露糖残基</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>4. Toll样受体中能与病毒单链RNA结合的是：(2.5分)</td>
      <td>A.TLR2<br>B.TLR3<br>C.TLR5<br>D.TLR8<br>E.TLR9</td>
      <td>D.TLR8</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>5. 不具吞噬功能，可通过ADCC效应杀伤肿瘤细胞的固有免疫细胞是：(2.5分)</td>
      <td>A.巨噬细胞<br>B.T细胞<br>C.NK细胞<br>D.NKT细胞<br>E.T细胞</td>
      <td>C.NK细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>6. NK细胞表面能够识别HLA I类分子的杀伤抑制性受体是:(2.5分)</td>
      <td>A.KIR2DL<br>B.KIR3DS<br>C.CD94/NKG2C<br>D.NKG2D<br>E.NKp30</td>
      <td>A.KIR2DL</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>7. 具有趋化中性粒细胞作用的补体成分是：(2.5分)</td>
      <td>A.C4b<br>B.C5b<br>C.C5a<br>D.C1<br>E.C2a</td>
      <td>C.C5a</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>8. 某孕妇为Rh-，第一胎分娩Rh+ 胎儿，为防止再次妊娠的Rh+ 胎儿产生溶血症，应给Rh-母亲注射:(2.5分)</td>
      <td>A.抗Rh抗体<br>B.Rh抗原<br>C.免疫抑制剂<br>D.免疫增强剂<br>E.以上都不是</td>
      <td>A.抗Rh抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>9. 补体经典激活途径中各成分的激活顺序为:(2.5分)</td>
      <td>A.C123456789<br>B.C124536789<br>C.C145236789<br>D.C124356789<br>E.C142356789</td>
      <td>E.C142356789</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>10. 下列哪种成分无酶活性:(2.5分)</td>
      <td>A.C1s<br>B.C1r<br>C.P因子<br>D.D因子<br>E.I因子</td>
      <td>E.I因子</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>11. 血管神经性水肿主要由于下列哪个成分缺陷所引起:(2.5分)</td>
      <td>A.H因子<br>B.I因子<br>C.C1INH<br>D.S蛋白<br>E.C4bp</td>
      <td>C.C1INH</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>12. 初次注入大量抗毒素的马血清所引起血清病的发病机理属于:(2.5分)</td>
      <td>A.Ⅰ型变态反应<br>B.Ⅱ型变态反应<br>C.Ⅲ型变态反应<br>D.Ⅳ型变态反应<br>E.Ⅴ型变态反应</td>
      <td>C.Ⅲ型变态反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>13. Ⅲ型超敏反应重要病理学特征是:(2.5分)</td>
      <td>A.红细胞浸润<br>B.巨噬细胞浸润<br>C.淋巴细胞浸润<br>D.嗜酸性粒细胞浸润<br>E.中性粒细胞浸润</td>
      <td>E.中性粒细胞浸润</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>14. 与输血反应有关的是： (2.5分)</td>
      <td>A.Ⅰ型超敏反应<br>B.Ⅱ型超敏反应<br>C.Ⅲ型超敏反应<br>D.Ⅳ型超敏反应<br>E.都不是</td>
      <td>B.Ⅱ型超敏反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>15. 下列哪一类细胞产生IgE：(2.5分)</td>
      <td>A.T淋巴细胞<br>B.B淋巴细胞<br>C.巨噬细胞<br>D.肥大细胞<br>E.嗜碱粒细胞</td>
      <td>B.B淋巴细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>16. 介导I型超敏反应的主要细胞类型:(2.5分)</td>
      <td>A.T淋巴细胞<br>B.NK细胞<br>C.巨噬细胞<br>D.肥大细胞<br>E.树突状细胞</td>
      <td>D.肥大细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>17. DTH皮肤试验阳性与下列物质有关:(2.5分)</td>
      <td>A.抗体、补体和CK<br>B.抗原、抗原致敏的T淋巴细胞和巨噬细胞<br>C.抗原抗体复合物、补体和中性粒细胞<br>D.IgG抗体、抗原和肥大细胞<br>E.抗原、巨噬细胞和补体</td>
      <td>B.抗原、抗原致敏的T淋巴细胞和巨噬细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>18. 不属于I型超敏反应的疾病是:(2.5分)</td>
      <td>A.荨麻疹<br>B.支气管哮喘<br>C.血清过敏性休克<br>D.过敏性鼻炎<br>E.链球菌感染后的肾小球肾炎</td>
      <td>E.链球菌感染后的肾小球肾炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>19. 当IgE结合于肥大细胞表面的FcεR后，下列哪些因素可使肥大细胞脱颗粒:(2.5分)</td>
      <td>A.变应原再次进入<br>B.抗IgE的IgG Fab段<br>C.抗IgE的IgG Fc段<br>D.IgM<br>E.IgA</td>
      <td>A.变应原再次进入</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>20. 迟发型超敏反应主要是由下列因素介导:(2.5分)</td>
      <td>A.IgE 结合到肥大细胞上<br>B.IgG 和IgM结合到组织抗原上<br>C.免疫复合物沉积在基底膜<br>D.CD4+ 和CD8+ T细胞<br>E.浆细胞</td>
      <td>D.CD4+ 和CD8+ T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>21. 关于免疫应答的调节，下列哪项是错误的？(2.5分)</td>
      <td>A.免疫应答不受遗传基因的制约<br>B.免疫调节的机制决定了免疫应答的发生及应答的强弱<br>C.免疫应答的调节可分为基因、细胞和分子三种水平的调节<br>D.神经-内分泌免疫网络参与免疫应答的调节<br>E.免疫调节机制失控或异常可导致免疫疾病的发生</td>
      <td>A.免疫应答不受遗传基因的制约</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>22. 影响抗原抗体反应的因素有:(2.5分)</td>
      <td>A.电解质、pH值和反应体积<br>B.温度、pH值和反应体积<br>C.温度、电解质和反应体积<br>D.抗原抗体比例、电解质、pH值和温度<br>E.温度、电解质、pH值和反应体积</td>
      <td>D.抗原抗体比例、电解质、pH值和温度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>23. 以下哪些细胞因子可增强NK细胞的活性? (2.5分)</td>
      <td>A.IL-2、IL-8<br>B.IL-2、IFN-γ、IL-12<br>C.IL-2、IL-4<br>D.IL-10、IFN-γ<br>E.IL-3、IL-4</td>
      <td>B.IL-2、IFN-γ、IL-12</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>24. 预防新生儿发生破伤风的最佳方法是?(2.5分)</td>
      <td>A.给新生儿注射破伤风抗毒素<br>B.给新生儿注射破伤风类毒素<br>C.给新生儿注射破伤风抗毒素和类毒素<br>D.怀孕早期给母亲注射破伤风类毒素进行免疫<br>E.分娩前给母亲注射破伤风类毒素</td>
      <td>E.分娩前给母亲注射破伤风类毒素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>25. 沉淀反应和凝集反应共同之处在于:(2.5分)</td>
      <td>A.参与抗原均为可溶性抗原<br>B.参与抗原均为颗粒性抗原<br>C.均可在半固体凝胶中进行<br>D.形成肉眼可见的抗原抗体复合物</td>
      <td>D.形成肉眼可见的抗原抗体复合物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>26. 单向琼脂扩散可用于:(2.5分)</td>
      <td>A.定性检测<br>B.定量检测<br>C.检测抗原抗体纯度<br>D.快速诊断</td>
      <td>B.定量检测</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>27. 对流免疫电泳，正确的是:(2.5分)</td>
      <td>A.与双向琼脂扩散相比，更不敏感<br>B.与双向琼脂扩散相比，试验时间更长<br>C.在一对抗原抗体孔中，抗体通常置于靠近阳极的孔，抗原置于靠近阴极的孔<br>D.在一对抗原抗体孔中，抗体通常置于靠近阴极的孔，抗原置于靠近阳极的孔</td>
      <td>C.在一对抗原抗体孔中，抗体通常置于靠近阳极的孔，抗原置于靠近阴极的孔</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>28. 对流免疫电泳的注意事项，不正确的是: (2.5分)</td>
      <td>A.琼脂浓度要高，以大于3%为宜<br>B.电泳时电流不宜过大，以免蛋白变性<br>C.抗原抗体电极方向不能搞错<br>D.抗原抗体浓度要适当，抗原太浓或太稀都不易出现沉淀线</td>
      <td>A.琼脂浓度要高，以大于3%为宜</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>29. 免疫标记技术常用标记物不包括:(2.5分)</td>
      <td>A.荧光素<br>B.酶<br>C.放射性同位素<br>D.绵羊红细胞</td>
      <td>D.绵羊红细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>30. 关于ELISA中的封闭步骤，正确的是:(2.5分)</td>
      <td>A.封闭是用无关蛋白封闭非特异性位点<br>B.无论何种情况下封闭均必不可少<br>C.即使封闭不当，也不可能使阴性本底增高<br>D.封闭后无需洗板就可加待检标本</td>
      <td>A.封闭是用无关蛋白封闭非特异性位点</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>31. （采用淋巴细胞分离液进行的）密度梯度离心法分离得到的细胞是:(2.5分)</td>
      <td>A.外周血单个核细胞（PBMC）<br>B.淋巴细胞和中性粒<br>C.只有淋巴细胞<br>D.血小板</td>
      <td>A.外周血单个核细胞（PBMC）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>32. 淋巴细胞转化试验（形态学检查法）中，典型淋巴母细胞的特征不包括:(2.5分)</td>
      <td>A.体积明显增大<br>B.可见1~4个明显核仁<br>C.胞浆嗜碱性，有伪足样突出<br>D.可见成堆或散在的染色体</td>
      <td>D.可见成堆或散在的染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>33. E玫瑰花环试验中，形成花环的细胞通常是:(2.5分)</td>
      <td>A.T细胞<br>B.B细胞<br>C.中性粒细胞<br>D.巨噬细胞</td>
      <td>A.T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>34. 与真菌细胞膜的类固醇结合，增加细胞膜通透性，导致真菌死亡的药物是：(2.5分)</td>
      <td>A.氟康唑<br>B.克霉唑<br>C.两性霉素B<br>D.多粘菌素E<br>E.灰黄霉素</td>
      <td>C.两性霉素B</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>35. Which of the following agents is considered a narrowspectrum antibiotic?(2.5分)</td>
      <td>A.Ceftriaxone.<br>B.Ciprofloxacin.<br>C.Isoniazid.<br>D.Imipenem.</td>
      <td>C.Isoniazid.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>36. 大环内酯类抗生素抗菌作用机制是：(2.5分)</td>
      <td>A.影响细菌细胞壁的合成<br>B.改变胞浆膜的通透性<br>C.抑制DNA合成<br>D.抑制70S始动复合物的形成<br>E.与核蛋白体50S亚基结合，抑制mRNA移位</td>
      <td>E.与核蛋白体50S亚基结合，抑制mRNA移位</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>37. 甲氧苄啶的抗菌作用机制是：(2.5分)</td>
      <td>A.抑制二氢叶酸还原酶<br>B.抑制二氢叶酸合成酶<br>C.抑制DNA回旋酶<br>D.抑制细胞壁黏肽合成<br>E.抑制细菌蛋白质合成的各个阶段</td>
      <td>A.抑制二氢叶酸还原酶</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>38. 下列属于环孢素的主要不良反应有：(2.5分)</td>
      <td>A.高血糖<br>B.荨麻疹<br>C.心律失常<br>D.肝肾损害<br>E.肌无力</td>
      <td>D.肝肾损害</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>39. 能特异性靶向IL-2受体的抗体药物是：(2.5分)</td>
      <td>A.巴利昔单抗<br>B.莫罗单抗<br>C.利妥昔单抗<br>D.英利昔单抗</td>
      <td>A.巴利昔单抗</td>
    </tr>
    <tr>
      <td>1</td>
      <td>7</td>
      <td>2014</td>
      <td>40. Which of the following drugs used to prevent allograft rejection can cause hyperlipidemia?(2.5分)</td>
      <td>A.Azathioprine.<br>B.Basiliximab.<br>C.Belatacept.<br>D.Mycophenolate mofetil.<br>E.Sirolimus</td>
      <td>E.Sirolimus</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>1. 哪个补体片段具有调理作用? (2.0分)</td>
      <td>A.C3b<br>B.C5a<br>C.C3a<br>D.C2a<br>E.C5b</td>
      <td>A.C3b</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>2. 具有趋化中性粒细胞作用的补体成分是(2.0分)</td>
      <td>A.C4b<br>B.C1<br>C.C5a<br>D.C5b<br>E.C2a</td>
      <td>C.C5a</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>3. 某孕妇为Rh-，第一胎分娩Rh+ 胎儿，为防止再次妊娠的Rh+ 胎儿产生溶血症，应给Rh-母亲注射(2.0分)</td>
      <td>A.免疫抑制剂<br>B.Rh抗原<br>C.抗Rh抗体<br>D.免疫增强剂<br>E.以上都不是</td>
      <td>C.抗Rh抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>4. 能够通过经典途径激活补体的是(2.0分)</td>
      <td>A.IgE<br>B.IgD<br>C.IgM<br>D.IgA</td>
      <td>C.IgM</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>5. 哪个是补体旁路途径的C3转化酶 (2.0分)</td>
      <td>A.C4b2a3b<br>B.C3bBb<br>C.C4b2a<br>D.C3bBb3b</td>
      <td>B.C3bBb</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>6. 体液中的补体抑制因子是(2.0分)</td>
      <td>A.H因子<br>B.IL-2<br>C.C1q<br>D.IgG1<br>E.B因子</td>
      <td>A.H因子</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>7. 补体经典激活途径中各成分的激活顺序为(2.0分)</td>
      <td>A.C145236789<br>B.C123456789<br>C.C124356789<br>D.C124536789<br>E.C142356789</td>
      <td>E.C142356789</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>8. 下列哪种成分无酶活性(2.0分)</td>
      <td>A.D因子<br>B.C1r<br>C.P因子<br>D.C1s<br>E.I因子</td>
      <td>E.I因子</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>9. 参与溶菌作用的补体成分是(2.0分)</td>
      <td>A.C56789<br>B.C42<br>C.C1<br>D.C3<br>E.C423</td>
      <td>A.C56789</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>10. 血管神经性水肿主要由于下列哪个成分缺陷所引起(2.0分)</td>
      <td>A.S蛋白<br>B.I因子<br>C.C1INH<br>D.H因子<br>E.C4bp</td>
      <td>C.C1INH</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>11. 药物过敏性血细胞减少症属于哪一型超敏反应？(2.0分)</td>
      <td>A.III型<br>B.II型<br>C.I型<br>D.IV型</td>
      <td>B.II型</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>12. IgE 抗体主要引起(2.0分)</td>
      <td>A.迟发型超敏反应<br>B.速发型超敏反应<br>C.细胞毒型超敏反应<br>D.血管炎型超敏反应<br>E.自身免疫性疾病</td>
      <td>B.速发型超敏反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>13. 初次注入大量抗毒素的马血清所引起血清病的发病机理属于(2.0分)</td>
      <td>A.Ⅱ型变态反应<br>B.Ⅳ型变态反应<br>C.Ⅰ型变态反应<br>D.Ⅲ型变态反应<br>E.Ⅴ型变态反应</td>
      <td>D.Ⅲ型变态反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>14. I型变态反应可通过下列哪种成分转移给正常人(2.0分)</td>
      <td>A.患者的致敏淋巴细胞<br>B.患者的血清<br>C.巨噬细胞释放的淋巴细胞激活因子<br>D.致敏淋巴细胞释放的转移因子<br>E.以上均不是</td>
      <td>B.患者的血清</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>15. Ⅲ型超敏反应重要病理学特征是(2.0分)</td>
      <td>A.巨噬细胞浸润<br>B.红细胞浸润<br>C.淋巴细胞浸润<br>D.嗜酸性粒细胞浸润<br>E.中性粒细胞浸润</td>
      <td>E.中性粒细胞浸润</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>16. 关于I型超敏反应，不正确的是： (2.0分)</td>
      <td>A.有IgE参与<br>B.有个体差异和遗传倾向<br>C.有补体直接参与<br>D.以生理功能紊乱为主</td>
      <td>C.有补体直接参与</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>17. 与输血反应有关的是： (2.0分)</td>
      <td>A.Ⅱ型超敏反应<br>B.Ⅰ型超敏反应<br>C.Ⅲ型超敏反应<br>D.Ⅳ型超敏反应</td>
      <td>A.Ⅱ型超敏反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>18. 与类风湿因子有关的最主要的Ig是(2.0分)</td>
      <td>A.IgG<br>B.IgD<br>C.IgM<br>D.IgA<br>E.IgE</td>
      <td>C.IgM</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>19. 下列哪一类细胞产生IgE (2.0分)</td>
      <td>A.巨噬细胞<br>B.T淋巴细胞<br>C.肥大细胞<br>D.B淋巴细胞<br>E.嗜碱粒细胞</td>
      <td>D.B淋巴细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>20. 在特异性变应原脱敏疗法中，诱导机体产生的封闭抗体的是(2.0分)</td>
      <td>A.IgM<br>B.IgG<br>C.IgD<br>D.IgE<br>E.IgA</td>
      <td>B.IgG</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>21. 介导I型超敏反应的主要细胞类型(2.0分)</td>
      <td>A.肥大细胞<br>B.T淋巴细胞<br>C.NK细胞<br>D.巨噬细胞<br>E.树突状细胞</td>
      <td>A.肥大细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>22. 超敏反应中不是由抗体直接参与的型别为(2.0分)</td>
      <td>A.II型<br>B.I型<br>C.III型<br>D.IV型</td>
      <td>D.IV型</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>23. 高亲和性的可结合到肥大细胞上的IgE分子部位是(2.0分)</td>
      <td>A.CH2功能区<br>B.H链恒定区<br>C.HVR区<br>D.Fab段<br>E.Fc段</td>
      <td>E.Fc段</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>24. DTH皮肤试验阳性与下列物质有关(2.0分)</td>
      <td>A.抗体、补体和CK<br>B.IgG抗体、抗原和肥大细胞<br>C.抗原抗体复合物、补体和中性粒细胞<br>D.抗原、抗原致敏的T淋巴细胞和巨噬细胞<br>E.抗原、巨噬细胞和补体</td>
      <td>D.抗原、抗原致敏的T淋巴细胞和巨噬细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>25. 关于IV 型超敏反应错误的是(2.0分)</td>
      <td>A.炎症区以单个核细胞浸润为主<br>B.反应速度慢<br>C.以IgG抗体介导为主<br>D.效应Tc细胞参与</td>
      <td>C.以IgG抗体介导为主</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>26. NK细胞在免疫调节中的作用体现在(2.0分)</td>
      <td>A.发挥靶细胞杀伤作用时受MHC限制<br>B.分泌IFN-γ增强Mφ功能<br>C.分泌IL-4和IL-6抑制T<br>D.分泌IL-3等细胞因子抑制血细胞发育<br>E.对异体骨髓移植排斥能力弱，但对异体实体</td>
      <td>B.分泌IFN-γ增强Mφ功能</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>27. AICD (2.0分)</td>
      <td>A.在免疫应答过程中只有细胞杀伤作用，而无免疫调节作用<br>B.对免疫应答的终止有调节作用<br>C.是一种程序性被动死亡<br>D.在免疫应答过程中只有免疫调节作用，而无细胞杀伤作用<br>E.主要通过淋巴细胞释放细胞毒颗粒实现的</td>
      <td>B.对免疫应答的终止有调节作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>28. 以下哪种不属于抑制性受体(2.0分)</td>
      <td>A.CD28<br>B.CTLA4<br>C.Fc R<br>D.PD-1<br>E.KIR</td>
      <td>A.CD28</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>29. 关于自然调节性T细胞的描述哪项是错误的(2.0分)</td>
      <td>A.高表达转录因子Foxp3<br>B.高表达CD25<br>C.以分泌细胞因子为主发挥抑制作<br>D.在胸腺诱导产生<br>E.具有抗原特异性</td>
      <td>C.以分泌细胞因子为主发挥抑制作</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>30. 除( )外以下分子均属于补体调节分子(2.0分)</td>
      <td>A.C1INH<br>B.C3b<br>C.I因子<br>D.C4BP<br>E.CD59</td>
      <td>B.C3b</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>31. 用于检测细胞免疫的免疫学技术是(2.0分)</td>
      <td>A.溶血空斑实验<br>B.对流免疫电泳<br>C.直接凝集反应<br>D.E玫瑰花环形成实验<br>E.协同凝集实验</td>
      <td>D.E玫瑰花环形成实验</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>32. 抗原-抗体反应的适宜酸碱度是(2.0分)</td>
      <td>A.pH=9<br>B.pH=2<br>C.pH=5<br>D.pH=10<br>E.pH=7</td>
      <td>E.pH=7</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>33. 双抗体夹心法检测血清中的甲胎蛋白（AFP），应选择的固相包被物是(2.0分)</td>
      <td>A.酶标记AFP<br>B.抗AFP抗体<br>C.酶标抗AFP抗体<br>D.纯化的AFP<br>E.同位素标记AFP抗体</td>
      <td>B.抗AFP抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>34. 凝集反应和沉淀反应的本质区别在于(2.0分)</td>
      <td>A.支持物不同<br>B.所用的溶液不同<br>C.检测的抗体不同<br>D.检测的抗原物理性质不同<br>E.需要的辅助试剂不同</td>
      <td>D.检测的抗原物理性质不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>35. 检测人类B细胞功能的实验是 (2.0分)</td>
      <td>A.E花环试验<br>B.肥达氏反应<br>C.溶血空斑试验<br>D.结核菌素试验<br>E.锡克试验</td>
      <td>C.溶血空斑试验</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>36. 患传染病后获得的免疫 (2.0分)</td>
      <td>A.自然被动免疫<br>B.人工自动免疫<br>C.自然自动免疫<br>D.自然免疫<br>E.人工被动免疫</td>
      <td>C.自然自动免疫</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>37. 预防乙肝病毒感染可采用的生物制品是(2.0分)</td>
      <td>A.类毒素<br>B.抗病毒血清<br>C.丙种球蛋白<br>D.抗毒素<br>E.乙肝病毒基因工程疫苗</td>
      <td>E.乙肝病毒基因工程疫苗</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>38. 下列不属于被动免疫治疗的是(2.0分)</td>
      <td>A.输注LAK细胞<br>B.输注活化的TIL细胞<br>C.注射IL-2<br>D.注射经射线照射致死的自身肿瘤细胞加BCG<br>E.注射IFN-α</td>
      <td>D.注射经射线照射致死的自身肿瘤细胞加BCG</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>39. 体外培育LAK细胞和TIL细胞常用的细胞因子是(2.0分)</td>
      <td>A.IL-1<br>B.IFN-γ<br>C.IL-2<br>D.TNF-α<br>E.GM-CSF</td>
      <td>C.IL-2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>40. 预防新生儿发生破伤风的最佳方法是(2.0分)</td>
      <td>A.给新生儿注射破伤风类毒素<br>B.怀孕早期给母亲注射破伤风类毒素进行免疫<br>C.给新生儿注射破伤风抗毒素<br>D.给新生儿注射破伤风抗毒素和类毒素<br>E.分娩前给母亲注射破伤风类毒素</td>
      <td>E.分娩前给母亲注射破伤风类毒素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>41. 不归入沉淀反应的是(2.0分)</td>
      <td>A.免疫电泳试验<br>B.琼脂扩散试验<br>C.环状沉淀试验<br>D.补体结合试验</td>
      <td>D.补体结合试验</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>42. 沉淀反应中，扩散试验与电泳结合，产生多种方法，不包括 (2.0分)</td>
      <td>A.交叉免疫电泳<br>B.对流免疫电泳<br>C.火箭免疫电泳<br>D.双向琼脂扩散</td>
      <td>D.双向琼脂扩散</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>43. 补体结合试验中的指示系统是(2.0分)</td>
      <td>A.凝集反应<br>B.溶血反应<br>C.沉淀反应<br>D.绵羊红细胞和待检抗体</td>
      <td>B.溶血反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>44. 关于ELISA中的封闭步骤，正确的是(2.0分)</td>
      <td>A.无论何种情况下封闭均必不可少<br>B.封闭是用无关蛋白封闭非特异性位点<br>C.即使封闭不当，也不可能使阴性本底增高<br>D.封闭后无需洗板就可加待检标本</td>
      <td>B.封闭是用无关蛋白封闭非特异性位点</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>45. 斑点免疫层析试验中，下列哪种结果是阴性结果(2.0分)</td>
      <td>A.出现两条红线，颜色深浅相近<br>B.出现一条红线（在参照区）<br>C.出现两条红线，颜色有深浅<br>D.没有红线出现</td>
      <td>B.出现一条红线（在参照区）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>46. 密度梯度离心法分离得到的细胞是(2.0分)</td>
      <td>A.只有淋巴细胞<br>B.淋巴细胞和中性粒<br>C.外周血单个核细胞（PMNC）<br>D.血小板</td>
      <td>C.外周血单个核细胞（PMNC）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>47. 在抗原抗体反应中，与可溶性抗原无关的是(2.0分)</td>
      <td>A.单扩<br>B.对流免疫电泳<br>C.反向间接凝集试验<br>D.直接凝集试验</td>
      <td>D.直接凝集试验</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>48. 如果沉淀反应体系中抗原抗体处于最适比例（即等价带），那么 (2.0分)</td>
      <td>A.总抗体结合价是抗原的二倍<br>B.在反应体系上清中只能检测到抗原<br>C.在反应体系上清中测不到抗原和抗体<br>D.抗原与抗体的浓度相同</td>
      <td>C.在反应体系上清中测不到抗原和抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>49. 下列方法中，哪项最敏感(2.0分)</td>
      <td>A.直接凝集试验<br>B.对流免疫电泳<br>C.双扩<br>D.单扩</td>
      <td>B.对流免疫电泳</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2007</td>
      <td>50. 用于检测细胞免疫的免疫学技术是(2.0分)</td>
      <td>A.E玫瑰花环形成实验<br>B.协同凝集实验<br>C.对流免疫电泳<br>D.直接凝集反应</td>
      <td>A.E玫瑰花环形成实验</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>1. 介导I型超敏反应的主要细胞类型(2.0分)</td>
      <td>A.NK细胞<br>B.T淋巴细胞<br>C.巨噬细胞<br>D.肥大细胞<br>E.树突状细胞</td>
      <td>D.肥大细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>2. 下列哪一类细胞产生IgE (2.0分)</td>
      <td>A.巨噬细胞<br>B.B淋巴细胞<br>C.T淋巴细胞<br>D.肥大细胞<br>E.嗜碱粒细胞</td>
      <td>B.B淋巴细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>3. 细胞自噬能引起细胞死亡的方式是(2.0分)</td>
      <td>A.Lysis<br>B.Programmed cell death<br>C.Necroptosis<br>D.Necrosis<br>E.yroptosis</td>
      <td>B.Programmed cell death</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>4. 与输血反应有关的是： (2.0分)</td>
      <td>A.Ⅱ型超敏反应<br>B.Ⅰ型超敏反应<br>C.Ⅲ型超敏反应<br>D.Ⅳ型超敏反应</td>
      <td>A.Ⅱ型超敏反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>5. 不归入沉淀反应的是(2.0分)</td>
      <td>A.环状沉淀试验<br>B.对流免疫电泳试验<br>C.琼脂扩散试验<br>D.补体结合试验</td>
      <td>D.补体结合试验</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>6. 沉淀反应中，扩散试验与电泳结合，产生多种方法，不包括(2.0分)</td>
      <td>A.火箭免疫电泳<br>B.交叉免疫电泳<br>C.对流免疫电泳<br>D.双向琼脂扩散</td>
      <td>D.双向琼脂扩散</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>7. 下列药物中，化疗指数最大的是(2.0分)</td>
      <td>A.LD50＝100 mg，ED50 50 mg<br>B.LD50＝50 mg，ED50＝100 mg<br>C.LD50＝500 mg，ED50 = 250 mg<br>D.LD50＝50 mg，ED50＝10 mg<br>E.LD50＝100 mg，ED50＝25 mg</td>
      <td>D.LD50＝50 mg，ED50＝10 mg</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>8. 淋巴细胞转化试验（形态学检查法）中，不计入转化的淋巴细胞的是(2.0分)</td>
      <td>A.小淋巴细胞<br>B.过渡型淋巴细胞<br>C.淋巴母细胞<br>D.核分裂相细胞</td>
      <td>A.小淋巴细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>9. 分子伴侣介导的自噬是 (2.0分)</td>
      <td>A.细胞外的异物蛋白被吞噬后，与溶酶体融合后被消化<br>B.由内质网来源的膜包绕待降解物形成自噬体，然后与溶酶体融合并降解其内容物;<br>C.溶酶体的膜直接包裹长寿命蛋白等，并在溶酶体内降解<br>D.胞质内蛋白结合到分子伴侣后被转运到溶酶体腔中，然后被溶酶体酶消化<br>E.内体与溶酶体的融合过程</td>
      <td>D.胞质内蛋白结合到分子伴侣后被转运到溶酶体腔中，然后被溶酶体酶消化</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>10. 化疗指数(CI)是指 (2.0分)</td>
      <td>A.ED95/LD5<br>B.LD95/ED5<br>C.LD50/ED50<br>D.ED50/LD50<br>E.LD50＝ED50</td>
      <td>C.LD50/ED50</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>11. I型变态反应可通过下列哪种成分转移给正常人(2.0分)</td>
      <td>A.患者的致敏淋巴细胞<br>B.巨噬细胞释放的淋巴细胞激活因子<br>C.致敏淋巴细胞释放的转移因子<br>D.患者的血清<br>E.以上均不是</td>
      <td>D.患者的血清</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>12. 关于免疫细胞调节作用的正确叙述是(2.0分)</td>
      <td>A.Th1细胞辅助体液免疫应答<br>B.单核-巨噬细胞参与免疫应答的调节<br>C.Th1细胞产生IL-10抑制Th2细胞的增殖<br>D.Th2细胞产生IFN-γ抑制Th1细胞的增殖<br>E.NK细胞与免疫应答调节无关</td>
      <td>B.单核-巨噬细胞参与免疫应答的调节</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>13. NK细胞在免疫调节中的作用体现在(2.0分)</td>
      <td>A.分泌IL-3等细胞因子抑制血细胞发育<br>B.分泌IFN-γ增强Mφ功能<br>C.发挥靶细胞杀伤作用时受MHC限制<br>D.分泌IL-4和IL-6抑制T<br>E.对异体骨髓移植排斥能力弱，但对异体实体</td>
      <td>B.分泌IFN-γ增强Mφ功能</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>14. AICD(2.0分)</td>
      <td>A.对免疫应答的终止有调节作用<br>B.在免疫应答过程中只有免疫调节作用，而无细胞杀伤作用<br>C.是一种程序性被动死亡<br>D.在免疫应答过程中只有细胞杀伤作用，而无免疫调节作用<br>E.主要通过淋巴细胞释放细胞毒颗粒实现的</td>
      <td>A.对免疫应答的终止有调节作用</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>15. 有关化疗指数(CI)的描述中错误的是(2.0分)</td>
      <td>A.CI是衡量药物安全性的有效指标之一<br>B.LD50/ED50反映CI<br>C.CI大说明药物临床应用不安全<br>D.CI反映药物的安全性<br>E.化疗药安全性也可用LD5／ED95反映</td>
      <td>C.CI大说明药物临床应用不安全</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>16. 应用直接免疫荧光技术鉴别特异性传染原时，荧光素是被结合到(2.0分)</td>
      <td>A.针对特异性抗体的抗体<br>B.针对人γ―球蛋白的特异性抗体<br>C.针对微生物的特异性抗体<br>D.微生物<br>E.针对微生物的非特异性抗体</td>
      <td>C.针对微生物的特异性抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>17. 单向琼脂扩散可用于(2.0分)</td>
      <td>A.定量检测<br>B.定性检测<br>C.检测抗原抗体纯度<br>D.快速诊断</td>
      <td>A.定量检测</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>18. 关于免疫调节的正确叙述是(2.0分)</td>
      <td>A.协同刺激分子受体分为高亲合性的CD28和低亲合性的<br>B.协同刺激分子与CTLA-4结合促进免疫应答<br>C.活化的T细胞才能表达CTLA-4<br>D.CTLA-4的表达密度大于CD28<br>E.协同刺激分子与CD28结合抑制免疫应答</td>
      <td>C.活化的T细胞才能表达CTLA-4</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>19. 下列不属于免疫增强剂的是(2.0分)</td>
      <td>A.烷化剂<br>B.西咪替丁<br>C.卡介苗<br>D.左旋咪唑<br>E.短小棒状杆菌</td>
      <td>A.烷化剂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>20. 检测人类B细胞功能的实验是 (2.0分)</td>
      <td>A.溶血空斑试验<br>B.E花环试验<br>C.肥达氏反应<br>D.结核菌素试验<br>E.锡克试验</td>
      <td>A.溶血空斑试验</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>21. 抗菌药物是(2.0分)</td>
      <td>A.对病原菌有杀灭作用的药物<br>B.对病原菌有杀灭或抑制作用的药物<br>C.对病原菌有抑制作用的药物<br>D.能用于预防细菌性感染的药物<br>E.能治疗细菌性感染的药物</td>
      <td>B.对病原菌有杀灭或抑制作用的药物</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>22. 自噬是指从粗面内质网的无核糖体附着区脱落的双层膜包裹部分胞质和细胞内需降解的细胞器、蛋白质等成分形成(2.0分)</td>
      <td>A.lysosome<br>B.autophagosome<br>C.复合物<br>D.抗体<br>E.以上都不是</td>
      <td>B.autophagosome</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>23. Mechanism of action of azathioprine is: (2.0分)</td>
      <td>A.inhibition of purine synthesis<br>B.inhibition of pyrimidine<br>C.inhibition of the enzyme calcineurin<br>D.inhibition of phospholipase A2</td>
      <td>A.inhibition of purine synthesis</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>24. 哪个是补体旁路途径的C3转化酶 (2.0分)</td>
      <td>A.C4b2a<br>B.C4b2a3b<br>C.C3bBb<br>D.C3bBb3b</td>
      <td>C.C3bBb</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>25. Ⅲ型超敏反应重要病理学特征是(2.0分)</td>
      <td>A.巨噬细胞浸润<br>B.淋巴细胞浸润<br>C.嗜酸性粒细胞浸润<br>D.红细胞浸润<br>E.中性粒细胞浸润</td>
      <td>E.中性粒细胞浸润</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>26. 血管神经性水肿主要由于下列哪个成分缺陷所引起(2.0分)</td>
      <td>A.I因子<br>B.H因子<br>C.C1INH<br>D.S蛋白<br>E.C4bp</td>
      <td>C.C1INH</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>27. Which drug is calcineurin inhibitor? (2.0分)</td>
      <td>A.Azathioprine<br>B.Cyclosporine<br>C.Prednisone<br>D.Mycophenolate Mofetil</td>
      <td>B.Cyclosporine</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>28. IgE 抗体主要引起(2.0分)</td>
      <td>A.细胞毒型超敏反应<br>B.血管炎型超敏反应<br>C.迟发型超敏反应<br>D.速发型超敏反应<br>E.自身免疫性疾病</td>
      <td>D.速发型超敏反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>29. 初次注入大量抗毒素的马血清所引起血清病的发病机理属于(2.0分)</td>
      <td>A.Ⅰ型变态反应<br>B.Ⅳ型变态反应<br>C.Ⅲ型变态反应<br>D.Ⅱ型变态反应<br>E.Ⅴ型变态反应</td>
      <td>C.Ⅲ型变态反应</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>30. 超敏反应中不是由抗体直接参与的型别为(2.0分)</td>
      <td>A.I型<br>B.III型<br>C.II型<br>D.IV型</td>
      <td>D.IV型</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>31. 抗菌谱是 (2.0分)</td>
      <td>A.药物的治疗指数<br>B.药物的抗菌范围<br>C.抗菌药的治疗效果<br>D.药物的抗菌能力<br>E.抗菌药的适应证</td>
      <td>B.药物的抗菌范围</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>32. 药物过敏性血细胞减少症属于哪一型超敏反应？(2.0分)</td>
      <td>A.III型<br>B.II型<br>C.I型<br>D.IV型</td>
      <td>B.II型</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>33. 自噬的生理意义中下列哪个表述是错误的? (2.0分)</td>
      <td>A.清除衰老的细胞器<br>B.使细胞活化<br>C.代谢应激<br>D.维持染色体的稳定<br>E.使细胞发生程序性死亡</td>
      <td>B.使细胞活化</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>34. 能够通过经典途径激活补体的是(2.0分)</td>
      <td>A.IgE<br>B.IgD<br>C.IgM<br>D.IgA</td>
      <td>C.IgM</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>35. 在特异性变应原脱敏疗法中，诱导机体产生的封闭抗体的是(2.0分)</td>
      <td>A.gE<br>B.IgG<br>C.IgM<br>D.IgD<br>E.IgA</td>
      <td>B.IgG</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>36. 与类风湿因子有关的最主要的Ig是(2.0分)</td>
      <td>A.IgM<br>B.IgG<br>C.IgD<br>D.IgA<br>E.IgE</td>
      <td>A.IgM</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>37. 淋巴细胞转化试验（形态学检查法）中，典型淋巴母细胞的特征不包括(2.0分)</td>
      <td>A.可见1~4个明显核仁<br>B.体积明显增大<br>C.胞浆嗜碱性，有伪足样突出<br>D.可见成堆或散在的染色体</td>
      <td>D.可见成堆或散在的染色体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>38. 目前国内应用的脊髓灰质炎疫苗是(2.0分)</td>
      <td>A.亚单位疫苗<br>B.合成肽疫苗<br>C.减毒活疫苗<br>D.重组载体疫苗<br>E.重组抗原疫苗</td>
      <td>C.减毒活疫苗</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>39. 高亲和性的可结合到肥大细胞上的IgE分子部位是(2.0分)</td>
      <td>A.HVR区<br>B.CH2功能区<br>C.H链恒定区<br>D.Fab段<br>E.Fc段</td>
      <td>E.Fc段</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>40. DTH皮肤试验阳性与下列物质有关(2.0分)</td>
      <td>A.抗体、补体和CK<br>B.抗原、抗原致敏的T淋巴细胞和巨噬细胞<br>C.gG抗体、抗原和肥大细胞<br>D.抗原抗体复合物、补体和中性粒细胞<br>E.抗原、巨噬细胞和补体</td>
      <td>B.抗原、抗原致敏的T淋巴细胞和巨噬细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>41. 关于IV 型超敏反应错误的是(2.0分)</td>
      <td>A.以IgG抗体介导为主<br>B.炎症区以单个核细胞浸润为主<br>C.反应速度慢<br>D.效应Tc细胞参与</td>
      <td>A.以IgG抗体介导为主</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>42. Mechanism of action of prednisone: (2.0分)</td>
      <td>A.Inhibition of the enzyme calcineurin<br>B.Inhibition of purine synthesis<br>C.Inhibition of pyrimidine<br>D.Inhibition of phospholipase A2</td>
      <td>D.Inhibition of phospholipase A2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>43. 关于I型超敏反应，不正确的是： (2.0分)</td>
      <td>A.有补体直接参与<br>B.有IgE参与<br>C.有个体差异和遗传倾向<br>D.以生理功能紊乱为主</td>
      <td>A.有补体直接参与</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>44. 下述试验方法中，最简便快速的是(2.0分)</td>
      <td>A.单向琼脂扩散试验<br>B.ELISA双抗体夹心法<br>C.斑点免疫层析试验<br>D.ELISA间接法</td>
      <td>C.斑点免疫层析试验</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>45. 哪个补体片段具有调理作用? (2.0分)</td>
      <td>A.C3b<br>B.C5a<br>C.C3a<br>D.C2a<br>E.C5b</td>
      <td>A.C3b</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>46. 具有趋化中性粒细胞作用的补体成分是(2.0分)</td>
      <td>A.C4b<br>B.C5a<br>C.C5b<br>D.C1<br>E.C2a</td>
      <td>B.C5a</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>47. 某孕妇为Rh-，第一胎分娩Rh+ 胎儿，为防止再次妊娠的Rh+ 胎儿产生溶血症，应给Rh-母亲注射(2.0分)</td>
      <td>A.抗Rh抗体<br>B.免疫增强剂<br>C.免疫抑制剂<br>D.Rh抗原<br>E.以上都不是</td>
      <td>A.抗Rh抗体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>48. 在体外培养中激发人类T细胞增殖反应最强的物质是(2.0分)</td>
      <td>A.美洲商陆（PWM）<br>B.乙型副伤寒杆菌<br>C.金黄色葡萄球菌Cowan I株<br>D.脂多糖（LPS）<br>E.植物血凝素（PHA）</td>
      <td>E.植物血凝素（PHA）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>49. 下列不属于免疫抑制剂的是 (2.0分)</td>
      <td>A.FK-506<br>B.抗代谢药物<br>C.环抱素A<br>D.烷化剂<br>E.胸腺素</td>
      <td>E.胸腺素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2008</td>
      <td>50. 体液中的补体抑制因子是(2.0分)</td>
      <td>A.H因子<br>B.L-2<br>C.C1q<br>D.IgG1<br>E.B因子</td>
      <td>A.H因子</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>1. 诱导细胞原癌基因激活的基因突变的方式不包括(2.0分)</td>
      <td>A.DNA扩增<br>B.DNA点突变<br>C.染色体重排<br>D.基因高度甲基化<br>E.基因低、去甲基化</td>
      <td>D.基因高度甲基化</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>2. 下列哪种为癌基因(2.0分)</td>
      <td>A.ras基因<br>B.p53基因<br>C.Rb基因<br>D.Apc基因<br>E.NF－1基因</td>
      <td>A.ras基因</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>3. 下列哪些肿瘤不与病毒感染密切相关有：(2.0分)</td>
      <td>A.肝细胞肝癌<br>B.宫颈癌<br>C.鼻咽癌<br>D.皮肤癌<br>E.Burkitt淋巴瘤</td>
      <td>D.皮肤癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>4. 下列哪项是化学致癌物的作用的根本机制： (2.0分)</td>
      <td>A.蛋白构象变化；<br>B.体细胞DNA损伤；<br>C.致癌物与RNA聚合酶结合；<br>D.免疫功能改变</td>
      <td>B.体细胞DNA损伤；</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>5. 关于肿瘤的论述，下列除哪些是正确的(2.0分)</td>
      <td>A.肿瘤的发生是多阶段、多步骤的长期过程<br>B.肿瘤的发生与原癌基因的激活和抑癌基因的失活有关<br>C.肿瘤的发生是单个基因突变的结果<br>D.肿瘤的发生是多因素造成的</td>
      <td>C.肿瘤的发生是单个基因突变的结果</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>6. 下列不属于抑癌基因的是(2.0分)</td>
      <td>A.bcl-2<br>B.p53<br>C.nm23<br>D.pRb<br>E.p16</td>
      <td>A.bcl-2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>7. 与恶性肿瘤浸润、转移发生有关的因素有 (2.0分)</td>
      <td>A.肿瘤细胞的阿米巴运动<br>B.肿瘤细胞释放蛋白溶解酶<br>C.肿瘤细胞间粘附力减弱<br>D.肿瘤细胞与细胞外基质成分的粘附力增强<br>E.以上均是</td>
      <td>E.以上均是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>8. 下列哪些细胞黏附分子可能与肿瘤转移的器官选择有关 (2.0分)</td>
      <td>A.整合素<br>B.E-钙粘素<br>C.选择素<br>D.免疫球蛋白超家族<br>E.CD44</td>
      <td>C.选择素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>9. 下列哪些分子在肿瘤中高表达提示预后良好(2.0分)</td>
      <td>A.MMP和TIMP<br>B.erbB2和P16<br>C.TIMP 和KAI1<br>D.Ras 和Myc<br>E.以上都不是</td>
      <td>C.TIMP 和KAI1</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>10. 下列哪些分子抑制肿瘤的侵犯和转移 (2.0分)</td>
      <td>A.MMP和u-PA<br>B.Kiss和肿瘤血管生成因子（TAF）<br>C.自分泌运动因子（AMF）和TIMP<br>D.angiostain 和nm23<br>E.以上都不是</td>
      <td>D.angiostain 和nm23</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>11. 血道转移的确切根据是(2.0分)</td>
      <td>A.血液中发现了瘤细胞<br>B. 在远隔器官形成了与原发瘤同样类型的肿瘤<br>C. 瘤细胞栓塞于远隔器官<br>D. 瘤细胞进入了静脉<br>E. 瘤细胞进入了动脉</td>
      <td>B. 在远隔器官形成了与原发瘤同样类型的肿瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>12. 关于良恶性肿瘤说法正确的是：(2.0分)</td>
      <td>A. 良性肿瘤患者可出现恶病质<br>B. 恶性肿瘤主要浸润破坏组织，一般没有压迫和阻塞症状<br>C. 良性肿瘤因浸润而产生压迫和阻塞症状<br>D. 恶性肿瘤也可有压迫和阻塞等良性肿瘤的症状<br>E. 以上都不是</td>
      <td>D. 恶性肿瘤也可有压迫和阻塞等良性肿瘤的症状</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>13. 交界性肿瘤是(2.0分)</td>
      <td>A. 混合性肿瘤<br>B. 介乎于肿瘤与非肿瘤之间的肿块组织<br>C. 癌前病变<br>D. 性质介于良、恶性之间的肿瘤<br>E. 分化好的恶性瘤</td>
      <td>D. 性质介于良、恶性之间的肿瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>14. 肿瘤的异质化是指(2.0分)</td>
      <td>A. 一种肿瘤转变为另一种性质的肿瘤<br>B. 肿瘤细胞生长过程中形成新的亚克隆过程<br>C. 肿瘤变得越来越恶性过程<br>D. 恶性肿瘤变的良性化过程<br>E. 以上都不对</td>
      <td>B. 肿瘤细胞生长过程中形成新的亚克隆过程</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>15. 下面属于恶性肿瘤的是(2.0分)</td>
      <td>A. 脂肪母细胞瘤<br>B. 肌纤维母细胞瘤<br>C. 子宫平滑肌瘤<br>D. 畸胎瘤<br>E. 精原细胞瘤</td>
      <td>E. 精原细胞瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>16. 肿瘤分级所依据的主要原则是(2.0分)</td>
      <td>A. 肿瘤分化程度的高低、异型性大小和转移情况<br>B. 肿瘤分化程度的高低、异型性大小和核分裂数的多少<br>C. 肿瘤的大小、浸润的深度和转移情况<br>D. 肿瘤的大小、异型性大小和转移情况<br>E. 肿瘤的异型性大小、浸润的深度和核分裂数的多少</td>
      <td>B. 肿瘤分化程度的高低、异型性大小和核分裂数的多少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>17. 判断子宫平滑肌肿瘤的良恶性最有价值指标是(2.0分)</td>
      <td>A.肿瘤是否有凝固性坏死及核分裂的多少<br>B.肿瘤的体积大小<br>C.肿瘤有无包膜<br>D.肿瘤是否为多发<br>E.肿瘤的颜色和质地</td>
      <td>A.肿瘤是否有凝固性坏死及核分裂的多少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>18. 下列哪一项不是肿瘤分级的根据？ (2.0分)</td>
      <td>A.核分裂数多少<br>B.分化程度<br>C.有无转移<br>D.组织异型性<br>E.细胞的多形性</td>
      <td>C.有无转移</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>19. 下列哪一项不是肉瘤的特征？ (2.0分)</td>
      <td>A.实质和间质分界不清<br>B.多经血道转移<br>C.一般不形成巢团状结构<br>D.多发生于青少年<br>E.发病率高于良性间叶组织肿瘤</td>
      <td>E.发病率高于良性间叶组织肿瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>20. 多形性腺瘤多见于肺(2.0分)</td>
      <td>A.乳腺<br>B.腮腺<br>C.前列腺<br>D.甲状腺</td>
      <td>C.前列腺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>21. 角化珠见于(2.0分)</td>
      <td>A.恶性畸胎瘤<br>B.尿路上皮癌<br>C.基底细胞癌<br>D.腺癌<br>E.鳞状细胞癌</td>
      <td>E.鳞状细胞癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>22. 关于恶性黑色素瘤，下列哪项叙述不正确？(2.0分)</td>
      <td>A.通过淋巴道和血道均可发生转移<br>B.高度恶性<br>C.肿瘤细胞内必定含有黑色素<br>D.多通过交界痣恶变而来<br>E.免疫组化HMB-45染色阳性</td>
      <td>C.肿瘤细胞内必定含有黑色素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>23. 下列肿瘤中易复发的是(2.0分)</td>
      <td>A.脂肪瘤<br>B.子宫平滑肌瘤<br>C.乳腺纤维腺瘤<br>D.涎腺多形性腺瘤<br>E.骨瘤</td>
      <td>D.涎腺多形性腺瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>24. 下述肿瘤，何者好发于AIDS患者？(2.0分)</td>
      <td>A.纤维肉瘤<br>B.隆突性皮纤维肉瘤<br>C.霍奇金淋巴瘤<br>D.横纹肌肉瘤<br>E.Kaposi 肉瘤</td>
      <td>D.横纹肌肉瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>25. 粘液腺癌是(2.0分)</td>
      <td>A.印戒细胞癌的一种<br>B.癌组织粘液性变<br>C.伴粘液变的恶性肿瘤<br>D.粘液瘤恶变<br>E.腺癌伴有大量细胞外粘液产生</td>
      <td>E.腺癌伴有大量细胞外粘液产生</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>26. 乳腺癌最好发于乳房的(2.0分)</td>
      <td>A.内上象限<br>B.外上象限<br>C.内下象限<br>D.外下象限<br>E.中央部</td>
      <td>B.外上象限</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>27. 肿瘤发生的主要免疫学机制是 (2.0分)</td>
      <td>A.免疫防御功能障碍<br>B.免疫监视功能障碍<br>C.免疫自稳功能障碍<br>D.免疫调节功能障碍<br>E.免疫功能亢进</td>
      <td>B.免疫监视功能障碍</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>28. 机体对抗肿瘤的免疫应答机制包括(2.0分)</td>
      <td>A.T细胞介导的细胞毒性<br>B.ADCC<br>C.CDC<br>D.以上都是</td>
      <td>D.以上都是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>29. 肿瘤细胞免疫逃逸的机制不包括(2.0分)</td>
      <td>A.缺乏共刺激分子<br>B.释放免疫抑制性物质<br>C.肿瘤细胞的"漏逸"<br>D.以上都不是</td>
      <td>D.以上都不是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>30. 关于Tumor-Associated Antigens (TAA)最准确的描述(2.0分)</td>
      <td>A.They are antigens found only in tumor cells<br>B.They can be found in both tumor and some normal cells, but the level is significantly higher in the tumor cells<br>C.They are typically the products of tumor suppressor genes; an example would be Rb<br>D.They are the result of genes mutated by DNA-damaging carcinogens such as MNNG<br>E.They are typically encoded by oncogenic viruses such as EBV</td>
      <td>B.They can be found in both tumor and some normal cells, but the level is significantly higher in the tumor cells</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>31. 在抗肿瘤免疫应答中，CTL主要发挥什么样的功能(2.0分)</td>
      <td>A.通过穿孔素和颗粒酶杀伤肿瘤细胞，诱导肿瘤细胞发生凋亡<br>B.通过分泌IFN- 和IL-2，活化巨噬细胞<br>C.产生活性氧，破坏肿瘤细胞膜<br>D.通过ADCC杀伤肿瘤<br>E.产生肿瘤特异性的抗体</td>
      <td>A.通过穿孔素和颗粒酶杀伤肿瘤细胞，诱导肿瘤细胞发生凋亡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>32. 什么是抗原调变(2.0分)</td>
      <td>A.肿瘤细胞表面抗原表位减少或丢失，从而使肿瘤细胞避免宿主免疫系统的杀伤<br>B.肿瘤细胞表面的抗原与正常细胞的膜分子差异很小<br>C.肿瘤细胞MHC-Ⅰ类抗原表达下降，逃避CTL的攻击<br>D.肿瘤细胞不表达MHC-II类抗原</td>
      <td>A.肿瘤细胞表面抗原表位减少或丢失，从而使肿瘤细胞避免宿主免疫系统的杀伤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>33. 肿瘤细胞主要通过什么机制来抵抗凋亡(2.0分)</td>
      <td>A.肿瘤细胞分泌IL-10<br>B.肿瘤细胞膜表面Fas表达显著减少或丢失，而FasL的表达增强<br>C.某些肿瘤能表达非经典的Ⅰ类分子<br>D.表达mCRP(膜结合补体调节蛋白)分子</td>
      <td>B.肿瘤细胞膜表面Fas表达显著减少或丢失，而FasL的表达增强</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>34. 肿瘤可诱导哪种抑制性细胞亚群来抑制免疫应答(2.0分)</td>
      <td>A.调节性T细胞<br>B.CTL（细胞毒性T细胞）<br>C.B细胞<br>D.都不是</td>
      <td>A.调节性T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>35. 关于肿瘤的免疫逃逸机制，下列哪项是错误的(2.0分)</td>
      <td>A.瘤细胞表面MHCⅠ类分子表达降低或缺失<br>B.瘤细胞不表达B7分子<br>C.宿主处于免疫缺陷状态<br>D.瘤细胞缺乏抗原性表位<br>E.瘤细胞不表达转铁蛋白受体</td>
      <td>E.瘤细胞不表达转铁蛋白受体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>36. 下列哪种是肿瘤细胞产生的对免疫细胞有抑制作用的细胞因子(2.0分)</td>
      <td>A.TGF-<br>B.FasL<br>C.P53<br>D.B7<br>E.MHC<br>F.中性粒细胞参与抗肿瘤作用</td>
      <td>A.TGF-</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>37. 阻碍细胞有丝分裂的抗癌药是(2.0分)</td>
      <td>A.阿霉素<br>B.氟尿嘧啶<br>C.长春新碱<br>D.甲氨蝶呤<br>E.以上都不是</td>
      <td>C.长春新碱</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>38. 烷化剂中易发生出血性膀胱炎的抗癌药是(2.0分)</td>
      <td>A.氮芥<br>B.环磷酰胺<br>C.马利兰<br>D.长春新碱<br>E.卡氮芥</td>
      <td>B.环磷酰胺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>39. 有细胞周期特异性的抗肿瘤药物是(2.0分)</td>
      <td>A.5-氟尿嘧啶<br>B.环磷酰胺<br>C.阿霉素<br>D.氮芥<br>E.塞替派</td>
      <td>A.5-氟尿嘧啶</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>40. 对儿童急性淋巴细胞性白血病疗效好、见效快的是(2.0分)</td>
      <td>A.长春新碱<br>B.阿糖胞苷<br>C.巯嘌呤<br>D.丝裂霉素<br>E.环磷酰胺</td>
      <td>A.长春新碱</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>41. 不抑制骨髓造血功能的抗肿瘤药物是(2.0分)</td>
      <td>A.烷化剂<br>B.抗代谢类<br>C.抗生素类<br>D.植物碱类<br>E.激素类</td>
      <td>E.激素类</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>42. 作为基本用药5-氟尿嘧啶治疗(2.0分)</td>
      <td>A.绒毛膜上皮癌<br>B.急性淋巴细胞白血病<br>C.慢性粒细胞性白血病<br>D.消化道肿瘤<br>E.恶性黑色素瘤</td>
      <td>D.消化道肿瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>43. 顺铂首选用于治疗(2.0分)</td>
      <td>A.慢性淋巴细胞性白血病<br>B.非精原细胞性睾丸瘤<br>C.多发性骨髓瘤<br>D.恶性淋巴瘤<br>E.绒毛膜上皮细胞癌</td>
      <td>B.非精原细胞性睾丸瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>44. 利妥昔单抗是以下哪个蛋白的抗体？(2.0分)</td>
      <td>A.EGFR<br>B.VEGF<br>C.CD20<br>D.Bcr-Abl<br>E.ER</td>
      <td>C.CD20</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>45. 己烯雌酚用于(2.0分)</td>
      <td>A.治疗前列腺癌<br>B.治疗绒毛膜上皮细胞癌<br>C.治疗高度分化性甲状腺癌<br>D.治疗慢性粒细胞白血病<br>E.治疗激素依赖性播散性乳腺癌</td>
      <td>A.治疗前列腺癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>46. 多形性腺瘤多见于(2.0分)</td>
      <td>A.肾<br>B.乳腺<br>C.肺<br>D.涎腺<br>E.甲状腺</td>
      <td>D.涎腺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>47. 下列哪项属于良性肿瘤? (2.0分)</td>
      <td>A.视网膜母细胞瘤<br>B.肾母细胞瘤<br>C.神经母细胞瘤<br>D.软骨母细胞瘤<br>E.肺母细胞瘤</td>
      <td>D.软骨母细胞瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>48. 胃肠间质瘤（GIST）生物学行为的判断主要依据(2.0分)</td>
      <td>A.肿瘤的体积和核分裂的多少<br>B.肿瘤细胞的异型性<br>C.肿瘤发生部位<br>D.肿瘤是否伴有神经分化<br>E.肿瘤与周围边界是否清楚</td>
      <td>A.肿瘤的体积和核分裂的多少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>49. 乳腺癌最好发于乳房的(2.0分)</td>
      <td>A.内上象限<br>B.中央部<br>C.内下象限<br>D.外下象限<br>E.外上象限</td>
      <td>E.外上象限</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2009</td>
      <td>50. 早期容易经淋巴道转移的是(2.0分)</td>
      <td>A.肾细胞癌<br>B.绒毛膜上皮癌<br>C.甲状腺乳头状癌<br>D.骨肉瘤<br>E.肝癌</td>
      <td>C.甲状腺乳头状癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>1. 诱导细胞原癌基因激活的基因突变的方式不包括： (3.0分)</td>
      <td>A.DNA扩增<br>B.DNA点突变<br>C.染色体重排<br>D.基因高度甲基化<br>E.基因低或去甲基化</td>
      <td>D.基因高度甲基化</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>2. 关于肿瘤的论述，下列除哪些是正确的 (3.0分)</td>
      <td>A.肿瘤的发生是多阶段、多步骤的长期过程<br>B.肿瘤的发生与原癌基因的激活和抑癌基因的失活有关<br>C.肿瘤的发生是单个基因突变的结果<br>D.肿瘤的发生是多因素造成的</td>
      <td>C.肿瘤的发生是单个基因突变的结果</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>3. 与恶性肿瘤浸润、转移发生有关的因素有 (3.0分)</td>
      <td>A.肿瘤细胞的阿米巴运动<br>B.肿瘤细胞释放蛋白溶解酶<br>C.肿瘤细胞间粘附力减弱<br>D.肿瘤细胞与细胞外基质成分的粘附力增强<br>E.以上均是</td>
      <td>E.以上均是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>4. 下列哪些分子抑制肿瘤的侵犯和转移 (3.0分)</td>
      <td>A.MMP和u-PA<br>B.Kiss和肿瘤血管生成因子（TAF）<br>C.自分泌运动因子（AMF）和TIMP<br>D.angiostain 和nm23<br>E.以上都不是</td>
      <td>D.angiostain 和nm23</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>5. 癌与肉瘤的最主要区别是(3.0分)</td>
      <td>A.瘤细胞的分布方式不同<br>B.发生的年龄不同<br>C.肿瘤内血管多少不同<br>D.转移的途径不同<br>E.组织来源不同</td>
      <td>E.组织来源不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>6. 下列说法正确的是：(3.0分)</td>
      <td>A.肿瘤通常为多发<br>B.肿瘤通常大小较一致<br>C.肿瘤只有在显微镜下才可诊断<br>D.肿瘤的大小与肿瘤的性质和发生部位等有关<br>E.黑色素瘤通常不发生转移</td>
      <td>D.肿瘤的大小与肿瘤的性质和发生部位等有关</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>7. 良性肿瘤的异型性主要是：(3.0分)</td>
      <td>A.细胞形态与组织结构均没有异型性<br>B.细胞形态异型性为主<br>C.组织结构异型性为主<br>D.细胞形态与组织结构均有异形性<br>E.以上都不是</td>
      <td>C.组织结构异型性为主</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>8. 肿瘤的异质化是指：(3.0分)</td>
      <td>A.一种肿瘤转变为另一种性质的肿瘤<br>B.肿瘤细胞生长过程中形成新的亚克隆过程<br>C.肿瘤变得越来越恶性过程<br>D.恶性肿瘤变的良性化过程<br>E.以上都不对</td>
      <td>B.肿瘤细胞生长过程中形成新的亚克隆过程</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>9. 血道转移的确切根据是：(3.0分)</td>
      <td>A.血液中发现了瘤细胞<br>B.在远隔器官形成了与原发瘤同样类型的肿瘤<br>C.瘤细胞栓塞于远隔器官<br>D.瘤细胞进入了静脉<br>E.瘤细胞进入了动脉</td>
      <td>B.在远隔器官形成了与原发瘤同样类型的肿瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>10. 肿瘤分级所依据的主要原则是 (3.0分)</td>
      <td>A.肿瘤分化程度的高低、异型性大小和转移情况<br>B.肿瘤分化程度的高低、异型性大小和核分裂数的多少<br>C. 肿瘤的大小、浸润的深度和转移情况<br>D. 肿瘤的大小、异型性大小和转移情况<br>E. 肿瘤的异型性大小、浸润的深度和核分裂数的多少</td>
      <td>B.肿瘤分化程度的高低、异型性大小和核分裂数的多少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>11. 判断子宫平滑肌肿瘤的良恶性最有价值指标是(3.0分)</td>
      <td>A.肿瘤是否有凝固性坏死及核分裂的多少<br>B.肿瘤的体积大小<br>C.肿瘤有无包膜<br>D.肿瘤是否为多发<br>E.肿瘤的颜色和质地</td>
      <td>A.肿瘤是否有凝固性坏死及核分裂的多少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>12. 哪种肿瘤属于良性肿瘤?(3.0分)</td>
      <td>A.精原细胞瘤<br>B.视网膜母细胞瘤<br>C.黑色素瘤<br>D.尤文氏瘤<br>E.软骨母细胞瘤</td>
      <td>E.软骨母细胞瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>13. 下列不正确的说法是： (3.0分)</td>
      <td>A. 黄曲霉诱发肝癌<br>B. 亚硝胺类主要与胃癌有关<br>C. 苯胺燃料厂工人膀胱癌多见<br>D. 单纯疱疹病毒不致癌<br>E.EB病毒与鼻咽癌关系密切</td>
      <td>D. 单纯疱疹病毒不致癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>14. 肿瘤的生物学特点以及每种肿瘤的特殊性主要是由哪种因素决定的(3.0分)</td>
      <td>A. 肿瘤的血管<br>B. 肿瘤的结缔组织的含量<br>C. 肿瘤的实质和间质的比例<br>D. 肿瘤的实质<br>E. 肿瘤的间质</td>
      <td>D. 肿瘤的实质</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>15. 生长分数是指肿瘤细胞群体中处于哪阶段的细胞的比例(3.0分)</td>
      <td>A. G0期和G1期<br>B. G1期和G2期<br>C. S期和G1期<br>D. G2期和G0期<br>E. S期和G2期</td>
      <td>E. S期和G2期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>16. 下列哪一项表述是不正确的(3.0分)</td>
      <td>A.肿瘤生长过程中能保留那些需要生长因子较少的亚克隆。<br>B.肿瘤生长过程中能保留那些具有较高抗原性的亚克隆。<br>C.肿瘤生长过程中能保留那些对抗癌药敏感性较低的亚克隆。<br>D.肿瘤生长过程中能保留那些侵袭能力较强的亚克隆。<br>E.肿瘤生长过程中能保留那些具有较低抗原性的亚克隆。</td>
      <td>B.肿瘤生长过程中能保留那些具有较高抗原性的亚克隆。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>17. 下列正确的说法是：(4.0分)</td>
      <td>A. 横纹肌肉瘤好发于成人<br>B. 骨肉瘤好发于青少年<br>C. 平滑肌肉瘤好发于青少年<br>D. 基底细胞癌好发于青少年<br>E. 以上都不对</td>
      <td>B. 骨肉瘤好发于青少年</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>18. 什么是抗原调变(3.0分)</td>
      <td>A.肿瘤细胞表面抗原表位减少或丢失，从而使肿瘤细胞避免宿主免疫系统的杀伤<br>B.肿瘤细胞表面的抗原与正常细胞的膜分子差异很小<br>C.肿瘤细胞MHC-Ⅰ类抗原表达下降，逃避CTL的攻击<br>D.肿瘤细胞不表达MHC-II类抗原</td>
      <td>A.肿瘤细胞表面抗原表位减少或丢失，从而使肿瘤细胞避免宿主免疫系统的杀伤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>19. 肿瘤可诱导哪种抑制性细胞亚群来抑制免疫应答(3.0分)</td>
      <td>A.调节性T细胞<br>B.CTL（细胞毒性T细胞）<br>C.B细胞<br>D.都不是</td>
      <td>A.调节性T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>20. 肿瘤细胞主要通过什么机制来抵抗凋亡(3.0分)</td>
      <td>A.肿瘤细胞分泌IL-10<br>B.肿瘤细胞膜表面Fas表达显著减少或丢失，而FasL的表达增强<br>C.某些肿瘤能表达非经典的Ⅰ类分子<br>D.表达mCRP(膜结合补体调节蛋白)分子</td>
      <td>B.肿瘤细胞膜表面Fas表达显著减少或丢失，而FasL的表达增强</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>21. 阻碍细胞有丝分裂的抗癌药是(3.0分)</td>
      <td>A.阿霉素<br>B.氟尿嘧啶<br>C.长春新碱<br>D.甲氨蝶呤<br>E.以上都不是</td>
      <td>C.长春新碱</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>22. 作为基本用药5-氟尿嘧啶治疗 (3.0分)</td>
      <td>A.绒毛膜上皮癌<br>B.急性淋巴细胞白血病<br>C.慢性粒细胞性白血病<br>D.消化道肿瘤<br>E.恶性黑色素瘤</td>
      <td>D.消化道肿瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>23. 下列陈述中哪一项是不正确的(3.0分)</td>
      <td>A.大的肿瘤通常生长缓慢、生长时间较长，且多为良性。<br>B.恶性肿瘤多呈浸润性生长。<br>C.肿瘤的硬度通常和肿瘤的种类有关。<br>D.瘤细胞多于间质的肿瘤一般较硬。<br>E.瘤组织发生坏死时变软。</td>
      <td>D.瘤细胞多于间质的肿瘤一般较硬。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>24. 关于良恶性肿瘤说法正确的是： (3.0分)</td>
      <td>A.良性肿瘤患者可出现恶病质<br>B.恶性肿瘤主要浸润破坏组织，一般没有压迫和阻塞症状<br>C.良性肿瘤因浸润而产生压迫和阻塞症状<br>D.恶性肿瘤也可有压迫和阻塞等良性肿瘤的症状<br>E.以上都不是</td>
      <td>D.恶性肿瘤也可有压迫和阻塞等良性肿瘤的症状</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>25. 肿瘤分级所依据的主要原则是(3.0分)</td>
      <td>A.肿瘤分化程度的高低、异型性大小和转移情况<br>B.肿瘤分化程度的高低、异型性大小和核分裂数的多少<br>C.肿瘤的大小、浸润的深度和转移情况<br>D.肿瘤的大小、异型性大小和转移情况<br>E.肿瘤的异型性大小、浸润的深度和核分裂数的多少</td>
      <td>B.肿瘤分化程度的高低、异型性大小和核分裂数的多少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>26. 血道转移的确切根据是：(3.0分)</td>
      <td>A.血液中发现了瘤细胞<br>B.在远隔器官形成了与原发瘤同样类型的肿瘤<br>C.瘤细胞栓塞于远隔器官<br>D.瘤细胞进入了静脉<br>E.瘤细胞进入了动脉</td>
      <td>B.在远隔器官形成了与原发瘤同样类型的肿瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>27. 判断子宫平滑肌肿瘤的良恶性最有价值指标是(3.0分)</td>
      <td>A.肿瘤是否有凝固性坏死及核分裂的多少<br>B.肿瘤的体积大小<br>C.肿瘤有无包膜<br>D.肿瘤是否为多发<br>E.肿瘤的颜色和质地</td>
      <td>A.肿瘤是否有凝固性坏死及核分裂的多少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>28. 下列哪一项不是肉瘤的特征？(3.0分)</td>
      <td>A.实质和间质分界不清<br>B.多经血道转移<br>C.一般不形成巢团状结构<br>D.多发生于青少年<br>E.发病率高于良性间叶组织肿瘤</td>
      <td>E.发病率高于良性间叶组织肿瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>29. 关于恶性黑色素瘤，下列哪项叙述不正确？(3.0分)</td>
      <td>A.通过淋巴道和血道均可发生转移<br>B.高度恶性<br>C.肿瘤细胞内必定含有黑色素<br>D.多通过交界痣恶变而来<br>E.免疫组化HMB-45染色阳性</td>
      <td>C.肿瘤细胞内必定含有黑色素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>30. 粘液腺癌是(3.0分)</td>
      <td>A.印戒细胞癌的一种<br>B.癌组织粘液性变<br>C.伴粘液变的恶性肿瘤<br>D.粘液瘤恶变<br>E.腺癌伴有大量细胞外粘液产生</td>
      <td>E.腺癌伴有大量细胞外粘液产生</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>31. 下述肿瘤，何者好发于AIDS患者？(3.0分)</td>
      <td>A.纤维肉瘤<br>B.隆突性皮纤维肉瘤<br>C.霍奇金淋巴瘤<br>D.横纹肌肉瘤<br>E.Kaposi 肉瘤</td>
      <td>D.横纹肌肉瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>32. 下列哪一项不是肿瘤分级的根据？(3.0分)</td>
      <td>A.核分裂数多少<br>B.分化程度<br>C.有无转移<br>D.组织异型性<br>E.细胞的多形性</td>
      <td>C.有无转移</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2010</td>
      <td>33. 不抑制骨髓造血功能的抗肿瘤药物是(3.0分)</td>
      <td>A.烷化剂<br>B.抗代谢类<br>C.抗生素类<br>D.植物碱类<br>E.激素类</td>
      <td>E.激素类</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>1. 诱导细胞原癌基因激活的基因突变的方式不包括(4.0分)</td>
      <td>A.DNA扩增<br>B.DNA点突变<br>C.染色体重排<br>D.基因高度甲基化<br>E.基因低、去甲基化</td>
      <td>D.基因高度甲基化</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>2. 关于肿瘤的论述，下列除哪些是正确的(4.0分)</td>
      <td>A.肿瘤的发生是多阶段、多步骤的长期过程<br>B.肿瘤的发生与原癌基因的激活和抑癌基因的失活有关<br>C.肿瘤的发生是单个基因突变的结果<br>D.肿瘤的发生是多因素造成的</td>
      <td>C.肿瘤的发生是单个基因突变的结果</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>3. 下列哪些分子抑制肿瘤的侵犯和转移(4.0分)</td>
      <td>A.MMP和u-PA<br>B.Kiss和肿瘤血管生成因子（TAF）<br>C.自分泌运动因子（AMF）和TIMP<br>D.angiostain 和nm23<br>E.以上都不是</td>
      <td>D.angiostain 和nm23</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>4. 下列哪些细胞黏附分子可能与肿瘤转移的器官选择有关(4.0分)</td>
      <td>A.整合素<br>B.E-钙粘素<br>C.选择素<br>D.免疫球蛋白超家族<br>E.CD44</td>
      <td>C.选择素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>5. 下列哪项是化学致癌物的作用的根本机制(4.0分)</td>
      <td>A.蛋白构象变化；<br>B.体细胞DNA损伤；<br>C.致癌物与RNA聚合酶结合；<br>D.免疫功能改变</td>
      <td>B.体细胞DNA损伤；</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>6. 以下对NK细胞杀瘤有关叙述，错误的是(4.0分)</td>
      <td>A.无特异性<br>B.无需预先活化，即可直接杀瘤<br>C.可依赖抗体通过ADCC方式杀瘤<br>D.依赖补体，通过CDC方式杀瘤<br>E.无MHC限制性</td>
      <td>D.依赖补体，通过CDC方式杀瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>7. 关于Tumor-Associated Antigens (TAA)最准确的描述(4.0分)</td>
      <td>A.They are antigens found only in tumor cells<br>B.They can be found in both tumor and some normal cells, but the level is significantly higher in the tumor cells<br>C.They are typically the products of tumor suppressor genes; an example would be Rb<br>D.They are the result of genes mutated by DNA-damaging carcinogens such as MNNG<br>E.They are typically encoded by oncogenic viruses such as EBV</td>
      <td>B.They can be found in both tumor and some normal cells, but the level is significantly higher in the tumor cells</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>8. 什么是抗原调变(4.0分)</td>
      <td>A.肿瘤细胞表面抗原表位减少或丢失，从而使肿瘤细胞避免宿主免疫系统的杀伤<br>B.肿瘤细胞表面的抗原与正常细胞的膜分子差异很小<br>C.肿瘤细胞MHC-Ⅰ类抗原表达下降，逃避CTL的攻击<br>D.肿瘤细胞不表达MHC-II类抗原<br>E.以上都不是</td>
      <td>A.肿瘤细胞表面抗原表位减少或丢失，从而使肿瘤细胞避免宿主免疫系统的杀伤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>9. 在抗肿瘤免疫应答中，CTL主要发挥什么样的功能(5.0分)</td>
      <td>A.通过穿孔素和颗粒酶杀伤肿瘤细胞，诱导肿瘤细胞发生凋亡<br>B.通过分泌IFN- 和IL-2，活化巨噬细胞<br>C.产生活性氧，破坏肿瘤细胞膜<br>D.通过ADCC杀伤肿瘤<br>E.产生肿瘤特异性的抗体</td>
      <td>A.通过穿孔素和颗粒酶杀伤肿瘤细胞，诱导肿瘤细胞发生凋亡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>10. 肿瘤局部的Gr-1+CD11b+髓系来源抑制性细胞主要发挥下述作用(4.0分)</td>
      <td>A.杀伤肿瘤细胞<br>B.激活树突状细胞<br>C.参与肿瘤免疫逃逸<br>D.产生抗体<br>E.协助CTL抗肿瘤</td>
      <td>C.参与肿瘤免疫逃逸</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>11. 来源于三个胚层组织的肿瘤称(4.0分)</td>
      <td>A.癌肉瘤<br>B.混合瘤<br>C.畸胎瘤<br>D.错构瘤<br>E.胚胎瘤</td>
      <td>C.畸胎瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>12. 皮下一肿块，边界清楚，有包膜，质硬，灰白色，切面性质均匀一致，无继发改变，可见纤细的编织状条纹，该肿物可能诊断为(4.0分)</td>
      <td>A.纤维瘤<br>B.纤维肉瘤<br>C.平滑肌瘤<br>D.平滑肌肉瘤<br>E.脂肪瘤</td>
      <td>A.纤维瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>13. 骨肉瘤的主要诊断依据是(4.0分)</td>
      <td>A.好发于青少年<br>B.血道转移<br>C.发生于长骨骨干<br>D.出现肿瘤性骨质<br>E.可发生病理性骨折</td>
      <td>D.出现肿瘤性骨质</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>14. 良性肿瘤的异型性主要表现在(4.0分)</td>
      <td>A.瘤细胞的多形性<br>B.细胞核的多形性<br>C.组织结构的异型性<br>D.病理性核分裂<br>E.细胞异型性</td>
      <td>C.组织结构的异型性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>15. 下列哪项最符合鳞状细胞癌的特征(5.0分)</td>
      <td>A.发生于原有单层扁平上皮的覆盖部位<br>B.呈外生性生长<br>C.癌细胞的排列及形态仍保留单层扁平上皮的某些特征<br>D.癌珠形成<br>E.主要经淋巴道转移</td>
      <td>C.癌细胞的排列及形态仍保留单层扁平上皮的某些特征</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>16. 胃癌癌细胞穿透浆膜脱落于腹膜上形成的转移瘤称为(4.0分)</td>
      <td>A.远处转移<br>B.接触性转移<br>C.肿瘤直接蔓延<br>D.种植性转移<br>E.移植性转移</td>
      <td>D.种植性转移</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>17. 下列哪项不属于细胞异型性(4.0分)</td>
      <td>A.核数目不一<br>B.核肿胀，核膜不清<br>C.核染色质分布不均<br>D.核大小不等，核畸形<br>E.病理性核分裂象</td>
      <td>B.核肿胀，核膜不清</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>18. 高分化鳞癌的组织学特点是(4.0分)</td>
      <td>A.实质与间质分界清楚<br>B.无细胞间桥<br>C.基底膜完整<br>D.有癌巢形成<br>E.有角化珠形成</td>
      <td>E.有角化珠形成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>19. 骨肉瘤是指(4.0分)</td>
      <td>A.骨原发性的恶性肿瘤，有反应性骨质增生<br>B.肉瘤细胞直接形成肿瘤性骨样组织或骨组织的肿瘤<br>C.骨组织起源的肉瘤<br>D.骨组织中肉瘤的总称<br>E.骨组织来源的未分化肿瘤</td>
      <td>B.肉瘤细胞直接形成肿瘤性骨样组织或骨组织的肿瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>20. 乳头状瘤的乳头中心(轴索)的成分是(5.0分)</td>
      <td>A.癌细胞<br>B.脉管<br>C.纤维结缔组织<br>D.癌细胞和纤维结缔组织<br>E.纤维结缔组织和脉管</td>
      <td>E.纤维结缔组织和脉管</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>21. 长春新碱使肿瘤细胞较多的处于增殖周期的(4.0分)</td>
      <td>A.S期<br>B.G0期<br>C.G1期<br>D.G2期<br>E.M期</td>
      <td>E.M期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>22. 博莱霉素主要用于治疗(4.0分)</td>
      <td>A.慢性粒细胞白血病<br>B.急性淋巴细胞白血病<br>C.绒毛膜上皮癌<br>D.前列腺癌<br>E.鳞状上皮癌</td>
      <td>E.鳞状上皮癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>23. 贝伐单抗bevacizumab是以下哪个蛋白的抗体？(5.0分)</td>
      <td>A.EGFR<br>B.VEGF<br>C.CD20<br>D.Bcr-Abl<br>E.ER</td>
      <td>B.VEGF</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2011</td>
      <td>24. 治疗绒毛膜上皮细胞癌的药物是(4.0分)</td>
      <td>A.己烯雌酚<br>B.丙酸睾丸酮<br>C.甲氨蝶呤<br>D.白消安<br>E.放射性碘131I</td>
      <td>C.甲氨蝶呤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>1. 下列哪种为癌基因：(2.5分)</td>
      <td>A.ras基因<br>B.p53基因<br>C.Rb基因<br>D.Apc基因<br>E.NF－1基因:</td>
      <td>A.ras基因</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>2. 下列哪些肿瘤不与病毒感染密切相关有：(2.5分)</td>
      <td>A.肝细胞肝癌<br>B.宫颈癌<br>C.鼻咽癌<br>D.皮肤癌<br>E.Burkitt淋巴瘤</td>
      <td>D.皮肤癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>3. 关于肿瘤的论述，下列除哪些是正确的：(2.5分)</td>
      <td>A.肿瘤的发生是多阶段、多步骤的长期过程<br>B.肿瘤的发生与原癌基因的激活和抑癌基因的失活有关<br>C.肿瘤的发生是单个基因突变的结果<br>D.肿瘤的发生是多因素造成的</td>
      <td>C.肿瘤的发生是单个基因突变的结果</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>4. 下列不属于抑癌基因的是：(2.5分)</td>
      <td>A.bcl-2<br>B.p53<br>C.nm23<br>D.pRb<br>E.p16</td>
      <td>A.bcl-2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>5. 下列哪些细胞黏附分子可能与肿瘤转移的器官选择有关(2.5分)</td>
      <td>A.整合素<br>B.E-钙粘素<br>C.选择素<br>D.免疫球蛋白超家族<br>E.CD44</td>
      <td>C.选择素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>6. 下列哪些分子在肿瘤中高表达提示预后良好(2.5分)</td>
      <td>A.MMP和TIMP<br>B.erbB2和P16<br>C.TIMP 和KAI1<br>D.Ras 和Myc<br>E.以上都不是</td>
      <td>C.TIMP 和KAI1</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>7. 骨肉瘤的好发部位是：(2.5分)</td>
      <td>A.头面骨<br>B.脊椎骨<br>C.扁骨<br>D.长骨<br>E.指(趾)骨</td>
      <td>D.长骨</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>8. 皮下一肿块，边界清楚，有包膜，质硬，灰白色，切面性质均匀一致，无继发改变，可见纤细的编织状条纹，该肿物可能诊断为： (2.5分)</td>
      <td>A.纤维瘤<br>B.纤维肉瘤<br>C.平滑肌瘤<br>D.平滑肌肉瘤<br>E.脂肪瘤</td>
      <td>A.纤维瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>9. 肉瘤的肉眼特点通常为： (2.5分)</td>
      <td>A.结节状、有包膜，切面灰白质硬<br>B.结节状、有包膜，切面灰白质软<br>C.分叶状，可有或无包膜，切面灰红或粉红色，质硬<br>D.形状不定，切面灰白色，质硬，干燥<br>E.不规则结节状，有无完整包膜不定，切面灰红色，湿润质软如鱼肉状</td>
      <td>E.不规则结节状，有无完整包膜不定，切面灰红色，湿润质软如鱼肉状</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>10. 以下哪项是癌与肉瘤的主要区别点： (2.5分)</td>
      <td>A.发病年龄<br>B.大体特点<br>C.组织结构<br>D.恶性程度<br>E.转移途径</td>
      <td>C.组织结构</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>11. 血道转移发生较早的癌是： (2.5分)</td>
      <td>A.绒毛膜癌<br>B.鼻咽癌<br>C.肝癌<br>D.肺癌<br>E.胃癌</td>
      <td>A.绒毛膜癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>12. 膀胱最常见的恶性肿瘤为： (2.5分)</td>
      <td>A.腺癌<br>B.鳞状细胞癌<br>C.移行细胞癌<br>D.纤维肉瘤<br>E.平滑肌肉瘤</td>
      <td>C.移行细胞癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>13. 高分化鳞癌的组织学特点是： (2.5分)</td>
      <td>A.实质与间质分界清楚<br>B.无细胞间桥<br>C.基底膜完整<br>D.有癌巢形成<br>E.有角化珠形成</td>
      <td>E.有角化珠形成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>14. 胃癌癌细胞穿透浆膜脱落于腹膜上形成的转移瘤称为： (2.5分)</td>
      <td>A.远处转移<br>B.接触性转移<br>C.肿瘤直接蔓延<br>D.种植性转移<br>E.移植性转移</td>
      <td>D.种植性转移</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>15. 下列哪项为纤维腺瘤的特征： (2.5分)</td>
      <td>A.多呈分叶状<br>B.包膜不完整，切除后易复发<br>C.易恶变<br>D.瘤实质由增生的腺上皮和纤维组织组成<br>E.常发生于卵巢</td>
      <td>D.瘤实质由增生的腺上皮和纤维组织组成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>16. 下列哪项不属于细胞异型性： (2.5分)</td>
      <td>A.核数目不一<br>B.核肿胀，核膜不清<br>C.核染色质分布不均<br>D.核大小不等，核畸形<br>E.病理性核分裂象</td>
      <td>B.核肿胀，核膜不清</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>17. 最能体现腺癌的特点的是：(2.5分)</td>
      <td>A.发生于腺上皮<br>B.癌细胞呈腺样排列<br>C.癌巢形成<br>D.呈结节样外观<br>E.异型性明显</td>
      <td>B.癌细胞呈腺样排列</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>18. 下图是哪种疾病的镜下表现： (2.5分)</td>
      <td>A.大肠腺癌<br>B.骨肉瘤<br>C.肝癌（间变癌）<br>D.何杰金氏病<br>E.食管鳞癌</td>
      <td>E.食管鳞癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>19. 骨肉瘤的主要诊断依据是： (2.5分)</td>
      <td>A.好发于青少年<br>B.血道转移<br>C.发生于长骨骨干<br>D.出现肿瘤性骨质<br>E.可发生病理性骨折</td>
      <td>D.出现肿瘤性骨质</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>20. 良性肿瘤的异型性主要表现在： (2.5分)</td>
      <td>A.瘤细胞的多形性<br>B.细胞核的多形性<br>C.组织结构的异型性<br>D.病理性核分裂<br>E.细胞异型性</td>
      <td>C.组织结构的异型性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>21. 乳头状瘤的乳头中心(轴索)的成分是： (2.5分)</td>
      <td>A.癌细胞<br>B.脉管<br>C.纤维结缔组织<br>D.癌细胞和纤维结缔组织<br>E.纤维结缔组织和脉管</td>
      <td>E.纤维结缔组织和脉管</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>22. 来源于三个胚层组织的肿瘤称： (2.5分)</td>
      <td>A.癌肉瘤<br>B.混合瘤<br>C.畸胎瘤<br>D.错构瘤<br>E.胚胎瘤</td>
      <td>C.畸胎瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>23. 肿瘤发生的主要免疫学机制是：(2.5分)</td>
      <td>A.免疫防御功能障碍<br>B.免疫监视功能障碍<br>C.免疫自稳功能障碍<br>D.免疫调节功能障碍<br>E.免疫功能亢进</td>
      <td>B.免疫监视功能障碍</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>24. 人HPV与下列哪种肿瘤的发生有关：(2.5分)</td>
      <td>A.宫颈癌<br>B.乳腺癌<br>C.黑色素瘤<br>D.肝癌<br>E.前列腺癌</td>
      <td>A.宫颈癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>25. 机体的抗肿瘤免疫效应机制中起主导作用的是：(2.5分)</td>
      <td>A.体液免疫<br>B.细胞免疫<br>C.巨噬细胞杀伤作用<br>D.NK细胞杀伤肿瘤<br>E.细胞因子杀瘤作用</td>
      <td>B.细胞免疫</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>26. 以下对NK细胞杀瘤有关叙述，错误的是：(2.5分)</td>
      <td>A.无特异性<br>B.无需预先活化，即可直接杀瘤<br>C.可依赖抗体通过ADCC方式杀瘤<br>D.依赖补体，通过CDC方式杀瘤<br>E.无MHC限制性</td>
      <td>D.依赖补体，通过CDC方式杀瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>27. 关于Tumor-Associated Antigens (TAA)最准确的描述：(2.5分)</td>
      <td>A.They are antigens found only in tumor cells<br>B.They can be found in both tumor and some normal cells, but the level is significantly higher in the tumor cells<br>C.They are typically the products of tumor suppressor genes; an example would be Rb<br>D.They are the result of genes mutated by DNA-damaging carcinogens such as MNNG<br>E.They are typically encoded by oncogenic viruses such as EBV</td>
      <td>B.They can be found in both tumor and some normal cells, but the level is significantly higher in the tumor cells</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>28. 什么是抗原调变：(2.5分)</td>
      <td>A.肿瘤细胞表面抗原表位减少或丢失，从而使肿瘤细胞避免宿主免疫系统的杀伤<br>B.肿瘤细胞表面的抗原与正常细胞的膜分子差异很小<br>C.肿瘤细胞MHC-Ⅰ类抗原表达下降，逃避CTL的攻击<br>D.肿瘤细胞不表达MHC-II类抗原<br>E.以上都不是</td>
      <td>A.肿瘤细胞表面抗原表位减少或丢失，从而使肿瘤细胞避免宿主免疫系统的杀伤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>29. 肿瘤细胞常高表达下述分子：(2.5分)</td>
      <td>A.MHC I类分子<br>B.MHC II类分子<br>C.CD80<br>D.CD86<br>E.TGF- 、IL-10等免疫抑制分子</td>
      <td>E.TGF- 、IL-10等免疫抑制分子</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>30. 肿瘤局部的Gr-1+CD11b+髓系来源抑制性细胞主要发挥下述作用：(2.5分)</td>
      <td>A.杀伤肿瘤细胞<br>B.激活树突状细胞<br>C.参与肿瘤免疫逃逸<br>D.产生抗体<br>E.协助CTL抗肿瘤</td>
      <td>C.参与肿瘤免疫逃逸</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>31. 下列哪个肿瘤细胞表面分子表达降低可使其逃逸机体免疫监视：(2.5分)</td>
      <td>A.B7<br>B.MHC II类分子<br>C.bcl-2<br>D.FasL<br>E.CD40</td>
      <td>A.B7</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>32. 长春新碱使肿瘤细胞较多的处于增殖周期的：(2.5分)</td>
      <td>A.S期<br>B.G0期<br>C.G1期<br>D.G2期<br>E.M期</td>
      <td>E.M期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>33. 抑制二氢叶酸还原酶的抗肿瘤药是：(2.5分)</td>
      <td>A.顺铂<br>B.阿霉素<br>C.环磷酰胺<br>D.5-氟尿嘧啶<br>E.甲氨蝶呤</td>
      <td>E.甲氨蝶呤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>34. 以下属于S期特异性的抗肿瘤药物是：(2.5分)</td>
      <td>A.喜树碱<br>B.博莱霉素<br>C.甲氨蝶呤<br>D.左旋门冬酰胺酶<br>E.鬼臼毒素</td>
      <td>C.甲氨蝶呤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>35. 以下属于M期特异性抗肿瘤药物是：(2.5分)</td>
      <td>A.长春新碱<br>B.环磷酰胺<br>C.鬼臼毒素<br>D.左旋门冬酰胺酶<br>E.甲氨蝶呤</td>
      <td>A.长春新碱</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>36. 博莱霉素主要用于治疗：(2.5分)</td>
      <td>A.慢性粒细胞白血病<br>B.急性淋巴细胞白血病<br>C.绒毛膜上皮癌<br>D.前列腺癌<br>E.鳞状上皮癌</td>
      <td>E.鳞状上皮癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>37. 治疗绒毛膜上皮细胞癌的药物是：(2.5分)</td>
      <td>A.己烯雌酚<br>B.丙酸睾丸酮<br>C.甲氨蝶呤<br>D.白消安<br>E.放射性碘131I</td>
      <td>C.甲氨蝶呤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>1. 下列属于周期非特异性抗肿瘤药物是：(2.5分)</td>
      <td>A.环磷酰胺<br>B.5-氟尿嘧啶<br>C.泼尼松<br>D.柔红霉素<br>E.丝裂霉素</td>
      <td>A.环磷酰胺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>2. 下列周期特异性抗肿瘤药物是：(2.5分)</td>
      <td>A.甲氨蝶呤<br>B.顺铂<br>C.羟基喜树碱<br>D.长春新碱<br>E.氟尿嘧啶</td>
      <td>C.泼尼松</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2012</td>
      <td>3. 阿霉素的特点是：(2.5分)</td>
      <td>A.骨髓抑制<br>B.肾毒性<br>C.心脏毒性<br>D.抑制DNA及RNA的合成<br>E.属于细胞周期特异性药物</td>
      <td>D.柔红霉素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>1. 下列哪种为癌基因：(2.5分)</td>
      <td>A.ras基因<br>B.p53基因<br>C.Rb基因<br>D.Apc基因<br>E.NF－1基因:</td>
      <td>A.ras基因</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>2. 下列哪些肿瘤不与病毒感染密切相关有：(2.5分)</td>
      <td>A.肝细胞肝癌<br>B.宫颈癌<br>C.鼻咽癌<br>D.皮肤癌<br>E.Burkitt淋巴瘤</td>
      <td>D.皮肤癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>3. 关于肿瘤的论述，下列除哪些是正确的：(2.5分)</td>
      <td>A.肿瘤的发生是多阶段、多步骤的长期过程<br>B.肿瘤的发生与原癌基因的激活和抑癌基因的失活有关<br>C.肿瘤的发生是单个基因突变的结果<br>D.肿瘤的发生是多因素造成的</td>
      <td>C.肿瘤的发生是单个基因突变的结果</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>4. 下列不属于抑癌基因的是：(2.5分)</td>
      <td>A.bcl-2<br>B.p53<br>C.nm23<br>D.pRb<br>E.p16</td>
      <td>A.bcl-2</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>5. 下列哪些细胞黏附分子可能与肿瘤转移的器官选择有关(2.5分)</td>
      <td>A.整合素<br>B.E-钙粘素<br>C.选择素<br>D.免疫球蛋白超家族<br>E.CD44</td>
      <td>C.选择素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>6. 下列哪些分子在肿瘤中高表达提示预后良好(2.5分)</td>
      <td>A.MMP和TIMP<br>B.erbB2和P16<br>C.TIMP 和KAI1<br>D.Ras 和Myc<br>E.以上都不是</td>
      <td>C.TIMP 和KAI1</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>7. 骨肉瘤的好发部位是：(2.5分)</td>
      <td>A.头面骨<br>B.脊椎骨<br>C.扁骨<br>D.长骨<br>E.指(趾)骨</td>
      <td>D.长骨</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>8. 皮下一肿块，边界清楚，有包膜，质硬，灰白色，切面性质均匀一致，无继发改变，可见纤细的编织状条纹，该肿物可能诊断为： (2.5分)</td>
      <td>A.纤维瘤<br>B.纤维肉瘤<br>C.平滑肌瘤<br>D.平滑肌肉瘤<br>E.脂肪瘤</td>
      <td>A.纤维瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>9. 肉瘤的肉眼特点通常为： (2.5分)</td>
      <td>A.结节状、有包膜，切面灰白质硬<br>B.结节状、有包膜，切面灰白质软<br>C.分叶状，可有或无包膜，切面灰红或粉红色，质硬<br>D.形状不定，切面灰白色，质硬，干燥<br>E.不规则结节状，有无完整包膜不定，切面灰红色，湿润质软如鱼肉状</td>
      <td>E.不规则结节状，有无完整包膜不定，切面灰红色，湿润质软如鱼肉状</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>10. 以下哪项是癌与肉瘤的主要区别点： (2.5分)</td>
      <td>A.发病年龄<br>B.大体特点<br>C.组织结构<br>D.恶性程度<br>E.转移途径</td>
      <td>C.组织结构</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>11. 血道转移发生较早的癌是： (2.5分)</td>
      <td>A.绒毛膜癌<br>B.鼻咽癌<br>C.肝癌<br>D.肺癌<br>E.胃癌</td>
      <td>A.绒毛膜癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>12. 膀胱最常见的恶性肿瘤为： (2.5分)</td>
      <td>A.腺癌<br>B.鳞状细胞癌<br>C.移行细胞癌<br>D.纤维肉瘤<br>E.平滑肌肉瘤</td>
      <td>C.移行细胞癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>13. 高分化鳞癌的组织学特点是： (2.5分)</td>
      <td>A.实质与间质分界清楚<br>B.无细胞间桥<br>C.基底膜完整<br>D.有癌巢形成<br>E.有角化珠形成</td>
      <td>E.有角化珠形成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>14. 胃癌癌细胞穿透浆膜脱落于腹膜上形成的转移瘤称为： (2.5分)</td>
      <td>A.远处转移<br>B.接触性转移<br>C.肿瘤直接蔓延<br>D.种植性转移<br>E.移植性转移</td>
      <td>D.种植性转移</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>15. 下列哪项为纤维腺瘤的特征： (2.5分)</td>
      <td>A.多呈分叶状<br>B.包膜不完整，切除后易复发<br>C.易恶变<br>D.瘤实质由增生的腺上皮和纤维组织组成<br>E.常发生于卵巢</td>
      <td>D.瘤实质由增生的腺上皮和纤维组织组成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>16. 下列哪项不属于细胞异型性： (2.5分)</td>
      <td>A.核数目不一<br>B.核肿胀，核膜不清<br>C.核染色质分布不均<br>D.核大小不等，核畸形<br>E.病理性核分裂象</td>
      <td>B.核肿胀，核膜不清</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>17. 最能体现腺癌的特点的是：(2.5分)</td>
      <td>A.发生于腺上皮<br>B.癌细胞呈腺样排列<br>C.癌巢形成<br>D.呈结节样外观<br>E.异型性明显</td>
      <td>B.癌细胞呈腺样排列</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>18. 下图是哪种疾病的镜下表现： (2.5分)</td>
      <td>A.大肠腺癌<br>B.骨肉瘤<br>C.肝癌（间变癌）<br>D.何杰金氏病<br>E.食管鳞癌</td>
      <td>E.食管鳞癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>19. 骨肉瘤的主要诊断依据是： (2.5分)</td>
      <td>A.好发于青少年<br>B.血道转移<br>C.发生于长骨骨干<br>D.出现肿瘤性骨质<br>E.可发生病理性骨折</td>
      <td>D.出现肿瘤性骨质</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>20. 良性肿瘤的异型性主要表现在： (2.5分)</td>
      <td>A.瘤细胞的多形性<br>B.细胞核的多形性<br>C.组织结构的异型性<br>D.病理性核分裂<br>E.细胞异型性</td>
      <td>C.组织结构的异型性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>21. 乳头状瘤的乳头中心(轴索)的成分是： (2.5分)</td>
      <td>A.癌细胞<br>B.脉管<br>C.纤维结缔组织<br>D.癌细胞和纤维结缔组织<br>E.纤维结缔组织和脉管</td>
      <td>E.纤维结缔组织和脉管</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>22. 来源于三个胚层组织的肿瘤称： (2.5分)</td>
      <td>A.癌肉瘤<br>B.混合瘤<br>C.畸胎瘤<br>D.错构瘤<br>E.胚胎瘤</td>
      <td>C.畸胎瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>23. Which of the following mechanisms may be involved in rejection of a tumor：(2.5分)</td>
      <td>A.T cell-mediated cytotoxicity<br>B.ADCC<br>C.Complement-dependent cytotoxicity<br>D.All of the above.<br>E.None of the above.</td>
      <td>D.All of the above.</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>24. 人HPV与下列哪种肿瘤的发生有关：(2.5分)</td>
      <td>A.宫颈癌<br>B.乳腺癌<br>C.黑色素瘤<br>D.肝癌<br>E.前列腺癌</td>
      <td>A.宫颈癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>25. 机体的抗肿瘤免疫效应机制中起主导作用的是：(2.5分)</td>
      <td>A.体液免疫<br>B.细胞免疫<br>C.巨噬细胞杀伤作用<br>D.NK细胞杀伤肿瘤<br>E.细胞因子杀瘤作用</td>
      <td>B.细胞免疫</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>26. 以下对NK细胞杀瘤有关叙述，错误的是：(2.5分)</td>
      <td>A.无特异性<br>B.无需预先活化，即可直接杀瘤<br>C.可依赖抗体通过ADCC方式杀瘤<br>D.依赖补体，通过CDC方式杀瘤<br>E.无MHC限制性</td>
      <td>D.依赖补体，通过CDC方式杀瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>27. 关于Tumor-Associated Antigens (TAA)最准确的描述：(2.5分)</td>
      <td>A.They are antigens found only in tumor cells<br>B.They can be found in both tumor and some normal cells, but the level is significantly higher in the tumor cells<br>C.They are typically the products of tumor suppressor genes; an example would be Rb<br>D.They are the result of genes mutated by DNA-damaging carcinogens such as MNNG<br>E.They are typically encoded by oncogenic viruses such as EBV</td>
      <td>B.They can be found in both tumor and some normal cells, but the level is significantly higher in the tumor cells</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>28. 什么是抗原调变：(2.5分)</td>
      <td>A.肿瘤细胞表面抗原表位减少或丢失，从而使肿瘤细胞避免宿主免疫系统的杀伤<br>B.肿瘤细胞表面的抗原与正常细胞的膜分子差异很小<br>C.肿瘤细胞MHC-Ⅰ类抗原表达下降，逃避CTL的攻击<br>D.肿瘤细胞不表达MHC-II类抗原<br>E.以上都不是</td>
      <td>A.肿瘤细胞表面抗原表位减少或丢失，从而使肿瘤细胞避免宿主免疫系统的杀伤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>29. 肿瘤细胞常高表达下述分子：(2.5分)</td>
      <td>A.MHC I类分子<br>B.MHC II类分子<br>C.CD80<br>D.CD86<br>E.TGF-?、IL-10等免疫抑制分子</td>
      <td>E.TGF-?、IL-10等免疫抑制分子</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>30. 肿瘤局部的Gr-1+CD11b+髓系来源抑制性细胞主要发挥下述作用：(2.5分)</td>
      <td>A.杀伤肿瘤细胞<br>B.激活树突状细胞<br>C.参与肿瘤免疫逃逸<br>D.产生抗体<br>E.协助CTL抗肿瘤</td>
      <td>C.参与肿瘤免疫逃逸</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>31. Which of the following statements is most true regarding therapy with anti-tumor antibodies? (2.5分)</td>
      <td>A.Their use is currently under investigation, but none have yet been approved for clinical use<br>B.They are important reagents in the application of LAK (Lymphokine-activated killers) therapy to tumors<br>C.Their use requires the prior pulsing of dendritic cells with B7 and/or IL-2.<br>D.They can be conjugated with toxins or radioactive components in order to deliver a toxic dose specifically to tumor cells<br>E.They are particularly useful in tumors which have been selected to express very high levels of MHC molecules</td>
      <td>D.They can be conjugated with toxins or radioactive components in order to deliver a toxic dose specifically to tumor cells</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>32. 长春新碱使肿瘤细胞较多的处于增殖周期的：(2.5分)</td>
      <td>A.S期<br>B.G0期<br>C.G1期<br>D.G2期<br>E.M期</td>
      <td>E.M期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>33. 异型性与分化之间的关系：(2.5分)</td>
      <td>A.异型性小，分化程度高<br>B.异型性大，分化程度高<br>C.异型性小，分化程度低</td>
      <td>A.异型性小，分化程度高</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>34. 抑制二氢叶酸还原酶的抗肿瘤药是：(2.5分)</td>
      <td>A.顺铂<br>B.阿霉素<br>C.环磷酰胺<br>D.5-氟尿嘧啶<br>E.甲氨蝶呤</td>
      <td>E.甲氨蝶呤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>35. 以下属于S期特异性的抗肿瘤药物是：(2.5分)</td>
      <td>A.喜树碱<br>B.博莱霉素<br>C.甲氨蝶呤<br>D.左旋门冬酰胺酶<br>E.鬼臼毒素</td>
      <td>C.甲氨蝶呤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>36. 以下属于M期特异性抗肿瘤药物是：(2.5分)</td>
      <td>A.长春新碱<br>B.环磷酰胺<br>C.鬼臼毒素<br>D.左旋门冬酰胺酶<br>E.甲氨蝶呤</td>
      <td>A.长春新碱</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>37. 博莱霉素主要用于治疗：(2.5分)</td>
      <td>A.慢性粒细胞白血病<br>B.急性淋巴细胞白血病<br>C.绒毛膜上皮癌<br>D.前列腺癌<br>E.鳞状上皮癌</td>
      <td>E.鳞状上皮癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>38. 肿瘤的转移方式为：(2.5分)</td>
      <td>A.血行<br>B.淋巴<br>C.种植性<br>D.A、B和C</td>
      <td>D.A、B和C</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>39. 请问以下大体标本是： (2.5分)</td>
      <td>A.肝癌<br>B.肺结节<br>C.肺转移性肝癌</td>
      <td>C.肺转移性肝癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>8</td>
      <td>2013</td>
      <td>40. 39 题中肿瘤的转移方式为：(2.5分)</td>
      <td>A.血行<br>B.淋巴<br>C.种植性<br>D.A、B和C</td>
      <td>A.血行</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>1. Fluorouracil（5-FU）属于(2.0分)</td>
      <td>A.周期非特异性药物，干扰蛋白质合成，作用于S期的药物<br>B.周期特异性药物，干扰DNA合成及干扰RNA功能，作用于S期及其他各期<br>C.周期非特异性药物，干扰RNA合成，作用于M期的药物<br>D.周期特异性药物，干扰DNA合成，作用于M期药物<br>E.周期特异性药物，干扰RNA合成，作用于M期药物</td>
      <td>B.周期特异性药物，干扰DNA合成及干扰RNA功能，作用于S期及其他各期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>2. Fluorouracil（5-FU）常见的严重不良反应是 (2.0分)</td>
      <td>A.变态反应<br>B.血压增高<br>C.骨髓抑制<br>D.高尿酸血症<br>E.头晕</td>
      <td>C.骨髓抑制</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>3. 阻碍细胞有丝分裂的抗癌药是(2.0分)</td>
      <td>A.氟尿嘧啶<br>B.丝裂霉素<br>C.紫杉醇<br>D.甲氨蝶呤以上都不是</td>
      <td>C.紫杉醇</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>4. 为了减轻甲氨蝶呤的毒性反应所用的救援剂是(2.0分)</td>
      <td>A.叶酸<br>B.甲酰四氢叶酸钙<br>C.磷酸亚铁<br>D.维生素B<br>E.维生素C</td>
      <td>B.甲酰四氢叶酸钙</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>5. 甲氨蝶呤抗肿瘤的主要机制是(2.0分)</td>
      <td>A.抑制二氢叶酸还原酶<br>B.抑制肿瘤细胞的蛋白质合成<br>C.阻碍肿瘤细胞的嘌呤合成代谢<br>D.干扰肿瘤细胞的RNA转录<br>E.阻止转录细胞的DNA复制</td>
      <td>A.抑制二氢叶酸还原酶</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>6. 烷化剂中易发生出血性膀胱炎的药物是(2.0分)</td>
      <td>A.环磷酰胺<br>B.氮芥<br>C.白消安<br>D.噻替派<br>E.顺铂</td>
      <td>A.环磷酰胺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>7. 放线菌素D对处于哪一期的肿瘤细胞作用较强？(2.0分)</td>
      <td>A.S期<br>B.G2期<br>C.G1期<br>D.G0期<br>E.M期</td>
      <td>C.G1期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>8. 可使肿瘤细胞集中于G1期，常作同步化治疗的药物是 (2.0分)</td>
      <td>A.羟基脲<br>B.放线菌素D<br>C.博来霉素<br>D.环磷酰胺<br>E.长春碱</td>
      <td>A.羟基脲</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>9. 氟尿嘧啶对下列哪种肿瘤疗效较好？ (2.0分)</td>
      <td>A.消化道癌和乳腺癌<br>B.膀胱癌和肺癌<br>C.绒毛膜上皮癌<br>D.卵巢癌<br>E.子宫颈癌</td>
      <td>A.消化道癌和乳腺癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>10. 对长春新碱的叙述，下列哪项是错误的？ (2.0分)</td>
      <td>A.对外周神经系统毒性较小<br>B.主要作用于M期细胞<br>C.能够抑制微管聚合，影响纺锤丝形成<br>D.对儿童急性淋巴细胞性白血病疗效好<br>E.可干扰蛋白质合成和RNA多聚酶</td>
      <td>A.对外周神经系统毒性较小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>11. 周期非特异性抗恶性肿瘤药对下列哪期肿瘤细胞不敏感(2.0分)</td>
      <td>A.G1期<br>B.G0期<br>C.S期<br>D.G2期<br>E.M期</td>
      <td>B.G0期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>12. 关于环磷酰胺的叙述，下列哪项是错误的？ (2.0分)</td>
      <td>A.须在体内转化为活性代谢产物发挥作用<br>B.抗瘤谱广，特别对恶性淋巴瘤疗效显著<br>C.体外无抗肿瘤作用<br>D.其代谢产物对肾脏、膀胱有刺激性，可致出血性膀胱炎<br>E.选择性高，不良反应少，脱发的发生率亦较其他烷化剂低</td>
      <td>E.选择性高，不良反应少，脱发的发生率亦较其他烷化剂低</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>13. 伴有心功能不全的肿瘤病人不宜应用哪一个抗癌药?(2.0分)</td>
      <td>A.Doxorubicin（adriamycin, ADM）<br>B.Mercaptopurine（6-MP）<br>C.Methotrexate（MTX）<br>D.Cytarabine（Ara-C）<br>E.Cisplatin（DDP）</td>
      <td>A.Doxorubicin（adriamycin, ADM）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>14. 具有骨髓抑制及心脏毒性的抗癌药为 (2.0分)</td>
      <td>A.阿霉素（ADM）<br>B.长春新碱 (VCR)<br>C.博来霉素（BLM）<br>D.丝裂霉素C（MMC）<br>E.甲氨蝶呤（MTX）</td>
      <td>A.阿霉素（ADM）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>15. 在下列抗肿瘤药中，骨髓抑制最轻的是 (2.0分)</td>
      <td>A.Vincristin（VCR）<br>B.Fluorouracil（5-Fu）<br>C.Methotrexate（MTX）<br>D.Thiotepa<br>E.Mercaptopurine（6-MP）</td>
      <td>A.Vincristin（VCR）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>16. 抗雌激素药tamoxifen（他莫昔芬）对下列哪一种肿瘤有效？(2.0分)</td>
      <td>A.慢性粒细胞性白血病<br>B.急性淋巴细胞性白血病<br>C.结肠癌<br>D.乳腺癌<br>E.前列腺癌</td>
      <td>D.乳腺癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>17. 表皮生长因子受体酪氨酸激酶抑制剂包括 (2.0分)</td>
      <td>A.吉非替尼（gifitinib）<br>B.三氧化二砷（arsenious acid）<br>C.维甲酸（retinoic acid）<br>D.甲氨蝶呤（MTX）<br>E.泼尼松（prednisone）</td>
      <td>A.吉非替尼（gifitinib）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>18. 伊马替尼（imatinib）属于 (2.0分)</td>
      <td>A.细胞凋亡诱导剂<br>B.DNA合成抑制药<br>C.免疫调节剂<br>D.血管再生抑制剂<br>E.酪氨酸激酶抑制剂</td>
      <td>E.酪氨酸激酶抑制剂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>19. 三氧化二砷（arsenious acid）属于 (2.0分)</td>
      <td>A.血管再生抑制剂<br>B.免疫调节剂<br>C.DNA合成抑制药<br>D.细胞凋亡诱导剂<br>E.酪氨酸激酶抑制剂</td>
      <td>D.细胞凋亡诱导剂</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>20. 抗肿瘤分子靶向药物属于 (2.0分)</td>
      <td>A.影响DNA结构与功能的药物<br>B.调节体内激素平衡的药物<br>C.非细胞毒类抗肿瘤药<br>D.细胞毒类抗肿瘤药<br>E.影响核酸生物合成的药物</td>
      <td>C.非细胞毒类抗肿瘤药</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>21. 肿瘤发生的主要免疫学机制是(2.0分)</td>
      <td>A.免疫自稳功能障碍<br>B.免疫监视功能障碍<br>C.免疫防御功能障碍<br>D.免疫调节功能障碍<br>E.免疫功能亢进</td>
      <td>B.免疫监视功能障碍</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>22. 机体对抗肿瘤的免疫应答机制包括(2.0分)</td>
      <td>A.ADCC<br>B.T细胞介导的细胞毒性<br>C.CDC<br>D.以上都是</td>
      <td>D.以上都是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>23. 肿瘤细胞免疫逃逸的机制不包括(2.0分)</td>
      <td>A.释放免疫抑制性物质<br>B.缺乏共刺激分子<br>C.肿瘤细胞的"漏逸"<br>D.以上都不是</td>
      <td>D.以上都不是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>24. 关于Tumor-Associated Antigens (TAA)最准确的描述(2.0分)</td>
      <td>A.They are antigens found only in tumor cells<br>B.They can be found in both tumor and some normal cells, but the level is significantly higher in the tumor cells<br>C.They are the result of genes mutated by DNA-damaging carcinogens such as MNNG<br>D.They are typically the products of tumor suppressor genes; an example would be Rb<br>E.They are typically encoded by oncogenic viruses such as EBV</td>
      <td>B.They can be found in both tumor and some normal cells, but the level is significantly higher in the tumor cells</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>25. 在抗肿瘤免疫应答中，CTL主要发挥什么样的功能(2.0分)</td>
      <td>A.通过穿孔素和颗粒酶杀伤肿瘤细胞，诱导肿瘤细胞发生凋亡<br>B.产生活性氧，破坏肿瘤细胞膜<br>C.通过分泌IFN- 和IL-2，活化巨噬细胞<br>D.通过ADCC杀伤肿瘤<br>E.产生肿瘤特异性的抗体</td>
      <td>A.通过穿孔素和颗粒酶杀伤肿瘤细胞，诱导肿瘤细胞发生凋亡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>26. 什么是抗原调变(2.0分)</td>
      <td>A.肿瘤细胞表面抗原表位减少或丢失，从而使肿瘤细胞避免宿主免疫系统的杀伤<br>B.肿瘤细胞MHC-Ⅰ类抗原表达下降，逃避CTL的攻击<br>C.肿瘤细胞表面的抗原与正常细胞的膜分子差异很小<br>D.肿瘤细胞不表达MHC-II类抗原</td>
      <td>A.肿瘤细胞表面抗原表位减少或丢失，从而使肿瘤细胞避免宿主免疫系统的杀伤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>27. 肿瘤细胞主要通过什么机制来抵抗凋亡(2.0分)</td>
      <td>A.某些肿瘤能表达非经典的Ⅰ类分子<br>B.肿瘤细胞膜表面Fas表达显著减少或丢失，而FasL的表达增强<br>C.肿瘤细胞分泌IL-10<br>D.表达mCRP(膜结合补体调节蛋白)分子</td>
      <td>B.肿瘤细胞膜表面Fas表达显著减少或丢失，而FasL的表达增强</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>28. 肿瘤可诱导哪种抑制性细胞亚群来抑制免疫应答(2.0分)</td>
      <td>A.B细胞<br>B.CTL（细胞毒性T细胞）<br>C.调节性T细胞<br>D.都不是</td>
      <td>C.调节性T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>29. 关于肿瘤的免疫逃逸机制，下列哪项是错误的(2.0分)</td>
      <td>A.宿主处于免疫缺陷状态<br>B.瘤细胞不表达B7分子<br>C.瘤细胞表面MHCⅠ类分子表达降低或缺失<br>D.瘤细胞缺乏抗原性表位<br>E.瘤细胞不表达转铁蛋白受体</td>
      <td>E.瘤细胞不表达转铁蛋白受体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>30. 关于肿瘤免疫的叙述，下列哪项是错误的(2.0分)</td>
      <td>A.静止的和活化的巨噬细胞均能杀伤瘤细胞<br>B.抗体并不是抗肿瘤的重要因素<br>C.NK细胞是机体抗肿瘤的第一道防线<br>D.细胞免疫是抗肿瘤的重要因素<br>E.中性粒细胞参与抗肿瘤作用</td>
      <td>A.静止的和活化的巨噬细胞均能杀伤瘤细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>31. 原位癌是指(2.0分)</td>
      <td>A.癌细胞仅限于上皮层内，尚未突破基底膜<br>B.未发生转移的癌<br>C.上皮细胞的不典型增生<br>D.近基底膜处的上皮癌变<br>E.癌细胞突破基底膜，但限于基底膜下3-5mm之内</td>
      <td>A.癌细胞仅限于上皮层内，尚未突破基底膜</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>32. 下列何者不是真性肿瘤 (2.0分)</td>
      <td>A.白血病<br>B.腺瘤<br>C.动脉瘤<br>D.纤维瘤<br>E.乳头状瘤</td>
      <td>C.动脉瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>33. 具有三个胚层组织的肿瘤称之(2.0分)</td>
      <td>A.畸胎瘤<br>B.癌肉瘤<br>C.纤维腺瘤<br>D.母细胞瘤<br>E.混合瘤</td>
      <td>A.畸胎瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>34. 肿瘤特性取决于(2.0分)</td>
      <td>A.肿瘤的间质<br>B.肿瘤的生长速度<br>C.肿瘤生长方式<br>D.肿瘤的转移<br>E.肿瘤的实质</td>
      <td>E.肿瘤的实质</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>35. 判断癌肿起源于鳞状细胞的依据 (2.0分)</td>
      <td>A.细胞多型性<br>B.癌细胞体积大，核浆比例增大<br>C.癌细胞呈巢状排列<br>D.有细胞间桥及角化珠形成<br>E.病理核分裂多</td>
      <td>D.有细胞间桥及角化珠形成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>36. 良性肿瘤的异型性主要表现在(2.0分)</td>
      <td>A.核浆比例失常<br>B.实质、间质排列紊乱<br>C.核染色深<br>D.瘤细胞大<br>E.瘤细胞核大</td>
      <td>B.实质、间质排列紊乱</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>37. 肿瘤生长速度主要取决于(2.0分)</td>
      <td>A.瘤细胞分化成熟程度<br>B.部位<br>C.机体抵抗力<br>D.是否用药<br>E.组织起源</td>
      <td>A.瘤细胞分化成熟程度</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>38. 下列哪项一般不是良性肿瘤特征(2.0分)</td>
      <td>A.不转移<br>B.生长慢<br>C.有包膜<br>D.浸润性生长<br>E.细胞分化好</td>
      <td>D.浸润性生长</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>39. 肿瘤组织分化程度愈高(2.0分)</td>
      <td>A.恶性程度愈低<br>B.转移愈早<br>C.恶性程度愈高<br>D.对放射愈敏感<br>E.预后愈差</td>
      <td>A.恶性程度愈低</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>40. 下列哪种良性肿瘤呈浸润性生长(2.0分)</td>
      <td>A.乳头状瘤<br>B.血管瘤<br>C.脂肪瘤<br>D.骨瘤<br>E.平滑肌瘤</td>
      <td>B.血管瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>41. 多形性腺瘤多见于(2.0分)</td>
      <td>A.肾<br>B.乳腺<br>C.涎腺<br>D.肺<br>E.甲状腺</td>
      <td>C.涎腺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>42. 下列哪项属于良性肿瘤?(2.0分)</td>
      <td>A.神经母细胞瘤<br>B.肾母细胞瘤<br>C.视网膜母细胞瘤<br>D.软骨母细胞瘤<br>E.肺母细胞瘤</td>
      <td>D.软骨母细胞瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>43. 胃肠间质瘤（GIST）生物学行为的判断主要依据(2.0分)</td>
      <td>A.肿瘤是否伴有神经分化<br>B.肿瘤发生部位<br>C.肿瘤的体积和核分裂的多少<br>D.肿瘤细胞的异型性<br>E.肿瘤与周围边界是否清楚</td>
      <td>C.肿瘤的体积和核分裂的多少</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>44. 乳腺癌最好发于乳房的(2.0分)</td>
      <td>A.外下象限<br>B.中央部<br>C.内下象限<br>D.内上象限<br>E.外上象限</td>
      <td>E.外上象限</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>45. 诊断鳞状细胞癌最可靠的依据是(2.0分)</td>
      <td>A.细胞多角形或梭形，胞浆红染<br>B.找到细胞间桥和角化<br>C.发生于被覆鳞状上皮的部位<br>D.形态类似鳞状上皮细胞<br>E.细胞呈巢状排列</td>
      <td>B.找到细胞间桥和角化</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>46. 下列肿瘤中，易复发的是(2.0分)</td>
      <td>A.唾腺多形性腺瘤<br>B.脂肪瘤<br>C.平滑肌瘤<br>D.乳腺纤维腺瘤<br>E.骨瘤</td>
      <td>A.唾腺多形性腺瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>47. 下列哪一项不是乳头状瘤的形态特点：(2.0分)</td>
      <td>A.乳头有结缔组织构成的中心索<br>B.基底膜完整，不向深层浸润<br>C.表面覆盖的上皮可以为鳞状上皮、腺上皮或泌尿上皮等<br>D.外耳道、膀胱等部位的乳头状瘤较易复发<br>E.细胞有明显异型性</td>
      <td>E.细胞有明显异型性</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>48. 下列哪项不是腺癌的好发部位？(2.0分)</td>
      <td>A.食管<br>B.胃肠道<br>C.乳腺<br>D.宫体<br>E.肝</td>
      <td>A.食管</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>49. 能引起血清中AFP升高的肿瘤是(2.0分)</td>
      <td>A.肝细胞性肝癌<br>B.胃腺癌<br>C.胰腺癌<br>D.大肠癌<br>E.胆管细胞癌</td>
      <td>A.肝细胞性肝癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2007</td>
      <td>50. 早期容易经淋巴道转移的是(2.0分)</td>
      <td>A.甲状腺乳头状癌<br>B.绒毛膜上皮癌<br>C.肾细胞癌<br>D.骨肉瘤<br>E.肝癌</td>
      <td>A.甲状腺乳头状癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>1. 乳腺癌最好发于乳房的(2.0分)</td>
      <td>A.内上象限<br>B.外下象限<br>C.内下象限<br>D.外上象限<br>E.中央部</td>
      <td>D.外上象限</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>2. 下列说法正确的是(2.0分)</td>
      <td>A.肿瘤只有在显微镜下才可诊断<br>B.肿瘤通常大小较一致<br>C.肿瘤通常为多发<br>D.肿瘤的大小与肿瘤的性质和发生部位等有关<br>E.黑色素瘤通常不发生转移</td>
      <td>D.肿瘤的大小与肿瘤的性质和发生部位等有关</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>3. 肿瘤细胞免疫逃逸的机制不包括(2.0分)</td>
      <td>A.肿瘤细胞的"漏逸"<br>B.释放免疫抑制性物质<br>C.缺乏共刺激分子<br>D.以上都不是</td>
      <td>D.以上都不是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>4. 关于Tumor-Associated Antigens (TAA)最准确的描述(2.0分)</td>
      <td>A.They are antigens found only in tumor cells<br>B.They are the result of genes mutated by DNA-damaging carcinogens such as MNNG<br>C.They are typically the products of tumor suppressor genes; an example would be Rb<br>D.They can be found in both tumor and some normal cells, but the level is significantly higher in the tumor cells<br>E.They are typically encoded by oncogenic viruses such as EBV</td>
      <td>D.They can be found in both tumor and some normal cells, but the level is significantly higher in the tumor cells</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>5. 在抗肿瘤免疫应答中，CTL主要发挥什么样的功能(2.0分)</td>
      <td>A.产生活性氧，破坏肿瘤细胞膜<br>B.通过ADCC杀伤肿瘤<br>C.通过分泌IFN- 和IL-2，活化巨噬细胞<br>D.通过穿孔素和颗粒酶杀伤肿瘤细胞，诱导肿瘤细胞发生凋亡<br>E.产生肿瘤特异性的抗体</td>
      <td>D.通过穿孔素和颗粒酶杀伤肿瘤细胞，诱导肿瘤细胞发生凋亡</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>6. 什么是抗原调变(2.0分)</td>
      <td>A.肿瘤细胞表面的抗原与正常细胞的膜分子差异很小<br>B.肿瘤细胞表面抗原表位减少或丢失，从而使肿瘤细胞避免宿主免疫系统的杀伤<br>C.肿瘤细胞MHC-Ⅰ类抗原表达下降，逃避CTL的攻击<br>D.肿瘤细胞不表达MHC-II类抗原</td>
      <td>B.肿瘤细胞表面抗原表位减少或丢失，从而使肿瘤细胞避免宿主免疫系统的杀伤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>7. 下列陈述中哪一项是不正确的(2.0分)</td>
      <td>A.大的肿瘤通常生长缓慢、生长时间较长，且多为良性。<br>B.瘤细胞多于间质的肿瘤一般较硬。<br>C.肿瘤的硬度通常和肿瘤的种类有关。<br>D.恶性肿瘤多呈浸润性生长。<br>E.瘤组织发生坏死时变软。</td>
      <td>B.瘤细胞多于间质的肿瘤一般较硬。</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>8. 病理诊断肉瘤的主要依据是 (2.0分)</td>
      <td>A.间质稀少<br>B.瘤细胞呈弥散分布<br>C.有肺转移<br>D.血液供应丰富<br>E.浸润性生长</td>
      <td>B.瘤细胞呈弥散分布</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>9. 角化珠见于(2.0分)</td>
      <td>A.恶性畸胎瘤<br>B.基底细胞癌<br>C.尿路上皮癌<br>D.腺癌<br>E.鳞状细胞癌</td>
      <td>E.鳞状细胞癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>10. 肿瘤细胞主要通过什么机制来抵抗凋亡(2.0分)</td>
      <td>A.某些肿瘤能表达非经典的Ⅰ类分子<br>B.肿瘤细胞膜表面Fas表达显著减少或丢失，而FasL的表达增强<br>C.肿瘤细胞分泌IL-10<br>D.表达mCRP(膜结合补体调节蛋白)分子</td>
      <td>B.肿瘤细胞膜表面Fas表达显著减少或丢失，而FasL的表达增强</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>11. 下列哪项不是决定肿瘤生长快慢的因素：(2.0分)</td>
      <td>A.肿瘤倍增时间<br>B.肿瘤生长分数<br>C.肿瘤生成与丢失<br>D.肿瘤血管形成<br>E.肿瘤组织来源</td>
      <td>E.肿瘤组织来源</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>12. 机体对抗肿瘤的免疫应答机制包括(2.0分)</td>
      <td>A.ADCC<br>B.T细胞介导的细胞毒性<br>C.CDC<br>D.以上都是</td>
      <td>D.以上都是</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>13. 放线菌素D对处于哪一期的肿瘤细胞作用较强？(2.0分)</td>
      <td>A.G2期<br>B.G0期<br>C.G1期<br>D.S期<br>E.M期</td>
      <td>C.G1期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>14. 纤维腺瘤最常见于(2.0分)</td>
      <td>A.皮下组织<br>B.乳腺<br>C.卵巢<br>D.消化道<br>E.胃肠道</td>
      <td>B.乳腺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>15. 肿瘤性增生与非肿瘤性增生的根本区别是： (2.0分)</td>
      <td>A.有核分裂象<br>B.有纤维母细胞，炎症细胞浸润<br>C.细胞不同程度失去了分化能力<br>D.有肿块形成<br>E.生长迅速</td>
      <td>C.细胞不同程度失去了分化能力</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>16. 血道转移的确切根据是：(2.0分)</td>
      <td>A.瘤细胞栓塞于远隔器官<br>B.在远隔器官形成了与原发瘤同样类型的肿瘤<br>C.血液中发现了瘤细胞<br>D.瘤细胞进入了静脉<br>E.瘤细胞进入了动脉</td>
      <td>B.在远隔器官形成了与原发瘤同样类型的肿瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>17. 关于良恶性肿瘤说法正确的是： (2.0分)</td>
      <td>A.良性肿瘤患者可出现恶病质<br>B.良性肿瘤因浸润而产生压迫和阻塞症状<br>C.恶性肿瘤主要浸润破坏组织，一般没有压迫和阻塞症状<br>D.恶性肿瘤也可有压迫和阻塞等良性肿瘤的症状<br>E.以上都不是</td>
      <td>D.恶性肿瘤也可有压迫和阻塞等良性肿瘤的症状</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>18. 交界性肿瘤是：(2.0分)</td>
      <td>A.癌前病变<br>B.混合性肿瘤<br>C.性质介于良、恶性之间的肿瘤<br>D.介乎于肿瘤与非肿瘤之间的肿块组织<br>E.分化好的恶性瘤</td>
      <td>C.性质介于良、恶性之间的肿瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>19. 肿瘤的异质化是指：(2.0分)</td>
      <td>A.肿瘤细胞生长过程中形成新的亚克隆过程<br>B.一种肿瘤转变为另一种性质的肿瘤<br>C.肿瘤变得越来越恶性过程<br>D.恶性肿瘤变的良性化过程<br>E.以上都不对</td>
      <td>A.肿瘤细胞生长过程中形成新的亚克隆过程</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>20. 下列哪种是肿瘤细胞产生的对免疫细胞有抑制作用的细胞因子(2.0分)</td>
      <td>A.TGF-<br>B.B7<br>C.P53<br>D.FasL<br>E.MHC</td>
      <td>A.TGF-</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>21. 肿瘤血道转移的确切证据是(2.0分)</td>
      <td>A.恶性肿瘤细胞侵入动脉<br>B.血液中查见肿瘤细胞<br>C.肿瘤细胞栓塞于远隔器官<br>D.恶性肿瘤细胞侵入静脉<br>E.在远隔器官形成同一类型的肿瘤</td>
      <td>E.在远隔器官形成同一类型的肿瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>22. 肿瘤组织分化程度越低，则 (2.0分)</td>
      <td>A.预后越好<br>B.恶性程度越低<br>C.异型性越大<br>D.对放疗越不敏感<br>E.与起源组织越相似</td>
      <td>C.异型性越大</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>23. 对长春新碱的叙述，下列哪项是错误的？ (2.0分)</td>
      <td>A.主要作用于M期细胞<br>B.能够抑制微管聚合，影响纺锤丝形成<br>C.对外周神经系统毒性较小<br>D.对儿童急性淋巴细胞性白血病疗效好<br>E.可干扰蛋白质合成和RNA多聚酶</td>
      <td>C.对外周神经系统毒性较小</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>24. 伴有心功能不全的肿瘤病人不宜应用哪一个抗癌药?(2.0分)</td>
      <td>A.Cytarabine（Ara-C）<br>B.Methotrexate（MTX）<br>C.Mercaptopurine（6-MP）<br>D.Doxorubicin（adriamycin, ADM）<br>E.Cisplatin（DDP）</td>
      <td>D.Doxorubicin（adriamycin, ADM）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>25. 肉瘤是指(2.0分)</td>
      <td>A.平滑肌来源的恶性肿瘤<br>B.横纹肌来源的恶性肿瘤<br>C.间叶组织来源的恶性肿瘤<br>D.神经组织来源的恶性肿瘤<br>E.间叶组织来源的良性肿瘤</td>
      <td>C.间叶组织来源的恶性肿瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>26. 交界性肿瘤是指(2.0分)</td>
      <td>A.癌前病变<br>B.介于良性和恶性肿瘤之间的肿瘤<br>C.同时具有癌和肉瘤结构的肿瘤<br>D.发生于表皮与真皮交界处的肿瘤<br>E.以上都不是</td>
      <td>B.介于良性和恶性肿瘤之间的肿瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>27. 哪种肿瘤属于良性肿瘤? (2.0分)</td>
      <td>A.视网膜母细胞瘤<br>B.精原细胞瘤<br>C.黑色素瘤<br>D.尤文氏瘤<br>E.软骨母细胞瘤</td>
      <td>E.软骨母细胞瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>28. 原位癌最常发现的部位是(2.0分)</td>
      <td>A.食管<br>B.胃<br>C.升结肠<br>D.小肠<br>E.横结肠</td>
      <td>A.食管</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>29. 下列肿瘤中易复发的是(2.0分)</td>
      <td>A.脂肪瘤<br>B.涎腺多形性腺瘤<br>C.乳腺纤维腺瘤<br>D.子宫平滑肌瘤<br>E.骨瘤</td>
      <td>B.涎腺多形性腺瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>30. 关于肿瘤的免疫逃逸机制，下列哪项是错误的(2.0分)</td>
      <td>A.宿主处于免疫缺陷状态<br>B.瘤细胞缺乏抗原性表位<br>C.瘤细胞不表达B7分子<br>D.瘤细胞表面MHCⅠ类分子表达降低或缺失<br>E.瘤细胞不表达转铁蛋白受体</td>
      <td>E.瘤细胞不表达转铁蛋白受体</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>31. 甲氨蝶呤抗肿瘤的主要机制是(2.0分)</td>
      <td>A.抑制二氢叶酸还原酶<br>B.抑制肿瘤细胞的蛋白质合成<br>C.阻碍肿瘤细胞的嘌呤合成代谢<br>D.干扰肿瘤细胞的RNA转录<br>E.阻止转录细胞的DNA复制</td>
      <td>A.抑制二氢叶酸还原酶</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>32. 高分化鳞癌的组织学特点是(2.0分)</td>
      <td>A.无细胞间桥<br>B.实质与间质分界清楚<br>C.基底膜完整<br>D.有癌巢形成<br>E.有角化珠形成</td>
      <td>E.有角化珠形成</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>33. 淋巴结转移癌的诊断依据是(2.0分)</td>
      <td>A.淋巴结的正常结构被破坏<br>B.淋巴结内形成癌巢<br>C.淋巴结肿大、变硬<br>D.淋巴结内出现异型细胞<br>E.淋巴结切面有坏死</td>
      <td>B.淋巴结内形成癌巢</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>34. 可使肿瘤细胞集中于G1期，常作同步化治疗的药物是 (2.0分)</td>
      <td>A.羟基脲<br>B.放线菌素D<br>C.博来霉素<br>D.环磷酰胺<br>E.长春碱</td>
      <td>A.羟基脲</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>35. 关于恶性黑色素瘤，下列哪项叙述不正确？ (2.0分)</td>
      <td>A.多通过交界痣恶变而来<br>B.高度恶性<br>C.肿瘤细胞内必定含有黑色素<br>D.通过淋巴道和血道均可发生转移<br>E.免疫组化HMB-45染色阳性</td>
      <td>C.肿瘤细胞内必定含有黑色素</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>36. 下列哪项不是癌前病变？(2.0分)</td>
      <td>A.结肠腺瘤性息肉<br>B.纤维囊性乳腺病<br>C.慢性萎缩性胃炎<br>D.胃溃疡<br>E.慢性肥厚性胃炎</td>
      <td>E.慢性肥厚性胃炎</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>37. 周期非特异性抗恶性肿瘤药对下列哪期肿瘤细胞不敏感 (2.0分)</td>
      <td>A.G1期<br>B.G0期<br>C.S期<br>D.G2期<br>E.M期</td>
      <td>B.G0期</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>38. 关于环磷酰胺的叙述，下列哪项是错误的？ (2.0分)</td>
      <td>A.体外无抗肿瘤作用<br>B.其代谢产物对肾脏、膀胱有刺激性，可致出血性膀胱炎<br>C.须在体内转化为活性代谢产物发挥作用<br>D.抗瘤谱广，特别对恶性淋巴瘤疗效显著<br>E.选择性高，不良反应少，脱发的发生率亦较其他烷化剂低</td>
      <td>E.选择性高，不良反应少，脱发的发生率亦较其他烷化剂低</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>39. 下面属于恶性肿瘤的是：(2.0分)</td>
      <td>A.肌纤维母细胞瘤<br>B.脂肪母细胞瘤<br>C.子宫平滑肌瘤<br>D.畸胎瘤<br>E.精原细胞瘤</td>
      <td>E.精原细胞瘤</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>40. 具有骨髓抑制及心脏毒性的抗癌药为 (2.0分)</td>
      <td>A.阿霉素（ADM）<br>B.博来霉素（BLM）<br>C.丝裂霉素C（MMC）<br>D.长春新碱 (VCR)<br>E.甲氨蝶呤（MTX）</td>
      <td>A.阿霉素（ADM）</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>41. 良性肿瘤对机体的影响主要取决于肿瘤的(2.0分)</td>
      <td>A.生长部位<br>B.生长速度<br>C.有无复发<br>D.生长方式<br>E.有无转移</td>
      <td>A.生长部位</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>42. 氟尿嘧啶对下列哪种肿瘤疗效较好？ (2.0分)</td>
      <td>A.膀胱癌和肺癌<br>B.绒毛膜上皮癌<br>C.消化道癌和乳腺癌<br>D.卵巢癌<br>E.子宫颈癌</td>
      <td>C.消化道癌和乳腺癌</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>43. 烷化剂中易发生出血性膀胱炎的药物是(2.0分)</td>
      <td>A.噻替派<br>B.白消安<br>C.氮芥<br>D.环磷酰胺<br>E.顺铂</td>
      <td>D.环磷酰胺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>44. 肿瘤发生的主要免疫学机制是 (2.0分)</td>
      <td>A.免疫监视功能障碍<br>B.免疫自稳功能障碍<br>C.免疫调节功能障碍<br>D.免疫防御功能障碍<br>E.免疫功能亢进</td>
      <td>A.免疫监视功能障碍</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>45. 肺转移性肾癌是指(2.0分)</td>
      <td>A.肺癌转移到肾<br>B.肺.肾癌转移到他处<br>C.肾癌转移到肺<br>D.肺癌和肾癌相互转移<br>E.他处转移到肺肾的癌</td>
      <td>C.肾癌转移到肺</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>46. 癌与肉瘤的最主要区别是(2.0分)</td>
      <td>A.发生的年龄不同<br>B.转移的途径不同<br>C.瘤细胞的分布方式不同<br>D.肿瘤内血管多少不同<br>E.组织来源不同</td>
      <td>E.组织来源不同</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>47. 肿瘤可诱导哪种抑制性细胞亚群来抑制免疫应答(2.0分)</td>
      <td>A.B细胞<br>B.CTL（细胞毒性T细胞）<br>C.调节性T细胞<br>D.都不是</td>
      <td>C.调节性T细胞</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>48. 决定肿瘤生长速度最为重要的是(2.0分)</td>
      <td>A.瘤组织内血管密度<br>B.生长分数<br>C.瘤细胞的生成与丢失<br>D.瘤细胞倍增时间<br>E.肿瘤的性质</td>
      <td>B.生长分数</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>49. 肿瘤的异型性是指(2.0分)</td>
      <td>A.良、恶性肿瘤之间的差异<br>B.癌与肉瘤之间的差异<br>C.肿瘤实质与间质之间的差异<br>D.肿瘤与起源组织之间的差异<br>E.癌与癌前病变之间的差异</td>
      <td>D.肿瘤与起源组织之间的差异</td>
    </tr>
    <tr>
      <td>1</td>
      <td>9</td>
      <td>2008</td>
      <td>50. 下列哪一种是良性肿瘤 (2.0分)</td>
      <td>A.蕈样霉菌病<br>B.霍奇金病<br>C.淋巴瘤<br>D.绒毛膜癌<br>E.成熟性囊性畸胎瘤</td>
      <td>E.成熟性囊性畸胎瘤</td>
    </tr>
  </tbody>
</table></body>
</html>